株探米国株
英語
エドガーで原本を確認する
00015907172024FYfalseP1YP1Y1iso4217:USDxbrli:sharesiso4217:USDxbrli:sharesctre:facilityctre:bedctre:statectre:investmentctre:loanctre:segmentxbrli:purectre:Agreementctre:propertyctre:renewal_optionctre:optionctre:numberOfFacilityctre:operatorctre:numberOfPropertyctre:option_to_renewctre:leasectre:renewalOptionctre:installmentctre:renewalctre:anniversaryctre:paymentInstallmentctre:extension_optionctre:windowutr:Ratectre:reportable_segment00015907172024-01-012024-12-3100015907172024-06-3000015907172025-02-1100015907172024-10-012024-12-3100015907172024-12-3100015907172023-12-3100015907172023-01-012023-12-3100015907172022-01-012022-12-310001590717us-gaap:CommonStockMember2021-12-310001590717us-gaap:AdditionalPaidInCapitalMember2021-12-310001590717us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2021-12-310001590717us-gaap:ParentMember2021-12-310001590717us-gaap:NoncontrollingInterestMember2021-12-3100015907172021-12-310001590717us-gaap:CommonStockMember2022-01-012022-12-310001590717us-gaap:AdditionalPaidInCapitalMember2022-01-012022-12-310001590717us-gaap:ParentMember2022-01-012022-12-310001590717us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2022-01-012022-12-310001590717us-gaap:CommonStockMember2022-12-310001590717us-gaap:AdditionalPaidInCapitalMember2022-12-310001590717us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2022-12-310001590717us-gaap:ParentMember2022-12-310001590717us-gaap:NoncontrollingInterestMember2022-12-3100015907172022-12-310001590717us-gaap:CommonStockMember2023-01-012023-12-310001590717us-gaap:AdditionalPaidInCapitalMember2023-01-012023-12-310001590717us-gaap:ParentMember2023-01-012023-12-310001590717us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2023-01-012023-12-310001590717us-gaap:NoncontrollingInterestMember2023-01-012023-12-310001590717us-gaap:CommonStockMember2023-12-310001590717us-gaap:AdditionalPaidInCapitalMember2023-12-310001590717us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2023-12-310001590717us-gaap:ParentMember2023-12-310001590717us-gaap:NoncontrollingInterestMember2023-12-310001590717us-gaap:CommonStockMember2024-01-012024-12-310001590717us-gaap:AdditionalPaidInCapitalMember2024-01-012024-12-310001590717us-gaap:ParentMember2024-01-012024-12-310001590717us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2024-01-012024-12-310001590717us-gaap:NoncontrollingInterestMember2024-01-012024-12-310001590717us-gaap:CommonStockMember2024-12-310001590717us-gaap:AdditionalPaidInCapitalMember2024-12-310001590717us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember2024-12-310001590717us-gaap:ParentMember2024-12-310001590717us-gaap:NoncontrollingInterestMember2024-12-310001590717ctre:SkilledNursingAssistedLivingAndIndependentLivingFacilitiesMember2024-12-310001590717ctre:SkilledNursingAssistedLivingAndIndependentLivingFacilitiesMember2024-01-012024-12-310001590717ctre:RealEstateSecuredLoanReceivableMember2024-01-012024-12-310001590717ctre:MezzanineLoanReceivableMember2024-01-012024-12-310001590717ctre:MezzanineLoanReceivableMember2024-12-310001590717us-gaap:FinanceReceivablesMember2024-01-012024-12-310001590717us-gaap:FinanceReceivablesMember2024-12-310001590717us-gaap:LoansReceivableMember2022-01-012022-12-310001590717us-gaap:BridgeLoanMember2022-01-012022-12-310001590717us-gaap:BridgeLoanMember2023-01-012023-12-310001590717srt:MinimumMemberus-gaap:BuildingMember2024-12-310001590717srt:MaximumMemberus-gaap:BuildingMember2024-12-310001590717srt:MinimumMemberus-gaap:BuildingImprovementsMember2024-12-310001590717srt:MaximumMemberus-gaap:BuildingImprovementsMember2024-12-310001590717us-gaap:FurnitureAndFixturesMember2024-12-310001590717ctre:VariousOtherOperatorsMember2024-12-310001590717ctre:EnsignMasterLeasesMemberctre:EnsignMember2024-12-310001590717ctre:EnsignMembersrt:MinimumMember2024-12-310001590717ctre:EnsignMembersrt:MaximumMember2024-12-310001590717ctre:EnsignOtherLeasesMemberctre:EnsignMember2020-01-012020-12-3100015907172020-12-310001590717ctre:EnsignOtherLeasesMemberctre:EnsignMember2024-12-310001590717ctre:EnsignOtherLeasesMemberctre:EnsignMember2024-01-012024-12-310001590717ctre:EnsignMasterLeasesMemberctre:EnsignMember2024-01-012024-12-310001590717ctre:EnsignMasterLeasesMemberus-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMemberctre:EnsignMember2024-01-012024-12-310001590717ctre:TripleNetLeasesMemberctre:EnsignMember2024-12-312024-12-310001590717ctre:TripleNetLeasesMemberus-gaap:SubsequentEventMemberctre:EnsignMember2025-01-010001590717ctre:PennantMasterLeaseMemberctre:EnsignMember2024-12-310001590717ctre:PACSMasterLeaseMember2024-12-310001590717ctre:PACSMasterLeaseMember2024-01-012024-12-310001590717ctre:PACSMasterLeaseMembersrt:MinimumMember2024-12-310001590717ctre:PACSMasterLeaseMember2021-12-310001590717ctre:PACSMasterLeaseMember2020-12-310001590717ctre:PriorityManagementGroupLLCMember2024-12-310001590717ctre:PriorityManagementGroupLLCMembersrt:MinimumMember2024-12-310001590717ctre:PriorityManagementGroupLLCMembersrt:MaximumMember2024-12-310001590717ctre:TripleNetLeasesMemberctre:SkilledNursingMultiServiceCampusesAssistedLivingAndIndependentLivingFacilitiesMemberctre:VariousOtherOperatorsMember2024-12-310001590717ctre:SkilledNursingMultiServiceCampusesAssistedLivingAndIndependentLivingFacilitiesMemberus-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember2024-12-310001590717ctre:SkilledNursingFacilityMemberctre:PropertiesWithPurchaseOptionLeaseExpirationMarch2029NextOption2022Member2024-01-012024-12-310001590717ctre:SkilledNursingFacilityMemberctre:PropertiesWithPurchaseOptionLeaseExpirationMarch2029NextOption2022Member2024-12-310001590717ctre:SkilledNursingFacilityMemberctre:PropertiesWithPurchaseOptionLeaseExpirationNovember2034NextOption2024Member2024-01-012024-12-310001590717ctre:SkilledNursingFacilityMemberctre:PropertiesWithPurchaseOptionLeaseExpirationNovember2034NextOption2024Member2024-12-310001590717ctre:SkilledNursingAndCampusFacilitiesMemberctre:PropertiesWithPurchaseOptionLeaseExpirationOctober2032NextOption2026Member2024-01-012024-12-310001590717ctre:SkilledNursingAndCampusFacilitiesMemberctre:PropertiesWithPurchaseOptionLeaseExpirationOctober2032NextOption2026Member2024-12-310001590717ctre:SkilledNursingAndCampusFacilitiesMemberctre:PropertiesWithPurchaseOptionLeaseExpirationMay2034NextOption2026Member2024-01-012024-12-310001590717ctre:SkilledNursingAndCampusFacilitiesMemberctre:PropertiesWithPurchaseOptionLeaseExpirationMay2034NextOption2026Member2024-12-310001590717ctre:SkilledNursingAndCampusFacilitiesMemberctre:PropertiesWithPurchaseOptionLeaseExpirationMay2034NextOption2027Member2024-01-012024-12-310001590717ctre:SkilledNursingAndCampusFacilitiesMemberctre:PropertiesWithPurchaseOptionLeaseExpirationMay2034NextOption2027Member2024-12-310001590717ctre:SkilledNursingFacilityMemberctre:PropertiesWithPurchaseOptionLeaseExpirationNovember2034NextOption2027Member2024-01-012024-12-310001590717ctre:SkilledNursingFacilityMemberctre:PropertiesWithPurchaseOptionLeaseExpirationNovember2034NextOption2027Member2024-12-310001590717ctre:SkilledNursingFacilityMemberctre:PropertiesWithPurchaseOptionLeaseExpirationNovember2039NextOption2027Member2024-01-012024-12-310001590717ctre:SkilledNursingFacilityMemberctre:PropertiesWithPurchaseOptionLeaseExpirationNovember2039NextOption2027Member2024-12-310001590717ctre:SkilledNursingFacilityMemberctre:PropertiesWithPurchaseOptionLeaseExpirationNovember2039NextOption2028Member2024-01-012024-12-310001590717ctre:SkilledNursingFacilityMemberctre:PropertiesWithPurchaseOptionLeaseExpirationNovember2039NextOption2028Member2024-12-310001590717ctre:SkilledNursingFacilityMemberctre:PropertiesWithPurchaseOptionLeaseExpirationNovember2039NextOption2029Member2024-01-012024-12-310001590717ctre:SkilledNursingFacilityMemberctre:PropertiesWithPurchaseOptionLeaseExpirationNovember2039NextOption2029Member2024-12-310001590717ctre:SkilledNursingFacilityMemberctre:PropertiesWithPurchaseOptionLeaseExpirationNovember2039NextOption2030Member2024-01-012024-12-310001590717ctre:SkilledNursingFacilityMemberctre:PropertiesWithPurchaseOptionLeaseExpirationNovember2039NextOption2030Member2024-12-310001590717ctre:SkilledNursingAndCampusFacilitiesMembersrt:MinimumMember2024-12-310001590717ctre:SkilledNursingAndCampusFacilitiesMembersrt:MaximumMember2024-12-310001590717ctre:SkilledNursingAndCampusFacilitiesMemberctre:PropertiesWithPurchaseOptionLeaseExpirationMay2034NextOption2027Membersrt:MinimumMember2024-12-310001590717ctre:SkilledNursingAndCampusFacilitiesMemberctre:PropertiesWithPurchaseOptionLeaseExpirationMay2034NextOption2027Membersrt:MaximumMember2024-12-310001590717ctre:SkilledNursingFacilityMemberctre:PropertiesWithPurchaseOptionLeaseExpirationNovember2039NextOption2028Membersrt:MinimumMember2024-12-310001590717ctre:SkilledNursingFacilityMemberctre:PropertiesWithPurchaseOptionLeaseExpirationNovember2039NextOption2028Membersrt:MaximumMember2024-12-310001590717ctre:SkilledNursingFacilityMemberctre:PropertiesWithPurchaseOptionLeaseExpirationNovember2039NextOption2029Membersrt:MinimumMember2024-12-310001590717ctre:SkilledNursingFacilityMemberctre:PropertiesWithPurchaseOptionLeaseExpirationNovember2039NextOption2029Membersrt:MaximumMember2024-12-310001590717ctre:LeaseIncomeOperatingExpenseReimbursementsMember2022-01-012022-12-310001590717ctre:LeaseIncomeContractualRentMember2022-01-012022-12-310001590717ctre:LeaseIncomeStraightLineRentMember2022-01-012022-12-310001590717ctre:SkilledNursingPropertiesMember2024-01-012024-12-310001590717ctre:MultiServiceCampusPropertiesMember2024-01-012024-12-310001590717ctre:AssistedLivingFacilitiesAndIndependentLivingFacilitiesMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMember2023-01-012023-12-310001590717ctre:MultiServiceCampusPropertiesMember2023-01-012023-12-310001590717ctre:AssistedLivingFacilitiesAndIndependentLivingFacilitiesMember2023-01-012023-12-310001590717ctre:SkilledNursingPropertiesMember2022-01-012022-12-310001590717ctre:MultiServiceCampusPropertiesMember2022-01-012022-12-310001590717ctre:SkilledNursingPropertiesMember2024-12-310001590717ctre:MultiServiceCampusPropertiesMember2024-12-310001590717ctre:AcquisitionOneYearMember2024-12-310001590717ctre:AcquisitionTwoYearMemberMember2024-12-310001590717ctre:AcquisitionThreeYearMember2024-12-310001590717ctre:JointVentureMember2024-01-012024-12-310001590717ctre:AssistedLivingFacilityMemberctre:JaybirdSeniorLivingInc.Member2024-08-012024-08-010001590717ctre:JaybirdLeaseMember2024-08-010001590717ctre:JaybirdLeaseMember2024-01-012024-12-310001590717ctre:JaybirdLeaseMember2024-08-012024-08-010001590717ctre:MasterLeaseTerminationMemberus-gaap:SubsequentEventMember2025-01-010001590717ctre:PACSMasterLeaseMemberctre:SkilledNursingFacilityMember2024-11-012024-11-010001590717ctre:PACSMasterLeaseMember2024-11-010001590717ctre:PACSMasterLeaseMember2024-11-012024-11-010001590717ctre:MasterLeaseTerminationMemberctre:SkilledNursingPropertiesMember2024-09-010001590717ctre:MasterLeaseTerminationMember2024-09-010001590717ctre:EnsignAmendedTripleNetMasterLeaseMember2024-09-010001590717ctre:SkilledNursingFacilityMemberctre:EnsignMember2024-09-010001590717ctre:MasterLeaseTerminationMemberctre:SkilledNursingPropertiesMember2024-08-010001590717ctre:JaybirdLeaseMember2024-12-310001590717ctre:MasterLeaseTerminationMember2024-07-310001590717ctre:NewBayshireLeaseMemberctre:SkilledNursingFacilityMember2024-04-012024-04-010001590717ctre:NewBayshireLeaseMember2024-04-010001590717ctre:NewBayshireLeaseMember2024-12-010001590717ctre:NewBayshireLeaseMemberctre:AssistedLivingFacilityMember2024-04-012024-04-010001590717ctre:NewBayshireLeaseMember2024-04-012024-04-010001590717ctre:SkilledNursingPropertiesMember2024-03-012024-03-010001590717ctre:EnsignAmendedTripleNetMasterLeaseMember2024-03-010001590717ctre:SkilledNursingFacilityMemberctre:EnsignMember2024-03-010001590717ctre:EduroAmendedTripleNetMasterLeaseMember2024-03-010001590717ctre:NewEmbassyLeaseAgreementMemberctre:MultiServiceCampusPropertiesMember2024-01-010001590717ctre:SkilledNursingFacilityMemberctre:NewEmbassyLeaseAgreementMember2024-03-010001590717ctre:NewEmbassyLeaseAgreementMember2024-03-010001590717ctre:HillstoneLeaseAmendmentAndTerminationMember2023-03-242023-03-240001590717ctre:HillstoneLeaseAmendmentAndTerminationMember2023-12-310001590717ctre:HillstoneLeaseAmendmentAndTerminationMember2023-12-312023-12-310001590717ctre:NobleNJLeaseTerminationAndNewRidgelineNJLeaseMember2023-10-240001590717ctre:PremierTerminationAndAmendedRidgelineLeaseMemberctre:AssistedLivingFacilityMember2023-09-010001590717ctre:PremierTerminationAndAmendedRidgelineLeaseMember2023-09-010001590717ctre:PremierTerminationAndAmendedRidgelineLeaseMember2023-09-012023-09-010001590717ctre:AmendedPennantLeaseMember2023-07-060001590717ctre:AmendedMomentumLeaseMemberctre:SkilledNursingFacilityMember2023-04-012023-04-010001590717ctre:AmendedMomentumLeaseMemberctre:SkilledNursingFacilityMember2023-04-010001590717ctre:AmendedMomentumLeaseMember2023-04-010001590717ctre:NobleVALeaseTerminationAndNewPennantLeaseMemberctre:AssistedLivingFacilityMember2023-03-160001590717ctre:NobleVALeaseTerminationAndNewPennantLeaseMember2023-03-150001590717ctre:NobleVALeaseTerminationAndNewPennantLeaseMember2023-03-160001590717ctre:NobleVALeaseTerminationAndNewPennantLeaseMember2023-03-162023-03-160001590717stpr:FLctre:AssistedLivingFacilityMember2022-08-310001590717stpr:FLctre:AssistedLivingFacilityMember2022-06-300001590717stpr:MDctre:AssistedLivingFacilityMember2022-06-300001590717stpr:MDctre:AssistedLivingFacilityMember2022-08-310001590717ctre:AssistedLivingFacilityMember2022-06-300001590717ctre:AssistedLivingFacilityMember2022-08-310001590717ctre:LandmarkMarylandMember2022-08-310001590717ctre:LandmarkMarylandMembersrt:MinimumMember2022-08-012022-08-310001590717ctre:LandmarkMarylandMembersrt:MaximumMember2022-08-012022-08-310001590717ctre:NobleAmendedMasterLeasesMember2022-08-310001590717ctre:AssistedLivingFacilityMemberctre:EnsignMember2022-04-010001590717ctre:TripleNetLeasesMemberctre:EnsignMember2022-04-010001590717ctre:EnsignAmendedTripleNetMasterLeaseMember2022-04-010001590717ctre:EnsignAmendedTripleNetMasterLease2Member2022-04-010001590717ctre:EnsignAmendedTripleNetMasterLeaseCombinedMember2022-04-010001590717ctre:AssistedLivingFacilityMemberctre:EnsignMember2022-03-010001590717ctre:EnsignAmendedTripleNetMasterLeaseMember2022-03-010001590717ctre:SkilledNursingFacilityMember2022-02-012022-02-010001590717ctre:EduroAmendedTripleNetMasterLeaseMember2022-02-010001590717ctre:WLCManagementFirmAmendedTripleNetMasterLeaseMember2022-03-012022-03-010001590717ctre:WLCManagementFirmAmendedTripleNetMasterLeaseMember2022-03-010001590717us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember2024-01-012024-12-310001590717ctre:HeldForInvestmentMember2024-01-012024-12-310001590717us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2024-01-012024-12-310001590717us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember2023-01-012023-12-310001590717ctre:HeldForInvestmentMember2023-01-012023-12-310001590717us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2023-01-012023-12-310001590717us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember2022-01-012022-12-310001590717ctre:HeldForInvestmentMember2022-01-012022-12-310001590717us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2022-01-012022-12-310001590717us-gaap:FairValueInputsLevel3Memberctre:FacilitiesHeldForSaleMember2024-12-310001590717us-gaap:FairValueInputsLevel3Memberus-gaap:MarketApproachValuationTechniqueMembersrt:MinimumMember2024-12-310001590717us-gaap:FairValueInputsLevel3Memberus-gaap:MarketApproachValuationTechniqueMembersrt:MaximumMember2024-12-310001590717us-gaap:FairValueInputsLevel3Memberus-gaap:MarketApproachValuationTechniqueMembersrt:WeightedAverageMember2024-12-310001590717us-gaap:FairValueInputsLevel3Memberus-gaap:MarketApproachValuationTechniqueMembersrt:MinimumMember2023-12-310001590717us-gaap:FairValueInputsLevel3Memberus-gaap:MarketApproachValuationTechniqueMembersrt:MaximumMember2023-12-310001590717us-gaap:FairValueInputsLevel3Memberus-gaap:MarketApproachValuationTechniqueMembersrt:WeightedAverageMember2023-12-310001590717us-gaap:FairValueInputsLevel3Memberus-gaap:MarketApproachValuationTechniqueMembersrt:MinimumMember2022-12-310001590717us-gaap:FairValueInputsLevel3Memberus-gaap:MarketApproachValuationTechniqueMembersrt:MaximumMember2022-12-310001590717us-gaap:FairValueInputsLevel3Memberus-gaap:MarketApproachValuationTechniqueMembersrt:WeightedAverageMember2022-12-310001590717ctre:AssistedLivingFacilityMember2024-01-012024-12-310001590717ctre:AssistedLivingFacilityMember2024-12-310001590717ctre:HeldForInvestmentMemberctre:AssistedLivingFacilityMember2024-09-300001590717ctre:HeldForInvestmentMemberctre:AssistedLivingFacilityMember2024-07-012024-09-300001590717ctre:AssistedLivingFacilityMember2024-04-012024-06-300001590717us-gaap:FairValueInputsLevel3Memberctre:AssistedLivingFacilityMemberctre:HeldForInvestmentMemberus-gaap:MarketApproachValuationTechniqueMember2024-09-300001590717ctre:HeldForInvestmentMemberctre:AssistedLivingFacilityMember2024-01-012024-12-310001590717ctre:SkilledNursingFacilityMember2023-01-012023-12-310001590717ctre:SkilledNursingFacilityMember2023-12-310001590717us-gaap:FairValueInputsLevel3Memberctre:SkilledNursingFacilityMember2023-12-310001590717ctre:SkilledNursingFacilityMember2022-01-012022-12-310001590717ctre:SkilledNursingFacilityMember2022-12-310001590717us-gaap:FairValueInputsLevel3Memberctre:SkilledNursingFacilityMember2022-12-310001590717ctre:HeldForInvestmentMemberctre:AssistedLivingFacilityMember2022-09-300001590717ctre:HeldForInvestmentMemberctre:AssistedLivingFacilityMember2022-07-012022-09-300001590717us-gaap:FairValueInputsLevel3Memberctre:AssistedLivingFacilityMemberctre:HeldForInvestmentMemberus-gaap:MarketApproachValuationTechniqueMember2022-09-300001590717ctre:HeldForInvestmentMemberctre:AssistedLivingFacilityMember2022-01-012022-12-310001590717ctre:HeldForInvestmentMemberctre:AssistedLivingFacilityMember2022-12-310001590717ctre:HeldForInvestmentMemberctre:AssistedLivingFacilityMember2022-10-012022-12-310001590717ctre:HeldForInvestmentMemberctre:NineAssistedLivingFacilityMember2022-01-012022-12-310001590717ctre:AssistedLivingFacilityMemberctre:HeldForInvestmentMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberctre:ValuationTechniqueTerminalCapitalizationRateMember2022-12-310001590717ctre:AssistedLivingFacilityMemberctre:HeldForInvestmentMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberctre:ValuationTechniqueTerminalCapitalizationRateMember2022-12-310001590717ctre:AssistedLivingFacilityMemberctre:HeldForInvestmentMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ValuationTechniqueDiscountedCashFlowMember2022-12-310001590717ctre:AssistedLivingFacilityMemberctre:HeldForInvestmentMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ValuationTechniqueDiscountedCashFlowMember2022-12-310001590717ctre:AssistedLivingFacilitiesMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2023-06-300001590717ctre:AssistedLivingFacilitiesMemberus-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember2023-06-300001590717ctre:SkilledNursingPropertiesMemberus-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember2022-09-300001590717ctre:SkilledNursingPropertiesMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2022-09-300001590717ctre:MultiServiceCampusPropertiesMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2022-09-300001590717us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember2022-12-310001590717us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember2023-01-012023-12-310001590717us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember2023-12-310001590717us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember2024-01-012024-12-310001590717us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember2024-12-310001590717us-gaap:LoansReceivableMemberctre:SkilledNursingFacilityMemberctre:MortgageSecuredLoanReceivableMember2024-12-310001590717us-gaap:LoansReceivableMemberctre:CampusMemberctre:MortgageSecuredLoanReceivableMember2024-12-310001590717us-gaap:LoansReceivableMemberctre:AssistedLivingFacilitiesMemberctre:MortgageSecuredLoanReceivableMember2024-12-310001590717us-gaap:LoansReceivableMemberctre:IndependentLivingFacilityMemberctre:MortgageSecuredLoanReceivableMember2024-12-310001590717us-gaap:LoansReceivableMemberctre:MortgageSecuredLoanReceivableMember2024-12-310001590717us-gaap:LoansReceivableMemberctre:MortgageSecuredLoanReceivableMember2023-12-310001590717us-gaap:LoansReceivableMemberctre:SkilledNursingFacilityMemberctre:MezzanineLoanReceivableMember2024-12-310001590717us-gaap:LoansReceivableMemberctre:CampusMemberctre:MezzanineLoanReceivableMember2024-12-310001590717us-gaap:LoansReceivableMemberctre:AssistedLivingFacilitiesMemberctre:MezzanineLoanReceivableMember2024-12-310001590717us-gaap:LoansReceivableMemberctre:IndependentLivingFacilityMemberctre:MezzanineLoanReceivableMember2024-12-310001590717us-gaap:LoansReceivableMemberctre:MezzanineLoanReceivableMember2024-12-310001590717us-gaap:LoansReceivableMemberctre:MezzanineLoanReceivableMember2023-12-310001590717us-gaap:LoansReceivableMember2024-12-310001590717us-gaap:LoansReceivableMember2023-12-310001590717us-gaap:OtherInvestmentsMemberctre:PreferredEquityMember2024-12-310001590717us-gaap:OtherInvestmentsMemberctre:PreferredEquityMember2023-12-310001590717us-gaap:OtherInvestmentsMemberctre:SkilledNursingFacilityMemberctre:OtherFinancingReceivablesMember2024-12-310001590717us-gaap:OtherInvestmentsMemberctre:CampusMemberctre:OtherFinancingReceivablesMember2024-12-310001590717us-gaap:OtherInvestmentsMemberctre:AssistedLivingFacilitiesMemberctre:OtherFinancingReceivablesMember2024-12-310001590717us-gaap:OtherInvestmentsMemberctre:IndependentLivingFacilityMemberctre:OtherFinancingReceivablesMember2024-12-310001590717us-gaap:OtherInvestmentsMemberctre:OtherFinancingReceivablesMember2024-12-310001590717us-gaap:OtherInvestmentsMemberctre:OtherFinancingReceivablesMember2023-12-310001590717ctre:MortgageSecuredLoanReceivableMember2024-12-310001590717ctre:MezzanineLoanReceivableMember2024-12-310001590717ctre:MortgageSecuredLoanReceivableMember2024-01-012024-12-310001590717us-gaap:OtherInvestmentsMemberctre:OtherFinancingReceivablesMember2024-01-012024-12-310001590717ctre:OtherRealEstateRelatedInvestmentsMember2024-12-310001590717ctre:OtherRealEstateRelatedInvestmentsMember2023-12-310001590717ctre:OtherRealEstateRelatedInvestmentsMember2022-12-310001590717ctre:MortgageSecuredLoanReceivableJanuary12027MaturityMember2024-01-010001590717ctre:AssistedLivingFacilitiesMemberctre:MortgageSecuredLoanReceivableJanuary12027MaturityMember2024-01-010001590717ctre:SkilledNursingFacilityMemberctre:MezzanineLoanMember2024-01-250001590717ctre:MezzanineLoanMember2024-01-250001590717ctre:MezzanineLoanMemberus-gaap:SecuredOvernightFinancingRateSofrMember2024-01-250001590717ctre:MezzanineLoanMemberctre:SecuredOvernightFinancingRateSOFRFloorMember2024-01-250001590717ctre:SkilledNursingFacilityMemberctre:MezzanineLoanMembersrt:MinimumMember2024-01-250001590717ctre:SkilledNursingFacilityMemberctre:MezzanineLoanMembersrt:MaximumMember2024-01-250001590717ctre:SkilledNursingFacilityMemberctre:MezzanineLoanMember2024-02-010001590717ctre:MezzanineLoanMember2024-02-010001590717ctre:SkilledNursingFacilityMemberctre:MezzanineLoanMember2024-02-020001590717ctre:MezzanineLoanMember2024-02-020001590717ctre:MezzanineLoanMemberus-gaap:SecuredOvernightFinancingRateSofrMember2024-02-020001590717ctre:MezzanineLoanMemberctre:SecuredOvernightFinancingRateSOFRFloorMember2024-02-020001590717ctre:SkilledNursingFacilityMemberctre:MezzanineLoanMembersrt:MinimumMember2024-02-020001590717ctre:SkilledNursingFacilityMemberctre:MezzanineLoanMembersrt:MaximumMember2024-02-020001590717ctre:SkilledNursingFacilityMemberctre:MortgageLoanMember2024-05-010001590717ctre:MortgageLoanMember2024-05-010001590717ctre:RegionalHealthcareFacilityMemberctre:MortgageLoanMember2024-06-030001590717us-gaap:SecuredOvernightFinancingRateSofrMemberctre:RegionalHealthcareFacilityMemberctre:MortgageLoanMember2024-06-030001590717ctre:MortgageLoanMemberctre:SecuredOvernightFinancingRateSOFRFloorMember2024-06-030001590717ctre:MortgageLoanMember2024-06-0300015907172024-06-030001590717ctre:SecuredBorrowingsMember2024-07-302024-07-300001590717ctre:SkilledNursingFacilityMember2024-08-010001590717ctre:SkilledNursingFacilityMember2024-08-012024-08-010001590717stpr:MDctre:SkilledNursingFacilityAndSkilledNursingAndCampusFacilitiesMember2024-10-012024-10-010001590717stpr:MDctre:SkilledNursingFacilityMemberctre:MortgageSecuredLoanReceivableMember2024-10-010001590717stpr:MDctre:MortgageSecuredLoanReceivableMember2024-10-010001590717stpr:MDctre:MortgageSecuredLoanReceivableMembersrt:MaximumMember2024-10-012024-10-010001590717stpr:MDctre:MortgageSecuredLoanReceivableMembersrt:MinimumMember2024-10-012024-10-010001590717stpr:MDctre:MortgageSecuredLoanReceivableMember2024-10-012024-10-010001590717stpr:COctre:SkilledNursingFacilityMemberctre:MortgageSecuredLoanReceivableMember2024-10-010001590717ctre:SkilledNursingFacilityMemberctre:MortgageSecuredLoanReceivableMember2024-10-010001590717stpr:COctre:MortgageSecuredLoanReceivableMember2024-10-010001590717ctre:SkilledNursingFacilityMemberctre:MortgageSecuredLoanReceivableMembersrt:MinimumMember2024-10-010001590717ctre:SkilledNursingFacilityMemberctre:MortgageSecuredLoanReceivableMembersrt:MaximumMember2024-10-010001590717ctre:MultiServiceCampusPropertiesMemberctre:MezzanineLoanReceivableMember2024-12-200001590717ctre:SkilledNursingFacilityMemberctre:MortgageSecuredLoanReceivableMember2024-12-270001590717ctre:SkilledNursingFacilityMemberctre:MortgageSecuredLoanReceivableMember2024-12-272024-12-2700015907172023-06-010001590717ctre:AssistedLivingFacilitiesMemberctre:MortgageSecuredLoanReceivableMay312024MaturityMember2023-06-010001590717ctre:MortgageSecuredLoanReceivableMay312024MaturityMember2023-06-012023-06-010001590717ctre:SkilledNursingFacilityMemberctre:MortgageSecuredLoanReceivableMember2023-06-290001590717ctre:SkilledNursingFacilityMemberctre:MortgageSecuredLoanReceivableJune292033MaturityMember2023-06-290001590717ctre:IndependentLivingFacilitiesMemberctre:MortgageSecuredLoanReceivableJune292033MaturityMember2023-06-290001590717ctre:SkilledNursingFacilityMemberctre:MortgageSecuredLoanReceivableJune292033MaturityMembersrt:MinimumMember2023-06-290001590717ctre:SkilledNursingFacilityMemberctre:MortgageSecuredLoanReceivableJune292033MaturityMembersrt:MaximumMember2023-06-290001590717ctre:SkilledNursingFacilityMemberctre:MortgageSecuredLoanReceivableAugust12028MaturityMember2023-07-170001590717ctre:SkilledNursingFacilityMemberctre:MortgageSecuredLoanReceivableAugust12028MaturityMember2023-07-172023-07-170001590717ctre:SkilledNursingFacilityMemberctre:MortgageSecuredLoanReceivableAugust12028MaturityMembersrt:MinimumMember2023-07-170001590717ctre:SkilledNursingFacilityMemberctre:MortgageSecuredLoanReceivableAugust12028MaturityMembersrt:MaximumMember2023-07-170001590717ctre:MultiTrancheFacilitiesMemberctre:MortgageSecuredLoanReceivableSeptember292026MaturityMember2023-09-290001590717ctre:MortgageSecuredLoanReceivableSeptember292026MaturityMember2023-09-290001590717ctre:SkilledNursingFacilityMemberctre:MortgageSecuredLoanReceivableSeptember292026MaturityMember2023-09-290001590717ctre:SkilledNursingFacilityMemberctre:MortgageSecuredLoanReceivableSeptember292026MaturityMember2023-09-292023-09-290001590717ctre:SkilledNursingFacilityMemberctre:MortgageSecuredLoanReceivableSeptember292026MaturityMembersrt:MinimumMember2023-09-290001590717ctre:SkilledNursingFacilityMemberctre:MortgageSecuredLoanReceivableSeptember292026MaturityMembersrt:MaximumMember2023-09-290001590717ctre:MortgageSecuredLoanReceivableSeptember292026MaturityMember2023-11-290001590717ctre:AssistedLivingFacilitiesMemberctre:MortgageSecuredLoanReceivableSeptember292026MaturityMember2023-11-290001590717ctre:SkilledNursingFacilityMemberctre:MortgageSecuredLoanReceivableSeptember292026MaturityMember2023-11-292023-11-290001590717ctre:MortgageSecuredLoanReceivableSeptember292026MaturityMember2023-11-292023-11-290001590717ctre:RealEstateSecuredLoanReceivableMember2023-12-012023-12-310001590717ctre:RealEstateSecuredLoanReceivableMember2023-12-152023-12-150001590717ctre:RealEstateSecuredLoanReceivableMember2022-08-310001590717ctre:MezzanineLoanReceivableMember2023-03-302023-03-300001590717ctre:SkilledNursingFacilityMember2020-12-310001590717ctre:RealEstateSecuredLoanReceivableMemberctre:NextWVRealtyLLCMember2022-06-300001590717ctre:NextWVRealtyLLCMember2022-06-012022-06-300001590717ctre:MezzanineLoanReceivableMemberctre:NextWVRealtyLLCMember2022-06-300001590717ctre:RealEstateSecuredLoanReceivableMemberctre:NextWVRealtyLLCMembersrt:MinimumMember2022-06-300001590717ctre:RealEstateSecuredLoanReceivableMemberctre:NextWVRealtyLLCMembersrt:MaximumMember2022-06-300001590717ctre:SkilledNursingFacilityMemberctre:BTrancheMortgageLoanMember2022-08-3100015907172022-08-310001590717ctre:RealEstateSecuredLoanReceivableMember2022-08-012022-08-310001590717ctre:RealEstateSecuredLoanReceivableMembersrt:MinimumMember2022-08-310001590717ctre:RealEstateSecuredLoanReceivableMembersrt:MaximumMember2022-08-310001590717ctre:RealEstateSecuredLoanReceivableMembersrt:WeightedAverageMember2022-08-310001590717ctre:RealEstateSecuredLoanReceivableMember2024-12-012024-12-310001590717ctre:RealEstateSecuredLoanReceivableMember2022-09-300001590717ctre:SkilledNursingFacilityMember2022-09-012022-09-300001590717ctre:RealEstateSecuredLoanReceivableMember2022-09-012022-09-300001590717ctre:RealEstateSecuredLoanReceivableMembersrt:MinimumMember2022-09-300001590717ctre:RealEstateSecuredLoanReceivableMembersrt:MaximumMember2022-09-300001590717ctre:RealEstateSecuredLoanReceivableMembersrt:WeightedAverageMember2022-09-3000015907172024-06-032024-06-030001590717ctre:MortgageSecuredLoanReceivableSeptember292026MaturityMemberctre:E3AcquisitionLLCMember2023-12-012023-12-310001590717us-gaap:OtherInvestmentsMemberctre:OtherFinancingReceivablesMember2024-12-050001590717ctre:NewCascadeLeaseMember2024-12-052024-12-050001590717ctre:NewCascadeLeaseMember2024-12-012024-12-010001590717us-gaap:LoansReceivableMember2024-12-310001590717us-gaap:LoansReceivableMember2023-12-310001590717us-gaap:LoansReceivableMember2023-01-012023-12-310001590717us-gaap:LoansReceivableMember2022-01-012022-12-310001590717ctre:SkilledNursingFacilityMemberus-gaap:LoansReceivableMember2022-01-012022-12-310001590717ctre:MultiServiceCampusPropertiesMemberus-gaap:LoansReceivableMember2022-01-012022-12-310001590717ctre:TrioHealthcareHoldingsLLCMemberctre:SkilledNursingFacilityMemberus-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember2022-12-310001590717ctre:TrioHealthcareHoldingsLLCMemberctre:MultiServiceCampusPropertiesMemberus-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember2022-12-310001590717ctre:MortgageSecuredLoanReceivableMember2023-01-012023-12-310001590717ctre:MortgageSecuredLoanReceivableMember2022-01-012022-12-310001590717ctre:MezzanineLoanReceivableMember2024-01-012024-12-310001590717ctre:MezzanineLoanReceivableMember2023-01-012023-12-310001590717ctre:MezzanineLoanReceivableMember2022-01-012022-12-310001590717ctre:PreferredEquityInvestmentsMember2024-01-012024-12-310001590717ctre:PreferredEquityInvestmentsMember2023-01-012023-12-310001590717ctre:PreferredEquityInvestmentsMember2022-01-012022-12-310001590717us-gaap:LoansReceivableMember2024-01-012024-12-310001590717ctre:OtherFinancingReceivablesMember2024-01-012024-12-310001590717ctre:OtherFinancingReceivablesMember2023-01-012023-12-310001590717ctre:OtherFinancingReceivablesMember2022-01-012022-12-310001590717ctre:OtherLoansReceivableMember2024-01-012024-12-310001590717ctre:OtherLoansReceivableMember2023-01-012023-12-310001590717ctre:OtherLoansReceivableMember2022-01-012022-12-310001590717us-gaap:FairValueInputsLevel1Memberctre:MortgageSecuredLoanReceivableMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001590717us-gaap:FairValueInputsLevel2Memberctre:MortgageSecuredLoanReceivableMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001590717us-gaap:FairValueInputsLevel3Memberctre:MortgageSecuredLoanReceivableMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001590717us-gaap:FairValueMeasurementsRecurringMemberctre:MortgageSecuredLoanReceivableMember2024-12-310001590717us-gaap:FairValueInputsLevel1Memberctre:MezzanineLoanReceivableMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001590717us-gaap:FairValueInputsLevel2Memberctre:MezzanineLoanReceivableMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001590717us-gaap:FairValueInputsLevel3Memberctre:MezzanineLoanReceivableMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001590717us-gaap:FairValueMeasurementsRecurringMemberctre:MezzanineLoanReceivableMember2024-12-310001590717us-gaap:FairValueInputsLevel1Memberus-gaap:FinanceReceivablesMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001590717us-gaap:FairValueInputsLevel2Memberus-gaap:FinanceReceivablesMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001590717us-gaap:FairValueInputsLevel3Memberus-gaap:FinanceReceivablesMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001590717us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FinanceReceivablesMember2024-12-310001590717us-gaap:FairValueInputsLevel1Memberctre:SecuredAndMezzanineLoansReceivableMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001590717us-gaap:FairValueInputsLevel2Memberctre:SecuredAndMezzanineLoansReceivableMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001590717us-gaap:FairValueInputsLevel3Memberctre:SecuredAndMezzanineLoansReceivableMemberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001590717ctre:SecuredAndMezzanineLoansReceivableMember2024-12-310001590717us-gaap:FairValueInputsLevel1Memberctre:MortgageSecuredLoanReceivableMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001590717us-gaap:FairValueInputsLevel2Memberctre:MortgageSecuredLoanReceivableMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001590717us-gaap:FairValueInputsLevel3Memberctre:MortgageSecuredLoanReceivableMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001590717us-gaap:FairValueMeasurementsRecurringMemberctre:MortgageSecuredLoanReceivableMember2023-12-310001590717us-gaap:FairValueInputsLevel1Memberctre:MezzanineLoanReceivableMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001590717us-gaap:FairValueInputsLevel2Memberctre:MezzanineLoanReceivableMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001590717us-gaap:FairValueInputsLevel3Memberctre:MezzanineLoanReceivableMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001590717us-gaap:FairValueMeasurementsRecurringMemberctre:MezzanineLoanReceivableMember2023-12-310001590717us-gaap:FairValueInputsLevel1Memberctre:SecuredAndMezzanineLoansReceivableMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001590717us-gaap:FairValueInputsLevel2Memberctre:SecuredAndMezzanineLoansReceivableMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001590717us-gaap:FairValueInputsLevel3Memberctre:SecuredAndMezzanineLoansReceivableMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001590717ctre:SecuredAndMezzanineLoansReceivableMember2023-12-310001590717ctre:InvestmentsInRealEstateSecuredLoanMember2023-12-310001590717ctre:InvestmentsInMezzanineLoansMember2023-12-310001590717ctre:InvestmentsInFinancingReceivableMember2023-12-310001590717ctre:InvestmentsInRealEstateSecuredLoanMember2024-01-012024-12-310001590717ctre:InvestmentsInMezzanineLoansMember2024-01-012024-12-310001590717ctre:InvestmentsInFinancingReceivableMember2024-01-012024-12-310001590717ctre:InvestmentsInRealEstateSecuredLoanMember2024-12-310001590717ctre:InvestmentsInMezzanineLoansMember2024-12-310001590717ctre:InvestmentsInFinancingReceivableMember2024-12-310001590717ctre:SecuredAndMezzanineLoansReceivableMember2024-01-012024-12-310001590717ctre:SecuredAndMezzanineLoansReceivableMember2023-01-012023-12-310001590717ctre:MezzanineLoansMember2023-01-012023-12-310001590717ctre:MortgageLoansReceivableMember2023-01-012023-12-310001590717us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember2023-12-310001590717us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember2024-12-310001590717us-gaap:FairValueInputsLevel3Memberctre:MortgageSecuredLoanReceivableMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2024-12-310001590717ctre:MortgageSecuredLoanReceivableMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2024-12-310001590717ctre:MortgageSecuredLoanReceivableMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2024-12-310001590717us-gaap:FairValueInputsLevel3Memberctre:MezzanineLoanReceivableMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2024-12-310001590717ctre:MezzanineLoanReceivableMembersrt:MinimumMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2024-12-310001590717ctre:MezzanineLoanReceivableMembersrt:MaximumMemberus-gaap:FairValueInputsLevel3Memberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2024-12-310001590717us-gaap:FairValueInputsLevel3Memberus-gaap:FinanceReceivablesMemberus-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2024-12-310001590717us-gaap:FairValueInputsLevel3Memberus-gaap:UnsecuredDebtMemberctre:PreferredEquityInvestmentMember2024-12-310001590717us-gaap:FairValueInputsLevel3Memberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:UnsecuredDebtMemberctre:PreferredEquityInvestmentMember2024-12-310001590717us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:UnsecuredDebtMemberctre:PreferredEquityInvestmentMember2024-12-310001590717us-gaap:FairValueInputsLevel3Memberus-gaap:UnsecuredDebtMemberctre:PreferredEquityInvestmentMember2023-12-310001590717us-gaap:FairValueInputsLevel3Memberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:UnsecuredDebtMemberctre:PreferredEquityInvestmentMember2023-12-310001590717us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:UnsecuredDebtMemberctre:PreferredEquityInvestmentMember2023-12-310001590717us-gaap:FairValueInputsLevel2Memberctre:SeniorUnsecuredNotesMemberus-gaap:UnsecuredDebtMember2024-12-310001590717us-gaap:FairValueInputsLevel2Memberctre:SeniorUnsecuredNotesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:UnsecuredDebtMember2024-12-310001590717us-gaap:FairValueInputsLevel2Memberctre:SeniorUnsecuredNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:UnsecuredDebtMember2024-12-310001590717us-gaap:FairValueInputsLevel2Memberctre:SeniorUnsecuredNotesMemberus-gaap:UnsecuredDebtMember2023-12-310001590717us-gaap:FairValueInputsLevel2Memberctre:SeniorUnsecuredNotesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:UnsecuredDebtMember2023-12-310001590717us-gaap:FairValueInputsLevel2Memberctre:SeniorUnsecuredNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:UnsecuredDebtMember2023-12-310001590717us-gaap:FairValueInputsLevel3Membersrt:MinimumMember2024-12-310001590717us-gaap:FairValueInputsLevel3Membersrt:MaximumMember2024-12-310001590717ctre:SeniorUnsecuredNotesMemberus-gaap:SeniorNotesMember2024-12-310001590717ctre:SeniorUnsecuredNotesMemberus-gaap:SeniorNotesMember2023-12-310001590717ctre:SeniorUnsecuredTermLoanMemberus-gaap:LoansPayableMember2024-12-310001590717ctre:SeniorUnsecuredTermLoanMemberus-gaap:LoansPayableMember2023-12-310001590717us-gaap:RevolvingCreditFacilityMember2024-12-310001590717us-gaap:RevolvingCreditFacilityMember2023-12-310001590717ctre:SeniorUnsecuredNotesMemberus-gaap:SeniorNotesMember2021-06-170001590717ctre:SeniorUnsecuredNotesMemberus-gaap:SeniorNotesMember2021-06-172021-06-170001590717ctre:SeniorUnsecuredNotesMemberus-gaap:SeniorNotesMemberus-gaap:DebtInstrumentRedemptionPeriodTwoMember2021-06-172021-06-170001590717ctre:SeniorUnsecuredNotesMemberus-gaap:SeniorNotesMemberus-gaap:DebtInstrumentRedemptionPeriodThreeMember2021-06-172021-06-170001590717us-gaap:RevolvingCreditFacilityMember2024-12-180001590717us-gaap:LetterOfCreditMember2022-12-160001590717ctre:SwinglineLoanMember2022-12-160001590717us-gaap:RevolvingCreditFacilityMember2022-12-160001590717ctre:SeniorUnsecuredTermLoanMemberus-gaap:LoansPayableMember2022-12-160001590717us-gaap:RevolvingCreditFacilityMemberus-gaap:BaseRateMembersrt:MinimumMember2022-12-162022-12-160001590717us-gaap:RevolvingCreditFacilityMemberus-gaap:BaseRateMembersrt:MaximumMember2022-12-162022-12-160001590717us-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrMembersrt:MinimumMember2022-12-162022-12-160001590717us-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrMembersrt:MaximumMember2022-12-162022-12-160001590717ctre:SeniorUnsecuredTermLoanMemberus-gaap:LoansPayableMemberus-gaap:BaseRateMembersrt:MinimumMember2022-12-162022-12-160001590717ctre:SeniorUnsecuredTermLoanMemberus-gaap:LoansPayableMemberus-gaap:BaseRateMembersrt:MaximumMember2022-12-162022-12-160001590717ctre:SeniorUnsecuredTermLoanMemberus-gaap:LoansPayableMemberus-gaap:SecuredOvernightFinancingRateSofrMembersrt:MinimumMember2022-12-162022-12-160001590717ctre:SeniorUnsecuredTermLoanMemberus-gaap:LoansPayableMemberus-gaap:SecuredOvernightFinancingRateSofrMembersrt:MaximumMember2022-12-162022-12-160001590717srt:MinimumMemberus-gaap:RevolvingCreditFacilityMember2022-12-162022-12-160001590717srt:MaximumMemberus-gaap:RevolvingCreditFacilityMember2022-12-162022-12-160001590717ctre:SeniorUnsecuredTermLoanMemberus-gaap:LoansPayableMember2024-09-192024-09-190001590717us-gaap:RevolvingCreditFacilityMember2019-02-092019-02-090001590717ctre:SecuredBorrowingsMember2024-06-030001590717ctre:SecuredBorrowingsMemberctre:SecuredOvernightFinancingRateSOFRFloorMember2024-06-032024-06-030001590717ctre:SecuredBorrowingsMemberus-gaap:SecuredOvernightFinancingRateSofrMembersrt:MaximumMember2024-06-032024-06-030001590717ctre:SecuredBorrowingsMemberus-gaap:SecuredOvernightFinancingRateSofrMember2024-06-032024-06-030001590717ctre:SecuredBorrowingsMembersrt:MaximumMember2024-06-030001590717ctre:UnderwrittenPublicOfferingMember2024-11-012024-11-010001590717ctre:UnderwrittenPublicOfferingMember2024-11-010001590717ctre:AtTheMarketOfferingProgramMember2024-08-290001590717ctre:AtTheMarketOfferingProgramMember2024-08-280001590717ctre:AtTheMarketOfferingProgramMember2024-01-012024-12-310001590717ctre:AtTheMarketOfferingProgramMember2023-01-012023-12-310001590717ctre:AtTheMarketOfferingProgramMember2022-01-012022-12-310001590717ctre:AtTheMarketOfferingProgramMember2024-12-3100015907172024-01-012024-03-3100015907172024-04-012024-06-3000015907172024-07-012024-09-300001590717ctre:O2024Q1DividendsMember2024-01-012024-03-310001590717ctre:O2024Q2DividendsMember2024-04-012024-06-300001590717ctre:O2024Q3DividendsMember2024-07-012024-09-300001590717ctre:O2024Q4DividendsMember2024-10-012024-12-3100015907172024-03-3100015907172024-09-3000015907172023-01-012023-03-3100015907172023-04-012023-06-3000015907172023-07-012023-09-3000015907172023-10-012023-12-310001590717ctre:O2023Q1DividendsMember2023-01-012023-03-310001590717ctre:O2023Q2DividendsMember2023-04-012023-06-300001590717ctre:O2023Q3DividendsMember2023-07-012023-09-300001590717ctre:O2023Q4DividendsMember2023-10-012023-12-3100015907172023-03-3100015907172023-06-3000015907172023-09-3000015907172022-01-012022-03-3100015907172022-04-012022-06-3000015907172022-07-012022-09-3000015907172022-10-012022-12-310001590717ctre:O2022Q1DividendsMember2022-01-012022-03-310001590717ctre:O2022Q2DividendsMember2022-04-012022-06-300001590717ctre:O2022Q3DividendsMember2022-07-012022-09-300001590717ctre:O2022Q4DividendsMember2022-10-012022-12-3100015907172022-03-3100015907172022-06-3000015907172022-09-300001590717us-gaap:RestrictedStockMember2021-01-012021-12-310001590717us-gaap:RestrictedStockMember2020-01-012020-12-310001590717us-gaap:RestrictedStockMemberctre:NonEmployeesMember2020-01-012020-12-310001590717ctre:PerformanceStockAwardsMemberctre:VestingPeriodRangeOneMembersrt:MinimumMember2021-01-012021-12-310001590717ctre:PerformanceStockAwardsMemberctre:VestingPeriodRangeOneMembersrt:MaximumMember2021-01-012021-12-310001590717ctre:PerformanceStockAwardsMemberctre:VestingPeriodRangeTwoMembersrt:MinimumMember2020-01-012020-12-310001590717ctre:PerformanceStockAwardsMemberctre:VestingPeriodRangeTwoMembersrt:MaximumMember2020-01-012020-12-310001590717ctre:PerformanceSharesTSRUnitsMember2024-01-012024-12-310001590717ctre:PerformanceSharesTSRUnitsMembersrt:MinimumMember2024-01-012024-12-310001590717ctre:PerformanceSharesTSRUnitsMembersrt:MaximumMember2024-01-012024-12-310001590717us-gaap:RestrictedStockMember2024-01-012024-12-310001590717ctre:BoardAwardsMember2024-01-012024-12-310001590717ctre:RestrictedStockAndPerformanceSharesMember2024-01-012024-12-310001590717ctre:BoardAwardsMembersrt:DirectorMember2024-01-012024-12-310001590717us-gaap:RestrictedStockMember2023-01-012023-12-310001590717ctre:BoardAwardsMembersrt:DirectorMember2023-01-012023-12-310001590717us-gaap:RestrictedStockMember2022-01-012022-12-310001590717ctre:BoardAwardsMembersrt:DirectorMember2022-01-012022-12-310001590717ctre:PerformanceSharesTSRUnitsMember2023-01-012023-12-310001590717ctre:PerformanceSharesTSRUnitsMember2022-01-012022-12-310001590717ctre:PerformanceStockAwardsMember2024-01-012024-12-310001590717ctre:PerformanceStockAwardsMember2023-01-012023-12-310001590717ctre:PerformanceStockAwardsMember2022-01-012022-12-310001590717ctre:ForwardEquityAgreementsMember2024-01-012024-12-310001590717ctre:ForwardEquityAgreementsMember2023-01-012023-12-310001590717ctre:ForwardEquityAgreementsMember2022-01-012022-12-310001590717ctre:ReportableSegmentMember2024-01-012024-12-310001590717ctre:ReportableSegmentMember2023-01-012023-12-310001590717ctre:ReportableSegmentMember2022-01-012022-12-310001590717ctre:InvestmentOneMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberctre:SkilledNursingFacilityMember2024-12-310001590717ctre:CTREMemberctre:InvestmentOneMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberctre:SkilledNursingFacilityMember2024-12-310001590717ctre:NoncontrollingInterestOwnersMemberctre:InvestmentOneMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberctre:SkilledNursingFacilityMember2024-12-310001590717ctre:InvestmentTwoMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberctre:SkilledNursingFacilityMember2024-12-310001590717ctre:CTREMemberctre:InvestmentTwoMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberctre:SkilledNursingFacilityMember2024-12-310001590717ctre:NoncontrollingInterestOwnersMemberctre:InvestmentTwoMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberctre:SkilledNursingFacilityMember2024-12-310001590717ctre:InvestmentThreeMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberctre:AssistedLivingFacilitiesMember2024-12-310001590717ctre:CTREMemberctre:InvestmentThreeMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberctre:AssistedLivingFacilitiesMember2024-12-310001590717ctre:NoncontrollingInterestOwnersMemberctre:InvestmentThreeMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberctre:AssistedLivingFacilitiesMember2024-12-310001590717ctre:InvestmentFourMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberctre:MultiServiceCampusPropertiesMember2024-12-310001590717ctre:CTREMemberctre:InvestmentFourMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberctre:MultiServiceCampusPropertiesMember2024-12-310001590717ctre:NoncontrollingInterestOwnersMemberctre:InvestmentFourMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberctre:MultiServiceCampusPropertiesMember2024-12-310001590717ctre:InvestmentFiveMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberctre:SkilledNursingFacilityMember2024-12-310001590717ctre:CTREMemberctre:InvestmentFiveMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberctre:SkilledNursingFacilityMember2024-12-310001590717ctre:NoncontrollingInterestOwnersMemberctre:InvestmentFiveMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberctre:SkilledNursingFacilityMember2024-12-310001590717ctre:InvestmentSixMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberctre:SkilledNursingFacilityMember2024-12-310001590717ctre:CTREMemberctre:InvestmentSixMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberctre:SkilledNursingFacilityMember2024-12-310001590717ctre:NoncontrollingInterestOwnersMemberctre:InvestmentSixMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMemberctre:SkilledNursingFacilityMember2024-12-310001590717ctre:InvestmentSevenMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2024-12-310001590717ctre:CTREMemberctre:InvestmentSevenMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2024-12-310001590717ctre:NoncontrollingInterestOwnersMemberctre:InvestmentSevenMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2024-12-310001590717us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2024-12-310001590717ctre:CTREMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2024-12-310001590717ctre:NoncontrollingInterestOwnersMemberus-gaap:VariableInterestEntityPrimaryBeneficiaryMember2024-12-310001590717ctre:JVPartner90Member2024-12-310001590717ctre:JVPartnerMember2024-01-030001590717ctre:JVPartnerMember2024-12-310001590717us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2023-12-310001590717ctre:EnsignAndPennantMember2024-12-310001590717ctre:TenantESGProgramMember2024-12-310001590717ctre:CapitalExpendituresMemberctre:RemainingCommitmentMember2024-12-310001590717us-gaap:LoansReceivableMemberctre:RemainingCommitmentMember2024-12-310001590717ctre:EarnOutObligationMemberctre:RemainingCommitmentMember2024-12-310001590717ctre:RemainingCommitmentMember2024-12-310001590717ctre:CapitalImprovementsAtTripleNetLeasedFacilitiesMember2024-12-310001590717stpr:VActre:SkilledNursingFacilityMember2024-01-012024-12-310001590717stpr:VActre:SkilledNursingFacilityMember2024-12-310001590717ctre:EnsignMemberctre:SkilledNursingFacilityMember2024-12-310001590717ctre:EnsignMemberctre:MultiServiceCampusPropertiesMember2024-12-310001590717ctre:EnsignMemberctre:AssistedAndIndependentLivingPropertiesMember2024-12-310001590717ctre:EnsignMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-01-012024-12-310001590717ctre:PriorityManagementGroupLLCMemberctre:SkilledNursingFacilityMember2024-12-310001590717ctre:PriorityManagementGroupLLCMemberctre:MultiServiceCampusPropertiesMember2024-12-310001590717ctre:PriorityManagementGroupLLCMemberctre:AssistedAndIndependentLivingPropertiesMember2024-12-310001590717ctre:PriorityManagementGroupLLCMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-01-012024-12-310001590717ctre:EnsignMemberctre:SkilledNursingFacilityMember2023-12-310001590717ctre:EnsignMemberctre:MultiServiceCampusPropertiesMember2023-12-310001590717ctre:EnsignMemberctre:AssistedAndIndependentLivingPropertiesMember2023-12-310001590717ctre:EnsignMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-12-310001590717ctre:PriorityManagementGroupLLCMemberctre:SkilledNursingFacilityMember2023-12-310001590717ctre:PriorityManagementGroupLLCMemberctre:MultiServiceCampusPropertiesMember2023-12-310001590717ctre:PriorityManagementGroupLLCMemberctre:AssistedAndIndependentLivingPropertiesMember2023-12-310001590717ctre:PriorityManagementGroupLLCMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-12-310001590717ctre:EnsignMemberctre:SkilledNursingFacilityMember2022-12-310001590717ctre:EnsignMemberctre:MultiServiceCampusPropertiesMember2022-12-310001590717ctre:EnsignMemberctre:AssistedAndIndependentLivingPropertiesMember2022-12-310001590717ctre:EnsignMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-12-310001590717ctre:PriorityManagementGroupLLCMemberctre:SkilledNursingFacilityMember2022-12-310001590717ctre:PriorityManagementGroupLLCMemberctre:MultiServiceCampusPropertiesMember2022-12-310001590717ctre:PriorityManagementGroupLLCMemberctre:AssistedAndIndependentLivingPropertiesMember2022-12-310001590717ctre:PriorityManagementGroupLLCMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-12-310001590717stpr:CActre:SkilledNursingFacilityMember2024-12-310001590717stpr:CActre:MultiServiceCampusPropertiesMember2024-12-310001590717stpr:CActre:AssistedAndIndependentLivingPropertiesMember2024-12-310001590717stpr:CAus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-01-012024-12-310001590717stpr:TXctre:SkilledNursingFacilityMember2024-12-310001590717stpr:TXctre:MultiServiceCampusPropertiesMember2024-12-310001590717stpr:TXctre:AssistedAndIndependentLivingPropertiesMember2024-12-310001590717stpr:TXus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-01-012024-12-310001590717stpr:CActre:SkilledNursingFacilityMember2023-12-310001590717stpr:CActre:MultiServiceCampusPropertiesMember2023-12-310001590717stpr:CActre:AssistedAndIndependentLivingPropertiesMember2023-12-310001590717stpr:CAus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-12-310001590717stpr:TXctre:SkilledNursingFacilityMember2023-12-310001590717stpr:TXctre:MultiServiceCampusPropertiesMember2023-12-310001590717stpr:TXctre:AssistedAndIndependentLivingPropertiesMember2023-12-310001590717stpr:TXus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-12-310001590717stpr:CActre:SkilledNursingFacilityMember2022-12-310001590717stpr:CActre:MultiServiceCampusPropertiesMember2022-12-310001590717stpr:CActre:AssistedAndIndependentLivingPropertiesMember2022-12-310001590717stpr:CAus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-12-310001590717stpr:TXctre:SkilledNursingFacilityMember2022-12-310001590717stpr:TXctre:MultiServiceCampusPropertiesMember2022-12-310001590717stpr:TXctre:AssistedAndIndependentLivingPropertiesMember2022-12-310001590717stpr:TXus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-12-310001590717ctre:SkilledNursingFacilityMemberctre:MezzanineLoanMemberus-gaap:SubsequentEventMember2025-01-100001590717stpr:MDctre:SkilledNursingFacilityMemberctre:MezzanineLoanMemberus-gaap:SubsequentEventMember2025-01-100001590717ctre:SkilledNursingFacilityMemberus-gaap:SubsequentEventMember2025-02-012025-02-010001590717us-gaap:SubsequentEventMember2025-02-012025-02-010001590717ctre:SkilledNursingFacilityMemberctre:SkilledNursingFacilityTennesseeJointVentureMemberus-gaap:SubsequentEventMember2025-02-010001590717ctre:SkilledNursingFacilityMemberctre:SkilledNursingFacilityTennesseeJointVentureMemberus-gaap:SubsequentEventMember2025-02-010001590717ctre:SkilledNursingFacilityMemberctre:JVPartnerMemberus-gaap:SubsequentEventMember2025-02-012025-02-010001590717ctre:SkilledNursingFacilityMemberus-gaap:SubsequentEventMember2025-02-010001590717ctre:SkilledNursingFacilityMemberus-gaap:SubsequentEventMember2025-01-012025-02-120001590717ctre:SkilledNursingFacilityCampusMemberus-gaap:SubsequentEventMember2025-01-012025-02-120001590717ctre:AssistedLivingFacilityMemberus-gaap:SubsequentEventMember2025-01-012025-02-120001590717us-gaap:SubsequentEventMember2025-02-120001590717us-gaap:SubsequentEventMember2025-01-012025-02-120001590717us-gaap:SubsequentEventMemberctre:AtTheMarketOfferingProgramMember2025-01-210001590717us-gaap:SubsequentEventMemberctre:AtTheMarketOfferingProgramMember2025-02-120001590717us-gaap:RestrictedStockMemberctre:OfficerAndEmployeeMemberus-gaap:SubsequentEventMember2025-01-282025-01-280001590717ctre:SkilledNursingPropertiesMemberctre:EnsignHighlandLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:EnsignHighlandLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:MeadowbrookHealthAssociatesLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:MeadowbrookHealthAssociatesLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:TerraceHoldingsAzLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:TerraceHoldingsAzLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:RillitoHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:RillitoHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:ValleyHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:ValleyHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CedarAvenueHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CedarAvenueHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GranadaInvestmentsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GranadaInvestmentsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:PlazaHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:PlazaHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:MountainviewCommunityCareLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:MountainviewCommunityCareLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CmHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CmHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:PolkHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:PolkHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:SnohomishHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:SnohomishHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CherryHealthHoldingsIncMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CherryHealthHoldingsIncMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GolfviewHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GolfviewHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:TenthEastHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:TenthEastHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:TrinityMillHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:TrinityMillHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CottonwoodHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CottonwoodHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:VerdeVillaHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:VerdeVillaHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:MesquiteHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:MesquiteHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:ArrowTreeHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:ArrowTreeHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:FortStreetHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:FortStreetHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:TrousdaleHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:TrousdaleHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:EnsignBellflowerLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:EnsignBellflowerLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:RbHeightsHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:RbHeightsHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:SanCorrineHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:SanCorrineHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:TempleHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:TempleHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:AnsonHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:AnsonHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:WillitsHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:WillitsHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:LufkinHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:LufkinHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:LowellHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:LowellHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:JeffersonRalstonHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:JeffersonRalstonHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:LafayetteHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:LafayetteHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:HillendahlHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:HillendahlHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:PriceHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:PriceHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:SilverLakeHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:SilverLakeHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:JordanHealthPropertiesLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:JordanHealthPropertiesLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:RegalRoadHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:RegalRoadHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:ParedesHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:ParedesHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:ExpresswayHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:ExpresswayHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:RioGrandeHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:RioGrandeHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:FifthEastHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:FifthEastHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:EmmettHealthcareHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:EmmettHealthcareHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:BurleyHealthcareHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:BurleyHealthcareHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:JoseyRanchHealthcareHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:JoseyRanchHealthcareHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:EvergladesHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:EvergladesHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:IrvingHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:IrvingHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:FallsCityHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:FallsCityHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GilletteParkHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GilletteParkHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GazeboParkHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GazeboParkHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:OlesonParkHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:OlesonParkHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:ArapahoeHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:ArapahoeHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:DixieHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:DixieHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:MemorialHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:MemorialHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:BogardusHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:BogardusHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:SouthDoraHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:SouthDoraHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:SilveradaHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:SilveradaHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:OremHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:OremHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:WisteriaHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:WisteriaHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:RenneAvenueHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:RenneAvenueHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:StillhouseHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:StillhouseHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:FigStreetHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:FigStreetHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:LowellLakeHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:LowellLakeHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:QueenswayHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:QueenswayHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:LongBeachHealthAssociatesLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:LongBeachHealthAssociatesLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:KingsCourtHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:KingsCourtHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:FiftyOneAvenueHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:FiftyOneAvenueHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:IvesHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:IvesHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GuadalupeHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GuadalupeHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:FortyNineStreetHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:FortyNineStreetHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:WillowsHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:WillowsHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:TulalipBayHoldingsMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:TulalipBayHoldingsMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:SkyHoldingsAzLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:SkyHoldingsAzLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:LemonRiverHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:LemonRiverHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:BethalUpdateMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:BethalUpdateMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:MiraMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:MiraMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:ShorelineHealthAndRehabilitationCenterMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:ShorelineHealthAndRehabilitationCenterMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:PristineSeniorLivingofCincinnatiRiverviewMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:PristineSeniorLivingofCincinnatiRiverviewMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:ShawMountainAtCascadiaMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:ShawMountainAtCascadiaMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:ArborNursingCenterMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:ArborNursingCenterMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:BroadmoorMedicalLodgeRockwallMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:BroadmoorMedicalLodgeRockwallMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:DecaturMedicalLodgeMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:DecaturMedicalLodgeMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:RoyceCityHealthandRehabilitationCenterMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:RoyceCityHealthandRehabilitationCenterMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:SalineCareNursingAndRehabilitationCenterMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:SalineCareNursingAndRehabilitationCenterMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:CarrierMillsNursingAndRehabilitationCenterMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:CarrierMillsNursingAndRehabilitationCenterMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:StoneBridgeNursingAndRehabilitationCenterMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:StoneBridgeNursingAndRehabilitationCenterMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:DuQuoinNursingAndRehabilitationCenterMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:DuQuoinNursingAndRehabilitationCenterMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:PinckneyvilleNursingAndRehabilitationCenterMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:PinckneyvilleNursingAndRehabilitationCenterMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:WellspringHealthAndRehabilitationOfCascadiaMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:WellspringHealthAndRehabilitationOfCascadiaMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:TheRioAtFoxHollowMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:TheRioAtFoxHollowMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:TheRioAtCabezonMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:TheRioAtCabezonMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:EldoradoRehabAndHealthcareMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:EldoradoRehabAndHealthcareMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:SecoraHealthAndRehabilitationOfCascadiaMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:SecoraHealthAndRehabilitationOfCascadiaMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:KindredNursingAndRehabilitationMountainValleyMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:KindredNursingAndRehabilitationMountainValleyMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:KindredNursingAndRehabilitationCaldwellMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:KindredNursingAndRehabilitationCaldwellMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:KindredNursingAndRehabilitationCanyonWestMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:KindredNursingAndRehabilitationCanyonWestMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:KindredTransitionalCareAndRehabilitationLewistonMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:KindredTransitionalCareAndRehabilitationLewistonMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:KindredNursingAndRehabilitationNampaMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:KindredNursingAndRehabilitationNampaMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:KindredNursingAndRehabilitationWeiserMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:KindredNursingAndRehabilitationWeiserMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:KindredNursingAndRehabilitationAspenParkMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:KindredNursingAndRehabilitationAspenParkMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:KindredTransitionalCareandRehabilitationRidgmarMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:KindredTransitionalCareandRehabilitationRidgmarMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:KindredTransitionalCareandRehabilitationMansfieldPlazaMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:KindredTransitionalCareandRehabilitationMansfieldPlazaMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:KindredTransitionalCareandRehabilitationGrapevineMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:KindredTransitionalCareandRehabilitationGrapevineMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:TheOaksAtLakewoodMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:TheOaksAtLakewoodMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:TheOaksAtTimberlineMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:TheOaksAtTimberlineMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:ProvidenceWatermanNursingCenterMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:ProvidenceWatermanNursingCenterMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:ProvidenceOrangeTreeMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:ProvidenceOrangeTreeMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:ProvidenceOntarioMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:ProvidenceOntarioMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:GreenvilleNursingandRehabilitationCenterMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:GreenvilleNursingandRehabilitationCenterMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:CopperRidgeHealthAndRehabilitationCenterMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:CopperRidgeHealthAndRehabilitationCenterMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:PrairieHeightsHealthcareCenterMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:PrairieHeightsHealthcareCenterMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:TheMeadowsOnUniversityMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:TheMeadowsOnUniversityMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:TheSuitesParkerMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:TheSuitesParkerMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:HuntingtonParkNursingCenterMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:HuntingtonParkNursingCenterMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:ShorelineCareCenterMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:ShorelineCareCenterMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:DowneyCareCenterMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:DowneyCareCenterMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:CourtyardHealthcareCenterMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:CourtyardHealthcareCenterMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GulfCoastBuyer1LLCMemberctre:AlpineSkilledNursingandRehabilitationMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GulfCoastBuyer1LLCMemberctre:AlpineSkilledNursingandRehabilitationMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GulfCoastBuyer1LLCMemberctre:TheBradfordSkilledNursingandRehabilitationMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GulfCoastBuyer1LLCMemberctre:TheBradfordSkilledNursingandRehabilitationMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GulfCoastBuyer1LLCMemberctre:ColonialOaksSkilledNursingAndRehabilitationMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GulfCoastBuyer1LLCMemberctre:ColonialOaksSkilledNursingAndRehabilitationMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GulfCoastBuyer1LLCMemberctre:TheGuestHouseSkilledNursingAndRehabilitationMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GulfCoastBuyer1LLCMemberctre:TheGuestHouseSkilledNursingAndRehabilitationMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GulfCoastBuyer1LLCMemberctre:PilgrimManorSkilledNursingAndRehabilitationMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GulfCoastBuyer1LLCMemberctre:PilgrimManorSkilledNursingAndRehabilitationMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GulfCoastBuyer1LLCMemberctre:ShreveportManorSkilledNursingAndRehabilitationMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GulfCoastBuyer1LLCMemberctre:ShreveportManorSkilledNursingAndRehabilitationMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GulfCoastBuyer1LLCMemberctre:BookerTWashingtonSkilledNursingAndRehabilitationMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GulfCoastBuyer1LLCMemberctre:BookerTWashingtonSkilledNursingAndRehabilitationMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GulfCoastBuyer1LLCMemberctre:LegacyWestRehabilitationAndHealthcareMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GulfCoastBuyer1LLCMemberctre:LegacyWestRehabilitationAndHealthcareMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GulfCoastBuyer1LLCMemberctre:LegacyAtJacksonvilleMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GulfCoastBuyer1LLCMemberctre:LegacyAtJacksonvilleMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GulfCoastBuyer1LLCMemberctre:PecanTreeRehabilitationAndHealthcareMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GulfCoastBuyer1LLCMemberctre:PecanTreeRehabilitationAndHealthcareMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:LakewestSNFRealtyLLCMemberctre:LakewestRehabilitationAndSkilledCareMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:LakewestSNFRealtyLLCMemberctre:LakewestRehabilitationAndSkilledCareMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:CascadiaOfNampaMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:CascadiaOfNampaMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:ValleySkilledNursingMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:ValleySkilledNursingMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:CascadiaOfBoiseMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:CascadiaOfBoiseMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:CooneyHealthcareAndRehabilitationMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:CooneyHealthcareAndRehabilitationMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:ElkhornHealthcareAndRehabilitationMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:ElkhornHealthcareAndRehabilitationMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:OneSixtyNorthPattersonAvenueLLCMemberctre:BuenaVistaCareCenterMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:OneSixtyNorthPattersonAvenueLLCMemberctre:BuenaVistaCareCenterMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:ElCentroPostAcuteCareMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:ElCentroPostAcuteCareMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:SedonaTraceHealthAndWellnessMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:SedonaTraceHealthAndWellnessMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:CedarPointeHealthAndWellnessSuitesMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:CedarPointeHealthAndWellnessSuitesMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:EnnisCareCenterMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:EnnisCareCenterMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:ParkBendRehabilitationAndHealthcareCenterMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:ParkBendRehabilitationAndHealthcareCenterMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:PrairieRidgeHealthAndRehabiliationMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:PrairieRidgeHealthAndRehabiliationMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:SpaldingPostAcuteMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:SpaldingPostAcuteMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:CasaAzulSkilledNursingAndRehabilitationMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:CtrPartnershipMemberctre:CasaAzulSkilledNursingAndRehabilitationMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A8665LaMesaBoulevardLLCMemberctre:CommunityConvalescentHospitalOfLaMesaMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A8665LaMesaBoulevardLLCMemberctre:CommunityConvalescentHospitalOfLaMesaMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A7039AlondaBoulevardLLCMemberctre:ParamountMeadowsNursingCenterMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A7039AlondaBoulevardLLCMemberctre:ParamountMeadowsNursingCenterMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A10625LeffingwellRoadLLCMemberctre:NorwalkMeadowsNursingCenterMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A10625LeffingwellRoadLLCMemberctre:NorwalkMeadowsNursingCenterMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A247E.BobierDriveLLCMemberctre:LaFuentePostAcuteMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A247E.BobierDriveLLCMemberctre:LaFuentePostAcuteMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:Capitola1935RealtyLLCMemberctre:PacificCoastManorMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:Capitola1935RealtyLLCMemberctre:PacificCoastManorMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:MorganHillsRealtyLLCMemberctre:PacificHillsManorMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:MorganHillsRealtyLLCMemberctre:PacificHillsManorMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:ColumbiaPostAcuteMemberctre:ColumbiaPostAcuteMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:ColumbiaPostAcuteMemberctre:ColumbiaPostAcuteMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:HoustonTransitionalCareMemberctre:HoustonTransitionalCareMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:HoustonTransitionalCareMemberctre:HoustonTransitionalCareMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:BrunswickRehabilitationAndHealthcareCenterMemberctre:BrunswickRehabilitationAndHealthcareCenterMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:BrunswickRehabilitationAndHealthcareCenterMemberctre:BrunswickRehabilitationAndHealthcareCenterMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:FletcherRehabilitationAndHealthcareCenterMemberctre:FletcherRehabilitationAndHealthcareCenterMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:FletcherRehabilitationAndHealthcareCenterMemberctre:FletcherRehabilitationAndHealthcareCenterMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:RamseurRehabilitationAndHealthcareCenterMemberctre:RamseurRehabilitationAndHealthcareCenterMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:RamseurRehabilitationAndHealthcareCenterMemberctre:RamseurRehabilitationAndHealthcareCenterMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:RockwellParkRehabilitationAndHealthcareCenterMemberctre:RockwellParkRehabilitationAndHealthcareCenterMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:RockwellParkRehabilitationAndHealthcareCenterMemberctre:RockwellParkRehabilitationAndHealthcareCenterMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:SevenOaksRehabilitationAndHealthcareCenterMemberctre:SevenOaksRehabilitationAndHealthcareCenterMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:SevenOaksRehabilitationAndHealthcareCenterMemberctre:SevenOaksRehabilitationAndHealthcareCenterMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A8170MurrayPropcoLLCMemberctre:GilroyHealthcareAndRehabilitationCenterMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A8170MurrayPropcoLLCMemberctre:GilroyHealthcareAndRehabilitationCenterMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GlenburnieNursingRehabilitationCenterMemberctre:GlenburnieNursingRehabilitationCenterMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:GlenburnieNursingRehabilitationCenterMemberctre:GlenburnieNursingRehabilitationCenterMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:DennettRehabCenterMemberctre:DennettRehabCenterMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:DennettRehabCenterMemberctre:DennettRehabCenterMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:MountainCityRehabCenterMemberctre:MountainCityRehabCenterMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:MountainCityRehabCenterMemberctre:MountainCityRehabCenterMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:SouthHillsPostAcuteMemberctre:SouthHillsPostAcuteMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:SouthHillsPostAcuteMemberctre:SouthHillsPostAcuteMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:PetersTownshipPostAcuteMemberctre:PetersTownshipPostAcuteMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:PetersTownshipPostAcuteMemberctre:PetersTownshipPostAcuteMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:MonroevillePostAcuteMemberctre:MonroevillePostAcuteMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:MonroevillePostAcuteMemberctre:MonroevillePostAcuteMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:WhitehallBoroughPostAcuteMemberctre:WhitehallBoroughPostAcuteMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:WhitehallBoroughPostAcuteMemberctre:WhitehallBoroughPostAcuteMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A704DupreeRoadTNLLCMemberctre:HaywoodPostAcuteMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A704DupreeRoadTNLLCMemberctre:HaywoodPostAcuteMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A175HospitalDriveTNLLCMemberctre:CherrywoodPostAcuteMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A175HospitalDriveTNLLCMemberctre:CherrywoodPostAcuteMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A900ProfessionalParkDriveTNLLCMemberctre:ParkMeadowsPostAcuteMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A900ProfessionalParkDriveTNLLCMemberctre:ParkMeadowsPostAcuteMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A119KittrellStreetTNLLCMemberctre:LewisParkPostAcuteMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A119KittrellStreetTNLLCMemberctre:LewisParkPostAcuteMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A444OneElevenPlaceTNLLCMemberctre:GrandviewPostAcuteMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A444OneElevenPlaceTNLLCMemberctre:GrandviewPostAcuteMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A727EastChurchStreetTNLLCMemberctre:LexingtonPostAcuteMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A727EastChurchStreetTNLLCMemberctre:LexingtonPostAcuteMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A835EastPoplarAvenueTNLLCMemberctre:SelmerPostAcuteMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A835EastPoplarAvenueTNLLCMemberctre:SelmerPostAcuteMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A2650NorthMtJulietRoadTNLLCMemberctre:CedarCreekPostAcuteMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A2650NorthMtJulietRoadTNLLCMemberctre:CedarCreekPostAcuteMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A202EastMtcsRoadTNLLCMemberctre:StoneRiverPostAcuteMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A202EastMtcsRoadTNLLCMemberctre:StoneRiverPostAcuteMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A813SDickersonRdTNLLCMemberctre:AltaHeightsPostAcuteMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A813SDickersonRdTNLLCMemberctre:AltaHeightsPostAcuteMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A895PowersBlvdTNLLCMemberctre:WaverlyHillsPostAcuteMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A895PowersBlvdTNLLCMemberctre:WaverlyHillsPostAcuteMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A1900ParrAvenueTNLLCMemberctre:OkeenaHealthAndRehabilitationCenterMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A1900ParrAvenueTNLLCMemberctre:OkeenaHealthAndRehabilitationCenterMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A2031AvondaleStreetTNLLCMemberctre:AvondaleHealthAndRehabilitationCenterMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A2031AvondaleStreetTNLLCMemberctre:AvondaleHealthAndRehabilitationCenterMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A800VolunteerDriveTNLLCMemberctre:RiverbendHealthAndRehabilitationCenterMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A800VolunteerDriveTNLLCMemberctre:RiverbendHealthAndRehabilitationCenterMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A1630EReelfootAveTNLLCMemberctre:UnionCityHealthAndRehabilitationMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A1630EReelfootAveTNLLCMemberctre:UnionCityHealthAndRehabilitationMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A5275MillenniumDriveALLLCMemberctre:TheHealthCenterAtResearchParkMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A5275MillenniumDriveALLLCMemberctre:TheHealthCenterAtResearchParkMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A460HanningsLaneTNLLCMemberctre:VanAyerSeniorLivingAndRehabilitationMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A460HanningsLaneTNLLCMemberctre:VanAyerSeniorLivingAndRehabilitationMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A1245ECollegeStTNLLCMemberctre:MeadowbrookHealthcareAndRehabilitationCenterMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A1245ECollegeStTNLLCMemberctre:MeadowbrookHealthcareAndRehabilitationCenterMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A7424MiddlebrookPikeTNLLCMemberctre:LegacyParkHealthAndRehabilitationMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A7424MiddlebrookPikeTNLLCMemberctre:LegacyParkHealthAndRehabilitationMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A7512MiddlebrookPikeTNLLCMemberctre:WellparkHealthAndRehabilitationMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A7512MiddlebrookPikeTNLLCMemberctre:WellparkHealthAndRehabilitationMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A1536ApplingCareLaneTNLLCMemberctre:ApplingwoodPostAcuteMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A1536ApplingCareLaneTNLLCMemberctre:ApplingwoodPostAcuteMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A5070SanderlinAvenueTNLLCMemberctre:ShelbyOaksPostAcuteMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A5070SanderlinAvenueTNLLCMemberctre:ShelbyOaksPostAcuteMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A765BertJohnstonAvenueTNLLCMemberctre:CovingtonPostAcuteMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A765BertJohnstonAvenueTNLLCMemberctre:CovingtonPostAcuteMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A45ForestCoveTNLLCMemberctre:CypressGrovePostAcuteMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A45ForestCoveTNLLCMemberctre:CypressGrovePostAcuteMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A121PhysiciansDrTNLLCMemberctre:NorthbrookePostAcuteMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A121PhysiciansDrTNLLCMemberctre:NorthbrookePostAcuteMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A597WestForestAvenueTNLLCMemberctre:WestTennesseeTransitionalCareMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A597WestForestAvenueTNLLCMemberctre:WestTennesseeTransitionalCareMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A1513N2ndStreetTNLLCMemberctre:HarborviewPostAcuteMember2024-12-310001590717ctre:SkilledNursingPropertiesMemberctre:A1513N2ndStreetTNLLCMemberctre:HarborviewPostAcuteMember2024-01-012024-12-310001590717ctre:SkilledNursingPropertiesMember2024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:EnsignSouthlandLlcMember2024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:EnsignSouthlandLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:MissionCcrcLlcMember2024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:MissionCcrcLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:WayneHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:WayneHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:FourthStreetHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:FourthStreetHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:BigSiouxRiverHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:BigSiouxRiverHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:PrairieHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:PrairieHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:SalmonRiverHealthHoldingsLlcMember2024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:SalmonRiverHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:CtrPartnershipMemberctre:LibertyNursingCenterOfWillardMember2024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:CtrPartnershipMemberctre:LibertyNursingCenterOfWillardMember2024-01-012024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:CtrPartnershipMemberctre:PremierEstatesOfMiddletownPremierRetirementEstatesOfMiddletownMember2024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:CtrPartnershipMemberctre:PremierEstatesOfMiddletownPremierRetirementEstatesOfMiddletownMember2024-01-012024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:CtrPartnershipMemberctre:TurlockNursingandRehabilitationCenterMember2024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:CtrPartnershipMemberctre:TurlockNursingandRehabilitationCenterMember2024-01-012024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:CtrPartnershipMemberctre:BridgeportMedicalLodgeMember2024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:CtrPartnershipMemberctre:BridgeportMedicalLodgeMember2024-01-012024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:CtrPartnershipMemberctre:TheVillasAtSaratogaMember2024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:CtrPartnershipMemberctre:TheVillasAtSaratogaMember2024-01-012024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:CtrPartnershipMemberctre:MadisonParkHealthcareMember2024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:CtrPartnershipMemberctre:MadisonParkHealthcareMember2024-01-012024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:CtrPartnershipMemberctre:OakviewHeightsNursingAndRehabilitationCenterMember2024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:CtrPartnershipMemberctre:OakviewHeightsNursingAndRehabilitationCenterMember2024-01-012024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:GulfCoastBuyer1LLCMemberctre:SpringLakeSkilledNursingAndRehabilitationMember2024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:GulfCoastBuyer1LLCMemberctre:SpringLakeSkilledNursingAndRehabilitationMember2024-01-012024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:GulfCoastBuyer1LLCMemberctre:TheVillageAtHeritageOaksMember2024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:GulfCoastBuyer1LLCMemberctre:TheVillageAtHeritageOaksMember2024-01-012024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:CtrPartnershipMemberctre:CityCreekPostAcuteAndAssistedLivingMember2024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:CtrPartnershipMemberctre:CityCreekPostAcuteAndAssistedLivingMember2024-01-012024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:NorthshoreHealthcareHoldingsLLCMemberctre:SanJuanCapistranoSeniorLivingMember2024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:NorthshoreHealthcareHoldingsLLCMemberctre:SanJuanCapistranoSeniorLivingMember2024-01-012024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:NorthshoreHealthcareHoldingsLLCMemberctre:CamarilloSeniorLivingMember2024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:NorthshoreHealthcareHoldingsLLCMemberctre:CamarilloSeniorLivingMember2024-01-012024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:NorthshoreHealthcareHoldingsLLCMemberctre:BayshireCarlsbadMember2024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:NorthshoreHealthcareHoldingsLLCMemberctre:BayshireCarlsbadMember2024-01-012024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:NorthshoreHealthcareHoldingsLLCMemberctre:BayshireRanchoMirageMember2024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:NorthshoreHealthcareHoldingsLLCMemberctre:BayshireRanchoMirageMember2024-01-012024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:CtrPartnershipMemberctre:ImbodenCreekLivingCenterMember2024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:CtrPartnershipMemberctre:ImbodenCreekLivingCenterMember2024-01-012024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:A407554thStreetLLCMemberctre:JacobHealthcareCenterMember2024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:A407554thStreetLLCMemberctre:JacobHealthcareCenterMember2024-01-012024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:A1740SanDimasLLCMemberctre:SkilledSanDimasLLCMember2024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:A1740SanDimasLLCMemberctre:SkilledSanDimasLLCMember2024-01-012024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:A17803ImperialHwyLLCMemberctre:SkilledYorbaLindaLLCMember2024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:A17803ImperialHwyLLCMemberctre:SkilledYorbaLindaLLCMember2024-01-012024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:NorthHoustonTransitionalCareMemberctre:NorthHoustonTransitionalCareMember2024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:NorthHoustonTransitionalCareMemberctre:NorthHoustonTransitionalCareMember2024-01-012024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:TorreyPinesSeniorLivingMemberctre:BayshireTorreyPinesMember2024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:TorreyPinesSeniorLivingMemberctre:BayshireTorreyPinesMember2024-01-012024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:RidgewayRehabCenterRidgewayVillageAssistedLivingMemberctre:RidgewayRehabCenterRidgewayVillageAssistedLivingMember2024-12-310001590717ctre:SkilledNursingCampusPropertiesMemberctre:RidgewayRehabCenterRidgewayVillageAssistedLivingMemberctre:RidgewayRehabCenterRidgewayVillageAssistedLivingMember2024-01-012024-12-310001590717ctre:SkilledNursingCampusPropertiesMember2024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:AvenueNHoldingsLlcMember2024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:AvenueNHoldingsLlcMember2024-01-012024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:MoeniumHoldingsLlcMember2024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:MoeniumHoldingsLlcMember2024-01-012024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:LafayetteHealthHoldingsLlcMember2024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:LafayetteHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:ExpoParkHealthHoldingsLlcMember2024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:ExpoParkHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:WisteriaHealthHoldingsLlcMember2024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:WisteriaHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:EvergladesHealthHoldingsLlcMember2024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:EvergladesHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:FlamingoHealthHoldingsLlcMember2024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:FlamingoHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:EighteenthPlaceHealthHoldingsLlcMember2024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:EighteenthPlaceHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:BoardwalkHealthHoldingsLlcMember2024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:BoardwalkHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:WillowsHealthHoldingsLlcMember2024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:WillowsHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:LockwoodHealthHoldingsLlcMember2024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:LockwoodHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:SaratogaHealthHoldingsLlcMember2024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:SaratogaHealthHoldingsLlcMember2024-01-012024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:SkyHoldingsAzLlcMember2024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:SkyHoldingsAzLlcMember2024-01-012024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:LemonRiverHoldingsLlcMember2024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:LemonRiverHoldingsLlcMember2024-01-012024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:MissionCcrcLlcMember2024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:MissionCcrcLlcMember2024-01-012024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:CtrPartnershipMemberctre:PreludeCottagesOfWoodburyMember2024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:CtrPartnershipMemberctre:PreludeCottagesOfWoodburyMember2024-01-012024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:CtrPartnershipMemberctre:LamplightInnOfBaltimoreMember2024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:CtrPartnershipMemberctre:LamplightInnOfBaltimoreMember2024-01-012024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:CtrPartnershipMemberctre:CroatanVillageMember2024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:CtrPartnershipMemberctre:CroatanVillageMember2024-01-012024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:CtrPartnershipMemberctre:CountrysideVillageMember2024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:CtrPartnershipMemberctre:CountrysideVillageMember2024-01-012024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:CtrPartnershipMemberctre:ArborPlaceMember2024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:CtrPartnershipMemberctre:ArborPlaceMember2024-01-012024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:CtrPartnershipMemberctre:ApplewoodofBrookfieldMember2024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:CtrPartnershipMemberctre:ApplewoodofBrookfieldMember2024-01-012024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:CtrPartnershipMemberctre:ApplewoodofNewBerlinMember2024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:CtrPartnershipMemberctre:ApplewoodofNewBerlinMember2024-01-012024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:CtrPartnershipMemberctre:MemoryCareCottagesinWhiteBearLakeMember2024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:CtrPartnershipMemberctre:MemoryCareCottagesinWhiteBearLakeMember2024-01-012024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:CtrPartnershipMemberctre:VistaDelLagoMember2024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:CtrPartnershipMemberctre:VistaDelLagoMember2024-01-012024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:CtrPartnershipMemberctre:InnAtBartonCreekMember2024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:CtrPartnershipMemberctre:InnAtBartonCreekMember2024-01-012024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:CtrPartnershipMemberctre:ChaptersLivingOfNorthwestChicagoMember2024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:CtrPartnershipMemberctre:ChaptersLivingOfNorthwestChicagoMember2024-01-012024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:CtrPartnershipMemberctre:ChaptersLivingOfElmhurstMember2024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:CtrPartnershipMemberctre:ChaptersLivingOfElmhurstMember2024-01-012024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:CtrPartnershipMemberctre:TheRidgeAtLansingMember2024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:CtrPartnershipMemberctre:TheRidgeAtLansingMember2024-01-012024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:CtrPartnershipMemberctre:TheRidgeAtBeavercreekMember2024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:CtrPartnershipMemberctre:TheRidgeAtBeavercreekMember2024-01-012024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:A2985N.G.StreetPropCoLLCMemberctre:VillasAtSanBernardinoMember2024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:A2985N.G.StreetPropCoLLCMemberctre:VillasAtSanBernardinoMember2024-01-012024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:SouthMountainMemberctre:SouthMountainMember2024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMemberctre:SouthMountainMemberctre:SouthMountainMember2024-01-012024-12-310001590717ctre:AssistedAndIndependentLivingPropertiesMember2024-12-310001590717ctre:SkilledNursingFacilityMemberctre:SecuredLoansMember2024-12-310001590717ctre:AssistedLivingFacilityMemberctre:SecuredLoansMember2024-12-310001590717ctre:IndependentLivingFacilityMemberctre:SecuredLoansMember2024-12-310001590717ctre:SkilledNursingFacilityAssistedLivingFacilityIndependentLivingFacilityMemberctre:SecuredLoansMember2024-01-012024-12-310001590717ctre:SkilledNursingFacilityAssistedLivingFacilityIndependentLivingFacilityMemberctre:SecuredLoansMember2024-12-310001590717stpr:NCctre:SkilledNursingFacilityMemberctre:SecuredLoansMember2024-12-310001590717stpr:NCctre:SkilledNursingFacilityCampusMemberctre:SecuredLoansMember2024-12-310001590717stpr:NCctre:SkilledNursingFacilityAndSkilledNursingFacilityCampusMemberctre:SecuredLoansMember2024-01-012024-12-310001590717stpr:NCctre:SkilledNursingFacilityAndSkilledNursingFacilityCampusMemberctre:SecuredLoansMember2024-12-310001590717stpr:WVctre:SkilledNursingFacilityMemberctre:SecuredLoansMember2024-12-310001590717stpr:WVctre:SkilledNursingFacilityCampusMemberctre:SecuredLoansMember2024-12-310001590717stpr:WVctre:SkilledNursingFacilityAndSkilledNursingFacilityCampusMemberctre:SecuredLoansMember2024-01-012024-12-310001590717stpr:WVctre:SkilledNursingFacilityAndSkilledNursingFacilityCampusMemberctre:SecuredLoansMember2024-12-310001590717stpr:GActre:SkilledNursingFacilityMemberctre:SecuredLoansMember2024-12-310001590717stpr:GActre:SkilledNursingFacilityMemberctre:SecuredLoansMember2024-01-012024-12-310001590717stpr:TNctre:SkilledNursingFacilityMemberctre:SecuredLoansMember2024-12-310001590717stpr:TNctre:SkilledNursingFacilityMemberctre:SecuredLoansMember2024-01-012024-12-310001590717ctre:California2023Memberstpr:CActre:SkilledNursingFacilityMemberctre:SecuredLoansMember2024-12-310001590717ctre:California2023Memberstpr:CActre:AssistedLivingFacilityMemberctre:SecuredLoansMember2024-12-310001590717ctre:California2023Memberstpr:CActre:IndependentLivingFacilityMemberctre:SecuredLoansMember2024-12-310001590717ctre:California2033Memberstpr:CActre:SkilledNursingFacilityAssistedLivingFacilityIndependentLivingFacilityMemberctre:SecuredLoansMember2024-01-012024-12-310001590717ctre:California2033Memberstpr:CActre:SkilledNursingFacilityAssistedLivingFacilityIndependentLivingFacilityMemberctre:SecuredLoansMember2024-12-310001590717stpr:MDctre:SkilledNursingFacilityMemberctre:SecuredLoansMember2024-12-310001590717stpr:MDctre:SkilledNursingFacilityMemberctre:SecuredLoansMember2024-01-012024-12-310001590717stpr:FLctre:SkilledNursingFacilityMemberctre:SecuredLoansMember2024-12-310001590717stpr:FLctre:SkilledNursingFacilityMemberctre:SecuredLoansMember2024-01-012024-12-310001590717stpr:WActre:SkilledNursingFacilityMemberctre:SecuredLoansMember2024-12-310001590717stpr:WActre:SkilledNursingFacilityMemberctre:SecuredLoansMember2024-01-012024-12-310001590717stpr:CO2024-12-310001590717stpr:COctre:SkilledNursingFacilityMemberctre:SecuredLoansMember2024-01-012024-12-310001590717stpr:COctre:SkilledNursingFacilityMemberctre:SecuredLoansMember2024-12-310001590717stpr:CA2024-12-310001590717ctre:California2025Memberstpr:CActre:SkilledNursingFacilityMemberctre:SecuredLoansMember2024-01-012024-12-310001590717ctre:California2025Memberstpr:CActre:SkilledNursingFacilityMemberctre:SecuredLoansMember2024-12-310001590717ctre:California20262Memberstpr:CActre:AssistedLivingFacilityMemberctre:SecuredLoansMember2024-12-310001590717ctre:California20262Memberstpr:CActre:AssistedLivingFacilityMemberctre:SecuredLoansMember2024-01-012024-12-310001590717ctre:California20261Memberstpr:CActre:SkilledNursingFacilityMemberctre:SecuredLoansMember2024-12-310001590717ctre:California20261Memberstpr:CActre:SkilledNursingFacilityMemberctre:SecuredLoansMember2024-01-012024-12-310001590717stpr:INctre:AssistedLivingFacilityMemberctre:SecuredLoansMember2024-12-310001590717stpr:INctre:AssistedLivingFacilityMemberctre:SecuredLoansMember2024-01-012024-12-310001590717stpr:FL2024-12-310001590717stpr:FLctre:AssistedLivingFacilityMemberctre:SecuredLoansMember2024-01-012024-12-310001590717stpr:FLctre:AssistedLivingFacilityMemberctre:SecuredLoansMember2024-12-310001590717stpr:VActre:SkilledNursingFacilityMemberctre:MezzanineLoansMember2024-12-310001590717stpr:VActre:SkilledNursingFacilityMemberctre:MezzanineLoansMember2024-01-012024-12-310001590717stpr:WVctre:SkilledNursingFacilityAndSkilledNursingFacilityCampusMemberctre:MezzanineLoansMember2024-01-012024-12-310001590717stpr:WVctre:SkilledNursingFacilityAndSkilledNursingFacilityCampusMemberctre:MezzanineLoansMember2024-12-310001590717stpr:MOctre:SkilledNursingFacilityMemberctre:MezzanineLoansMember2024-12-310001590717stpr:MOctre:SkilledNursingFacilityCampusMemberctre:MezzanineLoansMember2024-12-310001590717stpr:MOctre:AssistedLivingFacilityMemberctre:MezzanineLoansMember2024-12-310001590717stpr:MOctre:SkilledNursingFacilityMemberctre:MezzanineLoansMember2024-01-012024-12-310001590717stpr:CActre:SkilledNursingFacilityMemberctre:MezzanineLoansMember2024-12-310001590717stpr:CActre:SkilledNursingFacilityMemberctre:MezzanineLoansMember2024-01-012024-12-310001590717stpr:MDctre:SkilledNursingFacilityMemberctre:MezzanineLoansMember2024-12-310001590717stpr:MDctre:SkilledNursingFacilityMemberctre:MezzanineLoansMember2024-01-012024-12-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-K
 (Mark One)
☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2024
or
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from _____ to _____
Commission file number 001-36181
CareTrust REIT, Inc.
(Exact name of registrant as specified in its charter)
Maryland 46-3999490
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)
905 Calle Amanecer, Suite 300, San Clemente, CA 92673
(Address of principal executive offices, including zip code)
Registrant’s telephone number, including area code (949) 542-3130
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.01 per share CTRE New York Stock Exchange
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒   No ☐
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐   No ☒
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒   No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒   No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐
Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐


Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Act.) Yes ☐ No ☒ State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter: $3.9 billion.
As of February 11, 2025, there were 187,661,893 shares of the registrant’s common stock outstanding.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the definitive Proxy Statement for the registrant’s 2025 Annual Meeting of Stockholders, which will be filed with the Securities and Exchange Commission within 120 days after the end of fiscal year 2024, are incorporated by reference into Part III of this Report.



TABLE OF CONTENTS
 
PART I
Item 1.
Item 1A.
Item 1B.
Item 1C.
Item 2.
Item 3.
Item 4.
PART II
Item 5.
Item 6.
Item 7.
Item 7A.
Item 8.
Item 9.
Item 9A.
Item 9B.
Item 9C.
PART III
Item 10.
Item 11.
Item 12.
Item 13.
Item 14.
PART IV
Item 15.
Item 16.
Signatures



3

STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
Certain statements in this report may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Those forward-looking statements include all statements that are not historical statements of fact and those regarding our intent, belief or expectations, including, but not limited to, statements regarding: future financing plans, business strategies, growth prospects and operating and financial performance; expectations regarding the making of distributions and the payment of dividends; and compliance with and changes in governmental regulations.
Words such as “anticipate(s),” “expect(s),” “intend(s),” “plan(s),” “believe(s),” “may,” “will,” “would,” “could,” “should,” “seek(s)” and similar expressions, or the negative of these terms, are intended to identify such forward-looking statements. These statements are based on management’s current expectations and beliefs and are subject to a number of risks and uncertainties that could lead to actual results differing materially from those projected, forecasted or expected. Although we believe that the assumptions underlying the forward-looking statements are reasonable, we can give no assurance that our expectations will be attained. Factors which could have a material adverse effect on our operations and future prospects or which could cause actual results to differ materially from our expectations include, but are not limited to: (i) the ability and willingness of our tenants and borrowers to meet and/or perform their obligations under the agreements we have entered into with them, including without limitation, their respective obligations to indemnify, defend and hold us harmless from and against various claims, litigation and liabilities; (ii) the risk that we may have to incur additional impairment charges related to our assets held for sale if we are unable to sell such assets at the prices we expect; (iii) the impact of healthcare reform legislation, including minimum staffing level requirements, on the operating results and financial conditions of our tenants and borrowers; (iv) the ability of our tenants and borrowers to comply with applicable laws, rules and regulations in the operation of the properties we lease to them or finance; (v) the ability and willingness of our tenants to renew their leases with us upon their expiration, and the ability to reposition our properties on the same or better terms in the event of nonrenewal or in the event we replace an existing tenant, as well as any obligations, including indemnification obligations, we may incur in connection with the replacement of an existing tenant; (vi) the availability of and the ability to identify (a) tenants who meet our credit and operating standards, and (b) suitable acquisition opportunities and the ability to acquire and lease the respective properties to such tenants on favorable terms; (vii) the ability to generate sufficient cash flows to service our outstanding indebtedness; (viii) access to debt and equity capital markets; (ix) fluctuating interest rates; (x) the impact of public health crises, including significant COVID-19 outbreaks as well as other pandemics or epidemics; (xi) the ability to retain our key management personnel; (xii) the ability to maintain our status as a real estate investment trust (“REIT”); (xiii) changes in the U.S. tax law and other state, federal or local laws, whether or not specific to REITs; (xiv) other risks inherent in the real estate business, including potential liability relating to environmental matters and illiquidity of real estate investments; and (xv) any additional factors included in this report, including in the section entitled “Risk Factors” in Item 1A of this Annual Report, as such risk factors may be amended, supplemented or superseded from time to time by other reports we file with the Securities and Exchange Commission (the “SEC”), including subsequent Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q.
Forward-looking statements speak only as of the date of this report. Except in the normal course of our public disclosure obligations, we expressly disclaim any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in our expectations or any change in events, conditions or circumstances on which any statement is based.
TENANT AND BORROWER INFORMATION
This Annual Report on Form 10-K includes information regarding certain of our tenants that lease properties from us and our borrowers, most of which are not subject to SEC reporting requirements. The Ensign Group, Inc. (“Ensign”), The Pennant Group, Inc. (“Pennant”) and PACS Group, Inc. (“PACS”) are subject to the reporting requirements of the SEC and are required to file with the SEC annual reports containing audited financial information and quarterly reports containing unaudited financial information. You are encouraged to review Ensign, Pennant and PACS’s publicly available filings, which can be found at the SEC’s website at www.sec.gov.
The information related to our tenants and borrowers contained or referred to in this Annual Report on Form 10-K was provided to us by such tenants and borrowers or derived from SEC filings or other publicly available information. We have not verified this information through an independent investigation or otherwise. We have no reason to believe that this information is inaccurate in any material respect, but we cannot provide any assurance of its accuracy. We are providing this data for informational purposes only.

4

PART I
All references in this report to “CareTrust REIT,” the “Company,” “we,” “us” or “our” mean CareTrust REIT, Inc. together with its consolidated subsidiaries. Unless the context suggests otherwise, references to “CareTrust REIT, Inc.” mean the parent company without its subsidiaries.
ITEM  1.    Business
Our Company
CareTrust REIT is a self-administered, publicly-traded REIT engaged in the ownership, acquisition, financing, development and leasing of skilled nursing, seniors housing and other healthcare-related properties. As of December 31, 2024, CareTrust REIT owned, directly or in consolidated joint ventures, and leased to independent operators, 258 skilled nursing facilities (“SNFs”), multi-service campuses, assisted living facilities (“ALFs”) and independent living facilities (“ILFs”) (including facilities classified as held for sale) consisting of 28,088 operational beds and units located in 32 states with the highest concentration of properties by rental income located in California and Texas. As of December 31, 2024, we also had other real estate related investments consisting of three preferred equity investments, 15 real estate secured loans receivable and five mezzanine loans receivable with a carrying value of $795.2 million and one financing receivable with a carrying value of $96.0 million.
The following table summarizes our real estate investment portfolio as of December 31, 2024 (dollars in thousands):
Twelve Months Ended December 31, 2024
Owned Properties Number of Properties Number of Beds/Units Book Value as of December 31, 2024 Percentage of Book Value Rental Income Percentage of Total Revenue
Skilled nursing 192  20,930  $ 1,742,970  55  % $ 169,414  61  %
Multi-service campuses 30  4,272  408,045  13  % 43,372  16  %
Assisted living / independent living 36  2,886  132,936  % 15,475  %
Total Owned Properties 258  28,088  $ 2,283,951  72  % $ 228,261  83  %
Financing Receivable Number of Properties Number of Beds/Units Book Value as of December 31, 2024 Percentage of Book Value Interest Income Percentage of Total Revenue
Skilled nursing / assisted living / independent living 46  3,820  $ 96,004  % $ 1,009  *
Total Financing Receivable 46  3,820  $ 96,004  % $ 1,009  *
Other Real Estate Related Investments Number of Properties Number of Beds/Units Book Value as of December 31, 2024 Percentage of Book Value Interest Income Percentage of Total Revenue
Mortgage Loans 87  8,434  $ 660,392  21  % $ 35,972  13  %
Mezzanine Loans(1)
46  5,643  80,612  % 9,456  %
Preferred Equity 54,199  % 2,826  %
Total 133  14,077  $ 795,203  25  % $ 48,254  17  %
Total Portfolio 437  45,985  $ 3,175,158  100  % $ 277,524  100  %
(1)If we also have extended mezzanine financing to an affiliate of the borrower under a mortgage loan receivable, the applicable facility counts are included in both respective totals.
* Represents less than 1%
We generate revenues primarily by leasing healthcare-related properties to healthcare operators in triple-net lease arrangements, under which the tenant is solely responsible for the costs related to the facility (including property taxes, insurance, maintenance and repair costs and capital expenditures, subject to certain exceptions in the case of properties leased to Ensign and Pennant, as defined below). From time to time, we also extend secured mortgage loans to healthcare operators, secured by healthcare-related properties, extend secured mezzanine loans to healthcare operators, secured by membership interests in healthcare-related properties, and invest in preferred equity investments. From time to time, we also partner with third-party institutional investors to invest in healthcare real estate in consolidated joint ventures. Pursuant to our joint ventures, we typically contribute at least 90% of the joint venture’s total investment amount and we receive 100% of the preferred equity interest in the joint venture and a 50% common equity interest in the joint venture.
5

Our joint venture partner contributes the remaining total investment amount in exchange for a 50% common equity interest in the joint venture.
We conduct and manage our business as one operating segment for internal reporting and internal decision making purposes. We expect to grow our portfolio by pursuing opportunities to acquire additional properties that will be leased to a diverse group of local, regional, and national healthcare providers, which may include new or existing skilled nursing operators, as well as seniors housing operators, behavioral health facilities and related businesses. We also anticipate diversifying our portfolio over time, including by acquiring properties in different geographic markets, including internationally, and in different asset classes. In addition, we actively monitor the clinical, regulatory and financial operating results of our tenants and borrowers, and work to identify opportunities within their operations and markets that could improve their operating results at our facilities. We communicate such observations to our tenants and borrowers; however, we have no contractual obligation to do so. Moreover, our tenants and borrowers have sole discretion with respect to the day-to-day operation of the facilities they lease from us, and how and whether to implement any observation we may share with them. We also actively monitor the overall occupancy, skilled mix, and other operating metrics of our tenants and borrowers on at least a monthly basis. We have replaced tenants in the past, and may elect to replace tenants in the future, if they fail to meet the terms and conditions of their leases with us. The replacement tenants may include tenants with whom we have had no prior landlord-tenant relationship as well as current tenants with whom we are comfortable expanding our relationships. In addition, we may from time to time in the future repurpose facilities for other uses, such as behavioral health. We have also provided select tenants with strategic capital for facility upkeep and modernization, as well as short-term working capital loans when they are awaiting licensure and certification or conducting turnaround work in one or more of our properties, and we may continue to do so in the future. We have also assisted our tenants with transitioning to lower emissions technologies through our tenant incentive program, where we support efficiency projects through our dedicated tenant capital expenditure budget, providing sustainability incentives rent-free. In addition, we periodically reassess the investments we have made and the tenant relationships we have entered into, and have selectively disposed of facilities or investments, or terminated such relationships, and we expect to continue making such reassessments and, where appropriate, taking such actions.
We elected to be taxed as a REIT for U.S. federal income tax purposes beginning with our taxable year ended December 31, 2014. We believe that we have been organized and have operated, and we intend to continue to operate, in a manner to qualify for taxation as a REIT. We operate through an umbrella partnership, commonly referred to as an UPREIT structure, in which substantially all of our properties and assets are held through CTR Partnership, L.P. (the “Operating Partnership”). The Operating Partnership is managed by CareTrust REIT’s wholly owned subsidiary, CareTrust GP, LLC, which is the sole general partner of the Operating Partnership. To maintain REIT status, we must meet a number of organizational and operational requirements, including a requirement that we annually distribute to our stockholders at least 90% of our REIT taxable income, determined without regard to the dividends paid deduction and excluding any net capital gains.
6

Investment Activity
The following table summarizes our acquisitions from January 1, 2024 through February 12, 2025 (dollars in thousands):
Type of Facility
Purchase Price(1)
Initial Annual Cash Rent(2)
Number of Properties
Number of Beds/Units(3)
Skilled nursing(4)
$ 732,919  $ 67,924  43  4,632 
Multi-service campuses(4)
90,639  7,467  683 
Assisted living / independent living(4)
12,749  1,022  102 
Total $ 836,307  $ 76,413  50  5,417 
(1)Purchase price includes capitalized acquisition costs.
(2)Initial annual cash rent represents initial cash rent for the first twelve months.
(3)The number of beds/units includes operating beds at acquisition date.
(4)Includes facilities held in consolidated joint ventures. See Note 3, Real Estate Investments, Net, and Note 12, Variable Interest Entities, for additional information.
The following table summarizes our financing receivable investment from January 1, 2024 through February 12, 2025 (dollars in thousands):
Investment Type
Investment, at cost(1)
Initial Annual Interest Income(2)
Number of Properties
Number of Beds/Units(3)
Financing receivable $ 95,723  $ 11,560  46  3,820 
Total $ 95,723  $ 11,560  46  3,820 
(1)Investment does not include transaction costs given they were expensed during the year ended December 31, 2024 as a result of our election to use the fair value option.
(2)Represents annualized acquisition-date interest income.
(3)The number of beds/units includes operating beds at the investment date.
The following table summarizes our other real estate related investments from January 1, 2024 through February 12, 2025 (dollars in thousands):
Investment Type(1)
Investment
Initial Annual Interest Income(2)
Number of Properties
Number of Beds/Units(3)
Mortgage secured loans receivable $ 496,615  $ 44,210  50  5,172 
Mezzanine loans receivable 63,676  8,636  29  3,763 
Preferred equity 52,000  5,734  N/A N/A
Total $ 612,291  $ 58,580  79  8,935 
(1)Table excludes a $1.0 million mortgage loan originated in connection with the sale of one ALF during the period presented.
(2)Represents annualized acquisition-date interest income, less subservicing fees, if applicable. For floating rate loans, interest income has been calculated using the benchmark rate at loan origination.
(3)The number of beds/units includes operating beds at the investment date.
From January 1, 2024 through December 31, 2024, we sold 13 SNFs and four ALFs for net proceeds of $17.7 million, resulting in a net loss on sale of real estate of $2.2 million. Subsequent to December 31, 2024, we sold or disposed of three SNFs, one SNF Campus and one ALF, for which we expect to record an estimated gain on sale of real estate of $3.9 million.
Our Industry
The skilled nursing industry has evolved to meet the growing demand for post-acute and custodial healthcare services generated by an aging population, increasing life expectancies and the trend toward shifting of patient care to lower cost settings. We believe this evolution has led to a number of favorable improvements in the industry, as described below:
•Shift of Patient Care to Lower Cost Alternatives. The growth of the senior population in the United States continues to increase healthcare costs. In response, federal and state governments have adopted cost-containment measures that encourage the treatment of patients in more cost-effective settings such as SNFs, for which the staffing requirements and associated costs are often significantly lower than acute care hospitals, inpatient rehabilitation facilities and other post-acute care settings. As a result, SNFs are generally serving a larger population of higher-acuity patients than in the past. The same trend is impacting ALFs, which are now generally serving some patients who previously would have received services at SNFs.
7

•Significant Acquisition and Consolidation Opportunities. The skilled nursing industry is large and highly fragmented, characterized predominantly by numerous local and regional providers. We believe this fragmentation provides significant acquisition and consolidation opportunities for us.
•Widening Supply and Demand Imbalance. The number of SNFs has declined modestly over the past several years. According to the American Health Care Association, the nursing home industry was comprised of approximately 14,800 facilities as of July 2024, as compared with over 15,600 facilities as of July 2016. We expect that the supply/demand imbalance in the skilled nursing industry will increasingly favor skilled nursing and assisted living providers due to the shift of patient care to lower cost settings and an aging population.
•Increased Demand Driven by Aging Populations. As seniors account for a higher percentage of the total U.S. population, we believe the overall demand for skilled nursing services will increase. At present, the primary market demographic for skilled nursing services is individuals age 75 and older. The U.S. Census estimates that there were over 59 million people in the United States in 2023 over the age of 65. The U.S. Census estimates this group to be one of the fastest growing segments of the United States population, projecting that it will almost double between 2020 and 2060. According to the Centers for Medicare & Medicaid Services, nursing home care facilities and continuing care retirement expenditures are projected to grow from approximately $209.3 billion in 2023, which includes federal expenditures in response to the COVID-19 pandemic, to approximately $337.4 billion in 2032. Although seniors housing and skilled nursing occupancy rates declined during the COVID-19 pandemic, we believe that these trends in population will support an increasing demand for services in the long-term, which in turn will likely support an increasing demand for the services provided within our properties.
While most factors described above indicate projected growth for our industry, labor shortages and minimum staffing requirements from the Centers for Medicare and Medicaid Services (see “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Recent Developments — Regulatory Updates”) have led, and may continue to lead, to increased costs. Further, our operators have experienced increased costs due to inflation, elevated interest rates and related changes to consumer spending, including, but not limited to, an increase in individuals delaying or deferring moves to seniors housing, which could cause our operators to be unable or unwilling to make rental or interest payments when due. It is difficult to predict the duration of the effects of these economic and market conditions on the industry. In addition, current macroeconomic conditions and the resulting market volatility may adversely impact our ability to sell properties on acceptable terms, if at all, which could result in additional impairment charges.
Portfolio Summary
We have a geographically diverse portfolio, consisting of the following types of facilities as of December 31, 2024:
•Skilled Nursing Facilities. SNFs are licensed healthcare facilities that provide restorative, rehabilitative and nursing care for people not requiring the more extensive and sophisticated treatment available at acute care hospitals. Treatment programs include physical, occupational, speech, respiratory and other therapies, including sub-acute clinical protocols such as wound care and intravenous drug treatment. Charges for these services are generally paid from a combination of government reimbursement and private sources. As of December 31, 2024, our portfolio included 313 SNFs (excluding 3 SNFs held for sale), consisting of 189 owned facilities, 85 facilities related to our other real estate related investments and 39 facilities related to our financing receivable. Included in the 189 owned SNFs are 31 SNFs held in consolidated joint ventures. In addition, our portfolio includes 35 SNFs located on campuses that also have ALFs or ILFs, which we refer to as multi-service campuses (see below under “Multi-Service Campuses”).
•Assisted Living Facilities. ALFs are licensed healthcare facilities that provide personal care services, support and housing for those who need help with activities of daily living, such as bathing, eating and dressing, yet require limited medical care. The programs and services may include transportation, social activities, exercise and fitness programs, beauty or barber shop access, hobby and craft activities, community excursions, meals in a dining room setting and other activities sought by residents. These facilities are often apartment-like buildings with private residences ranging from single rooms to large apartments. Certain ALFs may offer higher levels of personal assistance for residents requiring memory care as a result of Alzheimer’s disease or other forms of dementia. The level of personal assistance that may be provided at ALFs is based in part on state regulations. Since states often apply differing license classifications, and standards, regulatory requirements may differ significantly between states. As of December 31, 2024, our portfolio included 51 ALFs (excluding 5 ALFs classified as held for sale and one facility which is non-operational), some of which also contain independent living and memory care units. The 51 ALFs consist of 27 owned facilities, 19 facilities related to our other real estate related investments and 5 facilities related to our financing receivable. Included in the 27 owned ALFs is one ALF held in a consolidated joint venture. Assisted living facilities that are not on a multi-service campus are sometimes referred to as seniors housing.
8

•Independent Living Facilities. ILFs, also known as retirement communities or senior apartments, are not healthcare facilities and are not licensed to provide healthcare services to residents. The facilities typically consist of entirely self-contained apartments, complete with their own kitchens, baths and individual living spaces, as well as parking for tenant vehicles. They are most often rented unfurnished, and generally can be personalized by the tenants, and are typically occupied by an individual or a couple over the age of 55. These facilities offer various services and amenities such as laundry, housekeeping, dining options/meal plans, exercise and wellness programs, transportation, social, cultural and recreational activities, on site security and emergency response programs. As of December 31, 2024, our portfolio included seven ILFs, consisting of three owned facilities, two facilities related to our other real estate related investments and two facilities related to our financing receivable. Independent living facilities that are not on a multi-service campus are sometimes referred to as seniors housing.
•Multi-Service Campuses. Multi-service campuses generally include some combination of co-located SNFs, ALFs, ILFs, and/or memory care units all housed at a single location and operated as a continuum of care. We also refer to continuing care retirement communities as multi-service campuses. These facilities are often marketed as an opportunity for residents to “age in place,” and tend to attract couples where the individuals may require or benefit from differing levels of care. As of December 31, 2024, our portfolio included 35 facilities that we classify as multi-service campuses (excluding two multi-service campuses classified as held for sale), consisting of 28 owned facilities and seven facilities related to our other real estate related investments. Included in the 28 owned facilities are two multi-service campuses held in consolidated joint ventures.
Our portfolio of SNFs, ALFs, ILFs and multi-service campuses is broadly diversified by geographic location throughout the United States, with concentrations in California and Texas based on rental income.
Significant Master Leases
Ensign
As of December 31, 2024, we leased 97 facilities to subsidiaries of Ensign, which have a total of 10,160 operational beds. We have leased a significant number of our properties to subsidiaries of Ensign on a triple-net basis under eight long-term leases, each with its own pool of properties, that have varying maturities and diversity in both facility type and geography (each an “Ensign Master Lease” and collectively, the “Ensign Master Leases”). The Ensign Master Leases provide for initial terms in excess of ten years with staggered expiration dates and no purchase options. At Ensign’s option, each Ensign Master Lease may be extended for up to three five-year renewal terms beyond the initial term and, if elected, the renewal will be effective for all of the leased facilities then subject to the applicable Ensign Master Lease. The Ensign Master Leases are guaranteed by Ensign and contain cross-default provisions. During the year ended December 31, 2020, the Company acquired four additional facilities, which have a total of 620 operational beds, leased to subsidiaries of Ensign on a triple-net basis under two separate master lease agreements (the “Ensign TX Master Leases”), each of which contains a purchase option. The obligations under the Ensign TX Master Leases for the four additional facilities are guaranteed by Ensign but do not contain cross-default provisions with the Ensign Master Leases. During the year ended December 31, 2024, the Company received written notice of Ensign’s intent to exercise the purchase option on these four facilities. As a result, these four facilities have been classified as held for sale as of December 31, 2024. During the year ended December 31, 2024, the Company, through a joint venture, acquired six facilities, which have a total of 586 operational beds, leased to subsidiaries of Ensign commencing on January 1, 2025, under a new triple-net master lease agreement (the “Ensign TN Master Lease”). The obligations under the Ensign TN Master Lease are guaranteed by Ensign. A default under the Ensign TN Master Lease constitutes a default under the Ensign Master Leases, but a default under the Ensign Master Leases and/or the Ensign TX Master Leases does not constitute a default under the Ensign TN Master Lease. As of December 31, 2024, annualized contractual rental income from the Ensign Master Leases was $68.2 million, and annualized contractual rental income from all Ensign leases (except the Ensign TN Master Lease which had not commenced) was $72.3 million, representing 26% and 28% of total annualized contractual rental income, respectively. Rent is escalated annually in June under the Ensign Master Leases, and in December under the Ensign TX Master Leases, by an amount equal to the product of (1) the lesser of the percentage change in the Consumer Price Index (“CPI”) (but not less than zero) or 2.5%, and (2) the prior year’s rent. Rent is escalated annually in January under the Ensign TN Master Lease by an amount equal to the lesser of (1) the product of (x) 2 and (y) the percentage change in the Consumer Price Index (“CPI”) (but not less than zero) or 2.5%, and (2) the prior year’s rent.
PACS
As of December 31, 2024, 14 of our properties were leased to affiliates of PACS Group, Inc. (“PACS”) on a triple-net basis under one long-term lease (the “PACS Master Lease”), and have a total of 1,827 operational beds. One of the facilities is included in assets held for sale as of December 31, 2024. The PACS Master Lease commenced on October 26, 2017, and provides for an initial term of fifteen years, with two five-year renewal options. During the year ended December 31, 2024, the Company, through a joint venture, acquired 11 facilities, which have a total of 1,186 operational beds, leased to subsidiaries of PACS commencing on December 1, 2024, under a new triple-net master lease agreement (the “PACS TN Master Lease”).
9

The PACS TN Master lease has an initial term of 15 years, with two five-year renewal options and includes purchase options for up to 6 facilities. As of December 31, 2024, annualized contractual rental income from the PACS Master Lease was $20.0 million (excluding the facility classified as held for sale), and annualized contractual rental income from all PACS leases was $37.9 million, representing 8% and 15% of total annualized contractual rental income, respectively. Rent is escalated annually in November under the PACS Master Lease by an amount equal to the product of (1) the lesser of the percentage change in the CPI (but not less than zero) or 3%, and (2) the prior year’s rent. Rent under the PACS TN Master Lease is escalated annually in December by an amount equal to the product of (1) the percentage change in the CPI and (2) the prior year’s rent (subject to a 2% floor and a 4% cap). The PACS TN Master lease also provides rent abatement of $0.3 million in the first year.
PMG
As of December 31, 2024, 15 of our properties were leased to subsidiaries of Priority Management Group (“PMG”) on a triple-net basis under one long-term lease (the “PMG Master Lease”), and have a total of 2,144 operational beds. The PMG Master Lease commenced on December 1, 2016, and provides for an initial term of fifteen years, with two five-year renewal options. As of December 31, 2024, annualized contractual rental income from the PMG Master Lease was $31.9 million, representing 12% of total annualized contractual rental income.
See “Risk Factors — Risks Related to Our Business and Operations — We are dependent on the healthcare operators that lease our properties as well as the borrowers under our mortgage secured loans to successfully operate their business and make contractual payments, and an event that materially and adversely affects their business, financial position or results of operations could materially and adversely affect our business, financial position or results of operations.”
We monitor the creditworthiness of our tenants by evaluating the ability of the tenants to meet their lease obligations to us based on the tenants’ financial performance, including the evaluation of any guarantees of tenant lease obligations. The primary basis for our evaluation of the credit quality of our tenants (and more specifically the tenants’ ability to pay their rent obligations to us) is the tenants’ lease coverage ratios. These coverage ratios compare (i) earnings before interest, income taxes, depreciation, amortization and rent (“EBITDAR”) to rent coverage, and (ii) earnings before interest, income taxes, depreciation, amortization, rent and management fees (“EBITDARM”) to rent coverage. We utilize a standardized 5% management fee when we calculate lease coverage ratios. We obtain various financial and operational information from our tenants each month. We regularly review this information to calculate the above-described coverage metrics, to identify operational trends, to assess the operational and financial impact of the changes in the broader industry environment (including the potential impact of government reimbursement and regulatory changes), and to evaluate the management and performance of the tenants’ operations. We also monitor the creditworthiness of our borrowers and the ability of the borrowers to meet their loan obligations to us based on the borrowers’ financial performance. Our monitoring process includes review of monthly financial statements and other operating data for each facility, quarterly review of borrower creditworthiness based on debt service coverage ratios and review of covenant compliance. These metrics help us identify potential areas of concern relative to our tenants’ or borrowers’ credit quality and ultimately the tenants’ or borrowers’ ability to generate sufficient liquidity to meet their ongoing obligations, including their obligations to continue paying contractual rents and interest due to us and satisfying other financial obligations to third parties, as prescribed by our triple-net leases and loan agreements.

10

Owned Properties
Properties by Type:
The following table displays the geographic distribution of our properties leased to third-party tenants, excluding those held for sale, and the related number of beds and units available for occupancy by facility type, as of December 31, 2024. The number of beds or units that are operational may be less than the official licensed capacity.
  Total SNFs Multi-Service Campuses
ALFs and ILFs
State Properties
Beds/Units
Facilities
Beds
Campuses
Beds/Units
Facilities
Beds/Units
CA(1)
51  6,390  33  3,828  12  2,004  558 
TX 43  5,414  38  4,726  476  212 
TN(1)
26  2,740  26  2,740  —  —  —  — 
ID 17  1,396  16  1,327  69  —  — 
UT 13  1,374  913  272  189 
AZ 11  1,353  984  —  —  369 
IL 11  1,053  642  275  136 
WA 10  900  803  —  —  97 
LA 1,164  949  215  —  — 
CO 788  520  —  —  268 
NC 493  390  —  —  103 
IA 354  185  169  —  — 
MD 431  187  108  136 
NE 366  220  146  —  — 
OH 379  116  197  66 
PA 597  597  —  —  —  — 
MT 260  260  —  —  —  — 
NV 304  92  —  —  212 
MN 62  —  —  —  —  62 
WI 89  —  —  —  —  89 
AL(1)
91  91  —  —  —  — 
GA 148  148  —  —  —  — 
KS 102  102  —  —  —  — 
MI 66  —  —  —  —  66 
MO 70  70  —  —  —  — 
ND 83  83  —  —  —  — 
NM 124  124  —  —  —  — 
OR 53  53  —  —  —  — 
SC 108  108  —  —  —  — 
SD 81  81  —  —  —  — 
VA 125  125  —  —  —  — 
WV 67  —  —  67  —  — 
Total 248  27,025  189  20,464  28  3,998  31  2,563 
(1)Includes facilities held in consolidated joint ventures. See Note 3, Real Estate Investments, Net, and Note 12, Variable Interest Entities, for additional information.



 
11

Facility Type — Rental Income and Occupancy:
The following tables display the annual rental income and occupancy for each facility type leased to third-party tenants for the years ended December 31, 2024 and 2023 and total beds/units for each facility type as of December 31, 2024 and 2023. Percentage occupancy in the below table is computed by dividing the average daily number of beds occupied by the total number of beds available for use during the periods indicated (beds are included in the computation following the date of acquisition, or through the date of disposition, only).
  For the Year Ended December 31, 2024
As of December 31, 2024
Facility Type Rental Income
(in thousands)
Percent
of Total 
Occupancy(1)
Total Beds/
Units 
SNFs(2)
$ 169,414  74  % 79  % 20,930 
Multi-Service Campuses(2)
43,372  19  % 79  % 4,272 
ALFs and ILFs(2)
15,475  % 74  % 2,886 
Total $ 228,261  100  % 28,088 
(1)Occupancy data excludes one non-operational ALF. Occupancy data derived solely from information provided by our tenants without independent verification by us. The leased facility financial performance data is presented one quarter in arrears.
(2)Includes facilities held in consolidated joint ventures. See Note 3, Real Estate Investments, Net, and Note 12, Variable Interest Entities, for additional information.
  For the Year Ended December 31, 2023
As of December 31, 2023
Facility Type Rental Income
(in thousands)
Percent
of Total 
Occupancy(1)
Total Beds/
Units 
SNFs(2)
$ 145,589  73  % 75  % 17,366 
Multi-Service Campuses 35,779  18  % 75  % 3,593 
ALFs and ILFs 17,231  % 75  % 2,969 
Total $ 198,599  100  % 23,928 
(1)Occupancy data excludes two facilities which are in the process of being repurposed, one non-operational SNF and two non-operational ALFs. Occupancy data derived solely from information provided by our tenants without independent verification by us. The leased facility financial performance data is presented one quarter in arrears.
(2)Includes facilities held in consolidated joint ventures. See Note 3, Real Estate Investments, Net, and Note 12, Variable Interest Entities, for additional information.
Financing Receivable
During 2024, we invested in 46 properties through a sale and leaseback transaction. We leased the properties back to an affiliate of the seller and provided the seller-lessee with purchase options. We determined that the sale and leaseback transaction met the accounting criteria to be presented as financing receivable on our consolidated balance sheets and recorded the payments from these properties as interest income from financing receivable on our consolidated statements of operations. See Note 2, Summary of Significant Accounting Policies, for additional information. The following table provides information regarding our investment in the financing receivable during the year ended December 31, 2024 (dollars in thousands):
For The Year Ended December 31, 2024
Lease Maturity State
Type of Properties
Number of Properties
Number of Beds/Units
Gross Investment(1)
Effective Interest Rate(2)
Interest Income from Financing Receivable
2039 IL SNF / Campus /ALF / ILF 46  3,820  $ 97,053  12.0  % $ 1,009 
(1)Gross investment includes $1.3 million of transaction costs.
(2)We leased these facilities back to the seller under a 15-year contract, with two five-year renewal options. The agreement provides for an initial contractual cash yield of 11.0% for the first three years, with annual CPI-based escalators beginning in year four, subject to a 3% cap. The agreement provides for deferred payments equal to 2.0% of the contractual cash yield in the first year and 0.5% of the contractual cash yield in the second year. At the time the seller-lessee exercises its purchase options, option proceeds will be used to repay any outstanding deferred payments as well as additional amounts such that we receive a contractual cash yield of 12.5% on our gross investment in the applicable properties through the option exercise date. If any deferred amounts remain unpaid, beginning in year eight, the deferred amounts are to be repaid in 24 equal monthly payments. The agreement provides the seller-lessee with options to purchase all facilities in separate tranches, with the first purchase option window beginning December 1, 2024. We have not received notice of exercise for the purchase option period currently open. See Note 5, Other Real Estate Related and Other Investments, for additional information.
12

Other Real Estate Related Investments
The following table summarizes our investments in mortgage loans, mezzanine loans and preferred equity investments (dollars in thousands):
Mortgage Loans
For The Year Ended December 31, 2024
For The Year Ended December 31, 2023
Maturity Investment Year State
Type of Properties
Principal Balance as of December 31, 2024
Wtd Avg Contractual Interest Rate
Interest Income
Interest Income
2025 2022 / 2023 CA, GA, IN SNF $ 38,901  9.2% $ 3,791  $ 4,711 
2026 2023 CA ALF / SNF 9,864  10.7% 1,069  169 
2027 2022 / 2024 Mid-Atlantic, FL SNF / Campus 76,000  8.4% 6,476  6,368 
2028 2023 FL SNF 15,727  9.0% 1,499  661 
2029 2024 Various SNF / Campus / ALF / ILF 425,000  8.7% 18,432  — 
2031 2024 TN SNF 26,675  9.1% 1,652  — 
2033 2023 CA Campus / ILF 25,993  9.0% 2,378  1,209 
2034 2024 CO, WA SNF 21,050  8.5% 226  — 
2039 2024 MD SNF 19,190  9.4% 449  — 
$ 658,400  8.8% $ 35,972  $ 13,118 
Mezzanine Loans
For The Year Ended December 31, 2024
For The Year Ended December 31, 2023
Maturity Investment Year State
Type of Properties
Principal Balance as of December 31, 2024
Wtd Avg Contractual Interest Rate
Interest Income
Interest Income
2027 2024 MO, VA SNF $ 44,800  14.0% $ 5,850  $ — 
2029 2024 CA SNF 7,365  11.5% 788  — 
2032 2022 Mid-Atlantic SNF / Campus 25,000  11.0% 2,796  2,778 
2034 2024 MD Campus 5,122  13.0% 22  — 
$ 82,287  12.8% $ 9,456  $ 2,778 
Preferred Equity Investments
For The Year Ended December 31, 2024
For The Year Ended December 31, 2023
Investment Year State
Type of Properties
Principal Balance as of December 31, 2024
Wtd Avg Contractual Interest Rate
Preferred Return
Preferred Return
2023 CA SNF $ 1,782  15.0% $ 272  $ 19 
2024 NC SNF / Campus 9,000  11.0% 583  — 
2024 Various SNF / Campus / ALF / ILF 43,000  11.0% 1,971  — 
$ 53,782  11.1% $ 2,826  $ 19 
Total Investments: $ 794,469  $ 48,254  $ 15,915 
13

Geographic Concentration — Rental Income:
The following table displays the geographic distribution of annual rental income for properties leased to third-party tenants for the years ended December 31, 2024 and 2023 (dollars in thousands).
  For the Year Ended December 31, 2024 For the Year Ended December 31, 2023
State 
Rental Income(1)
Percent of Total 
Rental Income(1)
Percent of Total 
CA $ 75,717  33  % $ 58,838  30  %
TX 47,950  21  % 43,768  22  %
LA 18,403  % 17,856  %
ID 15,389  % 14,943  %
AZ 13,625  % 13,293  %
UT 8,008  % 7,823  %
IL 6,996  % 6,975  %
WA 5,041  % 4,893  %
CO 4,519  % 5,960  %
NC 3,479  % 505  *
IA 3,426  % 4,584  %
OH 3,018  % 4,141  %
MT 2,321  % 2,254  %
NV 2,287  % 2,231  %
TN 2,055  % —  *
NM 1,925  % 1,083  %
GA 1,894  % 1,454  %
SD 1,810  % 972  *
MD 1,420  % 71  *
MO 1,341  % —  *
VA 1,192  % —  *
MN 1,133  * 1,100  %
NE 1,045  * 1,020  %
WI 857  * 556  *
WV 801  * 776  *
PA 747  * —  *
SC 580  * —  *
ND 498  * 475  *
OR 436  * 423  *
KS 233  * 511  *
MI 115  * 2,069  %
AL —  * —  *
FL —  * 25  *
Total $ 228,261  100  % $ 198,599  100  %
     * Represents less than 1%
(1) Includes facilities held in consolidated joint ventures. See Note 3, Real Estate Investments, Net, and Note 12, Variable Interest Entities, for additional information.
Investment and Financing Policies
Our investment objectives are to increase cash flow, provide quarterly cash dividends, maximize the value of our properties and acquire properties with cash flow growth potential. We intend to invest primarily in SNFs and seniors housing, including ALFs and ILFs, both domestically and internationally. We may determine in the future to expand our investments to include behavioral health facilities, medical office buildings, long-term acute care hospitals and inpatient rehabilitation facilities. We may utilize the RIDEA structure for future acquisitions (see “Business Strategies - Diversify Asset Portfolio” below). Our owned properties are located in 32 states and we intend to continue to acquire properties in other states throughout the United States. Although our portfolio currently consists primarily of owned real property, we have also invested in joint ventures through which we own properties, as well as mortgage loans receivable, mezzanine loans and preferred equity investments.
14

We expect that our future investments may also include first mortgages, mezzanine debt and other securities issued by, or joint ventures with, REITs or other entities that own real estate consistent with our investment objectives.
Our Competitive Strengths
We believe that our ability to acquire, integrate and improve facilities is a direct result of the following key competitive strengths:
Geographically Diverse Property Portfolio. Our portfolio of real estate held for investment, inclusive of our other real estate related investments and financing receivable, are located in 34 different states, with concentrations in California and Texas based on annualized rental and interest income. The properties in any one state do not account for more than 22% of our annualized run rate revenue as of December 31, 2024. We believe this geographic diversification will limit the effect of changes in any one market on our overall performance.
Long-Term, Triple-Net Lease Structure. All of our owned properties (including properties we own in consolidated joint ventures), are leased to our tenants under long-term, triple-net leases, pursuant to which the operators are responsible for all facility maintenance and repair, insurance required in connection with the leased properties and the business conducted on the leased properties, taxes levied on or with respect to the leased properties and all utilities and other services necessary or appropriate for the leased properties and the business conducted on the leased properties.
Financially Secure Primary Tenant. Ensign is an established provider of healthcare services with strong financial performance and accounted for 28% of total annualized contractual rental income as of December 31, 2024. Ensign is subject to the reporting requirements of the SEC and is required to file with the SEC annual reports containing audited financial information and quarterly reports containing unaudited financial information. Ensign’s publicly available filings can be found at the SEC’s website at www.sec.gov.
Investments in Joint Ventures. From time to time, we partner with third-party institutional investors to invest in healthcare real estate in consolidated joint ventures. Pursuant to our joint ventures, we typically contribute at least 90% of the joint venture’s total investment amount and we receive 100% of the preferred equity interest in the joint venture and a 50% common equity interest in the joint venture. Our joint venture partner contributes the remaining total investment amount in exchange for a 50% common ownership interest in the joint venture. These are investments that we typically consolidate as they are variable interest entities and as we are considered to be the primary beneficiary and have the power to direct the activities that most significantly impact the entity’s economic performance and have the obligation to absorb losses of, or the right to receive benefits from, the entity that could potentially be significant.
Lower Cost of Capital. Our ability to access the capital markets provides us greater flexibility to manage our cost of capital and also offers us the ability to fund future acquisitions through the issuance of additional shares, including under our ATM Program (as defined below). During the year ended December 31, 2024, we sold approximately 41.0 million shares at an average gross price of $26.35 for gross proceeds of approximately $1.1 billion under our ATM Program to fund current and future acquisitions. In addition, on November 1, 2024, we completed an underwritten public offering of 15.9 million shares at a price of $32.00 for gross proceeds of approximately $507.8 million to fund current and future acquisitions.
Ability to Identify Talented Operators. As a result of our management team’s operating experience and network of relationships and insight, we believe that we are able to identify and pursue working relationships with qualified local, regional and national healthcare providers and seniors housing operators. We expect to continue our disciplined focus on pursuing investment opportunities, primarily with respect to stabilized assets but also some strategic investments in new and/or improving properties, while seeking dedicated and engaged operators who possess local market knowledge, have solid operating records and emphasize quality services and outcomes. We intend to support these operators by providing strategic capital for facility acquisition, upkeep and modernization. Our management team’s experience gives us a key competitive advantage in objectively evaluating an operator’s financial position, care and service programs, operating efficiencies and likely business prospects.
Ability to Identify Strategic Borrowers. Our ability to execute a strategic approach to lending has resulted in additional real estate acquisition opportunities. As a result of our management team’s network of relationships and insight, we believe that our ability to originate loan investments to healthcare real estate owners has allowed us access to unique acquisition opportunities and contributed to our growth.
Experienced Management Team. David M. Sedgwick was appointed as our Chief Executive Officer effective January 1, 2022. At the time of his appointment, Mr. Sedgwick was serving as our President, a role he had filled since February 2021, and he continues to hold that title. He previously served as our Chief Operating Officer from August 2018 through 2021, and as our Vice President-Operations from CareTrust’s launch as an independent public company in 2014 to 2018. Mr. Sedgwick has more than 24 years of experience in the skilled nursing and seniors housing industry. Mr.
15

Sedgwick’s President, Chief Operating Officer and Vice President duties regularly involved him in matters related to new investments, asset management, tenant relations, portfolio management, portfolio optimization, investor relations and capital markets activities for the Company. Prior to joining CareTrust, Mr. Sedgwick served as the Chief Human Capital Officer and President of Facility Services at Ensign. Mr. Sedgwick has been a licensed nursing home administrator since 2001.
Our Chief Financial Officer, William M. Wagner, has more than 31 years of accounting and finance experience, primarily in real estate, including more than 20 years of experience working extensively for REITs. Most notably, he worked for both Nationwide Health Properties, Inc., a healthcare REIT, and Sunstone Hotel Investors, Inc., a lodging REIT, serving as Senior Vice President and Chief Accounting Officer of each company prior to joining us as our Chief Financial Officer.
James B. Callister was appointed as our Executive Vice President effective July 2022 and Chief Investment Officer effective December 31, 2022. Mr. Callister continues to serve as Secretary, and previously served as General Counsel from February 2021 to July 2022. Prior to joining the Company, Mr. Callister worked as a real estate attorney and a partner at the law firm of Sherry Meyerhoff Hanson & Crance LLP and, before that, at the law firm of O’Melveny & Myers LLP.
Flexible UPREIT Structure. We operate through an umbrella partnership, commonly referred to as an UPREIT structure, in which substantially all of our properties and assets are held through the Operating Partnership. Conducting business through the Operating Partnership allows us flexibility in the manner in which we structure the acquisition of properties. In particular, an UPREIT structure enables us to acquire additional properties from sellers in exchange for limited partnership units, which provides property owners the opportunity to defer the tax consequences that would otherwise arise from a sale of their real properties and other assets to us. As a result, this structure allows us to acquire assets in a more efficient manner and may allow us to acquire assets that the owner would otherwise be unwilling to sell because of tax considerations.
Business Strategies
Our primary goal is to create long-term stockholder value through the payment of consistent cash dividends and the growth of our asset base. To achieve this goal, we intend to pursue a business strategy focused on opportunistic acquisitions and property diversification. We also intend to further develop our relationships with tenants and healthcare providers with a goal to progressively expand the mixture of tenants managing and operating our properties.
The key components of our business strategies include:
Diversify Asset Portfolio. We diversify through the acquisition of new and existing facilities from third parties and the expansion and upgrade of current facilities, by strategically investing in new developments with options to acquire the developments at stabilization. In addition, we diversify through investing in high-quality borrowers, facility types and geography. We employ what we believe to be a disciplined, opportunistic acquisition strategy with a focus on the acquisition of SNFs, ALFs and ILFs. We may determine in the future to expand our investments to include behavioral health facilities, medical office buildings, long-term acute care hospitals and inpatient rehabilitation facilities. As we acquire, or invest in, additional properties, we expect to further diversify by geography, asset class and tenant within the healthcare and healthcare-related sectors. We may invest in seniors housing managed communities operated by third-party property managers pursuant to property management agreements utilizing the structure proposed in the REIT Investment Diversification and Empowerment Act of 2007, which is commonly referred to as a “RIDEA” structure. The seniors housing managed communities structure would give us direct exposure to the risks and benefits of the operations of the communities. The third-party property managers would manage our communities in exchange for the receipt of a management fee, and as such, we would not be directly exposed to the credit risk of the property managers in the same manner or to the same extent as our triple-net tenants. Under this management structure, we would be required to rely on a third-party operator to hire and train all facility employees, enter into third-party contracts for the benefit of the facility, comply with laws, and provide resident care and we would be substantially limited in our ability to control or influence day-to-day operators.
Maintain Balance Sheet Strength and Liquidity. We maintain a capital structure that provides the resources and flexibility to support the growth of our business. We intend to maintain a mix of credit facility debt, unsecured debt and possibly secured mortgage debt, which, together with our anticipated ability to complete future equity financings, including issuances of our common stock via registered public offerings or under our at-the-market equity program, we expect will fund the growth of our property portfolio.
Develop New Tenant Relationships. We cultivate new relationships with tenants and healthcare providers in order to expand the mix of tenants operating our properties. We expect that this objective will be achieved over time as part of our overall strategy to acquire new properties and further diversify our portfolio of healthcare properties.
Provide Capital to Underserved Operators. We believe there is a significant opportunity to be a capital source to healthcare operators, through the acquisition and leasing of healthcare properties to them that are consistent with our investment and financing strategy at appropriate risk-adjusted rates of return, which, due to size and other considerations, are not a focus for larger healthcare REITs. We pursue acquisitions and strategic opportunities that meet our investing and financing strategy and that are attractively priced, including funding development of properties through preferred equity or construction loans and thereafter entering into sale and leaseback arrangements with such developers as well as other secured term financing and mezzanine lending.
16

We utilize our management team’s operating experience, network of relationships and industry insight to identify both large and small quality operators in need of capital funding for future growth. In appropriate circumstances, we may negotiate with operators to acquire individual healthcare properties from those operators and then lease those properties back to the operators pursuant to long-term triple-net leases.
Fund Strategic Capital Improvements. We support operators by providing capital to them for a variety of purposes, including capital expenditures and facility modernization. We expect to structure these investments as either lease amendments that produce additional rents or as loans that are repaid by operators during the applicable lease term. We have also assisted our tenants with transitioning to lower emissions technologies through our tenant incentive program, where we support efficiency projects through our dedicated tenant capital expenditure budget, providing sustainability incentives rent-free.
Pursue Strategic Development Opportunities. We work with operators and developers to identify strategic development opportunities. These opportunities may involve replacing or renovating facilities that may have become less competitive. We also identify new development opportunities that present attractive risk-adjusted returns. We may provide funding to the developer of a property in conjunction with entering into a sale leaseback transaction or an option to enter into a sale leaseback transaction for the property.
Competition
We compete for real property investments with other REITs, investment companies, private equity and hedge fund investors, sovereign funds, pension funds, healthcare operators, lenders and other institutional investors. Some of these competitors are significantly larger and have greater financial resources and lower costs of capital than us. Increased competition will make it more challenging to identify and successfully capitalize on acquisition opportunities that meet our investment objectives. Our ability to compete is also impacted by national and local economic trends, availability of investment alternatives, availability and cost of capital, construction and renovation costs, existing laws and regulations, new legislation and population trends.
In addition, revenues from our properties are dependent on the ability of our tenants and operators to compete with other healthcare operators. Healthcare operators compete on a local and regional basis for residents and patients and their ability to successfully attract and retain residents and patients depends on key factors such as the number of facilities in the local market, the types of services available, the quality of care, reputation, age and appearance of each facility and the cost of care in each locality. Private, federal and state payment programs and the effect of other laws and regulations may also have a significant impact on the ability of our tenants and operators to compete successfully for residents and patients at the properties.
Sustainability and Corporate Social Responsibility
As triple-net landlords, our core responsibility lies in tracking, educating, and incentivizing our tenants, who hold decision-making authority at the property level, to make sustainable and financially prudent business decisions. We believe that environmental sustainability is an important part of our commitment to helping people live and age well in those communities. We are committed to sustainable practices in our corporate offices and to providing tenant education, support and incentives to make sustainable improvements at our net-leased properties.
In 2024, we published our fourth annual Corporate Sustainability Report (our “ESG Report”) as part of our ongoing commitment to provide regular reporting on our environmental, social and governance (“ESG”) priorities. Our ESG Report outlines our high priority ESG initiatives and goals for our company and our property portfolio. In our 2023 ESG Report, we included a Global Reporting Initiative (“GRI”) Index in reference to the GRI Standards as well as a Task Force on Climate-Related Financial Disclosures (“TCFD”) index to further align with applicable global standards for sustainability reporting.
Beginning in 2020, with the assistance of an ESG consultant, we designed a monitoring plan to collect key environmental data from a pilot group of 50 of our net-leased properties. The plan’s objective was to benchmark energy and water usage and the impact of our facilities on greenhouse gas emissions and climate change. During 2021, we began collecting data and have increased our tracking since, adding waste tracking in 2023 and reaching a total of 105 tracked properties by the end of 2024. We expect the data to help us identify the most promising opportunities for improvement in our portfolio, set informed ESG goals and measure progress over time. In addition, as a landlord and capital supplier to a key segment of the healthcare industry, we intend to seek further opportunities to encourage and incentivize fair and healthy work environments for healthcare workers and suitable living conditions for patients and residents, and to promote diversity, inclusion and the ethical treatment of employees, residents, patients and others wherever our activities and influence can be felt.
In 2022, we prepared “green” lease language for our form master lease to add new ESG-specific requirements in lease agreements when amending or modifying existing lease relationships. Our green lease strategy compliments our efforts to track utility data across our portfolio and work with tenants to identify ESG building operation opportunities.
17

During 2024, we increased leases with ESG requirements by 10% from September 2023.
During 2023, we partnered with a third party to conduct a portfolio level physical climate risk assessment on all standing assets. Physical risks assessed were heat, flood, precipitation, fire, and drought. In the overall portfolio physical climate risk assessment, four risk categories were defined with a portfolio risk percentage provided for each category, addressing each physical risk. The climate risk assessment found that the highest risk for our portfolio was heat caused by higher temperatures.
During 2023, we distributed a Tenant Climate Risk-Opportunity Survey and received a 50% response rate. This survey helped contribute to ESG dialogue with tenants and overall improved our risk management strategy. The survey found transitional risks for our tenants due to transitioning to a low carbon economy including increased material costs, volatility in utilities’ pricing, market preference for greener buildings, and higher insurance premiums.
Additionally, in 2023, we began tracking and engaging tenants to verify compliance with state-level energy benchmarking laws. In 2024, we expanded these efforts to include properties subject to building performance standards laws, offering support to tenants as needed and continuing to monitor compliance.
During 2024, we enhanced climate risk management by preparing tenant communications to share results from physical climate risk assessments and by developing resources to address physical climate hazards, including a Resiliency Checklist and heat resilience rebate opportunities. Additionally, towards the end of 2024, we distributed our second climate-related tenant survey, incorporating enhanced resiliency-focused questions for properties identified as having "extreme" physical risks, with response collection ongoing through 2025.
We have also published a Tenant Code of Conduct & Corporate Responsibility (our “Tenant ESG Program”). The Tenant ESG Program provides our eligible triple-net tenants with monetary inducements to make sustainable improvements to our properties. Incentive options include a wide variety of opportunities for tenants to upgrade everything from energy and environmental systems to water-saving landscaping and more. Our board of directors has authorized annual allocations of up to $500,000 to fund the Tenant ESG Program. As disclosed in our 2023 ESG Report, we tracked $370,427 in environmental improvements at our properties during the year ended December 31, 2023. In 2024, we utilized our utility data management software to identify the top 20 energy, water, and waste intensive properties and shared our findings with tenants in hopes that they would prioritize the top resource intensive properties for efficiency initiatives.
We have published our Environmental, Social and Governance policy, Policy on Human Capital, Policy on Human Rights and Responsibilities, Policy on Environmental Sustainability and information about our Tenant ESG Program on the Investor Relations section of our website at www.caretrustreit.com. The information found on, or otherwise accessible through, our website is not incorporated by reference into, nor does it form a part of, this report or any other document that we file with the SEC.
Governance
Our corporate governance structure was carefully crafted to align with the interests of our investors and other stakeholders with a core leadership team that has over 68 years of collective experience as operators and investors. The members of our board of directors each bring deep expertise in healthcare, real estate, investing, accounting, and/or business development. In this oversight role, our board of directors serves as the ultimate decision-making body of our company, except for those matters reserved to or shared with our stockholders.
Human Capital Resources
Our employees are the heart of our company. Our Policy on Human Capital reflects our commitment to the dignity and rights of all people, especially our employees and others whose professional lives may be impacted by our properties and business activities. It represents a critical commitment to, and investment in, the current and long-term health and well-being of our organization and its people. We believe our success depends on our ability to attract, develop and retain key personnel.
During 2024, we conducted an employee satisfaction survey with a 100% response rate and an overall satisfaction rate of 84%. The survey found that 78% or more employees agree that our comprehensive benefits package is very competitive and a strong point of working for CareTrust, employees are highly committed to their future at CareTrust, and that CareTrust has a culture that values inclusivity.
CareTrust invests significant time and resources in supporting and developing our employees and creating a desirable workplace. Our core philosophies and policies in this regard include:
Compensation and Benefits. The skills, experience and industry knowledge of key employees significantly benefit our performance. We believe we offer competitive compensation (including salary, incentive bonus and equity) and benefits packages (including a 401(k) plan with a fixed employer contribution, Flexible Spending Accounts (FSAs), employer-funded employee assistance program (EAP), a generous vacation, holiday and personal time off policy, and an array of voluntary benefits options and other benefits for employees and their families).
18

Our compensation program is designed to attract and reward talented individuals who possess the skills necessary to support our business objectives, assist in the achievement of our strategic goals and create long-term value for our stockholders.
As of December 31, 2024, we employed 21 full-time employees (including our executive officers), none of whom is subject to a collective bargaining agreement. Our comprehensive benefits package includes flexible work hours, the option to work remotely, and company workspaces/amenities.
Retention and Turnover. Recruiting, hiring, training and retaining excellent employees is a high priority for us. These activities carry real and substantial costs, which we regard as a meaningful investment in our workforce and our company. We believe that employee turnover is costly in direct and indirect ways, and we are committed to employee retention and satisfaction. During the year ended December 31, 2024, we did not experience any turnover, including executive officers.
Training and Education. CareTrust’s culture values continuous learning, improvement and professional development. This helps our employees to keep their skills current and to adapt to new responsibilities and emerging market needs. CareTrust provides financial support for professional associate dues and memberships, continuing education credits, and fees and travel expenses to attend relevant conferences and seminars.
Government Regulation, Licensing and Enforcement
Overview
As operators of healthcare facilities, tenants of our healthcare properties are typically subject to extensive and complex federal, state and local healthcare laws and regulations relating to fraud and abuse practices, government reimbursement, licensure and certificate of need and similar laws governing the operation of healthcare facilities, and we expect that the healthcare industry, in general, will continue to face significant regulation and pressure in the areas of fraud, waste and abuse, cost control, healthcare management and provision of services, among others. These regulations are wide-ranging and can subject our tenants to civil, criminal and administrative sanctions. Affected tenants may find it increasingly difficult and costly to comply with this complex and evolving regulatory environment because of a relative lack of guidance in many areas as certain of our healthcare properties are subject to oversight from several government agencies and the legal requirements often vary from one jurisdiction to another. Changes in laws and regulations and reimbursement enforcement activity and regulatory non-compliance by our tenants could have a significant effect on their operations and financial condition, which in turn may adversely affect us, as detailed below and set forth under “Risk Factors — Risks Related to Our Business and Operations.”
The following is a discussion of certain laws and regulations generally applicable to our tenants (as operators of our healthcare facilities) and, in certain cases, to us.
Enforcement
There are various extremely complex federal and state laws and regulations governing healthcare providers’ relationships and arrangements and prohibiting fraudulent and abusive practices by such providers. These laws include, but are not limited to, (i) federal and state false claims acts, which, among other things, prohibit providers from filing false claims or making false statements to receive payment from Medicare, Medicaid or other federal or state healthcare programs, (ii) federal and state anti-kickback and fee-splitting statutes, including the Medicare and Medicaid anti-kickback statute, which prohibit the payment or receipt of remuneration to induce referrals or recommendations of healthcare items or services, (iii) federal and state provider self-referral laws (including the federal law commonly referred to as the “Stark Law”), which generally prohibit referrals by physicians and in some cases other providers to entities with which the physician or an immediate family member has a financial relationship, and (iv) the federal Civil Monetary Penalties Law, which prohibits, among other things, the knowing presentation of a false or fraudulent claim for certain healthcare services. Violations of healthcare fraud and abuse laws carry civil, criminal and administrative sanctions, including punitive sanctions, monetary penalties, imprisonment, denial of Medicare and Medicaid reimbursement and potential exclusion from Medicare, Medicaid or other federal or state healthcare programs. These laws are enforced by a variety of federal, state and local agencies and can also be enforced by private litigants through, among other things, federal and state false claims acts, which allow private litigants to bring qui tam or “whistleblower” actions. Ensign and our other tenants are (and many of our future tenants are expected to be) subject to these laws, and some of them may in the future become the subject of governmental enforcement actions if they fail to comply with applicable laws.
•State and Federal “Fraud and Abuse” Laws and Regulations. The Medicare and Medicaid anti-fraud and abuse amendments to the Social Security Act (the “Anti-Kickback Law”) make it a felony, subject to certain exceptions, for any person to engage in illegal remuneration arrangements with vendors, physicians and other health care providers for the referral of Medicare beneficiaries or Medicaid recipients. When a violation occurs, the government may proceed criminally or civilly. If the government proceeds criminally, a violation is a felony and may result in imprisonment for up to five years, fines of up to $25,000 and mandatory exclusion from participation in all federal health care programs. If the government proceeds civilly, it may impose a civil monetary penalty of $50,000 per
19

violation and an assessment of not more than three times the total amount of remuneration involved, and it may exclude the parties from participation in all federal health care programs. Violations of the Anti-Kickback Statute also serve as a basis for federal False Claims Act cases. Many states have enacted laws similar to, and in some cases broader than, the Anti-Kickback Law.
The scope of prohibited payments in the Anti-Kickback Law is broad. The U.S. Department of Health and Human Services (“HHS”) has promulgated regulations which describe certain “safe harbor” arrangements that will not be deemed to constitute violations of the Anti-Kickback Law. An arrangement that fits squarely into a safe harbor is immune from prosecution under the Anti-Kickback Statute. The safe harbors described in the regulations are narrow and do not cover a wide range of economic relationships which many SNFs, physicians and other health care providers consider to be legitimate business arrangements not prohibited by the statute. Because the regulations describe safe harbors and do not purport to describe comprehensively all lawful and unlawful economic arrangements or other relationships between health care providers and referral sources, health care providers entering into these arrangements or relationships may be required to alter them in order to ensure compliance with the Anti-Kickback Law and may be subject to significant liability should an arrangement that does not fully satisfy a safe harbor be determined to be illegal. On November 20, 2020, HHS promulgated significant new Anti-Kickback Law regulations, including changes to existing safe harbors and the creation of new safe harbors, in an effort to reduce regulatory burden and incentivize coordinated care, including value-based arrangements.
The False Claims Act provides that any person who “knowingly presents, or causes to be presented” a “false or fraudulent claim for payment or approval” to the U.S. government, or its agents and contractors, is liable for a civil penalty ranging from $5,500 to $11,000 per claim, plus three times the amount of damages sustained by the government. Under the False Claims Act’s so-called “reverse false claims,” liability also could arise for “using” a false record or statement to “conceal,” “avoid” or “decrease” an “obligation” (which can include the retention of an overpayment) “to pay or transmit money or property to the government.” The False Claims Act also empowers and provides incentives to private citizens (commonly referred to as qui tam relator or whistleblower) to file suit on the government’s behalf. The qui tam relator’s share of the recovery can be between 15% and 25% in cases in which the government intervenes, and 25% to 30% in cases in which the government does not intervene. Notably, the Affordable Care Act amended certain jurisdictional bars to the False Claims Act, effectively narrowing the “public disclosure bar” (which generally requires that a whistleblower suit not be based on publicly disclosed information) and expanding the “original source” exception (which generally permits a whistleblower suit based on publicly disclosed information if the whistleblower is the original source of that publicly disclosed information), thus potentially broadening the field of potential whistleblowers.
•Restrictions on Referrals. The federal physician self-referral law and its implementing regulations (commonly referred to as the “Stark Law”) prohibits providers of “designated health services” from billing Medicare or Medicaid if the patient is referred by a physician (or his/her immediate family member) with a financial relationship with the entity, unless an exception applies. “Designated health services” include clinical laboratory services; physical therapy services; occupational therapy services; outpatient speech-language pathology; radiology services, including magnetic resonance imaging, computerized axial tomography scans, and ultrasound services; radiation therapy services and supplies; durable medical equipment and services; parenteral and enteral nutrients, equipment and services; prosthetics, orthotics, and prosthetic devices and supplies; home health services; outpatient prescription drugs; and inpatient and outpatient hospital services. The Stark Law also prohibits the furnishing entity from submitting a claim for reimbursement or otherwise billing Medicare or any other person or entity for improperly referred designated health services. Many designated health services are commonly provided in SNFs and ALFs. The new regulations promulgated by HHS, discussed above in “State and Federal ‘Fraud and Abuse’ Laws and Regulations”, include significant changes to the Stark Law regulations, including (i) new exceptions designed to enable more value-based arrangements, (ii) a modification to the existing exception for electronic health records items and services, and (iii) new exceptions for limited remuneration to physicians and for cybersecurity technology and related services.
An entity that submits a claim for reimbursement in violation of the Stark Law must refund any amounts collected and may be: (1) subject to a civil penalty of up to $15,000 for each self-referred service; and (2) excluded from participation in federal health care programs. In addition, a physician or entity that has participated in a “scheme” to circumvent the operation of the Stark Law is subject to a civil penalty of up to $100,000 and possible exclusion from participation in federal health care programs.
Reimbursement
Sources of revenue for our tenants include (and for our future tenants is expected to include), among other sources, governmental healthcare programs, such as the federal Medicare program and state Medicaid programs, and non-governmental payors, such as insurance carriers and health maintenance organizations.
20

As federal and state governments focus on healthcare reform initiatives, and as the federal government and many states face significant budget deficits, efforts to reduce costs by these payors will likely continue, which may result in reduced or slower growth in reimbursement for certain services provided by Ensign and our other tenants. Federal and state authorities are likely to continue to implement new and modified reimbursement methodologies, including value-based methodologies, that could have a negative impact on our tenants. Such changes to reimbursement methodologies could have a material impact on our tenants and we cannot provide assurances that the current revenue levels will be maintained under any future reimbursement arrangements. In addition, the impact of other health care reform efforts, such as “Medicare for all” or the provision of a new Medicare-like public option for consumers to receive health insurance, are impossible to predict.
The Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010 (collectively, the “Affordable Care Act”) serves as the primary vehicle for comprehensive healthcare reform in the United States. Efforts initiated by the previous administration and certain members of Congress to repeal or make significant changes to the Affordable Care Act, its implementation and/or its interpretation including the successful repeal of the penalty associated with the individual mandate of the Affordable Care Act, continue to cast uncertainty on the future of the Affordable Care Act. For example, on December 14, 2018, a U.S. District Court in Texas ruled the Affordable Care Act unconstitutional in its entirety. This decision was appealed, and on December 18, 2019, the Fifth Circuit Court of Appeals ruled that the Affordable Care Act’s individual mandate was unconstitutional but remanded the case for further analysis. The decision was appealed, and on June 17, 2021, the Supreme Court of the United States ruled that the plaintiffs lacked standing to challenge the Affordable Care Act’s minimum essential coverage provision. These types of challenges may impact the number of individuals that elect to obtain public or private health insurance or the scope of such coverage, if purchased.
Given the divided nature of Congress, it is unclear whether Congress will successfully expand health insurance coverage and assess alternative health care delivery and payment systems. The Republican Party currently controls the United States Senate and the House of Representatives (by a slim majority). Due to this, healthcare reform legislation would likely require at least some support from both Republican and Democratic lawmakers to become law and it is uncertain whether any healthcare reform legislation will ultimately become law. We cannot predict the ultimate content, timing or effect of any healthcare reform legislation or the impact of potential legislation on our business. If our tenants’ residents do not have insurance, it could adversely impact the tenants’ ability to satisfy their obligations to us. Expansion of health insurance coverage to more citizens could have a positive financial impact on our tenants and their ability to satisfy their obligations to us.
Other legislative changes have been proposed and adopted since the Affordable Care Act was enacted, which also may impact our business. For instance, CMS is required to measure, track, and publish readmission rates of SNFs and to implement a value-based purchasing program for SNFs (the “SNF VBP Program”). The SNF VBP Program increases Medicare reimbursement rates for SNFs that achieve certain levels of quality performance measures developed by CMS, relative to other facilities. The value-based payments authorized by the SNF VBP Program are funded by reducing Medicare payment for all SNFs by 2% and redistributing up to 70% of those funds to high-performing SNFs. However, there is no assurance that payments made by CMS as a result of the SNF VBP Program will be sufficient to cover a facility’s costs. If Medicare reimbursement provided to our healthcare tenants is reduced under the SNF VBP Program, that reduction may have an adverse impact on the ability of our tenants to meet their obligations to us.
See “Risk Factors — Risks Related to Our Business and Operations — Healthcare reform legislation impacts cannot accurately be predicted and could adversely affect our results of operations” for additional risks related to changes in Medicare reimbursement.
Increased Government Oversight and Transparency
Section 1150B of the Social Security Act requires employees of federally funded long-term care facilities to immediately report any reasonable suspicion of a crime committed against a resident of that facility. Those reports must be submitted to at least one law enforcement agency and the applicable Centers for Medicare & Medicaid Services (“CMS”) Survey Agency. Covered individuals who fail to report under Section 1150B are subject to various penalties, including civil monetary penalties of up to $300,000 and possible exclusion from participation in any Federal health care program. Medicare regulations require SNFs to establish and implement written policies to ensure the reporting of crimes that occur in federally funded SNFs in accordance with Section 1150B.
In August 2017, the HHS Office of Inspector General (“OIG”) issued a preliminary report regarding quality of care concerns by operators of SNFs. In its report, the OIG determined that CMS has inadequate procedures in place to ensure that incidents of potential abuse or neglect of Medicare beneficiaries residing in SNFs are identified and reported. The report was issued in connection with the OIG’s ongoing review of potential abuse and neglect of Medicare beneficiaries residing in SNFs.
As a result of the OIG report, CMS enforcement activity against SNF operators may increase, especially with regard to the reporting of potential abuse or neglect of SNF residents. Further, in July 2024, CMS adopted a final rule expanding its ability to impose penalties on SNFs for health and safety deficiencies/non-compliance.
21

This final rule allows for more per instance and per day civil monetary penalties to be imposed for such health and safety deficiencies/non-compliance, as appropriate. If any of our tenants or their employees are found to have violated any applicable reporting or health and safety requirements, they may become subject to penalties or other sanctions up to and including loss of licensure.
A final rule adopted by CMS that implemented certain portions of the Affordable Care Act and requires the disclosure of certain ownership, managerial, and other information regarding Medicare SNFs and Medicaid nursing facilities, became effective on January 16, 2024. The rule defines the term “real estate investment trust,” which sets the stage for Medicare SNFs to disclose whether each direct or indirect owning or managing entity is a real estate investment trust. This may enable CMS and others to scrutinize more closely how direct and indirect ownership and management correlate with care outcomes and to determine which environments are more likely to deliver better care for residents and patients.
Healthcare Licensure and Certificate of Need
Our healthcare facilities are subject to extensive federal, state and local licensure, certification and inspection laws and regulations. In addition, various licenses and permits are required to operate SNFs and ALFs, dispense narcotics, operate pharmacies, handle radioactive materials and operate equipment. Many states require certain healthcare providers to obtain a certificate of need, which requires prior approval for the construction, modification and closure of certain healthcare facilities. The ability to obtain such approval and/or the approval process may impact some of our tenants’ abilities to expand or change their businesses. Any failure to comply with any of these laws, regulations, or standards could result in penalties which may include loss or restriction of license, loss of accreditation, denial of reimbursement, imposition of fines, suspension or decertification from federal and state healthcare programs, or closure of the facility.
Privacy, Security and Data Breach Notification Laws
The Health Insurance Portability and Accountability Act of 1996, as amended (“HIPAA”) regulates the privacy and security of certain health information (“Protected Health Information”) and requires entities subject to HIPAA to provide notification of breaches of Protected Health Information. Entities subject to HIPAA include health plans, healthcare clearinghouses, and most health care providers (including many of our tenants). Business associates of these entities who create, receive, maintain or transmit Protected Health Information are also subject to HIPAA. Violations of the HIPAA requirements may result in civil monetary penalties of up to $50,000 per violation with a maximum civil penalty of $1.5 million in a calendar year for violations of the same requirement. However, a single breach or incident can result in violations of multiple requirements, resulting in possible penalties well in excess of $1.5 million. Breaches of unsecured Protected Health Information and other violations of HIPAA may have other material adverse consequences including material loss of business, business interruption, loss of patient or other critical data, regulatory enforcement, substantial legal liability and reputational harm. Certain violations of HIPAA can result in criminal penalties and enforcement.
Various other state and federal laws relate to privacy, security and the reporting of data breaches involving personal information (together with HIPAA, “Privacy Laws”). For example, various state laws and regulations may regulate the privacy and security of personal information, and require notification of affected individuals in the event of a data breach involving such individual’s personal information (including an individual’s name plus social security number, date of birth or credit card information, for example). Failure of the Company or its tenants to comply with applicable Privacy Laws could have a materially adverse effect on our Company. Failure of our tenants to comply with applicable Privacy Laws could have a material adverse effect on their ability to meet their obligations to us. Furthermore, the adoption of new Privacy Laws at the federal and state level could require us or our tenants to incur significant compliance costs.
Americans with Disabilities Act (the “ADA”)
Although most of our properties are not required to comply with the ADA because of certain “grandfather” provisions in the law, some of our properties must comply with the ADA and similar state or local laws to the extent that such properties are “public accommodations,” as defined in those statutes. These laws may require removal of barriers to access by persons with disabilities in certain public areas of our properties where such removal is readily achievable. Under our triple-net lease structure, our tenants would generally be responsible for additional costs that may be required to make our facilities ADA-compliant. Noncompliance with the ADA could result in the imposition of fines or an award of damages to private litigants.
Environmental Matters
A wide variety of federal, state and local environmental and occupational health and safety laws and regulations affect healthcare facility operations. These complex federal and state statutes, and their enforcement, involve a myriad of regulations, many of which involve strict liability on the part of the potential offender. Some of these federal and state statutes may directly impact us. Under various federal, state and local environmental laws, ordinances and regulations, an owner of real property, such as us, may be liable for the costs of removal or remediation of hazardous or toxic substances at, under or disposed of in connection with such property, as well as other potential costs relating to hazardous or toxic substances (including government fines and damages for injuries to persons and adjacent property).
22

The cost of any required remediation, removal, fines or personal or property damages and the owner’s liability therefore could exceed or impair the value of the property and/or the assets of the owner. In addition, the presence of such substances, or the failure to properly dispose of or remediate such substances, may adversely affect the owner’s ability to sell or rent such property or to borrow using such property as collateral which, in turn, could reduce our revenues. See “Risk Factors - General Risk Factors - Environmental compliance costs and liabilities may materially impair the value of properties owned by us.”
Labor and Employment Matters
A wide variety of federal, state and local labor and employment laws and regulations impact healthcare facility operations. Our tenants are required to comply with all applicable federal, state and local laws and regulations relating to employment, including occupational safety and health requirements, minimum staffing, wage and hour laws, overtime and other compensation requirements, employee benefits and other leave and sick pay requirements, proper classification of workers as employee or independent contractors, and immigration and equal employment opportunity laws, among others. These laws and regulations can vary significantly among jurisdictions, can change, and can be highly technical and involve strict liability for noncompliance with technical detail. Costs and expenses related to these requirements are a significant operating expense and may increase as laws and regulations change. For example, on October 13, 2023, California Senate Bill No. 525 (“SB 525”) was signed into law, requiring a substantial increase in the minimum wage for workers operating in certain health care facilities. As a result of SB 525, certain health care facilities (including licensed skilled nursing facilities) operating in California are required to increase the wages of their covered health care employees to at least $21 per hour from June 1, 2024 to May 31, 2026, $22 or $23 per hour (depending on facility type) from June 1, 2026 to May 31, 2028, and $25 per hour after June 1, 2028.
On April 22, 2024, CMS issued a final rule regarding minimum staffing requirements and increased inspections at nursing homes in order to establish comprehensive nurse staffing requirements. The rule consists of three core staffing requirements: (1) overall minimum standard of 3.48 total nurse staff hours per resident day; (2) minimum nurse staffing standards of 0.55 hours per resident day for registered nurses and 2.45 hours of care from a certified nurse’s aid per resident per day; and (3) a requirement to have a registered nurse onsite 24 hours a day, seven days a week. The rule includes a staggered implementation approach for which CMS will publish additional details on compliance as the implementation dates approach. The rule also includes possible waivers and temporary hardship exemptions for select facilities; however, no funding for the additional staff will be provided. We are currently evaluating the impact of the rule, but believe the unfunded mandate to increase staff may have a material and adverse impact on the financial condition of our tenants.
REIT Qualification
We elected to be taxed as a REIT for U.S. federal income tax purposes beginning with our taxable year ended December 31, 2014. Our qualification as a REIT will depend upon our ability to meet, on a continuing basis, various complex requirements under the Internal Revenue Code of 1986, as amended (the “Code”), relating to, among other things, the sources of our gross income, the composition and values of our assets, our distribution levels to our stockholders and the concentration of ownership of our capital stock. We believe that we are organized in conformity with the requirements for qualification and taxation as a REIT under the Code and that our manner of operation has and will enable us to continue to meet the requirements for qualification and taxation as a REIT.
The Operating Partnership
We own substantially all of our assets and properties and conduct our operations through the Operating Partnership. We believe that conducting business through the Operating Partnership provides flexibility with respect to the manner in which we structure the acquisition of properties. In particular, an UPREIT structure enables us to acquire additional properties from sellers in tax deferred transactions. In these transactions, the seller would typically contribute its assets to the Operating Partnership in exchange for units of limited partnership interest in the Operating Partnership (“OP Units”). Holders of OP Units will have the right, after a 12-month holding period, to require the Operating Partnership to redeem any or all of such OP Units for cash based upon the fair market value of an equivalent number of shares of CareTrust REIT’s common stock at the time of the redemption. Alternatively, we may elect to acquire those OP Units in exchange for shares of our common stock on a one-for-one basis. The number of shares of common stock used to determine the redemption value of OP Units, and the number of shares issuable in exchange for OP Units, is subject to adjustment in the event of stock splits, stock dividends, distributions of warrants or stock rights, specified extraordinary distributions and similar events. The Operating Partnership is managed by our wholly owned subsidiary, CareTrust GP, LLC, which is the sole general partner of the Operating Partnership and owns one percent of its outstanding partnership interests. As of December 31, 2024, CareTrust REIT is the only limited partner of the Operating Partnership, owning 99% of its outstanding partnership interests, and we have not issued OP Units to any other party.
23

The benefits of our UPREIT structure include the following:
•Access to capital. We believe the UPREIT structure provides us with access to capital for refinancing and growth. Because an UPREIT structure includes a partnership as well as a corporation, we can access the markets through the Operating Partnership issuing equity or debt as well as the corporation issuing capital stock or debt securities. Sources of capital include possible future issuances of debt or equity through public offerings or private placements.
•Growth. The UPREIT structure allows stockholders, through their ownership of common stock, and the limited partners, through their ownership of OP Units, an opportunity to participate in future investments we may make in additional properties.
•Tax deferral. The UPREIT structure provides property owners who transfer their real properties to the Operating Partnership in exchange for OP Units the opportunity to defer the tax consequences that otherwise would arise from a sale of their real properties and other assets to us or to a third party. As a result, this structure allows us to acquire assets in a more efficient manner and may allow us to acquire assets that the owner would otherwise be unwilling to sell because of tax considerations.
Insurance
We maintain, or require in our leases that our tenants maintain, all applicable lines of insurance on our properties and their operations. The amount and scope of insurance coverage provided by our policies and the policies maintained by our tenants is customary for similarly situated companies in our industry. However, we cannot assure you that our tenants will maintain the required insurance coverages, and the failure by any of them to do so could have a material adverse effect on us. We also cannot assure you that we will continue to require the same levels of insurance coverage under our leases, including the Ensign Master Leases, that such insurance will be available at a reasonable cost in the future or that the insurance coverage provided will fully cover all losses on our properties upon the occurrence of a catastrophic event, nor can we assure you of the future financial viability of the insurers.
Available Information
We file annual, quarterly and current reports, proxy statements and other information with SEC. The SEC maintains an internet site that contains these reports, and other information about issuers, like us, which file electronically with the SEC. The address of that site is http://www.sec.gov. We make available our reports on Form 10-K, 10-Q, and 8-K (as well as all amendments to these reports), and other information, free of charge, on the Investor Relations section of our website at www.caretrustreit.com. The information found on, or otherwise accessible through, our website is not incorporated by reference into, nor does it form a part of, this report or any other document that we file with the SEC.
24

ITEM 1A.    Risk Factors
Risks Related to Our Business and Operations
We are dependent on the healthcare operators that lease our properties as well as the borrowers under our mortgage secured loans and mezzanine loans to successfully operate their businesses and make contractual payments, and an event that materially and adversely affects their business, financial position or results of operations could materially and adversely affect our business, financial position or results of operations.
Because all of the properties we own are operated by our tenants pursuant to triple-net master leases (including properties we own in consolidated joint ventures), we are unable to directly implement strategic business decisions regarding the daily operation and marketing of these properties. While we have rights as the property owner under our triple-net leases and monitor our tenants’ and operators’ performance, we may have limited recourse under our master leases if we believe that a tenant or operator is not performing adequately, and any failure by a tenant to effectively conduct its operations or to maintain and improve our properties could adversely affect its business reputation and its ability to attract and retain residents in our properties, which in turn, could adversely affect their ability to make rental payments to us and otherwise adversely affect our results of operations, including our ability to repay our outstanding indebtedness or our ability to pay dividends to our stockholders as required to maintain our REIT status. Additionally, because each master lease is a triple-net lease, we depend on our tenants to pay all insurance, taxes, utilities and maintenance and repair expenses and to indemnify, defend and hold us harmless from and against various claims, litigation and liabilities arising in connection with their business. There can be no assurance that our tenants will have sufficient assets, income and financing to enable them to satisfy their contractual lease payment or indemnification obligations and our tenants have in the past, and may in the future, fail to make rent payments when due, or our tenants may declare bankruptcy.
Ensign leases or provides a guaranty for a significant portion of our properties. As of December 31, 2024, properties leased to Ensign and held for investment represented $68.2 million, or 26%, of total annualized contractual rental income, and properties leased to Pennant under the Pennant Master Lease for which Ensign provides a guaranty (the “Pennant Guaranty”) represented $7.5 million, or 3%, of total annualized contractual rental income. Ensign’s inability or unwillingness to meet its lease obligations or its obligations pursuant to the Pennant Guaranty could materially adversely affect our business, financial position or results of operations. In addition, Ensign’s inability to satisfy its other lease obligations including payment of insurance, taxes and utilities, could materially and adversely affect the condition of the properties leased to Ensign as well as Ensign’s business, financial position and results of operations. Accordingly, if Ensign were to experience a material and adverse effect on its business, financial position or results of operations, our business, financial position or results of operations could also be materially and adversely affected.
Further, our dependence on Ensign’s rental payments for a substantial portion of our rental income may limit our ability to enforce our rights under the Ensign leases or the Pennant Guaranty or to terminate the Ensign leases. Ensign’s failure to comply with its lease obligations or its obligations pursuant to the Pennant Guaranty, or with federal and state healthcare laws and regulations to which the leased properties are subject, could require us to find another lessee for such leased properties and result in a decrease in or cessation of rental payments. In such event, we may be unable to locate a suitable lessee at similar rental rates or at all, which would reduce our rental income.
In addition to the properties we own, from time to time, we originate loans receivable to certain borrowers in the form of mortgage secured loans or mezzanine loans, which are directly or indirectly secured by underlying properties owned by the borrowers. The ability of our borrowers to repay the loans is typically dependent primarily on the successful operation of the properties securing the loans. Because these properties are owned and operated by our borrowers, their affiliates, or unrelated third parties, we are unable to directly implement strategic business decisions regarding the daily operation of these properties. Any failure by a borrower to effectively conduct its operations in such a way to generate sufficient income, or any material adverse event that interferes with a borrower’s ability to generate sufficient income, may cause the borrower to be unable to make timely loan payments or to default on the loan.
Unstable market and economic conditions may have serious adverse consequences on our business, results of operations and financial condition.
Global credit and financial markets have experienced extreme volatility and disruptions over the past several years, including declines in consumer confidence, concerns about declines in economic growth, increases in the rate of inflation, increases in borrowing rates and changes in liquidity and credit availability, and uncertainty about economic stability, including most recently in connection with proposed policies of the Trump administration, actions undertaken by the U.S. Federal Reserve Board to address inflation, the military conflicts in Ukraine and Gaza and supply chain disruptions. While consumer sentiment is on the rise, concerns about declines in economic growth have faded and inflation has cooled there can be no assurance that further deterioration in credit and financial markets and confidence in economic conditions will not occur. Our general business strategy may be adversely affected by any such economic downturn, volatile business environment or unpredictable and unstable market conditions.
25

In addition, increased costs due to inflationary conditions may continue to adversely affect the operating expenses of our tenants and borrowers and their ability to meet their obligations to us and may also increase the costs for us to make capital improvements to our facilities.
There is significant uncertainty about the future relationship between the United States and other countries with respect to trade policies, taxes, government regulations, and tariffs. The Trump administration has indicated it will institute trade policy changes including the imposition of additional tariffs on imported products in an effort to address trade imbalances, specifically with China. In response to some of these actions, certain countries may impose retaliatory actions against the U.S. These policies may lead to supply chain constraints and additional inflation, further increasing operational costs of our facilities.
Our business could also be adversely impacted by volatility caused by geopolitical events, such as the conflicts in Ukraine and Gaza. A significant downturn in economic activity may cause a reduction in spending on healthcare matters and our tenants and borrowers may need to seek to lower their costs by renegotiating their agreements with us. Such reductions may disproportionately affect our revenue. In addition, if the current equity and credit markets deteriorate, it may make any necessary debt or equity financing more difficult, more costly, and more dilutive. Furthermore, our stock price may decline due in part to the volatility of the stock market and the general economic downturn.
Our tenants and borrowers depend on reimbursement from government and other third-party payors and if reimbursement rates from such payors are reduced by future legislative reform, it could cause our tenants’ and borrowers’ revenues to decline and could affect their ability to meet their obligations to us.
Sometimes, governmental payors freeze or reduce payments to healthcare providers, or provide annual reimbursement rate increases that are smaller than expected, due to budgetary and other pressures. Healthcare reimbursement will likely continue to be of significant importance to federal and state authorities. For example, the federal government and a number of states are currently managing budget deficits and, as a result, many states are focusing on the reduction of expenditures under their Medicaid programs, which may result in a freeze on Medicaid rates or a decrease in reimbursement rates for our tenants and borrowers. The need to control Medicaid expenditures may be exacerbated by the potential for increased enrollment in Medicaid due to unemployment and declines in family incomes. These potential reductions could be compounded by the potential for federal cost-cutting efforts that could lead to reductions in reimbursement to our tenants and borrowers under both the Medicaid and Medicare programs. Additionally, in July 2023, Medicare excluded marriage and family therapist services and mental health counselor services from SNF consolidated billing. While these services may still be billed by the clinicians providing the services, such services may not be covered under the SNFs Medicare Part A payment. While we cannot make any assessment as to the ultimate timing or the effect that any future legislative reforms may have on our tenants’ or borrowers’ costs of doing business and on the amount of reimbursement by government and other third-party payors, potential reductions in Medicaid and Medicare reimbursement, or in non-governmental third-party payor reimbursement, to our tenants and borrowers could reduce the revenues of our tenants and borrowers and their ability to meet their obligations to us.
We face potential adverse consequences of bankruptcy, insolvency or financial deterioration of our tenants or borrowers.
We receive a significant portion of our income as rental payments under leases of properties we own directly or through our joint ventures. We have no control over the success or failure of our tenants’ businesses and, at any time, any of our tenants may experience a downturn in its business that may weaken its financial condition. As a result, our tenants have in the past, and may in the future, fail to make rent payments when due, or our tenants may declare bankruptcy. Tenant bankruptcies or failures to make rent payments when due could result in termination of the tenant’s lease and could have a material adverse effect on our business, financial condition and results of operations and our ability to make distributions to our stockholders (which could adversely affect our ability to raise capital or service our indebtedness). This risk is magnified where we lease multiple properties to a single tenant, such as Ensign.
If a tenant is unable to comply with the terms of its lease, we may be forced to write off unpaid amounts due to us from the tenant, move to a cash basis method of accounting for recognizing rental income from the tenant or otherwise modify the tenant’s lease in ways that are unfavorable to us. Alternatively, failure of a tenant to perform under a lease could require us to declare a default, repossess the property, find a suitable replacement tenant, hire third-party managers to operate the property or sell the property. See Note 2, Summary of Significant Accounting Policies and Note 3, Real Estate Investments, Net for further information.
If one or more of our tenants files for bankruptcy relief, the U.S. Bankruptcy Code provides that a debtor has the option to assume or reject the unexpired lease within a certain period of time. Any bankruptcy filing by or relating to one of our tenants could bar all efforts by us to collect pre-bankruptcy debts from that tenant or seize its property. A tenant bankruptcy could also delay our efforts to collect past due balances under the leases and could ultimately preclude collection of all or a portion of these sums. It is possible that we may recover substantially less than the full value of any unsecured claims we hold, if any, which may have a material adverse effect on our business, financial condition and results of operations, and our ability to make distributions to our stockholders.
26

In addition, the loans receivable we originate in the form of mortgage secured loans or mezzanine loans are directly or indirectly secured by underlying properties owned by the borrowers. In the event of any default under any loan receivable held by us, we will bear a risk of loss of principal and accrued interest to the extent of any deficiency between the value of the underlying property directly or indirectly securing the loan and the principal and accrued interest of the loan, which could have a material adverse effect on our business, financial position or results of operations. In addition, with respect to a default of any of our mezzanine loans, we are not entitled to any payment until all senior debt holders are paid in full. Foreclosure on a property or other interest that secures a loan receivable can be an expensive and lengthy process that could have a substantial negative effect on our anticipated return on the foreclosed investment. In the event of the bankruptcy of a loan borrower, the loan to such borrower will be deemed to be secured only to the extent of the value of the underlying property or other assets, as applicable, at the time of bankruptcy (as determined by the bankruptcy court), and the lien securing the loan will be subject to the avoidance powers of the bankruptcy trustee or debtor-in-possession to the extent the lien is unenforceable under state law.
Replacement tenants or operators may be difficult to identify and we may be required to incur substantial renovation costs to make our healthcare properties suitable for such tenants or operators.
If our tenants terminate or do not renew their leases with us, we would attempt to reposition the properties with another tenant or operator. Rental payments on such properties could decline or cease altogether while we reposition the properties with a suitable replacement tenant or operator and we may be required to fund certain expenses and obligations (e.g., real estate taxes, debt costs and maintenance expenses) to preserve the value of, and avoid the imposition of liens on, such properties while they are being repositioned.
Healthcare facilities are typically highly customized and may not be easily adapted to non-healthcare-related uses. The improvements generally required to conform a property to healthcare use, such as upgrading electrical, gas and plumbing infrastructure and security, are costly and at times tenant-specific. A new or replacement tenant may require different features in a property, depending on that tenant’s particular operations. If a current tenant is unable to pay rent and vacates a property, we may incur substantial expenditures to modify a property before we are able to secure another tenant. Supply chain volatility and labor shortages may increase these construction costs. In addition, approvals of local authorities for any required modifications and/or renovations may be necessary, resulting in delays in transitioning a facility to a new tenant. These expenditures or renovations and delays could materially and adversely affect our business, financial condition or results of operations.
In addition, we may fail to identify suitable replacements or enter into leases or other arrangements with new tenants or operators on a timely basis or on terms as favorable to us as our current leases, if at all. If we experience a significant number of properties not under a lease due to the inability to find suitable replacement tenants or successfully reposition the property, our operating expenses could increase significantly. Even after a suitable replacement tenant or operator has taken over operation of a property, it may still take an extended period of time before such property is fully repositioned and value restored, if at all. Any of these results could have a material adverse effect on our business, financial condition and results of operations and our ability to make distributions to stockholders.
We have incurred and may in the future incur impairment charges, which could negatively impact our results of operations.
At each reporting period, we evaluate our real estate investments and other assets for impairment indicators whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. The existence of impairment indicators is based on factors such as market conditions, operating performance and legal structure. If we determine that an impairment has occurred, we are required to adjust the net carrying value of the asset, which could have a material adverse effect on our results of operations in the period in which the write-off occurs. For example, in the twelve months ended December 31, 2024, we recorded impairment charges of approximately $42.2 million.
The geographic concentration of some of our facilities could leave us vulnerable to an economic downturn, regulatory changes or acts of nature in those areas.
As a result of the concentration of our properties in California and Texas as described in “Portfolio Summary” under Item 1 of this Annual Report on Form 10-K, the conditions of local economies and real estate markets, including increases in real estate taxes, changes in governmental rules, regulations and reimbursement rates or criteria, changes in demographics, state funding, acts of nature, the impacts of climate change and other factors that may result in a decrease in demand and/or reimbursement for skilled nursing services in these states could have a disproportionately adverse effect on our tenants’ and borrowers’ revenue, costs and results of operations, which may affect their ability to meet their obligations to us.
Our owned facilities and the facilities securing our loans receivable that are located in Texas and certain other states in the southeast are especially susceptible to natural disasters such as hurricanes, tornadoes and flooding and our owned facilities and the facilities securing our loans receivable that are located in California are particularly susceptible to natural disasters such as fires, earthquakes and mudslides. These types of natural disasters will likely increase in number, scope and intensity as a result of climate change. Further, these acts of nature may cause disruption to our tenants or borrowers, their employees and the underlying facilities, which could have an adverse impact on our tenants’ or borrowers’ patients and businesses.
27

In order to provide patient care, our tenants and borrowers are dependent on consistent and reliable delivery of food, pharmaceuticals, utilities and other goods to the facilities they operate, and the availability of employees to provide services at the facilities. If the power supply, delivery of goods or the ability of employees to reach the facilities is interrupted in any material respect due to a natural disaster or other reasons, it would have a significant impact on the facilities and our tenants’ and borrowers’ businesses at those facilities. Furthermore, the impact, or impending threat, of a natural disaster may require that our tenants or borrowers evacuate one or more facilities, which would be costly and would involve risks, including potentially fatal risks, for the patients at such facilities. The impact of disasters and similar events is inherently uncertain. Such events could harm our tenants’ or borrowers’ patients and employees, severely damage or destroy one or more of the facilities they operate, harm our tenants’ or borrowers’ business, reputation, financial condition and financial performance, or otherwise cause our tenants’ or borrowers’ businesses to suffer in ways that we currently cannot predict.
In addition, to the extent that significant changes in the climate occur in areas where our properties are located, we may experience extreme weather, including higher temperatures, increases in precipitation, fire, drought and flood, all of which may result in physical damage to or a decrease in demand for properties located in these areas or affected by these conditions. Based on our overall portfolio physical climate risk assessment, we found that the highest climate risk for our portfolio was heat caused by higher temperatures, which may result in higher operating and energy costs for our tenants and borrowers and higher capital costs for resiliency measures for us and our tenants and borrowers to maintain the property and its value. Should the impact of climate change be material in nature, including destruction or degradation of our owned properties or the properties securing our loans receivable, or occur for lengthy periods of time, our financial condition or results of operations may be adversely affected. Increased costs to our tenants and borrowers to maintain the properties and take appropriate resiliency measures could harm the financial condition and financial performance of our tenants and borrowers. In addition, changes in federal and state legislation and regulation on climate change could result in increased capital expenditures to improve the energy efficiency of our existing properties and could also require us to spend more on our new development properties without a corresponding increase in revenue.
We are subject to risks associated with public health crises and government measures to prevent the spread of infectious diseases.
We are subject to risks associated with public health crises and government measures to prevent the spread of infectious diseases, including the global health concerns related to the COVID-19 pandemic and the H6 bird flu. The COVID-19 pandemic adversely impacted nearly all aspects of our business. Public health crises, including significant COVID-19 outbreaks and any future epidemics or pandemics, could result in similar adverse impacts on our business, results of operations, cash flows and financial condition. Risks to our business that have been associated with the COVID-19 pandemic, and may be associated with future COVID-19 outbreaks or other public health crises, include:
•one or more of our tenants or borrowers could experience deteriorating financial conditions and be unable or unwilling to pay rent on time and in full (which has, and could continue to result from, among other reasons (i) increased operating costs and staffing requirements related to compliance with Centers for Disease Control and Prevention (“CDC”) protocols, (ii) decreased occupancy rates, (iii) increased scrutiny by regulators, (iv) potential repayments of relief funds received by tenants, (v) nursing or other staffing shortages; or (vi) decisions by elderly individuals to avoid or delay entrance into assisted living and other long-term care facilities);
•the possibility we may have to restructure tenants’ or borrowers’ obligations and may not be able to do so on terms that are favorable to us;
•the potential need to recognize asset impairment charges or credit losses on our loans receivable if we determine that the full amount of our investments are not recoverable;
•increased costs or delays that we have incurred, and may continue to incur, if we need to reposition or transition any of our currently-leased properties to another tenant or operator, which have adversely impacted, and may in the future adversely impact, our revenues and results of operations;
•risks related to lawsuits and regulatory enforcement actions related to pandemic outbreaks involving us, our tenants, operators or borrowers, including increases in the costs of business, negative publicity and/or further decreases in occupancy and/or profitability at our facilities;
•the expiration, or lack of enforcement, of certain liability immunity for healthcare providers in relation to a qualified pandemic under the Public Readiness and Emergency Preparedness Act (the “PREP Act”);
•complete or partial closures of, or other operational issues at, one or more of our properties resulting from government actions or directives;
•limitations on our access to capital and other sources of funding, which could adversely impact our ability to make new property investments;
28

•our ability to continue to make cash distributions to our stockholders commensurate with historical levels; and
•our ability to repay outstanding debt or maintain compliance with covenants under our Third Amended Credit Facility (as defined below) and the indenture governing our Notes.
The extent to which public health crises may impact our business, results of operations, cash flows and financial condition depends on many factors which are highly uncertain and are difficult to predict. These factors include, but are not limited to, the duration and spread of any outbreak, the timing, distribution and efficacy of vaccines and other treatments, Unites States and foreign government actions to respond to the outbreak, the extent of disruption to our business and the business of our tenants and borrowers, and how quickly and to what extent normal operation conditions can resume.
We pursue property acquisitions and seek strategic opportunities in the ordinary course of our business, which may result in significant usage of management resources or costs, and we may not fully realize the potential benefits of such transactions.
We regularly review, evaluate, engage in discussions regarding, and pursue acquisitions of properties and seek other strategic opportunities in the ordinary course of business in order to maximize stockholder value. We may devote a significant amount of our management resources to, and incur significant costs in connection with, such transactions, which may not result in definitive agreements or the completion of any transaction and could negatively impact our operations. In addition, there is no assurance that we will fully realize the potential benefits of any past or future acquisition or strategic transaction.
If we cannot identify and purchase a sufficient quantity of suitable properties at favorable prices or if we are unable to finance acquisitions on commercially favorable terms, or at all, our business, financial position or results of operations could be materially and adversely affected. Furthermore, any future acquisitions may require the issuance of securities, the incurrence of debt, assumption of contingent liabilities or incurrence of significant expenditures, each of which could materially adversely impact our business, financial condition or results of operations. Additionally, the fact that we must distribute 90% of our REIT taxable income in order to maintain our qualification as a REIT may limit our ability to rely upon rental payments from our leased properties or subsequently acquired properties in order to finance acquisitions. As a result, if debt or equity financing is not available on acceptable terms, further acquisitions might be limited.
Investments in consolidated joint ventures involve risks not present in investments in which we are the sole investor.
We have invested, and may continue to invest, as a joint venture partner in joint ventures. Such investments may involve risks not otherwise present when acquiring real estate directly, including for example:

•the joint venture partner(s) may at any time have economic or business interests or goals which are or which may become inconsistent with our business interests or goals, including inconsistent goals relating to the sale of properties held in the joint venture or the timing of termination or liquidation of the joint venture;
•the possibility that the joint venture partner(s) might become insolvent or bankrupt;
•the possibility that we may incur liabilities as a result of an action taken by the joint venture partner(s);
•joint ventures may share certain approval rights over major decisions;
•a joint venture partner may be in a position to take action contrary to our instructions or requests or contrary to our policies or objectives, including our policy with respect to qualifying and maintaining our qualification as a REIT;
•our ability to sell or transfer our interest in the joint ventures on advantageous terms when we so desire may be limited or restricted under the terms of our agreements with the counterparties in the joint ventures;
•we may be required to contribute additional capital if the counterparties in the joint ventures fail to fund their share of required capital contributions;
•disputes between us and a joint venture partner may result in litigation or arbitration that would increase our expenses and distract our officers and directors from focusing their time and effort on our business and result in subjecting the properties owned by the applicable joint venture to additional risk; or
•under certain joint venture arrangements, neither joint venture partner may have the power to control the venture, and an impasse could be reached which might have a negative influence on the joint venture.

In the future, our joint ventures may also involve property development, which presents additional risks that could render a development project less profitable or not profitable at all and, under certain circumstances, may prevent completion of development activities once undertaken.
Increased competition has resulted and may further result in lower net revenues for some of our tenants and borrowers and may affect their ability to meet their financial and other contractual obligations to us.
The healthcare industry is highly competitive. The occupancy levels at, and results of operations from, our owned facilities and the facilities securing loans receivable are dependent on our ability and the ability of our borrowers and tenants to compete with other tenants and operators on a number of different levels, including the quality of care provided, reputation, the physical appearance of a facility, price, the range of services offered, family preference, amenities, alternatives for healthcare delivery, the supply of competing properties, physicians, staff, referral sources, location, and the size and demographics of the population in the surrounding area.
29

Operating expenses such as food, utilities, taxes, insurance, labor costs (including due to minimum wage laws and minimum staffing requirements) and rent or debt service continue to increase. In addition, our tenants and borrowers face an increasingly competitive labor market for skilled management personnel and nurses together with Medicaid reimbursement in some states that does not cover the full cost of caring for residents. Significant turnover, or a shortage of nurses or other trained personnel or general inflationary pressures on wages, may force tenants, borrowers or operators to enhance pay and benefits packages to compete effectively for skilled personnel, or to use more expensive contract personnel, but they may be unable to offset these added costs by increasing the rates charged to residents. Further, the Trump administration has announced its intention to engage in the mass deportation of undocumented immigrants and sharply limit the amount of legal immigration, which would further increase competition and wages for labor. Any increase in labor costs and other property operating expenses or any failure by our tenants or borrowers to attract and retain qualified personnel could reduce the revenues of our borrowers and tenants and their ability to meet their obligations to us.
Our tenants and borrowers also compete with numerous other companies providing similar healthcare services or alternatives such as home health agencies, life care at home, community-based service programs, retirement communities and convalescent centers. We cannot be certain that our tenants and borrowers will be able to achieve occupancy and rate levels, or manage their expenses, in a way that will enable them to meet all of their obligations to us. Further, many competing companies may have resources and attributes that are superior to those of our tenants and borrowers. They may encounter increased competition that could limit their ability to maintain or attract residents or expand their businesses or to manage their expenses, either of which could adversely affect their ability to meet their obligations to us, potentially decreasing our revenues, impairing our assets, and/or increasing our collection and dispute costs.
In addition, if development of seniors housing facilities outpaces demand for those assets in markets in which we are located, those markets may become saturated and our seniors housing tenants and operators could experience decreased occupancy, which may affect their ability to meet their financial and other contractual obligations to us.
Required regulatory approvals can delay or prohibit transfers of our healthcare properties, which could result in periods in which we are unable to receive rent for such properties.
Our tenants and borrowers that operate SNFs and other healthcare facilities must be licensed under applicable state law and, depending upon the type of facility, certified or approved as providers under the Medicare and/or Medicaid programs. Prior to the transfer of the operations of such healthcare properties to successor operators, the new operator generally must become licensed under state law and, in certain states, receive change of ownership approvals under certificate of need laws (which provide for a certification that the state has made a determination that a need exists for the beds located on the property) and, if applicable, file for a Medicare and Medicaid change of ownership. Upon termination or expiration of existing leases, delays or the failure of the new tenant in receiving regulatory approvals from the applicable federal, state or local government agencies, has in the past prolonged, and may in the future prolong, the period during which we are unable to collect rent and the property may experience performance declines. We could also incur substantial additional expenses in connection with any licensing, receivership or change of ownership proceedings.
We may not be able to sell properties when we desire because real estate investments are relatively illiquid, which could materially and adversely affect our business, financial position or results of operations.
Real estate investments are generally illiquid. As a result, we may be unable to vary our portfolio promptly in response to changes in the real estate market. A downturn in the real estate market could materially and adversely affect the value of our properties and our ability to sell such properties for acceptable prices or terms. We also cannot predict the length of time needed to find a willing purchaser and to close the sale of a property or portfolio of properties. These factors and any others that would impede our ability to respond to adverse changes in the performance of our properties could materially and adversely affect our business, financial position or results of operations and our ability to pay dividends and make distributions.
We, our tenants or our borrowers may experience uninsured or underinsured losses, which could result in a significant loss of the capital we have invested in a property, decrease anticipated future revenues or cause us to incur unanticipated expenses.
Our lease and lending agreements require that the tenant or borrower, as applicable, maintain general and professional liability insurance and comprehensive liability and hazard insurance. However, there are certain types of losses (including, but not limited to, losses arising from environmental conditions or of a catastrophic nature, such as earthquakes, wildfires, hurricanes and floods) that may be uninsurable or not economically insurable. In addition, insurance coverage may be insufficient to pay the full current market value or replacement cost of any loss. Inflation, changes in tort liability laws, changes in building codes and ordinances, environmental considerations, and other factors also might make it infeasible to use insurance proceeds to protect a tenant in a liability claim or replace a property after such property has been damaged or destroyed. Under such circumstances, the insurance proceeds received might not be adequate to restore the economic position with respect to such tenant or property.
30

If one of our tenants or borrowers experiences a material general or professional liability loss that is uninsured or exceeds policy coverage limits, it may be unable to satisfy its payment obligations to us. If one of our properties experiences a loss that is uninsured or that exceeds policy coverage limits, we could lose the capital invested in the damaged property as well as the anticipated future cash flows from the property.
In addition, even if damage to our owned properties or the properties securing our loans receivable is covered by insurance, business disruptions caused by a casualty event may result in lost revenue for our tenants, borrowers or us for which insurance may not fully compensate them or us for such loss of revenue. If one of our tenants or borrowers experiences such a loss, it may be unable to satisfy its payment obligations to us.
We are, and may continue to be, exposed to contingent rent escalators, which could hinder our profitability and growth. 
We derive revenue primarily by leasing our assets under long-term triple-net leases with rental rates that, subject to certain limitations, are generally fixed with annual rent escalations contingent on changes in the Consumer Price Index, subject to maximum fixed percentages. If the Consumer Price Index does not increase, our revenues may not increase. In addition, if economic conditions result in significant increases in the Consumer Price Index, but the escalations under our leases are capped, our growth and profitability also may be limited.
Cybersecurity incidents or other damage to the information systems and technology of us, our tenants or borrowers could harm our business.
We rely on information technology networks, enterprise and other cloud-based applications and other information systems to process, transmit and store electronic information, and to manage and support our business processes, including financial transactions and records, and to maintain personal information and tenant and lease data. We purchase some of our information technology, including software and cloud-based technology, from third party service providers, on whom we and our systems depend. While we have taken steps to protect the security of our information systems, we have, from time to time, experienced cybersecurity incidents of varying degrees, although none of these cyber incidents has had a material adverse impact on our business, financial condition or results of operations. The technology infrastructure and systems of some of our cloud solution and other third party service providers have also in the past experienced, and may in the future experience, cybersecurity incidents of varying degrees. Cybersecurity incidents can be caused by ransomware, computer denial-of-service attacks, worms, and other malicious software programs or other attacks, including the covert introduction of malware to computers and networks, and the use of techniques or processes that change frequently, may be disguised or difficult to detect, or are designed to remain dormant until a triggering event, and may continue undetected for an extended period of time. Cybersecurity incidents also result from social engineering or impersonation of authorized users as well as efforts to discover and exploit any design flaws, bugs, security vulnerabilities or security weaknesses, intentional or unintentional acts by employees or other insiders with access privileges, intentional acts of vandalism or fraud by third parties and sabotage. The risk of cybersecurity incidents has generally increased as the number, intensity and sophistication of attacks and intrusions from around the world have increased.
We have engaged a third-party cybersecurity firm who serves as our dedicated information technology and cybersecurity team and helps us oversee, implement and manage our processes and controls to assess, identify and manage risks from cybersecurity threats. It is possible that our processes and controls will not detect or protect against all cybersecurity threats or incidents. In addition, any failure on the part of our outsourced cybersecurity team to effectively monitor and protect our information systems could make us more vulnerable to cybersecurity incidents. Our technology infrastructure and information systems are also vulnerable to damage or interruption from natural disasters, power loss and telecommunications failures. Failure to maintain proper function, security and availability of our information systems or the loss or misuse of the data maintained in those systems could interrupt our operations, damage our reputation, subject us to significant costs to respond and implement remediation measures and liability claims or regulatory penalties and could have a material adverse effect on our business, financial condition and results of operations.
Our tenants or borrowers may also from time to time experience cybersecurity incidents or other damage or interruption to their information systems that disrupt their operations or result in the loss or misuse of confidential information or other sensitive or personal information. Any resulting financial impact to our tenants or borrowers, including liability claims or regulatory penalties, costs to respond and implement remediation measures as well as operational consequences or business impacts resulting from any damage to their reputation or harm to their business relationships, could negatively impact the ability of our tenants or borrowers to meet their financial and other contractual obligations to us, which could have a material adverse effect on our business, financial condition and results of operations.
Bank failures or other events affecting financial institutions could have a material adverse effect on our, our tenants’ or our borrowers’ liquidity, results of operations, and financial condition.
The failure of a bank, or events involving limited liquidity, defaults, non-performance, or other adverse conditions in the financial or credit markets impacting financial institutions, or concerns or rumors about such events, may adversely impact us, either directly or through an adverse impact on our tenants, operators, and borrowers.
31

A bank failure or other event affecting financial institutions could lead to disruptions in our or our tenants’, operators’, and borrowers’ access to bank deposits or borrowing capacity, including access to letters of credit from certain of our tenants relating to lease obligations. In addition, in the event of a bank failure or liquidity crisis, our or our tenants’, operators’, and borrowers’ deposits in excess of the Federal Deposit Insurance Corporation (“FDIC”) limits may not be backstopped by the U.S. government, and banks or financial institutions with which we or our tenants, operators, and borrowers do business may be unable to obtain needed liquidity from other banks, government institutions, or by acquisition. Any adverse effects to our tenants’, operators’, or borrowers’ liquidity or financial performance could affect their ability to meet their financial and other contractual obligations to us, which could have a material adverse effect our business, results of operations, and financial condition.
Risks Related to Laws and Regulations
Healthcare reform legislation impacts cannot accurately be predicted and could adversely affect our results of operations.
We, our borrowers and the healthcare operators leasing our properties depend on the healthcare industry and are susceptible to risks associated with healthcare reform. Legislative proposals are introduced each year that would introduce major changes in the healthcare system, both nationally and at the state level. For example, we believe that efforts may be made to, among other things, transition Federal payment programs further in the direction of value based care, but we cannot predict whether or in what form any of these measures may be enacted, or what effect they would have on our business or the businesses of our tenants if enacted. Efforts may also be made to reduce the age at which individuals become eligible for Medicare, which could have an adverse impact on our tenants because Medicare sometimes reimburses long term care providers at rates lower than those paid by commercial payors. In addition, the Biden Administration announced a focus on implementing minimum staffing requirements and increased inspections as part of nursing home reforms announced in the 2022 State of the Union Address. On April 22, 2024, CMS issued a final rule regarding minimum staffing requirements and increased inspections at nursing homes in order to establish comprehensive nurse staffing requirements. The rule consists of three core staffing requirements: (1) overall minimum standard of 3.48 total nurse staff hours per resident day; (2) minimum nurse staffing standards of 0.55 hours per resident day for registered nurses and 2.45 hours of care from a certified nurse’s aid per resident per day; and (3) a requirement to have a registered nurse onsite 24 hours a day, seven days a week. The rule includes a staggered implementation approach for which CMS will publish additional details on compliance as the implementation dates approach. The rule also includes possible waivers and temporary hardship exemptions for select facilities; however, no funding for the additional staff will be provided. We are currently evaluating the impact of the rule, but believe the unfunded mandate to increase staff may have a material and adverse impact on the financial condition of our tenants, operators and borrowers. We cannot predict how the new Trump Administration will implement the rule. We also cannot predict whether any future legislation related to staffing will be adopted or, if adopted, the impact such legislation may have on our tenants or our business.
Our tenants and borrowers are subject to extensive federal, state and local laws and regulations affecting the healthcare industry that include those relating to, among other things, licensure, conduct of operations, ownership of facilities, addition of facilities and equipment, allowable costs, services, prices for services, qualified beneficiaries, quality of care, patient rights and insurance, fraudulent or abusive behavior, labor and employment issues and financial and other arrangements that may be entered into by healthcare providers. See “Government Regulation, Licensing and Enforcement” in Item 1 of this Annual Report on Form 10-K for more information. If our borrowers, tenants or operators fail to comply with the laws, regulations and other requirements applicable to their businesses and the operation of our properties, they could become ineligible to receive reimbursement from governmental and private third-party payor programs, face bans on admissions of new patients or residents, suffer civil or criminal penalties or be required to make significant operational changes. The cost to comply with these laws, regulations and other requirements results in increased costs of doing business for our tenants, operators and borrowers. For example, on October 13, 2023, California Senate Bill No. 525 (“SB 525”) was signed into law, requiring a substantial increase in the minimum wage for workers operating in certain health care facilities. As a result of SB 525, certain health care facilities (including licensed skilled nursing facilities) operating in California are required to increase the wages of their covered health care employees to at least $21 per hour from June 1, 2024 to May 31, 2026, $22 or $23 per hour (depending on facility type) from June 1, 2026 to May 31, 2028, and $25 per hour after June 1, 2028. After the initial implementation was delayed by the Governor of California in June 2024, SB 525 went into effect on October 16, 2024. If our tenants, operators and borrowers are unable to offset these increased costs, their operating results and financial condition will be adversely impacted and our tenants and borrowers may be unable to satisfy their obligations to us.
We believe that additional resources may be dedicated to regulatory enforcement, which could further increase our tenants’ and borrowers’ costs of doing business and negatively impact their ability to pay their obligations to us. Changes in enforcement policies by federal and state governments have also resulted in a significant increase in inspection rates, citations of regulatory deficiencies and sanctions, including terminations from Medicare and Medicaid programs, bars on Medicare and Medicaid payments for new admissions, civil monetary penalties and criminal penalties. Our tenants, operators and borrowers could be forced to expend considerable resources responding to an investigation, lawsuit or other enforcement action under applicable laws or regulations.
32

Additionally, if our tenants’ or borrowers’ residents do not have insurance, it could adversely impact the tenants’ or borrowers’ ability to satisfy their obligation to us.
Tenants and borrowers that fail to comply with applicable requirements of governmental reimbursement programs, such as Medicare or Medicaid, may cease to operate or be unable to meet their financial and other contractual obligations to us.
Our tenants and borrowers are subject to the following risks, among others, relating to governmental healthcare reimbursement programs: statutory and regulatory changes; retroactive rate adjustments; recovery of program overpayments or set-offs; administrative rulings; policy interpretations; payment or other delays by fiscal intermediaries or carriers; government funding restrictions (at a program level or with respect to specific facilities); and interruption or delays in payments due to any ongoing governmental investigations and audits.
We expect healthcare reimbursement will continue to be a significant focus for federal and state authorities in their cost control efforts. We cannot predict the timing or effects of any future legislative reforms on our tenants’ and borrowers’ business costs or government and other third-party payor reimbursement. More generally, because of the dynamic nature of the legislative and regulatory environment for health care products and services, and in light of existing federal budgetary concerns, we cannot predict the impact that broad-based, far-reaching legislative or regulatory changes could have on the U.S. economy, our business or that of our operators and tenants. The failure of any of our tenants and borrowers to comply with these laws, requirements and regulations could materially and adversely affect their ability to meet their financial and contractual obligations to us.
Government investigations and enforcement actions brought against the health care industry have increased dramatically over the past several years and are expected to continue, particularly in the area of Medicare/Medicaid false claims, as well as an increase in the intensity of enforcement actions resulting from these investigations. Some of these enforcement actions represent novel legal theories and expansions in the application of the False Claims Act.
Medicare, Medicaid and other governmental health care payors require reporting of extensive financial information in a specific format or content. These requirements are technical and complex and may not be properly implemented by billing or reporting personnel. For certain required information, False Claims Act violations may occur without any intent to defraud by mere negligence or recklessness in information submission to the government. New billing systems, medical procedures and procedures for which there is not clear guidance may all result in liability. In addition, violations of the Anti-Kickback Law or Stark Law and, for provider tenants who received pandemic relief funds, the failure to comply with terms and conditions related to receipt or repayment of those funds, may form the basis for a federal False Claims Act violation. See “Government Regulation, Licensing and Enforcement,” in Item 1 of this Annual Report on Form 10-K for more information.
Many states have adopted laws similar to the False Claims Act, some of which apply to claims submitted to private and commercial payors, not just governmental payors. Violations of such laws by an operator of a health care property could result in loss of accreditation, denial of reimbursement, imposition of fines, suspension or decertification from government healthcare programs, civil liability, and in certain limited instances, criminal penalties, loss of license or closure of the property and/or the incurrence of considerable costs arising from an investigation or regulatory action.
If we, our tenants or borrowers fail to adhere to applicable privacy and data security laws, this could have a material adverse effect on us or on our tenants’ and borrowers’ ability to meet their obligations to us.
We and our tenants and borrowers are subject to HIPAA and various other state and federal laws that relate to privacy and data security, including the reporting of data breaches involving personal information as discussed in “Government Regulation, Licensing and Enforcement - Privacy, Security and Data Breach Notification Laws” in Item 1 of this Annual Report on Form 10-K. Failure by us or our tenants and borrowers to comply with these requirements could have a material adverse effect on us and the ability of our tenants and borrowers to meet their obligations to us. Furthermore, the adoption of new privacy, security and data breach notification laws at the federal and state level could require us or our tenants and borrowers to incur significant compliance costs. In addition, the cost and operational consequences of responding to data breaches and implementing remediation measures could be significant.
Tenants and borrowers that fail to comply with federal, state and local licensure, certification and inspection laws and regulations may cease to operate or be unable to meet their financial and other contractual obligations to us.
The healthcare operators that operate the properties we lease to our tenants or that secure our loans receivable are subject to extensive federal, state, local and industry-related licensure, certification and inspection laws, regulations and standards. Our tenants’ or borrowers’ failure to comply with any of these laws, regulations or standards could result in adverse publicity and reputational harm as well as penalties which may include loss or restriction of license, loss of accreditation, denial of reimbursement, imposition of fines, suspension or decertification from federal and state healthcare programs, or closure of the facility. Though the regulatory environment in which SNFs operate is more restrictive than for ALFs, ALFs face similar penalties for noncompliance with applicable legal requirements. For example, operations at our properties may require a license, registration, certificate of need, provider agreement or certification.
33

Failure of any tenant or borrower to obtain, or the loss or imposition of restrictions on any required license, registration, certificate of need, provider agreement or certification would prevent a facility from operating in the manner intended by such tenant. Additionally, failure of our tenants or borrowers to generally comply with applicable laws and regulations could adversely affect facilities owned by us, result in adverse publicity and reputational harm, and therefore could materially and adversely affect us. See “Government Regulation, Licensing and Enforcement - Healthcare Licensure and Certificate of Need” in Item 1 of this Annual Report on Form 10-K for additional information.
Environmental compliance costs and liabilities may materially impair the value of properties owned by us.
Under various federal, state and local laws, ordinances and regulations, as a current or previous owner of real estate, we may be required to investigate and clean up certain hazardous or toxic substances or petroleum released at a property, and may be held liable to a governmental entity or to third parties for property damage and for investigation and cleanup costs incurred by the third parties in connection with the contamination. In addition, some environmental laws create a lien on the contaminated site in favor of the government for damages and the costs it incurs in connection with the contamination. Neither we nor our tenants carry environmental insurance on our properties. Contamination or the failure to remediate contamination may materially adversely affect our ability to sell or lease the real estate or to borrow using the real estate as collateral. As the owner of a site, we may also be held liable to third parties for damages and injuries resulting from environmental contamination emanating from the site. Although we generally require our tenants, as operators of our healthcare properties, to indemnify us for environmental liabilities they cause, such liabilities could exceed the financial ability of the tenant to indemnify us or the value of the contaminated property. We may also experience environmental liabilities arising from conditions not known to us.
Risks Related to Our Status as a REIT
If we fail to qualify or remain qualified as a REIT, we will be subject to U.S. federal income tax as a regular corporation and could face substantial tax liability, which could adversely affect our ability to raise capital or service our indebtedness.
We currently operate, and intend to continue to operate, in a manner that will allow us to continue to qualify to be taxed as a REIT for U.S. federal income tax purposes. We elected to be taxed as a REIT for U.S. federal income tax purposes beginning with our taxable year ended December 31, 2014. We received an opinion of our counsel with respect to our qualification as a REIT in connection with becoming a public company. Investors should be aware, however, that opinions of advisors are not binding on the IRS or any court. The opinion of our counsel represents only the view of our counsel based on its review and analysis of existing law and on certain representations as to factual matters and covenants made by us, including representations relating to the values of our assets and the sources of our income. The opinion is expressed as of the date issued. Our counsel has no obligation to advise us or the holders of any of our securities of any subsequent change in the matters stated, represented or assumed or of any subsequent change in applicable law. Furthermore, both the validity of the opinion of our counsel and our qualification as a REIT will depend on our satisfaction of certain asset, income, organizational, distribution, stockholder ownership and other requirements on a continuing basis, the results of which will not be monitored by our counsel. Our ability to satisfy the asset tests depends upon our analysis of the characterization and fair market values of our assets, some of which are not susceptible to a precise determination, and for which we will not obtain independent appraisals.
If we fail to qualify to be taxed as a REIT in any year, we would be subject to U.S. federal income tax, including any applicable alternative minimum tax, on our taxable income at regular corporate rates, and dividends paid to our stockholders would not be deductible by us in computing our taxable income. Any resulting corporate liability could be substantial and would reduce the amount of cash available for distribution to our stockholders, which could have an adverse impact on the value of our common stock. Unless we were entitled to relief under certain Code provisions, we also would be disqualified from re-electing to be taxed as a REIT for the four taxable years following the year in which we failed to qualify to be taxed as a REIT, which could adversely affect our financial condition and results of operations.
Legislative or other actions affecting REITs could have a negative effect on us.
The rules dealing with U.S. federal income taxation are constantly under review by persons involved in the legislative process and by the IRS and the U.S. Department of the Treasury (the “Treasury”). Changes to the tax laws or interpretations thereof, with or without retroactive application, could materially and adversely affect our investors or us. We cannot predict how changes in the tax laws, including any tax reform called for by the current presidential administration, might affect our investors or us. New legislation, Treasury regulations, administrative interpretations or court decisions could significantly and negatively affect our ability to qualify to be taxed as a REIT or the U.S. federal income tax consequences to our investors and us of such qualification. For instance, the “Tax Cuts and Jobs Act” (the “Act”) significantly changed the U.S. federal income tax laws applicable to businesses and their owners, including REITs and their shareholders. Technical corrections or other amendments to the Act or administrative guidance interpreting the Act may be forthcoming at any time. We cannot predict the long-term effect of the Act or any future law changes on REITs or their shareholders. Changes to the U.S. federal tax laws and interpretations thereof, whether under the Act or otherwise, could adversely affect an investment in our stock No prediction can be made regarding whether new legislation or regulation (including new tax measures) will be enacted by legislative bodies or governmental agencies, nor can we predict what consequences would result from this legislation or regulation.
34

Accordingly, no assurance can be given that the currently anticipated tax treatment of an investment will not be modified by legislative, judicial or administrative changes, possibly with retroactive effect.
We could fail to qualify to be taxed as a REIT if income we receive from our tenants is not treated as qualifying income.
Under applicable provisions of the Code, we will not be treated as a REIT unless we satisfy various requirements, including requirements relating to the sources of our gross income. Rents received or accrued by us from our tenants will not be treated as qualifying rent for purposes of these requirements if the leases are not respected as true leases for U.S. federal income tax purposes and are instead treated as service contracts, joint ventures or other arrangements. If the leases are not respected as true leases for U.S. federal income tax purposes, we will likely fail to qualify to be taxed as a REIT.
In addition, subject to certain exceptions, rents received or accrued by us from our tenants will not be treated as qualifying rent for purposes of these requirements if we or a beneficial or constructive owner of 10% or more of our stock beneficially or constructively owns 10% or more of the total combined voting power of all classes of stock entitled to vote or 10% or more of the total value of all classes of stock. CareTrust REIT’s charter provides for restrictions on ownership and transfer of CareTrust REIT’s shares of stock, including restrictions on such ownership or transfer that would cause the rents received or accrued by us from our tenants to be treated as non-qualifying rent for purposes of the REIT gross income requirements. Nevertheless, there can be no assurance that such restrictions will be effective in ensuring that rents received or accrued by us from our tenants will not be treated as qualifying rent for purposes of REIT qualification requirements.
Dividends payable by REITs do not qualify for the reduced tax rates available for some dividends.
The maximum U.S. federal income tax rate applicable to income from “qualified dividends” payable by U.S. corporations to U.S. stockholders that are individuals, trusts and estates is currently 20%. Dividends payable by REITs, however, generally are not eligible for the reduced rates. However, for taxable years beginning before January 1, 2026, under the Tax Cuts and Jobs Act, noncorporate taxpayers may deduct up to 20% of certain qualified business income, including "qualified REIT dividends" (generally, dividends received by a REIT shareholder that are not designated as capital gain dividends or qualified dividend income), subject to certain limitations, resulting in an effective maximum U.S. federal income tax rate of 29.6% on such income. Although these rules do not adversely affect the taxation of REITs, the more favorable rates applicable to regular corporate qualified dividends, together with the recently reduced corporate tax rate (currently, 21%), could cause investors who are individuals, trusts and estates to perceive investments in REITs to be relatively less attractive than investments in the stocks of non-REIT corporations that pay dividends, which could adversely affect the value of the stock of REITs, including our stock. Although these rules do not adversely affect the taxation of REITs, the more favorable rates applicable to regular corporate qualified dividends could cause investors who are individuals, trusts and estates to perceive investments in REITs to be relatively less attractive than investments in the stocks of non-REIT corporations that pay dividends, which could adversely affect the value of the stock of REITs, including our stock.
REIT distribution requirements could adversely affect our ability to execute our business plan.
We generally must distribute annually at least 90% of our REIT taxable income, determined without regard to the dividends paid deduction and excluding any net capital gains, in order for us to qualify to be taxed as a REIT (assuming that certain other requirements are also satisfied) so that U.S. federal corporate income tax does not apply to earnings that we distribute. To the extent that we satisfy this distribution requirement and qualify for taxation as a REIT but distribute less than 100% of our REIT taxable income, determined without regard to the dividends paid deduction and including any net capital gains, we will be subject to U.S. federal corporate income tax on our undistributed net taxable income. In addition, we will be subject to a 4% nondeductible excise tax if the actual amount that we distribute to our stockholders in a calendar year is less than a minimum amount specified under U.S. federal income tax laws. We intend to make distributions to our stockholders to comply with the REIT requirements of the Code.
Our funds from operations are generated primarily by rents paid under leases with our tenants. From time to time, we may generate taxable income greater than our cash flow as a result of differences in timing between the recognition of taxable income and the actual receipt of cash or the effect of nondeductible capital expenditures, the creation of reserves or required debt or amortization payments. If we do not have other funds available in these situations, we could be required to borrow funds on unfavorable terms, sell assets at disadvantageous prices or distribute amounts that would otherwise be invested in future acquisitions in order to make distributions sufficient to enable us to pay out enough of our taxable income to satisfy the REIT distribution requirement and to avoid being subject to corporate income tax and the 4% excise tax in a particular year. These alternatives could increase our costs or reduce our equity.
Even if we remain qualified as a REIT, we may face other tax liabilities that reduce our cash flow.
Even if we remain qualified for taxation as a REIT, we may be subject to certain U.S. federal, state, and local taxes on our income and assets, including taxes on any undistributed income and state or local income, property and transfer taxes.
35

For example, we may hold some of our assets or conduct certain of our activities through one or more taxable REIT subsidiaries (each, a “TRS”) or other subsidiary corporations that will be subject to U.S. federal, state, and local corporate-level income taxes as regular C corporations. In addition, we may incur a 100% excise tax on transactions with a TRS if they are not conducted on an arm’s-length basis. Any of these taxes would decrease cash available for distribution to our stockholders.
Complying with REIT requirements may cause us to forgo otherwise attractive acquisition opportunities or liquidate otherwise attractive investments.
To qualify as a REIT for U.S. federal income tax purposes, we must on an ongoing basis satisfy tests concerning, among other things, the sources of our income, the nature and diversification of our assets, the amounts we distribute to our stockholders and the ownership of our shares of beneficial interest. We may be required to make distributions to our stockholders at disadvantageous times or when we do not have funds readily available for distribution. Thus, compliance with the REIT requirements may hinder our ability to make certain attractive investments.
Complying with REIT requirements may limit our ability to hedge effectively and may cause us to incur tax liabilities.
The REIT provisions of the Code substantially limit our ability to hedge our assets and liabilities. Income from certain hedging transactions that we may enter into to manage risk of interest rate changes with respect to borrowings made or to be made to acquire or carry real estate assets does not constitute “gross income” for purposes of the 75% or 95% gross income tests that apply to REITs, provided that certain identification requirements are met. For taxable years beginning after December 31, 2015, income from new transactions entered into to hedge the income or loss from prior hedging transactions, where the indebtedness or property which was the subject of the prior hedging transaction was extinguished or disposed of, will not constitute gross income for purposes of the 75% or 95% gross income tests. To the extent that we enter into other types of hedging transactions or fail to properly identify such transaction as a hedge, the income is likely to be treated as non-qualifying income for purposes of both of the gross income tests. As a result of these rules, we may be required to limit our use of advantageous hedging techniques or implement those hedges through a TRS. This could increase the cost of our hedging activities because the TRS may be subject to tax on gains or expose us to greater risks associated with changes in interest rates than we would otherwise want to bear. In addition, losses in the TRS will generally not provide any tax benefit, except that such losses could theoretically be carried back or forward against past or future taxable income in the TRS.
Risks Related to Our Capital Resources and Indebtedness
From time to time, we may have substantial indebtedness and we are able to incur significant additional indebtedness.
As of December 31, 2024, we had approximately $400.0 million of indebtedness representing our 3.875% Senior Notes due 2028 (the “Notes”) and no borrowings outstanding under our unsecured revolving credit facility. High levels of indebtedness could have one or more of the following adverse consequences, among others: require us to dedicate a substantial portion of our cash flow from operations to make principal and interest payments on our indebtedness, thereby reducing our cash flow available to fund working capital, dividends, capital expenditures and acquisitions and other general corporate purposes; require us to maintain certain debt coverage and other financial ratios at specified levels, thereby reducing our financial flexibility; make it more difficult for us to satisfy our financial obligations, including the Notes and borrowings under the Third Amended Revolving Facility (as defined below); increase our vulnerability to general adverse economic and industry conditions or a downturn in our business; limit, along with the financial and other restrictive covenants in our indebtedness, our ability to borrow additional funds on favorable terms or at all to expand our business or ease liquidity constraints; limit our ability to refinance all or a portion of our indebtedness on or before maturity on the same or more favorable terms or at all; and require us to dispose of one or more of our properties at disadvantageous prices in order to service our indebtedness or to raise funds to pay such indebtedness at maturity.
In addition, failure to satisfy our obligations under the Notes or our other debt or to comply with the financial and other restrictive covenants contained in the indenture governing the Notes or the Third Amended Credit Agreement (as defined below), could result in an event of default, which could result in all of our debt becoming immediately due and payable and permit certain of our lenders to foreclose on our assets securing such debt. Further, our Third Amended Credit Agreement and the indenture governing the Notes permit us to incur substantial additional debt, including secured debt, subject to our compliance with certain financial covenants set forth in the Third Amended Credit Agreement and our ability to satisfy certain covenants in the indenture governing the Notes. See “Risk Factors - Risks Related to Our Capital Resources and Indebtedness - Covenants in our debt agreements restrict our activities and could adversely affect our business” for a summary of these covenants.
We may be unable to service our indebtedness.
Our ability to make scheduled payments on and to refinance our indebtedness depends on and is subject to our future financial and operating performance, which in turn is affected by general and regional economic, financial, competitive, business and other factors beyond our control, including the availability of financing in the international banking and capital markets.
36

Our business may fail to generate sufficient cash flow from operations or future borrowings may be unavailable to us under the Third Amended Revolving Facility or from other sources in an amount sufficient to enable us to service our debt, to refinance our debt or to fund our other liquidity needs. If we are unable to meet our debt obligations or to fund our other liquidity needs, we will need to restructure or refinance all or a portion of our debt. We may be unable to refinance such debt on commercially reasonable terms or at all. If we were unable to make payments or refinance our debt or obtain new financing under these circumstances, we would have to consider other options, such as asset sales, equity issuances and/or negotiations with our lenders to restructure such debt. The Third Amended Credit Agreement and the indenture governing the Notes restrict, and market or business conditions may limit our ability to take, these actions. Any debt restructuring or refinancing could be at higher interest rates and may require us to comply with more onerous covenants that could further restrict our business operations.
We rely on our subsidiaries for our operating funds.
We conduct our operations through subsidiaries and depend on our subsidiaries for the funds necessary to operate and repay our debt obligations, including funds transfers to us which are necessary to make the payments due under the Notes. The obligations under the Notes are fully and unconditionally guaranteed, jointly and severally, on an unsecured basis, by us and all of our existing and future subsidiaries (other than CTR Partnership, L.P. and CareTrust Capital Corp.) that guarantee obligations under the Third Amended Revolving Facility. However, under certain circumstances, one or more of our subsidiaries may be released from, or may not be required to provide, a guarantee of the Notes, and in such circumstances, will not be responsible for any obligations with respect to the Notes. Each of our subsidiaries is a distinct legal entity and has no obligation, contingent or otherwise, to transfer funds to us. In addition, the ability of our subsidiaries to transfer funds to us could be restricted by the terms of subsequent financings.
Covenants in our debt agreements restrict our activities and could adversely affect our business.
Our debt agreements contain covenants that limit our and our subsidiaries’ ability to engage in various transactions including, as applicable: incurring or guaranteeing additional secured and unsecured debt; creating liens on our and our subsidiaries’ assets; paying dividends or making other distributions on, redeeming or repurchasing capital stock; making investments or other restricted payments; entering into transactions with affiliates; engaging in non-healthcare related business activities; creating restrictions on the ability of our subsidiaries to pay distributions or other amounts to us; selling assets; effecting a consolidation or merger or selling all or substantially all of our assets; making acquisitions; and amending organizational documents.
These covenants limit our operational flexibility and could prevent us from taking advantage of business opportunities as they arise, growing our business or competing effectively. The Third Amended Credit Agreement requires us to comply with financial maintenance covenants to be tested quarterly and also contains customary events of default, including the failure to make timely payments under the Third Amended Revolving Facility or other material indebtedness, failure to satisfy certain covenants (including financial maintenance covenants), the occurrence of a change of control and specified events of bankruptcy and insolvency. Our ability to meet these requirements may be affected by events beyond our control and, if we fail to do so, we may be unable to obtain waivers from the lenders or amend the covenants.
Increases in interest rates could increase our existing and future debt borrowing costs and adversely affect our stock price.
Certain of our existing debt obligations require interest and related payments to vary with the movement of certain indices, such as the Secured Overnight Financing Rate, and we may incur additional indebtedness in connection with new credit facilities or financing of acquisitions or development activities. Interest rates in recent years have increased, and may continue to increase, our interest costs for any new debt and our obligations under our Third Amended Revolving Facility, which could make acquisition financings more costly or lower our current period earnings. Rising interest rates could limit our ability to refinance existing debt when it matures or cause us to pay higher interest rates upon refinancing. In addition, interest rate increases could decrease credit access globally, thereby decreasing the amount others are willing to pay for our assets and limiting our ability to reposition our portfolio promptly in response to changes in economic or other conditions. Further, the dividend yield on our common stock, as a percentage of the price of such common stock, will influence the price of such common stock. Thus, an increase in market interest rates may lead prospective purchasers of our common stock to expect a higher dividend yield, which could adversely affect the market price of our common stock.
A credit rating downgrade could impair our ability to obtain additional debt financing on favorable terms, if at all, and significantly reduce the trading price of our common stock.
Our credit rating can affect the amount, type and terms of capital financings we obtain. Factors affecting our credit rating include, among others, our financial performance, success in raising sufficient equity capital, adverse changes in our debt and fixed charge coverage ratios, our capital structure, level of indebtedness and future changes in the regulatory framework applicable to our operators and industry. We may be unable to maintain our current credit ratings, and in the event that our current credit ratings deteriorate, a ratings agency downgrades our credit rating or places our rating under watch or review for possible downgrade, we would likely incur higher borrowing costs, which would make it more difficult or expensive to obtain additional financing or refinance existing obligations and commitments and the trading price of our common stock may decline.
37

Risks Related To Our Common Stock and Organizational Documents
Our charter restricts the ownership and transfer of our outstanding stock, which may have the effect of delaying, deferring or preventing a transaction or change of control of our company.
In order for us to qualify to be taxed as a REIT, not more than 50% in value of our outstanding shares of stock may be owned, beneficially or constructively, by five or fewer individuals at any time during the last half of each taxable year after our first taxable year as a REIT. Additionally, at least 100 persons must beneficially own our stock during at least 335 days of a taxable year (other than our first taxable year as a REIT). Our charter, with certain exceptions, authorizes our board of directors to take such actions as are necessary and desirable to preserve our qualification as a REIT. Our charter also provides that, unless exempted by the board of directors, no person may own more than 9.8% in value or in number of shares, whichever is more restrictive, of the outstanding shares of our common stock, or more than 9.8% in value of the outstanding shares of all classes or series of our stock. The constructive ownership rules are complex and may cause shares of stock owned directly or constructively by a group of related individuals or entities to be constructively owned by one individual or entity. These ownership limits could delay or prevent a transaction or a change in control of us that might involve a premium price for shares of our stock or otherwise be in our stockholders’ best interests. The acquisition of less than 9.8% of our outstanding stock by an individual or entity could cause that individual or entity to own constructively in excess of 9.8% in value of our outstanding stock, and thus violate our charter’s ownership limit. Our charter also prohibits any person from owning shares of our stock that would result in our being “closely held” under Section 856(h) of the Code or otherwise cause us to fail to qualify to be taxed as a REIT. In addition, our charter provides that (i) no person shall beneficially or constructively own shares of stock to the extent such beneficial or constructive ownership of stock would result in us failing to qualify as a “domestically controlled qualified investment entity” within the meaning of Section 897(h) of the Code, and (ii) no person shall beneficially or constructively own shares of stock to the extent such beneficial or constructive ownership would cause us to own, beneficially or constructively, more than a 9.9% interest (as set forth in Section 856(d)(2)(B) of the Code) in a tenant of our real property. Any attempt to own or transfer shares of our stock in violation of these restrictions may result in the transfer being automatically void.
Maryland law and provisions in our charter and bylaws may inhibit our stockholders from realizing a premium on their stock by delaying or preventing takeover attempts by third parties.
Our charter, bylaws and Maryland law contain provisions intended to deter coercive takeovers and inadequate takeover bids and to encourage prospective acquirors to negotiate with our board of directors rather than to attempt a hostile takeover. As currently in effect, our charter and bylaws, among other things, (1) contain transfer and ownership restrictions on the percentage by number and value of outstanding shares of our stock that may be owned or acquired by any stockholder; (2) prohibit stockholders action by non-unanimous written consent; (3) permit the board of directors, without further action of the stockholders, to amend the charter to increase or decrease the aggregate number of authorized shares or the number of shares of any class or series that may be issued; (4) permit the board of directors to classify or reclassify any unissued shares of common or preferred stock and set the preferences, rights and other terms of the classified or reclassified shares; (5) establish certain advance notice procedures for stockholder proposals, and provide procedures for the nomination of candidates for our board of directors; (6) provide that special meetings of stockholders may only be called by the Company or upon written request of 25% of all the votes entitled to be cast at such meeting; (7) provide that a director may only be removed by stockholders for cause and upon the vote of two-thirds of the outstanding shares of common stock; and (8) require supermajority approval to amend or repeal certain charter provisions. In addition, specific anti-takeover provisions of the Maryland General Corporation Law (“MGCL”) could make it more difficult for a third party to attempt a hostile takeover, including:
•“business combination” provisions that, subject to limitations, prohibit certain business combinations between us and an “interested stockholder” (defined generally as any person who beneficially owns 10% or more of the voting power of our shares or an affiliate thereof) for five years after the most recent date on which the stockholder becomes an interested stockholder, and thereafter impose special appraisal rights and special stockholder voting requirements on these combinations; and
•“control share” provisions that provide that “control shares” of our company (defined as shares which, when aggregated with other shares controlled by the stockholder, entitle the stockholder to exercise one of three increasing ranges of voting power in electing directors) acquired in a “control share acquisition” (defined as the direct or indirect acquisition of ownership or control of “control shares”) have no voting rights except to the extent approved by our stockholders by the affirmative vote of at least two-thirds of all the votes entitled to be cast on the matter, excluding all interested shares.
38

Our bylaws contain a provision that exempts from the MGCL’s control share acquisition statute any and all acquisitions by any person of shares of our stock. However, there can be no assurance that this provision will not be amended or eliminated, in whole or in part, at any time in the future.
We believe these provisions protect our stockholders from coercive or unfair takeover tactics by requiring potential acquirors to negotiate with our board of directors and by providing our board of directors with more time to assess any acquisition proposal. These provisions are not intended to prevent all takeovers, but they may delay, defer or prevent a change of control transaction even if such transaction involves a premium price for our common stock or it is in our stockholders’ best interests. These provisions may also prevent or discourage attempts to remove and replace incumbent directors.
Our bylaws provide that the Circuit Court for Baltimore City, Maryland will be the sole and exclusive forum for substantially all disputes between us and our stockholders, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers or other employees.
Our bylaws provide that, unless we consent in writing to the selection of an alternative forum, the Circuit Court for Baltimore City, Maryland is the sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of us, (ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer or other employee, (iii) any action asserting a claim arising pursuant to any provision of the MGCL, or (iv) any action asserting a claim governed by the internal affairs doctrine, and any of our record or beneficial stockholders who commences such an action shall cooperate in a request that the action be assigned to the Court’s Business & Technology Case Management Program. This exclusive forum provision is intended to apply to claims arising under the MGCL and would not apply to claims brought pursuant to the Exchange Act of 1934 or Securities Act of 1933, each as amended, or any other claim for which the federal courts have exclusive jurisdiction. The exclusive forum provision in our bylaws will not relieve us of our duties to comply with the federal securities laws and the rules and regulations thereunder, and our stockholders will not be deemed to have waived our compliance with these laws, rules and regulations.
This exclusive forum provision may limit a stockholder's ability to bring a claim in a judicial forum of its choosing for disputes with us or our directors, officers or other employees, which may discourage lawsuits against us and our directors, officers and other employees. In addition, stockholders who do bring a claim in the Circuit Court for Baltimore City, Maryland could face additional litigation costs in pursuing any such claim, particularly if they do not reside in or near Maryland. The Circuit Court for Baltimore City, Maryland may also reach different judgments or results than would other courts, including courts where a stockholder would otherwise choose to bring the action, and such judgments or results may be more favorable to us than to our stockholders. However, the enforceability of similar exclusive forum provisions in other companies' certificates of incorporation has been challenged in legal proceedings, and it is possible that a court could find this type of provision and/or the jurisdictional limitation contained therein to be inapplicable to, or unenforceable in respect of, one or more of the specified types of actions or proceedings. If a court were to find the exclusive forum provision contained in our bylaws to be inapplicable or unenforceable in an action, we might incur additional costs associated with resolving such action in other jurisdictions.
We cannot assure you of our ability to pay dividends in the future.
We expect to make quarterly dividend payments in cash with the annual dividend amount no less than 90% of our annual REIT taxable income, determined without regard to the dividends paid deduction and excluding any net capital gains. Our ability to pay dividends may be adversely affected by a number of factors, including the risk factors described in this annual report. Dividends are authorized by our board of directors and declared by us based upon a number of factors, including but not limited to actual results of operations, restrictions under Maryland law or applicable debt covenants, our financial condition, our taxable income, the annual distribution requirements under the REIT provisions of the Code and our operating expenses. There is no assurance that our operating results will allow for specified levels of cash dividends or year-to-year increases in the future.
Furthermore, while we are required to pay dividends in order to maintain our REIT status (as described under “Risks Related to Our Status as a REIT - REIT distribution requirements could adversely affect our ability to execute our business plan”), we may elect not to maintain our REIT status and discontinue paying dividends. Even if we do elect to maintain our REIT status, after completing various procedural steps, we may elect to comply with the applicable distribution requirements by distributing, under certain circumstances, a portion of the required amount in the form of shares of our common stock in lieu of cash. Either of these actions could negatively affect our business and financial condition as well as the market price of our common stock.
ITEM 1B. Unresolved Staff Comments We have implemented several cybersecurity processes and controls to aid in our efforts to assess, identify, and manage material risks from cybersecurity threats, as such term is defined in Item 106(a) of Regulation S-K.
None.
39

ITEM 1C.    Cybersecurity
Cybersecurity Risk Management and Strategy
We have engaged a third-party cybersecurity firm who serves as our dedicated information technology (IT) and cybersecurity team and helps us oversee, implement and manage these processes and controls.
To identify and assess material risks from cybersecurity threats, we consider cybersecurity threat risks individually and alongside other company risks as part of our overall risk assessment process. Management determines and prioritizes appropriate risk responses for each identified enterprise risk. In doing so, management coordinates with relevant subject matter specialists as appropriate for each relevant risk area, including our third-party IT and cybersecurity team with respect to information technology and security risks.
Management is accountable for our day to day risk management activities. With the assistance of our third-party IT and cybersecurity team, we employ a range of tools and services, including a governance, risk and compliance platform, to inform our managements’ risk identification and assessment relating to our technology program. With this platform, we map our cybersecurity and risk management program to the Center for Internet Security (“CIS”) framework.
Processes and controls we have implemented with the assistance of our third-party IT and cybersecurity team to assess, identify, manage and protect against material risks from cybersecurity threats include the following:

•perform 24/7 security monitoring through an automated detection software managed by our third party cybersecurity firm;
•conduct annual cybersecurity management and incident training for employees involved in our systems and processes that handle sensitive data;
•conduct regular phishing email training for all employees with access to corporate email and other systems to enhance awareness and responsiveness to such possible threats;
•leverage the CIS Controls incident handling framework to help us identify, protect, detect, respond, and recover when there is an actual or potential cybersecurity incident.
At least annually, our third-party IT and cybersecurity firm conducts a cybersecurity risk assessment. We periodically review reporting on these risks and our cybersecurity threats, the status of our security infrastructure, our risk management activities and the status of, and our responses to, any cybersecurity incidents.
Through our incident response policy, we have designated an incident response team composed of representatives of management and other employees as well as representatives from our outsourced cybersecurity firm that has responsibility for overseeing cybersecurity incidents. Led by management, our third-party IT and cybersecurity team is responsible for the day-to-day investigation of and response to potential information security-related incidents. Pursuant to our incident response policy, incidents meeting specified severity levels are required to be escalated to the incident response team for review and response. The goal of the policy is to prevent, detect and react to information security incidents, determine their scope and risk, respond appropriately to the incident, communicate the results and risk to relevant stakeholders, and reduce the likelihood of the incident from reoccurring.
Pursuant to our incident response policy, if we are notified of a cybersecurity incident impacting a third-party service provider that affects our information systems or data, we will respond on the same basis as any other incident. We are implementing a business use case review process and vendor risk assessment for all third-party service providers that will access or implicate our materially significant technology or data. If we deem the cybersecurity risk of a particular service provider too great, such service provider will not be approved or access will be terminated.
Based on information known to us, we do not believe any risks from cybersecurity threats, including as a result of previous cybersecurity incidents, have materially affected or are reasonably likely to materially affect us, including our business strategy, results of operations or financial condition. We can give no assurance that we have detected or protected against all cybersecurity threats or incidents. Please refer to “Cybersecurity incidents or other damage to the information systems and technology of us or our tenants could harm our business” and “If we or our tenants fail to adhere to applicable privacy and data security laws, this could have a material adverse effect on us or on our tenants’ ability to meet their obligations to us” included “Item 1A, Risk Factors” of this Annual Report on Form 10-K for additional information about material risks related to cybersecurity threats.
Cybersecurity Governance
As described above, we have engaged a third-party IT and cybersecurity firm to whom we have outsourced primary responsibility to oversee, implement and manage our processes and controls to assess, identify, and manage material risks from cybersecurity threats.
40

Members of this dedicated third-party IT and cybersecurity team include a virtual chief information security officer (vCISO) who is responsible for the overall development and implementation of our cybersecurity strategy and responses as well as individuals having the position of cybersecurity analyst, cybersecurity engineer, and director of information security. Our management, including our Chief Executive Officer, oversees the work of our third-party IT and cybersecurity team and regularly communicates with members of the team. Through the policies and controls described above, including our incident response policy, representatives of the third-party IT and cybersecurity team as well as members of our management, including our Chief Executive Officer, are informed about cybersecurity threats and incidents affecting our information systems and direct our efforts to prevent, detect, mitigate and remediate cybersecurity threats and incidents. The representatives of our third-party IT and cybersecurity team who lead our cybersecurity risk management and risk assessment process have collectively over 30 years of prior work experience in various roles managing information systems, developing cybersecurity strategy, implementing information security and cybersecurity programs, identifying and assessing cybersecurity risks and establishing incident response plans. The members of the cybersecurity team hold degrees in computer engineering and cybersecurity as well as advanced cybersecurity certifications, including a Certified Information Systems Security Professional (CISSP) certification, a Certified Information Systems Auditor (CISA) credential and a Certified Information Security Manager (CISM) certification. Other members of our third-party cybersecurity team have also obtained various professional certifications and advanced training in the areas of information security and cybersecurity.
Our audit committee is responsible for overseeing our overall risk assessment and risk management program as well as our policies and practices related to our information technology systems, information security and cybersecurity risks. The audit committee reviews at least annually our enterprise risks and related risk management program. In addition, on a quarterly basis, the audit committee receives a report from management on our cybersecurity threat risk management and strategic processes covering topics such as cybersecurity incidents and any remedial actions, if needed, data security posture, the results of third-party risk assessments as well as our cybersecurity risk management processes and strategies. Outside of quarterly presentations, the chair of the audit committee would be notified following any cybersecurity incident meeting specified severity levels, and the audit committee would also be expected to review management’s materiality assessment regarding any cybersecurity incident requiring disclosure to the Securities and Exchange Commission. Through their participation in meetings of the audit committee, other members of the Board are also kept apprised of material risks from cybersecurity threats and our related risk management activities.
ITEM 2. Properties

As of December 31, 2024, all of the properties we own are leased under long-term, triple-net leases (including properties we own in consolidated joint ventures). The following table displays the expiration of the annualized contractual cash rental income under our lease agreements as of December 31, 2024, excluding properties classified as held for sale and one ALF which is non-operational, by year and total investment (dollars in thousands) and, in each case, without giving effect to any renewal or purchase options:
Lease
Maturity Percent of Total Percent of
Year
Investment(1)
Investment
Rent(1)
Total Rent
2026 $ 25,116  0.9  % $ 868  0.3  %
2027 46,801  1.7  % 5,613  2.1  %
2029 105,696  3.9  % 8,543  3.1  %
2031 490,317  18.2  % 52,466  19.3  %
2032 278,386  10.3  % 27,467  10.1  %
2033 147,818  5.5  % 22,352  8.2  %
2034 453,119  16.8  % 45,336  16.6  %
2036 169,678  6.3  % 14,564  5.3  %
2038 319,580  11.8  % 33,514  12.3  %
2039 564,154  20.9  % 54,694  20.1  %
2044 97,973  3.7  % 6,895  2.6  %
Total $ 2,698,638  100.0  % $ 272,312  100.0  %
(1)Includes facilities held in consolidated joint ventures. See Note 3, Real Estate Investments, Net, and Note 12, Variable Interest Entities, for additional information.
See the “Tenant Purchase Options” section of Note 3, Real Estate Investments, Net, in the Notes to consolidated financial statements for additional information on leases subject to purchase options.
41

The information set forth under “Portfolio Summary” in Item 1 of this Annual Report on Form 10-K is incorporated by reference herein.
ITEM  3.    Legal Proceedings
The Company and its subsidiaries are and may become from time to time a party to various claims and lawsuits arising in the ordinary course of business, but none of the Company or any of its subsidiaries is, and none of their respective properties are, the subject of any material legal proceedings. Claims and lawsuits may include matters involving general or professional liability asserted against our tenants, which are the responsibility of our tenants and for which we are entitled to be indemnified by our tenants under the insurance and indemnification provisions in the applicable leases.
ITEM  4.    Mine Safety Disclosures
None.
PART II
ITEM  5.    Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of
Common Equity
Our common stock is listed on the New York Stock Exchange under the symbol “CTRE.”
At February 11, 2025, we had approximately 52 stockholders of record.

To maintain REIT status, we are required each year to distribute to stockholders at least 90% of our annual REIT taxable income after certain adjustments. All distributions will be made by us at the discretion of our board of directors and will depend on our financial position, results of operations, cash flows, capital requirements, debt covenants (which include limits on distributions by us), applicable law, and other factors as our board of directors deems relevant. For example, while the Notes and our Third Amended Credit Agreement permit us to declare and pay any dividend or make any distribution that is necessary to maintain our REIT status, those distributions are subject to certain financial tests under the indenture governing the Notes, and therefore, the amount of cash distributions we can make to our stockholders may be limited.

Distributions with respect to our common stock can be characterized for federal income tax purposes as taxable ordinary dividends, non-dividend distributions or a combination thereof. Following is the characterization of our annual cash dividends on common stock:
 
Year Ended December 31,
Common Stock 2024 2023
Ordinary dividend $ 0.8529  $ 0.8218 
Non-dividend distributions 0.2971  0.2932 
Total taxable distribution 1.1500  1.1150 
Distributions allocated from prior tax year(1)
(0.2800) (0.2750)
Distributions allocated to subsequent tax year(2)
0.2900  0.2800 
Total distributions declared $ 1.1600  $ 1.1200 
(1) Because our aggregate cash distributions exceeded our annual earnings and profits, the cash distribution declared in the fourth quarter of 2023 and paid in January 2024, of $0.280 per share, will be treated as a 2024 distribution for federal income tax purposes.
(2) Because our aggregate cash distributions exceeded our annual earnings and profits, the cash distribution declared in the fourth quarter of 2024 and paid in January 2025, of $0.290 per share, will be treated as a 2025 distribution for federal income tax purposes.
42


Stock Price Performance Graph
The graph below compares the cumulative total return of our common stock, the S&P 500 REIT Index, the RMS (MSCI U.S. REIT Total Return Index) and the Russell 2000 Index (“Russell 2000”). Total cumulative return is based on a $100 investment in CareTrust REIT common stock and in each of the indices at the market close on December 31, 2019 and assumes quarterly reinvestment of dividends before consideration of income taxes. Stockholder returns over the indicated periods should not be considered indicative of future stock prices or stockholder returns.
 COMPARISON OF CUMULATIVE TOTAL RETURN
AMONG S&P 500 REIT INDEX, RMS, RUSSELL 2000 AND CARETRUST REIT, INC.
RATE OF RETURN TREND COMPARISON
DECEMBER 31, 2019 - DECEMBER 31, 2024
(DECEMBER 31, 2019 = $100)
Stock Price Performance Graph Total Return
The stock performance graph shall not be deemed soliciting material or to be filed with the SEC or subject to Regulation 14A or 14C under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or to the liabilities of Section 18 of the Exchange Act, nor shall it be incorporated by reference into any past or future filing under the Securities Act of 1933 or the Exchange Act, except to the extent we specifically request that it be treated as soliciting material or specifically incorporate it by reference into a filing under the Securities Act of 1933 or the Exchange Act.
Stock Graph.jpg
December 31,
2019 2020 2021 2022 2023 2024
CareTrust REIT, Inc. $ 100.00  $ 113.67  $ 122.62  $ 105.83  $ 134.60  $ 169.91 
S&P 500 $ 100.00  $ 118.40  $ 152.39  $ 124.79  $ 157.59  $ 197.02 
RMS $ 100.00  $ 92.43  $ 132.23  $ 99.82  $ 113.54  $ 123.47 
Russell 2000 $ 100.00  $ 119.96  $ 137.74  $ 109.59  $ 128.14  $ 142.93 
S&P 500 Real Estate Index $ 100.00  $ 97.83  $ 143.02  $ 105.65  $ 118.71  $ 124.92 
43


ITEM 6.    [Reserved]

ITEM 7.    Management’s Discussion and Analysis of Financial Condition and Results of Operations
The discussion below contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors, including those which are discussed in the section titled “Risk Factors.” Also see “Statement Regarding Forward-Looking Statements” preceding Part I.
The following discussion and analysis should be read in conjunction with our accompanying consolidated financial statements and the notes thereto.
Our Management’s Discussion and Analysis of Financial Condition and Results of Operations is organized as follows:
•Overview
•Recent Developments
•Results of Operations
•Liquidity and Capital Resources
•Critical Accounting Estimates
•Impact of Inflation
Overview
CareTrust REIT is a self-administered, publicly-traded REIT engaged in the ownership, acquisition, financing, development and leasing of skilled nursing, seniors housing and other healthcare-related properties. As of December 31, 2024, we owned, directly or indirectly in consolidated joint ventures, and leased to independent operators 258 skilled nursing facilities (“SNFs”), multi-service campuses, assisted living facilities (“ALFs”) and independent living facilities (“ILFs”), consisting of 28,088 operational beds and units located in 32 states with the highest concentration of properties by rental income located in California and Texas. As of December 31, 2024, we also had other real estate related investments consisting of three preferred equity investments, 15 real estate secured loans receivable and five mezzanine loans receivable with a carrying value of $795.2 million and one financing receivable with a carrying value of $96.0 million.
Recent Developments
Market Trends and Uncertainties
Recent macroeconomic conditions, particularly inflation (including higher supply costs), elevated interest rates and related changes to consumer spending, including, but not limited to, causing individuals to delay or defer moves to seniors housing, has adversely impacted and could continue to adversely impact our tenants’ ability to meet some of their financial obligations to us. Higher interest rates have also increased our costs of capital to finance acquisitions and increased our borrowing costs. We continue to monitor changes in the interest rate environment and the effect of changing rates on our business. In addition, current macroeconomic conditions and the resulting market volatility may adversely impact our ability to sell properties on acceptable terms, if at all, which could result in additional impairment charges.
As a result of the above factors, our tenants are continuing to experience elevated operating costs at their facilities. At a portfolio wide level, occupancy levels at our seniors housing facilities, comprising our ALFs and ILFs, continue to remain below occupancy levels at the onset of the COVID-19 pandemic. Within our SNFs, occupancy levels have continued to improve since their trough in January 2021 and have reached or exceeded occupancy levels prior to the onset of the COVID-19 pandemic, for most of our tenants.
As a result of impacts experienced by our operators since the onset of the COVID-19 pandemic and due to recent market trends and uncertainties, the ability of some of our tenants and borrowers to meet their financial obligations to us in full has been negatively impacted. From time to time in the past, we have taken actions to reposition one or more properties with a replacement tenant or sell the property and, in certain cases, we have also restructured tenants’ long-term obligations. See “Impairment of Real Estate Assets, Assets Held for Sale and Asset Sales” below. During the three and twelve months ended December 31, 2024, we collected 98.8% and 98.5% of contractual rents and interest due from our tenants and borrowers excluding cash deposits, respectively. In the event our tenants or borrowers are unable to satisfy their obligations to us and we are unable to effect these actions on terms that are as favorable to us as those currently in place, our rental and interest income would be adversely impacted and we may incur additional expenses or obligations and be required to recognize additional impairment charges or fair value adjustments.
44

For more information regarding the potential impact of public health crises, including COVID-19, and macroeconomic conditions on our business, see “Risk Factors” in Item 1A of this report.
Regulatory Updates
On October 13, 2023, California Senate Bill No. 525 (“SB 525”) was signed into law, requiring a substantial increase in the minimum wage for workers operating in certain health care facilities. As a result of SB 525, certain health care facilities (including licensed skilled nursing facilities) operating in California are required to increase the wages of their covered health care employees to at least $21 per hour, which was initially required to be effective from June 1, 2024 to May 31, 2026, $22 or $23 per hour (depending on facility type) from June 1, 2026 to May 31, 2028, and $25 per hour after June 1, 2028. After the initial implementation was delayed by the Governor of California in June 2024, SB 525 went into effect on October 16, 2024.
The Centers for Medicare and Medicaid Services (“CMS”) issued a final rule on July 31, 2024, updating Medicare payment policies and rates for SNFs for fiscal year 2025. This update includes a 4.2% increase in Medicare Part A payments to SNFs, totaling approximately $1.4 billion. These increases are expected to partially offset some of our tenants’ higher operating costs. Further, in this final rule, CMS expanded its ability to impose penalties on SNFs for health and safety deficiencies/non-compliance by allowing for more per instance and per day civil monetary penalties to be imposed for such health and safety deficiencies/non-compliance, as appropriate.
On April 22, 2024, CMS issued a final rule regarding minimum staffing requirements and increased inspections at nursing homes in order to establish comprehensive nurse staffing requirements. The rule consists of three core staffing requirements: (1) overall minimum standard of 3.48 total nurse staff hours per resident day; (2) minimum nurse staffing standards of 0.55 hours per resident day for registered nurses and 2.45 hours of care from a certified nurse’s aid per resident per day; and (3) a requirement to have a registered nurse onsite 24 hours a day, seven days a week. The rule includes a staggered implementation approach for which CMS will publish additional details on compliance as the implementation dates approach. The rule also includes possible waivers and temporary hardship exemptions for select facilities; however, no funding for the additional staff will be provided. We are currently evaluating the impact of the rule, but believe the unfunded mandate to increase staff may have a material and adverse impact on the financial condition of our tenants.
Recent Investments
The following table summarizes the Company’s acquisitions from January 1, 2024 through February 12, 2025 (dollars in thousands):
Type of Property
Purchase Price(1)
Initial Annual Cash Rent(2)
Number of Properties
Number of Beds/Units(3)
Skilled nursing(4)
$ 732,919  $ 67,924  43  4,632 
Multi-service campuses(4)
90,639  7,467  683 
Assisted living(4)
12,749  1,022  102 
Total $ 836,307  $ 76,413  50  5,417 
(1)Purchase price includes capitalized acquisition costs.
(2)Initial annual cash rent represents initial cash rent for the first twelve months.
(3)The number of beds/units includes operating beds at acquisition date.
(4)Includes facilities held in consolidated joint ventures. See Note 3, Real Estate Investments, Net, and Note 12, Variable Interest Entities for additional information.
The following table summarizes our financing receivable investment from January 1, 2024 through February 12, 2025 (dollars in thousands):
Investment Type
Investment(1)
Initial Annual Interest Income(2)
Number of Properties
Number of Beds/Units(3)
Financing receivable $ 95,723  $ 11,560  46  3,820 
Total $ 95,723  $ 11,560  46  3,820 
(1)Investment does not include transaction costs given they were expensed during the year ended December 31, 2024 as a result of our election to use the fair value option.
(2)Represents annualized investment-date interest income.
(3)The number of beds/units includes operating beds at the investment date.
45

The following table summarizes other real estate related investments by the Company from January 1, 2024 through February 12, 2025 (dollars in thousands):
Investment Type(1)
Investment
Initial Annual Interest Income(2)
Number of Properties
Number of Beds/Units(3)
Mortgage secured loans receivable $ 496,615  $ 44,210  50  5,172 
Mezzanine loans receivable 63,676  8,636  29  3,763 
Preferred equity 52,000  5,734  N/A N/A
Total $ 612,291  $ 58,580  79  8,935 
(1)Table excludes a $1.0 million mortgage loan originated in connection with the sale of one ALF during the period presented.
(2)Represents annualized acquisition-date interest income, less subservicing fees, if applicable. For floating rate loans, interest income has been calculated using the benchmark rate at loan origination.
(3)The number of beds/units includes operating beds at the investment date.
Financing Activities
On December 18, 2024, we amended and restated our Second Amended Credit Agreement (as defined under “― Liquidity and Capital Resources ― Material Cash Requirements” below). See Note 7, Debt, for additional information.
On September 19, 2024, we prepaid in full the $200.0 million aggregate principal amount outstanding under the Term Loan (as defined under “― Liquidity and Capital Resources ― Material Cash Requirements” below). See Note 7, Debt, for additional information.
On June 3, 2024, KeyBank National Association purchased a $75.0 million undivided participation interest in a $165.0 million mortgage loan from us (see Note 5, Other Real Estate Related and Other Investments, for additional information). On July 30, 2024, we exercised the call option on the $75.0 million secured borrowing. See Note 7, Debt, for additional information.
Public Offering of Common Stock
On November 1, 2024, we completed an underwritten public offering of 15.9 million newly issued shares of our common stock at a price of $32.00, resulting in gross proceeds of $507.8 million. The proceeds were used to fund acquisitions during the fourth quarter of 2024.
At-The-Market Offering of Common Stock
On January 21, 2025, we entered into a new equity distribution agreement to issue and sell, from time to time, up to $750.0 million in aggregate offering price of our common stock through an “at-the-market” equity offering program (the “New ATM Program”) and terminated our previous $750.0 million “at-the-market” equity offering program (together, with all previous at-the-market equity offering programs, the “Previous ATM Programs” and together with the New ATM Program, the “ATM Programs”). In addition to the issuance and sale of shares of our common stock, we may also enter into one or more forward sales agreements (each, an “ATM forward contract”) with sales agents for the sale of shares of our common stock under the ATM Program. There were no outstanding ATM forward contracts that had not settled as of December 31, 2024.
The following tables summarize the ATM Program activity for the year ended December 31, 2024 (in thousands, except per share amounts).
For the Year Ended
December 31, 2024
Number of shares 40,986 
Average sales price per share $ 26.35 
Gross proceeds(1)
$ 1,079,852 
(1) Total gross proceeds is before $13.4 million of commissions paid to the sales agents and forward adjustments during the year ended December 31, 2024, under the ATM Program.
As of February 12, 2025, we had $750.0 million available for future issuances under the ATM Program.
46

Impairment of Real Estate Assets, Assets Held for Sale, and Asset Sales
Impairment of Real Estate Assets
During the year ended December 31, 2024, we recognized aggregate impairment charges of $42.2 million, of which $18.8 million related to properties held for sale, $9.4 million related to properties held for investment, and $14.0 million related to properties that were sold.
Asset Sales and Held for Sale Reclassifications
We periodically reassess our investments and tenant relationships, and from time to time we have selectively disposed of certain facilities or investments, or terminated tenant relationships, and we expect to continue making such reassessments and, where appropriate, taking such actions. We classify our real estate investments as held for sale when the applicable criteria have been met, which includes a formal plan to sell the properties that is expected to be completed within one year, among other criteria. Upon designation as held for sale, we cease depreciation and record the investment at the lower of carrying value or estimated fair value less costs to sell, which could result in an impairment of the real estate investments held for sale, if necessary.
The following table summarizes our dispositions for the year ended December 31, 2024 (dollars in thousands):
Year Ended December 31,
2024
Number of facilities 17
Net sales proceeds $ 17,715 
Net carrying value 19,923 
Net loss on sale $ (2,208)
The following table summarizes our assets held for sale activity for the periods presented (dollars in thousands):
Net Carrying Value Number of Facilities
December 31, 2023 $ 15,011  14
Additions to assets held for sale 104,447  15 
Assets sold (19,923) (17)
Impairment of real estate held for sale (37,266) — 
Assets reclassified to held for investment (5,008) (2)
December 31, 2024 $ 57,261  10 
Subsequent to December 31, 2024, we sold or disposed of three SNFs, one SNF Campus and one ALF, for which we expect to record an estimated gain on sale of real estate of $3.9 million.
47


Results of Operations

Operating Results
Our primary business consists of acquiring, developing, financing and owning real property to be leased to third party tenants in the healthcare sector.
Year Ended December 31, 2024 Compared to Year Ended December 31, 2023  
  Year Ended December 31, Increase
(Decrease)
Percentage
Difference
  2024 2023
  (dollars in thousands)
Revenues:
Rental income $ 228,261  $ 198,599  $ 29,662  15  %
Interest income from financing receivable 1,009  —  1,009  100  %
Interest income from other real estate related investments and other income 67,016  19,171  47,845  250  %
Expenses:
Depreciation and amortization 56,831  51,199  5,632  11  %
Interest expense 30,310  40,883  (10,573) (26) %
Property taxes 7,838  6,170  1,668  27  %
Impairment of real estate investments 42,225  36,301  5,924  16  %
Transaction costs 1,326  —  1,326  100  %
Provision for loan losses, net 4,900  —  4,900  100  %
Property operating expenses 5,714  3,423  2,291  67  %
General and administrative 28,923  21,805  7,118  33  %
Other income (loss):
Loss on extinguishment of debt (657) —  (657) 100  %
(Loss) gain on sale of real estate, net (2,208) 2,218  (4,426) (200) %
Unrealized gain (loss) on other real estate related investments, net 9,045  (6,485) 15,530  (239) %
Net loss attributable to noncontrolling interests
Net loss attributable to noncontrolling interests (681) (13) (668) *
•Not meaningful
Rental income. Rental income increased by $29.7 million as detailed below:
Year Ended
(in thousands)
December 31, 2024
December 31, 2023
Increase/(Decrease)
Contractual cash rent $ 218,750  $ 192,746  $ 26,004 
Tenant reimbursements 6,676  5,498  1,178 
Total contractual rent 225,426  198,244  27,182 
Straight-line rent (28) (29)
Amortization of lease incentives (22) —  (22)
Amortization of below market leases 2,885  384  2,501 
Total rental income $ 228,261  $ 198,599  $ 29,662 

Total contractual rent includes initial contractual cash rent and tenant reimbursements, as adjusted for applicable rental escalators and rent increases due to capital expenditures funded by us. For tenants on a cash basis, this represents the lesser of the amount that would be recognized on a straight-line basis or cash that has been received.
48

Total contractual cash rent increased by $27.2 million due to an increase of $25.9 million in contractual cash rent from real estate investments made after January 1, 2023, an increase of $5.1 million from increases in rental rates for our existing tenants, a $1.2 million increase in tenant reimbursements, and an increase of $0.4 million related to transfers of facilities between operators, partially offset by a $4.6 million decrease in rental income related to certain tenants on a cash basis method of accounting and a $0.8 million decrease related to the disposal of real estate.
Interest income from financing receivable. During the year ended December 31, 2024, we recorded $1.0 million of interest income related to an investment classified as a financing receivable in December 2024.
Interest income from other real estate related investments and other income. The $47.8 million, or 250%, increase in interest and other income is primarily due to an increase of $33.2 million related to the origination of loans receivable subsequent to January 1, 2023, an increase of $16.2 million in interest income on money market funds, an increase of $0.4 million due to originations of other loans, and an increase of $0.2 million related to a loan origination fee received during the year ended December 31, 2024, partially offset by a decrease of $1.5 million related to repayments of loans receivable and a decrease of $0.7 million related to prepayment penalties on one mezzanine loan receivable and one mortgage loan receivable during the year ended December 31, 2023. See above under “Recent Developments” for additional information on the origination of loans receivable.
Depreciation and amortization. Depreciation and amortization expense increased $5.6 million, or 11%, for the year ended December 31, 2024 from $56.8 million compared to $51.2 million for the year ended December 31, 2023. The $5.6 million increase in depreciation and amortization was primarily due to an increase of $9.8 million related to new real estate investments and capital improvements made after January 1, 2023, partially offset by a decrease in depreciation of $2.8 million due to assets becoming fully depreciated after January 1, 2023, and a $1.4 million decrease from assets sold and classified as held for sale.
Interest expense. Interest expense decreased by $10.6 million as detailed below:
Change in interest expense for the year ended December 31, 2024 compared to the year ended December 31, 2023
(in thousands)
Decreases to interest expense due to:
Decrease in outstanding borrowing amount for the Prior Revolving Facility $ (8,517)
Decrease due to prepayment of Term Loan (4,007)
Total decrease to interest expense (12,524)
Increases to interest expense due to:
Issuance of secured borrowing 931 
Increase in interest rates for the Term Loan 650 
Other changes in interest expense 370 
Total increases to interest expense 1,951 
Total change in interest expense $ (10,573)
Property taxes. Property taxes increased $1.7 million, or 27%, for the year ended December 31, 2024 compared to December 31, 2023. The increase was primarily due to a $2.8 million increase in property taxes due to new real estate investments made after January 1, 2023, partially offset by a decrease of $1.1 million related to properties sold after January 1, 2023.
Impairment of real estate investments. During the year ended December 31, 2024, we recognized aggregate impairment charges of $42.2 million, of which $18.8 million related to properties held for sale, $9.4 million related to properties held for investment, and $14.0 million related to properties that were sold. During the year ended December 31, 2023, we recognized aggregate impairment charges of $36.3 million, of which $26.8 million related to properties held for sale, $8.0 million related to properties held for investment, and $1.5 million related to properties that were sold.
Transaction costs. During the year ended December 31, 2024, we recognized $1.3 million of transaction costs related to the investment in a financing receivable for which we elected the fair value option. No such transaction costs were recorded during the year ended December 31, 2023.
49

Provision for loan losses, net. During the year ended December 31, 2024, we recorded a $4.9 million expected credit loss related to one other loan receivable with a principal balance of $4.9 million that has been placed on non-accrual status. No provision for loan losses was recognized during the year ended December 31, 2023.
Property operating expenses. During the years ended December 31, 2024 and 2023, we recognized $5.7 million and $3.4 million, respectively, of property operating expenses related to assets we plan to sell or repurpose, re-tenant, or have sold.
General and administrative expense. General and administrative expense increased by $7.1 million as detailed below:
Year Ended
(in thousands)
December 31, 2024
December 31, 2023
Increase/(Decrease)
Incentive compensation $ 9,699  $ 5,350  $ 4,349 
Cash compensation 6,474  5,636  838 
Share-based compensation 6,130  5,153  977 
Other administrative expense 1,400  1,041  359 
Professional services 2,785  2,399  386 
Taxes and insurance 1,019  908  111 
Other expenses 1,416  1,318  98 
Total change in general and administrative expense $ 28,923  $ 21,805  $ 7,118 
Loss on extinguishment of debt. During the year ended December 31, 2024, we recorded a $0.7 million loss on extinguishment of debt related to the exit fee associated with the call of the secured borrowing and the write-off of deferred financing costs associated with the prepayment of the Term Loan (as defined below). No loss on extinguishment of debt was recognized during the year ended December 31, 2023.
(Loss) gain on sale of real estate, net. During the year ended December 31, 2024, we recorded a $2.3 million loss on the sale of real estate related to the sale of 12 SNFs, partially offset by a $0.1 million gain on the sale of real estate related to the sale of four ALFs and one SNF. During the year ended December 31, 2023, we recorded a $2.3 million gain on sale of real estate related to the sale of two ALFs and one SNF, partially offset by a $0.1 million loss on sale of real estate related to the sale of two ALFs.
Unrealized gain (loss) on other real estate related investments, net. During the year ended December 31, 2024, we recorded an unrealized gain of $17.8 million due to a decrease in interest rates during the second half of 2024, partially offset by an unrealized loss of $8.8 million due to an increase in interest rates during the first half of 2024. During the year ended December 31, 2023, we recorded an unrealized loss of $8.1 million due to rising interest rates and a $0.3 million loss due to a loan origination fee paid, partially offset by unrealized gains of $0.7 million due to a decrease in projected forward interest rates and a reversal of a previously recognized unrealized loss of $1.2 million related to the repayment of one mezzanine loan receivable and the partial repayment of one mortgage loan receivable.

Year Ended December 31, 2023 Compared to Year Ended December 31, 2022
For discussion related to the results of operations and changes in financial condition for fiscal 2023 compared to fiscal 2022, refer to Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our fiscal 2023 Annual Report on Form 10-K, which was filed with the SEC on February 8, 2024.
Liquidity and Capital Resources
To qualify as a REIT for federal income tax purposes, we are required to distribute at least 90% of our REIT taxable income, determined without regard to the dividends paid deduction and excluding any net capital gains, to our stockholders on an annual basis. Accordingly, we intend to make, but are not contractually bound to make, regular quarterly dividends to common stockholders from cash flow from operating activities. All such dividends are at the discretion of our board of directors.
Our short-term liquidity requirements consist primarily of operating and interest expenses directly associated with our properties, including:
•interest expense and scheduled debt maturities on outstanding indebtedness;
50

•general and administrative expenses;
•dividend plans;
•operating lease obligations; and
•capital expenditures for improvements to our properties.
Our long-term liquidity needs consist primarily of funds necessary to pay for acquisitions and other investments (including mortgage and mezzanine loan originations), capital expenditures, and scheduled debt maturities. We intend to invest in and/or develop additional healthcare and seniors housing properties as suitable opportunities arise and so long as adequate sources of financing are available. We expect that future investments in and/or development of properties, including any improvements or renovations of current or newly-acquired properties, will depend on and will be financed by, in whole or in part, our existing cash, borrowings available to us under the Third Amended Revolving Facility (as defined below), future borrowings or the proceeds from sales of shares of our common stock pursuant to our ATM Program or additional issuances of common stock or other securities. In addition, we may seek financing from U.S. government agencies, including through Fannie Mae and the U.S. Department of Housing and Urban Development, in appropriate circumstances in connection with acquisitions and refinancing of existing mortgage loans.
We believe that our expected operating cash flow from rent collections and interest payments on our other real estate related investments, together with our cash balance, available borrowing capacity under the Third Amended Revolving Facility, and availability under the ATM Program will be sufficient to meet ongoing debt service requirements, dividend plans, operating lease obligations, capital expenditures, working capital requirements and other needs for at least the next 12 months. We expect to meet our long-term liquidity needs with cash flows from operations and financing arrangements. While we may from time to time sell properties as part of our hold / investment strategy on an investment-by-investment basis, we currently do not expect to sell any of our properties to meet liquidity needs. Our quarterly cash dividend and any failure of our operators to pay rent or of our borrowers to make interest or principal payments may impact our available capital resources.
We have filed an automatic shelf registration statement with the U.S. Securities and Exchange Commission that expires in February 2026 and at or prior to such time we expect to file a new shelf registration statement. The shelf registration statement allows us or certain of our subsidiaries, as applicable, to offer and sell shares of common stock, preferred stock, warrants, rights, units and debt securities through underwriters, dealers or agents or directly to purchasers, in one or more offerings on a continuous or delayed basis, in amounts, at prices and on terms we determine at the time of the offering. On January 21, 2025, we entered into the New ATM Program. In addition to the issuance and sale of shares of our common stock, we may also enter into one or more ATM forward contracts with sales agents for the sale of shares of our common stock under the ATM Program. See “At-The-Market Offering of Common Stock” for information regarding activity under the ATM Program.
Although we are subject to restrictions on our ability to incur indebtedness, we expect that we will be able to refinance existing indebtedness or incur additional indebtedness for acquisitions or other purposes, if needed. However, there can be no assurance that we will be able to refinance our indebtedness, incur additional indebtedness or access additional sources of capital, such as by issuing common stock or other debt or equity securities, on terms that are acceptable to us or at all.
We currently are in compliance with all debt covenants on our outstanding indebtedness.
Cash Flows
The following table presents selected data from our consolidated statements of cash flows for the years presented:
  Year Ended December 31,
  2024 2023
  (dollars in thousands)
Net cash provided by operating activities $ 244,251  $ 154,767 
Net cash used in investing activities (1,513,683) (267,815)
Net cash provided by financing activities 1,188,806  394,318 
Net (decrease) increase in cash and cash equivalents (80,626) 281,270 
Cash and cash equivalents as of the beginning of period 294,448  13,178 
Cash and cash equivalents as of the end of period $ 213,822  $ 294,448 
Year Ended December 31, 2024 Compared to Year Ended December 31, 2023
Net cash provided by operating activities for the year ended December 31, 2024 was $244.3 million compared to $154.8 million for the year ended December 31, 2023, an increase of $89.5 million. Operating cash inflows are derived primarily from the rental payments received under our lease agreements, including as a result of new investments, and interest payments received on our other real estate related investments. Operating cash outflows consist primarily of interest expense on our borrowings and general and administrative expenses.
51

The net increase of $89.5 million in cash provided by operating activities for the year ended December 31, 2024 is primarily due to an increase in interest income received on our other real estate related investments, rental income received, and a decrease in cash paid for interest expense, partially offset by an increase in cash paid for operating expenses related to assets we plan to sell, have sold, or repurpose and an increase in cash paid for general and administrative expense.
Cash used in investing activities for the year ended December 31, 2024 was primarily comprised of $1,472.1 million in acquisitions of real estate, investments in real estate related investments and other loans receivable, and investments in financing receivable, $8.0 million of purchases of equipment, furniture and fixtures and improvements to real estate, and $52.0 million in preferred equity investments, partially offset by $13.9 million in net proceeds from real estate sales and $4.5 million of payments received on real estate related investments and other loans receivable. Cash used in investing activities for the year ended December 31, 2023 was primarily comprised of $297.9 million in acquisitions of real estate and investments in real estate related investments and other loans receivable and $11.0 million of purchases of equipment, furniture and fixtures and improvements to real estate, and $1.8 million in preferred equity investments, partially offset by $26.5 million of payments received on real estate related investments and other loans receivable and $16.3 million in net proceeds from real estate sales.
Our cash flows provided by financing activities for the year ended December 31, 2024 were primarily comprised of $1,552.9 million of net proceeds from the issuance of common stock, $75.0 million in proceeds from a secured borrowing and $19.8 million in contributions from noncontrolling interests net of distributions, partially offset by a $200.0 million prepayment of the Term Loan, $172.2 million in dividends paid, a $75.0 million payment on the secured borrowing, a $9.2 million payment on extinguishment of debt and deferred financing costs, and a $2.5 million net settlement adjustment on restricted stock. Our cash flows provided by financing activities for the year ended December 31, 2023 were primarily comprised of $634.4 million of net proceeds from the issuance of common stock under the ATM Program and $1.9 million in net contributions from noncontrolling interests, partially offset by $125.0 million in net payments under our Revolving Credit Facility (as defined below), $115.5 million in dividends paid and a $1.5 million net settlement adjustment on restricted stock.

Year Ended December 31, 2023 Compared to Year Ended December 31, 2022
For discussion related to the cash flows for fiscal 2023 compared to fiscal 2022, refer to Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our fiscal 2023 Annual Report on Form 10-K, which was filed with the SEC on February 8, 2024.

Material Cash Requirements
Our material cash requirements from known contractual and other obligations include:
3.875% Senior Unsecured Notes due 2028
On June 17, 2021, our wholly owned subsidiary, CTR Partnership, L.P. (the “Operating Partnership”), and its wholly owned subsidiary, CareTrust Capital Corp. (together with the Operating Partnership, the “Issuers”), completed a private offering of $400.0 million aggregate principal amount of 3.875% Senior Notes due 2028 (the “Notes”). The Notes mature on June 30, 2028. The Notes accrue interest at a rate of 3.875% per annum payable semiannually in arrears on June 30 and December 30 of each year, commencing on December 30, 2021. The obligations under the Notes are guaranteed, jointly and severally, on an unsecured basis, by us and all of our subsidiaries (other than the Issuers) that guarantee obligations under the Amended Credit Facility (as defined below). As of December 31, 2024, we were in compliance with all applicable financial covenants under the indenture governing the Notes. See Note 7, Debt, to our consolidated financial statements included in this report for further information about the Notes.
Unsecured Revolving Credit Facility and Term Loan
On December 16, 2022, we, together with certain of our subsidiaries, entered into a second amended and restated credit and guaranty agreement with KeyBank National Association, as administrative agent, an issuing bank and swingline lender the “Second Amended Credit Agreement”). The Operating Partnership is the borrower under the Second Amended Credit Agreement, and the obligations thereunder are guaranteed, jointly and severally, on an unsecured basis, by us and substantially all of our subsidiaries. The Second Amended Credit Agreement, which amends and restates our amended and restated credit and guaranty agreement, dated as of February 8, 2019 (as amended, the “Prior Credit Agreement”) provides for: (i) an unsecured revolving credit facility (the “Prior Revolving Facility”) with revolving commitments in an aggregate principal amount of $600.0 million, including a letter of credit subfacility for 10% of the then available revolving commitments and a swingline loan subfacility for 10% of the then available revolving commitments and (ii) the continuation of the unsecured term loan credit facility which was previously extended under the Prior Credit Agreement (the “Term Loan” and together with the Prior Revolving Facility, the “Second Amended Credit Facility”) in an aggregate principal amount of $200.0 million. Future borrowings under the Second Amended Credit Facility will be used for working capital purposes, for capital expenditures, to fund acquisitions and for general corporate purposes.
52

On October 10, 2023, we entered into the First Amendment to the Second Amended Credit Agreement with KeyBank National Association (the “First Amendment”). The First Amendment restates the definition of Consolidated Total Asset Value to include net proceeds from at-the-market forward commitments executed but not yet closed as of the relevant date as if such proceeds had actually been received.
On September 19, 2024 (the “Prepayment Date”), we prepaid all $200.0 million aggregate principal amount of our outstanding Term Loan. The Term Loan was prepaid at the principal amount of the Term Loan, plus accrued and unpaid interest thereon up to, but not including, the Prepayment Date. During the third quarter of 2024, we recorded a loss on extinguishment of debt of $0.3 million related to the write-off of deferred financing costs associated with the prepayment of the Term Loan.
On December 18, 2024, we, together with certain of our subsidiaries, entered into a third amended and restated credit and guaranty agreement with KeyBank National Association, as administrative agent, an issuing bank and swingline lender, and the lenders party thereto (as amended from time to time, the “Third Amended Credit Agreement”). The Third Amended Credit Agreement, which amends and restates our Second Amended Credit Agreement provides for an unsecured revolving credit facility (the “Third Amended Revolving Facility”) with revolving commitments in an aggregate principal amount of $1.2 billion, including a letter of credit subfacility for 10% of the then available revolving commitments and a swingline loan subfacility for 10% of the then available revolving commitments. Future borrowings under the Third Amended Revolving Facility will be used for working capital purposes, for capital expenditures, to fund acquisitions and for general corporate purposes.
The Third Amended Credit Agreement also provides that, subject to customary conditions, including obtaining lender commitments and pro forma compliance with financial maintenance covenants under the Third Amended Credit Agreement, the Operating Partnership may seek to increase the aggregate principal amount of the revolving commitments and/or establish one or more new tranches of term loans under the Third Amended Credit Facility in an aggregate amount not to exceed $800.0 million.
As of December 31, 2024, we had no borrowings outstanding under the Third Amended Revolving Facility. The Third Amended Revolving Facility has a maturity date of February 9, 2029, and includes, at our sole discretion, two, six-month extension options. Prior to the prepayment, the Term Loan had a maturity date of February 8, 2026.
The interest rates applicable to loans under the Third Amended Revolving Facility are, at the Operating Partnership’s option, equal to either a base rate plus a margin ranging from 0.05% to 0.55% per annum or Adjusted Term SOFR or Adjusted Daily Simple SOFR (each as defined in the Third Amended Credit Agreement) plus a margin ranging from 1.05% to 1.55% per annum based on the debt to asset value ratio of the Company and our consolidated subsidiaries (subject to decrease at the Operating Partnership’s election if we obtain certain specified investment grade ratings on our senior long-term unsecured debt). In addition, the Operating Partnership will pay a facility fee on the revolving commitments under the Third Amended Revolving Facility ranging from 0.15% to 0.35% per annum, based on the debt to asset value ratio of the Company and our consolidated subsidiaries (unless we obtain certain specified investment grade ratings on our senior long-term unsecured debt and the Operating Partnership elects to decrease the applicable margin as described above, in which case the Operating Partnership will pay a facility fee on the revolving commitments ranging from 0.125% to 0.30% per annum based off the credit ratings of the Company’s senior long-term unsecured debt).
As of December 31, 2024, we were in compliance with all applicable financial covenants under the Third Amended Credit Agreement. See Note 7, Debt, to our consolidated financial statements included in this report for further information about the Third Amended Credit Agreement.
Capital Expenditures
As of December 31, 2024, we had committed to fund expansions, construction, capital improvements and ESG incentives, which provides eligible triple-net tenants with monetary inducements to make sustainable improvements to our properties, at certain triple-net leased facilities totaling $6.6 million, of which $5.7 million is subject to rent increase at the time of funding. We expect to fund the capital expenditures in the next one to two years. As of December 31, 2024, we entered into a purchase and sale agreement which provided for an earn-out obligation of up to $10.0 million for one SNF in Virginia which was acquired during 2024. The earn-out is available, contingent on the operator achieving certain thresholds per the agreement, beginning in October 2025 through October 2026. See Note 13, Commitments and Contingencies, to our consolidated financial statements included in this report for further information regarding our obligation to finance certain capital expenditures under our triple-net leases.
Dividend Plans
We are required to pay dividends in order to maintain our REIT status, and we expect to make quarterly dividend payments in cash with the annual dividend amount no less than 90% of our annual REIT taxable income, determined without regard to the dividends paid deduction and excluding any net capital gains.
53

See Note 8, Equity and Redeemable Noncontrolling Interest, to our consolidated financial statements included in this report for a summary of the cash dividends per share of our common stock declared by our board of directors for 2024, 2023 and 2022.
Critical Accounting Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Management believes that the assumptions and estimates used in preparation of the underlying consolidated financial statements are reasonable. Actual results, however, could differ from those estimates and assumptions. 
Accounting estimates are deemed critical if they involve a significant level of estimation uncertainty and have had or are reasonably likely to have a material impact on our financial condition or results of operations. Below is a summary of the critical accounting estimates used in the preparation of our consolidated financial statements. For a discussion of our significant accounting policies, see Note 2, Summary of Significant Accounting Policies, to our consolidated financial statements included in this report.
Impairment of Long-Lived Assets. At each reporting period, we evaluate our real estate investments held for use for potential impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. The judgment regarding the existence of impairment indicators, used to determine if an impairment assessment is necessary, is based on factors such as, but not limited to, market conditions, operator performance and legal structure. If indicators of impairment are present, we evaluate the carrying value of the related real estate investments in relation to the future undiscounted cash flows of the underlying facilities. The most significant inputs to the undiscounted cash flows include, but are not limited to, historical and projected facility level financial results, a lease coverage ratio, the intended hold period by us, and a terminal capitalization rate. The analysis is also significantly impacted by determining the lowest level of cash flows, which generally would be at the master lease level of cash flows. Provisions for impairment losses related to long-lived assets are recognized when expected future undiscounted cash flows are determined to be less than the carrying values of the assets. The impairment is measured as the excess of carrying value over fair value. The fair value of the real estate investment is based on current market conditions and considers matters such as the forecasted operating cash flows, lease coverage ratios, capitalization rates, and, where applicable, terms of recent lease agreements or the results of negotiations with prospective tenants.
We classify our real estate investments as held for sale when the applicable criteria have been met, which includes a formal plan to sell the properties that is expected to be completed within one year, among other criteria. Upon designation as held for sale, we write down the excess of the carrying value over the estimated fair value less costs to sell, resulting in an impairment of the real estate investments, if necessary, and cease depreciation. The fair value of the assets held for sale is based on estimated sales prices, which are considered to be Level 3 measurements within the fair value hierarchy. Estimated sales prices are determined using a market approach (comparable sales model), which relies on certain assumptions by management, including: (i) comparable market transactions, (ii) estimated prices per unit, and (iii) binding agreements for sales and non-binding offers to purchase from unrelated third-parties. There are inherent uncertainties in making these assumptions.
If circumstances arise that previously were considered unlikely and, as a result, we decide not to sell a real estate investment previously classified as held for sale or otherwise no longer meets the held for sale criteria, the respective assets are reclassified as real estate investments held for use. A real estate investment that is reclassified is measured and recorded individually at the lower of (a) its carrying amount before the real estate investment was classified as held for sale, adjusted for any depreciation expense that would have been recognized had the real estate investment been continuously classified as held for use, or (b) the fair value at the date of the decision not to sell or change in circumstances that led to the real estate investment no longer meeting the criteria of held for sale. The fair value of the real estate investment is determined in a similar manner to the fair value determination for real estate investments held for use described above.
Our ability to accurately estimate future cash flows and estimate and allocate fair values impacts the timing and recognition of impairments. While we believe our assumptions are reasonable, changes in these assumptions may have a material impact on financial results. Given the impacts of current macroeconomic events, the projected cash flows that we use to assess fair value for purposes of impairment testing are subject to greater uncertainty than normal. If in the future we reduce our estimate of cash flow projections, we may need to impair our real estate assets. We have not materially changed the assumptions used in the analysis during the year ended December 31, 2024.
Revenue Recognition. We recognize lease revenue in accordance with ASC 842, Leases. See Note 2, Summary of Significant Accounting Policies, in the Notes to Consolidated Financial Statements for further detail. Our assessment of collectibility of tenant receivables includes a binary assessment of whether or not substantially all of the amounts due under a tenant’s lease agreement are probable of collection.
54

This assessment involves significant judgment by management and considers the operator’s performance and anticipated trends, payment history, and the existence and creditworthiness of guarantees, among other factors, in making this determination. For such leases that are deemed probable of collection, revenue continues to be recorded on a straight-line basis over the lease term, if applicable. For such leases that are deemed not probable of collection, revenue is recorded as the lesser of (i) the amount which would be recognized on a straight-line basis or (ii) cash that has been received from the tenant, with any tenant and deferred rent receivable balances charged as a direct write-off against rental income in the period of the change in the collectibility determination. Management’s judgement can impact the timing of write-offs and recovery adjustments. We did not materially change the assumptions used in the analysis during the year ended December 31, 2024.
Fair Value of Other Real Estate Related Investments. We have elected the fair value option for our mortgage loans receivable, mezzanine loans receivable and financing receivable for which such election is permitted, as provided for under ASC 825, Financial Instruments (“ASC 825”). For financial instruments that are traded in an "active market," the best measure of fair value is the quoted market price. In cases where market-observable data is not available, the data used for the measurement must reflect assumptions that market participants would use in pricing the asset or liability (including adjustments that market participants demand for the risk associated with the unobservable data or the model used to determine fair value). We have concluded to use a present value technique, a discounted cash flow model, to determine fair value.
The determination of estimated fair value of our mortgage loans, mezzanine loans and financing receivable requires the use of both macroeconomic and microeconomic assumptions and/or inputs, which are generally based on current market and economic conditions, such as changes in the risk-free or benchmark rate and changes attributable to instrument-specific credit risk (e.g., changes in credit spread associated with the instrument). Changes in market and/or economic conditions could have a significant adverse effect on the estimated fair value of our financial instruments. Changes to assumptions, including assumed benchmark rates and credit spreads, may significantly impact the estimated fair value of our investments.
Because of the inherent uncertainty of valuation, the estimated fair value of our financial instruments may differ significantly from the values that would have been used had a ready market for the financial instruments existed, and the differences could be material to our consolidated financial statements.
Impact of Inflation
Our rental income in future years will be impacted by changes in inflation. Almost all of our triple-net lease agreements, including the Ensign leases, provide for an annual rent escalator based on the percentage change in the Consumer Price Index (but not less than zero), subject to maximum fixed percentages.

ITEM 7A.     Quantitative and Qualitative Disclosures About Market Risk
Our primary market risk exposure is interest rate risk with respect to our variable rate indebtedness.
Our Third Amended Credit Agreement provides for: (i) an unsecured revolving credit facility (the “Third Amended Revolving Facility”) with revolving commitments in an aggregate principal amount of $1.2 billion, including a letter of credit subfacility for 10% of the then available revolving commitments and a swingline loan subfacility for 10% of the then available revolving commitments.
The interest rates applicable to loans under the Third Amended Revolving Facility are, at the Operating Partnership’s option, equal to either a base rate plus a margin ranging from 0.05% to 0.55% per annum or Adjusted Term SOFR or Adjusted Daily Simple SOFR (each as defined in the Third Amended Credit Agreement) plus a margin ranging from 1.05% to 1.55% per annum based on the debt to asset value ratio of the Company and our consolidated subsidiaries (subject to decrease at the Operating Partnership’s election if we obtain certain specified investment grade ratings on our senior long-term unsecured debt). As of December 31, 2024, we had no borrowings outstanding under the Third Amended Revolving Facility.
An increase in interest rates could make the financing of any acquisition by us more costly as well as increase the costs of our variable rate debt obligations. Rising interest rates could also limit our ability to refinance our debt when it matures or cause us to pay higher interest rates upon refinancing and increase interest expense on refinanced indebtedness. Increased inflation may also have a pronounced negative impact on the interest expense we pay in connection with our outstanding indebtedness, as these costs could increase at a rate higher than our rents.
We may, in the future, manage, or hedge, interest rate risks related to our borrowings by means of interest rate swap agreements. However, the REIT provisions of the Code substantially limit our ability to hedge our assets and liabilities. See “Risk Factors - Risks Related to Our Status as a REIT - Complying with REIT requirements may limit our ability to hedge effectively and may cause us to incur tax liabilities.” As of December 31, 2024, we had no swap agreements to hedge our interest rate risks. We also expect to manage our exposure to interest rate risk by maintaining a mix of fixed and variable rates for our indebtedness.
55

ITEM  8. Financial Statements and Supplementary Data
See the Index to Consolidated Financial Statements on page F-1 of this report.
ITEM  9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosures
None.
ITEM  9A.    Controls and Procedures
Disclosure Controls and Procedures
We maintain disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) that are designed to ensure that information required to be disclosed in our reports under the Exchange Act is processed, recorded, summarized and reported within the time periods specified in the SEC’s rules and regulations and that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.
As of December 31, 2024, we carried out an evaluation, under the supervision and with the participation of management, including our Chief Executive Officer and Chief Financial Officer, regarding the effectiveness of our disclosure controls and procedures. Based on the foregoing, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of December 31, 2024.
Management’s Annual Report on Internal Control over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets; (ii) provide reasonable assurance that the transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and our directors; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.
We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, regarding the effectiveness of our internal control over financial reporting using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control - Integrated Framework (2013). Based on this evaluation, our management concluded that our internal control over financial reporting was effective as of December 31, 2024.
Changes in Internal Control over Financial Reporting
There has been no change in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the quarter ended December 31, 2024, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Attestation Report of the Independent Registered Public Accounting Firm
The effectiveness of our internal control over financial reporting as of December 31, 2024 has been audited by Deloitte & Touche LLP, an independent registered public accounting firm, as stated in their report which is included herein.
56


REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the stockholders and the Board of Directors of CareTrust REIT, Inc.

Opinion on Internal Control over Financial Reporting
We have audited the internal control over financial reporting of CareTrust REIT, Inc. and subsidiaries (the “Company”) as of December 31, 2024, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2024, based on criteria established in Internal Control — Integrated Framework (2013) issued by COSO.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements as of and for the year ended December 31, 2024, of the Company and our report dated February 12, 2025, expressed an unqualified opinion on those financial statements.
Basis for Opinion
The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Annual Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

Definition and Limitations of Internal Control over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.


/s/ Deloitte & Touche LLP

Costa Mesa, California
February 12, 2025
57


ITEM 9B.    Other Information
Insider Trading Arrangements
None.

ITEM 9C. Disclosure Regarding Foreign Jurisdictions That Prevent Inspections ITEM 10.
Not applicable.

58


PART III
Directors, Executive Officers and Corporate Governance
The information required under Item 10 is incorporated herein by reference to our definitive proxy statement to be filed with the SEC within 120 days after the end of our fiscal year ended December 31, 2024 in connection with our 2025 Annual Meeting of Stockholders.
Code of Conduct and Ethics
We have adopted a code of business conduct and ethics that applies to all employees, including employees of our subsidiaries, as well as each member of our Board of Directors. The code of business conduct and ethics is available at our website at www.caretrustreit.com under the Investors-Governance section. We intend to satisfy any disclosure requirement under applicable rules of the Securities and Exchange Commission or the New York Stock Exchange regarding an amendment to, or waiver from, a provision of this code of business conduct and ethics by posting such information on our website, at the address specified above.
ITEM  11.    Executive Compensation
The information required under Item 11 is incorporated herein by reference to our definitive proxy statement to be filed with the SEC within 120 days after the end of our fiscal year ended December 31, 2024 in connection with our 2025 Annual Meeting of Stockholders.
ITEM  12.    Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
The information required under Item 12 is incorporated herein by reference to our definitive proxy statement to be filed with the SEC within 120 days after the end of our fiscal year ended December 31, 2024 in connection with our 2025 Annual Meeting of Stockholders.
ITEM 13. Certain Relationships and Related Transactions, and Director Independence

The information required under Item 13 is incorporated herein by reference to our definitive proxy statement to be filed with the SEC within 120 days after the end of our fiscal year ended December 31, 2024 in connection with our 2025 Annual Meeting of Stockholders.
ITEM  14.    Principal Accountant Fees and Services
The information required under Item 14 is incorporated herein by reference to our definitive proxy statement to be filed with the SEC within 120 days after the end of our fiscal year ended December 31, 2024 in connection with our 2025 Annual Meeting of Stockholders.
59

PART IV


ITEM  15.    Exhibit and Financial Statement Schedules
(a)(1) Financial Statements
  See Index to Consolidated Financial Statements on page F-1 of this report.
(a)(2) Financial Statement Schedules
  Schedule III: Real Estate Assets and Accumulated Depreciation
Schedule IV: Mortgage Loans on Real Estate
  Note: All other schedules have been omitted because the required information is presented in the financial statements and the related notes or because the schedules are not applicable.
(a)(3) Exhibits
61

*101.INS Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
*101.SCH XBRL Taxonomy Extension Schema Document
*101.CAL XBRL Taxonomy Extension Calculation Linkbase Document
*101.DEF XBRL Taxonomy Extension Definition Linkbase Document
*101.LAB XBRL Taxonomy Extension Label Linkbase Document
*101.PRE XBRL Taxonomy Extension Presentation Linkbase Document
*104 Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
 
*    Filed herewith.
**    Furnished herewith.
+    Management contract or compensatory plan or arrangement.
62

ITEM 16.     Form 10-K Summary
None.
63




SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
CARETRUST REIT, INC.
By:
/S/ DAVID M. SEDGWICK
  David M. Sedgwick
  President and Chief Executive Officer
Dated: February 12, 2025
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
Name 
Title
Date 
/s/ DAVID M. SEDGWICK President and Chief Executive Officer (Principal Executive Officer) February 12, 2025
David M. Sedgwick
/s/ WILLIAM M. WAGNER Chief Financial Officer and Treasurer (Principal Financial Officer) February 12, 2025
William M. Wagner
/s/ LAUREN BEALE Chief Accounting Officer (Principal Accounting Officer) February 12, 2025
Lauren Beale
/s/ DIANA LAING Director February 12, 2025
Diana Laing
/s/ ANNE OLSON Director February 12, 2025
Anne Olson
/s/ SPENCER PLUMB Director February 12, 2025
Spencer Plumb
/s/ CAREINA WILLIAMS Director February 12, 2025
Careina Williams



64

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
 
 
Page  
Report of Independent Registered Public Accounting Firm (PCAOB ID No. 34) with respect to CareTrust REIT, Inc.
Consolidated Balance Sheets as of December 31, 2024 and 2023
Consolidated Statements of Operations for the years ended December 31, 2024, 2023 and 2022
Consolidated Statements of Equity and Redeemable Noncontrolling Interest for the years ended December 31, 2024, 2023 and 2022
Consolidated Statements of Cash Flows for the years ended December 31, 2024, 2023 and 2022
Notes to Consolidated Financial Statements
Schedule III: Real Estate Assets and Accumulated Depreciation
Schedule IV: Mortgage Loans on Real Estate

F-1

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the stockholders and the Board of Directors of CareTrust REIT, Inc.
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of CareTrust REIT, Inc. and subsidiaries (the "Company") as of December 31, 2024 and 2023, the related consolidated statements of operations, equity and redeemable noncontrolling interest, and cash flows, for each of the three years in the period ended December 31, 2024, and the related notes and the schedules listed in the Index at Item 15 (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2024, in conformity with accounting principles generally accepted in the United States of America.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2024, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 12, 2025, expressed an unqualified opinion on the Company's internal control over financial reporting.
Basis for Opinion
These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
Critical Audit Matter
The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.
Impairment of Real Estate Investments, Assets Held for Sale, Net and Asset Sales — Refer to Notes 2 and 4 to the financial statements
Critical Audit Matter Description
The Company classifies its real estate investments as held for sale when the applicable criteria have been met, which includes a formal plan to sell the properties that is expected to be completed within one year, among other criteria. Upon designation as held for sale, the Company writes down the excess of the carrying value over the estimated fair value less costs to sell, resulting in an impairment of the real estate investments, if necessary.
The fair value of the assets held for sale is based on a market approach using estimated sales prices (comparable sales model), which relies on certain assumptions by management, including: (i) comparable market transactions, (ii) estimated prices per unit, and (iii) binding agreements for sales and non-binding offers to purchase from unrelated third-parties. There are inherent uncertainties in making these assumptions.
We identified the impairment of real estate investments held for sale as a critical audit matter because of the significant estimates and assumptions management makes to determine the fair value of real estate investments held for sale.
F-2

This required a high degree of auditor judgment and an increased extent of effort, including the need to involve our fair value specialists, when performing audit procedures to evaluate the reasonableness of management’s estimate of fair value.
As of December 31, 2024, the Company had real estate investments held for sale of $57.3 million. For the year ended December 31, 2024, the Company recognized impairment charges of $37.3 million related to real estate investments held for sale.
How the Critical Audit Matter Was Addressed in the Audit
Our audit procedures related to the significant inputs to the fair value of real estate investments held for sale included the following, among others:
•We tested the effectiveness of controls over management’s determination of fair value for real estate investments held for sale.
•We assessed the reasonableness of the valuation methodology used and the concluded real estate investment fair value by obtaining sales comparison data.
•We used the assistance of our fair value specialists in obtaining relevant market data, where necessary.
•We considered the properties disposed in the period and subsequent period to evaluate if the retrospective review provides any indication of error or bias in the fair value estimates.
•We read and considered terms of executed arrangements and evidence regarding terms for arrangements in the process of negotiation at or near the valuation date.
•We held discussions with management to understand individual real estate investment specific factors that impacted the Company’s fair value determination.

/s/ Deloitte & Touche LLP
Costa Mesa, California
February 12, 2025

We have served as the Company's auditor since 2019.

F-3

CARETRUST REIT, INC.
CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share amounts)
December 31,
2024 2023
Assets:
Real estate investments, net $ 2,226,740  $ 1,567,119 
Financing receivable, at fair value (including accrued interest of $281 as of December 31, 2024)
96,004  — 
Other real estate related investments (including accrued interest of $4,725 and $1,727 as of December 31, 2024 and 2023, respectively)
795,203  180,368 
Assets held for sale, net 57,261  15,011 
Cash and cash equivalents 213,822  294,448 
Accounts and other receivables 1,174  395 
Prepaid expenses and other assets, net 35,608  23,337 
Deferred financing costs, net 11,204  4,160 
Total assets $ 3,437,016  $ 2,084,838 
Liabilities and Equity:
Senior unsecured notes payable, net $ 396,927  $ 396,039 
Senior unsecured term loan, net —  199,559 
Accounts payable, accrued liabilities and deferred rent liabilities 56,318  33,992 
Dividends payable 54,388  36,531 
Total liabilities 507,633  666,121 
Commitments and contingencies (Note 13)
Redeemable noncontrolling interest 18,243  — 
Equity:
Preferred stock, $0.01 par value; 100,000,000 shares authorized, no shares issued and outstanding as of December 31, 2024 and 2023
—  — 
Common stock, $0.01 par value; 500,000,000 shares authorized, 186,993,010 and 129,992,796 shares issued and outstanding as of December 31, 2024 and 2023, respectively
1,870  1,300 
Additional paid-in capital 3,439,117  1,883,147 
Cumulative distributions in excess of earnings (532,570) (467,628)
Total stockholders' equity 2,908,417  1,416,819 
Noncontrolling interests 2,723  1,898 
Total equity 2,911,140  1,418,717 
Total liabilities and equity $ 3,437,016  $ 2,084,838 





See accompanying notes to consolidated financial statements.
F-4

CARETRUST REIT, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share amounts)
 
  Year Ended December 31,
  2024 2023 2022
Revenues:
Rental income $ 228,261  $ 198,599  $ 187,506 
Interest income from financing receivable 1,009  —  — 
Interest income from other real estate related investments and other income 67,016  19,171  8,626 
Total revenues 296,286  217,770  196,132 
Expenses:
Depreciation and amortization 56,831  51,199  50,316 
Interest expense 30,310  40,883  30,008 
Property taxes 7,838  6,170  4,333 
Impairment of real estate investments 42,225  36,301  79,062 
Transaction costs 1,326  —  — 
Provision for loan losses, net 4,900  —  3,844 
Property operating expenses 5,714  3,423  5,039 
General and administrative 28,923  21,805  20,165 
Total expenses 178,067  159,781  192,767 
Other income (loss):
Loss on extinguishment of debt (657) —  — 
(Loss) gain on sale of real estate, net (2,208) 2,218  (3,769)
Unrealized gain (loss) on other real estate related investments, net 9,045  (6,485) (7,102)
Total other income (loss) 6,180  (4,267) (10,871)
Net income (loss) 124,399  53,722  (7,506)
Net loss attributable to noncontrolling interests (681) (13) — 
Net income (loss) attributable to CareTrust REIT, Inc. $ 125,080  $ 53,735  $ (7,506)
Earnings (loss) per common share attributable to CareTrust REIT, Inc:
Basic $ 0.81  $ 0.50  $ (0.08)
Diluted $ 0.80  $ 0.50  $ (0.08)
Weighted-average number of common shares:
Basic 154,795  105,956  96,703 
Diluted 155,167  106,152  96,703 






See accompanying notes to consolidated financial statements.
F-5

CARETRUST REIT, INC.
CONSOLIDATED STATEMENTS OF EQUITY AND REDEEMABLE NONCONTROLLING INTEREST
(in thousands, except share and per share amounts)
 
  Common Stock Additional
Paid-in
Capital
Cumulative
Distributions
in Excess
of Earnings
Total Stockholders’ Equity Noncontrolling Interests Total
Equity
Redeemable Noncontrolling Interest
Shares Amount
Balance as of December 31, 2021 96,296,673  $ 963  $ 1,196,839  $ (282,045) $ 915,757  $ —  $ 915,757  $ — 
Issuance of common stock, net 2,405,000  24  47,212  —  47,236  —  47,236  — 
Vesting of stock-based compensation awards, net of shares withheld for employee taxes 308,439  (4,472) —  (4,469) —  (4,469) — 
Amortization of stock-based compensation —  —  5,758  —  5,758  —  5,758  — 
Common dividends ($1.10 per share)
—  —  —  (107,403) (107,403) —  (107,403) — 
Net loss —  —  —  (7,506) (7,506) —  (7,506) — 
Balance as of December 31, 2022 99,010,112  990  1,245,337  (396,954) 849,373  —  849,373  — 
Issuance of common stock, net 30,868,714  309  634,137  —  634,446  —  634,446  — 
Vesting of stock-based compensation awards, net of shares withheld for employee taxes 113,970  (1,480) —  (1,479) —  (1,479) — 
Amortization of stock-based compensation —  —  5,153  —  5,153  —  5,153  — 
Common dividends ($1.12 per share)
—  —  —  (124,409) (124,409) —  (124,409) — 
Distributions to noncontrolling interests —  —  —  —  —  (41) (41) — 
Contributions from noncontrolling interests —  —  —  —  —  1,952  1,952  — 
Net income (loss) —  —  —  53,735  53,735  (13) 53,722  — 
Balance as of December 31, 2023 129,992,796  1,300  1,883,147  (467,628) 1,416,819  1,898  1,418,717  — 
Issuance of common stock, net 56,855,925  569  1,552,325  —  1,552,894  —  1,552,894  — 
Vesting of stock-based compensation awards, net of shares withheld for employee taxes 144,289  (2,485) —  (2,484) —  (2,484) — 
Amortization of stock-based compensation —  —  6,130  —  6,130  —  6,130  — 
Common dividends ($1.16 per share)
—  —  —  (190,022) (190,022) —  (190,022) — 
Distributions to noncontrolling interests —  —  —  —  —  (69) (69) — 
Contributions from noncontrolling interests —  —  —  —  —  1,429  1,429  18,389 
Net income (loss) —  —  —  125,080  125,080  (535) 124,545  (146)
Balance as of December 31, 2024 186,993,010  $ 1,870  $ 3,439,117  $ (532,570) $ 2,908,417  $ 2,723  $ 2,911,140  $ 18,243 


See accompanying notes to consolidated financial statements.
F-6

CARETRUST REIT, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
  Year Ended December 31,
  2024 2023 2022
Cash flows from operating activities:
Net income (loss) $ 124,399  $ 53,722  $ (7,506)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization (including below-market ground leases) 56,932  51,257  50,378 
Amortization of deferred financing costs 2,816  2,436  2,095 
Loss on extinguishment of debt 282  —  — 
Unrealized (gain) loss on other real estate related investments, net (9,045) 6,485  7,102 
Amortization of stock-based compensation 6,130  5,153  5,758 
Straight-line rental income 28  29  (17)
Amortization of lease incentives 22  —  — 
Amortization of below market leases (2,885) (384) — 
Adjustment for collectibility of rental income —  —  1,417 
Noncash interest income (3,279) (407) (1,165)
Loss (gain) on sale of real estate, net 2,208  (2,218) 3,769 
Impairment of real estate investments 42,225  36,301  79,062 
Provision for loan losses, net 4,900  —  3,844 
Change in operating assets and liabilities:
Accounts and other receivables (808) (9) 604 
Prepaid expenses and other assets, net (3,719) (21) 123 
Accounts payable, accrued liabilities and deferred rent liabilities 24,045  2,423  (1,049)
Net cash provided by operating activities 244,251  154,767  144,415 
Cash flows from investing activities:
Acquisitions of real estate, net of deposits applied (812,002) (233,776) (21,915)
Purchases of equipment, furniture and fixtures and improvements to real estate (8,054) (10,976) (7,292)
Preferred equity investments (52,000) (1,782) — 
Investment in real estate related investments and other loans receivable (559,188) (60,319) (149,650)
Investment in financing receivable (95,723) —  — 
Principal payments received on real estate related investments and other loans receivable 4,512  26,525  6,308 
Escrow deposits for potential acquisitions of real estate (5,167) (3,800) — 
Net proceeds from sales of real estate 13,939  16,313  45,149 
Net cash used in investing activities (1,513,683) (267,815) (127,400)
Cash flows from financing activities:
Proceeds from the issuance of common stock, net 1,552,894  634,446  47,236 
Proceeds from the secured borrowing 75,000  —  — 
Borrowings under unsecured revolving credit facility —  185,000  160,000 
Payments on senior unsecured term loan (200,000) —  — 
Payment on secured borrowing (75,000) —  — 
Payments on unsecured revolving credit facility —  (310,000) (115,000)
Payments on extinguishment of debt and deferred financing costs (9,188) (68) (5,361)
Net-settle adjustment on restricted stock (2,484) (1,479) (4,469)
Dividends paid on common stock (172,165) (115,492) (106,138)
Contributions from noncontrolling interests 19,818  1,952  — 
Distributions to noncontrolling interests (69) (41) — 
Net cash provided by (used in) financing activities 1,188,806  394,318  (23,732)
Net (decrease) increase in cash and cash equivalents (80,626) 281,270  (6,717)
Cash and cash equivalents as of the beginning of period 294,448  13,178  19,895 
Cash and cash equivalents as of the end of period $ 213,822  $ 294,448  $ 13,178 
Supplemental disclosures of cash flow information:
Interest paid $ 27,933  $ 40,028  $ 25,912 
Supplemental schedule of noncash investing and financing activities:
Increase in dividends payable $ 17,857  $ 8,982  $ 1,265 
Right-of-use asset obtained in exchange for new operating lease obligation $ 1,748  $ 369  $ — 
Transfer of pre-acquisition costs to acquired assets $ 58  $ —  $
Sale of real estate settled with note receivable $ 1,000  $ 2,000  $ 12,000 
Liabilities assumed by buyer in connection with sale of real estate $ 2,776  $ —  $ — 

See accompanying notes to consolidated financial statements.
F-7

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1. ORGANIZATION
Description of Business—CareTrust REIT, Inc.’s (“CareTrust REIT” or the “Company”) primary business consists of acquiring, financing, developing and owning real property to be leased to third-party tenants in the healthcare sector. As of December 31, 2024, the Company owned, directly or in consolidated joint ventures, and leased to independent operators, 258 skilled nursing facilities (“SNFs”), multi-service campuses, assisted living facilities (“ALFs”) and independent living facilities (“ILFs”) consisting of 28,088 operational beds and units located in 32 states with the highest concentration of properties by rental income located in California and Texas. As of December 31, 2024, the Company also had other real estate related investments consisting of three preferred equity investments, 15 real estate secured loans receivable, and five mezzanine loans receivable with a carrying value of $795.2 million and one financing receivable with a carrying value of $96.0 million.
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation—The accompanying consolidated financial statements of the Company reflect, for all periods presented, the historical financial position, results of operations and cash flows of the Company prepared in accordance with accounting principles generally accepted in the United States (“GAAP”).
Consolidation—The accompanying consolidated financial statements include the accounts of CareTrust REIT, its wholly-owned subsidiaries, and variable interest entities (“VIEs”) over which the Company exercises control. All intercompany transactions and account balances within the Company have been eliminated, and net earnings are reduced by the portion of net earnings attributable to noncontrolling interests.
Variable Interest Entities—The Company is required to continually evaluate its VIE relationships and consolidate these entities when it is determined to be the primary beneficiary of their operations. A VIE is broadly defined as an entity where either: (i) the equity investment at risk is insufficient to finance that entity’s activities without additional subordinated financial support, (ii) substantially all of an entity’s activities either involve or are conducted on behalf of an investor that has disproportionately few voting rights, or (iii) the equity investors as a group lack any of the following: (a) the power through voting or similar rights to direct the activities of an entity that most significantly impact the entity’s economic performance, (b) the obligation to absorb the expected losses of an entity, or (c) the right to receive the expected residual returns of an entity. Criterion (iii) above is generally applied to limited partnerships and similarly structured entities by assessing whether a simple majority of the limited partners hold substantive rights to participate in the significant decisions of the entity or have the ability to remove the decision maker or liquidate the entity without cause. If neither of those criteria are met, the entity is a VIE.
The designation of an entity as a VIE is reassessed upon certain events, including, but not limited to: (i) a change to the contractual arrangements of the entity or in the ability of a party to exercise its participation or kick-out rights, (ii) a change to the capitalization structure of the entity, or (iii) acquisitions or sales of interests that constitute a change in control.
A variable interest holder is considered to be the primary beneficiary of a VIE if it has the power to direct the activities of a VIE that most significantly impact the entity’s economic performance and has the obligation to absorb losses of, or the right to receive benefits from, the entity that could potentially be significant to the VIE. The Company qualitatively assesses whether it is (or is not) the primary beneficiary of a VIE. The Company’s consideration of various factors include, but is not limited to, which activities most significantly impact the entity’s economic performance and the ability to direct those activities, its form of ownership interest, its representation on the VIE’s governing body, the size and seniority of its investment, its ability and the rights of other investors to participate in policy making decisions, its ability to manage its ownership interest relative to the other interest holders, and its ability to replace the VIE manager and/or liquidate the entity.
For any investment in a joint venture that is not considered to be a VIE, the Company would evaluate the type of ownership rights held by limited partner(s) that may preclude consolidation by the majority interest holder. The assessment of limited partners’ rights and their impact on the control of a joint venture should be made at inception of the joint venture and continually reassessed. See Note 12, Variable Interest Entities, for additional information.
F-8

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Noncontrolling Interests—The Company presents the portion of any equity that the Company does not own in entities that the Company controls (and thus consolidates) as noncontrolling interests and classifies those interests as a component of consolidated equity, separate from stockholders' equity, on the Company’s consolidated balance sheets. For consolidated joint ventures, the Company allocates net income or loss utilizing the hypothetical liquidation at book value method, in which the Company allocates income or loss based on the change in each unitholders’ claim on the net assets of the joint venture partners at period end after adjusting for any distributions or contributions made during such period. The Company includes net income (loss) attributable to the noncontrolling interests in net income (loss) in the consolidated statements of operations.
Redeemable Noncontrolling Interest —One of the Company’s noncontrolling interest holders has the ability to put its equity interests to the Company during specified option exercise periods, subject to certain conditions. The put option is payable in cash and subject to changes in redemption value. Accordingly, the Company records the redeemable noncontrolling interest outside of permanent equity. The redeemable noncontrolling interest was initially measured at fair value on the date of issuance and is adjusted for additional contributions and distributions and the proportionate share of the net earnings or losses. When the redemption of the noncontrolling interest becomes probable, the Company will record the redeemable noncontrolling interest at the greater of its carrying amount or redemption value at the end of each reporting period by making an election either to accrete changes in the redemption value of the redeemable noncontrolling interest over the period from the date it is probable of exercise to the earliest redemption date or to recognize the entire adjustment on the date redemption becomes probable. Redeemable noncontrolling interest adjustments of carrying value to redemption value are reflected in additional paid-in-capital on the Company’s consolidated balance sheets. The adjustment of carrying value to the redemption value that reflects a redemption in excess of fair value is included as an adjustment to net income available to the Company’s stockholders in the calculation of earnings per share.
Lessor Accounting—The Company recognizes lease revenue in accordance with Accounting Standards Codification (“ASC”) 842, Leases. The Company’s lease agreements typically contain annual escalators based on the percentage change in the Consumer Price Index which are accounted for as variable lease payments in the period in which the change occurs. For lease agreements that contain fixed rent escalators, the Company generally recognizes lease revenue on a straight-line basis of accounting. The Company generates revenues primarily by leasing healthcare-related properties to healthcare operators in triple-net lease arrangements, under which the tenant is solely responsible for the costs related to the property. Tenant reimbursements related to property taxes and insurance paid by the lessee directly to a third party on behalf of a lessor are required to be excluded from variable payments and from recognition in the lessor’s statements of operations. Otherwise, tenant recoveries for taxes and insurance are classified as additional rental revenues recognized by the lessor on a gross basis in its statements of operations.
As part of the Company’s acquisitions and/or amendments, the Company may commit to provide incentive payments to its lessees. During the year ended December 31, 2024, the Company funded $2.9 million in lease incentives. Lease incentives are amortized over the initial term of the respective lease as an adjustment to rental revenue. Lease incentives are included in prepaid expenses and other assets, net on the Company’s consolidated balance sheets.
The Company’s assessment of collectibility of its tenant receivables includes a binary assessment of whether or not substantially all of the amounts due under a tenant’s lease agreement are probable of collection. The Company considers the operator’s performance and anticipated trends, payment history, and the existence and creditworthiness of guarantees, among other factors, in making this determination. For such leases that are deemed probable of collection, revenue continues to be recorded on a straight-line basis over the lease term, if applicable. For such leases that are deemed not probable of collection, revenue is recorded as the lesser of (i) the amount which would be recognized on a straight-line basis or (ii) cash that has been received from the tenant, with any tenant and deferred rent receivable balances charged as a direct write-off against rental income in the period of the change in the collectibility determination. Such write-offs and recoveries are recorded as decreases or increases through rental income on the Company’s consolidated statements of operations. For the years ended December 31, 2024 and 2023, the Company did not record any recovery adjustments or write-off adjustments to rental income. For the year ended December 31, 2022, the Company did not record any recovery adjustments and wrote-off $1.4 million of rental income. See Note 3, Real Estate Investments, Net for further detail.
Interest Income—Interest income is recognized as earned over the term of the related other real estate related investment under the effective interest method, or on a straight-line basis if not materially different from the effective interest method. Interest income is recorded on an accrual basis to the extent that such amounts are expected to be collected. When concerns exist as to the ultimate collection of principal or interest due under a loan, the loan is placed on non-accrual status, and the Company will not recognize interest income until the cash is received, or the loan returns to accrual status. If the Company determines that the collection of interest according to the contractual terms of the loan is probable, the Company will resume the accrual of interest.
F-9

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Estimates and Assumptions—The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Management believes that the assumptions and estimates used in preparation of the underlying consolidated financial statements are reasonable. Actual results, however, could differ from those estimates and assumptions.
Real Estate Acquisition Valuation— In accordance with ASC 805, Business Combinations, the Company’s acquisitions of real estate investments generally do not meet the definition of a business, and are treated as asset acquisitions. The assets acquired and liabilities assumed are measured at their acquisition date relative fair values. Acquisition costs are capitalized as incurred. The Company allocates the acquisition costs to the tangible assets, identifiable intangible assets/liabilities and assumed liabilities on a relative fair value basis. The Company assesses fair value based on available market information, such as capitalization and discount rates, comparable sale transactions and relevant per square foot or unit cost information. A real estate asset’s fair value may be determined utilizing cash flow projections that incorporate such market information. Estimates of future cash flows are based on a number of factors including historical operating results, known and anticipated trends, as well as market and economic conditions. The fair value of tangible assets of an acquired property is based on the value of the property as if it is vacant.
The Company recognizes acquired “above or below market” leases at their fair value (for asset acquisitions) using discount rates which reflect the risks associated with the leases acquired. The fair value is based on the present value of the difference between (i) the contractual amounts due pursuant to each in-place lease and (ii) management’s estimate of fair market lease rates for each in-place lease, generally measured over a period equal to the remaining term of the lease for above market leases and the initial term plus the extended term for any leases with renewal options that are reasonably certain to be exercised for below market leases. Other intangible assets acquired include amounts for in-place lease values that are based on an evaluation of the specific characteristics of each property and the acquired tenant lease(s). Factors considered include estimates of carrying costs during hypothetical expected lease-up periods, market conditions, and costs to execute similar leases. In estimating carrying costs, the Company includes estimates of lost rents at market rates during the hypothetical expected lease-up periods, which are dependent on local market conditions and expected trends. In estimating costs to execute similar leases, the Company considers leasing commissions, legal, and other related costs. The following table summarizes the Company’s intangible lease liabilities (dollars in thousands):
December 31, 2024 December 31, 2023
Gross intangible lease liability $ 9,858  $ 7,289 
Accumulated amortization (3,269) (384)
Intangible liabilities, net $ 6,589  $ 6,905 
Weighted average remaining amortization period in years 1.8 3
Impairment of Long-Lived Assets—At each reporting period, the Company evaluates its real estate investments held for use for potential impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. The judgment regarding the existence of impairment indicators, used to determine if an impairment assessment is necessary, is based on factors such as, but not limited to, market conditions, operator performance and legal structure. If indicators of impairment are present, the Company evaluates the carrying value of the related real estate investments in relation to the future undiscounted cash flows of the underlying facilities. The most significant inputs to the undiscounted cash flows include, but are not limited to, historical and projected facility level financial results, a lease coverage ratio, the intended hold period by the Company, and a terminal capitalization rate. The analysis is also significantly impacted by determining the lowest level of cash flows, which generally would be at the master lease level of cash flows. Provisions for impairment losses related to long-lived assets are recognized when expected future undiscounted cash flows are determined to be less than the carrying values of the assets. The impairment is measured as the excess of carrying value over fair value. All impairments are taken as a period cost at that time, and depreciation is adjusted going forward to reflect the new value assigned to the asset.
The Company classifies its real estate investments as held for sale when the applicable criteria have been met, which includes a formal plan to sell the properties that is expected to be completed within one year, among other criteria. Upon designation as held for sale, the Company writes down the excess of the carrying value over the estimated fair value less costs to sell, resulting in an impairment of the real estate investments, if necessary, and ceases depreciation.
F-10

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In the event of impairment, the fair value of the real estate investment is based on current market conditions and considers matters such as the forecasted operating cash flows, lease coverage ratios, capitalization rates, comparable sales data, and, where applicable, contracts or the results of negotiations with purchasers or prospective purchasers.
If circumstances arise that previously were considered unlikely and, as a result, the Company decides not to sell a real estate investment previously classified as held for sale or otherwise no longer meets the held for sale criteria, the respective assets are reclassified as real estate investments held for use. A real estate investment that is reclassified is measured and recorded individually at the lower of (a) its carrying amount before the real estate investment was classified as held for sale, adjusted for any depreciation expense that would have been recognized had the real estate investment been continuously classified as held for use, or (b) the fair value at the date of the decision not to sell or change in circumstances that led to the real estate investment no longer meeting the criteria of held for sale.
The Company’s ability to accurately estimate future cash flows and estimate and allocate fair values impacts the timing and recognition of impairments. While the Company believes its assumptions are reasonable, changes in these assumptions may have a material impact on financial results.
For the years ended December 31, 2024, 2023 and 2022, the Company recorded impairment charges of $42.2 million, $36.3 million and $79.1 million, respectively. See Note 4, Impairment of Real Estate Investments, Assets Held For Sale, Net and Asset Sales, for additional information.
Financing Receivable—The Company may from time to time enter into a contract to acquire an asset and lease it back to the seller in a sale and leaseback transaction. In accordance with ASC 842, Leases, the Company is required to determine whether the transaction qualifies as a sale with control of the asset being transferred to the Company. A failed sale and leaseback transaction is accounted for as a financing receivable in accordance with ASC 310, Receivables. If control of the asset subsequently is deemed to have transferred to the Company, the financing receivable would be reclassified as real estate investments. No gain or loss would be recognized, and the related assets and liabilities would be recorded at their relative fair values on the date control is transferred. One of the Company’s investments is accounted for as a financing receivable within the Company’s consolidated balance sheets, since control of the underlying assets did not transfer to the Company due to the existence of options for the seller-lessee to repurchase the real estate assets, which generally preclude accounting for the transfer of real estate assets as a sale. The Company elected the fair value option for the financing receivable, and thereby, acquisition costs incurred in connection with entering into the financing receivable were expensed and recorded in transaction costs in the consolidated statements of operations. Instruments for which the fair value option has been elected are measured at fair value on a recurring basis with changes in fair value recognized in other income (loss) on the consolidated statements of operations. Fair value was estimated using an internal valuation model that considered expected future cash flows of the investment, market interest rates, and the underlying collateral value. Interest income from financing receivable on the Company’s consolidated statements of operations is recognized under the effective interest method.
Other Real Estate Related Investments—Included in other real estate related investments on the Company’s consolidated balance sheets at December 31, 2024, are three preferred equity investments, 15 real estate secured loans receivable and five mezzanine loans receivable. The Company elected the fair value option for all secured and mezzanine loans receivable. Instruments for which the fair value option has been elected are measured at fair value on a recurring basis with changes in fair value recognized in other income (loss) on the consolidated statements of operations. Fair value was estimated using an internal valuation model that considered the expected future cash flows of the investment, the underlying collateral value, market interest rates and other credit enhancements. The Company elected the practical expedient not to record the preferred equity investments at fair value as the fair value is not readily determinable. The preferred equity investments are accounted for at unpaid principal balance, plus accrued return, net of reserves. The Company recognizes return income on a monthly basis based on the outstanding investment including any accrued and unpaid return, to the extent there is outside contributed equity or cumulative earnings from operations. As the preferred member of the joint venture, the Company is not entitled to share in the joint venture’s earnings or losses. Rather, the Company is entitled to receive a preferred return, which is deferred if the cash flow of the joint venture is insufficient to pay all of the accrued preferred return. The unpaid accrued preferred return is added to the balance of the preferred equity investment up to the estimated economic outcome assuming a hypothetical liquidation of the book value of the joint venture. Any unpaid accrued preferred return, whether recorded or unrecorded by the Company, will be repaid upon redemption or as available cash flow is distributed from the joint venture.
Prepaid expenses and other assets—Prepaid expenses and other assets consist of prepaid expenses, deposits, pre-acquisition costs and other loans receivable. During the year ended December 31, 2024, the Company determined that the remaining contractual obligations under one other loan receivable was not collectible and recorded a 4.9 million expected credit loss. During the year ended December 31, 2022, the Company determined that the remaining contractual obligations under two other loans receivable were not collectible and recorded a $4.6 million expected credit loss, net of a loan loss recovery of $0.8 million related to a loan previously written-off.
F-11

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The Company did not record an expected credit loss or recovery during the year ended December 31, 2023. Expected credit losses and recoveries are recorded in provision for loan losses, net in the consolidated statements of operations.
The Company’s other loans receivable are reflected at amortized cost, net of an allowance for credit loss, on the accompanying consolidated balance sheets. The amortized cost of a loan receivable is the outstanding unpaid principal balance, net of unamortized discounts, costs and fees directly associated with the origination of the loan.
Income Taxes—The Company has elected to be taxed as a real estate investment trust (“REIT”) under the Internal Revenue Code of 1986, as amended (the “Code”). The Company believes it has been organized and has operated, and the Company intends to continue to operate, in a manner to qualify for taxation as a REIT under the Code. To qualify as a REIT, the Company must meet certain organizational and operational requirements, including a requirement to distribute to its stockholders at least 90% of the Company’s annual REIT taxable income (computed without regard to the dividends paid deduction or net capital gain and which does not necessarily equal net income as calculated in accordance with GAAP). As a REIT, the Company generally will not be subject to federal income tax to the extent it distributes as qualifying dividends all of its REIT taxable income to its stockholders. If the Company fails to qualify as a REIT in any taxable year, it will be subject to federal income tax on its taxable income at regular corporate income tax rates and generally will not be permitted to qualify for treatment as a REIT for federal income tax purposes for the four taxable years following the year during which qualification is lost unless the Internal Revenue Service grants the Company relief under certain statutory provisions. 
Real Estate Depreciation and Amortization—Real estate costs related to the acquisition and improvement of properties are capitalized and amortized over the expected useful life of the asset on a straight-line basis. Repair and maintenance costs are charged to expense as incurred and significant replacements and betterments are capitalized. Repair and maintenance costs include all costs that do not extend the useful life of the real estate asset. The Company considers the period of future benefit of an asset to determine its appropriate useful life. Expenditures for tenant improvements are capitalized and amortized over the shorter of the tenant’s lease term or expected useful life. The Company anticipates the estimated useful lives of its assets by class to be generally as follows:
Building
25-40 years
Building improvements
10-25 years
Tenant improvements Shorter of lease term or expected useful life
Integral equipment, furniture and fixtures
5 years
Identified intangible assets Shorter of lease term or expected useful life
 Cash and Cash Equivalents—Cash and cash equivalents consist of bank term deposits and money market funds with original maturities of three months or less at time of purchase and therefore approximate fair value. The fair value of these investments is determined based on “Level 1” inputs, which consist of unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets. The Company places its cash and cash equivalents with high credit quality financial institutions.
The Company’s cash and cash equivalents balance periodically exceeds federally insurable limits. The Company monitors the cash balances in its operating accounts and adjusts the cash balances as appropriate; however, these cash balances could be impacted if the underlying financial institutions fail or are subject to other adverse conditions in the financial markets. To date, the Company has experienced no loss or lack of access to cash in its operating accounts.
Deferred Financing Costs—External costs incurred from placement of the Company’s debt are capitalized and amortized on a straight-line basis over the terms of the related borrowings, which approximates the effective interest method. For senior unsecured notes payable and the senior unsecured term loan, deferred financing costs are netted against the outstanding debt amounts on the consolidated balance sheets. For the unsecured revolving credit facility, deferred financing costs are included in assets on the Company’s consolidated balance sheets. Amortization of deferred financing costs is classified as interest expense in the consolidated statements of operations. Accumulated amortization of deferred financing costs was $3.3 million and $4.8 million at December 31, 2024 and 2023, respectively.
When financings are terminated, unamortized deferred financing costs, as well as charges incurred for the termination, are expensed at the time the termination is made. Gains and losses from the extinguishment of debt are presented within other income (loss) in the Company’s consolidated statements of operations. During the year ended December 31, 2024, the Company recorded a loss on extinguishment of debt of $0.7 million. See Note 7, Debt, for further detail.
Stock-Based Compensation—The Company accounts for share-based payment awards in accordance with ASC 718, Compensation – Stock Compensation (“ASC 718”). ASC 718 requires all entities to apply a fair value-based measurement method in accounting for share-based payment transactions with directors, officers and employees.
F-12

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The Company measures and recognizes compensation expense for all share-based payment awards made to directors, officers and employees based on the grant date fair value, amortized over the requisite service period of the award. Compensation expense for awards with performance-based vesting conditions is recognized based upon the probability that the performance target will be met. Compensation expense for awards with market-based vesting conditions is recognized based upon the estimated number of awards to be earned and is recognized provided that the requisite service is rendered, regardless of when, if ever, the market condition is satisfied. Forfeitures of stock-based awards are recognized as they occur. Net income (loss) reflects stock-based compensation expense of $6.1 million, $5.2 million and $5.8 million for the years ended December 31, 2024, 2023 and 2022, respectively.
Concentration of Credit Risk—The Company is subject to concentrations of credit risk consisting primarily of contractual obligations of operators and borrowers under its lease and lending agreements. See Note 14, Concentration of Risk, for a discussion of major operator concentration.
Segment Disclosures —The Company is subject to disclosures about segments of an enterprise and related information in accordance with ASC 280, Segment Reporting. The Company has one reportable segment consisting of investments in healthcare-related real estate assets. See Note 11, Segment Reporting, for additional information.
Earnings Per Share—The Company calculates earnings per share (“EPS”) in accordance with ASC 260, Earnings Per Share. Basic EPS is computed by dividing net income applicable to common stock by the weighted-average number of common shares outstanding during the period. Diluted EPS reflects the additional dilution for all potentially-dilutive securities. See Note 10, Earnings (Loss) Per Common Share, for additional information.
Beds, Units, Occupancy and Other Measures—Beds, units, occupancy and other non-financial measures used to describe real estate investments included in these Notes to the consolidated financial statements are presented on an unaudited basis and are not subject to audit by the independent registered public accounting firm in accordance with the standards of the Public Company Accounting Oversight Board.
Recent Accounting Pronouncements
Adopted—On November 27, 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”), to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses and the inclusion of a segment reporting footnote. The guidance is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company adopted ASU 2023-07 during the year ended December 31, 2024. See Note 11, Segment Reporting, for further detail.
Not Yet Adopted—On November 4, 2024, the FASB issued ASU 2024-03, which requires disaggregated disclosures of income statement expenses for public business entities. The ASU requires disaggregation of certain expense captions into specified categories in disclosures within the footnotes to the financial statements. The ASU is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The Company is still evaluating its adoption timeline and the impact on its disclosures.
3. REAL ESTATE INVESTMENTS, NET
The following table summarizes the Company’s investment in owned properties, and properties held in consolidated joint ventures, held for use at December 31, 2024 and 2023 (dollars in thousands):
 
December 31, 2024 December 31, 2023
Land $ 367,044  $ 279,276 
Buildings and improvements 2,220,287  1,620,014 
Integral equipment, furniture and fixtures 113,803  100,504 
Identified intangible assets 4,388  5,283 
Real estate investments 2,705,522  2,005,077 
Accumulated depreciation and amortization (478,782) (437,958)
Real estate investments, net $ 2,226,740  $ 1,567,119 
F-13

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Significant Master Leases
Ensign — As of December 31, 2024, 97 of the Company’s 258 facilities were leased to subsidiaries of The Ensign Group, Inc. (“Ensign”) on a triple-net basis under multiple long-term leases (each, an “Ensign Master Lease” and, collectively, the “Ensign Master Leases”) which commenced on June 1, 2014 and were subsequently modified. The obligations under the Ensign Master Leases are guaranteed by Ensign. A default by any subsidiary of Ensign with regard to any facility leased pursuant to an Ensign Master Lease will result in a default under all of the Ensign Master Leases. As of December 31, 2024, annualized contractual rental income from the Ensign Master Leases was $68.2 million and is escalated annually, in June, by an amount equal to the product of (1) the lesser of the percentage change in the Consumer Price Index (“CPI”) (but not less than zero) or 2.5%, and (2) the prior year’s rent. In addition to rent, the subsidiaries of Ensign that are tenants under the Ensign Master Leases are solely responsible for the costs related to the leased properties (including property taxes, insurance, and maintenance and repair costs). See below under “Lease Amendments and Terminations” for further detail on Ensign lease amendments.
During the year ended December 31, 2020, the Company acquired four additional facilities leased to subsidiaries of Ensign on a triple-net basis under two separate master lease agreements, each of which contains a purchase option. As of December 31, 2024, annualized contractual rental income from the four additional Ensign facilities was $4.1 million and is escalated annually, in December, by an amount equal to the product of (1) the lesser of the percentage change in the CPI (but not less than zero) or 2.5%, and (2) the prior year’s rent. In addition to rent, the subsidiaries of Ensign that are tenants under the four additional facilities are solely responsible for the costs related to the leased properties (including property taxes, insurance, and maintenance and repair costs). The obligations under the lease agreements for the four additional facilities are guaranteed by Ensign but do not contain cross-default provisions with the Ensign Master Leases. During December 2024, the Company received written notice that Ensign will exercise the purchase option and as such these four facilities have been classified as held for sale as of December 31, 2024. See Note 15, Subsequent Events, for additional information.
On December 31, 2024, the Company, through a consolidated joint venture, acquired six additional facilities leased to subsidiaries of Ensign on a triple-net basis under one separate master lease agreement, which commenced January 1, 2025 (the “Ensign TN Master Lease”). The annualized contractual rental income under the Ensign TN Master Lease is $7.1 million and is escalated annually, in January, by an amount equal to the product of (1) the prior year’s rent, and (2) the product of (x) 2 and (y) the annual CPI increase (not to exceed 2.5%).
Ensign provides a guaranty for eight properties leased to The Pennant Group, Inc. (“Pennant”) under the Pennant Master Lease (defined below), which represent $7.5 million of total annualized contractual rental income as of December 31, 2024.
PACS— As of December 31, 2024, 14 of the Company’s properties were leased to affiliates of PACS Group, Inc. (“PACS”) on a triple-net basis under one long-term lease (the “PACS Master Lease”), and have a total of 1,827 operational beds. One of the facilities is included in held for sale as of December 31, 2024. The PACS Master Lease commenced on October 26, 2017, and provides for an initial term of 15 years, with two five-year renewal options. During the year ended December 31, 2024, the Company, through a joint venture, acquired 11 facilities, which have a total of 1,186 operational beds, leased to subsidiaries of PACS commencing on December 1, 2024, under a new triple-net master lease agreement (the “PACS TN Master Lease”). The PACS TN Master Lease has an initial term of 15 years, with two five-year renewal options. As of December 31, 2024, annualized contractual rental income from the PACS Master Lease was $20.0 million (excluding the facility classified as held for sale), and annualized contractual rental income from all PACS leases was $37.9 million (excluding $0.3 million of rent abatement in the first year of the PACS TN Master Lease), representing 8% and 15% of total annualized contractual rental income, respectively. Rent is escalated annually in November under the PACS Master Lease by an amount equal to the product of (1) the lesser of the percentage change in the CPI (but not less than zero) or 3%, and (2) the prior year’s rent. Rent under the PACS TN Master Lease is escalated annually in December by an amount equal to the product of (1) the percentage change in the CPI and (2) the prior year’s rent (subject to a 2% floor and a 4% cap). The PACS TN Master Lease also provides rent abatement of $0.3 million in the first year. Subsequent to December 31, 2024, the PACS TN Master Lease was amended, see Note 15, Subsequent Events, for additional information.
PMG — As of December 31, 2024, 15 of the Company’s facilities were leased to subsidiaries of Priority Management Group (“PMG”) on a triple-net basis under one long-term lease (the “PMG Master Lease”). The PMG Master Lease commenced on December 1, 2016, and provides an initial term of fifteen years, with two five-year renewal options. As of December 31, 2024, annualized contractual rental income from the PMG Master Lease was $31.9 million and is escalated annually by an amount equal to the product of (1) the lesser of the percentage change in the CPI (but not less than zero) or 3.0%, and (2) the prior year’s rent. In addition to rent, the subsidiaries of PMG that are tenants under the PMG Master Lease are solely responsible for the costs related to the leased properties (including property taxes, insurance, and maintenance and repair costs).
F-14

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Portfolio
As of December 31, 2024, 103 of the Company’s 258 facilities were leased to various other operators under triple-net leases. All of these leases contain annual escalators based on the percentage change in the CPI (but not less than zero), some of which are subject to a cap, or fixed rent escalators. As of December 31, 2024, one of the Company’s 258 facilities was non-operational and was disposed of subsequent to year end. As of December 31, 2024, 10 facilities were held for sale. See Note 4, Impairment of Real Estate Investments, Assets Held for Sale, Net and Asset Sales, and Note 15, Subsequent Events, for additional information.
As of December 31, 2024, the Company’s total future contractual minimum rental income for all of its tenants, excluding operating expense reimbursements, assets held for sale and non-operational assets, was as follows (dollars in thousands):
Year Amount
2025 $ 273,728 
2026 281,304 
2027 283,468 
2028 281,736 
2029 277,286 
Thereafter 1,588,781 
$ 2,986,303 
F-15

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Tenant Purchase Options
Certain of the Company’s operators hold purchase options allowing them to acquire properties they currently lease from the Company. A summary of these purchase options is presented below (dollars in thousands):
Asset Type Properties Lease Expiration
Option Period Open Date(1)
Option Type(2)
Current Cash Rent(3)
SNF 1 March 2029 04/1/2022
(4)
A / B
(7)
$ 858 
SNF 4 November 2034 12/1/2024
(4)
A
(11)
4,079 
SNF / Campus 2 October 2032 11/1/2026
(5)
B 3,367 
(9)
SNF / Campus 1 May 2034 6/1/2026
(8)
B 1,293 
(10)
SNF / Campus 1 May 2034 6/1/2027
(8)
B 1,293 
(10)
SNF 1 November 2034 12/1/2027
(4)
A 1,100 
SNF 2 November 2039 12/1/2027
(6)
B 3,460 
(12)
SNF 2 November 2039 12/1/2028
(6)
B 3,460 
(12)
SNF 1 November 2039 12/1/2029
(6)
B 1,615 
(13)
SNF 1 November 2039 12/1/2030
(6)
B 1,615 
(13)
(1)The Company has not received notice of exercise for the option periods that are currently open, except as described in footnote (11) below.
(2)Option type includes:
A - Fixed base price.
B - Fixed capitalization rate on lease revenue.
(3)Based on annualized cash revenue for contracts in place as of December 31, 2024.
(4)Option window is open until the expiration of the lease term.
(5)Option window is open for six months from the option period open date.
(6)Option window is open for one year from the option period open date.
(7)Purchase option reflects two option types.
(8)Purchase option window is open for nine months from the option period open date.
(9)Purchase option provides for the purchase of two of three facilities. The current cash rent shown is an average of the range of $3.2 million to $3.5 million.
(10)Purchase option provides for the purchase of one of five facilities. The current cash rent shown is an average of the range of $1.0 million to $1.6 million. If the operator exercises its option to extend the term of the master lease, beginning on June 1, 2035 and ending nine months thereafter, the operator will have a purchase option for all facilities then remaining in the master lease.
(11)The operator notified the Company of their intent to exercise the purchase option of the four SNFs in December 2024. The Company classified the four facilities as held for sale as of December 31, 2024 and subsequently sold the facilities in January 2025. See Note 15, Subsequent Events, for additional information.
(12)Purchase option provides for the purchase of two of six facilities. The current cash rent shown is an average of the range of $2.4 million to $4.6 million.
(13)Purchase option provides for the purchase of one of six facilities. The current cash rent shown is an average of the range of $0.9 million to $2.3 million.
Rental Income
The following table summarizes components of the Company’s rental income (dollars in thousands):
For the Year Ended December 31,
Rental Income 2024 2023 2022
Contractual rent due(1)
$ 225,426  $ 198,244  $ 188,906 
Straight-line rent (28) (29) 17 
Amortization of lease incentives (22) —  — 
Amortization of below-market lease intangible 2,885  384  — 
Adjustment for collectibility(2)
—  —  (1,417)
Total $ 228,261  $ 198,599  $ 187,506 
(1)Includes initial cash rent and tenant operating expense reimbursements, as adjusted for applicable rental escalators and rent increases due to capital expenditures funded by the Company. For tenants on a cash basis, this represents the lesser of the amount that would be recognized on a straight-line basis or cash that has been received. Tenant operating expense reimbursements for the years ended December 31, 2024, 2023 and 2022 were $6.7 million, $5.5 million, and $2.8 million, respectively.
(2)During the year ended December 31, 2022, and in accordance with ASC 842, the Company evaluated the collectibility of lease payments through maturity and determined that it was not probable that the Company would collect substantially all of the contractual obligations from five existing and former operators. As such, the Company reversed $0.7 million of operating expense reimbursements, $0.2 million of contractual rent and $0.5 million of straight-line rent during the year ended December 31, 2022. If lease payments are subsequently deemed probable of collection, the Company will reestablish the receivable which will result in an increase in rental income for such recoveries.
F-16

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Recent Real Estate Acquisitions
The following table summarizes the Company’s acquisitions for the years ended December 31, 2024, 2023 and 2022 (dollars in thousands):
Type of Property
Purchase Price(1)
Initial Annual Cash Rent(2)
Number of Properties
Number of Beds/Units(3)
December 31, 2024
Skilled nursing(4)(6)
$ 712,471  $ 65,924  42  4,508 
Multi-service campuses(4)
90,639  7,467  683 
ALF / ILF(4)
12,749  1,022  102 
Total $ 815,859  $ 74,413  49  5,293 
December 31, 2023
Skilled nursing(4) (5)
$ 169,181  $ 13,764  10  1,256 
Multi-service campuses(5)
25,276  1,916  168 
ALF / ILF 39,318  3,495  241 
Total $ 233,775  $ 19,175  15  1,665 
December 31, 2022
Skilled nursing $ 8,918  $ 815  135 
Multi-service campuses 13,003  1,235  130 
Total $ 21,921  $ 2,050  265 
(1)Purchase price includes capitalized acquisition costs.
(2)Initial annual cash rent represents initial cash rent for the first twelve months.
(3)The number of beds/units includes operating beds at acquisition date.
(4)Includes facilities held in consolidated joint ventures. See Note 12, Variable Interest Entities, for additional information.
(5)One acquisition including three SNFs and one multi-service campus provides for annual fixed increases from $6.8 million in year one to $7.6 million in year two and $8.9 million in year three.
(6)Initial annual cash rent for 11 properties does not consider rent abatement of $0.3 million.

Lease Amendments and Terminations
Ridgeline Lease Termination and NC Jaybird Lease. Effective December 31, 2024, the Company terminated its master lease with affiliates of Ridgeline Properties, LLC (“Ridgeline”). The Company entered into a new master lease (the “NC Jaybird Lease”) with affiliates of Jaybird Senior Living, Inc. (“Jaybird”) with respect to two ALFs in North Carolina previously leased to Ridgeline. The NC Jaybird Lease commenced on January 1, 2025 with an initial term of approximately 12 years, featuring two five-year renewal options and CPI-based rent escalators. Under the NC Jaybird Lease, Jaybird will receive three months of abated rent, followed by 15 months of rent calculated as a percentage of the tenants’ gross revenue. Subsequently, the next twelve months will have a fixed annual cash rent amount of $0.8 million increasing annually based on CPI. Annual rent under the terminated master lease for the two ALFs in North Carolina was $0.8 million. Four facilities which were under the Ridgeline master lease are currently held for sale and two facilities are in the process of transferring operations.
Amended PACS Master Lease. On November 1, 2024, the Company acquired four skilled nursing facilities. The facilities were leased to affiliates of PACS. In conjunction with the acquisition of the four facilities, the Company amended the existing PACS Master Lease to include the four skilled nursing facilities. The PACS Master Lease had a remaining term at the date of amendment of approximately 8 years. Annual cash rent under the amended lease increased by approximately $5.0 million, with $1.1 million in deferred rent over the first twenty-four months to be repaid over twenty-four months, beginning in the third lease year.
Lease Termination and Amended Ensign Lease. Effective September 1, 2024, one SNF in Kansas was removed from a master lease with a skilled nursing operator and the Company terminated the master lease. Annual cash rent under the terminated master lease prior to lease termination was approximately $0.8 million. In connection with the lease termination, the Company amended and extended one existing triple-net master lease with subsidiaries of Ensign to include the one SNF. The amended lease has a remaining term of approximately 15 years with two five-year renewal options and CPI-based rent escalators. Annual cash rent under the applicable Ensign master lease, as amended, increased by approximately $0.6 million.
F-17

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Lease Termination and New Jaybird Lease. Effective August 1, 2024, two ALFs in Illinois were removed from a master lease with a seniors housing operator and the Company terminated the master lease. In connection with the lease termination, the Company entered into a new master lease (the “Jaybird Lease”) with Jaybird with respect to the two ALFs. The new Jaybird Lease commenced on August 1, 2024 with an initial term of approximately 12 years, featuring two five-year renewal options and CPI-based rent escalators. Under the Jaybird Lease, Jaybird will receive three months of abated rent, followed by 15 months of rent calculated as a percentage of the tenants’ gross revenue. Subsequently, the next twelve months will have a fixed annual cash rent amount of $1.8 million with annual CPI-based rent escalators. Annual rent under the terminated master lease was $1.8 million.
New Bayshire Lease. On April 1, 2024, a new master lease with affiliates of Bayshire, LLC (“Bayshire”) commenced to lease one SNF that was previously under a short-term master lease until Bayshire received regulatory approval. The short-term master lease was terminated. The Bayshire master lease had a term of approximately 15 years at the date of the lease, with two five-year renewal options and 3% fixed rent escalators. Initial annual cash rent under the new Bayshire master lease was $2.6 million. The Bayshire lease provides for a rent deferral of $0.4 million in the first year to be repaid in 15 installments beginning in year two.
Amended Eduro Lease and Amended Ensign Lease. On March 1, 2024, operations of two SNFs in Colorado operated by affiliates of Eduro Healthcare, LLC (“Eduro”) were transferred to subsidiaries of Ensign. In connection with the transfer, the Company partially terminated the Eduro master lease and amended one existing triple-net master lease with Ensign to include the two SNFs and extended the initial lease term by 15 years. The applicable Ensign master lease, as amended, had a remaining term at the date of amendment of approximately 20 years with two five-year renewal options and CPI-based rent escalators. Annual cash rent under the applicable Ensign master lease, as amended, increased by approximately $2.1 million and annual cash rent under the Eduro master lease, as amended, decreased by the same amount.
New Embassy Lease and Hillstone Lease Amendment and Termination. Effective January 1, 2024, the Company entered into a new triple-net master lease with Embassy Healthcare Holdings, Inc. (“Embassy”) with respect to one multi-service campus, formerly leased to an affiliate of Hillstone Healthcare, Inc. (“Hillstone”). The Embassy lease had an initial term at the date of the lease of approximately 10 years with two five-year renewal options and CPI-based rent escalators. Annual cash rent under the lease is approximately $0.6 million and the master lease provides Embassy with a partial rent abatement until required authorizations with respect to the ALF portion of the facility are obtained and occupancy levels reach a certain percentage.
On March 24, 2023, the Company amended its master lease with affiliates of Hillstone. In connection with the lease amendment, the Company agreed to defer rent of approximately $0.7 million for 12 months from December 2022 through November 2023 to be repaid as a percentage of adjusted gross revenues of one underlying facility, as defined in the amended lease, beginning January 1, 2025, until deferred rent has been paid in full. On December 31, 2023, the Company terminated its master lease with Hillstone. Annual cash rent under the Hillstone master lease prior to lease termination was approximately $1.3 million. Hillstone paid a lease termination fee of approximately $0.8 million to cover unpaid contractual rent.
Noble NJ Lease Termination and New Ridgeline NJ Lease. On October 24, 2023, the Company entered into a new master lease (the “Ridgeline NJ Lease”) with affiliates of Ridgeline to lease two ALFs in New Jersey which were non-operational and under a short-term lease (the “Noble NJ Lease”) which was terminated in connection with the Ridgeline NJ Lease. The Ridgeline NJ Lease had an initial term at the date of the lease of approximately 10 years from the facility opening date, which was expected to occur in the second quarter of 2024 upon final regulatory approval and final licensing of both facilities, with two five-year renewal options and CPI-based escalators. Annual cash rent under the Ridgeline NJ Lease was approximately $1.0 million beginning on the first day of the second lease year.
Premier Termination and Amended Ridgeline Lease. Effective September 1, 2023, six ALFs in Michigan and North Carolina were removed from the master lease with affiliates of Premier Senior Living, LLC (“Premier”) and the Company terminated the Premier master lease. Annual cash rent under the Premier master lease prior to lease termination was approximately $2.7 million. In connection with the lease termination, the Company amended its existing triple-net master lease with affiliates of Ridgeline with respect to the six ALFs. The Ridgeline lease had a remaining term at the date of the lease amendment of approximately 15 years with two five-year renewal options and CPI-based rent escalators. Annual cash rent under the amended lease increased by approximately $2.7 million. The amended lease provided for $0.2 million in rent abatement and a $0.2 million rent deferral that was required to be repaid beginning in December 2024.
F-18

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Amended Pennant Lease. On July 6, 2023, the Company amended its master lease with affiliates of Pennant (the “Pennant Master Lease”). In connection with the lease amendment, the Company extended the initial lease term. The Pennant Master Lease, as amended, had a remaining term at the date of amendment of approximately 15 years, with two five-year renewal options and CPI-based rent escalators. Annual cash rent under the amended Pennant Master Lease remained unchanged.
Amended Momentum Lease. On April 1, 2023, the Company acquired one SNF. In connection with the acquisition, the Company amended its existing triple-net master lease with affiliates of Momentum Skilled Services (“Momentum”) to include the one SNF and extended the initial lease term. The Momentum master lease, as amended, had a remaining term at the date of amendment of approximately 15 years, with two five-year renewal options and CPI-based rent escalators. Annual cash rent under the amended lease increased by approximately $1.0 million.
Noble VA Lease Termination and New Pennant Lease. Effective March 16, 2023, two ALFs in Wisconsin were removed from a master lease with affiliates of Noble VA Holdings (“Noble VA”) and the Company terminated the applicable Noble VA master lease. Annual cash rent under the applicable Noble VA master lease prior to lease termination was approximately $2.3 million. In connection with the lease termination, the Company entered into a new lease (the “New Pennant Lease”) with Pennant with respect to the two ALFs. The New Pennant Lease had an initial term at the date of the lease of approximately 15 years with two five-year renewal options and CPI-based rent escalators. Annual cash rent under the new lease was approximately $0.8 million and the master lease provides Pennant with three months deferred rent to be repaid before the expiration or termination of the lease.
Noble Partial Lease Termination and New Landmark Leases. In June and August of 2022, one ALF in Florida and one ALF in Maryland were removed from a master lease with affiliates of Noble Senior Services (“Noble”) and the Company amended the applicable Noble master lease to reflect the removal of the two ALFs. Annual cash rent under the applicable Noble master lease decreased by approximately $1.1 million. In connection with the partial lease termination, the Company entered into a lease with Landmark Recovery of Maryland, LLC and Landmark Recovery of Florida, LLC (collectively “Landmark”) to repurpose the facilities to behavioral health treatment centers. Rent under the leases will commence 12 - 18 months following commencement of the lease term or, if earlier, upon Landmark obtaining all licensure, permits, and other required regulatory authorizations with respect to operating the facility. The leases will expire on the 20th anniversary of the rent commencement date and both contain one 10-year renewal option and CPI-based rent escalators.
Pennant Partial Lease Termination and Amended Ensign Master Leases. On April 1, 2022, operations at two ALFs in California and Washington operated by Pennant were transferred to Ensign. In connection with the transfers, the Company amended the Pennant Master Lease to reflect the removal of the two ALFs and amended two existing Ensign Master Leases to include the two ALFs. The applicable Ensign Master Leases, as amended, had a remaining term at the date of amendment of approximately five years and 16 years, respectively, both with three five-year renewal options and CPI-based rent escalators. Annual cash rent under each of the two applicable Ensign Master Leases, as amended, increased by approximately $0.4 million and annual cash rent under the Pennant Master Lease, as amended, decreased by $0.8 million.
On March 1, 2022, operations at one ALF in Arizona operated by affiliates of Pennant were transferred to affiliates of Ensign. In connection with the transfer, the Company amended the Pennant Master Lease to reflect the removal of the ALF and amended an existing Ensign Master Lease to include the one ALF. The applicable Ensign Master Lease, as amended, had a remaining term at the date of amendment of approximately 11 years, with two five-year renewal options and CPI-based rent escalators. Annual cash rent under the applicable Ensign Master Lease, as amended, increased by approximately $0.3 million and annual cash rent under the Pennant Master Lease, as amended, decreased by the same amount.
Amended Eduro Master Lease. On February 1, 2022, the Company acquired one SNF. In conjunction with the acquisition, the Company amended its existing triple-net master lease with affiliates of Eduro to include the one SNF and extended the initial lease term. The Eduro master lease, as amended, had a remaining term at the date of amendment of approximately 12 years, with two five-year renewal options and CPI-based rent escalators. Annual cash rent under the Eduro master lease, as amended, increased by approximately $0.8 million.
F-19

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Amended WLC Master Lease. On March 1, 2022, the Company acquired one multi-service campus. In conjunction with the acquisition, the Company amended its existing triple-net master lease with affiliates of WLC Management Firm, LLC (“WLC”) to include the one multi-service campus. The WLC master lease, as amended, had a remaining term at the date of amendment of approximately 12 years, with two five-year renewal options and CPI-based rent escalators. Annual cash rent under the WLC master lease, as amended, increased by approximately $1.2 million.
4. IMPAIRMENT OF REAL ESTATE INVESTMENTS, ASSETS HELD FOR SALE, NET AND ASSET SALES
During the year ended December 31, 2024, the Company recognized aggregate impairment charges of $42.2 million, of which $18.8 million related to properties held for sale, $9.4 million related to properties held for investment, and $14.0 million related to properties that were sold. During the year ended December 31, 2023, the Company recognized aggregate impairment charges of $36.3 million, of which $26.8 million related to properties held for sale, $8.0 million related to properties held for investment, and $1.5 million related to properties that were sold. During the year ended December 31, 2022, the Company recognized aggregate impairment charges of $79.1 million, of which $14.4 million related to properties held for sale, $19.7 million related to properties held for investment, and $45.0 million related to properties that were sold. These charges are reported in impairment of real estate investments in the consolidated statements of operations.
Impairment of Real Estate Investments Held for Sale
As of December 31, 2024, there were 10 facilities classified as held for sale, all of which have been recorded at the lesser of their carrying value or fair value less estimated costs to sell.
The fair values of the assets held for sale were based on estimated sales prices, which are considered to be Level 3 measurements within the fair value hierarchy. Estimated sales prices were determined using a market approach (comparable sales model), which relies on certain assumptions by management, including: (i) comparable market transactions, (ii) estimated prices per unit, and (iii) binding agreements for sales and non-binding offers to purchase from unrelated third-parties. There are inherent uncertainties in making these assumptions. For the Company’s impairment calculations on assets held for sale during the twelve months ended December 31, 2024, the Company’s fair value estimates primarily relied on a market approach and utilized prices per unit ranging from $7,000 to $116,000, with a weighted average price per unit of $60,000. For the Company’s impairment calculations on assets held for sale during the twelve months ended December 31, 2023, the Company’s fair value estimates primarily relied on a market approach and utilized prices per unit ranging from $8,000 to $85,000, with a weighted average price per unit of $20,000. For the Company’s impairment calculations on assets held for sale during the twelve months ended December 31, 2022, the Company’s fair value estimates primarily relied on a market approach and utilized prices per unit ranging from $20,000 to $85,000, with a weighted average price per unit of $55,000.
Impairment of Real Estate Investments Held for Investment
During the quarter ended December 31, 2024, the Company recognized an impairment charge of $5.0 million related to one ALF with a carrying value of $5.0 million which was non-operational. In January 2025, the Company deeded the improvements back to the ground lessor for no consideration.
During the third quarter of 2024, the Company determined that two ALFs, with a carrying value of $5.0 million, that were classified as held for sale at June 30, 2024 no longer met the held for sale criteria. During the second quarter of 2024, the Company recognized $4.4 million of impairment charges in connection with the write down of the assets’ carrying values to their estimated fair value less costs to sell. The Company reclassified these ALFs out of assets held for sale at their fair value at the date of the decision not to sell of approximately $5.0 million, or a weighted average price per unit of $45,000. During the year ended December 31, 2024, the Company recognized approximately $4.4 million in impairment charges related to these two ALFs.
During the year ended December 31, 2023, the Company recognized an impairment charge of $8.0 million related to one SNF. The Company wrote down its carrying value of $8.7 million to its estimated fair value of $0.7 million, which is included in real estate investments, net on the Company’s consolidated balance sheets. The fair value of the asset was based on comparable market transactions and considered Level 3 measurements within the fair value hierarchy. For the Company’s impairment calculation, the Company’s fair value estimates primarily relied on a market approach and utilized prices per unit of $7,000.
F-20

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
During the year ended December 31, 2022, the Company recognized an impairment charge of $1.7 million related to one SNF. The Company wrote down its carrying value of $2.8 million to its estimated fair value of $1.1 million, which is included in real estate investments, net on the Company’s condensed consolidated balance sheets. The fair value of the asset was based on comparable market transactions and considered Level 3 measurements within the fair value hierarchy. For the Company’s impairment calculation, the Company’s fair value estimates primarily relied on a market approach and utilized prices per unit of $20,000.
During the third quarter of 2022, the Company determined that one ALF, with a carrying value of $4.9 million, that was classified as held for sale at June 30, 2022 no longer met the held for sale criteria. The Company reclassified this ALF out of assets held for sale at its fair value at the date of the decision not to sell of approximately $4.9 million, or a weighted average price per unit of $125,000. During the year ended December 31, 2022, the Company recognized approximately $1.4 million in impairment charges related to this one ALF.
During the fourth quarter of 2022, the Company determined that nine ALFs, with a carrying value of $50.8 million, that were classified as held for sale at September 30, 2022, no longer met the held for sale criteria. The Company reclassified the nine ALFs out of assets held for sale at their fair value at the date of the decision not to sell of approximately $47.8 million. During the year ended December 31, 2022, the Company recognized approximately $16.6 million in impairment charges related to these nine ALFs. The fair value of assets reclassified as real estate investments held for use was based on an income approach using current market conditions and considers matters such as the forecasted operating cash flows, lease coverage ratios, capitalization rates, and, where applicable, terms of recent lease agreements or the results of negotiations with prospective tenants, which are considered to be Level 3 measurements within the fair value hierarchy. There are inherent uncertainties in making these assumptions. For the Company’s impairment calculations, the Company’s fair value estimates primarily relied on an income approach. When utilizing an income approach, assumptions include, but are not limited to, terminal capitalization rates ranging from 7.5% to 8.75% and discount rates ranging from 8.5% to 9.75%.
Asset Sales and Held for Sale Reclassifications
The following table summarizes the Company’s dispositions for the years ended December 31, 2024, 2023 and 2022 (dollars in thousands):
Twelve Months Ended December 31,
2024 2023
2022(1)
Number of facilities 17 5 13
Net sales proceeds(2)
$ 17,715  $ 18,313  $ 57,149 
Net carrying value 19,923  16,095  60,918 
Net (loss) gain on sale $ (2,208) $ 2,218  $ (3,769)
(1)Net sales proceeds, net carrying value and net (loss) gain on sale also reflect a land parcel that was sold during the year ended December 31, 2022, which is not included in the number of facilities.
(2)Net sales proceeds includes $1.0 million of seller financing in connection with the sale of one ALF in January 2024. Net sales proceeds includes $2.0 million of seller financing in connection with the sale of one ALF in June 2023. Net sales proceeds includes $12.0 million of seller financing in connection with the sale of six SNFs and one multi-service campus in September 2022.
F-21

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The following table summarizes the Company’s assets held for sale activity for the years ended December 31, 2024 and 2023 (dollars in thousands):
Net Carrying Value Number of Facilities
December 31, 2022 $ 12,291 
Additions to assets held for sale 47,114  14 
Assets sold (16,095) (5)
Impairment of real estate held for sale (28,299) — 
December 31, 2023 15,011  14
Additions to assets held for sale 104,447  15 
Assets sold (19,923) (17)
Impairment of real estate held for sale (37,266) — 
Assets reclassified to held for investment (5,008) (2)
December 31, 2024 $ 57,261  10 

F-22

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
5. OTHER REAL ESTATE RELATED AND OTHER INVESTMENTS

As of December 31, 2024 and 2023, the Company’s other real estate related investments, inclusive of accrued interest, consisted of the following (dollars in thousands):
Other Real Estate Related Investments:
Facility Count and Type
As of December 31, 2024
Loans Receivable, at Fair Value: SNF Campus ALF ILF
Principal Balance as of December 31, 2024
Fair Value as of December 31, 2024(1)
Fair Value as of December 31, 2023(1)
Weighted Average Contractual Interest Rate(2), (3)
Maturity Date
Mortgage secured loans receivable(4)
62  19  $ 658,400  $ 660,392  $ 156,769  8.8  % 5/31/2025 - 9/30/2039
Mezzanine loans receivable(4)
40  —  82,287  80,612  21,799  12.8  % 7/25/2027 - 12/31/2034
Total $ 740,687  $ 741,004  $ 178,568 
As of December 31, 2024
Principal Balance as of December 31, 2024
Book Value as of December 31, 2024
Book Value as of December 31, 2023
Weighted Average Contractual Interest Rate Maturity Date
Preferred Equity $ 53,782  $ 54,199  $ 1,801  11.1  % N/A
Total $ 53,782  $ 54,199  $ 1,801 
Facility Count and Type
As of December 31, 2024
Financing Receivable, at Fair Value: SNF Campus ALF ILF
Principal Balance as of December 31, 2024
Fair Value as of December 31, 2024(5)
Fair Value as of December 31, 2023
Weighted Average Effective Interest Rate(6)
Maturity Date
Financing Receivable 39  —  $ 95,723  $ 96,004  $ —  12.0  % 11/30/2039
Total $ 95,723  $ 96,004  $ — 
(1)Fair value of mortgage secured loans receivable includes $3.4 million and $1.5 million of accrued interest as of December 31, 2024 and 2023, respectively. Fair value of mezzanine loans receivable includes $0.9 million and $0.2 million of accrued interest as of December 31, 2024 and 2023, respectively.
(2)Rates are net of subservicing fee, if applicable.
(3)Three mortgage secured loans receivable and two mezzanine loans receivable use term secured overnight financing rate (“SOFR”), which are subject to a floor for certain of the loans. Term SOFR used as of December 31, 2024 was 4.34%.
(4)If the Company also has extended mezzanine financing to an affiliate of the borrower under a mortgage loan receivable, the applicable facility counts are included in both respective totals.
(5)Fair value of financing receivable includes $0.3 million of accrued interest for the year ended December 31, 2024.
(6)The Company leased these facilities back to the seller under a 15-year contract, with two five-year renewal options. The agreement provides for an initial contractual cash yield of 11.0% for the first three years, with annual CPI-based escalators beginning in year four, subject to a 3% cap. The agreement provides for deferred payments equal to 2.0% of the contractual cash yield in the first year and 0.5% of the contractual cash yield in the second year. At the time the seller-lessee exercises its purchase options, option proceeds will be used to repay any outstanding deferred payments as well as additional payments such that the Company receives a contractual cash yield of 12.5% on its gross investment in the applicable properties through the option exercise date. If any deferred amounts remain unpaid, beginning in year eight, the deferred amounts are to be repaid in 24 equal monthly payments. The Company has not received notice of exercise for the purchase option period currently open.
F-23

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The following table summarizes the Company’s other real estate related investments activity for the years ended December 31, 2024, 2023, and 2022 (dollars in thousands):
For the Year Ended December 31,
2024
2023
2022
Origination of other real estate related investments $ 607,203  $ 53,834  $ 147,150 
Accrued interest, net 2,998  388  1,165 
Unrealized gain (loss) on other real estate related investments, net 9,045  (6,485) (7,102)
Payments of other real estate related investments (4,412) (25,537) — 
Net change in other real estate related investments $ 614,834  $ 22,200  $ 141,213 
The fair value option is elected on an instrument by instrument basis and must be applied to an entire instrument and is irrevocable once elected. The Company’s primary purpose in electing the fair value option for these instruments was to align with management’s view of the underlying economics of the loans and the manner in which they are managed.
2024 Other Real Estate Related Investment Transactions
On January 1, 2024, the Company closed on the sale of one ALF. In connection with the sale, the Company provided affiliates of the purchaser of the property with a $1.0 million mortgage loan which bears interest at a rate of 9.0%. The mortgage loan is secured by the ALF and is set to mature on January 1, 2027. The mortgage loan may be prepaid in whole before the maturity date. The Company elected the fair value option for the mortgage loan.
On January 25, 2024, the Company extended a $9.8 million mezzanine loan for a portfolio of ten SNFs located in Missouri secured by a pledge of membership interests in an up-tier holding company of the borrower group. The Company participated in the loan alongside a co-lender pursuant to a participation agreement entered into between the Company and the co-lender. Pursuant to such agreement, the Company provided $9.8 million in mezzanine loan proceeds and the co-lender provided the remaining $10.2 million of loan proceeds. As a participant in the loan, and subject to limited exceptions, the Company is entitled to receive its proportionate share of loan payments made by the borrower with each co-lender’s proportionate share being given equal weight. The loan bears interest at term SOFR plus 8.75%, with a term SOFR floor of 6%, payable monthly and net of a 0.75% subservicing fee. Commencing on February 1, 2026, monthly principal payments shall be due. The mezzanine loan is set to mature on July 25, 2027, with two six-month extension options and may (subject to certain restrictions) be prepaid in whole before the maturity date for an exit fee ranging from 1% to 2% of the loan plus unpaid interest payments equal to 24 months (less the amount of monthly interest payments made by the borrower through the date of prepayment). The Company elected the fair value option for the mezzanine loan.
On February 1, 2024, the Company extended a $7.4 million mezzanine loan for one SNF located in California secured by a pledge of membership interests in an up-tier holding company of the borrower group. The loan bears interest at 11.5%, payable monthly. The mezzanine loan is set to mature on January 31, 2029, and may not (subject to certain limited exceptions) be prepaid prior to the date that is 18 months following the loan closing. The Company elected the fair value option for the mezzanine loan.
On February 2, 2024, the Company extended a $35.0 million mezzanine loan for a portfolio of 15 SNFs located in Virginia secured by a pledge of membership interests in an up-tier holding company of the borrower group. The Company participated in the loan alongside a co-lender pursuant to a participation agreement entered into between the Company and the co-lender. Pursuant to such agreement, the Company provided $35.0 million in mezzanine loan proceeds and the co-lender provided the remaining $50.0 million of loan proceeds. As a participant in the loan, and subject to limited exceptions, the Company is entitled to receive its proportionate share of loan payments made by the borrower with each co-lender’s proportionate share being given equal weight. The loan bears interest at term SOFR plus 8.75%, with a term SOFR floor of 6%, payable monthly and net of a 0.75% subservicing fee. Commencing on February 2, 2026, monthly principal payments shall be due. The mezzanine loan is set to mature on August 1, 2027, with two six-month extension options and may (subject to certain restrictions) be prepaid in whole before the maturity date for an exit fee ranging from 1% to 2% of the loan plus unpaid interest payments equal to 18 months (less the amount of monthly interest payments made by the borrower through the date of prepayment). The Company elected the fair value option for the mezzanine loan.
F-24

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
On May 1, 2024, the Company extended a $26.7 million mortgage loan to a skilled nursing real estate owner. The mortgage loan is secured by two SNFs and bears interest at a rate of 9.1%, payable monthly. The mortgage loan is set to mature on May 1, 2031 and includes a one year extension option. The mortgage loan may not be prepaid prior to July 31, 2029, subject to certain limited exceptions. The mortgage loan includes a purchase option with an exercise window that opens during the initial 90-day period of each of the 4th, 5th and 6th loan years, with the purchase option price for the facilities being calculated by dividing the amount of the then annual base rent by an agreed upon lease yield. The Company elected the fair value option for the mortgage loan.
On June 3, 2024, the Company extended a $165.0 million mortgage loan to a regional health care real estate owner. The mortgage loan is secured by eight SNFs located in North Carolina and bears interest at a rate of SOFR plus 4.25%, with a term SOFR floor of 5.15%, payable monthly and net of a 0.25% subservicing fee. Commencing on June 1, 2027, monthly principal payments will be due. The mortgage loan is set to mature on June 1, 2029, and includes two six-month extension options. The mortgage loan may not be prepaid prior to June 1, 2026, subject to certain limited exceptions. The Company elected the fair value option for the mortgage loan. Concurrently with closing, KeyBank National Association purchased a $75.0 million participation in the mortgage loan from the Company. On July 30, 2024, the Company exercised the call option on the $75.0 million secured borrowing at a call purchase price equal to the principal amount plus accrued and unpaid interest and an exit fee of $0.4 million. See Note 7, Debt, for additional information.
On August 1, 2024, the Company extended a $260.0 million mortgage loan to a skilled nursing real estate owner. The loan is secured by a first priority mortgage lien on a real estate portfolio of 37 SNFs, ALFs and multi-service campuses located in various states and bears interest at a fixed rate of 8.4%, payable monthly. The mortgage loan is set to mature on August 1, 2029 and has a 24-month lockout period on prepayment subject to certain exceptions. The mortgage loan may otherwise be prepaid in part or in whole after the 24-month lockout period with agreed upon exit fees, as applicable. The Company elected the fair value option for the mortgage loan.
On October 1, 2024, and in connection with a $55.5 million skilled nursing acquisition, the Company extended a $19.2 million mortgage loan to a skilled nursing operator. The loan is secured by a first priority ground leasehold mortgage lien on a SNF located in Maryland and bears interest at an initial annual rate of 9.35% with annual CPI-based escalators, payable monthly. The mortgage loan has a term of 15 years and is set to mature on September 30, 2039, with two five-year extension options. The mortgage loan provides for a put option, giving the borrower the right to require the lender to purchase the underlying ground leasehold and property associated with the mortgage loan. The exercise window for the put option is between 90 to 30 days prior to the maturity date. The mortgage loan also provides for a purchase option in favor of the Company (subject to certain requirements) with two exercise windows. The first exercise window is on or before October 1, 2026. The second purchase option window opens January 1, 2039, and remains open for 6 months. The Company elected the fair value option for the mortgage loan.
On October 1, 2024, the Company extended a $9.8 million mortgage loan to a skilled nursing real estate owner. The loan is secured by a first priority mortgage lien on a SNF located in Colorado and bears interest at a fixed rate of 8.5%, payable monthly. The mortgage loan is set to mature on September 30, 2034. The mortgage provides a one-year extension option and may (subject to certain restrictions) be prepaid in whole, after the 18th month following the loan closing, for an exit fee ranging from 0% to 2% of the loan plus unpaid interest payments. The Company elected the fair value option for the mortgage loan.
On December 20, 2024, the Company extended a $5.1 million mezzanine loan for one multi service campus located in Maryland secured by a pledge of membership interests in an up-tier holding company of the borrower group. The loan bears interest at a rate of 13%, with annual CPI-based escalators. The mezzanine loan is set to mature on December 31, 2034. The mezzanine loan may not be prepaid in whole or in part prior to maturity. The Company elected the fair value option for the mezzanine loan.
On December 27, 2024, the Company extended an $11.3 million mortgage loan to a skilled nursing real estate owner. The loan is secured by a first priority mortgage lien on one SNF located in Washington and bears interest at a fixed rate of 8.5%. The mortgage loan is set to mature on December 27, 2034. The mortgage provides a one-year extension option and may (subject to certain restrictions) be prepaid in whole, after 18 months, for an exit fee ranging from 0% to 2% of the loan plus unpaid interest payments. The Company elected the fair value option for the mortgage loan.
F-25

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
2023 Other Real Estate Related Investment Transactions
On June 1, 2023, the Company closed on the sale of one ALF. In connection with the sale, the Company provided affiliates of the purchaser of the properties with a $2.0 million mortgage loan which bears interest at a rate of 9.0%. The mortgage loan is secured by the ALF and was set to mature on May 31, 2024. The maturity date was subsequently extended to May 31, 2025. The mortgage loan has a one-year extension option and may be prepaid in whole before the maturity date. The Company elected the fair value option for the mortgage loan.
On June 29, 2023, the Company extended a $26.0 million mortgage loan to a skilled nursing real estate owner. The mortgage loan is secured by one SNF campus and one ILF and bears interest at a rate of 9.0%. The mortgage loan is set to mature on June 29, 2033 and may (subject to certain restrictions) be prepaid in whole before the maturity date for an exit fee ranging from 0% to 3% of the loan plus unpaid interest payments. The Company elected the fair value option for the mortgage loan.
On July 17, 2023, the Company extended a $15.7 million mortgage loan to a skilled nursing real estate owner. The mortgage loan is secured by two SNFs and bears interest at a rate of 9.0%. The mortgage loan is set to mature on August 1, 2028, with one five-year extension option and may (subject to certain restrictions) be prepaid in whole before the maturity date for an exit fee ranging from 2% to 3% of the loan plus unpaid interest payments; provided, however, that no exit fee is payable in connection with the loan being refinanced pursuant to a loan (or loans) provided by Fannie Mae, Freddie Mac, Federal Housing Administration, or a similar governmental authority. The Company elected the fair value option for the mortgage loan.
On September 29, 2023, the Company extended a $3.6 million mortgage loan as part of a larger, multi-tranche real estate secured term loan facility to a skilled nursing real estate owner. The secured term loan was structured with an “A” and a “B” tranche (with the payments on the “B” tranche being subordinate to the “A” tranche pursuant to the terms of a written agreement between the lenders). The Company’s $3.6 million secured mortgage loan constituted the entirety of the “B” tranche with its payments subordinated accordingly and bears interest at a rate of 12.0%. The mortgage loan is secured by three SNFs. The mortgage loan is set to mature on September 29, 2026, with two six-month extension options and may (subject to certain restrictions) be prepaid in whole before the maturity date for an exit fee ranging from 0% to 2% of any proposed financing in connection with the loan being refinanced by the U.S. Department of Housing and Urban Development (“HUD”). The Company elected the fair value option for the mortgage loan.
On November 29, 2023, the Company extended a $6.3 million mortgage loan to an assisted living real estate owner. The mortgage loan is secured by one ALF and bears interest at a rate of 9.9%. The mortgage loan is set to mature on June 1, 2026, with two six-month extension options and may (subject to certain restrictions) be prepaid in whole before the maturity date for an exit fee of 2% of the loan plus unpaid interest payments; provided, however, that no exit fee is payable in connection with the loan being refinanced pursuant to a loan (or loans) provided by Fannie Mae, Freddie Mac, Federal Housing Administration, or a similar governmental authority. The Company elected the fair value option for the mortgage loan.
    On December 15, 2023, a partial payment of $10.5 million was made on one $22.3 million mortgage loan receivable. See below under “2022 Other Real Estate Related Investment Transactions” for further detail. On March 30, 2023, one $15.0 million mezzanine loan was prepaid in full. The $15.0 million mezzanine loan was originated in 2020 for nine skilled nursing facilities secured by membership interests in the borrower, with an annual interest rate of 12%.
2022 Other Real Estate Related Investment Transactions
In June 2022, the Company extended a $75.0 million term loan to a skilled nursing real estate owner as part of a larger, multi-tranche, senior secured term loan facility. The senior secured term loan was structured with an “A” tranche, a “B” tranche, and a “C” tranche (with the “C” tranche being the most subordinate). The Company’s $75.0 million term loan constituted the entirety of the “C” tranche with its payments subordinated accordingly. The senior secured term loan facility is secured by an 18-facility skilled nursing portfolio in the Mid-Atlantic region, operated by a large, regional skilled nursing operator. In connection with the senior secured term loan facility and the borrower’s acquisition of the skilled nursing portfolio, the Company also extended to the borrower group a $25.0 million mezzanine loan. The “C” tranche of the senior secured term loan bears interest at 8.5%, less a servicing fee equal to the positive difference, if any, between the lesser of the contractual interest payment and actual payment of interest made by the borrower and a hypothetical interest payment at a rate of 8.25%, resulting in an effective interest rate of 8.375%. The “C” tranche senior secured term loan is set to mature on June 30, 2027 and may (subject to certain restrictions) be prepaid in whole or in part before the maturity date for an exit fee ranging from 1% to 3% of the loan plus unpaid interest payments through the end of the month of prepayment; provided, however, that no exit fee is payable in connection with portions of the loan being refinanced pursuant to a loan (or loans) provided by or insured by HUD, Federal Housing Administration, or a similar governmental authority.
F-26

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The mezzanine loan bears interest at 11% and is secured by a pledge of membership interests in an up-tier affiliate of the borrower group. The mezzanine loan is set to mature on June 30, 2032, and may (subject to certain restrictions) be prepaid in whole or in part before the maturity date, commencing on June 30, 2029, for an exit fee ranging from 1% to 3% of the loan plus unpaid interest payments through the date of prepayment. The “C” tranche senior secured term loan and mezzanine loan both require monthly interest payments. The Company elected the fair value option for both the “C” tranche term loan and the mezzanine loan.
In August 2022, the Company extended a $22.3 million term loan as part of a larger, multi-tranche real estate secured term loan facility to a skilled nursing real estate owner. The secured term loan was structured with an “A” and a “B” tranche (with the payments on the “B” tranche being subordinate to the “A” tranche pursuant to the terms of a written agreement between the lenders). The Company’s $22.3 million secured term loan constituted the entirety of the “B” tranche with its payments subordinated accordingly. The secured term loan is primarily secured by five skilled nursing facilities, four of which are operated by an existing operator and one of which is operated by a large, regional skilled nursing operator. The “B” tranche secured term loan is set to mature on August 1, 2025, with two one-year extension options and may (subject to certain restrictions) be prepaid in whole or in part before the maturity date for an exit fee ranging from 2% to 3% of the loan plus unpaid interest payments; provided, however, that no exit fee is payable in connection with portions of the loan being refinanced pursuant to a loan (or loans) provided by or insured by HUD, Federal Housing Administration, or a similar governmental authority. The "B" tranche secured term loan bears interest at a rate based on term secured overnight financing rate, calculated as a fraction, with the numerator being the difference between (i) the monthly payment of interest of term SOFR plus a 4.25% spread and (ii) the amount of such monthly payment of interest of term SOFR plus a 2.75% spread, and with the denominator being the average daily balance of the outstanding principal amount during the applicable month, with such fraction expressed as a percentage and annualized, with a term SOFR floor of 1.0% and less a subservicing fee of 50% over 8.25%. The “B” tranche secured term loan requires monthly interest payments. The Company elected the fair value option for the “B” tranche secured term loan. In December 2023, in accordance with the terms and conditions set forth in the loan agreement, the borrower elected to cause one of the skilled nursing facilities to be released from the loan, and in connection with the same, the borrower partially prepaid the loan in the amount of $10.5 million and in December 2024, the borrower elected to cause another skilled nursing facility to be released from the loan and partially prepaid the loan in the amount of $4.4 million.
In September 2022, the Company extended a $24.9 million term loan as part of a larger, multi-tranche real estate secured term loan facility to a skilled nursing real estate owner. The secured term loan was structured with an “A” and a “B” tranche (with the payments on the “B” tranche being subordinate to the “A” tranche pursuant to the terms of a written agreement between the lenders). The Company’s $24.9 million secured term loan constituted the entirety of the “B” tranche with its payments subordinated accordingly. The secured term loan is primarily secured by four skilled nursing facilities operated by an operator in the Southeast. The “B” tranche secured term loan is set to mature on September 8, 2025, with two one-year extension options and may (subject to certain restrictions) be prepaid in whole or in part before the maturity date for an exit fee ranging from 1% to 3% of the loan plus unpaid interest payments; provided, however, that no exit fee is payable in connection with portions of the loan being refinanced pursuant to a loan (or loans) provided by or insured by the United States Department of Housing and Urban Development, Federal Housing Administration, or a similar governmental authority. The “B” tranche secured term loan provides for an earn-out advance of $4.7 million if certain conditions are met. During the fourth quarter of 2024, the conditions for the earn-out were met and the $4.7 million was funded. The "B" tranche secured term loan bears interest at a rate based on term SOFR, calculated as a fraction, with the numerator being the difference between (i) the monthly payment of interest of term SOFR plus a 4.50% spread and (ii) the amount of such monthly payment of interest of term SOFR plus a 2.85% spread, and with the denominator being the average daily balance of the outstanding principal amount during the applicable month, with such fraction expressed as a percentage and annualized, with a term SOFR floor of 1.0% and less a subservicing fee of 100% over 9.00%. The “B” tranche secured term loan requires monthly interest payments. The Company elected the fair value option for the “B” tranche secured term loan.
Preferred Equity Investments
On June 3, 2024, the Company funded a $9.0 million preferred equity investment in an uptier parent entity of the borrower under the $165.0 million mortgage loan described above under “2024 Other Real Estate Related Investment Transactions.” The Company's initial contractual yield on its preferred equity investment is 11%. Prepayment of the preferred equity investment is restricted, subject to certain carveouts, prior to the senior mortgage loan being paid off in full.
F-27

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
On August 1, 2024, the Company funded a $43.0 million preferred equity investment in an uptier holding company of the borrowers under the $260.0 million mortgage loan described above under “2024 Other Real Estate Related Investment Transactions.” The Company's initial contractual yield on its preferred equity investment is 11%.
In December 2023, the Company completed a $1.8 million preferred equity investment in E3 Acquisition, LLC, which owns the borrowers under the $3.6 million mortgage loan noted above under “2023 Other Real Estate Related Investment Transactions.” The preferred equity investment yields a return of 15% calculated on the outstanding carrying value of the investment. The preferred equity investment is expected to be repaid with proceeds from the refinancing of the Company’s $3.6 million mortgage loan with HUD, provided, however, that if the repayment occurs sooner than 15 months from the investment date, the Company will receive the amount had the preferred equity investment remained outstanding for the full 15 months.
Financing Receivable
On December 5, 2024, the Company invested $95.7 million, exclusive of transaction costs, to acquire a portfolio of 46 properties in Illinois in a sale and leaseback transaction with affiliates of Cascade Capital Partners, LLC (“Cascade”). In connection with the transaction, the Company entered into a new triple-net master lease with Cascade and provided Cascade with options to repurchase the properties, structured over multiple tranches, with various option window start dates, beginning December 1, 2024, and open through the remainder of the 15-year term. As such, the Company determined that the sale and leaseback transaction met the accounting criteria to be presented as a financing receivable on its consolidated balance sheets and recorded interest income from financing receivable on its consolidated statements of operations. Interest income is based on an imputed interest rate over the term of the applicable financing arrangement and as a result the interest recognized in any particular period will not equal the cash payments from the agreement in that period. Cash received from the financing receivable was $0.7 million during the year ended December 31, 2024. The Company elected the fair value option for the financing receivable.
Other Loans Receivables
As of December 31, 2024 and 2023, the Company’s other loans receivable, included in prepaid expenses and other assets, net on the Company’s consolidated balance sheets, consisted of the following (dollars in thousands):
As of December 31, 2024
Investment
Principal Balance as of December 31, 2024
Book Value as of December 31, 2024
Book Value as of December 31, 2023
Weighted Average Contractual Interest Rate Maturity Date
Other loans receivable $ 21,979  $ 22,010  $ 17,156  9.0  % 9/30/2025 - 12/31/2027
Expected credit loss —  (6,994) (2,094)
Total $ 21,979  $ 15,016  $ 15,062 
The following table summarizes the Company’s other loans receivable activity for the years ended December 31, 2024, 2023 and 2022 (dollars in thousands):
For the Year Ended December 31,
2024
2023
2022
Origination of loans receivable $ 4,985  $ 8,486  $ 14,500 
Principal payments (100) (988) (6,307)
Accrued interest, net (31) 58  (4)
Provision for loan losses, net (4,900) —  (3,844)
Net (decrease) increase in other loans receivable $ (46) $ 7,556  $ 4,345 
F-28

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Expected credit losses and recoveries are recorded in provision for loan losses, net in the consolidated statements of operations. During the year ended December 31, 2024, the Company recorded a 4.9 million expected credit loss related to one other loan receivable with a principal balance of 4.9 million that has been placed on non-accrual status. During the year ended December 31, 2023, the Company had no additional expected credit loss and did not consider any loan receivable investments to be impaired. During the year ended December 31, 2022, the Company recorded a $4.6 million expected credit loss related to two other loans receivable that have been placed on non-accrual status, including an unfunded loan commitment of $0.4 million, net of a loan loss recovery of $0.8 million related to a loan previously written-off. During the year ended December 31, 2022, the Company fully reserved and wrote-off $2.5 million, related to one other loan receivable, in connection with the sale of six SNFs and one multi-service campus.
The following table summarizes the interest and other income recognized from the other real estate related investments, other loans receivable, and other investments during the years ended December 31, 2024, 2023 and 2022 (dollars in thousands):
For the Year Ended December 31,
Investment 2024 2023 2022
Mortgage secured loans receivable $ 35,972  $ 13,329  $ 4,853 
Mezzanine loans receivable 9,456  3,683  3,489 
Preferred equity investments 2,826  18  — 
Other loans receivable 1,227  847  284 
Financing receivable 1,009  —  — 
Other(1)
17,535  1,294  — 
Total $ 68,025  $ 19,171  $ 8,626 
(1)Other income is comprised primarily of interest income on money market funds.

6. FAIR VALUE MEASUREMENTS
The Company determines fair value based on quoted prices when available or through the use of alternative approaches, such as discounting the expected cash flows using market interest rates commensurate with the credit quality and duration of the investment. GAAP guidance defines three levels of inputs that may be used to measure fair value:

Level 1 – Quoted prices in active markets for identical assets and liabilities that the reporting entity has the ability to access at the measurement date.

Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability or can be corroborated with observable market data for substantially the entire contractual term of the asset or liability.

Level 3 – Unobservable inputs reflect the entity’s own assumptions about the assumptions that market participants would use in the pricing of the asset or liability and are consequently not based on market activity, but rather through particular valuation techniques.

The determination of where an asset or liability falls in the hierarchy requires significant judgment and considers factors specific to the asset or liability. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company evaluates its hierarchy disclosures each quarter and, depending on various factors, it is possible that an asset or liability may be classified differently from quarter to quarter. Changes in the type of inputs may result in a reclassification for certain assets. The Company does not expect that changes in classifications between levels will be frequent.
F-29

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Items Measured at Fair Value on a Recurring Basis
The following table presents information about the Company’s assets measured at fair value on a recurring basis as of December 31, 2024 and 2023, aggregated by the level in the fair value hierarchy within which those instruments fall (dollars in thousands):
Level 1 Level 2 Level 3
Balance as of December 31, 2024
Assets:
Mortgage secured loans receivable $ —  $ —  $ 660,392  $ 660,392 
Mezzanine loan receivable —  —  80,612  80,612 
Financing receivable —  —  96,004  96,004 
Total $ —  $ —  $ 837,008  $ 837,008 
Level 1 Level 2 Level 3
Balance as of December 31, 2023
Assets:
Mortgage secured loans receivable $ —  $ —  $ 156,769  $ 156,769 
Mezzanine loans receivable —  —  21,799  21,799 
Total $ —  $ —  $ 178,568  $ 178,568 
The following table details the Company’s assets measured at fair value on a recurring basis using Level 3 inputs (dollars in thousands):
Investments in Real Estate Secured Loans Investments in Mezzanine Loans Investment in Financing Receivable
Balance as of December 31, 2023
$ 156,769  $ 21,799  $ — 
Originations 497,916  57,287  95,723 
Accrued interest, net 1,965  635  281 
Unrealized gains on other real estate related investments, net 8,154  891  — 
Payments (4,412) —  — 
Balance as of December 31, 2024
$ 660,392  $ 80,612  $ 96,004 
Real estate secured and mezzanine loans receivable: The fair value of the secured and mezzanine loans receivables were estimated using an internal valuation model that considered the expected future cash flows of the investment, the underlying collateral value, market interest rates and other credit enhancements. As such, the Company classifies each instrument as Level 3 due to the significant unobservable inputs used in determining market interest rates for investments with similar terms. During the year ended December 31, 2024, the Company recorded a net unrealized gain of $9.0 million on its secured and mezzanine loans receivable, to bring the interest rates in line with market rates. Future changes in market interest rates or collateral value could materially impact the estimated discounted cash flows that are used to determine the fair value of the secured and mezzanine loans receivable. During the year ended December 31, 2023, the Company recorded a net unrealized loss of $6.5 million on the Company’s secured and mezzanine loans receivable due to rising interest rates, an origination fee paid, a reversal of a previously recognized unrealized loss related to the repayment of one mezzanine loan receivable, and the partial repayment of one mortgage loan receivable. As of December 31, 2024 and 2023, the Company did not have any loans that were 90 days or more past due.
The following table shows the quantitative information about unobservable inputs related to the Level 3 fair value measurements comprising the investments in secured and mezzanine loans receivables as of December 31, 2024:
Type
Book Value as of December 31, 2024
Valuation Technique Unobservable Inputs
Range
Mortgage secured loans receivable $ 660,392  Discounted cash flow Discount Rate
8% - 14%
Mezzanine loan receivable 80,612  Discounted cash flow Discount Rate
12% - 14%
F-30

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Financing receivable: The fair value is determined using a widely accepted valuation technique, discounted cash flow analysis on the expected cash flows. The discount rate used to value the future cash inflows of the financing receivable at December 31, 2024 was 12.0%.
For the year ended December 31, 2024, there were no classification changes in assets and liabilities with Level 3 inputs in the fair value hierarchy.
Items Measured at Fair Value on a Non-Recurring Basis
Real Estate Investments: The Company performs quarterly impairment review procedures, primarily through continuous monitoring of events and changes in circumstances that could indicate the carrying value of its real estate assets may not be recoverable. The Company estimates fair values using Level 3 inputs and uses a combined income and market approach. Specifically, the fair value of the real estate investment is based on current market conditions and considers matters such as the forecasted operating cash flows, lease coverage ratios, capitalization rates, comparable sales data, and, where applicable, contracts or the results of negotiations with purchasers or prospective purchasers. For the years ended December 31, 2024, 2023 and 2022, the Company recorded impairment charges of $42.2 million, $36.3 million and $79.1 million, respectively. See Note 4, Impairment of Real Estate Investments, Assets Held for Sale, Net and Asset Sales, for additional information.
Items Disclosed at Fair Value
Considerable judgment is necessary to estimate the fair value disclosure of financial instruments. The estimates of fair value presented herein are not necessarily indicative of the amounts that could be realized upon disposition of the financial instruments. A summary of the face value, carrying amount and fair value of the Company’s preferred equity investments and the Notes (as defined in Note 7, Debt, below) as of December 31, 2024 and 2023 using Level 2 inputs is as follows (dollars in thousands):  
  December 31, 2024 December 31, 2023
Level Face
Value
Carrying
Amount
Fair
Value
Face
Value
Carrying
Amount
Fair
Value
Financial assets:
Preferred equity investments 3 $ 53,782  $ 54,199  $ 54,199  $ 1,782  $ 1,801  $ 1,801 
Financial liabilities:
Senior unsecured notes payable 2 $ 400,000  $ 396,927  $ 381,812  $ 400,000  $ 396,039  $ 362,500 
Cash and cash equivalents, accounts and other receivables, accounts payable, and accrued liabilities: The carrying values for these instruments approximate their fair values due to the short-term nature of these instruments.
Preferred equity investments: The fair values of the preferred equity investments were estimated using an internal valuation model that considered the expected future cash flows of the investments, the underlying collateral value, market interest rates and other credit enhancements. The Company utilized discount rates ranging from 11% to 15% in its fair value calculations. As such, the Company classifies these instruments as Level 3.
Senior unsecured notes payable: The fair value of the Notes was determined using third-party quotes derived from orderly trades.
Unsecured revolving credit facility and senior unsecured term loan: The fair values approximate their carrying values as the interest rates are variable and approximate prevailing market interest rates and spreads for similar debt arrangements.

F-31

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
7. DEBT
The following table summarizes the balance of the Company’s indebtedness as of December 31, 2024 and 2023 (dollars in thousands):
December 31, 2024 December 31, 2023
Principal Deferred Carrying Principal Deferred Carrying
Amount Loan Fees Amount Amount Loan Fees Amount
Senior unsecured notes payable $ 400,000  $ (3,073) $ 396,927  $ 400,000  $ (3,961) $ 396,039 
Senior unsecured term loan —  —  —  200,000  (441) 199,559 
Unsecured revolving credit facility(1)
—  —  —  —  —  — 
$ 400,000  $ (3,073) $ 396,927  $ 600,000  $ (4,402) $ 595,598 
(1)Deferred financing fees are included in deferred financing costs, net on the balance sheet, and not reflected as a reduction to the unsecured revolving credit facility.
Senior Unsecured Notes Payable
2028 Senior Notes. On June 17, 2021, the Company’s wholly owned subsidiary, CTR Partnership, L.P. (the “Operating Partnership”), and its wholly owned subsidiary, CareTrust Capital Corp. (together with the Operating Partnership, the “Issuers”) completed a private offering of $400.0 million aggregate principal amount of 3.875% Senior Notes due 2028 (the “Notes”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A and to non-U.S. persons outside the United States in reliance on Regulation S under the Securities Act of 1933, as amended. The Notes were issued at par, resulting in gross proceeds of $400.0 million and net proceeds of approximately $393.8 million after deducting underwriting fees and other offering expenses. The Notes mature on June 30, 2028. The Notes accrue interest at a rate of 3.875% per annum payable semiannually in arrears on June 30 and December 30 of each year, commencing on December 30, 2021.
The Issuers may redeem some or all of the Notes at any time prior to March 30, 2028 at a price equal to 100% of the principal amount of the Notes redeemed plus accrued and unpaid interest on the Notes, if any, to, but not including, the redemption date, plus a “make-whole” premium. At any time on or after March 30, 2028, the Issuers may redeem some or all of the Notes at a redemption price equal to 100% of the principal amount of the Notes redeemed plus accrued interest on the Notes, if any, to, but not including, the redemption date. If certain changes of control of the Company occur, the Issuers will be required to make an offer to holders of the Notes to repurchase their Notes at a price of 101% of their principal amount plus accrued and unpaid interest, if any, to, but not including, the repurchase date.
The obligations under the Notes are fully and unconditionally guaranteed, jointly and severally, on an unsecured basis, by the Company and all of CareTrust’s existing and future subsidiaries (other than the Issuers) that guarantee obligations under the Amended Credit Facility (as defined below); provided, however, that such guarantees are subject to automatic release under certain customary circumstances.
The indenture governing the Notes contains customary covenants such as limiting the ability of the Company and its restricted subsidiaries to: incur or guarantee additional indebtedness; incur or guarantee secured indebtedness; pay dividends or distributions on, or redeem or repurchase, capital stock; make certain investments or other restricted payments; sell assets; enter into transactions with affiliates; merge or consolidate or sell all or substantially all of their assets; and create restrictions on the ability of the Issuers and their restricted subsidiaries to pay dividends or other amounts to the Issuers. The indenture governing the Notes also requires the Company and its restricted subsidiaries to maintain a specified ratio of unencumbered assets to unsecured indebtedness. These covenants are subject to a number of important and significant limitations, qualifications and exceptions. The indenture governing the Notes also contains customary events of default.
As of December 31, 2024, the Company was in compliance with all applicable financial covenants under the indenture governing the Notes.

Unsecured Revolving Credit Facility and Term Loan
On December 18, 2024, the Operating Partnership, as the borrower, the Company, as guarantor, CareTrust GP, LLC, and certain of the Operating Partnership’s wholly owned subsidiaries, entered into a third amended and restated credit and guaranty agreement with KeyBank National Association, as administrative agent, an issuing bank and swingline lender (as amended from time to time, the “Third Amended Credit Agreement”).
F-32

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The Third Amended Credit Agreement, which amends and restates the Second Amended Credit Agreement (as defined below) provides for an upsized unsecured revolving credit facility (the “Third Amended Revolving Facility”) with revolving commitments in an aggregate principal amount of $1.2 billion, including a letter of credit subfacility for 10% of the then available revolving commitments and a swingline loan subfacility for 10% of the then available revolving commitments. Future borrowings under the Third Amended Revolving Facility will be used for working capital purposes, for capital expenditures, to fund acquisitions and for general corporate purposes.
On December 16, 2022, the Operating Partnership, as the borrower, the Company, as guarantor, CareTrust GP, LLC, and certain of the Operating Partnership’s wholly owned subsidiaries, entered into a second amended and restated credit and guaranty agreement with KeyBank National Association, as administrative agent, an issuing bank and swingline lender (as amended from time to time, the “Second Amended Credit Agreement”). The Second Amended Credit Agreement, which amends and restates the Company’s amended and restated credit and guaranty agreement, dated as of February 8, 2019 (as amended, the “Prior Credit Agreement”) provided for: (i) an unsecured revolving credit facility (the “Prior Revolving Facility”) with revolving commitments in an aggregate principal amount of $600.0 million, including a letter of credit subfacility for 10% of the then available revolving commitments and a swingline loan subfacility for 10% of the then available revolving commitments and (ii) the continuation of the unsecured term loan credit facility which was previously extended under the Prior Credit Agreement (the “Term Loan” and together with the Prior Revolving Facility, the “Second Amended Credit Facility”) in an aggregate principal amount of $200.0 million. Future borrowings under the Second Amended Credit Facility will be used for working capital purposes, for capital expenditures, to fund acquisitions and for general corporate purposes.
On October 10, 2023, the Operating Partnership, the Company, CareTrust GP, LLC, certain of the Operating Partnership’s wholly owned subsidiaries and KeyBank National Association entered into the First Amendment to the Second Amended Credit Agreement (the “First Amendment”). The First Amendment restates the definition of Consolidated Total Asset Value to include net proceeds from at-the-market forward commitments executed but not yet closed as of the relevant date as if such proceeds had actually been received.
The interest rates applicable to loans under the Third Amended Revolving Facility are, at the Operating Partnership’s option, equal to either a base rate plus a margin ranging from 0.05% to 0.55% per annum or Adjusted Term SOFR or Adjusted Daily Simple SOFR (each as defined in the Third Amended Credit Agreement) plus a margin ranging from 1.05% to 1.55% per annum based on the debt to asset value ratio of the Company and its consolidated subsidiaries (subject to decrease at the Operating Partnership’s election if the Company obtains certain specified investment grade ratings on its senior long-term unsecured debt). The interest rates applicable to loans under the Term Loan were, at the Operating Partnership’s option, equal to either a base rate plus a margin ranging from 0.50% to 1.20% per annum or Adjusted Term SOFR or Adjusted Daily Simple SOFR plus a margin ranging from 1.50% to 2.20% per annum based on the debt to asset value ratio of the Company and its consolidated subsidiaries (subject to decrease at the Operating Partnership’s election if the Company obtains certain specified investment grade ratings on its senior long-term unsecured debt). In addition, the Operating Partnership will pay a facility fee on the revolving commitments under the Third Amended Revolving Facility ranging from 0.15% to 0.35% per annum, based on the debt to asset value ratio of the Company and its consolidated subsidiaries (unless the Company obtains certain specified investment grade ratings on its senior long-term unsecured debt and the Operating Partnership elects to decrease the applicable margin as described above, in which case the Operating Partnership will pay a facility fee on the revolving commitments ranging from 0.125% to 0.30% per annum based on the credit ratings of the Company’s senior long-term unsecured debt).
On September 19, 2024 (the “Prepayment Date”), the Company elected to prepay all $200.0 million aggregate principal amount of their outstanding Term Loan. The Term Loan was prepaid at the principal amount of the Term Loan, plus accrued and unpaid interest thereon up to, but not including, the Prepayment Date. During the year ended December 31, 2024, the Company recorded a loss on extinguishment of debt of $0.3 million related to the write-off of deferred financing costs associated with the prepayment of the Term Loan. As of December 31, 2024, the Operating Partnership had no borrowings outstanding under the Third Amended Revolving Facility.
The Third Amended Revolving Facility has a maturity date of February 9, 2029, and includes, at the sole discretion of the Operating Partnership, two six-month extension options.
The Third Amended Credit Facility is guaranteed, jointly and severally, by the Company and its wholly owned subsidiaries that are party to the Third Amended Credit Agreement (other than the Operating Partnership).
F-33

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The Third Amended Credit Agreement contains customary covenants that, among other things, restrict, subject to certain exceptions, the ability of the Company and its subsidiaries to grant liens on their assets, incur indebtedness, sell assets, make investments, engage in acquisitions, mergers or consolidations, amend organizational documents and pay certain dividends and other restricted payments. The Third Amended Credit Agreement requires the Company to comply with financial maintenance covenants to be tested quarterly, consisting of a maximum debt to asset value ratio, a minimum fixed charge coverage ratio, a minimum tangible net worth, a maximum secured debt to asset value ratio, a maximum unsecured debt to unencumbered properties asset value ratio and a minimum unsecured interest coverage ratio. The Third Amended Credit Agreement also contains certain customary events of default, including the failure to make timely payments under the Third Amended Credit Facility or other material indebtedness, the failure to satisfy certain covenants (including the financial maintenance covenants), the occurrence of change of control and specified events of bankruptcy and insolvency.
As of December 31, 2024, the Company was in compliance with all applicable financial covenants under the Third Amended Credit Agreement.
Secured Borrowing
On June 3, 2024, KeyBank National Association purchased a $75.0 million undivided participation interest in a $165.0 million mortgage loan from the Company (see Note 5, Other Real Estate Related and Other Investments, for additional information), which bore interest at a rate of SOFR, with a term SOFR floor of 3.00%, plus 2.5% or 2.25%, depending on the debt yield of the loan, and payable monthly. As the transaction did not qualify as a sale in accordance with GAAP, the Company recorded the participation interest as a secured borrowing in the amount of $75.0 million in the consolidated balance sheet. The participating interest could be prepaid in whole before the maturity date for an exit fee of up to 0.50% of the loan plus unpaid interest. The participation interest provided for a put option, subject to certain restrictions, and a call option for the then-outstanding loan amount plus accrued and unpaid interest. On July 30, 2024, the Company exercised the call option on the $75.0 million secured borrowing and recorded a loss on extinguishment of debt of $0.4 million related to the exit fee. The exit fee is included in loss on extinguishment of debt in the consolidated statements of operations.
Schedule of Debt Maturities
As of December 31, 2024, the Company’s debt maturities were (dollars in thousands):  
Year
Amount
2025 $ — 
2026 — 
2027 — 
2028 400,000 
2029 — 
Thereafter — 
  $ 400,000 

8. EQUITY AND REDEEMABLE NONCONTROLLING INTEREST
Common Stock
Public Offering of Common Stock—On November 1, 2024, the Company completed an underwritten public offering of 15.9 million newly issued shares of its common stock at a price of $32.00, resulting in gross proceeds of $507.8 million. The proceeds were used to fund acquisitions during the fourth quarter of 2024.
At-The-Market Offering—On August 29, 2024, the Company entered into a new equity distribution agreement to issue and sell, from time to time, up to $750.0 million in aggregate offering price of its common stock through an “at-the-market” equity offering program (the “New ATM Program”) and terminated its previous $500.0 million “at-the-market” equity offering program (together, with all previous at-the-market equity offering programs, the “Previous ATM Programs” and together with the New ATM Program, the “ATM Program”). In addition to the issuance and sale of shares of its common stock, the ATM Program also provides for the ability to enter into one or more forward sales agreements (each, an “ATM forward contract”) with sales agents for the sale of the Company’s shares of common stock under the ATM Program.
F-34

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The Company expects to fully physically settle forward equity sales by delivery of shares of common stock to the forward purchaser and receive cash proceeds upon one or more settlement dates, which are typically a one-year term, at the Company’s discretion, prior to the final settlement date, at which time the Company expects to receive aggregate net cash proceeds at settlement equal to the number of shares sold on a forward basis multiplied by the relevant forward price per share. The weighted average forward sale price that the Company expects to receive upon physical settlement will be subject to adjustment for (i) a floating interest rate factor equal to a specified daily rate less a spread, (ii) the forward purchaser’s stock borrowing costs and (iii) scheduled dividends through the settlement. There were no outstanding ATM forward contracts that had not settled as of December 31, 2024.
The following tables summarize ATM Program activity (or activity under any predecessor at-the-market equity offering programs) for the years ended December 31, 2024, 2023 and 2022 (in thousands, except per share amounts):
For the Year Ended December 31,
2024 2023 2022
Number of shares 40,986  30,869  2,405 
Average sales price per share $ 26.35  $ 20.86  $ 20.00 
Gross proceeds(1)
$ 1,079,852  $ 643,802  $ 48,100 
(1)Total gross proceeds is before $13.4 million, $8.3 million, and $0.6 million of commissions paid to the sales agents and forward adjustments during the years ended December 31, 2024, 2023 and 2022, respectively, under the ATM Program. In addition, total gross proceeds is before other costs related to the ATM Program.
As of December 31, 2024, the Company had $440.1 million available for future issuances under the ATM Program. See Note 15, Subsequent Events, for additional information on the Company’s ATM Program subsequent to December 31, 2024.
F-35

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Dividends on Common Stock — The following table summarizes the cash dividends per share of common stock declared by the Company’s board of directors for 2024, 2023 and 2022 (dollars in thousands, except per share amounts):
For the Three Months Ended
2024 March 31, June 30, September 30, December 31,
Dividends declared per share $ 0.29  $ 0.29  $ 0.29  $ 0.29 
Dividends payment date April 15, 2024 July 15, 2024 October 15, 2024 January 15, 2025
Dividends payable as of record date $ 41,192  $ 44,721  $ 49,721  $ 54,388 
Dividends record date March 28, 2024 June 28, 2024 September 30, 2024 December 31, 2024
2023
Dividends declared per share $ 0.28  $ 0.28  $ 0.28  $ 0.28 
Dividends payment date April 14, 2023 July 14, 2023 October 13, 2023 January 12, 2024
Dividends payable as of record date[1]
$ 27,846  $ 27,853  $ 32,403  $ 36,531 
Dividends record date March 31, 2023 June 30, 2023 September 29, 2023 December 29, 2023
2022
Dividends declared per share $ 0.275  $ 0.275  $ 0.275  $ 0.275 
Dividends payment date April 15, 2022 July 15, 2022 October 14, 2022 January 13, 2023
Dividends payable as of record date[1]
$ 26,691  $ 26,683  $ 26,683  $ 27,386 
Dividends record date March 31, 2022 June 30, 2022 September 30, 2022 December 30, 2022
(1)Dividends payable includes dividends on performance stock awards that will be paid if and when the shares subject to such awards vest if deemed probable of meeting their performance condition.
Redeemable Noncontrolling Interest
Arrangements with noncontrolling interest holders are assessed for appropriate balance sheet classification based on the redemption and other rights held by the noncontrolling interest holder. One of the Company’s noncontrolling interest holders has the ability to put its equity interest to the Company during specified option exercise periods, subject to certain conditions. The put option is payable in cash and subject to changes in redemption value. Accordingly, the Company records the redeemable noncontrolling interest outside of permanent equity. The redeemable noncontrolling interest is adjusted for additional contributions and distributions and the proportionate share of the net earnings or losses. When the redemption of the noncontrolling interest becomes probable, the Company will record the redeemable noncontrolling interest at the greater of its carrying amount or redemption value at the end of each reporting period by making an election either to accrete changes in the redemption value of the redeemable noncontrolling interest over the period from the date it is probable of exercise to the earliest redemption date or to recognize the entire adjustment on the date redemption becomes probable. In addition to the rights of the redeemable noncontrolling interest holder, the Company has the ability to call the interest of the noncontrolling interest holder during specified option exercise periods.
As of December 31, 2024, the redeemable noncontrolling interest did not meet the conditions for redemption.
9. STOCK-BASED COMPENSATION
All stock-based awards are subject to the terms of the CareTrust REIT, Inc. and CTR Partnership, L.P. Incentive Award Plan (the “Plan”). The Plan provides for the granting of stock-based compensation, including stock options, restricted stock, performance awards, restricted stock units, relative total stockholder return-based stock awards and other incentive awards to officers, employees and directors in connection with their employment with or services provided to the Company. Under the Plan, 5,000,000 shares have been authorized for awards.
F-36

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Under the Plan, restricted stock awards (“RSAs”) vest in equal annual installments over a three year period for the RSAs granted after 2020 and a four year period for the RSAs granted in 2020. RSAs granted to non-employee members of the board of directors (“Board Awards”) vest in full on the earlier to occur of the Company’s next Annual Meeting of Stockholders or one year. Performance stock awards (“PSAs”) granted were subject to both time and performance based conditions and vest over a one-to three year period for PSAs granted in 2021 and over a one-to-four year period for PSAs granted in 2020. The amount of such PSAs that ultimately vested was dependent on the Company’s Normalized Funds from Operations (“NFFO”) per share, as defined by the Compensation Committee, meeting or exceeding a specified per share amount for the applicable vesting period. Relative total shareholder return units (“TSR Units”) granted since 2021 are subject to both time and market based conditions and cliff vest after a three-year period. The amount of such market awards that will ultimately vest is dependent on the Company’s total shareholder return (“TSR”) performance relative to a custom TSR peer group consisting of other publicly traded healthcare REITs and will range from 0% to 200% of the TSR Units initially granted. The RSAs, PSAs, and Board Awards are valued on the date of grant based on the closing price of the Company’s common stock, while the TSR Units are valued on the date of grant using a Monte Carlo valuation model. The vesting of certain awards may accelerate, as defined in the grant agreement, upon retirement, a change in control or other events.
The following table summarizes the status of the restricted stock award and performance award activity for the year ended December 31, 2024:
Shares Weighted Average Share Price
Unvested balance at December 31, 2023 510,596  $ 21.01 
Granted:
RSAs 225,815  27.38 
Board Awards 21,712  23.95 
Vested (169,963) 20.68 
Forfeited (35,161) 20.48 
Unvested balance at December 31, 2024 552,999  $ 23.86 
As of December 31, 2024, the weighted-average remaining vesting period of such awards was 1.9 years.
The following table summarizes the Company’s RSA and Board Award grants during the year ended December 31, 2024 (dollars in thousands, except per share amounts):
Grants Vested
Shares Weighted Average Share Price Grant Date Fair Value Shares Vest Date Fair Value
During year ended December 31, 2024(1)
RSAs 225,815  $ 27.38  $ 6,183  145,195  $ 3,051 
Board Awards 21,712  23.95  520  24,768  593 
(1)The Compensation Committee granted annual awards for 2025 in December 2024.
F-37

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The following table summarizes the Company’s RSA and Board Award grants during the years ended December 31, 2023 and 2022 (dollars in thousands, except per share amounts):
Grants
Shares Weighted Average Share Price Grant Date Fair Value
During year ended December 31, 2023(1)
RSAs 166,122  $ 22.41  $ 3,722 
Board Awards 24,768  19.38  480 
During year ended December 31, 2022(2)
RSAs 159,663  $ 19.56  $ 3,123 
Board Awards 25,992  16.93  440 
(1)The Compensation Committee granted annual awards for 2024 in December 2023.
(2)The Compensation Committee granted annual awards for 2023 in December 2022.
The fair value of the TSR Units is estimated on the date of the grant using a Monte Carlo valuation model. The risk-free rate is based on the U.S. Treasury yield curve in effect at the grant date for the expected performance period. Expected volatility is based on historical volatility for the most recent weighted average period ending on the grant date for the Company and the selected TSR peer group, and is calculated on a daily basis. The following table reflects the weighted-average key assumptions used in this valuation for awards granted during the years ended December 31, 2024, 2023 and 2022:
For the Year Ended December 31, 2024
For the Year Ended December 31, 2023 For the Year Ended December 31, 2022
Risk-free interest rate 4.30  % 4.08  % 3.91  %
Expected stock price volatility 24.45  % 26.44  % 52.90  %
Expected service period 3.03 years 3.04 years 3.04 years
Expected dividend yield (assuming full reinvestment) —  % —  % —  %
Weighted average fair value per share at date of grant $ 34.10  $ 27.41  $ 26.53 
The total fair value of the TSR Units granted during the years ended December 31, 2024, 2023 and 2022 was $4.9 million, $2.9 million and $2.5 million, respectively.
The following table summarizes the stock-based compensation expense recognized (dollars in thousands):
  For Year Ended December 31,
  2024 2023 2022
Stock-based compensation expense $ 6,130  $ 5,153  $ 5,758 
As of December 31, 2024, there was $15.9 million of unamortized stock-based compensation expense related to the unvested RSAs, Board Awards, and TSR Units.

F-38

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
10. EARNINGS (LOSS) PER COMMON SHARE
The following table presents the calculation of basic and diluted earnings (loss) per common share attributable to CareTrust REIT, Inc. (“EPS”) for the Company’s common stock for the years ended December 31, 2024, 2023 and 2022, and reconciles the weighted-average common shares outstanding used in the calculation of basic EPS to the weighted-average common shares outstanding used in the calculation of diluted EPS for the years ended December 31, 2024, 2023 and 2022 (amounts in thousands, except per share amounts):
 
  Year Ended December 31,
  2024 2023 2022
Numerator:
Net income (loss) attributable to CareTrust REIT, Inc. $ 125,080  $ 53,735  $ (7,506)
Less: Net income allocated to participating securities (445) (400) (440)
Numerator for basic and diluted earnings available to common stockholders $ 124,635  $ 53,335  $ (7,946)
Denominator:
Weighted-average basic common shares outstanding 154,795  105,956  96,703 
Dilutive potential common shares - performance stock awards 372  164  — 
Dilutive potential common shares - forward equity agreements —  32  — 
Weighted-average diluted common shares outstanding 155,167  106,152  96,703 
Earnings (loss) per common share attributable to CareTrust REIT, Inc., basic $ 0.81  $ 0.50  $ (0.08)
Earnings (loss) per common share attributable to CareTrust REIT, Inc., diluted $ 0.80  $ 0.50  $ (0.08)
Antidilutive unvested restricted stock awards, total shareholder units, performance awards, and forward equity shares excluded from the computation 553  475  744 

F-39

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
11. SEGMENT REPORTING
The chief operating decision maker (“CODM”) is the President and Chief Executive Officer. The Company represents a single reportable segment, based on how its CODM evaluates the business and allocates resources. The CODM assesses performance for the Company and decides how to allocate resources based on consolidated net income that is also reported on the consolidated statements of operations. The CODM does not review segment assets at a different asset level or category than the amounts disclosed in the consolidated balance sheets. The CODM uses net income to evaluate the performance of the Company in deciding whether to reinvest profits into the Company.
The CODM evaluates performance based on net income, as follows (in thousands):
  Year Ended December 31,
  2024 2023 2022
Revenues:
Rental income $ 228,261  $ 198,599  $ 187,506 
Interest income from financing receivable 1,009  —  — 
Interest income from other real estate related investments and other income 67,016  19,171  8,626 
Total revenues 296,286  217,770  196,132 
Expenses:
Depreciation and amortization 56,831  51,199  50,316 
Interest expense 30,310  40,883  30,008 
Property taxes 7,838  6,170  4,333 
Impairment of real estate investments 42,225  36,301  79,062 
Transaction costs 1,326  —  — 
Provision for loan losses, net 4,900  —  3,844 
Property operating expenses 5,714  3,423  5,039 
General and administrative
Cash compensation 6,474  5,636  6,107 
Incentive compensation 9,699  5,350  3,550 
Share-based compensation 6,130  5,153  5,758 
Professional services 2,785  2,399  1,897 
Taxes and insurance 1,019  908  897 
Other expenses(1)
2,816  2,359  1,956 
Total general and administrative 28,923  21,805  20,165 
Total expenses 178,067  159,781  192,767 
Other income (loss):
Loss on extinguishment of debt (657) —  — 
(Loss) gain on sale of real estate, net (2,208) 2,218  (3,769)
Unrealized gain (loss) on other real estate related investments, net 9,045  (6,485) (7,102)
Total other income (loss) 6,180  (4,267) (10,871)
Net income (loss) 124,399  53,722  (7,506)
Net loss attributable to noncontrolling interests (681) (13) — 
Net income (loss) attributable to CareTrust REIT, Inc. $ 125,080  $ 53,735  $ (7,506)
(1) Other expenses include certain overhead expenses.
12. VARIABLE INTEREST ENTITIES
Noncontrolling Interests—The Company has entered into ventures with unrelated third parties to own real estate and has concluded that such ventures are VIEs. As the Company exercises power over and receives economic benefits from the VIEs, the Company is considered the primary beneficiary and consolidates the VIEs.
F-40

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
The following table summarizes the Company’s investments in variable interest entities as of December 31, 2024 (dollars in thousands):
Gross Investment
Investment Year State Facility Type Number of Facilities CTRE Noncontrolling Interests Total
2023 CA SNF 1 $ 25,459  $ 653  $ 26,112 
2023 CA SNF 2 34,269  879  35,148 
2024 CA ALF 1 10,760  276  11,036 
2024 CA Multi-service campuses 2 28,076  720  28,796 
2024 CA SNF 1 24,503  628  25,131 
2024
(1)
TN, AL SNF 27 422,646  18,389  441,035 
2024
(2)
- - - 1,275  225 1,500 
Total 34 $ 546,988  $ 21,770  $ 568,758 
(1) The noncontrolling interest is classified as a redeemable noncontrolling interest on the consolidated balance sheets.
(2) The Company entered into a joint venture to acquire real estate. The gross investment amounts represent a deposit.
Pursuant to the Company’s JVs, the Company typically contributes at least 90% of the joint venture’s total investment amount and receives 100% of the preferred equity interest in the joint venture and a 50% common equity interest in the joint venture. The Company’s joint venture partner contributes the remaining total investment amount in exchange for a 50% common ownership interest in the joint venture.
Total assets and total liabilities on the Company’s consolidated balance sheets include VIE assets and liabilities as follows (in thousands):
December 31, 2024
December 31, 2023
Assets:
Real estate investments, net $ 565,959  $ 68,106 
Cash and cash equivalents 6,506  — 
Prepaid and other assets 8,317  2,800 
Total assets 580,782  70,906 
Liabilities:
Accounts payable, accrued liabilities and deferred rent liabilities 10,332  7,239 
Total liabilities $ 10,332  $ 7,239 
F-41

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
13. COMMITMENTS AND CONTINGENCIES
The Company and its subsidiaries are and may become from time to time a party to various claims and lawsuits arising in the ordinary course of business, which are not individually or in the aggregate anticipated to have a material adverse effect on the Company’s results of operations, financial condition or cash flows. Claims and lawsuits may include matters involving general or professional liability asserted against the Company’s tenants, which are the responsibility of the Company’s tenants and for which the Company is entitled to be indemnified by its tenants under the insurance and indemnification provisions in the applicable leases.
In the normal course of business, the Company enters into various commitments, typically consisting of funding of capital expenditures and short-term working capital loans to existing tenants while they await licensure and certification or are conducting turnaround work in one or more of the Company’s properties.
Capital expenditures for each property leased under the Company’s triple-net leases are generally the responsibility of the tenant, except for the facilities leased under certain master lease agreements, with certain subsidiaries of Ensign and Pennant, under which the tenant will have an option to require the Company to finance certain capital expenditures up to an aggregate of 20% of the Company’s initial investment in such property, subject to a corresponding rent increase at the time of funding. For the Company’s other triple-net master leases, the tenants also have the option to request capital expenditure funding that would generally be subject to a corresponding rent increase at the time of funding, which are subject to tenant compliance with the conditions to the Company’s approval and funding of their requests. The Company has also provided select tenants with strategic capital for facility upkeep and modernization. The Company’s Tenant Code of Conduct and Corporate Responsibility policy (the “Tenant ESG Program”) provides eligible triple-net tenants of the Company with monetary inducements to make sustainable improvements to the Company’s properties. Incentive options include a wide variety of opportunities for tenants to upgrade everything from energy and environmental systems to water-saving landscaping and more. The Company’s board of directors has authorized annual allocations of up to $500,000 to fund the Tenant ESG Program.
The table below summarizes the Company’s existing, known commitments and contingencies as of December 31, 2024 (dollars in thousands):
Remaining Commitment
Capital expenditures(1)
$ 6,565 
Other loans receivable(2)
6,826 
Earn-out obligation(3)
10,000 
$ 23,391 
(1)As of December 31, 2024, the Company had committed to fund expansions, construction, capital improvements and ESG incentives at certain triple-net leased facilities totaling $6.6 million, of which $5.7 million is subject to rent increase at the time of funding.
(2)Represents working capital loan commitments.
(3)Includes an earn-out obligation of up to $10.0 million under a purchase and sale agreement for one SNF in Virginia, which was acquired during 2024. The earn-out is available, contingent on the operator achieving certain thresholds per the agreement, beginning in October 2025 through October 2026.

14. CONCENTRATION OF RISK
Concentrations of credit risk arise when one or more tenants, operators, or obligors related to the Company’s investments are engaged in similar business activities or activities in the same geographic region, or have similar economic features that would cause their ability to meet contractual obligations, including those to the Company, to be similarly affected by changes in economic conditions.
F-42

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Major operator or borrower concentration – The Company has operators and borrowers from which it derived 10% or more of its revenue for the years ended December 31, 2024, 2023 and 2022. The following table sets forth information regarding the Company’s major operators as of December 31, 2024, 2023 and 2022:
  Number of Facilities Number of Beds/Units Percentage of Total Revenue
Operator(1)
SNF Campus ALF/ILF SNF Campus ALF/ILF
December 31, 2024(2)
Ensign 92  8 9,708  997 661  26  %
PMG 13  2 —  1,742  402 —  12  %
December 31, 2023(2)
Ensign 83  8 8,738  997  661  32  %
PMG 13  2 —  1,742  402  —  14  %
December 31, 2022(3)
Ensign 83  8 8,741  997  661  35  %
PMG 13  2 —  1,742  402  —  16  %
(1)See Note 3, Real Estate Investments, Net, for further information regarding Ensign and PMG. Ensign is subject to the registration and reporting requirements of the SEC and is required to file with the SEC annual reports containing audited financial information and quarterly reports containing unaudited financial information. Ensign’s financial statements, as filed with the SEC, can be found at http://www.sec.gov. The Company has not verified this information through an independent investigation or otherwise.
(2)The Company’s rental income and interest income on other real estate related investments and financing receivable, exclusive of operating expense reimbursements and adjustments for collectibility.
(3)The Company’s rental income, exclusive of operating expense reimbursements and adjustments for collectibility.
Major geographic concentration – The following table provides information regarding the Company’s concentrations with respect to certain states, from which the Company derived 10% or more of its revenue for the years ended December 31, 2024, 2023 and 2022:
  Number of Facilities Number of Beds/Units Percentage of Total Revenue
State SNF Campus ALF/ILF SNF Campus ALF/ILF
December 31, 2024(1)
CA 43  12 10  5,104  2,004  872  28  %
TX 38  3 4,726  476 212  18  %
December 31, 2023(1)
CA 40  9 4,615  1,527  656  28  %
TX 40  3 5,123  536  212  21  %
December 31, 2022(2)
CA 27  8 3,048  1,359  437  26  %
TX 38  3 4,849  536  242  22  %
(1)Based on the Company’s rental income and interest income on other real estate related investments and financing receivable, exclusive of operating expense reimbursements and adjustments for collectibility.
(2)Based on the Company’s rental income, exclusive of operating expense reimbursements and adjustments for collectibility.

15. SUBSEQUENT EVENTS
The Company evaluates subsequent events in accordance with ASC 855, Subsequent Events. The Company evaluates subsequent events up until the date the consolidated financial statements are issued.
F-43

CARETRUST REIT, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Recent Investments and Acquisitions
On January 10, 2025, the Company advanced the second installment of a mezzanine loan for one SNF secured by a pledge of membership interests in an up-tier holding company of the borrower group for $6.4 million. The loan bears interest at a rate of 13%, with annual CPI-based escalators. The mezzanine loan is set to mature on December 31, 2034. The mezzanine loan may not be prepaid in whole or in part prior to maturity.
On February 1, 2025, the Company contributed $19.7 million to a JV that purchased one SNF in Tennessee for $20.4 million. In exchange the Company holds 100% of the preferred equity interests in the JV and 50% of the common equity interest in the JV. The JV partner contributed the remaining $0.7 million of the total investment in exchange for 50% of the common equity interest in the JV. In connection with the acquisition of the facility, the JV amended the PACS TN Master Lease. The lease, as amended, has a remaining term of approximately 15 years, with two five-year renewal options. Annual cash rent under the amended lease increased by approximately $2.0 million, with annual CPI-based escalators. See Note 3, Real Estate Investments, Net, for further information regarding the PACS TN Master Lease.
Asset Sales
Subsequent to December 31, 2024, the Company sold or disposed of three SNFs, one SNF Campus and one ALF with an aggregate carrying value of $40.5 million. In connection with the sales, the Company expects to record a gain on sale of real estate of approximately $3.9 million.
Recent ATM Program
On January 21, 2025, the Company entered into a new equity distribution agreement to issue and sell, from time to time, up to $750.0 million in aggregate offering price of its common stock through an “at-the-market” equity offering program (the “New 2025 ATM Program”) and terminated its previous $750.0 million “at-the-market” equity offering program. In addition to the issuance and sale of shares of its common stock, the New 2025 ATM Program also provides for the ability to enter into one or more forward sales agreements with sales agents for the sale of the Company’s shares of common stock under the ATM Program.
As of February 12, 2025, the Company had $750.0 million available for future issuances under the New 2025 ATM Program.
Equity Award Grant
On January 28, 2025, the Compensation Committee of the Company’s Board of Directors granted 137,920 shares of RSA awards to officers and employees. Each share had a fair market value on the date of grant of $27.17 per share based on the closing market price of the Company’s common stock on that date, and the shares vest on January 31, 2026.

F-44

SCHEDULE III
REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION
DECEMBER 31, 2024
(dollars in thousands)
Initial Cost to Company Costs Capitalized Since Acquisition Gross Carrying Value
Description Facility Location Encum. Land Building
Improvs.
Improvs. Land Building
Improvs.
Total (1) Accum. Depr. Const./Ren. Date Acq.
Date
Skilled Nursing Properties:
Ensign Highland LLC Highland Manor Phoenix, AZ $ —  $ 257  $ 976  $ 926  $ 257  $ 1,902  $ 2,159  $ (1,597) 2013 2000
Meadowbrook Health Associates LLC Sabino Canyon Tucson, AZ —  425  3,716  1,940  425  5,656  6,081  (3,895) 2012 2000
Terrace Holdings AZ LLC Desert Terrace Phoenix, AZ —  113  504  971  113  1,475  1,588  (1,165) 2004 2002
Rillito Holdings LLC Catalina Tucson, AZ —  471  2,041  3,055  471  5,096  5,567  (4,061) 2013 2003
Valley Health Holdings LLC North Mountain Phoenix, AZ —  629  5,154  1,519  629  6,673  7,302  (4,847) 2009 2004
Cedar Avenue Holdings LLC Upland Upland, CA —  2,812  3,919  1,994  2,812  5,913  8,725  (4,234) 2011 2005
Granada Investments LLC Camarillo Camarillo, CA —  3,526  2,827  1,522  3,526  4,349  7,875  (3,319) 2010 2005
Plaza Health Holdings LLC Park Manor Walla Walla, WA —  450  5,566  1,055  450  6,621  7,071  (4,890) 2009 2006
Mountainview Communitycare LLC Park View Gardens Santa Rosa, CA —  931  2,612  653  931  3,265  4,196  (2,549) 1963 2006
CM Health Holdings LLC Carmel Mountain San Diego, CA —  3,028  3,119  2,071  3,028  5,190  8,218  (3,726) 2012 2006
Polk Health Holdings LLC Timberwood Livingston, TX —  60  4,391  1,167  60  5,558  5,618  (3,904) 2009 2006
Snohomish Health Holdings LLC Emerald Hills Lynnwood, WA —  741  1,663  1,998  741  3,661  4,402  (3,091) 2009 2006
Cherry Health Holdings LLC Pacific Care Hoquiam, WA —  171  1,828  2,038  171  3,866  4,037  (3,348) 2010 2006
Golfview Holdings LLC Cambridge SNF Richmond, TX —  1,105  3,110  1,067  1,105  4,177  5,282  (2,849) 2007 2006
Tenth East Holdings LLC Arlington Hills Salt Lake City, UT —  332  2,426  2,507  332  4,933  5,265  (4,111) 2013 2006
Trinity Mill Holdings LLC Carrollton Carrollton, TX —  664  2,294  902  664  3,196  3,860  (2,781) 2007 2006
Cottonwood Health Holdings LLC Holladay Salt Lake City, UT —  965  2,070  958  965  3,028  3,993  (2,813) 2008 2007
Verde Villa Holdings LLC Lake Village Lewisville, TX —  600  1,890  470  600  2,360  2,960  (1,835) 2011 2007
Mesquite Health Holdings LLC Willow Bend Mesquite, TX —  470  1,715  8,632  441  10,376  10,817  (9,318) 2012 2007
Arrow Tree Health Holdings LLC Arbor Glen Glendora, CA —  2,165  1,105  324  2,165  1,429  3,594  (1,277) 1965 2007
Fort Street Health Holdings LLC Draper Draper, UT —  443  2,394  759  443  3,153  3,596  (2,041) 2008 2007
Trousdale Health Holdings LLC Brookfield Downey, CA —  1,415  1,841  1,861  1,415  3,702  5,117  (2,712) 2013 2007
Ensign Bellflower LLC Rose Villa Bellflower, CA —  937  1,168  357  937  1,525  2,462  (1,149) 2009 2007
RB Heights Health Holdings LLC Osborn Scottsdale, AZ —  2,007  2,793  1,762  2,007  4,555  6,562  (3,172) 2009 2008
San Corrine Health Holdings LLC Salado Creek San Antonio, TX —  310  2,090  719  310  2,809  3,119  (1,708) 2005 2008
Temple Health Holdings LLC Wellington Temple, TX —  529  2,207  1,163  529  3,370  3,899  (2,281) 2008 2008
Anson Health Holdings LLC Northern Oaks Abilene, TX —  369  3,220  1,725  369  4,945  5,314  (3,286) 2012 2008
Willits Health Holdings LLC Northbrook Willits, CA —  490  1,231  500  490  1,731  2,221  (1,135) 2011 2008
Lufkin Health Holdings LLC Southland Lufkin, TX —  467  4,644  782  467  5,426  5,893  (2,197) 1988 2009
Lowell Health Holdings LLC Littleton Littleton, CO —  217  856  1,735  217  2,591  2,808  (1,934) 2012 2009
Jefferson Ralston Holdings LLC Arvada Arvada, CO —  280  1,230  834  280  2,064  2,344  (1,236) 2012 2009
Lafayette Health Holdings LLC Julia Temple Englewood, CO —  1,607  4,222  6,195  1,607  10,417  12,024  (7,027) 2012 2009
F-45

SCHEDULE III
REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION
DECEMBER 31, 2024
(dollars in thousands)
Hillendahl Health Holdings LLC Golden Acres Dallas, TX —  2,133  11,977  1,421  2,133  13,398  15,531  (7,482) 1984 2009
Price Health Holdings LLC Pinnacle Price, UT —  193  2,209  849  193  3,058  3,251  (1,519) 2012 2009
Silver Lake Health Holdings LLC Provo Provo, UT —  2,051  8,362  2,011  2,051  10,373  12,424  (4,308) 2011 2009
Jordan Health Properties LLC Copper Ridge West Jordan, UT —  2,671  4,244  1,507  2,671  5,751  8,422  (2,519) 2013 2009
Regal Road Health Holdings LLC Sunview Youngstown, AZ —  767  4,648  155  193  5,377  5,570  (2,730) 2012 2009
Paredes Health Holdings LLC Alta Vista Brownsville, TX —  373  1,354  190  373  1,544  1,917  (630) 1969 2009
Expressway Health Holdings LLC Veranda Harlingen, TX —  90  675  430  90  1,105  1,195  (627) 2011 2009
Rio Grande Health Holdings LLC Grand Terrace McAllen, TX —  642  1,085  870  642  1,955  2,597  (1,273) 2012 2009
Fifth East Holdings LLC Paramount Salt Lake City, UT —  345  2,464  1,065  345  3,529  3,874  (1,836) 2011 2009
Emmett Healthcare Holdings LLC River's Edge Emmet, ID —  591  2,383  69  591  2,452  3,043  (1,087) 1972 2010
Burley Healthcare Holdings LLC Parke View Burley, ID —  250  4,004  424  250  4,428  4,678  (2,117) 2011 2010
Josey Ranch Healthcare Holdings LLC Heritage Gardens Carrollton, TX —  1,382  2,293  478  1,382  2,771  4,153  (1,278) 1996 2010
Everglades Health Holdings LLC Victoria Ventura Ventura, CA —  1,847  5,377  682  1,847  6,059  7,906  (2,147) 1990 2011
Irving Health Holdings LLC Beatrice Manor Beatrice, NE —  60  2,931  245  60  3,176  3,236  (1,469) 2011 2011
Falls City Health Holdings LLC Careage Estates of Falls City Falls City, NE —  170  2,141  82  170  2,223  2,393  (967) 1972 2011
Gillette Park Health Holdings LLC Careage of Cherokee Cherokee, IA —  163  1,491  12  163  1,503  1,666  (817) 1967 2011
Gazebo Park Health Holdings LLC Careage of Clarion Clarion, IA —  80  2,541  97  80  2,638  2,718  (1,468) 1978 2011
Oleson Park Health Holdings LLC Careage of Ft. Dodge Ft. Dodge, IA —  90  2,341  759  90  3,100  3,190  (2,189) 2012 2011
Arapahoe Health Holdings LLC Oceanview Texas City, TX —  158  4,810  759  128  5,599  5,727  (2,850) 2012 2011
Dixie Health Holdings LLC Hurricane Hurricane, UT —  487  1,978  98  487  2,076  2,563  (749) 1978 2011
Memorial Health Holdings LLC Pocatello Pocatello, ID —  537  2,138  698  537  2,836  3,373  (1,502) 2007 2011
Bogardus Health Holdings LLC Whittier East Whittier, CA —  1,425  5,307  1,079  1,425  6,386  7,811  (3,058) 2011 2011
South Dora Health Holdings LLC Ukiah Ukiah, CA —  297  2,087  1,621  297  3,708  4,005  (2,405) 2013 2011
Silverada Health Holdings LLC Rosewood Reno, NV —  1,012  3,282  103  1,012  3,385  4,397  (1,159) 1970 2011
Orem Health Holdings LLC Orem Orem, UT —  1,689  3,896  3,235  1,689  7,131  8,820  (4,062) 2011 2011
Wisteria Health Holdings Wisteria Abilene, TX —  746  9,903  290  746  10,193  10,939  (3,010) 2008 2011
Renee Avenue Health Holdings LLC Monte Vista Pocatello, ID —  180  2,481  966  180  3,447  3,627  (1,806) 2013 2012
Stillhouse Health Holdings LLC Stillhouse Paris, TX —  129  7,139  129  7,145  7,274  (1,582) 2009 2012
Fig Street Health Holdings LLC Palomar Vista Escondido, CA —  329  2,653  1,094  329  3,747  4,076  (1,999) 2007 2012
Lowell Lake Health Holdings LLC Owyhee Owyhee, ID —  49  1,554  29  49  1,583  1,632  (458) 1990 2012
Queensway Health Holdings LLC Atlantic Memorial Long Beach, CA —  999  4,237  2,331  999  6,568  7,567  (3,317) 2008 2012
Long Beach Health Associates LLC Shoreline Long Beach, CA —  1,285  2,343  2,172  1,285  4,515  5,800  (2,570) 2013 2012
Kings Court Health Holdings LLC Richland Hills Ft. Worth, TX —  193  2,311  318  193  2,629  2,822  (942) 1965 2012
51st Avenue Health Holdings LLC Legacy Amarillo, TX —  340  3,925  32  340  3,957  4,297  (1,352) 1970 2013
Ives Health Holdings LLC San Marcos San Marcos, TX —  371  2,951  274  371  3,225  3,596  (1,066) 1972 2013
Guadalupe Health Holdings LLC The Courtyard (Victoria East) Victoria, TX —  80  2,391  15  80  2,406  2,486  (640) 2013 2013
49th Street Health Holdings LLC Omaha Omaha, NE —  129  2,418  24  129  2,442  2,571  (957) 1960 2013
Willows Health Holdings LLC Cascade Vista Redmond, WA —  1,388  2,982  202  1,388  3,184  4,572  (1,348) 1970 2013
Tulalip Bay Health Holdings LLC Mountain View Marysville, WA —  1,722  2,642  (980) 742  2,642  3,384  (1,013) 1966 2013
F-46

SCHEDULE III
REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION
DECEMBER 31, 2024
(dollars in thousands)
Sky Holdings AZ LLC Bella Vita Health and Rehabilitation Center Glendale, AZ —  228  1,124  1,380  228  2,504  2,732  (2,094) 2004 2002
Lemon River Holdings LLC Plymouth Tower Riverside, CA —  152  357  1,493  152  1,850  2,002  (1,610) 2012 2009
CTR Partnership, L.P. Bethany Rehabilitation Center Lakewood, CO —  1,668  15,375  105  1,668  15,480  17,148  (3,836) 1989 2015
CTR Partnership, L.P. Mira Vista Care Center Mount Vernon, WA —  1,601  7,425  —  1,601  7,425  9,026  (1,810) 1989 2015
CTR Partnership, L.P. Shoreline Health and Rehabilitation Center Shoreline, WA —  1,462  5,034  —  1,462  5,034  6,496  (1,206) 1987 2015
CTR Partnership, L.P. Premier Estates of Cincinnati-Riverview Cincinnati, OH —  833  18,086  792  833  18,878  19,711  (4,465) 1992 2015
CTR Partnership, L.P. Shaw Mountain at Cascadia Boise, ID —  1,801  6,572  395  1,801  6,967  8,768  (1,724) 1989 2016
CTR Partnership, L.P. Arbor Nursing Center Lodi, CA —  768  10,712  58  768  10,770  11,538  (2,254) 1982 2016
CTR Partnership, L.P. Broadmoor Medical Lodge Rockwall, TX —  1,232  22,152  —  1,232  22,152  23,384  (4,477) 1984 2016
CTR Partnership, L.P. Decatur Medical Lodge Decatur, TX —  990  24,909  —  990  24,909  25,899  (5,034) 2013 2016
CTR Partnership, L.P. Royse City Medical Lodge Royse City, TX —  606  14,660  —  606  14,660  15,266  (2,962) 2009 2016
CTR Partnership, L.P. Saline Care Nursing & Rehabilitation Center Harrisburg, IL —  1,022  5,713  —  1,022  5,713  6,735  (1,119) 2009 2017
CTR Partnership, L.P. Carrier Mills Nursing & Rehabilitation Center Carrier Mills, IL —  775  8,377  —  775  8,377  9,152  (1,640) 1968 2017
CTR Partnership, L.P. StoneBridge Nursing & Rehabilitation Center Benton, IL —  439  3,475  —  439  3,475  3,914  (681) 2014 2017
CTR Partnership, L.P. DuQuoin Nursing & Rehabilitation Center DuQuoin, IL —  511  3,662  —  511  3,662  4,173  (717) 2014 2017
CTR Partnership, L.P. Pinckneyville Nursing & Rehabilitation Center Pinckneyville, IL —  406  3,411  —  406  3,411  3,817  (668) 2014 2017
CTR Partnership, L.P. Wellspring Health and Rehabilitation of Cascadia Nampa, ID —  775  5,044  336  775  5,380  6,155  (1,028) 2011 2017
CTR Partnership, L.P. The Rio at Fox Hollow Brownsville, TX —  1,178  12,059  —  1,178  12,059  13,237  (2,286) 2016 2017
CTR Partnership, L.P. The Rio at Cabezon Albuquerque, NM —  2,055  9,749  —  2,055  9,749  11,804  (1,848) 2016 2017
CTR Partnership, L.P. Eldorado Rehab & Healthcare Eldorado, IL —  940  2,093  —  940  2,093  3,033  (392) 1993 2017
CTR Partnership, L.P. Secora Health and Rehabilitation of Cascadia Portland, OR —  1,481  2,216  110  1,481  2,326  3,807  (436) 2012 2017
CTR Partnership, L.P. Mountain Valley Kellogg, ID —  916  7,874  —  916  7,874  8,790  (1,443) 1971 2017
CTR Partnership, L.P. Caldwell Care Caldwell, ID —  906  7,020  516  906  7,536  8,442  (1,382) 1947 2017
CTR Partnership, L.P. Canyon West Caldwell, ID —  312  10,410  461  312  10,871  11,183  (1,993) 1969 2017
CTR Partnership, L.P. Lewiston Health and Rehabilitation Lewiston, ID —  625  12,087  215  625  12,302  12,927  (2,230) 1964 2017
CTR Partnership, L.P. The Orchards Nampa, ID —  785  8,923  272  785  9,195  9,980  (1,667) 1958 2017
CTR Partnership, L.P. Weiser Care Weiser, ID —  80  4,419  389  80  4,808  4,888  (872) 1964 2017
CTR Partnership, L.P. Aspen Park Moscow, ID —  698  5,092  274  698  5,366  6,064  (1,020) 1965 2017
CTR Partnership, L.P. Ridgmar Medical Lodge Fort Worth, TX —  681  6,587  1,256  681  7,843  8,524  (1,695) 2006 2017
CTR Partnership, L.P. Mansfield Medical Lodge Mansfield, TX —  607  4,801  1,073  607  5,874  6,481  (1,265) 2006 2017
CTR Partnership, L.P. Grapevine Medical Lodge Grapevine, TX —  1,602  4,536  891  1,602  5,427  7,029  (1,177) 2006 2017
CTR Partnership, L.P. The Oaks at Lakewood Tacoma, WA —  1,001  1,779  —  1,001  1,779  2,780  (322) 1989 2017
F-47

SCHEDULE III
REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION
DECEMBER 31, 2024
(dollars in thousands)
CTR Partnership, L.P. The Oaks at Timberline Vancouver, WA —  446  869  —  446  869  1,315  (157) 1972 2017
CTR Partnership, L.P. Providence Waterman Nursing Center San Bernardino, CA —  3,831  19,791  —  3,831  19,791  23,622  (3,587) 1967 2017
CTR Partnership, L.P. Providence Orange Tree Riverside, CA —  2,897  14,700  345  2,897  15,045  17,942  (2,756) 1969 2017
CTR Partnership, L.P. Providence Ontario Ontario, CA —  4,204  21,880  —  4,204  21,880  26,084  (3,966) 1980 2017
CTR Partnership, L.P. Greenville Nursing & Rehabilitation Center Greenville, IL —  188  3,972  —  188  3,972  4,160  (840) 1973 2017
CTR Partnership, L.P. Copper Ridge Health and Rehabilitation Center Butte, MT —  220  4,974  39  220  5,013  5,233  (954) 2010 2018
CTR Partnership, L.P. Prairie Heights Healthcare Center Aberdeen, SD —  1,372  7,491  38  1,372  7,529  8,901  (1,340) 1965 2018
CTR Partnership, L.P. The Meadows on University Fargo, ND —  989  3,275  429  989  3,704  4,693  (559) 1966 2018
CTR Partnership, L.P. The Suites - Parker Parker, CO —  1,178  17,857  —  1,178  17,857  19,035  (2,779) 2012 2018
CTR Partnership, L.P. Huntington Park Nursing Center Huntington Park, CA —  3,131  8,876  302  3,131  9,178  12,309  (1,488) 1955 2019
CTR Partnership, L.P. Shoreline Care Center Oxnard, CA —  1,699  9,004  819  1,699  9,823  11,522  (1,367) 1962 2019
CTR Partnership, L.P. Downey Care Center Downey, CA —  2,502  6,141  —  2,502  6,141  8,643  (934) 1967 2019
CTR Partnership, L.P. Courtyard Healthcare Center Davis, CA —  2,351  9,256  48  2,351  9,304  11,655  (1,433) 1969 2019
Gulf Coast Buyer 1 LLC Alpine Skilled Nursing and Rehabilitation Ruston, LA —  2,688  23,825  —  2,688  23,825  26,513  (3,613) 2014 2019
Gulf Coast Buyer 1 LLC The Bradford Skilled Nursing and Rehabilitation Shreveport, LA —  3,758  21,325  17  3,758  21,342  25,100  (3,261) 1980 2019
Gulf Coast Buyer 1 LLC Colonial Oaks Skilled Nursing and Rehabilitation Bossier City, LA —  1,635  21,180  —  1,635  21,180  22,815  (3,136) 2013 2019
Gulf Coast Buyer 1 LLC The Guest House Skilled Nursing and Rehabilitation Shreveport, LA —  3,437  20,889  2,845  3,437  23,734  27,171  (3,824) 2006 2019
Gulf Coast Buyer 1 LLC Pilgrim Manor Skilled Nursing and Rehabilitation Bossier City, LA —  2,979  24,617  1,978  2,979  26,595  29,574  (3,921) 2008 2019
Gulf Coast Buyer 1 LLC Shreveport Manor Skilled Nursing and Rehabilitation Shreveport, LA —  676  10,238  602  676  10,840  11,516  (1,662) 2008 2019
Gulf Coast Buyer 1 LLC Booker T. Washington Skilled Nursing and Rehabilitation Shreveport, LA —  2,452  9,148  113  2,452  9,261  11,713  (1,479) 2013 2019
Gulf Coast Buyer 1 LLC Legacy West Rehabilitation and Healthcare Corsicana, TX —  120  6,682  436  120  7,118  7,238  (1,227) 2002 2019
Gulf Coast Buyer 1 LLC Legacy at Jacksonville Jacksonville, TX —  173  7,481  148  173  7,629  7,802  (1,246) 2006 2019
Gulf Coast Buyer 1 LLC Pecan Tree Rehabilitation and Healthcare Gainesville, TX —  219  10,097  255  219  10,352  10,571  (1,648) 1990 2019
Lakewest SNF Realty, LLC Lakewest Rehabilitation and Skilled Care Dallas, TX —  —  6,905  —  —  6,905  6,905  (1,094) 2011 2019
CTR Partnership, L.P. Cascadia of Nampa Nampa, ID —  880  14,117  —  880  14,117  14,997  (2,094) 2017 2019
CTR Partnership, L.P. Valley Skilled Nursing Modesto, CA —  798  7,671  —  798  7,671  8,469  (1,045) 2016 2019
CTR Partnership, L.P. Cascadia of Boise Boise, ID —  1,597  15,692  —  1,597  15,692  17,289  (2,059) 2018 2020
CTR Partnership, L.P. Cooney Healthcare and Rehabilitation Helena, MT —  867  7,431  20  867  7,451  8,318  (853) 1984 2020
F-48

SCHEDULE III
REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION
DECEMBER 31, 2024
(dollars in thousands)
CTR Partnership, L.P. Elkhorn Healthcare and Rehabilitation Clancy, MT —  183  7,380  576  183  7,956  8,139  (938) 1960 2020
160 North Patterson Avenue, LLC Buena Vista Care Center Goleta, CA —  7,987  7,237  552  7,987  7,789  15,776  (735) 1967 2021
CTR Partnership, L.P. El Centro Post-Acute Care El Centro, CA —  1,283  8,133  135  1,283  8,268  9,551  (823) 1962 2021
CTR Partnership, L.P. Sedona Trace Health and Wellness Austin, TX —  3,282  12,763  —  3,282  12,763  16,045  (1,222) 2017 2021
CTR Partnership, L.P. Cedar Pointe Health and Wellness Suites Cedar Park, TX —  3,325  11,738  —  3,325  11,738  15,063  (1,111) 2017 2021
CTR Partnership, L.P. Ennis Care Center Ennis,TX —  568  8,055  100  568  8,155  8,723  (641) 1982 2022
CTR Partnership, L.P. Park Bend Rehabilitation and Healthcare Center Burleson, TX —  1,877  6,616  718  1,877  7,334  9,211  (406) 1988 2023
CTR Partnership, L.P. Prairie Ridge Health and Rehabiliation Overland Park , KS —  1,301  5,025  —  1,301  5,025  6,326  (243) 1987 2023
CTR Partnership, L.P. Spalding Post Acute Griffin , GA —  680  11,044  1,853  680  12,897  13,577  (522) 2022 2023
CTR Partnership, L.P. Casa Azul Skilled Nursing and Rehabilitation Katy , TX —  3,413  10,451  —  3,413  10,451  13,864  (449) 2005 2023
8665 La Mesa Boulevard, LLC Community Convalescent Hospital of La Mesa La Mesa , CA —  5,346  21,528  —  5,346  21,528  26,874  (873) 1968 2023
7039 Alonda Boulevard, LLC Paramount Meadows Nursing Center Paramount , CA —  3,640  15,380  369  3,640  15,749  19,389  (623) 1969 2023
10625 Leffingwell Road, LLC Norwalk Meadows Nursing Center Norwalk , CA —  4,932  14,229  —  4,932  14,229  19,161  (586) 1964 2023
247 E. Bobier Drive, LLC La Fuente Post Acute Vista , CA —  4,882  20,793  —  4,882  20,793  25,675  (748) 1990 2023
Capitola 1935 Realty LLC Pacific Coast Manor Capitola , CA —  5,231  16,321  —  5,231  16,321  21,552  (493) 1964 2023
Morgan Hills Realty LLC Pacific Hills Manor Morgan Hill , CA —  3,239  14,418  —  3,239  14,418  17,657  (447) 2014 2023
CTR Partnership, L.P. Columbia Post Acute Columbia, MO —  1,619  15,678  —  1,619  15,678  17,297  (352) 2017 2024
CTR Partnership, L.P. Houston Transitional Care Houston, TX —  2,668  17,434  —  2,668  17,434  20,102  (399) 2022 2024
1070 Old Ocean Highway, LLC Brunswick Rehabilitation and Healthcare Center Bolivia, NC —  551  16,589  —  551  16,589  17,140  (282) 2009 2024
86 Old Airport Road, LLC Fletcher Rehabilitation and Healthcare Center Fletcher, NC —  1,547  15,316  —  1,547  15,316  16,863  (263) 2002 2024
7166 Jordan Road, LLC Ramseur Rehabilitation and Healthcare Center Ramseur, NC —  747  15,085  —  747  15,085  15,832  (275) 2002 2024
1930 West Sugar Creek Road, LLC Rockwell Park Rehabilitation and Healthcare Center Charlotte, NC —  2,217  16,213  —  2,217  16,213  18,430  (278) 1993 2024
3514 Sidney Road, LLC Seven Oaks Rehabilitation and Healthcare Center Columbia, SC —  583  10,847  —  583  10,847  11,430  (184) 1980 2024
8170 Murray Propco, LLC Gilroy Healthcare and Rehabilitation Center Gilroy, CA —  6,539  19,162  —  6,539  19,162  25,701  (206) 1968 2024
CTR Partnership, L.P. Glenburnie Nursing & Rehabilitation Center Richmond, VA —  —  31,567  —  —  31,567  31,567  (274) 2005 2024
CTR Partnership, L.P. Dennett Rehab Center Oakland, MD —  1,134  18,227  —  1,134  18,227  19,361  (131) 2023 2024
CTR Partnership, L.P. Mountain City Rehab Center Frostburg, MD —  853  20,334  —  853  20,334  21,187  (135) 1995 2024
CTR Partnership, L.P. South Hills Post Acute Bethel Park, PA —  1,835  12,726  —  1,835  12,726  14,561  (58) 2021 2024
CTR Partnership, L.P. Peters Township Post Acute Canonsburg, PA —  1,651  12,509  —  1,651  12,509  14,160  (57) 1988 2024
CTR Partnership, L.P. Monroeville Post Acute Monroeville, PA —  1,182  10,906  —  1,182  10,906  12,088  (48) 1996 2024
CTR Partnership, L.P. Whitehall Borough Post Acute Pittsburgh, PA —  1,323  13,119  —  1,323  13,119  14,442  (57) 1999 2024
704 Dupree Road TN LLC Haywood Post Acute Brownsville, TN —  508  17,027  —  508  17,027  17,535  (38) 2022 2024
F-49

SCHEDULE III
REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION
DECEMBER 31, 2024
(dollars in thousands)
175 Hospital Drive TN LLC Cherrywood Post Acute McKenzie, TN —  1,187  16,873  —  1,187  16,873  18,060  (42) 2020 2024
900 Professional Park Drive TN LLC Park Meadows Post Acute Clarksville, TN —  1,785  21,328  —  1,785  21,328  23,113  (52) 2018 2024
119 Kittrell Street TN LLC Lewis Park Post Acute Hohenwald, TN —  826  11,505  —  826  11,505  12,331  (28) 1996 2024
444 One Eleven Place TN LLC Grandview Post Acute Cookeville, TN —  1,636  20,941  —  1,636  20,941  22,577  (53) 2024 2024
727 East Church Street TN LLC Lexington Post Acute Lexington, TN —  551  15,171  —  551  15,171  15,722  (34) 2024 2024
835 East Poplar Avenue TN LLC Selmer Post Acute Selmer, TN —  765  19,394  500  765  19,894  20,659  (43) 1995 2024
2650 North Mt Juliet Road TN LLC Cedar Creek Post Acute Mount Juliet, TN —  1,719  12,640  —  1,719  12,640  14,359  (32) 2021 2024
202 East Mtcs Road TN LLC Stone River Post Acute Murfreesboro, TN —  1,607  7,649  —  1,607  7,649  9,256  (23) 1996 2024
813 S Dickerson Rd TN LLC Alta Heights Post Acute Goodlettsville, TN —  1,324  13,075  —  1,324  13,075  14,399  (32) 2005 2024
895 Powers Blvd TN LLC Waverly Hills Post Acute Waverly, TN —  1,071  9,821  —  1,071  9,821  10,892  (28) 1989 2024
1900 Parr Avenue TN LLC Okeena Health and Rehabilitation Center Dyersburg, TN —  1,122  30,135  —  1,122  30,135  31,257  (67) 1989 2024
2031 Avondale Street TN LLC Avondale Health and Rehabilitation Center Humboldt, TN —  810  10,127  —  810  10,127  10,937  (25) 2011 2024
800 Volunteer Drive TN LLC Riverbend Health and Rehabilitation Center Paris, TN —  963  26,215  —  963  26,215  27,178  (59) 2023 2024
1630 E Reelfoot Ave TN LLC Union City Health and Rehabilitation Union City, TN —  885  14,562  —  885  14,562  15,447  —  1996 2024
5275 Millennium Drive AL LLC The Health Center at Research Park Huntsville, AL —  1,246  9,659  64  1,246  9,723  10,969  —  2006 2024
460 Hannings Lane TN LLC VanAyer Senior Living and Rehabilitation Martin, TN —  819  9,771  —  819  9,771  10,590  —  2023 2024
1245 E College St TN LLC Meadowbrook Healthcare and Rehabilitation Center Pulaski, TN —  437  13,488  483  437  13,971  14,408  —  1991 2024
7424 Middlebrook Pike TN LLC Legacy Park Health and Rehabilitation Knoxville, TN —  1,181  15,678  106  1,181  15,784  16,965  —  1972 2024
7512 Middlebrook Pike TN LLC Wellpark Health and Rehabilitation Knoxville, TN —  1,662  1,188  —  1,662  1,188  2,850  —  2015 2024
1536 Appling Care Lane TN LLC Applingwood Post Acute Cordova, TN —  482  12,015  —  482  12,015  12,497  —  1997 2024
5070 Sanderlin Avenue TN LLC Shelby Oaks Post Acute Memphis, TN —  788  9,153  —  788  9,153  9,941  —  1964 2024
765 Bert Johnston Avenue TN LLC Covington Post Acute Covington, TN —  794  15,735  —  794  15,735  16,529  —  2023 2024
45 Forest Cove TN LLC Cypress Grove Post Acute Jackson, TN —  960  16,359  —  960  16,359  17,319  —  2022 2024
121 Physicians Dr TN LLC Northbrooke Post Acute Jackson, TN —  663  17,643  —  663  17,643  18,306  —  1997 2024
597 West Forest Avenue TN LLC West Tennessee Transitional Care Jackson, TN —  1,779  6,929  —  1,779  6,929  8,708  —  2013 2024
1513 N 2nd Street TN LLC Harborview Post Acute Memphis, TN —  1,764  18,429  —  1,764  18,429  20,193  —  2020 2024
—  237,804  1,637,220  103,779  236,191  1,742,612  1,978,803  (299,886)
Multi-Service Campus Properties:
Ensign Southland LLC Southland Care Norwalk, CA —  966  5,082  2,213  966  7,295  8,261  (6,356) 2011 1999
Mission CCRC LLC St. Joseph's Villa Salt Lake City, UT —  1,962  11,035  464  1,962  11,499  13,461  (4,503) 1994 2011
Wayne Health Holdings LLC Careage of Wayne Wayne, NE —  130  3,061  122  130  3,183  3,313  (1,401) 1978 2011
4th Street Holdings LLC West Bend Care Center West Bend, IA —  180  3,352  —  180  3,352  3,532  (1,408) 2006 2011
Big Sioux River Health Holdings LLC Hillcrest Health Hawarden, IA —  110  3,522  75  110  3,597  3,707  (1,421) 1974 2011
Prairie Health Holdings LLC Colonial Manor of Randolph Randolph, NE —  130  1,571  22  130  1,593  1,723  (1,078) 2011 2011
Salmon River Health Holdings LLC Discovery Care Center Salmon, ID —  168  2,496  —  168  2,496  2,664  (775) 2012 2012
F-50

SCHEDULE III
REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION
DECEMBER 31, 2024
(dollars in thousands)
CTR Partnership, L.P. Liberty Nursing Center of Willard Willard, OH —  144  11,097  50  144  11,147  11,291  (2,608) 1985 2015
CTR Partnership, L.P. Premier Estates of Middletown/Premier Retirement Estates of Middletown Middletown, OH —  990  7,484  380  990  7,864  8,854  (1,900) 1985 2015
CTR Partnership, L.P. Turlock Nursing and Rehabilitation Center Turlock, CA —  1,258  16,526  75  1,258  16,601  17,859  (3,477) 1986 2016
CTR Partnership, L.P. Bridgeport Medical Lodge Bridgeport, TX —  980  27,917  —  980  27,917  28,897  (5,642) 2014 2016
CTR Partnership, L.P. The Villas at Saratoga Saratoga, CA —  8,709  9,736  1,397  8,709  11,133  19,842  (2,180) 2004 2018
CTR Partnership, L.P. Madison Park Healthcare Huntington, WV —  601  6,385  —  601  6,385  6,986  (1,022) 1924 2018
CTR Partnership, L.P. Oakview Heights Nursing & Rehabilitation Center Mt. Carmel, IL —  298  8,393  —  298  8,393  8,691  (1,405) 2004 2019
Gulf Coast Buyer 1 LLC Spring Lake Skilled Nursing and Rehabilitation Shreveport, LA —  3,217  21,195  2,729  3,217  23,924  27,141  (4,136) 2008 2019
Gulf Coast Buyer 1 LLC The Village at Heritage Oaks Corsicana, TX —  143  11,429  462  143  11,891  12,034  (1,974) 2007 2019
CTR Partnership, L.P. City Creek Post-Acute and Assisted Living Sacramento, CA —  3,980  10,106  1,488  3,980  11,594  15,574  (1,913) 1990 2019
Northshore Healthcare Holdings LLC San Juan Capistrano Senior Living San Juan Capistrano, CA —  11,176  25,298  350  11,176  25,648  36,824  (2,615) 1999 2021
Northshore Healthcare Holdings LLC Camarillo Senior Living Camarillo, CA —  7,516  30,552  —  7,516  30,552  38,068  (3,014) 2000 2021
Northshore Healthcare Holdings LLC Bayshire Carlsbad Carlsbad, CA —  7,398  19,714  —  7,398  19,714  27,112  (1,973) 1999 2021
Northshore Healthcare Holdings LLC Bayshire Rancho Mirage Rancho Mirage, CA —  4,024  16,790  —  4,024  16,790  20,814  (1,715) 2000 2021
CTR Partnership, L.P. Imboden Creek Living Center Decatur, IL —  131  12,499  91  131  12,590  12,721  (999) 2003 2022
4075 54th Street, LLC Jacob Healthcare Center San Diego , CA —  4,949  20,227  —  4,949  20,227  25,176  (835) 1994 2023
1740 San Dimas, LLC Bayshire San Dimas San Dimas, CA —  9,592  5,936  —  9,592  5,936  15,528  (136) 1999 2024
17803 Imperial Hwy, LLC Bayshire Yorba Linda Yorba Linda, CA —  6,493  6,025  —  6,493  6,025  12,518  (126) 1999 2024
CTR Partnership, L.P. North Houston Transitional Care Houston, TX —  2,419  14,525  —  2,419  14,525  16,944  (332) 2022 2024
CTR Partnership, L.P. Bayshire Torrey Pines San Diego, CA —  19,009  13,079  —  19,009  13,079  32,088  (270) 1999 2024
CTR Partnership, L.P. Ridgeway Rehab Center & Ridgeway Village Assisted Living Catonsville, MD —  1,622  10,421  —  1,622  10,421  12,043  (84) 2023 2024
—  98,295  335,453  9,918  98,295  345,371  443,666  (55,298)
Assisted and Independent Living Properties:
Avenue N Holdings LLC Cambridge ALF Rosenburg, TX —  124  2,301  392  124  2,693  2,817  (1,690) 2007 2006
Moenium Holdings LLC Grand Court Mesa, AZ —  1,893  5,268  1,210  1,893  6,478  8,371  (4,292) 1986 2007
Lafayette Health Holdings LLC Chateau Des Mons Englewood, CO —  420  1,160  189  420  1,349  1,769  (581) 2011 2009
Expo Park Health Holdings LLC Canterbury Gardens Aurora, CO —  570  1,692  248  570  1,940  2,510  (1,182) 1986 2010
Wisteria Health Holdings LLC Wisteria IND Abilene, TX —  244  3,241  81  244  3,322  3,566  (2,229) 2008 2011
Everglades Health Holdings LLC Lexington Ventura, CA —  1,542  4,012  113  1,542  4,125  5,667  (1,221) 1990 2011
Flamingo Health Holdings LLC Desert Springs ALF Las Vegas, NV —  908  4,767  281  908  5,048  5,956  (3,509) 1986 2011
18th Place Health Holdings LLC Rose Court Phoenix, AZ —  1,011  2,053  490  1,011  2,543  3,554  (1,321) 1974 2011
Boardwalk Health Holdings LLC Park Place Reno, NV —  367  1,633  52  367  1,685  2,052  (732) 1993 2012
Willows Health Holdings LLC Cascade Plaza Redmond, WA —  2,835  3,784  395  2,835  4,179  7,014  (1,792) 2013 2013
Lockwood Health Holdings LLC Santa Maria Santa Maria, CA —  1,792  2,253  585  1,792  2,838  4,630  (1,834) 1967 2013
F-51

SCHEDULE III
REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION
DECEMBER 31, 2024
(dollars in thousands)
Saratoga Health Holdings LLC Lake Ridge Orem, UT —  444  2,265  176  444  2,441  2,885  (681) 1995 2013
Sky Holdings AZ LLC Desert Sky Assisted Living Glendale, AZ —  61  304  372  61  676  737  (566) 2004 2002
Lemon River Holdings LLC The Grove Assisted Living Riverside, CA —  342  802  3,360  342  4,162  4,504  (3,623) 2012 2009
Mission CCRC LLC St. Joseph's Villa IND Salt Lake City, UT —  411  2,312  258  411  2,570  2,981  (2,111) 1994 2011
CTR Partnership, L.P. Prelude Cottages of Woodbury Woodbury, MN —  430  6,714  289  430  7,003  7,433  (1,733) 2011 2014
CTR Partnership, L.P. Lamplight Inn of Baltimore Baltimore, MD —  —  3,697  733  —  —  —  —  2014 2016
CTR Partnership, L.P. Croatan Village New Bern, NC —  312  6,919  155  129  2,946  3,075  (30) 2010 2016
CTR Partnership, L.P. Countryside Village Pikeville, NC —  131  4,157  —  52  1,674  1,726  (17) 2011 2016
CTR Partnership, L.P. Arbor Place Lodi, CA —  392  3,605  59  392  3,664  4,056  (759) 1984 2016
CTR Partnership, L.P. Applewood of Brookfield Brookfield, WI —  493  14,002  105  243  6,091  6,334  (357) 2013 2017
CTR Partnership, L.P. Applewood of New Berlin New Berlin, WI —  356  10,812  139  190  5,172  5,362  (295) 2016 2017
CTR Partnership, L.P. Memory Care Cottages in White Bear Lake White Bear Lake, MN —  1,611  5,633  —  1,611  5,633  7,244  (1,056) 2016 2017
CTR Partnership, L.P. Vista Del Lago Escondido, CA —  4,362  7,997  —  4,362  7,997  12,359  (1,117) 2015 2019
CTR Partnership, L.P. Inn at Barton Creek Bountiful, UT —  2,480  4,804  15  2,480  4,819  7,299  (640) 1999 2020
CTR Partnership, L.P. Chapters Living of Northwest Chicago Bartlett , IL —  1,964  5,650  —  1,964  5,650  7,614  (265) 2017 2023
CTR Partnership, L.P. Chapters Living of Elmhurst Elmhurst , IL —  2,852  7,348  —  2,852  7,348  10,200  (339) 2017 2023
CTR Partnership, L.P. The Ridge at Lansing Lansing , MI —  888  9,871  —  888  9,871  10,759  (443) 2018 2023
CTR Partnership, L.P. The Ridge at Beavercreek Beavercreek , OH —  1,165  8,616  —  1,165  8,616  9,781  (381) 2018 2023
2985 N. G. Street PropCo, LLC Villas at San Bernardino San Bernardino, CA —  1,631  9,263  —  1,631  9,263  10,894  (238) 2003 2024
CTR Partnership, L.P. South Mountain Boonsboro, MD —  1,205  508  —  1,205  508  1,713  —  2022 2024
—  33,236  147,443  9,697  32,558  132,304  164,862  (35,034)
—  $ 369,335  $ 2,120,116  $ 123,394  $ 367,044  $ 2,220,287  $ 2,587,331  $ (390,218)
(1) The aggregate cost of real estate for federal income tax purposes was $2.6 billion.
F-52

SCHEDULE III
REAL ESTATE ASSETS AND ACCUMULATED DEPRECIATION
DECEMBER 31, 2024
(dollars in thousands)
  Year Ended December 31,
Real estate: 2024 2023 2022
Balance at the beginning of the period $ 1,899,290  $ 1,721,871  $ 1,873,806 
Acquisitions 793,733  233,876  21,252 
Improvements 6,514  8,878  5,896 
Impairment (4,430) (10,078) (29,803)
Sales and/or transfers to assets held for sale, net (107,776) (55,257) (149,280)
Balance at the end of the period $ 2,587,331  $ 1,899,290  $ 1,721,871 
Accumulated depreciation:
Balance at the beginning of the period $ (350,732) $ (315,914) $ (304,785)
Depreciation expense (50,896) (45,275) (42,131)
Impairment 906  2,076  10,232 
Sales and/or transfers to assets held for sale, net 10,504  8,381  20,770 
Balance at the end of the period $ (390,218) $ (350,732) $ (315,914)

F-53

SCHEDULE IV
MORTGAGE LOANS ON REAL ESTATE
DECEMBER 31, 2024
(dollars in thousands)
Description Contractual Interest Rate Maturity Date Periodic Payment Terms Prior Liens Principal Balance
Book Value (1)
Carrying Amount of Loans Subject to Delinquent Principal or Interest
Mortgage Secured Loans:
Multiple (21 SNF, 15 ALF, 1 ILF)
8.4  % 2029
(3)
$ —  $ 260,000  $ 262,888  N/A
North Carolina (5 SNF, 3 SNF Campus)
9.2  %
(2)
2029
(3)
—  165,000  169,974  N/A
West Virginia (17 SNF, 1 SNF Campus)
8.4  % 2027
(3)
482,000 
(4)
75,000  71,804  N/A
Georgia (4 SNF)
9.0  %
(2)
2025
(3)
80,575 
(5)
29,600  28,825  N/A
Tennessee (2 SNF)
9.1  % 2031
(3)
—  26,675  27,339  N/A
California (1 SNF, 1 ALF & 1 ILF)
9.0  % 2033
(3)
—  25,993  24,800  N/A
Maryland (1 SNF)
9.4  % 2039
(3)
—  19,190  17,769  N/A
Florida (2 SNF)
9.0  % 2028
(3)
—  15,727  15,621  N/A
Washington (1 SNF)
8.5  % 2034
(3)
—  11,250  11,263  N/A
Colorado (1 SNF )
8.5  % 2034
(3)
—  9,800  9,940  N/A
California (3 SNF)
10.3  %
(2)
2025
(3)
24,825 
(5)
7,301  7,245  N/A
California (1 ALF)
9.9  % 2026
(3)
—  6,300  6,409  N/A
California (4 SNF)
12.0  % 2026
(3)
38,330 
(6)
3,564  3,491  N/A
Indiana (1 ALF)
9.0  % 2025
(3)
—  2,000  2,016  N/A
Florida (1 ALF)
9.0  % 2027
(3)
—  1,000  1,008  N/A
Mezzanine Loans:
Virginia (15 SNF)
14.0  % 2027
(3)
270,000  35,000  35,422  N/A
West Virginia (17 SNF, 1 SNF Campus)
11.0  %
(2)
2032
(3)
557,000 
(4)
25,000  22,690  N/A
Missouri (6 SNF, 2 Campus, 2 ALF)
14.0  %
(2)
2027
(3)
100,200  9,800  9,918  N/A
California (2 SNF)
11.5  % 2029
(3)
13,597  7,365  7,438  N/A
Maryland (1 SNF Campus)
13.0  % 2034
(3)
15,276  5,122  5,144  N/A
$ 1,581,803  $ 740,687  $ 741,004 
(1)The aggregate cost for federal income tax purposes was $740.7 million as of December 31, 2024.
(2)Interest rates are variable and represent the rate in effect as of December 31, 2024.
(3)Interest is due monthly, and principal is due at the maturity date.
(4)The secured term loan was structured with an “A” tranche, a “B” tranche, and a “C” tranche, with the “C” tranche being the most subordinate. The Company’s loan constituted the entirety of the “C” tranche. The Company also extended a mezzanine loan to the borrower group. Accordingly, the amounts of the prior liens at December 31, 2024 are estimated.
(5)The secured term loan was structured with an “A” and a “B” tranche, with the “B” tranche being subordinate to the “A” tranche pursuant to the terms of a written agreement between the lenders. The Company’s loan constituted the entirety of the “B” tranche. Accordingly, the amounts of the prior liens at December 31, 2024 are estimated.
(6)The first mortgage loans on these properties are not held by the Company. Accordingly, the amounts of the prior liens at December 31, 2024 are estimated.

F-54

SCHEDULE IV
MORTGAGE LOANS ON REAL ESTATE
DECEMBER 31, 2024
(dollars in thousands)
Changes in mortgage secured and mezzanine loans are summarized as follows (in thousands):
Year Ended December 31,
2024 2023 2022
Balance at beginning of period $ 178,568  $ 156,368  $ 15,155 
Additions during period:
New mortgage and mezzanine loans 555,203  53,834  147,150 
Interest income added to principal 2,600  388  1,165 
Deductions during period:
Paydowns/Repayments (4,412) (25,537) — 
Unrealized gain (loss), net 9,045  (6,485) (7,102)
Balance at end of period $ 741,004  $ 178,568  $ 156,368 

F-55
EX-10.14 2 ex1014assetpurchasagreement.htm EX-10.14 Document
Execution Version




ASSET PURCHASE AGREEMENT
by and between
THE SELLER PARTIES SET FORTH ON EXHIBIT A
and
THE PURCHASER PARTIES SET FORTH ON EXHIBIT B
Dated as of October 21, 2024



TABLE OF CONTENTS
Article I CERTAIN DEFINITIONS........................................................................................ 6
1.1...... Defined Terms...................................................................................................... 6
1.2...... Terms Generally................................................................................................. 23
Article II PURCHASE AND SALE OF ASSETS................................................................. 24
2.1...... Sale of Purchased Assets.................................................................................... 24
2.2...... Excluded Assets.................................................................................................. 25
2.3...... Assumption of Liabilities................................................................................... 27
2.4...... Excluded Liabilities............................................................................................ 28
2.5...... Purchase Price; Deposit..................................................................................... 28
2.6...... Purchase Price Allocation.................................................................................. 29
2.7...... Limitation on Assignment of Purchased Assets.............................................. 30
2.8...... Inspections........................................................................................................... 31
2.9...... WTTC Facility – WTHC Declaration.............................................................. 32
Article III CLOSING.............................................................................................................. 33
3.1...... Initial Closing...................................................................................................... 33
3.2...... Interim Documents............................................................................................. 35
3.3...... Effective Time..................................................................................................... 35
3.4...... Transfer of Purchased Assets............................................................................ 35
3.5...... Designation of Purchased Assets....................................................................... 35
3.6...... Operations Transfer Agreements..................................................................... 35
Article IV REPRESENTATIONS AND WARRANTIES OF SELLER............................... 36
4.1...... Corporate............................................................................................................ 36
4.2...... Financial Statements; Undisclosed Liabilities................................................. 37
4.3...... Taxes.................................................................................................................... 37
4.4...... Real Property...................................................................................................... 38
4.5...... Title to Purchased Assets; Absence of Encumbrances................................... 40
4.6...... Intellectual Property.......................................................................................... 40
4.7...... Corporate Contracts.......................................................................................... 41
4.8...... Litigation............................................................................................................. 41
4.9...... Stimulus Funds................................................................................................... 41
4.10.... Material Contracts............................................................................................. 41
4.11.... Compliance with Health Care Laws................................................................. 43
4.12.... Environmental Matters..................................................................................... 44
4.13.... Absence of Certain Changes............................................................................. 45
4.14.... Brokers and Finders.......................................................................................... 46
4.15.... Solvency............................................................................................................... 46
4.16.... Insurance............................................................................................................. 46
4.17.... No Other Representations or Warranties; Reliance on Representations and Warranties.......................................................................................................... 46
4.18.... Disclosure Updates............................................................................................. 47
4.19.... Employment and Labor Matters...................................................................... 47
4.20.... Employee Benefits.............................................................................................. 47
4.21.... Bankruptcy......................................................................................................... 47
4.22.... OFAC................................................................................................................... 48
Article V REPRESENTATIONS AND WARRANTIES OF PURCHASER....................... 48
5.1...... Corporate............................................................................................................ 48
5.2...... Litigation............................................................................................................. 49
5.3...... Brokers and Finders.......................................................................................... 49
1



5.4...... HSR...................................................................................................................... 49
5.5...... Sufficient Funds; Solvency................................................................................ 49
5.6...... Third Party Reports........................................................................................... 49
5.7...... OFAC................................................................................................................... 49
5.8...... Independent Investigation; Completion of Due Diligence.............................. 49
5.9...... AS-IS; No Other Representations or Warranties........................................... 50
Article VI COVENANTS....................................................................................................... 51
6.1...... Interim Conduct................................................................................................. 51
6.2...... Certain Tax Matters........................................................................................... 52
6.3...... Reasonable Best Efforts; Cooperation; Regulatory Filings........................... 53
6.4...... Announcement and Disclosure.......................................................................... 55
6.5...... Other Regulatory Filings................................................................................... 57
6.6...... Efforts and Actions............................................................................................. 57
6.7...... Corporate Contracts; Overhead and Shared Services................................... 59
6.8...... Risk of Loss; Casualty Loss; Condemnation................................................... 60
6.9...... Title and Survey Matters; Estoppel Certificates............................................. 61
6.10.... Encumbrance Release........................................................................................ 63
6.11.... Financing Cooperation...................................................................................... 63
6.12.... Third Party Reports........................................................................................... 64
6.13.... Non-Competition................................................................................................ 64
6.14.... Non-Solicit........................................................................................................... 65
6.15.... Notice of Breach................................................................................................. 65
6.16.... Reverse 1031....................................................................................................... 66
6.17.... Assumed Contracts............................................................................................ 66
6.18.... Connected Facilities........................................................................................... 66
6.19.... CID....................................................................................................................... 67
6.20.... Knoxville Facilities............................................................................................. 67
Article VII CLOSING CONDITIONS; SUBSEQUENT CLOSINGS.................................. 68
7.1...... Conditions to the Initial Closing....................................................................... 68
7.2...... Escrow Facilities................................................................................................. 71
7.3...... Subsequent Closings........................................................................................... 72
7.4...... Conditions to each Subsequent Closing........................................................... 72
7.5...... Subsequent Closing Purchase Price; Adjustment; Payment......................... 74
7.6...... Failure of Closing Condition Not Evidence of Breach.................................... 76
Article VIII POST-CLOSING RIGHTS AND OBLIGATIONS........................................... 76
8.1...... Assumed Liabilities; Excluded Liabilities........................................................ 76
Article IX INDEMNIFICATION........................................................................................... 76
9.1...... Survival of Representations, Warranties and Covenants.............................. 76
9.2...... Indemnification by Seller.................................................................................. 77
9.3...... Indemnification by Purchaser........................................................................... 77
9.4...... Indemnification Limitations.............................................................................. 77
9.5...... Assumption of Defense....................................................................................... 79
9.6...... Non-Assumption of Defense.............................................................................. 80
9.7...... Indemnified Party’s Cooperation as to Proceedings....................................... 80
9.8...... Damages Disclaimed.......................................................................................... 80
9.9...... Individual Liability Disclaimed........................................................................ 80
9.10.... Exclusive Remedy Post-Closing........................................................................ 81
9.11.... Application of Indemnity Escrow Funds......................................................... 81
2



9.12.... Non-Recourse Parties......................................................................................... 81
9.13.... Interim Indemnity; Guaranty........................................................................... 82
9.14.... Execution Date R&W Breach Guaranty.......................................................... 82
9.15.... CID Guarantees.................................................................................................. 82
Article X TERMINATION AND BREACH......................................................................... 82
10.1.... Termination and Breach Events....................................................................... 82
10.2.... Effect of Termination or Breach....................................................................... 84
10.3.... Third Party Reports Following Termination.................................................. 86
Article XI MISCELLANEOUS............................................................................................. 86
11.1.... Schedules............................................................................................................. 86
11.2.... Expenses.............................................................................................................. 86
11.3.... Entirety of Agreement....................................................................................... 86
11.4.... Notices................................................................................................................. 87
11.5.... Amendments; Waivers....................................................................................... 87
11.6.... Counterparts; Facsimile.................................................................................... 88
11.7.... Assignment; Binding Nature; No Beneficiaries............................................... 88
11.8.... Headings.............................................................................................................. 89
11.9.... Construction....................................................................................................... 89
11.10.. Governing Law..................................................................................................... 89
11.11.. Forum; Waiver of Jury Trial............................................................................ 89
11.12.. Remedies Cumulative........................................................................................ 90
11.13.. Severability......................................................................................................... 90
11.14.. Enforcement........................................................................................................ 90
11.15.. No Recourse to Financing Sources................................................................... 90


Exhibits
Exhibit A:    Seller Parties
Exhibit B:    Purchaser Parties
Exhibit C:    Facilities
Exhibit C-1    Census Facilities
Exhibit C-2    Exempt Facilities
Exhibit D:    Real Property
Exhibit E:    Deposit Agreement
Exhibit F:    Form of Bill of Sale and Assignment and Assumption Agreement
Exhibit G:    Form of Indemnity Escrow Agreement
Exhibit H:    Form of Deeds
Exhibit I:    Form of Operations Transfer Agreement
Exhibit J:    Form of Interim Management Agreement
Exhibit K    Form of Interim Sublease Agreement
Exhibit L    List of Required Consents
Exhibit M    Current Resident Census
Exhibit N    Form of Interim Indemnity Guaranty
Exhibit O    Form of Execution Date R&W Guaranty
Exhibit P    Form of CID Guaranty
Exhibit Q Seller Leased Parcel Descriptions Exhibit R Seller Leased Parcel Lease Agreement Terms
3



Exhibit T-1    Champion Facilities
Exhibit T-2    Ensign Facilities
Exhibit T-3    Links Facilities
Exhibit T-4    PACS Facilities

4



ASSET PURCHASE AGREEMENT
Exhibit S Third Party Reports THIS ASSET PURCHASE AGREEMENT (this “Agreement”), dated as of October 21, 2024 (the “Execution Date”), is by and between the entities listed as “Property Owner” set forth on Exhibit A (each, individually a “Property Owner” and collectively, the “Property Owners”), the entities listed as “Current Operator” set forth on Exhibit A (each, individually a “Current Operator” and collectively, the “Current Operators” and together with the Property Owners and Current Operators, collectively, the “Seller”), and the entities listed as “Purchaser Parties” set forth on Exhibit B (collectively, the “Purchaser”). Each of Seller and Purchaser may be referred to herein as a “Party” and collectively as the “Parties.”
RECITALS
A.    Each Property Owner is the fee simple owner of the Facilities listed opposite such Property Owner’s name set forth on Exhibit C attached hereto.
B.    Each Current Operator is the tenant and licensed operator of the Facilities listed opposite such Current Operator’s name set forth on Exhibit C attached hereto.
C.    Subject to the terms and conditions hereof, Purchaser desires to purchase the Purchased Assets and assume the Assumed Liabilities, and Seller desires to sell (or cause to be sold) the Purchased Assets and transfer the Assumed Liabilities to Purchaser, upon the terms and conditions set forth herein.
NOW, THEREFORE, in consideration of the premises and the mutual covenants and agreements hereinafter set forth, the Parties, intending to be legally bound, hereby agree as follows:
Article I
CERTAIN DEFINITIONS
1.1Defined Terms. As used in this Agreement and the Exhibits and Schedules attached to this Agreement, the following definitions shall apply:
“AAP” has the meaning ascribed to it in Section 4.9.
“Accounts Receivable” means all accounts receivable and incentive payments of the Businesses, including (a) all trade accounts receivable and other rights to payment from customers of the Seller and the full benefit of all security for such accounts or rights to payment, including all trade accounts receivable representing amounts receivable in respect of services rendered to residents of the Facilities, including those due to the Seller from Medicare, Medicaid, Veteran’s Administration, TRICARE f/k/a CHAMPUS, commercial insurers or any other third-party payor, resident or responsible party, (b) all other accounts or notes receivable of the Seller relating to services rendered to residents of the Facilities and the full benefit of all security for such accounts or notes, (c) amounts due from third-party payors with respect to amounts recoverable for bad debts and estimated settlements from third-party payors, and (d) any claim, remedy or other right related to any of the foregoing.
5



“Action” means any claim, action, cause of action or suit (whether in contract or tort), litigation (whether at Law or in equity, whether civil or criminal), or any written controversy, assessment, arbitration, investigation, hearing, charge, complaint, demand, settlement, notice or proceeding to, from, by or before any Governmental Authority of which the Parties thereto have received written notice.
“Administrative Transfer” has the meaning ascribed to it in Section 3.2.
“Affiliate” means, with respect to any Person, any other Person directly or indirectly controlling, controlled by, or under common control with such first Person. For purposes of this definition, “control” (including, for the avoidance of doubt, its correlative meanings “controlled by” and “under common control with”), when used with respect to any Person, means the power to direct the management and policies of such Person, directly or indirectly, whether through the ownership of voting securities, by contract or otherwise.
“Agreement” has the meaning ascribed to it in the Preamble.
“Alternate Arrangements” has the meaning ascribed to it in Section 9.4(c).
“Applicable Law” means, with respect to any Person, any federal, state, territorial, provisional, foreign or local law (including common law), constitution, treaty, convention, ordinance, code, rule, regulation, order, injunction, judgment, decree, ruling or other similar requirement enacted, adopted, promulgated or applied by a Governmental Authority that is binding upon or applicable to such Person.
“Assumed Contracts” has the meaning ascribed to it in Section 6.17.
“Assumed Liabilities” has the meaning ascribed to it in Section 2.3.
“Average Resident Census” means, (a) with respect to the Phase I Initial Closing, the average number of Verified Residents at the applicable Facilities during the period beginning on the date which is thirty (30) days prior to the Phase I Initial Closing Date and ending on the day immediately prior to the Phase I Initial Closing Date, determined using the applicable Facilities’ Verified Resident census for each day during such period, (b) with respect to the Phase II Initial Closing, the average number of Verified Residents at the applicable Facilities during the period beginning on the date which is sixty (60) days prior to the Phase II Initial Closing Date and ending on the day immediately prior to the Phase II Initial Closing Date, determined using the applicable Facilities’ Verified Resident census for each day during such period, and (c) with respect to a Subsequent Closing, the average number of Verified Residents at the applicable Facilities during the period beginning on the date which is thirty (30) days prior to the Census Date and ending on the day immediately prior to the Census Date, determined using the applicable Facilities’ Verified Resident census for each day during such period.
6



“Benefit Plan” means each material written (i) “employee benefit plan” as defined in Section 3(3) of ERISA, (ii) compensation, severance, change in control, transaction bonus, retention or similar plan, agreement, arrangement, program or policy or (iii) other plan, agreement, arrangement, program or policy providing for compensation, bonuses, profit-sharing, equity or equity-based compensation or other forms of incentive or deferred compensation, vacation benefits, insurance (including any self-insured arrangement), medical, dental, vision, prescription or fringe benefits, life insurance, expatriate benefits, perquisites, disability or sick leave benefits, employee assistance program, workers’ compensation, supplemental unemployment benefits or post-employment or retirement benefits (including compensation, pension, health, medical or insurance benefits) that is contributed to, required to be contributed to, sponsored, maintained or entered into by Seller or its ERISA Affiliates; provided that a Benefit Plan shall not include any governmental plan or program requiring the mandatory payment of social insurance taxes or similar contributions to a governmental fund with respect to the wages of an employee or any other plan, agreement, arrangement, program or policy administered or maintained by a Governmental Authority.
“Bill of Sale and Assignment and Assumption Agreement” has the meaning ascribed to it in Section 7.1(b)(viii).
“Broker” or “Brokers” have the meaning ascribed to them in Section 4.14.
“Business” or “Businesses” means all business conducted by Seller in connection with the SNF Business.
“Business Day” means any day that is not (i) a Saturday or Sunday, or (ii) a legal holiday on which banks are authorized or required by Law to be closed in New York, New York, or (iii) one of the following Jewish Holidays, with the dates of said holidays for 2024 set forth in parentheticals: Purim (March 24), Passover (April 23 - April 30), Shavuot (June 12 - June 13), “Nine Days” (August 5 – August 13), Rosh Hashana (October 3 - 4), Yom Kippur (October 12), and Sukkot (October 17 – October 23), Shemini Atzeres (October 24) and Simchas Torah (October 25).
“Business Employee” means the employees of the Businesses and the Manager set forth on Schedule 1.1(a), which shall be updated by Seller at least five (5) days before each Closing to reflect any Business Employee that is terminated or hired in the Ordinary Course, in each case, after the Execution Date.
“Cash” means, with respect to any Person as of any time, the cash and cash equivalents (including marketable securities in accordance with GAAP) and security deposits held by or on behalf of such Person at such time, and shall include checks, ACH transactions and other wire transfers and drafts deposited or available for deposit for the account of such Person at such time (net of issued but uncleared checks and drafts written or issued by or to such Person), in each case calculated and determined in accordance with GAAP.
“Casualty Loss” has the meaning ascribed to it in Section 6.8(a).
“Casualty OoC” has the meaning ascribed to it in the definition of the term “Out of Compliance.”
7



“Casualty Threshold” has the meaning ascribed to it in Section 6.8(a)(i).
“Census Date” has the meaning ascribed to it in Section 7.5(b).
“Census Discount Amount” means the product of the Census Discount Percentage multiplied by the applicable Facility Purchase Price.
“Census Discount Percentage” means (i) with respect to an Exempt Facility, the Census Percentage Decrease, and (ii) with respect to a Census Facility, the Census Percentage Decrease minus eight and seventy-five hundredths’ percent (8.75% or 0.0875), expressed in decimal form.
“Census Discounted Facility Purchase Price” means an amount equal to difference of the applicable Facility Purchase Price less the Census Discount Amount.
“Census Facilities” means the skilled nursing facilities listed on Exhibit C-1.
“Census 15% OoC” has the meaning ascribed to it in the definition of the term “Out of Compliance.”
“Census Floor” means, (i) with respect to the Exempt Facility known as AHC Wellpark, fifteen (15) Verified Residents, and (ii) with respect to the WTTC Facility, fifty (50) Verified Residents.
“Census Floor OoC” has the meaning ascribed to it in the definition of the term “Out of Compliance.”
“Census OoC” has the meaning ascribed to it in the definition of the term “Out of Compliance.”
“Census Percentage Decrease” has the meaning ascribed to it in Section 7.5(b).
“Champion Facilities” shall mean those Facilities set forth on Exhibit T-1.
“CID” has the meaning ascribed to it in Section 6.19.
“Closing” means, with respect to (i) the Phase I Facilities, either the Phase I Initial Closing or a Subsequent Closing applicable to the Phase I Facilities, and (ii) the Phase II Facilities, either the Phase II Initial Closing or a Subsequent Closing applicable to the Phase II Facilities, in each case, as applicable, and as determined in accordance with Article VII.
“Closing Conditions” means, with respect to (i) the Phase I Initial Closing and Phase II Initial Closing, the conditions set forth in Section 7.1, and (ii) and with respect to any Subsequent Closing, the conditions set forth in Section 7.4.
“Closing Date” means, with respect to any Facility, the day on which its applicable Closing (if any) occurs, including the Phase I Initial Closing Date, Phase II Initial Closing Date and each Subsequent Closing Date, as applicable.
8



“Closing Document” has the meaning ascribed to it in Section 9.1.
“Code” means the Internal Revenue Code of 1986, as amended.
“Competition Laws” means statutes, rules, regulations, orders, decrees, administrative and judicial doctrines, and other laws that are designed or intended to prohibit, restrict or regulate actions having the purpose or effect of monopolization, lessening of competition or restraint of trade.
“Condemnation” means a taking or voluntary conveyance of all or part of any property or any interest in or right accruing to or use of any property, as the result of, or in settlement of, any condemnation or other eminent domain proceeding by any Governmental Authority.
“Condemnation Award” has the meaning ascribed to it in Section 6.8(b)(ii)(A).
“Condemnation Threshold” has the meaning ascribed to it in Section 6.8(b)(ii)(A).
“Confidential Information” has the meaning ascribed to it in Section 6.4(b).
“Confidentiality Agreement” means (a) that certain Access and Due Diligence Agreement dated effective as of June 28, 2024, between Seller and EAGLE ARC PARTNERS, LLC, and (b) that certain Non-Disclosure Agreement dated May 17, 2024, between JE EVANS LLC and BM EAGLE MANAGEMENT, LLC.
“Consents” means, as the context requires, the consent of (a) counterparties to (i) any Contract if so required by the Contract, and (ii) any Real Property Leases if so required by such Real Property Leases; and (b) a Governmental Authority if so required regarding any License or other governmental authorization of the transactions contemplated herein required by Law.
“Contract” means any binding contract or agreement including any union or collective bargaining agreement, cable, energy or utility agreement, employment agreement, licensing agreement, insurance contract, insurance policy, lease (including any capital or operating leases related to office equipment), sublease, purchase order, sales order, delivery order or instrument of indebtedness (including Debt), whether written or oral.
“Corporate Contracts” means all Contracts between any Seller or any of their respective Affiliates, on the one hand, and any third party, on the other hand, that have been entered into on a national or regional basis including any Contract pursuant to which any services are provided by or to any businesses or operations of Seller or any of its Affiliates that is not the SNF Business.
“Cost Reports” means all cost reports exclusively related to any of the Businesses filed by Seller prior to the Execution Date pursuant to the requirements of any applicable Government Reimbursement Programs for cost-based payments or reimbursement due to or claimed by Seller from any applicable Government Reimbursement Programs or their fiscal intermediaries or payor agents.
9



“COVID-19” means SARS-CoV-2 or COVID-19, and any variants or evolutions thereof or related or associated epidemics, pandemic or disease outbreaks.
“Cured Facility” means (i) with respect to any Escrow Facility which was subject to a Casualty OoC, that all repairs and restoration to such Escrow Facility as may be necessary to restore such Escrow Facility to operations in the Ordinary Course have been completed, as reasonably agreed upon by Purchaser and Seller, (ii) with respect to any Escrow Facility which was subject to a Regulatory OoC, such regulatory condition shall be subject to a plan of correction approved by the applicable Governmental Authority and fully implemented and corrected to the reasonable satisfaction of the Purchaser and applicable OTA Transferee (it being acknowledged and agreed that no party may require a further survey or resurvey by such Governmental Authority as a condition to such “reasonable satisfaction”), (iii) with respect to any Escrow Facility which was subject to a Census 15% OoC (A) the average number of Verified Residents at such Facility with respect to any thirty (30) day period after the Initial Closing Date (calculated using such Facility’s Verified Resident census for each day during such period) rises, such that such average number is no longer fifteen-percent (15%) or more below the Current Resident Census at such Facility, and (B) thereafter the daily Verified Resident census remains above such baseline number of Verified Residents for ten (10) consecutive days, (iv) with respect to any Escrow Facility which was subject to a Census Floor OoC (A) the average number of Verified Residents at such Facility with respect to any thirty (30) day period after the Initial Closing Date (calculated using such Facility’s Verified Resident census for each day during such period) rises, such that such average number is equal to or greater than the Census Floor for such Facility, and (B) thereafter the daily Verified Resident census remains above such Census Floor for ten (10) consecutive days, (v) solely with respect to the WTTC Facility, Seller has obtained the WTTC Waiver, (vi) solely with respect to any Title Cure Escrow Facility, Seller shall have cured all title exceptions in the applicable Title Objection Notice which Seller elected to cure, or (vii) solely with respect to the Knoxville Facilities, Seller shall have obtained the Knoxville Billing Approval; provided, that in each case, if a Facility is an Escrow Facility on account of more than one condition of the definition of “Out of Compliance”, then such Escrow Facility shall not be deemed a Cured Facility hereunder unless and until all such conditions are deemed cured hereunder.
“Current Representation” has the meaning ascribed to it in Section 6.4(d)(i).
“Current Resident Census” means the number of Verified Residents at the Facilities as of October 20, 2024, as more particularly shown on Exhibit M attached hereto.
“Data Room” means the virtual data room located at https://app.box.com/folder/271882556548 including all documents and materials posted thereto as of the Initial Closing Date.
“Debt” means, with respect to any Person, any long-term or short-term indebtedness of such Person, including any amounts owing under capital leases, amounts outstanding under notes payable to financial institutions, amounts outstanding under lines of credit, amounts owing under notes payable, and any prepayment penalties or expenses payable in connection with the foregoing transactions.
10



“Deeds” has the meaning ascribed to it in Section 7.1(b)(viii).
“Deferred Consent” has the meaning ascribed to it in Section 2.7(b).
“Deferred Item” has the meaning ascribed to it in Section 2.7(b).
“Department” means the Governmental Authority in each state that regulates and oversees the operations of each Facility and is responsible for issuing the Licenses required to lawfully operate such Facility as a skilled nursing facility.
“Deposit” has the meaning ascribed to it in Section 2.5(b).
“Deposit Agreement” has the meaning ascribed to it in Section 2.5(b).
“Deposit Escrow Account” has the meaning ascribed to it in Section 2.5(b).
“Disclosure Update” has the meaning ascribed to it in Section 4.18.
“DPNA” means a determination of denial of payment for new admission.
“Effective Time” has the meaning ascribed to it in Section 3.3.
“Encumbrance” means any charge, claim, condition, equitable interest, lien, encumbrance, license, pledge, security interest, mortgage, right of way, easement, encroachment, servitude, right of first offer or first refusal, buy/sell agreement and any other restriction or covenant with respect to, or condition governing the use, construction, voting (in the case of any security or equity interest), transfer, receipt of income or exercise of any other attribute of ownership.
“End Date” means the Outside Date; provided, however, that if on the Outside Date all of the applicable Closing Conditions contained in Section 7.4 are satisfied (other than those conditions that by their terms are to be satisfied at the Closing, so long as each such condition is capable of being satisfied) or, to the extent permitted by applicable Law, waived other than the conditions set forth in Section 7.4(a)(i)(A) (Cured Facility) (provided that such condition is then capable of being satisfied through the exercise of commercially reasonable efforts), then Seller may, by written notice to Purchaser, extend the End Date for up to ninety (90) days, and all references to the term “End Date” shall be deemed to mean the End Date as so extended.
“Ensign Facilities” shall mean those Facilities set forth on Exhibit T-2.
“Environment” means the indoor or outdoor environment, including soil, surface water, ground water, wetlands, land, stream sediments, surface or subsurface strata, climate, atmosphere, and air.
“Environmental Law” means all Laws that relate to or govern the regulation, quality, protection or improvement of human health, pollution, or the Environment, including (a) emissions, discharges, Releases, or threatened Releases of or exposures to Hazardous Substances, (b) protection of public health, the Environment or worker health and safety, (c) the manufacture, generation, processing, distribution, handling, transport, use, treatment, storage or disposal of Hazardous Substances, or (d) recordkeeping, notification, warning, disclosure and reporting requirements respecting Hazardous Substances.
11



“ERISA” means the Employee Retirement Income Security Act of 1974, as amended, and the rules and regulations promulgated thereunder.
“ERISA Affiliate” means any entity which is a member of (A) a controlled group of corporations (as defined in Section 414(b) of the Code), (B) a group of trades or businesses under common control (as defined in Section 414(c) of the Code), or (C) an affiliated service group (as defined under Section 414(m) of the Code or the regulations under Section 414(o) of the Code), any of which includes or included the Seller.
“Escrow Facility” has the meaning ascribed to it in Section 7.2.
“Escrow Facility Threshold” means, (i) with respect to the Phase I Initial Closing, ten percent (10%), and (ii) with respect to the Phase II Initial Closing, fifteen percent (15%), provided, however, that if the WTTC Facility or the Knoxville Facilities become an Escrow Facility pursuant to Section 7.2(a), or if there is any Title Cure Escrow Facility, then such Facility shall not be included in the numerator or the denominator in determining the Escrow Facility Threshold.
“Escrowable Casualty Loss” has the meaning ascribed to it in Section 6.8(a)(ii).
“Estimator” has the meaning ascribed to it in Section 6.8(a).
“Excluded Assets” has the meaning ascribed to it in Section 2.2.
“Excluded Facility” means a Facility initially intended to be sold by a Seller and purchased by a Purchaser pursuant to this Agreement and excluded by Purchaser pursuant to either of Sections 6.8(a)(iii) (Casualty) or 6.8(b)(ii)(B) (Condemnations) or by Seller pursuant to the provisions of Section 2.9.
“Excluded Liabilities” has the meaning ascribed to it in Section 2.4.
“Exclusion Threshold” has the meaning ascribed to it in Section 6.8(a)(iii).
“Execution Date” has the meaning ascribed to it in the Preamble.
“Execution Date R&W Breach” has the meaning ascribed to it in Section 9.4(a)(ii).
“Exempt Facilities” means the skilled nursing facilities listed on Exhibit C-2.
“Expiration Date” has the meaning ascribed to it in Section 9.1.
“Facilities” means the skilled nursing facilities listed on Exhibit C.
12



“Facility Allocation” shall mean the allocation of the Purchase Price among each of the Facilities set forth on Schedule 7.2 attached hereto (with the amount so allocated being such Facility’s “Facility Purchase Price”); the Facility Allocation also sets forth each Facility’s Pro-Rata Percentage.
“Facility Purchase Price” has the meaning ascribed to it in the definition of “Facility Allocation.”
“Financial Statements” means the audited balance sheets and profit and loss statements relating to the operations of the Business for the 2022 and 2023 fiscal years and the unaudited balance sheets and profit and loss statements relating to the operations of the Business for the 2024 fiscal year.
“Financing” means any debt or equity financing or financings in connection with the transactions contemplated by this Agreement including any offering or private placement of debt securities or borrowing of loans and any related commitment letter or engagement letter and including any credit facilities, working capital financing or capital markets debt financing or equity or equity-related offerings.
“Financing Sources” means the agents, arrangers, lenders and other entities that have committed to provide or arrange or otherwise entered into agreements in connection with any Financing, including the parties to any commitment letter or engagement letter in respect of any Financing or to any joinder agreements, indentures, credit agreements or other agreements entered into pursuant thereto or relating thereto, together with their Affiliates and the current, former or future officers, directors, employees, partners, trustees, shareholders, equityholders, managers, members, limited partners, controlling persons, agents and representatives of each of them and the successors and assigns of the foregoing Persons.
“Fraud” means intentional fraud under Delaware common law committed by any of any of the individuals included in the definition of Sellers’ Knowledge. “Fraud” shall not include any equitable fraud, constructive fraud, statutory fraud, negligent misrepresentation or omission, or any form of fraud based on recklessness, negligence, or similar theories.
“Fundamental Representations” has the meaning ascribed to it in Section 9.1.
“GAAP” means U.S. generally accepted accounting principles, as in effect on the Execution Date, consistently applied.
“Government Reimbursement Programs” means the Medicare program, the TRICARE program, VA program, any relevant state Medicaid program and any other similar or successor federal, state or local health care payment programs with or sponsored by any Governmental Authority.
“Governmental Authority” means any governmental or regulatory body, agency, authority, commission, department, bureau, court, tribunal or political subdivision, whether federal, state, local or foreign, including any intermediary, carrier, instrumentality, or agency thereof.
13



“Harbor View Real Property and Van Ayer Real Property” means the real property set forth on Exhibit D attributable to AHC Harbor View and AHC Van Ayer.
“Hazardous Substances” means any chemicals, materials, compounds or substances defined, regulated, listed or otherwise classified under any Applicable Law as a “hazardous substance,” “extremely hazardous substance,” “hazardous material,” “hazardous waste,” “universal waste,” “mixed waste,” “bio-hazardous waste,” “medical waste,” “radioactive waste,” “pharmaceutical waste,” “commingled waste,” “toxic substance,” “toxin,” “pollutant” or “contaminant,” including petroleum (including petroleum products, constituents, additives, or derivatives thereof), asbestos, asbestos-containing materials, mold and polychlorinated biphenyls.
“Health Care Laws” means any federal, state, provincial and local Laws, including program instructions and guidance, that are generally applicable to or relating to the operation of a healthcare or medical facility or entity, entity participating in any Government Authority program or entity holding any healthcare License, including (i) (A) the federal Anti-Kickback Statute (42 U.S.C. § 1320a-7b(b)); (B) the Physician Self-Referral Law, commonly known as the “Stark Law” (42 U.S.C. §1395nn); (C) the criminal health care fraud statute(18 U.S.C. § 1347); (D) the civil False Claims Act (31 U.S.C. § 3729 et seq.); (E) the Federal, Food, Drug and Cosmetic Act (21 U.S.C. § 301 et seq.); (F) the Federal Controlled Substances Act (21 U.S.C.§ 801 et seq.); (G) the Clinical Laboratory Improvement Amendments of 1988 (42 U.S.C. § 263a et seq.); (H) TRICARE (10 U.S.C. §§ 1071 et seq.); (I) Sections 1320a-7, 1320a-7a, and 1320a-7b of Title 42 of the United States Code and the regulations promulgated pursuant to such statutes;(ii) HIPAA; (iii) Medicare (Title XVIII of the Social Security Act) and the regulations promulgated thereunder; (iv) Medicaid (Title XIX of the Social Security Act) and the regulations promulgated thereunder; (v) quality, safety and medical necessity Laws relating to the regulation, provision or administration of, or payment for, healthcare products or services; (vi) rules governing the provision of services to employees with workers compensation coverage or licensure or certification as a healthcare organization to provide such services; (vii) licensure Laws relating to the regulation, provision or administration of, or payment for, healthcare products or services, including Laws relating to the so-called “corporate practice of medicine” and fee splitting; (viii) regulation of ordering, prescribing, storing and distributing controlled substances and radioactive materials; (ix)regulation of advertising of physician, provider or health care items or services; and (x) pricing of health care items or services, and/or mandated reporting of illnesses, diseases, and adverse events or incidents.
“Health Care Regulatory Approvals” has the meaning ascribed to it in Section 6.5.
“HSR Act” shall mean the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended from time to time, together with the rules and regulations promulgated thereunder.
“Impairment Estimate” has the meaning ascribed to it in Section 6.8(b)(ii).
14



“Impairment Percentage” has the meaning ascribed to it in Section 6.8(b)(ii).
“Includable Condemned Facility” has the meaning ascribed to it in Section 6.8(b)(ii)(A).
“Income Tax” means any U.S. federal, state, local or non-U.S. Tax based on or measured by reference to net income.
“Indemnification Cap” has the meaning ascribed to it in Section 9.4(a)(ii).
“Indemnification Obligations” means the respective indemnification obligations of Seller and Purchaser under Article IX.
“Indemnification Threshold” has the meaning ascribed to it in Section 9.4(a)(i).
“Indemnified Party” means any Person entitled to indemnification under Article IX of this Agreement and Article X of the OTAs.
“Indemnifying Party” means any Person required to provide indemnification under Article IX and Article X of the OTAs.
“Indemnity Escrow Agreement” has the meaning ascribed to it in Section 2.5(b).
“Indemnity Escrow Funds” has the meaning ascribed to it in Section 2.5(b).
“Initial Closing” means the Phase I Initial Closing or the Phase II Initial Closing, as applicable.
“Initial Closing Date” means the Phase I Initial Closing Date or the Phase II Initial Closing Date, as applicable.
“Intellectual Property” means any right, title and interest in and to all intellectual property rights throughout the world, including all (a) patents and patent applications, (b) Trademarks, (c) copyrights (including rights in software), (d) trade secrets, know-how and rights to proprietary information and data, (e) domain names and websites, (f) the Seller names and marks, and (g) any registrations or applications for any of the foregoing.
“Interim Documents” shall mean any Interim Management Agreement, Interim Sublease, Interim Indemnity Guaranty, and any other interim agreement consistent with state Law entered into pending an Administrative Transfer.
“Interim Indemnity” has the meaning ascribed to it in Section 9.13(a).
“Interim Indemnity Guaranty” has the meaning ascribed to it in Section 9.13(b).
“Interim Management Agreement” means an interim management agreement substantially in the form attached hereto as Exhibit J entered into by a Current Operator and an OTA Transferee during the interim period before issuance of the Licensure to the applicable OTA Transferee has been approved for a Facility by an applicable Government Authority whereby the applicable OTA Transferee shall manage such Facility on behalf of such Current Operator.
15



“Interim Period” means the period during which the Interim Documents are in effect.
“Interim Sublease” means an interim sublease agreement substantially in the form attached hereto as Exhibit K entered into by a Current Operator and a OTA Transferee during the interim period before issuance of the Licensure to an OTA Transferee has been approved for a Facility by an applicable Government Authority whereby the applicable OTA Transferee shall lease a Facility back to the applicable Current Operator holding the license.
“IRS” means the U.S. Internal Revenue Service.
“Knowledge” means, when used with respect to Seller, the actual knowledge of any of the following individuals: Michael Bailey - CEO AHP, Jeff Bogle - CFO AHP, Robin Bradley - COO AHP, Jason Bailey - SVP, Corporate Development AHP, Philip Clark - General Counsel AHP, Charlie Canon - AHC Controller, Greg Haynes - SVP, AHC Operations, in each case, after reasonable inquiry (provided that reasonable inquiry does not require any invasive or penetration testing). Purchaser acknowledges that no individual named above shall have any liability under this Agreement in connection with the transactions contemplated hereby and shall not be named individually in any suit, demand or proceeding relating to this Agreement or the transactions contemplated hereby solely as a result of being named as a knowledge party hereunder.
“Knoxville Billing Approval” has the meaning ascribed to it in Section 6.20.
“Knoxville Facilities” shall mean (i) the Facility known as “AHC Knoxville”, located at 7424 Middlebrook Pike, Knoxville, TN 37909, and (ii) the Facility known as “AHC WellPark”, located at 7512 Middlebrook Pike, Knoxville, TN 37909.
“Law” means any common law, federal, state or local law, treaty, statute, code, ordinance, rule, regulation or other requirement enacted or promulgated by any Governmental Authority.
“License” means any material permit, license or other governmental authorization required to operate a Business.
“Licensure” has the meaning ascribed to it in Section 6.5.
“Licensure Condition” has the meaning ascribed to it in Section 7.1(a)(iii).
“Links Facilities” shall mean those Facilities set forth on Exhibit T-3.
“Loss” or “Losses” in respect of any matter, means any out-of-pocket loss, liability, cost, expense, judgment, settlement or damage actually incurred arising out of or resulting from such matter including, but in no way limited to, to the extent reasonable, (a) attorneys’ fees, and (b)
16



costs of successfully enforcing any Indemnification Obligations. provided, however, that in all instances wherever used “Loss” or “Losses” shall be subject to the limitations of Section 9.8.
“Manager” means Tennessee Health Management, LLC, a Tennessee limited liability company.
“Mandatory Cure Items” has the meaning ascribed to it in Section 6.9(a).
“Material Adverse Effect” means any fact, condition, circumstance, occurrence, effect, change, event or development that, individually or in the aggregate, has a material adverse effect on the business, financial condition or results of operations of the Businesses, taken as a whole, excluding any fact, condition, circumstance, occurrence, effect, change, event or development resulting from or relating to (i) any Excluded Asset or Excluded Liability or (ii) (a) changes in GAAP or changes in accounting requirements applicable to any industry in which each Business operates, (b) changes in the financial, securities, currency, capital or credit markets or in general economic, political or regulatory conditions in any jurisdiction in which each Business operates (including any state, federal or local government shutdown), (c) changes (or proposed changes) in Applicable Law or conditions generally affecting any industry in which the Businesses operate, (d) acts of war, sabotage or terrorism, cyberattacks or disasters (including hurricanes, tornadoes, floods, fires, earthquakes and weather-related events or other “acts of God”), pandemics, epidemics or other outbreaks of disease or public health events (including COVID-19) or any escalation or worsening thereof or any responses thereto, (e) the negotiation, execution or performance of this Agreement, the announcement, pendency or consummation of the transactions contemplated hereby, the identity of Purchaser or any other facts or circumstances relating to Purchaser or the announcement or other disclosure of Purchaser’s plans or intentions with respect to the conduct of the Businesses after the Closing, including the effect of any of the foregoing on the relationships, contractual or otherwise, of the Businesses with clients, customers, partners, principals, employees, suppliers, vendors, service providers or Governmental Authorities or third parties, (f) reserved, (g) any failure to meet any internal or analysts’ projections, forecasts or predictions in respect of financial performance (it being understood that any underlying facts giving rise or contributing to such failure that are not otherwise excluded from the definition of “Material Adverse Effect” may be taken into account in determining whether there has been a Material Adverse Effect), (h) any action taken (or omitted to be taken) at the request of or with the written consent of Purchaser or (i) any action taken (or omitted to be taken) by Seller or any of its Affiliates that is required to be taken or omitted or are expressly contemplated pursuant to this Agreement or (j) any matter or other item clearly disclosed on the Schedules or other materials delivered to Purchaser as of the date hereof, except, in the case of clauses (a), (b), and (c), to the extent the Businesses, taken as a whole, are materially and disproportionately affected thereby relative to other participants in the industry or industries in which the Businesses operate (in which case only the incremental material and disproportionate effect or effects may be taken into account in determining whether there has been a Material Adverse Effect).
“Material Contract” has the meaning ascribed to it in Section 4.10(a)(xiv).
17



“Measurement Date” means the day immediately prior to an Initial Closing Date or a Subsequent Closing Date, as applicable.
“Notice of Indemnification” has the meaning ascribed to it in Section 9.5.
“OFAC List” has the meaning ascribed to it in Section 4.22.
“Order” means any writ, order, judgment, injunction, ruling, legally binding agreement, stipulation or decree (including a consent decree) of any Governmental Authority.
“Ordinary Course” means the ordinary course of business of Seller, consistent with past practice. “OTA” has the meaning ascribed to such term in Section 3.6.
“OTA Transferee” means each of the entities designated by Purchaser that will be the transferee of certain assets and liabilities pursuant to an OTA.
“Out of Compliance” shall mean, with respect to any Facility, that as of the Measurement Date (it being expressly acknowledged that a Facility’s status as of any other date is not relevant for purposes hereof), such Facility (x) (A) is subject to an order from any Governmental Authority prohibiting the acceptance of new admissions; (B) is subject to a DPNA; (C) has had any nursing home license or Medicare or Medicaid certification revoked and/or terminated, (D) has been designated as a facility subject to the Special Focus Facility or any successor or similar program as defined by Centers for Medicare & Medicaid Services or any other applicable Governmental Authority (provided that this clause (D) shall be inapplicable to any Facility which is a Special Focus Facility candidate), (E) has received an “IJ” or higher survey deficiency, unless such survey deficiency is subject to a plan of correction approved by the applicable Governmental Authority and fully implemented and corrected to the reasonable satisfaction of the Purchaser and applicable OTA Transferee (it being acknowledged and agreed that no party may require a further survey or resurvey by such Governmental Authority as a condition to such “reasonable satisfaction”) (each of the types of Out of Compliance identified in the foregoing clauses (A) through (E) being a “Regulatory OoC”), (y) (A) solely with respect to the Census Facilities (but not including any Exempt Facilities), (i) as of the Initial Closing Date, has experienced a drop of fifteen-percent (15%) or more in the Average Resident Census relative to the Current Resident Census, or (ii) for any Subsequent Closing, such Facility is not a Cured Facility pursuant to subsection (iii) of the definition of “Cured Facility” (each a “Census 15% OoC”), and (B) solely with respect to the Exempt Facilities (but not including any Census Facilities), (i) as of the Initial Closing Date, the Average Resident Census at such Exempt Facility is less than the applicable Census Floor, or (ii) for any Subsequent Closing, such Facility is not a Cured Facility pursuant to subsection (iv) of the definition of “Cured Facility” (each, a “Census Floor OoC” and both a Census 15% OoC and a Census Floor OoC shall be referred to herein as a “Census OoC”); or (z) is subject to an Escrowable Casualty Loss (a “Casualty OoC”).
“Outside Date” means (i) with respect to the Phase I Facilities, July 1, 2025, and (ii) with respect to the Phase II Facilities, August 1, 2025.
18



“Overhead and Shared Services” means ancillary corporate or shared services provided to or in support of the Business that are general corporate, overhead or other services or provided to both (a) the Business, and (b) any other business or facility of Seller and its Affiliates that is not a Business subject to this Agreement.
“PACS Facilities” shall mean those Facilities set forth on Exhibit T-4.
“Party” or “Parties” have the meaning ascribed to them in the Preamble.
“Permitted Encumbrances” means (i) Encumbrances for Taxes that are not yet due or are being contested in good faith and for which adequate accruals or reserves have been established in the Financial Statements if required pursuant to GAAP to the extent such reserves are held in escrow by the Title Company after closing until satisfaction of such Taxes such that the Title Company is willing to provide title insurance coverage for such Encumbrances, (ii) statutory Encumbrances of landlords and Encumbrances of carriers, warehousemen, mechanics, materialmen and other Encumbrances imposed by Law, in each case, for amounts not yet due or that are being contested in good faith and for which adequate accruals or reserves have been established in the Financial Statements if required pursuant to GAAP and to the extent sufficient reserves are held in escrow by the Title Company after closing until satisfaction of such Encumbrances such that the Title Company is willing to provide title insurance coverage for such Encumbrances, (iii) zoning, entitlement, building and land use regulations, customary covenants, easements, rights-of-way, restrictions and other similar charges or encumbrances which do not, in each of the foregoing cases, individually or in the aggregate, materially and adversely interfere with, and are not violated by, the current use or occupancy of or diminish the value of the affected property materially and adversely, in each case in the ordinary conduct of the Business thereon, (iv) Encumbrances that will be released by Seller prior to or as of an applicable Closing Date, (v) Encumbrances specifically listed in Schedule B-II of the Title Reports (but excluding “standard exceptions”) to the extent not appearing on Schedule 6.9 or objected to by Purchaser pursuant to the terms hereof, (vi) purchase money Encumbrances securing rental payments under capital lease arrangements which Purchaser has elected to assume as an Assumed Contract, (vii) matters set forth in the Third Party Reports, to the extent not appearing on Schedule 6.9; (viii) Encumbrances arising under this Agreement or any of the Transaction Documents; (ix) residency agreements of residents; (x) those exceptions Purchaser elects (or is deemed to have elected) to take title to pursuant to Section 6.9; and (xi) Encumbrances disclosed on Schedule 1.1(b).
“Person” means an individual, partnership, venture, unincorporated association, organization, syndicate, corporation, limited liability company, or other entity, trust, trustee, executor, administrator or other legal or personal representative or any government or any agency or political subdivision thereof.
“Phase I Facilities” means the Champion Facilities and the PACS Facilities.
“Phase I Initial Closing” has the meaning ascribed to it in Section 3.1(a).
“Phase I Initial Closing Date” has the meaning ascribed to it in Section 3.1(a).
19



“Phase II Facilities” means the Ensign Facilities and the Links Facilities.
“Phase II Initial Closing” has the meaning ascribed to it in Section 3.1(b).
“Phase II Initial Closing Date” has the meaning ascribed to it in Section 3.1(b).
“Post-Closing Period” has the meaning ascribed to it in Section 6.2(a).
“Post-Closing Representation” has the meaning ascribed to it in Section 6.4(d)(i).
“Post-Closing Tax Period” means any Tax period starting on the Closing Date and, with respect to a Straddle Tax Period, the portion of such Tax period beginning on the Closing Date.
“Pre-Closing Period” has the meaning ascribed to it in Section 6.2(a).
“Pre-Closing R&W Breach” has the meaning ascribed to it in Section 6.15.
“Pre-Closing R&W Breach Notice” has the meaning ascribed to it in Section 6.15.
“Pre-Closing Tax Period” means any Tax period ending on or before the Closing Date and, with respect to a Straddle Tax Period, the portion of such Tax period ending on the Closing Date.
“Pro-Rata Percentage” means, with respect to each Facility, the percentage such Facility’s Facility Purchase Price bears to the Purchase Price considered as a whole. Each Facility’s Pro-Rata Percentage is set forth on the Facility Allocation.
“Property Taxes” means any real or personal property Taxes or any other ad valorem Taxes or similar obligations.
“Purchase Price” means Five Hundred Million Eight Hundred Seventy-Nine Thousand and 00/100 Dollars ($500,879,000.00).
“Purchase Price Allocation” has the meaning ascribed to it in Section 2.6(a).
“Purchased Assets” has the meaning ascribed to it in Section 2.1.
“Purchaser” has the meaning ascribed to it in the Preamble.
“Purchaser Assignees” means any Person to which Purchaser may assign its rights and obligations under this Agreement.
“Purchaser Indemnified Parties” has the meaning ascribed to it in Section 9.2.
“Purchaser Parties” means the entities listed on Exhibit B.
20



“Real Property” means the real property set forth on Exhibit D , including all buildings and other improvements located thereon and easements, licenses, permits, certificates, construction warranties and appurtenances relating thereto.
“Real Property Lease” has the meaning ascribed to it in Section 4.4(a).
“Rejected Contracts” has the meaning ascribed to it in Section 6.17.
“Release” means any releasing, spilling, leaking, pumping, pouring, emitting, emptying, discharging, injecting, escaping, leaching, dumping, disposing, depositing, leaching, or migrating into the Environment.
“Repair Estimate” has the meaning ascribed to it in Section 6.8(a).
“Required Consents” shall mean those consents set forth on Exhibit L attached hereto, if any.
“Restricted Counties” shall mean (i) those certain counties where the Phase I Facilities are located as of the Phase I Initial Closing Date, and (ii) those certain counties where the Phase II Facilities are located as of the Phase II Initial Closing Date.
“Seller” has the meaning ascribed to it in the Preamble.
“Seller Confidential Information” has the meaning ascribed to it in Section 6.4(c).
“Seller Encumbrance Release Transactions” means the (i) release, termination and discharge of all Encumbrances on the Purchased Assets (other than Permitted Encumbrances, but including such Encumbrances set forth in subsection (iv) of the definition of Permitted Encumbrances), and (ii) execution, delivery and receipt, as applicable, of any required notices of prepayment, customary pay-off letters, lien terminations, releases, instruments of discharge and similar documentation.
“Seller Indemnified Parties” has the meaning ascribed to it in Section 9.3.
“Seller Leased Parcel Lease Agreement” means commercially reasonable triple-net lease agreements and shared services agreements for the Seller Leased Parcels containing the essential terms and conditions set forth on Exhibit R hereto, which shall be negotiated in good faith and agreed to in advance of the Phase I Initial Closing.
“Seller Leased Parcels” has the meaning ascribed to it in Section 6.18.
“SNF Business” means the skilled nursing facility business conducted by Seller exclusively at or exclusively related to any one or more of the Facilities.
“Stimulus Funds” has the meaning set forth in Section 4.9.
21



“Straddle Tax Period” means a Tax period that begins before, and ends after, the Initial Closing Date.
“Subsequent Closing” has the meaning ascribed to it in Section 7.3.
“Subsequent Closing Date” shall mean, with respect to each applicable Escrow Facility, the date upon which the Subsequent Closing occurs pursuant to Section 7.3.
“Subsequent Closing Trigger Date” has the meaning ascribed to it in Section 7.3.
“Subsidiary” means, with respect to any Person, any entity of which securities or other ownership interests having ordinary voting power to elect a majority of the board of directors or other persons performing similar functions are at the time directly or indirectly owned by such first Person.
“Survey Condition” shall mean, with respect to all Facilities other than AHC Millennium, such Facility has not been surveyed by the State of Tennessee Health Facilities Commission, Division of Licensure and Regulation Regional Office during the fifteen (15) month period immediately prior to the Closing Date.
“Tax” or “Taxes” means taxes, fees, levies, duties, tariffs, imposts and governmental impositions or charges of any kind imposed by any federal, state or local taxing authority, including (a) income, franchise, profits, gross receipts, ad valorem, net worth, value added, sales, use, service, real or personal property, special assessments, capital stock, license, payroll, withholding, employment, estimated, social security, workers’ compensation, unemployment compensation or insurance contributions, utility, severance, production, excise, stamp, occupation, premiums, windfall profits, transfer, gains, business and occupation, disability, quality assurance fee, bed tax, provider tax or other tax, duty or charge of any kind whatsoever, however denominated; and (b) interest, penalties, additional taxes and additions to tax imposed by a taxing authority with respect thereto.
“Tax Return” means any report, return, document, declaration, attachment or other information or filing required to be supplied to any Taxing Authority with respect to Taxes, including information returns and any documents with respect to or accompanying payments of estimated Taxes, or with respect to or accompanying requests for the extension of time in which to file any such report, return, document, declaration, attachment or other information.
“Taxing Authority” means a Governmental Authority responsible for the imposition of any Taxes.
“Third Party Reports” means the due diligence reports described on Exhibit S, all of which are in the Data Room.
“Title Company” has the meaning ascribed to it in Section 6.9(a).
“Title Cure Escrow Facility” has the meaning ascribed to it in Section 7.2(a).
22



“Title Objection Notice” has the meaning ascribed to it in Section 6.9(a).
“Title Reports” has the meaning ascribed to it in Section 6.9(a).
“Title Update” has the meaning ascribed to it in Section 6.9(c).
“Trademarks” means trademarks, trade names, service marks, service names, trade dress, slogans, all identifiers of source, fictitious business names (d/b/a’s) and logos, whether registered or unregistered, domestic and foreign, and all goodwill symbolized thereby and associated therewith, and trademark and service mark registrations and applications.
“Transaction Documents” means (a) this Agreement, (b) the Bills of Sale and Assignment and Assumption Agreements, (c) the Deeds, (d) the Confidentiality Agreement, (e) the OTAs, (f) if applicable, the Interim Documents and the Interim Indemnity Guaranty, and (g) all other documents contemplated by this Agreement and the OTAs or entered into in connection with the transactions contemplated thereby.
“Transfer Taxes” has the meaning ascribed to it in Section 6.2(d).
“U.S.” means the United States of America.
“Verified Residents” means residents of a Facility (x) with verified third party payor insurance sources, (y) who are not ineligible under Applicable Law or regulation from participating in Medicare or Medicaid and assumedly would be financially and clinically eligible for Medicare and Medicaid services or (z) in the reasonable determination of the applicable Current Operator, who otherwise have the financial means to pay the out of pocket costs of occupancy at the Facility.
“WTHC Declaration” means that certain Declaration of Restrictive Covenants for Jackson-Madison Medical Office Park, Section II dated May 31, 2010, by West Tennessee Healthcare, Inc. (“WTHC”), and recorded in Book T1905, Page 999 in the Register’s Office of Madison County, Tennessee.
“WTHC Declaration Rights” means the rights of WTHC to purchase the WTTC Facility as more particularly set forth in Article III, Sections 1, 2 and 3 of the WTHC Declaration.
“WTTC Facility” means that certain skilled nursing facility known as “AHC WTTC” located at 597 West Forest Avenue, Jackson, TN 38301.
1.2Terms Generally. The definitions in Section 1.1 and elsewhere in this Agreement shall apply equally to both the singular and plural forms of the terms defined. Whenever the context may require, any pronoun shall include the corresponding masculine, feminine and neuter forms. The words “include,” “includes” and “including” shall be deemed to be followed by the phrase “without limitation.” The words “herein,” “hereof” and “hereunder” and words of similar import refer to this Agreement (including the Exhibits to this Agreement, the Schedules and the Schedules) in its entirety and not to any part hereof unless the context shall otherwise require. All references herein to Articles, Sections, Exhibits, Schedules and the Schedules shall be deemed references to Articles and Sections of, and Exhibits, addendums and Schedules to,
23



this Agreement unless the context shall otherwise require. Unless the context shall otherwise require, any references to any agreement or other instrument or any Law are to such agreement, instrument or Law as the same may be amended and supplemented from time to time (and, in the case of any Law, to any successor provisions). Any reference to any Law shall be deemed also to refer to all rules and regulations promulgated thereunder, unless the context requires otherwise. The use of the words “or,” “either” or “any” in this Agreement shall not be exclusive. Any reference in this Agreement to a “day” or a number of “days” (without explicit reference to “Business Days”) shall be interpreted as a reference to a calendar day or number of calendar days. If any action is to be taken or given on or before a particular calendar day, or any period is set to expire on a particular calendar day, and such calendar day is not a Business Day, then such action may be deferred, or such period shall be extended, until the next Business Day. A right or obligation of Seller shall be read to be the right or obligation of the applicable Seller party, and a right or obligation of Purchaser shall be read to be the right or obligation of the applicable Purchaser Party or Purchaser Assignee, as appropriate for the context; provided that this is not intended to create the right of multiple parties to duplicative remedies in the event of a breach or default.
Article II
PURCHASE AND SALE OF ASSETS
2.12.1    Sale of Purchased Assets.
(a)Sale of Purchased Assets. Subject to the provisions of this Agreement, with respect to each Facility or Business on its applicable Closing Date and as of the applicable Effective Time, Purchaser shall purchase from Seller, and Seller shall sell, convey, transfer, assign, and deliver to Purchaser, or such Purchaser Parties or Purchaser Assignees as designated by Purchaser, all of Seller’s right, title and interest in and to the following properties, rights and assets of Seller relating to such Facility or Business, which, for the avoidance of doubt shall not include the Excluded Assets (collectively, the “Purchased Assets”), free and clear of all Encumbrances other than Permitted Encumbrances:
(i)the Real Property;
(ii)the rights under the Assumed Contracts;
(iii)all bed operating rights, to the extent applicable, with respect to a Facility;
(iv)all claims, deposits, prepayments, award, prepaid expenses, warranties, guarantees, refunds, causes of action, rights of recovery, rights of set-off and rights of recoupment of every kind and nature (whether or not known or unknown or contingent or non-contingent) of Seller with respect to the Purchased Assets, including all right, title and interest, if any, of Seller to any unpaid award for (1) any taking by condemnation or (2) any damage to the Real Property by reason of a change of grade of any street or highway;
(v)all books and records of Seller with respect to the SNF Business;
(vi)all transferable Licenses from all permitting, licensing, accrediting and certifying agencies, and the rights to all data and records held by such permitting, licensing and certifying agencies, in each case, with respect to the Businesses;
(vii)all telephone numbers utilized in the operation of the Businesses;
24



(viii)all rights to proceeds of or claims under any loss of income insurance or equivalent insurance maintained by Seller and any rent insurance or equivalent coverage maintained by Seller that are, in each case, applicable to the Businesses, and required to be assigned by Seller to Purchaser pursuant to Section 6.8;
(ix)all goodwill symbolized and associated with the Businesses;
(x)all maintenance records, property condition reports, surveys, appraisals, warranties and blueprints with respect to each Facility;
(xi)all furniture, fixtures, furnishings, equipment, appliances, tools, instruments, machinery, and all other items of tangible personal property which are located at or used in connection with the operation of the Businesses; and
(xii)all Intellectual Property of Seller.
2.2Excluded Assets. Notwithstanding anything to the contrary contained herein, Seller shall not sell, convey, transfer, assign or deliver to Purchaser, the Purchaser Parties or Purchaser Assignees, and Purchaser shall not purchase from Seller, any properties, rights and assets of Seller other than the Purchased Assets, including the following excluded assets (the “Excluded Assets”):
(a)any asset or class of assets excluded from the definition of Purchased Assets by virtue of the limitations expressed therein;
(b)all Cash and any Accounts Receivable as of the Effective Time;
(c)the Corporate Contracts;
(d)any prepaid expenses, security deposits and other current assets of the Business as of the Effective Time;
(e)all Overhead and Shared Services, including any Contracts for or assets related to Overhead and Shared Services;
(f)all rights under Assumed Contracts arising prior to the Effective Time, including any rebates or portions thereof related to the period prior to the Effective Time;
(g)Licenses and permits that are not assignable or transferable, whether with or without third party consent, to Seller;
(h)assets of Seller disposed of in the Ordinary Course prior to the Effective Time; provided that, except as expressly set forth in this Agreement, Seller shall not dispose of any assets without the prior written consent of Purchaser (other than supplies used at the Facility in the Ordinary Course, provided that it shall also be replenished to a quantity sufficient to comply with applicable Law);
(i)any management agreement or lease agreement between Seller and its Affiliates;
(j)all rights with respect to the Stimulus Funds;
25



(k)all insurance policies and any claims and rights to proceeds thereunder to the extent relating to the period prior to the Effective Time, except as otherwise expressly stated herein to the contrary;
(l)the minute books and ownership records of Seller, including all organizational documents, stock registers and such other books and records of Seller as they pertain to the ownership, organization, or existence of Seller and duplicate copies of such records;
(m)any claims for refunds of Taxes and other governmental charges imposed on Seller or any related reserves held by a taxing authority of whatever nature including, but not limited to, those with respect to a Facility or the Businesses attributable to periods ending on or prior to the applicable Closing Date;
(n)all shares of any capital stock, or partner interests in any partnership of Seller or its Affiliates;
(o)Seller’s rights under this Agreement and the Transaction Documents;
(p)All of Seller’s email accounts;
(q)Seller’s attorney-client privilege;
(r)all Benefit Plans and all assets related thereto;
(s)Seller’s information technology systems, emails, email accounts, software licenses, corporate minute books, records, marketing materials, policies and procedures, and all assets that are used at the corporate level and do not solely relate to the operations of the Businesses;
(t)all claims or rights of any Seller with and among any other Seller or amounts due from Affiliates;
(u)all unclaimed property of any third party as of the applicable Closing, including, without limitation, property which is subject to applicable escheat Laws;
(v)all claims, rights, interests and proceeds (whether received in cash or by credit to amounts otherwise due to a third party) with respect to amounts overpaid by Seller to any third party with respect to periods prior to the applicable Closing (e.g. such overpaid amounts may be determined by billing audits undertaken by Seller or Seller’s consultants) to the extent not offset against any underpayments by any applicable third party payor in respect of services rendered prior to the applicable Closing;
(w)any receipts (i) relating to Seller’s Cost Reports or rights to settlements and retroactive adjustments on the same (whether resulting from an appeal by Seller or otherwise) with respect to time periods prior to the applicable Closing, or (ii) which result from Seller’s pursuit of one or more appeals pertaining to a Government Reimbursement Program to the extent not offset against any overpayments by such Government Reimbursement Program in respect of services rendered prior to the applicable Closing;
(x)the items of personal property brought to the Facility by Business Employees or residents of the Facilities that are not used or held for use with the Businesses and the operation of any of the Facilities;
26



(y)all trade names, trademarks, service marks, domain names (URLs) and websites owned by Seller or its Affiliates including, without limitation, any use of the names “AHC” or “American Health Companies” in whole or in part, or any derivation thereof, and all references to any of the foregoing on social media channels (including, without limitation, Facebook, Twitter and YouTube) associated with any or all of the Facility or Seller or its Affiliates;
(z)all items on Schedule 2.2(z);
(aa)any assets listed as “Excluded Assets” pursuant to the terms of an OTA;
(ab)any asset transferred to an OTA Transferee under the terms of an Operations Transfer Agreement;
(ac)the Excluded Facilities (if any); and
(ad)the Rejected Contracts.
2.3Assumption of Liabilities. At the Effective Time, Purchaser shall assume and agree to pay, perform, discharge and satisfy when due in accordance with their respective terms the following liabilities (the “Assumed Liabilities”):
(a)any Taxes with respect to the operation of the Business for any periods (or portions thereof) beginning after the Effective Time and, to the extent provided by Section 6.2(d), certain Transfer Taxes;
(b)all liabilities to the extent arising out of the Purchaser’s ownership or operation of the Purchased Assets after the Effective Time;
(c)all liabilities expressly assumed by Purchaser pursuant to the Transaction Documents;
(d)any liabilities of Seller, solely to the extent Purchaser or any OTA Transferee is provided a credit for such liabilities at an applicable Closing;
(e)all liabilities under the Assumed Contracts arising with respect to the period after the applicable Effective Time;
(f)all other liabilities set forth on Schedule 2.3.
2.4Excluded Liabilities. Purchaser is assuming only the Assumed Liabilities from Seller and is not assuming any other liability of Seller of whatever nature, whether presently in existence or arising hereafter. All such other liabilities (collectively, the “Excluded Liabilities”) shall be retained by and remain liabilities of Seller, including, without limitation, any and all Retained Liabilities (as defined in the OTAs).
2.5Purchase Price; Deposit.
(a)In consideration of the assignment, transfer and delivery of all of the Purchased Assets, Purchaser shall (i) pay to Seller or, at the direction of Seller, one or more of Seller’s Affiliates, an aggregate cash amount equal to the Purchase Price, which shall be allocated to the Facilities as set forth on Schedule 7.2; and (ii) assume the Assumed Liabilities. At the Initial Closing and each Subsequent Closing, (x) Purchaser shall pay to Seller or, at the direction of Seller, one or more of Seller Parties, the Purchase Price of the Facilities being acquired at such Closing (the “Transferred Facilities”), and (y) the Purchased Assets and Assumed Liabilities relating to the Transferred Facilities shall be transferred to and assumed by Purchaser or such Purchaser Party or Purchaser Assignee designated by Purchaser. Payment of the Purchase Price at each Closing shall be in immediately available funds by wire transfer to one or more bank accounts designated in writing by Seller to Purchaser at least two (2) Business Days prior to such Closing.
27



(b)No later than one (1) Business Day after the Execution Date, Purchaser shall deliver a deposit in an amount equal to Ten Million Dollars ($10,000,000) (the “Initial Deposit”) into an escrow account with Title Company to be held pursuant to this Agreement and the Escrow Agreement (the “Deposit Escrow Account”) attached hereto as Exhibit E (the “Deposit Agreement”). At or prior to the Phase I Closing, Purchaser shall deliver an additional deposit in an amount equal to Five Million Dollars ($5,000,000) (the “Additional Deposit” and together with the Initial Deposit, the “Deposit”) into the Deposit Escrow Account, which Additional Deposit shall be held in accordance with the Deposit Agreement. The Deposit shall serve as a portion of the Purchase Price applicable to the Phase II Facilities, and, except as otherwise set forth in Sections 7.2(a)(iv) and 7.5(c), shall be applied at the Phase II Initial Closing. Any interest on the Deposit (or any portion thereof, whether released pursuant to this Section 2.5 or any other section of this Agreement) shall follow the Deposit (or such portion thereof).
(c)At the Phase I Initial Closing, Purchaser, the Title Company and Sellers shall create a post-Closing indemnification escrow account pursuant to the terms of an Escrow Agreement to be entered into by Seller, Purchaser, Purchaser Assignees, the OTA Transferees, and the Title Company in the form attached hereto as Exhibit G (or such other form mutually acceptable to the parties thereto) (the “Indemnity Escrow Agreement”). At each Closing, Seller shall deposit with the Title Company two-tenths of one percent (0.2%) of that portion of the Purchase Price which is paid at such Closing to be held pursuant to the Indemnity Escrow Agreement (such deposits, collectively, the “Indemnity Escrow Funds”). The Indemnity Escrow Funds will be used, if necessary, to satisfy any Losses as a result of indemnification claims payable to the Purchaser Indemnified Parties under Article IX of this Agreement and will be held and disbursed in accordance with the provisions of this Agreement and the Indemnity Escrow Agreement. The Indemnity Escrow Agreement shall provide for the release to Seller of any Indemnity Escrow Funds not subject to pending indemnification claims on a Facility by Facility basis in three equal installments - thirty-three percent (33%) of the Indemnity Escrow Funds less any amounts already released by Title Company to Purchaser in satisfaction of indemnification claims on each of the one-year and two-year anniversary of the Closing Date with respect to such Facility and the balance on the three-year anniversary of the Initial Closing Date with respect to such Facility. Notwithstanding the foregoing, in the event that (i) the Purchase Price as to any Facility is reduced pursuant to the terms of this Agreement, (ii) the indemnification escrow established pursuant to the OTA applicable to such Facility is reduced in accordance with the terms of such OTA, and (iii) following said reduction, the aggregate of the Indemnity Escrow Funds hereunder and the indemnification escrow funds actually funded pursuant to all of the OTAs is more than 2.5% of the Purchase Price actually paid by Purchaser (such excess shall be referred to hereunder as the “Indemnity Escrow Excess”), then the Indemnity Escrow Funds hereunder shall be reduced by an amount equal to the Indemnity Escrow Excess, and if necessary to accomplish the same, an amount of any Indemnity Escrow Funds already funded into escrow hereunder at a prior Closing shall be released to Seller. For the avoidance of doubt, Seller shall have no obligation under this Agreement or the other Transaction Documents to deposit more than 2.5% of the Purchase Price actually paid at any Closing, provided that any allocations of costs or assumption of liabilities contemplated by this Agreement to result in a credit against the Purchase Price to be provided at Closing shall not be deemed to reduce the Purchase Price for purposes of this Section 2.5(c).
28



(d)In the event that any Facility (other than the AHC Lewis County and AHC Mt. Juliet Facilities, which, for the avoidance of doubt, are Special Focus Facility candidates as of the Execution Date), is listed on the candidate and/or watch list for the Special Focus Facility List maintained by the Centers for Medicare & Medicaid Services, at Closing, the Facility Purchase Price with respect to such Facility shall be reduced by fifteen percent (15%).
2.6Purchase Price Allocation.
(a)The Purchase Price shall be allocated among the Purchased Assets for Tax purposes as set forth on Schedule 2.6 attached hereto, which shall be agreed upon by the Purchaser and Seller prior to the Initial Closing Date, and shall constitute a binding allocation of the Purchase Price amongst the Purchased Assets for Tax purposes (the “Purchase Price Allocation”). If agreed upon as set forth in the immediately preceding sentence, Purchaser and Seller agree that the Purchase Price (including any Assumed Liabilities that are treated as consideration for the Purchased Assets for federal income tax purposes) and all other amounts constituting consideration within the meaning of Section 1060 of the Code, shall be allocated among the Purchased Assets based on the principles as set forth in Section 1060 of the Code and the regulations promulgated thereunder, as reflected in the IRS Form 8594. If the Seller and Purchaser agree upon the Purchase Price Allocation, Seller and Purchaser agree to (i) be bound by the Purchase Price Allocation, (ii) act in accordance with the Purchase Price Allocation in the preparation and the filing of all Tax Returns (including filing or causing to be filed Form 8594 with applicable U.S. federal income Tax Returns for the taxable year that includes the Initial Closing Date) and in the course of any Tax audit, Tax review or Tax litigation relating thereto, and (iii) take no position and not cause their Affiliates to take any position inconsistent with the Purchase Price Allocation for Income Tax purposes, unless otherwise required pursuant to a “determination” within the meaning of Section 1313(a) of the Code. If the Purchaser and Seller are unable to agree upon an allocation prior to the Initial Closing Date, each of Purchaser and Seller shall adopt their own allocation and complete and execute a Form 8594 in accordance with such allocation and Purchaser’s allocation shall control with respect to the amount to be stated on any transfer tax declaration and in calculating any transfer, recordation or similar tax paid in connection with the conveyance of the Purchased Assets; provided, however, that Purchaser’s allocation must be commercially reasonable based on the value of the Purchased Assets included in each asset class set forth in the allocation and the allocation to each such asset class shall not be deemed accepted by or binding upon Seller for purposes of any Tax Returns or other filings prepared or filed by Seller after the Closing.
(b)In the event that the Purchase Price Allocation is disputed, in whole or in part, by any Governmental Authority, the Party receiving the notice of such dispute shall promptly notify the other Parties in writing of such dispute and shall use commercially reasonable efforts to keep the other Parties apprised of material developments concerning the resolution of such dispute.
2.7Limitation on Assignment of Purchased Assets.
(a)Prior to each Initial Closing, Seller shall use its reasonable best efforts to obtain all applicable Consents requested by Purchaser or set forth on Schedule 2.7 in connection with the transfer and assignment of the Purchased Assets and Assumed Liabilities to Purchaser in accordance with the terms hereof. Any fees, costs, payments or other liabilities incurred in connection with obtaining such Consents shall be borne by Seller; provided, however that Purchaser shall pay any fees, costs, payments or other liabilities relating to obtaining any required Consents to assign the Assumed Contracts elected by Purchaser (excluding any Real Property Leases), provided that (i) Seller shall cooperate in good faith to minimize the amount of any such fees, costs, payments or other liabilities, and (ii) if such fees, costs, payments or other liabilities are material, Purchaser may instruct Seller in writing to cease seeking such Consent with respect to a Purchased Asset if it acknowledges to Seller that the Purchased Assets that are the subject of such Consent shall not be transferred hereunder. Notwithstanding the foregoing, the filing fee with respect to the HSR Act, if any, shall be paid by Purchaser and all other fees, costs, payments and other liabilities incurred in connection with obtaining any Consent required in connection with the HSR Act shall be borne by the party incurring such fees, costs, payments and other liabilities. Nothing in this Agreement shall require Seller or any of its Affiliates to pay any money or other consideration or grant any other accommodation or concession to any Person or to initiate any claim or proceeding against any Person (including in connection with obtaining any Consent).
29



(b)Notwithstanding any other provision of this Agreement to the contrary, this Agreement shall not constitute an agreement to sell, convey, transfer, novate or assign any Purchased Asset or any claim, right or benefit arising thereunder, or any right thereunder if an attempted assignment, without the consent of, or other action by, any third party (including any Governmental Authority), including any prior approval, notification and/or consultation with any union, works council or other employee representative, would constitute a breach or default thereunder or would adversely affect the rights or obligations of Purchaser or Seller or any of their respective Affiliates thereunder or violate any Applicable Law (any such Purchased Asset or any claim, right or benefit arising thereunder, a “Deferred Item”). If such Consent is not obtained or such other action is not taken with respect to any consent disclosed on Schedule 2.7 (each, a “Deferred Consent”) prior to an applicable Closing then, in each such case, (i) the Deferred Item shall not be assigned or transferred to Purchaser pursuant to this Agreement and there shall not be any reduction in the Purchase Price, (ii) Seller and Purchaser will, for a period of twelve (12) months following the applicable Closing Date, use their respective reasonable best efforts to seek to obtain such Deferred Consent as soon as practicable after the applicable Closing and (iii) until such Deferred Consent is obtained, Seller and Purchaser shall cooperate in a mutually agreeable arrangement under which Purchaser will obtain the benefits and assume the obligations thereunder in accordance with this Agreement in a manner that would not require any Deferred Consent. Until such Deferred Consent is received, Seller or its Affiliate, as applicable, shall hold the applicable Purchased Asset(s) for Purchaser’s benefit and account and manage and operate such Purchased Asset(s) for Purchaser’s benefit and account, with all gains, income, Losses, damages, Taxes and Tax benefits or other items generated to be for Purchaser’s account (including as an Assumed Liability).
(c)For the avoidance of doubt, neither Seller nor any of Seller’s Affiliates shall have any obligation to obtain any Deferred Consent or to provide such an alternative arrangement (and the failure to do so shall not be deemed to be a breach of Seller’s representations, warranties or covenants hereunder or to contribute to a Material Adverse Effect) other than the undertaking to use reasonable best efforts to obtain such consent as set forth in this Section 2.7. To the extent that, in connection with obtaining a third party’s consent with respect to any Purchased Asset, one or more of the parties hereto (or their respective Affiliates) enter into an agreement with such third party that provides for an allocation of liability among the parties hereto (or such Affiliates), with respect to such Purchased Asset that is inconsistent with the terms of this Agreement, the parties hereto agree that, as among themselves, the provisions of this Agreement shall control. In the event that the assignment of any Purchased Asset or the assumption of any Assumed Liability is required under Applicable Law to be effected pursuant to a separate agreement, such separate agreement shall serve solely to effect the assignment or novation of the Purchased Assets and the assumption of the Assumed Liabilities and no such separate agreement shall have any effect on the value being given or received by Seller or Purchaser, including the allocation of assets and liabilities as between them, all of which shall be determined solely in accordance with this Agreement and, in the event of any conflicts between such separate agreement and this Agreement, the terms of this Agreement shall control in all respects.
30



(d)For the avoidance of doubt, the provisions of this Section 2.7 shall not apply to the Required Consents.
2.8Inspections.
(a)Prior to Closing, Purchaser shall have the right from time to time, upon not less than two (2) Business Day’s prior notice to Seller (which notice shall be by phone or email to pclark@amhealthpartners.com and jbailey@amhealthpartners.com and shall specify the time, date and location of such proposed inspections) to enter upon the Real Property at reasonable times during normal business hours (or as otherwise reasonably scheduled with Seller) for the purpose of conducting noninvasive inspections for purposes of Third Party Reports. Seller or Seller’s agent shall have the right to accompany Purchaser during any activities performed by Purchaser or its representatives on the Real Property. Notwithstanding anything to the contrary herein, no Phase II environmental inspections or other invasive inspections or sampling of soil or materials, including without limitation construction materials, either as part of the Phase I inspections or any other inspections, shall be performed without the prior written consent of Seller, which may be withheld in its sole and absolute discretion, and if consented to by Seller, the proposed scope of work and the party who will perform the work shall be subject to Seller’s review and approval.
(b)In all events, during any entry on the Real Property or in connection with its inspections, testing or other examinations of the Real Property, Purchaser shall not injure or otherwise cause bodily harm to any person thereon. Further, Purchaser shall repair or restore any damage caused by Purchaser, or their respective employees, contractors, representatives or agents, to the real or personal property constituting or located on the Real Property. Prior to Closing, Seller’s prior written consent (which shall not be unreasonably withheld, conditioned or delayed) must be obtained prior to any communications with any of the Facilities residents (or resident families) and Business Employees. Purchaser shall pay all costs incurred for any such inspections of the Businesses initiated by Purchaser. Purchaser shall indemnify and hold all Sellers harmless from and against any and all claims for death of or injury to persons or damage to property to the extent arising out of or as a result of the negligent or wrongful acts or omissions of Purchaser, any authorized representatives, or designees of Purchaser conducting Purchaser’s due diligence investigation; provided, however, that the foregoing indemnity and hold harmless obligation shall not extend to, and in no event shall Purchaser be liable to Sellers for, any (i) diminution in the market value of any of the Purchased Assets and/or any of the Businesses resulting from the information disclosed by any such investigation or tests (unless due to the negligence or willful misconduct of any Purchaser or breach of any Purchaser’s obligations under this Agreement), (ii) negligence or willful misconduct of any of the Sellers or any agent, contractor, or employee of any of the Sellers, or (iii) pre-existing condition(s) on or about any of the Purchased Assets and/or any of the Businesses (except and to the extent such pre-existing condition(s) is/are exacerbated by Purchaser’s entry onto and investigation of any of the Real Property). Prior to entry on the Real Property, Purchaser, as well as their respective consultants and contractors, shall provide evidence of sufficient insurance, including general liability coverage not less than $2,000,000 per occurrence and $3,000,000 in the aggregate, to protect Seller from any losses they may incur as a result of any Purchaser’s inspections of the Real Property. This Section shall survive the Closings or earlier termination of this Agreement.
2.9WTTC Facility – WTHC Declaration. Notwithstanding anything herein to the contrary, Purchaser acknowledges that pursuant to the WTHC Declaration, Seller must afford WTHC the right to exercise the WTHC Declaration Rights with respect to the WTTC Facility. Prior to the Closing Date, Seller shall use its commercially reasonable, diligent and good faith efforts to pursue a written waiver of the WTHC Declaration Rights from WTHC with respect to the transaction contemplated by this Agreement (the “WTTC Waiver”), and Seller shall keep Purchaser apprised of the status of such waiver. In the event WTHC exercises the WTHC Declaration Rights and elects to purchase the WTTC Facility, then Seller shall provide Purchaser written notice identifying the WTTC Facility as an Excluded Facility, and this Agreement shall be null and void as to the WTTC Facility, the portion of the Deposit allocated to the WTTC Facility (as set forth on Schedule 2.6) shall be immediately refunded to Purchaser, and neither party shall have any further rights or obligations under this Agreement or the Transaction Documents with respect to the WTTC Facility. For the avoidance of doubt, in the event Seller is unable to obtain the WTTC Waiver contemplated by this Section 2.9, such failure shall not be deemed a breach or default by Seller of this Agreement.
31



Article III
CLOSING
3.1Initial Closing.
(a)Phase I Initial Closing. Subject to the satisfaction or waiver of the Closing Conditions in Section 7.1, the closing of the transactions applicable to the Phase I Facilities contemplated hereby (the “Phase I Initial Closing”) shall be held remotely by the delivery of documents and signatures (or their electronic counterparts), together with the Purchase Price applicable to the Phase I Facilities into escrow with the Title Company on or before 5:00 p.m. CT on November 29, 2024, so as to allow for the Phase I Initial Closing to occur at 11:59 p.m. CT on November 30, 2024, pursuant to the provisions of Section 3.1(a)(i) below, or if the Closing Conditions in Section 7.1, are not satisfied as of such date, as promptly thereafter as is reasonably practicable following the satisfaction of such conditions, and in any event prior to the Outside Date (the day on which the Phase I Initial Closing actually occurs, the “Phase I Initial Closing Date”).
(i)In order to accomplish the Phase I Initial Closing at 11:59 p.m. CT on November 30, 2024, the Parties agree to enter into an irrevocable escrow agreement with the Title Company and the applicable OTA Transferees providing that on or prior to 5:00 p.m. CT on November 29, 2024, (i) the Parties and applicable OTA Transferees shall deliver all Closing Documents and signatures (or their electronic counterparts) contemplated by this Agreement or the other Transaction Documents to be delivered at the Phase I Initial Closing to the Title Company, (ii) Purchaser shall deliver the Purchase Price to be paid at the Phase I Initial Closing to the Title Company, (iii) the Parties and the applicable OTA Transferees shall deliver irrevocable escrow instructions providing for the automatic release of the Closing Documents from escrow as of 11:59 p.m. CT on November 30, 2024, (iv) the Purchaser shall have delivered irrevocable escrow instructions providing for the automatic release of the Purchase Price applicable to the Facilities subject to the Phase I Initial Closing to Seller upon the opening of the Federal Reserve Bank on December 2, 2024, and (v) the Phase I Initial Closing shall be deemed effective as of 11:59 p.m. CT on November 30, 2024; provided, however, that (x) Purchaser shall have the right to terminate said escrows and demand a return of any of the Purchase Price so funded at any time prior to 11:59 p.m. CT on November 30, 2024 if any circumstance exists which would otherwise permit the termination by Purchaser of this Agreement pursuant to the terms of this Agreement (disregarding any cure periods), and (y) in the event that a Phase I Facility becomes an Escrow Facility in between Purchaser’s funding of the Purchase Price applicable to the Phase I Facilities into escrow and 11:59 p.m. CT on November 30, 2024, the Facility Purchase Price for such Escrow Facility funded by Purchaser pursuant to this Section 3.1(a) shall be immediately released from escrow back to Purchaser, and the Transaction Documents associated with such Facility withheld from the Phase I Initial Closing.
32



(b)Phase II Initial Closing. Subject to the satisfaction or waiver of the Closing Conditions in Section 7.1, the closing of the transactions applicable to the Phase II Facilities contemplated hereby (the “Phase II Initial Closing”) shall be held remotely by the delivery of documents and signatures (or their electronic counterparts), together with the Purchase Price to be paid at the Phase II Initial Closing into escrow with the Title Company on or before 5:00 p.m. CT, on December 31, 2024, so as to allow for the Phase II Initial Closing to occur effective as of 11:59 p.m. CT on December 31, 2024 pursuant to the provisions of Section 3.1(b)(i) below, or if the Closing Conditions in Section 7.1, are not satisfied as of such date, as promptly thereafter as is reasonably practicable following the satisfaction of such conditions, and in any event prior to the Outside Date (the day on which the Phase II Initial Closing actually occurs, the “Phase II Initial Closing Date”). Notwithstanding the actual time at which the Phase II Initial Closing occurs, the Phase II Initial Closing shall be considered effective as of 11:59 p.m. on the Phase II Initial Closing Date.
(i)In order to accomplish the Phase II Initial Closing at 11:59 p.m. CT on December 31, 2024, the Parties agree to enter into an irrevocable escrow agreement with the Title Company and the applicable OTA Transferees providing that on or prior to 2:00 p.m. CT on December 31, 2024, (i) the Parties and applicable OTA Transferees shall deliver all Closing Documents and signatures (or their electronic counterparts) contemplated by this Agreement or the other Transaction Documents to be delivered at the Phase II Initial Closing to the Title Company, (ii) Purchaser shall deliver the Purchase Price to be paid at the Phase II Initial Closing to the Title Company, (iii) the Parties and the applicable OTA Transferees shall deliver irrevocable escrow instructions providing for the automatic release of the Closing Documents from escrow as of 11:59 p.m. CT on December 31, 2024, (iv) the Purchaser shall have delivered irrevocable escrow instructions providing that the Purchase Price to be paid at the Phase II Initial Closing are released to the Seller effective 11:59 p.m. CT on December 31, 2024, constitute the sole property of the Seller, and shall be disbursed per the direction of the Seller upon the opening of the Federal Reserve Bank on January 2, 2025, and (v) the Phase II Initial Closing shall be deemed effective as of 11:59 p.m. CT on December 31, 2024; provided, however, that (x) Purchaser shall have the right to terminate said escrows and demand a return of any of the Purchase Price so funded at any time prior to 11:59 p.m. CT on December 31, 2024 if any circumstance exists which would otherwise permit the termination by Purchaser of this Agreement pursuant to the terms of this Agreement (disregarding any cure periods), and (y) in the event that a Phase II Facility becomes an Escrow Facility in between Purchaser’s funding of the Purchase Price applicable to the Phase II Facilities into escrow and 11:59 p.m. CT on December 31, 2024, the Facility Purchase Price for such Escrow Facility funded by Purchaser pursuant to this Section 3.1(b) shall be immediately released from escrow back to Purchaser, and the Transaction Documents associated with such Facility withheld from the Phase II Initial Closing.
(c)Except as otherwise specifically set out in this Agreement, matters pertaining to a Closing or a Closing Date shall be read and deemed to be related to: (i) prior to such anticipated Closing Date, the Facilities and related Purchased Assets which are anticipated to be or qualified to become Transferred Facilities as of such Closing Date, and (ii) after such anticipated Closing Date, the Facilities and related Purchased Assets which became Transferred Facilities as of such Closing Date; provided that, if a Facility fails to become a Transferred Facility on a Closing Date as the result of a breach or default of a Party that is not the result of it becoming an Escrow Facility, nothing in this paragraph is intended to waive the rights of the non-breaching party regarding such breach pursuant to Article X hereof.
3.2Interim Documents. For any Facilities that are subject to an Interim Document following an applicable Closing, the applicable Current Operator and OTA Transferee shall have a final administrative transfer (each, an “Administrative Transfer” and collectively, “Administrative Transfers”) to finalize all pending transfers of the Purchased Assets not previously accomplished on the applicable Closing Date and terminate the Interim Documents upon receipt by such OTA Transferee, as applicable, of the Licensure to operate, or receipt of such written assurances from the Department, in form and substance reasonably acceptable to such OTA Transferee, that the Licensure to operate has been or will be issued by the Department.
33



3.3Effective Time. Notwithstanding the release of the Purchase Price and any Closing Documents, except as expressly set forth in Section 3.1, Closing shall be deemed effective for each applicable Facility or Business as of 12:00:01 a.m. CT on the day after its applicable Closing Date (its applicable “Effective Time”). For purposes of clarity in determining the “Effective Time” as defined in the OTA, the Closing Date as used herein shall mean November 30, 2024 for the Phase I Initial Closing, and the Closing Date as used herein shall mean December 31, 2024 for the Phase II Initial Closing, such that the Effective Time of each OTA shall be 12:00:01 a.m. CT on December 1, 2024, and January 1, 2025, respectively, subject to all closing conditions set forth in this Agreement. To the extent necessary, any matters related to an Administrative Transfer shall be deemed effective under the OTAs as of 12:00:01 a.m. local time at such Facility on the day after such Administrative Transfer for the Facilities involved therein (such time being the “Effective Time” specific to the Facilities involved in each Administrative Transfer, respectively, for purposes of the OTAs). To the extent of any gap between the Effective Time of the Closing of the transactions contemplated by this APA and the “Effective Time” under the OTAs, Current Operator hereby agrees to remain in possession of the Facilities to satisfy any regulatory requirements until such time as the “Effective Time” shall have occurred under the applicable OTAs.
3.4Transfer of Purchased Assets. At each applicable Closing, Seller shall deliver to Purchaser, Purchaser Parties and/or Purchaser Assignees applicable instruments of transfer in the forms attached hereto and as described more fully in Article VII.
3.5Designation of Purchased Assets. Within three (3) days following the Execution Date, Purchaser shall provide written notice to Seller that identifies which Purchased Assets, if any, shall be assigned to a Purchaser Party or Purchaser Assignee in connection with the Initial Closing. Seller hereby acknowledges and agrees that certain Purchased Assets will not be held by Purchaser following the Closings and instead shall be held by Purchaser Parties or Purchaser Assignees, as applicable. With respect to each Purchaser Party and each Purchaser Assignee, (and except with respect to the obligations to pay the Purchase Price under Section 2.5 for which it shall be the sole obligor) Purchaser shall retain primary liability hereunder for all pre-Closing obligations owed to Seller with respect to such assigned Purchased Assets unless Seller otherwise releases Purchaser from such liability. For the avoidance of doubt, this Section shall not impact Purchaser’s liabilities under Article IX and Article X of this Agreement.
3.6Operations Transfer Agreements. Contemporaneously with the Parties’ entry into this Agreement, and as a condition precedent to the effectiveness of this Agreement, Purchaser shall cause the OTA Transferee with respect to each Facility, and Seller shall cause the applicable Current Operator with respect to each Facility, to enter into an Operations Transfer Agreement in substantially the form attached hereto as Exhibit I (each, an “OTA”).
Article IV
REPRESENTATIONS AND WARRANTIES OF SELLER
Seller represents and warrants to Purchaser as of (i) the Execution Date and (ii) each applicable Closing Date, solely with respect to the applicable Facilities, Businesses and Purchased Assets conveyed, purchased or assumed at such applicable Closing (except, in each case, in the case of representations and warranties that by their terms speak as of a specified date, in which case solely as of such specified date) as follows (all of which are qualified by the contents of the Third Party Reports referenced on Exhibit S and the Schedules attached hereto (it being understood that any matter disclosed on any Schedule will be deemed to apply and qualify the Section or Subsection of this Article IV to which it corresponds in number and each other Section or Subsection of this Article IV to the extent that it is reasonably apparent on its face that such information is applicable to such other Section or Subsection)):
34



4.1Corporate.
(a)Organization. Each Seller is an entity duly organized and validly existing under the Laws of the jurisdiction of its organization.
(b)Power and Authority; Authorization; Enforceability. Each Seller has all necessary corporate, limited liability or similar power and authority to own, operate and lease its respective properties and assets, to carry on its business as and where such is now being conducted, including each Business. Each Seller has all necessary corporate, partnership or similar power and authority to enter into the documents and instruments to be executed and delivered by Seller pursuant hereto and to carry out the transactions contemplated hereby. The execution and delivery of the Transaction Documents and the performance of this Agreement by each Seller has been duly and validly authorized. This Agreement constitutes the legal, valid and binding obligation of each Seller, enforceable against each Seller in accordance with its terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium and other similar Laws and equitable principles relating to or limiting creditors’ rights generally.
(c)Qualification. With respect to each Business, each Seller is duly qualified or licensed to do business, and is in good standing, in all jurisdictions (domestic and foreign) in which the character or the location of the assets owned or leased by it or the nature of the business conducted by it requires such licensing or qualification.
(d)No Conflicts or Violations. Subject to obtaining the Consents, and the accuracy of the representations and warranties of Purchaser set forth in Section 5.4, neither the execution and delivery of this Agreement or the other Transaction Documents, the consummation of the transactions contemplated hereby and thereby, nor the fulfillment of the terms hereof by Seller shall (i) violate or result in a breach of any of the material terms and provisions of, constitute a default under, conflict with, or result in any acceleration of rights, benefits or obligations of any party under any Contract to which Seller is a party or by which it is bound, (ii) materially violate any Order of any Governmental Authority applicable to Seller, (iii) result in the creation of any material Encumbrance upon any Purchased Asset pursuant to the terms of any such Contract, (iv) constitute a material violation by Seller of any Applicable Law, (v) result in the breach of any of the material terms or conditions of, or constitute a default under, or otherwise cause any impairment of, any permit, license or other governmental authorization held by any Seller, (vi) conflict with or violate any organizational document of Seller, or (vii) result in any Debt or credit facility of any Seller or any of their respective Affiliates (other than any Debt or credit facility to be repaid and terminated at or prior to the Initial Closing) becoming due prior to its scheduled maturity, or enable or permit (with or without notice or lapse of time or both) the holder or holders thereof or any trustee, agent or representative on its or their behalf to cause any such Debt or credit facility to become due, or to require the prepayment, repurchase, redemption or defeasance thereof or to require an offer to be made to prepay, repurchase, redeem or defease such Debt or credit facility, prior to its scheduled maturity, except in the case of sub-clause (i) except where any such violation or breach would not reasonably be expected to have a Material Adverse Effect.
4.2Financial Statements; Undisclosed Liabilities.
35



Seller has made available in the Data Room to Purchaser, prior to the Execution Date, the Financial Statements. The Financial Statements, in all material respects, are complete and accurate and present fairly the financial position and results of operations of each Business as of the dates and periods indicated, and have been prepared in accordance with GAAP subject to normal year-end adjustments that are not materially adverse and the absence of notes and, to the extent consistent with GAAP, Seller’s past practices in preparing financial statements, subject, in the case of any quarterly Financial Statements included therein, to normal year-end audit adjustments made in the Ordinary Course.
4.3Taxes. Except to the extent related to U.S. federal, state or local Taxes (or Tax Returns) of Seller:
(a)All income and other material Tax Returns required to be filed by Seller or required to be filed with respect to the Businesses or the Purchased Assets have, in each case, been timely filed with the appropriate taxing authorities. Each such Tax Return is true, correct and complete in all material respects (taking into account applicable extensions).
(b)All material Taxes due and payable by or with respect to Seller, the Businesses and the Purchased Assets (whether or not shown to be due and payable on any Tax Return) have been timely paid in full.
(c)Seller has withheld or collected all material Taxes required by law to have been withheld or collected in connection with amounts paid or owing to any employee, independent contractor, creditor, stockholder, member or other third party, and all such Taxes withheld or collected have been timely paid over to the proper authorities to the extent due and payable. Seller has timely and properly withheld or collected all material sales, use, ad valorem, and value added Taxes and has timely remitted all such Taxes to the proper authorities to the extent due and payable.
(d)There is no Action now pending or threatened in writing against or with respect to the Purchased Assets or the Businesses in respect of any Tax.
(e)There are no agreements or arrangements with any Taxing Authority with regard to Tax liabilities of the Businesses or Purchased Assets, other than settlements or compromises with respect to asserted Tax liabilities for prior Tax years that do not impose any payment obligation on such Businesses or Purchased Assets after their applicable Closing Date.
(f)Seller is not a party to, or otherwise bound by (nor does Seller have any obligation under) any Tax Sharing Agreement and there are no Tax Sharing Agreements that relate to the Businesses or the Purchased Assets.
(g)There are no outstanding proposed tax adjustments with respect to Businesses or the Purchased Assets or outstanding proposed tax adjustments with respect to Seller the non-payment of which, would result in an Encumbrance on any Purchased Asset (other than a Permitted Encumbrance or other Encumbrance that would not be material to the Businesses, taken as a whole).
(h)Reserved.
(i)None of the assets of or relating to the Businesses constitutes, for U.S. federal income tax purposes, an interest in an entity taxable as a partnership or corporation.
36



(j)All transactions and agreements between any of Seller and its Affiliates have been carried out on an arm’s length basis and comply in all respects with all applicable transfer pricing requirements, and, to the extent requested, Seller has delivered to Purchaser, or made available to Purchaser for review, accurate and complete copies of all material transfer pricing studies and other transfer pricing documentation required to be prepared under any statutory, regulatory or administrative Tax provision.
(k)(i) The accruals and reserves for unpaid Taxes of the Seller with respect to the Businesses (excluding any reserve for deferred Taxes established to reflect timing differences between book and Tax income) specifically set forth and included in the Financial Statements are adequate in accordance with GAAP to fully cover all Taxes accrued or accruable through the date hereof and such reserves for Taxes, as adjusted for operations and transactions and the passage of time through the applicable Closing Date, are adequate to cover all unpaid Taxes of the Seller with respect to the Businesses accruing through such Closing Date, and (ii) Seller has no liability for Taxes incurred after the date of the Financial Statements other than Taxes incurred by it in the Ordinary Course.
(l)This Section 4.3 contains the sole and exclusive representations and warranties of Seller with respect to Taxes. No representation or warranty is made in this Agreement with respect to the amount, sufficiency or availability of any Tax asset available in or to be carried forward to a Post-Closing Tax Period.
4.4Real Property.
(a)Schedule 4.4(a) identifies each lease, sublease or other agreement under which the Real Property is leased or otherwise occupied by or managed by any third party which is not an Affiliate of Seller, including all amendments thereto (together with all amendments thereto, each a “Real Property Lease”).
(b)Seller has not received any written notice of any pending Condemnation affecting all or any portion of the Real Property and, to Seller’s Knowledge, no such Condemnation is currently threatened.
(c)Except as set out on Schedule 4.4(c), to Seller’s Knowledge, there are no Contracts which would grant to any other Person the right of use or occupancy of the Real Property or any portion thereof, and there is no Person in possession of the Real Property or any portion thereof other than Seller.
(d)Seller has made available to Purchaser true, accurate and complete copies of each Real Property Lease and any lease or lease agreement for more than five hundred (500) square feet which is not cancelable without penalty on thirty (30) days or less advance written notice under which any portion of the Real Property is leased or otherwise occupied or managed by any Person, including all material amendments thereto.
(e)(i) There exists no material default, breach or dispute on the part of Seller under any Real Property Lease which is beyond any applicable notice and cure period, and (ii) to Seller’s Knowledge, there exists no material default or breach by the landlord, sublessor, licensor or other obligor under any Real Property Lease.
37



(f)The Real Property identified on Exhibit D are all of the parcels of real property owned, leased, used or occupied by the Seller in the operation of the Businesses. To Seller’s Knowledge, except for Permitted Encumbrances, and except as set forth in the Title Reports, there are no encumbrances, easements or rights of way of record (or, if not of record, of which Seller has Knowledge) granted on or appurtenant to or otherwise affecting any of the Real Property. The Real Property is in material compliance with restrictions, covenants and agreements of record. To Seller’s Knowledge, all of the Real Property currently has permanent rights of access to and from dedicated public rights of way or by private easement, as applicable. To Seller’s Knowledge, no fact or condition exists that would prohibit or adversely affect the current existing rights of access to and from any Real Property from and to the existing public highways and roads or private easements, and to Seller’s Knowledge, there is no pending restriction or denial, governmental or otherwise, upon such ingress or egress. To Seller’s Knowledge, each parcel of Real Property is comprised of a single, complete tax parcel, or if any Real Property is comprised of more than one (1) tax parcel, then such Real Property includes the entirety of all related tax parcels, or except as otherwise shown on an accurate survey. Except as otherwise disclosed to Purchaser, to the Knowledge of Seller, Seller has not received any written notice from any Governmental Authority that the Real Property is in violation of any (i) Laws, (ii) certificates of occupancy, or (iii) zoning matters.
(g)To Seller’s Knowledge, and except as shown on an accurate survey, there is not any (i) claim of adverse possession or prescriptive rights involving or affecting any Real Property; (ii) buildings or other improvement located on any Real Property that encroaches on or over the boundaries of neighboring or adjacent properties; or (iii) structure, paving or other buildings or improvements of any other Person that encroaches on or over the boundaries of any Real Property. To Seller’s Knowledge, and except as shown on an accurate survey, none of the Real Property is located in a flood plain, flood hazard area, wetland or lakeshore erosion area within the meaning of any Law, regulation or ordinance. No public improvements have been commenced and, to Seller’s Knowledge, none are planned that, in either case, may result in special assessments against or otherwise materially adversely affect the use of any Real Property (individually or in the aggregate). To Seller’s Knowledge, no portion of any Real Property is subject to any rollback Taxes, recapture provisions, additional Taxes or assessments, or penalties as a result of having been at any time classified or zoned for agricultural, forest cropland, or similar use. To Seller’s Knowledge, there is no (1) planned or proposed increase in assessed valuations of any Facilities or Real Property except as set forth on Schedule 4.4(g); (2) Order requiring repair, alteration, or correction of any existing condition affecting any Facilities or Real Property, except as set forth on Schedule 4.4(g); (3) underground storage tanks except as otherwise set forth in any environmental report obtained by Purchaser; (4) notice from any local building inspector or written notice of any code violations affecting any of the Facilities or Real Property; or (5) work that has been done or labor or materials that has or have been furnished to any Facilities or Real Property during the one year period immediately preceding the Execution Date for which liens could be filed against any Facilities or Real Property that has not been, or will not be, fully paid or bonded over prior to the applicable Closing.
(h)To Seller’s Knowledge, there is no outstanding damage to any Facilities or Real Property that would currently constitute a Casualty Loss, except as otherwise disclosed to Purchaser or as set forth on Schedule 4.4(h).
(i)To Seller’s Knowledge, there are no unsatisfied written requests for repairs, restorations or alterations, inoperable equipment, or structural systems, mechanical systems and furniture, fixtures or equipment, in each case, the cost of which is in excess of $100,000 to repair or replace, and which will not be complete prior to the Initial Closing with regard to any one of the Facilities or Real Property, except as otherwise disclosed to Purchaser or as set forth on Schedule 4.4(i).
(j)Notwithstanding anything else in this Agreement to the contrary, this Section 4.4 and Sections 4.3, 4.5, 4.8, 4.12 and 4.13 contain the only representations and warranties made by Seller with respect to the Real Property matters.
38



4.5Title to Purchased Assets; Absence of Encumbrances. (a) Each Seller has (or will have, as of applicable Closing) good and marketable title to, or in the case of personal property held under a lease or other Contract (subject to the terms of the lease or other Contract), which personal property and the relevant Contract are identified on Schedule 4.5, an enforceable leasehold interest in, or right to use, the Purchased Assets, and (b) to the Knowledge of Seller, none of the Purchased Assets is subject to any Encumbrance other than Permitted Encumbrances.
4.6Intellectual Property.
(a)Schedule 4.6 contains a list of all Seller names and marks, registrations and applications for registration of patents, trademarks, and copyrights included in the Intellectual Property, in each case as of the Execution Date.
(b)(i) Seller owns or possesses all licenses or other rights to use all Intellectual Property necessary to conduct the Businesses as presently conducted, (ii) each Business as currently conducted does not misappropriate or infringe upon any Intellectual Property rights of others, (iii) Seller has not received any written notice from any third party that a Business as currently conducted misappropriates or infringes upon any Intellectual Property rights of others, and (iv) Seller has not received any written notice that any third party is infringing any Intellectual Property owned by Seller and used in connection with a Business.
(c)Notwithstanding anything else in this Agreement to the contrary, this Section 4.6 contains the only representations and warranties made by Seller with respect to Intellectual Property matters.
4.7Corporate Contracts. Schedule 4.7 lists all Corporate Contracts pursuant to which any services are provided by or to any Facility or the Businesses. Seller has provided Purchaser with access to the Data Room that includes a summary of certain terms of each such Corporate Contract.
4.8Litigation. Except as disclosed on Schedule 4.8, (i) there is no material Action pending or, to Seller’s Knowledge, threatened against Seller with respect to the Purchased Assets or the Businesses, and (ii) Seller is not subject to any material Order relating to the Purchased Assets or the Businesses.
4.9Stimulus Funds. Schedule 4.9 attached hereto contains a true, complete and correct list of (a) the type and the amount of all Stimulus Funds received by Seller, and (b) the current amount of such Stimulus Funds that have not yet been expended by such Parties as of the Execution Date. As used herein, “Stimulus Funds” means any grant payments, stimulus payments, retroactive rate adjustments, credits and any and all other payments and support paid with respect to a Business in relation to COVID-19 relief efforts, as well as other funds related to the Coronavirus Aid, Relief and Economic Security Act, Paycheck Protection Program, CMS Accelerated and Advance Payments (“AAP”) or any other state or federal stimulus funding related to the COVID-19 pandemic, but expressly limited to such amounts that relate to the period prior to the Effective Time.
4.10Material Contracts.
(a)Schedule 4.10 sets out, as of the Execution Date, all of the following agreements to which the Property Owners are party to constituting Purchased Assets:
(i)any agreement that Seller or its Subsidiaries reasonably anticipates will involve annual payments or consideration furnished to Seller and its Subsidiaries (in the aggregate) of more than $150,000 after the date hereof, or any other agreement that is material to the ownership of the Real Property;
39



(ii)any collective bargaining agreement or other Contract with any labor organization, labor union or labor association;
(iii)any binding sales, distribution or other similar agreement (excluding purchase orders entered into in the Ordinary Course) providing for the purchase by Seller of materials, supplies, goods, services, equipment or other tangible assets requiring annual payments by Seller of $250,000 or more after the date hereof;
(iv)any agreement (A) containing covenants limiting the freedom of the Businesses to engage or participate or compete in any line of business, or with any Person or in any geographic region or (B) granting a third party exclusive rights of any type or scope with respect to any applicable products, technology, rights in Intellectual Property or other aspects of the Businesses;
(v)any agreement as obligor or guarantor relating to indebtedness for borrowed money (excluding intercompany loans) in excess of $250,000 or the deferred purchase price of property (in either case, whether incurred, assumed, guaranteed or secured by any asset);
(vi)any Contract between the Seller and its Affiliates;
(vii)any material agreements to which Seller grants to or obtains from a third party a license under any Intellectual Property, other than any (A) licenses for non-customized commercial or off the shelf computer software that are generally available on nondiscriminatory pricing terms or licensed for internal use in object code only on the relevant licensor’s non-negotiated standard terms, and (B) non-exclusive licenses granted or obtained in the Ordinary Course;
(viii)any agreement involving resolution or settlement of any actual or threatened Action in excess of $250,000 which is not covered by insurance and (A) that has not been fully performed by Seller or (B) otherwise imposes continuing obligations on Seller or the Businesses;
(ix)any agreement containing “most-favored nation,” “most favored pricing” or similar clauses in favor of any Person;
(x)any agreement pursuant to which Seller grants any other party any rights of first refusal, rights of first negotiation, or similar rights;
(xi)any agreement providing for Seller to indemnify a third party, other than such agreements entered into in the Ordinary Course;
(xii)any material agreement with any Governmental Authority excluding any agreement with any state-owned enterprise or partially state-owned enterprise entered into in the Ordinary Course; or
(xiii)any acquisition or divestiture contract that contains financial covenants, indemnities or other payment obligations (including “earn-out” or other contingent payment obligations) that would reasonably be expected to result in the making of payments after the Initial Closing Date in excess of $250,000.
40



(xiv)Each agreement, contract, lease, arrangement or commitment required to be disclosed pursuant to this Section 4.10 (each, a “Material Contract”) is a valid and binding agreement of the applicable Seller party thereto and is in full force and effect and neither Seller nor, to the knowledge of Seller as of the date hereof, any other party thereto is in default or breach in any respect under the terms of any such Material Contract, and, to the knowledge of Seller, no event has occurred which, with lapse of time or action by a third party, would result in a material default under any Material Contract. As of the date hereof, Seller has not received any written notice of termination with respect to, and, to the knowledge of Seller, no party has threatened to terminate, any Material Contract.
4.11Compliance with Health Care Laws. Except as, individually or in the aggregate, would not reasonably be expected to be material to the Businesses, as a whole, since December 31, 2022:
(a)each Seller has conducted its business and operations in material compliance with all applicable Health Care Laws.
(b)each Facility (i) has been certified for participation in the Government Reimbursement Programs set forth on Schedule 4.11(b); and (ii) is in compliance in all material respects with the conditions of participation in such Government Reimbursement Programs. All Government Reimbursement Programs in which a Seller is currently participating and all associated provider numbers for such Government Reimbursement Programs are listed on Schedule 4.11(b).
(c)(i) all claims submitted to any Government Reimbursement Program by Seller have been in compliance in all material respects with all Laws applicable to such Government Reimbursement Programs, and (ii) the Seller has repaid or caused to be repaid all material known and undisputed refunds or overpayments which have become due to any Government Reimbursement Program, or will repay or cause to be repaid such refunds or overpayments, within the timeframes set forth in 42 C.F.R. § 401.305 and 42 CFR § 422.326.
(d)Except as set forth on Schedule 4.11(d), (i) except for any Ordinary Course surveys, audits or other inspections, Seller has not received from any Governmental Authority any written notice or written communication alleging material noncompliance (or with respect to any subpoena or civil investigative demand relating to potential material noncompliance) by such party with any Health Care Laws that has not been cured in all material respects, (ii) there is no civil, criminal or administrative Action or any material governmental action including any civil investigative demand or subpoena (other than investigations or sealed legal proceedings that are not within the Knowledge of the Seller) alleging material noncompliance under any Health Care Laws or related to material non-compliance with, or asserting any material liability under, any Health Care Laws that is currently pending against the Seller, and (iii) neither the Seller, nor, to the Knowledge of the Seller, any director, officer or managing employee of the Seller or, to the Knowledge of the Seller, any independent contractor providing direct care services to residents or patients on behalf of any Facility, has been debarred or excluded from participation any Government Reimbursement Program, or, to the Knowledge of the Seller, engaged in any activities during the course of such person’s engagement with Seller which are grounds for exclusion from participation in any Government Reimbursement Programs.
(e)Except as set forth on Schedule 4.11(e), except for any Ordinary Course surveys, audits or other inspections, Seller has not received written notice of any material action (i) pending or (ii) threatened by any Government Reimbursement Program to revoke or terminate the participation of such party in such Government Reimbursement Program that remains outstanding and has not been rescinded, removed or cured in all material respects by the applicable Government Reimbursement Program.
41



(f)(i) there are no sanctions currently in effect with respect to any Facility that would prevent such Facility from conducting its operations, or (ii) there are no material restrictions on the Licenses held by any Facility. The Company has not received written notice from any Governmental Authority that such Governmental Authority intends to revoke, withdraw or suspend any License to operate a Facility that remains outstanding and has not been rescinded or removed by the applicable Governmental Authority.
(g)to the Knowledge of the Seller, Seller has not been a defendant in any qui tam or False Claims Act legal proceeding, nor has made any voluntary disclosure to the Office of Inspector General or the U.S. Centers for Medicare and Medicaid Services relating to any Health Care Laws that has not yet been resolved.
(h)Seller is in compliance in all material respects with HIPAA and comparable state Law equivalents in the states in which they operate. To the Knowledge of the Seller, no “Security Incident” or “Breach,” (as those terms are defined by HIPAA) has occurred, exclusive of pings or other broadcast attacks on any firewall, port scan, or unsuccessful log on attempts of the Businesses.
(i)the Seller has filed when due all cost reports required to be filed under any Government Reimbursement Program. All such cost reports have been prepared in all material respects in accordance with and in compliance with Applicable Law.
(j)no Seller has received written notice of any dispute between such party and any Governmental Authority regarding such cost reports, nor has any Seller received any written notice of any audits or violations with respect to any cost reports and, to the Knowledge of the Seller, no such audits or violations are threatened.
(k)no Seller has received written notice that any Facility has been, or will be, placed on the Special Focus Facility List maintained by the Centers for Medicare & Medicaid Services.
(l)Notwithstanding anything else in this Agreement to the contrary, this Section 4.11 contains the only representations and warranties made by Seller with respect to Health Care Laws.
4.12Environmental Matters. Except where, individually or in the aggregate, it would not reasonably be expected to be material to the Businesses, as a whole:
(a)The conduct of the Business by Seller is in compliance with all applicable Environmental Laws. Each Seller has obtained all approvals and permits required to be obtained from Governmental Authorities for the Business under Environmental Laws, and Seller is in compliance with the terms and conditions of all such permits and approvals.
(b)There has been no Release or threatened Release of Hazardous Substances at any Facility that requires remediation pursuant to applicable Environmental Laws except as set forth on Schedule 4.12(b).
(c)Seller has not treated, stored, disposed of, arranged for or permitted the disposal of, transported, handled, released, or exposed any Person to, any Hazardous Substance, or owned or operated any property or facility contaminated by any Hazardous Substance so as would give rise to any liability for response costs, corrective action costs, personal injury, property damage, natural resources damages or attorney fees, or any investigative, corrective or remedial obligations, pursuant to any Environmental Laws.
42



(d)Seller has not received any written notice, notification or demand from any Governmental Authority with respect to the Business or any Facility pursuant to Environmental Law. Seller has not received any written notice of material claims, legal proceedings, Orders, fines or penalties under Environmental Laws, or otherwise regarding the Release or threatened Release of Hazardous Substances, in each case with respect to the Business or any Facility, pending or, to Seller’s Knowledge, threatened, against Seller.
(e)All environmental audits, investigations or assessments in the possession or control of Seller, or to which Seller has access, relating to the Business or any Facility has been provided to or otherwise made available in the Data Room to Purchaser.
(f)There are no past or present (or, to Seller’s Knowledge, future) events, conditions, circumstances, activities, practices, incidents, actions, omissions or plans that may interfere with or prevent compliance or continued compliance by each Business with all Environmental Laws or give rise to any liability under Environmental Laws;
(g)Notwithstanding anything else in this Agreement to the contrary, this Section 4.12 contains the only representations and warranties made by Seller with respect to Environmental Laws.
4.13Absence of Certain Changes. Since January 1, 2024, Seller has operated each Business in the Ordinary Course and, to Seller’s Knowledge, there has not occurred any event, development or change that, individually or in the aggregate, which would reasonably be expected to be material to the Businesses, taken as a whole, and during such time period, Seller has not:
(a)sold, transferred, leased to others or otherwise disposed of any Purchased Assets without the prior written consent of Purchaser, other than supplies used at a Facility in the Ordinary Course, provided that it shall also be replenished to a quantity sufficient to comply with applicable Law;
(b)permitted any of the Purchased Assets to become subject to an Encumbrance which will not be released as of the applicable Closing, other than a Permitted Encumbrance;
(c)changed its method of accounting or its accounting principles or practices, including any policies or practices with respect to revenue recognition or the establishment of reserves for Accounts Receivable, utilized in the preparation of the Financial Statements, other than as required consistent with its past accounting practices or GAAP; or
(d)settled any material Action by any Person or before any court or Governmental Authority alleging a violation of any Applicable Law, Real Property Lease or Material Contract by Seller relating to any of the Purchased Assets or the Businesses other than general and professional liability claims settled in the Ordinary Course.
4.14Brokers and Finders. Except as set forth on Schedule 4.14, Seller has not engaged, nor is Seller liable to pay any fees, costs or commissions to, any broker, finder, agent or financial advisor (each, a “Broker” and collectively, “Brokers”) in connection with the transactions contemplated hereby.
43



4.15Solvency. Seller is not entering into the Transaction Documents with the intent to hinder, delay or defraud either present or future creditors.
4.16Insurance. Seller and its Affiliates maintain policies of fire and casualty, liability and other forms of insurance with respect to the Businesses in such amounts, with such deductibles and against such risks and losses as are, in Seller’s judgment, commercially reasonable and in conformity with the insurance obligations imposed on Seller under all applicable Material Contracts and Real Property Leases. The insurance policies maintained by each Seller with respect to the Businesses are set forth on Schedule 4.16. All such policies are in full force and effect, all premiums due and payable thereon have been paid (other than retroactive or retrospective premium adjustments that are not yet, but may be, required to be paid with respect to any period ending prior to the Initial Closing Date), and no notice of cancellation or termination has been received with respect to any such policy which has not been replaced on substantially similar terms prior to the date of such cancellation. The Businesses have been conducted in a manner so as to conform in all material respects to all applicable provisions of such insurance policies. Seller has not received any written notice from the insurance companies that Seller is not in compliance with such insurance policies.
4.17No Other Representations or Warranties; Reliance on Representations and Warranties. EXCEPT FOR THE REPRESENTATIONS AND WARRANTIES CONTAINED IN THIS AGREEMENT OR IN THE OTHER TRANSACTION DOCUMENTS, SELLER DOES NOT MAKE ANY OTHER EXPRESS OR IMPLIED REPRESENTATION OR WARRANTY WITH RESPECT TO THE BUSINESSES, THE PURCHASED ASSETS, THE ASSUMED LIABILITIES OR ANY OTHER MATTER IN CONNECTION WITH THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT, AND SELLER DISCLAIMS ANY OTHER REPRESENTATIONS OR WARRANTIES, EXPRESS OR IMPLIED, INCLUDING WITH RESPECT TO (A) ANY FINANCIAL PROJECTIONS OR OTHER FORWARD-LOOKING INFORMATION WITH RESPECT TO THE BUSINESS OR ANY FACILITY, (B) MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE, (C) ANY MATERIALS RELATING TO THE TRANSACTIONS CONTEMPLATED HEREBY PROVIDED BY SELLER’S AGENTS OR REPRESENTATIVES, OR (D) ANY OTHER MATTER THAT, UNDER APPLICABLE LAW, WILL BE DEEMED TO GIVE RISE TO ANY EXPRESS OR IMPLIED WARRANTY. EXCEPT FOR THE REPRESENTATIONS AND WARRANTIES CONTAINED IN THIS ARTICLE IV OR IN THE OTHER TRANSACTION DOCUMENTS, ALL PURCHASED ASSETS ARE CONVEYED ON AN “AS IS” AND “WHERE IS” BASIS.
4.18Disclosure Updates. At any time, and from time to time on or prior to an applicable Closing Date, Seller may supplement or amend the Schedules and/or information in the Data Room (collectively, a “Disclosure Update”), with respect to any matter which has not yet been subject to an applicable Closing. No such Disclosure Update shall be evidence, in and of itself, that corresponding representations and warranties are no longer true and correct in all material respects. It is specifically agreed that the Schedules and/or information in the Data Room may be amended to add immaterial, as well as material, items. No such Disclosure Update shall have any affect for purposes of the condition set forth in Sections 7.1(b)(i) or 7.4(b)(i) or the indemnification provisions of Article IX with respect to the facts and circumstances underlying such Disclosure Update or otherwise be deemed to cure any breach, and the delivery of any such Disclosure Update shall not limit or otherwise affect the remedies available hereunder to the party receiving such notice.
4.19Employment and Labor Matters.
44



(a)Schedule 1.1(a) lists Business Employees on the date hereof, along with the amount of the current annual salaries and total compensation paid or due for services to each employee for the most recent fiscal year-end and the year-to-date, and a full and complete description of any commitments to such Facility Employees with respect to compensation payable thereafter. To the Seller’s Knowledge, no Facility Employee has any plans to terminate employment with the Seller.
(b)Except as set forth on Schedule 4.19, Seller has never been a party to any collective bargaining agreement, employment agreement or other labor contract, and there are no pending or, to Seller’s knowledge, threatened labor disputes at any Facility including, but not limited to, any strike, slowdown, picketing, work stoppage, organizational activities or employee grievance process affecting any Facility. Seller has complied in all material respects with all Applicable Laws governing wage, hour, payroll and all other employment and labor matters.
4.20Employee Benefits. None of Seller nor any of its ERISA Affiliates has sponsored, contributed to or been obligated under Title I or IV of ERISA to contribute to a “defined benefit plan” (as defined in ERISA Section 3(35)), a plan that was ever subject to Sections 412 or 430 of the Code, or Part 3 of Title I of ERISA or a multiemployer plan as defined in Section 3(37) of ERISA.
4.21Bankruptcy. No insolvency proceedings of any character, including without limitation, bankruptcy, receivership, reorganization, composition or arrangement with creditors, voluntary or involuntary, affecting the Seller (other than as a creditor) are pending or are being contemplated by the Seller, or to the Seller’s knowledge are being threatened against the Seller, and the Seller has made any assignment for the benefit of creditors or taken any action in contemplation of or which would constitute the basis for the institution of such insolvency proceedings.
4.22OFAC. Seller and their Affiliates and controlling members are not currently identified on the OFAC List, and each is not a Person with whom a citizen of the United States is prohibited from engaging in transactions by any trade embargo, economic sanction, or other prohibition of United States law, regulation, or executive order of the President of the United States. “OFAC List” means the list of specially designated nationals and blocked Persons subject to financial sanctions that is maintained by the U.S. Treasury Department, Office of Foreign Assets Control and any other similar list maintained by the U.S. Treasury Department, Office of Foreign Assets Control pursuant to any legal requirements, including, without limitation, trade embargo, economic sanctions, or other prohibitions imposed by Executive Order of the President of the United States. The OFAC List currently is accessible through the internet website https://www.treasury.gov/ofac/downloads/sdnlist.pdf.
Article V
REPRESENTATIONS AND WARRANTIES OF PURCHASER
Purchaser represents and warrants to Seller as of the Execution Date and as of the Closing Date (or in the case or representations and warranties that by their terms speak as of a specified date, as of such specified date) as follows:
5.1Corporate.
(a)Organization. Purchaser is a limited liability company duly formed, validly existing and in good standing under the Laws of the jurisdiction of its formation.
45



(b)Power and Authority; Authorization; Enforceability. Purchaser has all necessary limited liability company power and authority to own, operate and lease its properties and assets, to carry on its businesses as and where such is now being conducted, to enter into the documents and instruments to be executed and delivered by Purchaser pursuant hereto and to carry out the transactions contemplated hereby. The execution and delivery of the Transaction Documents by Purchaser and performance of this Agreement by Purchaser have been duly and validly authorized by its board(s) of directors and by all other necessary limited liability company action on the part of Purchaser. This Agreement constitutes the legal, valid and binding obligation of Purchaser, enforceable against Purchaser in accordance with its terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium and other similar Laws and equitable principles relating to or limiting creditors’ rights generally.
(c)Qualification. Purchaser is, or as of each Closing will be, duly qualified or licensed to do business, and is in good standing, in all jurisdictions in which the character or the location of the assets owned or leased by it, or the nature of the business conducted by it requires such licensing or qualification.
(d)No Conflicts or Violations. Neither the execution and delivery of this Agreement, the consummation of the transactions contemplated hereby, nor the fulfillment of the terms hereof by Purchaser will (i) violate or result in a breach of any of the material terms and provisions of, constitute a default under, conflict with, or result in any acceleration of rights, benefits or obligations of any party under any Contract to which Purchaser is a party or by which it is bound, (ii) violate any Order applicable to Purchaser, (iii) constitute a material violation by Purchaser of any Applicable Law, (iv) result in the breach of any of the material terms or conditions of, or constitute a default under, or otherwise cause any impairment of, any permit, license or other governmental authorization held by Purchaser, or (v) conflict with or violate any charter document, operating agreement or partnership agreement of Purchaser, except in the case of sub-clause (i) to the extent that any such violation, individually or in the aggregate, would not reasonably be expected to prevent, or materially impede, interfere with, hinder or delay the consummation of the transactions contemplated by this Agreement.
(e)Except for the applicable state licensure requirements for the states in which the Businesses are located, and compliance with the HSR Act, no material authorizations, approvals, waivers or consents are required to be obtained, or notices to be made, by Purchaser to consummate the transactions contemplated hereby.
5.2Litigation. No lawsuit, governmental investigation or legal, administrative or arbitration action or proceeding is pending or threatened against Purchaser, which questions the validity of this Agreement or seeks to prohibit, enjoin or otherwise challenge the consummation of the transactions contemplated hereby.
5.3Brokers and Finders. Except as set forth on Schedule 5.3, no Broker has been engaged by Purchaser in connection with the transactions contemplated hereby. No fees, commissions or costs of any such Broker will be owed by Purchaser.
5.4HSR. No filings under the HSR Act are required in connection with the transactions contemplated by this Agreement.
5.5Sufficient Funds; Solvency. Purchaser is not entering into the Transaction Documents with the intent to hinder, delay or defraud either present or future creditors. Purchaser will at each Closing have the financial resources necessary to consummate the transaction contemplated by this Agreement, and perform all of its respective obligations hereunder, including but not limited to the ability to pay the Purchase Price and any indemnification required hereunder. Purchaser’s obligations hereunder are not contingent upon any third party financing. Purchaser is solvent and both prior to and after consummation of the transactions contemplated hereby will have sufficient funds to operate its business and pay its debts as they become due and will not have unreasonably small capital with which to conduct its business; and no bankruptcy, insolvency, reorganization or similar action or proceeding, whether voluntary or involuntary, is pending, or has been threatened in writing, against Purchaser.
46



5.6Third Party Reports. Exhibit S sets forth a list of the Third Party Reports.
5.7OFAC. Purchaser and their Affiliates and controlling members are not currently identified on the OFAC List, and each is not a Person with whom a citizen of the United States is prohibited from engaging in transactions by any trade embargo, economic sanction, or other prohibition of United States law, regulation, or executive order of the President of the United States.
5.8Independent Investigation; Completion of Due Diligence.
(a)Purchaser has conducted or will conduct its own independent due diligence investigation, review and analysis of the Purchased Assets, Businesses, results of operations, prospects, condition (financial or otherwise) or assets of the Seller, and acknowledges that it has been provided adequate access to the personnel, properties, assets, premises, books and records, and other documents and data of Seller for such purposes. Purchaser acknowledges and agrees that (i) in making its decision to enter into this Agreement and to consummate the transactions contemplated hereby, Purchaser has relied solely upon its own investigation and the express representations and warranties of Seller set forth in Article IV of this Agreement and the related Schedules, (ii) neither Seller nor any other Person has made any representation or warranty as to Seller, the Purchased Assets, the Businesses or this Agreement, except as expressly set forth in Article IV of this Agreement, and (iii) Purchaser has completed its due diligence investigation of Seller, the Purchased Assets and the Businesses as of the Execution Date.
(b)As of the Execution Date, Purchaser has no actual knowledge (defined to be limited to the actual knowledge of Elliott Mandelbaum and Maxwell Luce with no duty to investigate) (i) that any of Seller’s representations or warranties set forth in the Agreement or the Transaction Documents are not true and correct in all material respects, or (ii) that Seller is in material breach of any of its covenants and/or obligations under the Agreement or the Transaction Documents.
5.9AS-IS; No Other Representations or Warranties. Purchaser acknowledges that, except as set forth in this Agreement or in the other Transaction Documents, it has or will have inspected the Purchased Assets and, subject to the terms hereof, agree to purchase the same in its present “AS IS-WHERE IS” condition. Except for the specific representations and warranties expressly made by the Seller in Article IV of this Agreement or in the other Transaction Documents, (a) Purchaser represents and warrants that (i) the Seller is not making and have not made any representation or warranty, expressed or implied, at law or in equity, in respect of the Businesses, the Purchased Assets or the Seller’s respective businesses, assets, liabilities, operations, prospects, or condition (financial or otherwise), including with respect to merchantability or fitness for any particular purpose of any assets, the nature or extent of any liabilities, the prospects of the business, the effectiveness or the success of any operations, or the accuracy or completeness of any confidential information memoranda, documents, projections, material or other information (financial or otherwise) regarding the Seller or the Purchased Assets furnished to the Purchaser or any of its representatives or made available to the Purchaser or its representatives in the Data Room, management presentations or in any other form in expectation of, or in connection with, the transactions contemplated by this Agreement, or in respect of any other matter or thing whatsoever, and (ii) neither the Seller, nor any of their Representatives has any authority, express or implied, to make any representations, warranties or agreements not specifically set forth in this Agreement or in the other Transaction Documents and subject to the limited remedies herein provided, (b) the Purchaser specifically disclaims that it is relying upon or has relied upon any such other representations or warranties that may have been made by any Person and not set forth in this Agreement or in the other Transaction Documents, and acknowledges and agrees that the Seller and their respective Affiliates have specifically disclaimed and do hereby specifically disclaim any such other representation or warranty made by any Person, (c) the Purchaser specifically disclaims any obligation or duty by the Seller or any of their respective Affiliates to make any disclosures of fact not required to be disclosed pursuant to the specific representations and warranties set forth in Article IV of this Agreement or in the other Transaction Documents, and (d) the Purchaser is entering into the contemplated transactions and acquiring the Purchased Assets in connection with the contemplated transactions subject only to the specific representations and warranties set forth in Article IV of this Agreement or in the other Transaction Documents.
47



Article VI
COVENANTS
6.1Interim Conduct.
(a)During the period from the Execution Date and continuing until the earlier of the termination of this Agreement or the consummation of an applicable Closing, Seller shall (except as set forth on Schedule 6.1(a) or to the extent consented to in writing by Purchaser, which consent shall not be unreasonably withheld or delayed) operate each Facility in the Ordinary Course and use commercially reasonable efforts consistent with past practice to seek (i) to preserve intact the goodwill of each Business and to preserve, maintain and protect the value of each Business, (ii) to preserve relationships with material customers, suppliers, physicians, distributors, licensors, licensees, and others having business dealings with each Business (other than pursuant to any Overhead and Shared Services) and (iii) to repair, replace and maintain the plumbing, mechanical, electrical and other systems of each Facility in good working order and condition, consistent with the Ordinary Course.
(b)During the period from the Execution Date and continuing until the earlier of the termination of this Agreement or the applicable Closing, Seller shall comply in all material respects, with any surveys or inspections by any Governmental Authority arising from the transactions contemplated by this Agreement and the Transaction Documents and the requirements of any plan or plans of correction (including the removal of any DPNA) proposed in response to any inspection or survey conducted by any Governmental Authority that commences on or prior to the applicable Closing and pay any fines or penalties (including any civil monetary penalties) resulting from such inspections or surveys or if appealed, Seller shall retain liability for all costs and expenses in pursuing such appeals and the liability for any penalties not rescinded. In addition, Seller shall consult with Purchaser on such appeals and notify Purchaser of the final disposition of such matters. Seller shall, with respect to each Facility, make any capital repair or physical improvements necessary to (1) remove a cited deficiency from any Governmental Authority, (2) correct any immediate jeopardy violations, and (3) terminate a DPNA.
(c)Without limiting the foregoing, and except as set forth on Schedule 6.1(c), during the period from the Execution Date and continuing until the earlier of the termination of this Agreement or the consummation of an applicable Closing, Seller shall not undertake any of the following with respect to any Purchased Asset or Assumed Liability except as contemplated by the Transaction Documents, or as necessary to consummate the transactions contemplated by this Agreement and the Transaction Documents, without the prior written consent of Purchaser, which consent shall not be unreasonably withheld or delayed:
48



(i)sell, lease, license or otherwise dispose of any of the Purchased Assets (other than supplies used at the Facility in the Ordinary Course, provided that it shall also be replenished to a quantity sufficient to comply with applicable Law), or create, incur or suffer to exist any Encumbrance (other than a Permitted Encumbrance) on any of the Purchased Assets, which would not be released as of the applicable Closing Date;
(ii)terminate or waive any material right included in the Purchased Assets of substantial value;
(iii)agree in writing to take any of the foregoing actions.
6.2Certain Tax Matters.
(a)Apportionment of Certain Taxes. All Property Taxes levied with respect to the Purchased Assets shall be apportioned between the Seller and Purchaser as of the Effective Time based on the number of days of the applicable taxable period prior to the Effective Time (with respect to such taxable period, the “Pre-Closing Period”) and after the Effective Time (with respect to such taxable period, the “Post-Closing Period”). Seller shall be responsible, and to the extent not paid prior to an applicable Closing, provide Purchaser with a credit at such Closing, for Seller’s proportionate share of any such Taxes that are attributable to the Pre-Closing Period, and Purchaser shall be liable for its proportionate share of any such Taxes that are attributable to the Post-Closing Period. If the exact amount of Property Taxes is not known at such Closing, the proration will be based on an amount equal to 103% of the prior assessment year’s Property Taxes and shall be adjusted directly between Seller and Purchaser once actual figures become available after such Closing.
(b)Certain Tax Returns. Seller shall prepare or cause to be prepared and shall file or cause to be filed all Tax Returns relating to Taxes arising out of the operation of the Businesses or the ownership of the Purchased Assets with respect to the Pre-Closing Period. All such Tax Returns shall be prepared in accordance with Seller’s past custom and practice, except to the extent otherwise required by Applicable Law. Purchaser shall pay to Seller promptly on demand all Property Taxes levied with respect to the Purchased Assets with respect to the Post-Closing Period included in any such Tax Return prepared or caused to be prepared by Seller for which Purchaser is responsible pursuant to Section 6.2(a) to the extent paid by Seller; provided, however, if Purchaser does not promptly pay to Seller any such liabilities, Seller shall have the right to pursue an indemnification claim for such liabilities in accordance with Section 9.2 hereof.
(c)Tax Cooperation. Purchaser and Seller shall furnish or cause to be furnished to each other, upon written request, as promptly as reasonably practicable, to the extent they have access to the same, such information and assistance relating to the Businesses, the Purchased Assets or the Assumed Liabilities as is reasonably necessary for the filing of all Tax Returns, the making of any election relating to Taxes, the preparation for any audit by any Governmental Authority, and the prosecution or defense of any claims, suit or proceeding relating to any Tax. Any expenses incurred in furnishing such information or assistance shall be borne by the Party requesting it.
49



(d)Transfer Taxes. All sales, transfer (including real estate transfer), stamp, documentary, filing, recordation and other similar Taxes, together with interest, additions or penalties with respect thereto resulting from the transactions contemplated by this Agreement (including the purchase of the Purchased Assets hereunder) (“Transfer Taxes”), shall be paid by Purchaser. Any Tax Returns required to be filed in connection with any Transfer Taxes shall be prepared and filed when due by the Purchaser and Purchaser shall provide Seller with a copy of such Tax Return for review and comment at least five (5) Business Days prior to such filing, unless the Seller is otherwise required as a matter of Law to be the remitting party, in which case the Purchaser shall prepare the return for filing by the Seller and shall provide the Seller with a copy of such Tax Return for review and comment at least five (5) Business Days prior to such filing.
6.3Reasonable Best Efforts; Cooperation; Regulatory Filings.
(a)In accordance with the terms and conditions set forth in this Agreement, each of the Parties shall use its reasonable best efforts to take, or cause to be taken, all actions that are necessary, proper or advisable to consummate and make effective the sale, conveyance, assignment, transfer and delivery of each of the Facilities and the other transactions contemplated by this Agreement, including using reasonable best efforts to accomplish each of the following: (i) taking of all reasonable acts necessary to cause the Closing Conditions to be satisfied, (ii) obtaining all necessary consents, approvals, waivers, Orders and authorizations from Governmental Authorities and making all necessary registrations, declarations and filings with Governmental Authorities, (iii) taking all reasonable steps as may be necessary to avoid any objections or legal proceedings by any Governmental Authority, and (iv) the obtaining of all necessary consents, approvals or waivers from third parties; provided, however, that the foregoing provisions of this Section 6.3(a) shall not require either (A) either Party to perform, satisfy or discharge any obligations of any other Party under this Agreement or otherwise, or (B) Seller to expend any money other than for filing fees or expenses or de minimis costs or expenses or agree to any restrictions in order to obtain any consents or waivers, except as set forth in Section 6.3(e).
(b)Subject to the terms and conditions of this Agreement, Purchaser and Seller shall use their respective reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary or desirable under Applicable Laws to consummate the transactions contemplated by this Agreement and the other Transaction Documents as promptly as practicable, including in connection with (i) preparing and filing as promptly as practicable with any Governmental Authority or other third party all documentation to effect all necessary or desirable filings, notices, petitions, statements, registrations, submissions of information, applications and other documents, (ii) obtaining and maintaining all approvals, consents, registrations, permits, authorizations and other confirmations required to be obtained from any Governmental Authority or other third party that are necessary or desirable to consummate the transactions contemplated by this Agreement and the other Transaction Documents as promptly as practicable, and (iii) to the extent permitted by Applicable Law, entering into the Interim Documents at the applicable Closing so as to expedite transfer of the Businesses to Purchaser. Seller and Purchaser agree to execute and deliver such other documents, certificates, agreements and other writings and use reasonable best efforts to take such other actions as may be necessary or desirable in order to consummate or implement expeditiously the transactions contemplated by this Agreement, to vest in Purchaser title to the Purchased Assets and to assure and evidence the assumption by Purchaser of the Assumed Liabilities.
(c)Reserved.
50



(d)Without limiting the generality of anything contained in this Section 6.3, and subject to any limitations under applicable Laws, each party hereto shall use reasonable best efforts to (i) give the other parties prompt notice of the making or commencement of any Legal Proceeding with respect to the transactions contemplated by this Agreement, (ii) keep the other parties reasonably informed as to the status of any such Legal Proceeding, (iii) promptly inform the other parties of any communication to or from the FTC, DOJ or any other Governmental Authority in connection with any such Legal Proceeding, (iv) upon request, promptly furnish to the other parties, subject to an appropriate confidentiality agreement to limit disclosure to outside counsel and consultants retained by such counsel, with copies of documents provided to or received from any Governmental Authority in connection with any such Legal Proceeding (other than Item “4(c)” and “4(d)” documents as those terms are used in the rules and regulations under the HSR Act), (v) subject to an appropriate confidentiality agreement to limit disclosure to counsel and outside consultants retained by such counsel, and to the extent reasonably practicable, consult in advance and cooperate with the other parties and consider in good faith the views of the other Party in connection with any analysis, appearance, presentation, memorandum, brief, argument, opinion, proposal or other communication to be made or submitted in connection with any such Legal Proceeding, and (vi) in connection with any such Legal Proceeding in respect of the transactions contemplated by this Agreement, each Party hereto shall provide reasonable advance notice of and permit authorized Representatives of the other Party to be present at each in person meeting or telephone conference relating to such Legal Proceeding.
(e)Upon the terms and conditions set forth herein, each of the Parties shall use reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, and to assist and cooperate with the other parties in doing, all things, necessary, proper or advisable to make effective as promptly as reasonably practicable, the transactions contemplated by this Agreement in accordance with the terms hereof. For purposes of this Section 6.3, “reasonable best efforts” shall require the Parties to defend, litigate, or contest any lawsuit, action, or order by any Governmental Authority. For purposes of this Section 6.3, Purchaser shall also use its reasonable best efforts to (i) propose, negotiate, consent to, offer to undertake, commit to and effect, by consent decree, hold separate orders, trust or otherwise, the sale, divestiture, license or disposition of the assets, properties, equity interests or businesses of Purchaser or any of its Affiliates and/or of the assets, properties, equity interests or businesses proposed to be acquired pursuant to the transactions; (ii) offer to take, commit to take or take any action that Purchaser and each of its Affiliates are capable of taking that limits their freedom of action or behavior with respect to the operation or retention of any of the assets, properties, equity interests or businesses of Purchaser or its Affiliates and/or of the assets, properties, equity interests or businesses proposed to be acquired pursuant to the transactions; (iii) terminate any existing relationships and contractual rights and obligations; and (iv) make amendments or modifications to this Agreement and the other Transaction Documents. No actions or undertakings taken by Purchaser pursuant to this Section 6.3(e) shall entitle Purchaser to any offset or reduction to the Purchase Price; and any actions or undertakings taken by Purchaser pursuant to this Section 6.3(e) involving the assets, properties, equity interests or businesses of Seller or its Affiliates shall be conditioned upon the occurrence of the Initial Closing.
(f)Without limiting the generality of the foregoing, prior to closing, the Purchaser shall not, and shall cause its Affiliates not to, acquire or agree to acquire any assets or business if such action would reasonably be expected to: impose any material delay in the obtaining of, or increase the risk in a material manner of not obtaining, any consents of any Governmental Authority necessary to consummate the transactions contemplated by this Agreement or the expiration or termination of any applicable waiting period; increase the risk in a material manner of any Governmental Authority seeking or entering an Order prohibiting the consummation of the transactions contemplated by this Agreement; increase the risk in a material manner of not being able to remove any such Order on appeal or otherwise; or delay in a material manner or prevent the consummation of the transactions contemplated by this Agreement.
6.4Announcement and Disclosure.
51



(a)Any press release announcing the execution of this Agreement shall be issued in such form as shall be mutually agreed upon by Seller and Purchaser, which agreement shall not be unreasonably withheld, conditioned or delayed. Unless otherwise required by Applicable Law (including any securities laws) or the rules of any securities exchange on which a party’s or its Affiliates’ securities are listed, neither Seller nor Purchaser shall, and each shall cause their respective Affiliates not to, make any public announcement or publicly disseminate any written communication with respect to this Agreement or the transactions contemplated hereby (including broad communications to Business Employees), or otherwise communicate with any news media regarding this Agreement or the transactions contemplated hereby, without the prior written consent of Purchaser and Seller; provided that if any such announcement or communication is so required, Purchaser and Seller shall consult with each other, to the extent reasonably practicable, in advance as to the contents and timing thereof; provided, further, that after the transactions contemplated by this Agreement have been announced Seller and its Affiliates and Purchaser and its Affiliates shall be entitled to respond to questions in the ordinary course or issue any press release or make any other public statement that, in each case, consistent (as to nature and scope) with any public statement previously issued or made by it in accordance with the provisions of this Section 6.4
(b)Except as may be necessary to enforce this Agreement, or to comply with Applicable Laws including securities Laws, for three (3) years after the Initial Closing, Seller shall (i) treat and hold as confidential any proprietary and confidential information of Seller related exclusively to the Purchased Assets or the Assumed Liabilities (collectively, “Confidential Information”), and (ii) refrain from using any of the Confidential Information except in connection with this Agreement or the operation of the Businesses. The term “Confidential Information” shall not include information that is or becomes generally available to the public by actions of Persons other than Seller or that pertains to any of the Excluded Assets or the Excluded Liabilities. If Seller is required to disclose any Confidential Information in order to comply with, or avoid violating, any Applicable Law, Seller will use commercially reasonable efforts to provide Purchaser with prompt notice thereof to the extent legally permissible. With the exception of securities filings reasonably required of a public company, to the extent legally permissible and at Purchaser’s sole expense, Seller shall provide Purchaser, in advance of any such disclosure, with copies of any Confidential Information that Seller intends to disclose (and, if applicable, the text of the disclosure language itself) and shall reasonably cooperate with Purchaser, at Purchaser’s sole expense, if permitted by Applicable Law, to the extent Purchaser may reasonably seek to limit such disclosure in a manner consistent with Applicable Law.
(c)Except as may be necessary to enforce this Agreement or any other Transaction Document, for three (3) years after the Initial Closing, Purchaser shall (i) treat and hold as confidential any proprietary and confidential information of Seller or any of its Affiliates that does not relate exclusively to the Purchased Assets or the Assumed Liabilities related to the Businesses, including any proprietary and confidential information relating to any of the Excluded Assets or the Excluded Liabilities (collectively, “Seller Confidential Information”), and (ii) refrain from using any of Seller Confidential Information except in connection with this Agreement. The term “Seller Confidential Information” shall not include information that is or becomes generally available to the public by actions of Persons other than Purchaser or any of its Affiliates. If Purchaser is required to disclose any Seller Confidential Information in order to avoid violating any Applicable Law, Purchaser will use commercially reasonable efforts to provide Seller with prompt notice thereof to the extent legally permissible. To the extent legally permissible and at Seller’s sole expense, Purchaser shall provide Seller, in advance of any such disclosure, with copies of any Seller Confidential Information that Purchaser intends to disclose (and, if applicable, the text of the disclosure language itself) and shall reasonably cooperate with Seller, at Seller’s sole expense, if permitted by Applicable Law, to the extent Seller may reasonably seek to limit such disclosure in a manner consistent with Applicable Law.
52



(d)Waiver of Conflicts Regarding Representation; Non-assertion of Attorney-Client Privilege.
(i)Purchaser waives and shall not assert, and agrees to cause its Affiliates to waive and not to assert, any conflict of interest or other objection arising out of or relating to the representation, after the Closings (the “Post-Closing Representation”), of Seller or any of its Affiliates or any shareholder, officer, employee or director of Seller or any of its Affiliates (any such Person, a “Designated Person”) in any matter involving or relating to this Agreement or any other Transaction Document or the transactions contemplated hereby or thereby, by any legal counsel currently representing Seller or any of its Affiliates in connection with this Agreement or any other Transaction Document or the transactions contemplated hereby or thereby (the “Current Representation”).
(ii)Purchaser waives and agrees not to assert, and agrees to cause its Affiliates to waive and to not assert, any attorney-client privilege or attorney work product doctrine with respect to any communication between any legal counsel and any Designated Person occurring during the Current Representation or in connection with any Post-Closing Representation, including in connection with a dispute with Purchaser or any of its Affiliates, it being the intention of the parties hereto that all such rights to such attorney-client privilege or attorney work product doctrine and to control such attorney-client privilege or work product doctrine shall be retained by Seller; provided, that the foregoing waiver and acknowledgment of retention shall not extend to any communication not involving this Agreement or any other Transaction Document or the transactions contemplated hereby or thereby, or to communications with any Person other than the Designated Persons and their advisors.
(iii)Purchaser, on behalf of itself and its Affiliates agrees that no communications (including email or other written communications) subject to attorney-client privilege or attorney work product doctrine in connection with the Current Representation shall be subject to disclosure, directly or indirectly, to Purchaser or any Person acting on behalf of Purchaser, and Purchaser shall, without the necessity of further documentation of transfer, be deemed to have irrevocably assigned and transferred to Seller, the attorney-client privilege or attorney work product doctrine and expectation of client confidence with respect to all such communications, and all books and records and other documents of the Seller containing any such advice, communication or other materials, and the same shall be controlled by Seller and shall not be used or claimed by, and no copies shall be retained by, Purchaser or any of its Affiliates.
(iv)Nothing in this Section 6.4(d) is intended to or shall be deemed to operate as a waiver of any applicable privilege or protection that could be asserted to prevent disclosure of any confidential communication by any legal counsel currently representing Seller or any of its Affiliates.
(v)Seller and Purchaser agree to take, and to cause their respective Affiliates to take, all steps reasonably necessary to implement the intent of this Section 6.4(d).
6.5Other Regulatory Filings. Subject to the terms of this Agreement, from the Execution Date until all applicable Closings have been completed, or the earlier termination of this Agreement, Purchaser and the OTA Transferees will be responsible for taking all steps which may be taken prior to the Closings in order to obtain on or after the Closings all Licenses from Governmental Authorities that are required as a result of the transactions contemplated in this Agreement and the OTAs. Without limiting the generality of the foregoing, upon the Title Company’s confirmation of receipt of the Deposit, Purchaser shall cause OTA Transferees to, and OTA Transferees shall, immediately submit to (a)(i) the State of Tennessee Health Facilities Commission, Division of Licensure and Regulation and (ii) the Alabama Department of Public Health, Bureau of Health Provider Standards, as applicable, an application for licensure with respect to operation of each Facility (“Licensure”), and (b) applications to be certified to participate in the Medicare and Medicaid reimbursement programs, (the foregoing, collectively, the “Health Care Regulatory Approvals”). Seller agrees to use commercially reasonable efforts (at no out-of-pocket cost to Seller) to cooperate with Purchaser and the OTA Transferees in obtaining such Health Care Regulatory Approvals.
53



6.6Efforts and Actions. Subject in each case to the provisions of Section 2.8 of this Agreement:
(a)Each Party shall from time to time and without further consideration, before and after the Closings, execute such further instruments and take such other actions as any other Party hereto shall reasonably request for itself or on behalf of a third party, provided such requests are solely in furtherance of its obligations set forth in any of the Transaction Documents and are wholly consistent therewith, to effectuate the purposes and terms set forth in the Transaction Documents and to provide for the orderly implementation of the Closings and, following the Closings, of the respective Parties’ rights and obligations as set forth in this Agreement.
(b)Upon reasonable advance notice by Purchaser or an OTA Transferee, Seller shall permit reasonable access by Purchaser, each OTA Transferee and their respective representatives to seek to establish personal relationships with Persons who have business relations with the Businesses; provided, however, that except as contemplated by the Transaction Documents or permitted by Seller in writing, neither Purchaser nor any OTA Transferee shall have the right to amend or modify any agreements applicable to the operation of any Business unless any such amendments or modifications are contingent on Closing regarding any applicable Business. Seller shall be entitled, if it so elects, to have a representative participate in any such discussions.
(c)With reasonable coordination with and advance notice to Seller, Purchaser and each OTA Transferee shall be entitled to visit the Facilities to assess operational needs for the operation of the Businesses after the Effective Time.
(d)From the Execution Date until all applicable Closings have been completed, or the earlier termination of this Agreement, but subject to Applicable Law and the Confidentiality Agreement, Seller will use reasonable best efforts to (i) give Purchaser, its counsel and other authorized representatives reasonable access to the properties, books and records of the Businesses, (ii) furnish to Purchaser, its counsel and other authorized representatives such financial and operating data and other information relating to the Business as such Persons may reasonably request and (iii) instruct the Business Employees, counsel and financial advisors of Seller to reasonably cooperate with Purchaser in its investigation of the Businesses. For the avoidance of doubt, the Confidentiality Agreement shall remain in effect in accordance with its terms, and such information, and all information provided pursuant to this Section 6.6 shall be treated as “Confidential Information” pursuant to the terms of the Confidentiality Agreement. Notwithstanding the foregoing, Purchaser, its counsel and other authorized representatives and its other agents shall not have access to (A) any information where such access or disclosure would, in the good faith judgment of Seller, be unreasonable or jeopardize the health and safety of any resident, employee of the Businesses, (B) any properties of the Businesses, including the Purchased Assets and Real Property, for purposes of conducting any sampling or other invasive investigation, including of the air, soil, soil gas, surface water, groundwater, building materials or other environmental media, (C) any information to the extent relating to any Affiliates of the Seller, (D) Seller Tax records, or (E) which would otherwise violate the terms of the Confidentiality Agreement.
54



(e)For a period of five (5) years after the Phase I Initial Closing Date, but subject to Applicable Law, Purchaser will (i) maintain the books and records of the Businesses, provided that, Purchaser shall not be required to retain such books and records for which Seller has been provided with a copy and (ii) upon request, afford promptly to Seller and its authorized Representatives reasonable access to the properties, books, records, employees and auditors of the Business (A) to the extent requested to permit Seller or any of their Affiliates to comply with their financial reporting, accounting, tax, litigation, contractual or auditing obligations with respect to the period prior to the Closings with respect to the Business or the Excluded Assets or Excluded Liabilities, (B) in connection with any Action related to either the Excluded Assets or Excluded Liabilities, or the conduct of the Business or the ownership of the Purchased Assets prior to the Closings and for which Seller or such Affiliate has retained liability under this Agreement and (C) otherwise to the extent that Seller, in requesting such access, reasonably deems such access necessary or desirable in order to determine any matter relating to its rights and obligations hereunder.
(f)Any access granted or cooperation provided pursuant to this Section 6.6 shall be conducted in such manner as not to interfere unreasonably with the conduct of the business of the Party granting such access or providing such cooperation. The party to whom such access or other cooperation is granted pursuant to this Section 6.6 shall bear all of the out-of-pocket costs and expenses (including attorneys’ fees, but excluding reimbursement for general overhead, salaries and employee benefits) reasonably incurred by the other party, its Affiliates or any of their representatives in connection therewith.
(g)In furtherance of the foregoing, from and after each applicable Closing Date, Purchaser will provide and, as applicable, cause its employees and its Affiliates and their employees to provide, all cooperation reasonably requested by or on behalf of Seller, which cooperation will include furnishing or causing to be furnished records, information and testimony as requested by Seller, its Affiliates or their respective representatives and causing employees who possess knowledge pertaining to any such Action to provide information, recollections and explanations with respect thereto and make themselves available, including for consultation with respect to settlement discussions and to attend strategy sessions and judicial and arbitration proceedings, as requested by Seller, its Affiliates or their respective representatives in connection therewith; provided, that, notwithstanding the foregoing, Purchaser will only be obligated to cause any person to cooperate with Seller pursuant to this Section 6.6 if and for so long as Purchaser is capable of directing the actions of such person.
(h)Notwithstanding anything to the contrary contained herein, nothing in this Section 6.6 shall require (i) Seller or Purchaser, as applicable, to provide the other party or its representatives with access to (A) personnel records of employees relating to individual performance or evaluation records, medical histories or other information which, in the disclosing party’s good faith determination, is sensitive or the disclosure of which would violate Applicable Law or could subject such party or its Affiliates to risk of liability or (B) information the disclosure of which, in the disclosing party’s good faith determination, would conflict with contractual obligations to which such party or any of its Affiliates is bound, violate any Applicable Law or result in the forfeiture or waiver of any attorney-client or similar legal privilege; provided, that the parties hereto shall cooperate in good faith to develop substitute arrangements, to the extent reasonably possible, that do not result in the violation of such Applicable Law, breach of such obligations or loss or reduction of such privilege, or (ii) either party’s independent accountants to make available to the other party or its representatives any work papers unless and until such Person has signed a customary confidentiality and hold harmless agreement relating to such access to work papers in form and substance reasonably acceptable to such independent accountants.
55



6.7Corporate Contracts; Overhead and Shared Services. Purchaser acknowledges that the Businesses currently benefit from the Corporate Contracts and currently receive Overhead and Shared Services from various Affiliates of Seller. Purchaser further acknowledges that, as it relates to the operation of the Businesses after each applicable Closing, all such benefits from the Corporate Contracts and the provision of Overhead and Shared Services to such Facility shall cease, and any agreement by the applicable Business with Seller or any of its Affiliates in respect to the Corporate Contracts or the provision of Overhead and Shared Services to such Facility shall terminate. No Overhead and Shared Services shall be provided by Seller or any of its Affiliates to any Business unless otherwise contemplated by the Transaction Documents. Unless otherwise agreed to by the Parties, the Corporate Contracts shall be deemed to be Rejected Contracts.
6.8Risk of Loss; Casualty Loss; Condemnation.
(a)If, between the date of this Agreement and an applicable Closing, any of the Real Property included in the Purchased Assets shall be destroyed or damaged in whole or in part (other than damage that is of such a de minimis nature that it would not reasonably be expected to have any material effect on the use or value of the affected Facility) by fire, earthquake, flood, or other casualty (a “Casualty Loss”), Seller shall deliver notice of such Casualty Loss to Purchaser, and Seller shall engage an engineer, architect or contractor selected by Seller and reasonably satisfactory to Purchaser or a major regional or national commercial real estate broker selected by Seller and reasonably satisfactory to Purchaser (“Estimator”) to make a reasonable determination of the cost to repair such Casualty Loss (a “Repair Estimate”), and the following shall apply:
(i)If (x) the Repair Estimate provides a cost to repair the Casualty Loss of less than fifteen percent (15%) of such Facility’s Facility Purchase Price (the “Casualty Threshold”) and (y) the Casualty Loss is not reasonably likely to prevent the applicable Facility from being operated in the Ordinary Course in all material respects on and after the Closing Date, then (A) such Facility shall be included in the Closing in which it would have otherwise participated hereunder absent the occurrence of such Casualty Loss, (B) at such Closing, Purchaser shall take such Facility as-is, together with the insurance proceeds, if any, or the right to receive the same, relating to such Casualty Loss and the rights to any other claims arising as a result of the Casualty Loss, and (C) the Facility Purchase Price paid with respect to such Facility shall be reduced by the amount of any applicable insurance deductible to the extent the same is borne by Purchaser.
(ii)If (A) the Repair Estimate provides a cost to repair the Casualty Loss in excess of the Casualty Threshold but below the Exclusion Threshold, or (B) the Casualty Loss is reasonably likely to prevent the applicable Facility from being operated in in the Ordinary Course in all material respects on and after the Closing Date and the Repair Estimate shows a cost to repair the Casualty Loss below the Exclusion Threshold (an “Escrowable Casualty Loss”), such Facility shall be designated as Out of Compliance pursuant to clause (z) of the definition thereof, and Sections 7.2(b) and 7.3 through 7.5 hereof (Attempted Cure; Subsequent Closing) shall apply.
(iii)If the Repair Estimate provides a cost to repair the Casualty Loss of twenty-five percent (25%) or greater of such Facility’s Facility Purchase Price (the “Exclusion Threshold”), then Purchaser shall have the right, in its sole and absolute discretion, to elect to exclude such Facility from the transactions contemplated by this Agreement by delivering written notice to Seller within twenty (20) days of the Estimator’s delivery of the Repair Estimate designating such Facility as an “Excluded Facility”. If Purchaser timely designates a Facility as an Excluded Facility the Purchase Price shall be reduced by such Facility’s Facility Purchase Price. If Purchaser does not timely designate such Facility as an Excluded Facility, such Facility shall be treated as being subject to an Escrowable Casualty Loss, shall be designated as Out of Compliance pursuant to clause (z) of the definition thereof, and Sections 7.2(b) and 7.3 through 7.5 hereof (Attempted Cure; Subsequent Closing) shall apply.
56



(b)If, between the date of this Agreement and an applicable Closing, any Condemnation is commenced with respect to any of the Real Property, Seller shall deliver notice of such Condemnation to Purchaser and the following shall apply:
(i)If the Condemnation is of such a de minimis nature that it would, as reasonably determined by an Estimator selected in the manner set forth in Section 6.8(a), not reasonably be expected to have any material effect on the use or value of the affected Facility, then the Closing shall take place as provided herein, without reduction of the Purchase Price, and Seller shall assign to Purchaser at the Closing all of Seller’s right, title and interest in and to all awards made in respect of such Condemnation and to pay over to Purchaser all amounts theretofore received by Seller (net of any reasonable out-of-pocket expenses) in connection with such Condemnation.
(ii)With respect to Condemnations other than those described in the foregoing Section 6.8(b)(i), Seller shall engage an Estimator (in the manner set forth in Section 6.8(a)) to make a reasonable determination of the amount by which the Condemnation affects the value of the Facility (the “Impairment Estimate”) based on its usage prior to the Condemnation (expressed as a percentage) (the “Impairment Percentage”).
(A)If the Impairment Estimate shows an Impairment Percentage of twenty-five percent (25%) or less (the “Condemnation Threshold”), then (x) such Facility shall constitute an “Includable Condemned Facility” and be included in the Closing in which it would have otherwise participated hereunder absent the occurrence of such Condemnation, (y) at such Closing Purchaser shall take such Facility notwithstanding the Condemnation, together with the proceeds of any award for such Condemnation, if any, or the right to receive the same (the “Condemnation Award”), and (z) if the aggregate amount of the Condemnation Award is less than the Impairment Percentage multiplied by the Facility Purchase Price for such Facility, then the Facility Purchase Price paid with respect to such Facility at the applicable Closing shall be reduced by an amount equal to such difference.
(B)If the Impairment Estimate shows an Impairment Percentage in excess of the Condemnation Threshold, then Purchaser shall have the right, in its sole and absolute discretion, to elect to exclude such Facility from the transactions contemplated by this Agreement by delivering written notice to Seller within twenty (20) days of the Estimator’s delivery of the Impairment Estimate designating such Facility as an “Excluded Facility”. If Purchaser timely designates a Facility as an Excluded Facility, the Purchase Price shall be reduced by such Facility’s Facility Purchase Price. If Purchaser does not timely designate such Facility as an Excluded Facility, such Facility shall be treated as being an Includable Condemned Facility, and Section 6.8(b)(ii)(A) hereof shall apply.
6.9Title and Survey Matters; Estoppel Certificates.
57



(a)Purchaser has obtained from First American Title Insurance Company title insurance commitments for the Real Property (the “Title Reports”) and delivered the same to Seller prior to the Execution Date. Prior to the Execution Date, Purchaser has reviewed the Title Reports, surveys, zoning reports and flood elevation certificates (if applicable) obtained by Purchaser for the Real Property (collectively, the “Real Property Reports”), and Purchaser and Seller have agreed that Seller shall remove or cure such exceptions and other matters as are identified on Schedule 6.9 attached hereto prior to the Initial Closing. Except for Mandatory Cure Items (defined below), Purchaser is deemed to have approved all items contained in the Real Property Reports which do not appear on Schedule 6.9, which approved items shall be Permitted Encumbrances. Notwithstanding anything to the contrary herein, whether or not included in a Title Objection Notice (as defined below) or on Schedule 6.9, Seller shall be obligated to cure all encumbrances affecting the Real Property constituting (A) liens securing a mortgage, deed of trust or trust deed created by or through Seller or any of its Affiliates or any Current Operator or any Affiliate of any Current Operator; (B) judgment liens against Seller; (C) broker’s liens caused by Seller; (D) any memorandum of lease between Seller and its Affiliates, and (E) any mechanics’ liens or materialman’s liens caused by Seller (all such encumbrances, collectively, the “Mandatory Cure Items”). In no event shall any Mandatory Cure Items be deemed to be Permitted Encumbrances. At each Closing, Seller shall cause the Title Company to issue standard form owner’s policies of title insurance with respect to each parcel of Real Property transferred at such Closing pursuant hereto. Such policies shall be standard ALTA Form 2006 owner’s policies in the full amount of the portion of the Purchase Price allocated to each such parcel of Real Property pursuant to Schedule 2.6, insuring fee title thereto, subject only to the Permitted Encumbrances. Purchaser may coordinate with Title Company to have the standard exceptions deleted, if available.
(b)Seller shall be responsible for fifty percent (50%) of the base cost of any final title policy for the Real Property. Purchaser shall be responsible for fifty percent (50%) of the base cost of any final title policy and for the cost of any extended coverage to any final title policy. Purchaser may request such endorsements to the title policies, at Purchaser’s sole cost and expense.
(c)Prior to each applicable Closing, Purchaser may obtain updated title insurance commitments (each a “Title Update”) from Landmark Abstract Agency LLC (the “Title Company”). Purchaser has instructed the Title Company to simultaneously deliver directly to Purchaser and Seller (or Seller’s counsel) copies of each Title Update (including tax and departmental searches) ordered by Purchaser or otherwise issued by the Title Company, and copies of all underlying documentation referenced as an exception in such Title Update as soon as reasonably available.
(d)Purchaser shall have the right to deliver one or more written notices (each, a “Title Objection Notice”) to Seller objecting to any items contained in a Title Update which are not Permitted Encumbrances and which reflect matters first coming of record from and after the date on which such Title Report was prepared, which would (x)(i) create a material and adverse lack of compliance with Applicable Law, or (ii) materially interfere with the continued use or occupancy of the affected Real Property in the manner operated as of the Execution Date and (y) materially and adversely affect the value of the affected Real Property if not removed or otherwise cured, such Title Objection Notice to be delivered prior to the earlier of (i) ten (10) Business Days after Purchaser’s receipt of such Title Update, and (ii) seven (7) days prior to the applicable Closing Date. Failure of Purchaser to provide a Title Objection Notice within such period (or to include any such matters in a timely delivered and valid Title Objection Notice) shall be deemed Purchaser’s approval of all items contained in such Title Update. All such items that are not objected to by Purchaser in a timely delivered and valid Title Objection Notice shall be deemed to be Permitted Encumbrances and the Purchase Price shall not be reduced. Seller shall use commercially reasonable efforts and expend such amounts as it deems appropriate in its commercially reasonable discretion to remove or cure prior to the applicable Closing any title exceptions that are not Permitted Encumbrances to which Purchaser properly and timely objects to in the Title Objection Notice and to which Seller agrees to cure prior to Closing (which cure may, at Seller’s election, involve obtaining, at Seller’s expense, title insurance from Title Company acceptable to Purchaser insuring against the effect of such exceptions). Seller shall not have any obligation to remove or cure any such exceptions or pay any amounts to cure or remove the same except that Seller shall be obligated to cure or remove any Mandatory Cure Items and any exceptions created by, through or under Seller after the date of this Agreement and otherwise not agreed to by Purchaser. Seller shall notify Purchaser in writing within seven (7) days after receipt of notice from Purchaser regarding such exceptions whether Seller elects to attempt to remove or cure any such exceptions, and Seller’s failure to deliver such notice in a timely manner shall be deemed an election by Seller not to remove or cure such exceptions. If Seller notifies Purchaser that Seller has elected not to remove or cure any such exceptions (or is deemed to have elected not to remove or cure such exceptions), then Purchaser shall notify Seller within seven (7) days after receipt of such notice (or date of deemed election, as applicable) whether Purchaser elects to proceed to the Closing for such Facility, taking title subject to such exceptions, or not to proceed to the Closing, in which case the Parties shall be relieved of any further obligations hereunder with respect to such Facility. Failure of Purchaser to provide such notice in a timely manner shall be deemed an election by Purchaser to proceed to the Closing for such Facility. If Purchaser elects (or is deemed to have elected) to take title subject to any such exceptions under this Section 6.9, such exceptions shall become Permitted Encumbrances and the Purchase Price shall not be reduced. Further, in the event that any zoning, building or fire code violations are disclosed in an updated zoning report which violations were not previously disclosed in any Third Party Reports received by Purchaser prior to the Execution Date, Seller shall use commercially reasonable efforts to cure such violation prior to Closing, provided, however, such cure shall not be a condition to Closing.
58



(e)Purchaser shall be responsible for the costs of any new or updated surveys obtained by Purchaser.
6.10Encumbrance Release. Seller shall consummate on or prior to each applicable Closing Date, the Seller Encumbrance Release Transactions with respect to the Purchased Assets to be conveyed on such Closing Date pursuant hereto.
6.11Financing Cooperation.
(a)Seller shall use commercially reasonable efforts to provide, and to cause its Affiliates and their respective representatives to (i) provide as promptly as reasonably practicable (1) such information as may be reasonably requested by Purchaser to facilitate the pledging by Purchaser of, and granting, recording and perfection of security interests in, collateral constituting Purchased Assets, and to facilitate Purchaser’s ability to obtain, at Purchaser’s cost, surveys and title insurance for the benefit of a Financing Source, and (2) other information (financial or otherwise) relating to the Businesses and the Purchased Assets as may be reasonably requested by Purchaser or its Financing Sources, which information may include information to be used by Purchaser in the preparation of an information package regarding the business, operations, financial projections and prospects of the Businesses or the Purchased Assets as customary or reasonably necessary for the completion of such Financing or to prepare customary offering or information documents to be used by Purchaser for the completion of the Financing; (ii) cooperate with the marketing efforts of Purchaser and the Financing Sources, including participating in a reasonable number of meetings and due diligence sessions, at times and at locations reasonably acceptable to Seller; (iii) make available upon reasonable notice, personnel with appropriate seniority and expertise relating to Seller, the Businesses, and the Purchased Assets, in each case, as may be reasonably requested by Purchaser, or as may be reasonably requested by the Financing Sources; (iv) subject to satisfactory confidentiality and limitation of use provisions, provide authorization letters acceptable to Seller to the Financing Sources authorizing the distribution of specified information to prospective lenders or investors; (v) subject to any contractual agreement in effect, obtain any applicable customary payoff letters and instruments of discharge to be delivered at the Closing(s); and (vi) subject to any contractual agreement in effect, execute and deliver any pledge and security documents (including mortgages), other definitive financing documents, or other certificates or documents as may be reasonably requested by Purchaser related to the Purchased Assets; provided that (A) none of Seller nor any of its Affiliates shall be required to take any action that would be prohibited by any Applicable Law, (B) no obligations of Seller or any of its Affiliates under any certificate, contract, or other document or instrument delivered pursuant to this Section 6.11 shall be effective until the applicable Closing Date, and none of Seller nor any of its Affiliates shall be required to take any action pursuant to this Section 6.11 under any certificate, contract, or other document or instrument that is not contingent upon the applicable Closing or that would be effective prior to the applicable Closing Date, (C) any requested cooperation shall not interfere with the ongoing operations of Seller and its Affiliates, (D) Seller and its Affiliates shall not be deemed to be in breach of this Section 6.11(a) unless a court of competent jurisdiction has determined by final and non-appealable judgment that a Financing was not consummated solely due to the failure of Seller and its Affiliates to comply with this Section 6.11(a), and (E) for the avoidance of doubt, it is hereby understood and agreed that neither the obtaining of the Financing, any alternative debt financing from the same or alternative sources or a refinancing transaction, nor the completion of any issuance of securities contemplated by the Financing, is a condition to any Closing.
59



(b)Seller shall, and shall cause its Affiliates to, execute and deliver such documents, and take such actions, as may be necessary or reasonably requested by Purchaser to facilitate the consummation of each Seller Encumbrance Release Transaction.
(c)Purchaser shall, promptly upon request by Seller accompanied by a reasonably detailed invoice, reimburse Seller for all reasonable and documented out-of-pocket costs and expenses (including reasonable attorneys’ fees) incurred by Seller or any of its Affiliates in satisfying its obligations under this Section 6.11.
6.12Third Party Reports. Notwithstanding anything herein to the contrary, Seller shall have no duty to perform any repairs or replacements identified in any property condition assessment included within the Third Party Reports or otherwise obtained by Purchaser or its Affiliates prior to the Execution Date, except to the extent such item is identified on Schedule 6.9 hereto or Seller is otherwise required to cure such item pursuant to the terms of Section 6.9 of this Agreement.
6.13Non-Competition. For a period commencing upon the Phase I Initial Closing and ending three (3) years after the Phase I Initial Closing, neither Seller nor its Affiliates shall directly or indirectly own, operate or manage any skilled nursing facility within the Restricted Counties (the “Non-Competition Covenant”). In connection with a violation of the Non-Competition Covenant, Purchaser shall have all remedies at law and/or equity to enforce such Non-Competition Covenant. Seller further acknowledges that the scope and duration of the provisions of this Section 6.13 are reasonable. The terms and provisions of this Section 6.13 shall survive the Closings. For avoidance of doubt, the provisions of this Section 6.13 shall not be applicable to Seller’s ownership and operation of any Escrow Facilities prior to any Subsequent Closing, or any Facility which has not otherwise become a Transferred Facility hereunder, or to the ownership and operation of any Excluded Facility by Seller from and after the date such Excluded Facility is terminated in accordance with the provisions of Section 6.8 of this Agreement.
6.14Non-Solicit.
60



(a)Purchaser agrees that neither Purchaser, the OTA Transferees nor any of their respective Affiliates shall solicit or attempt to solicit for employment or hire any Business Employee for a period of one (1) year following the termination of this Agreement; provided, however, that this Section 6.14(a) will not prohibit Purchaser, the OTA Transferees or any of their respective Affiliates from (a) hiring any Person who is presented by a bona-fide professional placement agency which was not directed by Purchaser, an OTA Transferee or their respective Affiliates to target the Business Employees, (b) soliciting via a general solicitation or hiring any Person who first contacts Purchaser, an OTA Transferee or their respective Affiliates in response to general solicitation, or (c) soliciting or hiring any Person who has been terminated by the Seller at least three (3) months prior to commencement of any solicitation of such Person by Purchaser, an OTA Transferee or their respective Affiliates or any employment discussions between Purchaser, an OTA Transferee or their respective Affiliates and such Person. The provisions of this Section 6.14(a) shall terminate with respect to each Business and Facility upon the consummation of the Closing applicable thereto (it being understood that this Section 6.14(a) shall continue in effect following the Initial Closing with respect to any Business Employee employed at or on behalf of an Escrow Facility until the occurrence of a Subsequent Closing relating thereto).
(b)Seller agrees that neither Seller nor any of their respective Affiliates shall solicit or attempt to solicit for employment or hire any Transitioned Employees for a period of two (2) years following the Closing Date for the Facility at which the applicable Transitioned Employees were/are employed; provided, however, that this Section 6.14(b) will not prohibit Seller or any of their respective Affiliates from (a) hiring any Person who is presented by a bona-fide professional placement agency which was not directed by Seller or any of their respective Affiliates to target the Transitioned Employees, (b) soliciting via a general solicitation or hiring any Person who first contacts Seller or any of their respective Affiliates in response to general solicitation, or (c) soliciting or hiring any Person who has been terminated by the Purchaser or an OTA Transferee or their respective Affiliates at least three (3) months prior to commencement of any solicitation of such Person by Seller or any of their respective Affiliates or any employment discussions between Seller or any of their respective Affiliates and such Person. The provisions of this Section 6.14(b) shall survive the Closings.
6.15Notice of Breach. If either Elliott Mandelbaum or Maxwell Luce, as representatives of Purchaser, becomes aware prior to the Closing Date that any of the representations and warranties of Seller under the Transaction Documents are no longer true and correct in all material respects, or were not true and correct as of the Execution Date (a “Pre-Closing R&W Breach”), Purchaser shall promptly notify Seller in writing pursuant to the terms of Section 11.4 below of such Pre-Closing R&W Breach and specifically identify any matters that make the representations and warranties set forth in the Transaction Documents not true and correct in all material respects and whether Purchaser believes, in its good faith and commercially reasonable judgment, such Pre-Closing R&W Breach can be cured to make the representations and warranties of Seller under the Transaction Documents true and correct prior to the Closing Date (such notice is referred to herein as the “Pre-Closing R&W Breach Notice”). Seller shall use commercially reasonably efforts to cure any Pre-Closing R&W Breach, but shall have no obligations to cure any such Pre-Closing R&W Breach prior to Closing.
6.16Reverse 1031. Seller is aware that that certain Purchaser Assignees intend to perform an IRC Section 1031 tax-deferred exchange (the “Exchange”), and each Purchaser Assignee reserves the right to include the transactions contemplated by this Agreement by and through an assignment of such Purchaser Assignee’s rights, as part of an Exchange for the benefit of Purchaser Assignee, at no cost, expense or liability to Seller. Seller agrees to execute any and all documents as are reasonably necessary in connection therewith, provided that the Closings with respect to the applicable Real Property shall not be contingent upon or subject to the completion of such an Exchange. Seller agrees to cooperate with any such Purchaser Assignee in such an exchange, and in return, Purchaser Assignees agree to hold Seller harmless from any and all claims, costs or liabilities resulting from such an Exchange. Seller agrees and consents to partial assignments of this Agreement to any qualified intermediary by one or more Purchaser Assignees in connection with an Exchange.
61



6.17Assumed Contracts. If the Purchaser wishes to assume any of the Material Contracts, then at or prior to the Initial Closing, the Purchaser will provide the Seller with a list of the Contracts that it will assume as of the applicable Closing Date (the “Assumed Contracts”). In accordance with the terms of the Bill of Sale and Assignment and Assumption Agreement, Seller shall assign to Purchaser all of each Seller’s rights, title and interest in, to and under the Assumed Contracts. Any Contracts that are neither Assumed Contracts hereunder nor Assumed Contracts under the OTAs shall be referred to herein as the “Rejected Contracts.” All Contracts that are not assignable by their terms and accordingly cannot be included in the Assumed Contracts shall be deemed Rejected Contracts. Each Seller shall remain responsible for all liabilities and obligations (i) under the Rejected Contracts, (ii) under the Assumed Contracts to the extent such liabilities and obligations accrue or arise prior to the applicable Closing Date, or (iii) for services or supplies which were performed or rendered prior to the applicable Closing Date, and shall indemnify and hold Purchaser harmless on account of the same. The indemnification obligations set forth in this Section 6.17 shall be subject to Article IX. To the extent any third party consent is required in connection with the assignment and assumption of the Assumed Contracts, each Seller hereby covenants and agrees to use commercially reasonable efforts to obtain such third party consent prior to the applicable Closing Date. To the extent Sellers shall be unable to obtain such third party consent, Purchaser shall not assume such Assumed Contract, and such Assumed Contract shall be considered a Rejected Contract hereunder.
6.18Connected Facilities. The Parties acknowledge that as of the Execution Date, the Harbor View Real Property and Van Ayer Real Property contains the property depicted on the attached Exhibit Q as Lot 1 (each a “Seller Leased Parcel”) upon which Affiliates of Seller operate a psychiatric hospital business which is not subject to the transaction contemplated by this Agreement. At the applicable Closing, Seller shall (i) convey the entirety of the Harbor View Real Property and Van Ayer Real Property to Purchaser, it being acknowledged that the Purchase Price (as defined) has been increased to reflect that the Purchase Price for the Seller Leased Parcel contained within the Harbor View Real Property shall be Five Hundred and Four Thousand and 00/100 Dollars ($504,000.00) and the Purchase Price for the Seller Leased Parcel contained within the Van Ayer Real Property shall be Three Hundred Seventy-Five Thousand and 00/100 Dollars ($375,000.00), and (ii) lease each Seller Leased Parcel from (at Purchaser’s sole election) either Purchaser or the applicable OTA Transferee pursuant to the Seller Leased Parcel Lease Agreements.
6.19CID. Sellers have received that certain Civil Investigative Demand No. 24-872 addressed to American Home Companies LLC d/b/a American Health Partners, 201 Jordan Road, Suite 200, Franklin, TN 37067 (the “CID”). At such time as Seller, based on the advice of counsel, reasonably determines appropriate, but in no event later than November 15, 2024, counsel for Seller shall notify the Department of Justice verbally and then in writing that the applicable Facilities subject to the CID are owned by Seller but are being sold to Purchaser effective as of the applicable Closing Date pursuant to an asset purchase agreement that had been negotiated between Seller and Purchaser over the course of several months. All future correspondence related to the CID should continue to be addressed and delivered to Seller through its counsel as previously communicated to the DOJ and agreed to by the DOJ. Seller will be responsible for responding to the CID and Seller’s counsel for the CID shall provide Purchaser with updates about material developments which may adversely impact the Sellers, the OTA Transferees or the Facilities
6.20Knoxville Facilities. The Parties acknowledge that as of the Execution Date, the Seller has not received its “tie-in” notice from CMS for the Knoxville Facilities, and as such, pursuant to that certain Operations Transfer Agreement (the “Knoxville OTA”) dated as of June 21, 2024 by and between Presbyterian Homes of Tennessee, Inc., a Tennessee non-profit corporation (the “Knoxville Seller”) and Knoxville Healthcare Center I, LLC d/b/a AHC
62



Knoxville and WellPark Healthcare Center, LLC d/b/a AHC WellPark, each a Tennessee limited liability company, Seller is currently (a) billing Medicare for services provided to and performed for Medicare beneficiaries at the Knoxville Facilities under the name and the existing Medicare provider number (the “Existing Knoxville Medicare Provider Number”) of Knoxville Seller, and (b) billing the Tennessee Medicaid Agency for services provided to and performed for Medicaid beneficiaries at AHC Knoxville under the name and the existing Medicaid provider number (the “Existing Knoxville Medicaid Provider Number”) of Knoxville Seller. In order to allow for the continued billing of Medicare at the Knoxville Facilities, and the billing of Medicaid at AHC Knoxville, Seller agrees to use commercially reasonable efforts to obtain, on or prior to the Phase II Initial Closing Date, either (x) written consent from the Knoxville Seller to allow for the applicable OTA Transferee for (i) each of the Knoxville Facilities to utilize the Existing Knoxville Medicare Provider Number in accordance with the Knoxville OTA until Seller receives its “tie-in” notice from CMS for the Knoxville Facilities, and (ii) AHC Knoxville to utilize the Existing Knoxville Medicaid Provider Number in accordance with the Knoxville OTA until Seller receives its own Medicaid provider number for AHC Knoxville, or (y) Seller shall have obtained both (i) its “tie-in” notice from CMS for the Knoxville Facilities, and (ii) a Medicaid provider number for AHC Knoxville (the completion of either subsection (x) or (y) above shall be referred to herein as the “Knoxville Billing Approval”). For the avoidance of doubt, in the event Seller is unable to obtain the Knoxville Billing Approval contemplated by this Section 6.20, such failure shall not be deemed a breach or default by Seller of this Agreement.
Article VII
CLOSING CONDITIONS; SUBSEQUENT CLOSINGS
7.1Conditions to the Initial Closing.
(a)Mutual Conditions to the Initial Closing. The respective obligations of Seller, on the one hand, and Purchaser, on the other hand, to consummate the transactions contemplated hereby at each Initial Closing shall be subject to the satisfaction at or prior to the applicable Initial Closing Date of each of the following conditions (any of which conditions may be waived by the mutual written agreement of Seller, on the one hand, and Purchaser, on the other hand, in whole or in part):
(i)there shall be no Order in effect expressly precluding consummation of such Initial Closing;
(ii)the Required Consents, if any, shall have been obtained with respect to all Facilities and Business included in the applicable Initial Closing;
(iii)Purchaser shall have (or, if applicable, shall have caused the applicable OTA Transferee to), on or before the applicable Initial Closing Date, (A) obtained all necessary Licenses, Consents, approvals, waivers, orders and authorizations from Governmental Authorities (or shall have obtained such oral or written assurances from the Government Authority, in form and substance reasonably acceptable to Purchaser and such OTA Transferee), that the applicable Health Care Regulatory Approvals have been obtained, and that a License to operate such Business has been (or will be issued by the applicable Government Authority effective as of the Effective Time) and (B) made all other necessary registrations, declarations and filings with Governmental Authorities in order to consummate the transactions contemplated under this Agreement and the OTAs to occur at the applicable Initial Closing; provided, however, to the extent allowed by Applicable Law, and where the only remaining unfulfilled conditions to the applicable Initial Closing (other than conditions that by their terms will be satisfied at the Initial Closing) is the issuance or approval of a License to operate such Business (the “Licensure Condition”), this condition shall be deemed satisfied by the Purchaser (or, if applicable, the applicable OTA Transferee) entering into the Interim Documents at the Initial Closing; and
63



(iv)the aggregate Pro-Rata Percentage of all Escrow Facilities does not exceed the Escrow Facility Threshold.
(b)Purchaser Conditions to the Initial Closing. The obligations of Purchaser to consummate the transactions contemplated hereby at each Initial Closing also shall be subject to the satisfaction at or prior to the Initial Closing Date or waiver by Purchaser in Purchaser’s sole discretion, of each of the following conditions:
(i)all the representations and warranties of Seller contained in this Agreement shall be true and correct in all material respects as of the Initial Closing Date, with the same effect as though such representations and warranties had been made on and as of the Initial Closing Date (except to the extent expressly made as of an earlier date, in which case as of such earlier date), except where the failure to be true and correct would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect;
(ii)solely with respect to the Phase I Initial Closing, the Average Resident Census of the Facilities as of the Initial Closing Date shall not be more than fifteen (15%) lower than the aggregate Current Resident Census of the Facilities. For the avoidance of doubt, failure of this condition to the Phase I Initial Closing shall not be a default by Seller under this Agreement;
(iii)solely with respect to the Phase II Initial Closing, the Average Resident Census of the Phase II Facilities as of the Phase II Initial Closing Date shall not be more than fifteen (15%) lower than the aggregate Current Resident Census of the Phase II Facilities. For the avoidance of doubt, failure of this condition to the Phase II Initial Closing shall not be a default by Seller under this Agreement;
(iv)all of the covenants of Sellers contained in this Agreement to be performed by Sellers on or before the applicable Initial Closing Date with respect to the Transferred Facilities being transferred at such Initial Closing shall have been performed in all material respects, except where the failure to so perform would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect;
(v)each Seller participating in the Initial Closing shall have delivered to Purchaser a certificate of a duly authorized officer of Seller dated as of the Initial Closing Date stating that the conditions specified in Sections 7.1(b)(i) through 7.1(b)(ii) have been satisfied with respect to such Seller;
(vi)with respect to the transactions contemplated hereby at the Phase I Initial Closing, no Material Adverse Effect shall have occurred with respect to the Phase I Facilities;
(vii)with respect to the transactions contemplated hereby at the Phase II Initial Closing, no Material Adverse Effect shall have occurred with respect to the Phase II Facilities;
(viii)Reserved;
64



(ix)At or prior to each Initial Closing, (A) each Seller shall have executed and delivered a Bill of Sale and Assignment and Assumption Agreement in the form attached hereto as Exhibit F (each, a “Bill of Sale and Assignment and Assumption Agreement”) with respect to their respective Business and Purchased Assets being conveyed to Purchaser at such Initial Closing, (B) each Property Owner shall have executed and delivered deeds in the forms attached hereto as Exhibit H with respect to any Real Property identified on Exhibit D (the “Deeds”) being conveyed at such Initial Closing, (C) each Current Operator shall have executed and delivered an OTA in substantially the form attached hereto as Exhibit I for each Facility being conveyed at such Initial Closing; (D), if applicable, each Current Operator shall have executed and delivered the Interim Documents for each applicable Facility and, to the extent a Survey Condition applies to such Facility, the Interim Indemnity Guaranty, and (E) the Sellers shall have executed and delivered all other Transaction Documents required to be delivered at such Initial Closing.
(x)Seller shall have consummated, or contemporaneously will consummate, as the case may be, each Seller Encumbrance Release Transaction with respect to Purchased Assets being conveyed at the Initial Closing;
(xi)Title Company shall have delivered to Purchaser good and valid title insurance policies (or irrevocable “marked-up” title insurance commitments equivalent to title insurance policies) for each Real Property being conveyed at the Initial Closing, dated as of the Initial Closing Date, including such affidavits, certificates, indemnities, resolutions, agreements or other deliverables as may be reasonably required by Title Company in connection with the same;
(xii)Seller shall have either (a) delivered evidence to Purchaser that all AAP funds received by Seller or their Affiliates in respect of Facilities or Business included in the Initial Closing have been repaid to Medicare as of the Initial Closing; or (b) to the extent such AAP funds have not been recouped or otherwise repaid to Medicare as of the Initial Closing (such outstanding amounts are referred to herein as “Outstanding AAP Obligations”), deposited with the Title Company an amount equal to the Outstanding AAP Obligations as security for Seller’s, or such Affiliates’ obligation to repay such amount in accordance with Applicable Law and to ensure that such Outstanding AAP Obligations are not otherwise recouped from payments due and owing to Purchaser or OTA Transferee arising from the provision of goods or services to residents of the applicable Facilities from and after the Initial Closing;
(xiii)With respect to the transactions contemplated by the OTAs applicable to the Facilities included in each Initial Closing:
(A)all the representations and warranties of Current Operators contained in such OTAs subject to such Initial Closing shall be true and correct in all material respects as of the Initial Closing Date, with the same effect as though such representations and warranties had been made on and as of the Initial Closing Date (except to the extent expressly made as of an earlier date, in which case as of such earlier date), except where the failure to be true and correct would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect;
(B)all of the covenants of Current Operators contained in such OTAs subject to such Initial Closing to be performed by Current Operators on or before the Initial Closing Date shall have been performed in all material respects on or before the Initial Closing, except where such failure would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
(c)Seller Conditions to the Initial Closing. The obligations of Seller to consummate the transactions contemplated hereby at the Initial Closing also shall be subject to the satisfaction at or prior to the Initial Closing Date or waiver by Seller in Seller’s sole discretion, of each of the following conditions:
65



(i)all the representations and warranties of Purchaser contained in this Agreement shall be true and correct in all material respects as of the Initial Closing Date with the same effect as though such representations and warranties had been made on and as of the Initial Closing Date (except to the extent expressly made as of an earlier date, in which case as of such earlier date);
(ii)all of the covenants of Purchaser contained in this Agreement to be performed by Purchaser on or before the Initial Closing Date shall have been performed in all material respects on or before the Initial Closing Date;
(iii)Purchaser shall have delivered to Seller a certificate of a duly authorized officer of Purchaser dated as of the Initial Closing Date stating that the conditions specified in Sections 7.1(c)(i) and 7.1(c)(ii) have been satisfied;
(iv)Purchaser shall have executed and delivered (or shall have caused the applicable OTA Transferee to execute and deliver) a Bill of Sale and Assignment and Assumption Agreement for each Facility, the Seller Leased Parcel Lease Agreement for each of the Seller Leased Parcels, the Transaction Documents, and the Interim Documents for each applicable Facility included in the Initial Closing;
(v)Solely with respect to the Phase II Initial Closing, Purchaser shall have delivered the Additional Deposit to the Title Company; and
(vi)Purchaser shall have delivered to Seller by wire transfer of immediately available funds the Purchase Price applicable to the Facilities included in such Initial Closing in accordance with Section 2.5.
(d)In the event any of the conditions in this Section 7.1 are not satisfied or waived upon the Initial Closing Date, which failure is not due to the default of either Party hereunder, the Initial Closing shall be deferred until all such conditions are satisfied, but in no event later than the Outside Date.
7.2Escrow Facilities.
(a)As of the Initial Closing Date, any Facilities meeting the following criteria shall be deemed an “Escrow Facility”: (v) any Facility that is Out of Compliance, (x) if (and only if) Seller has not obtained the WTTC Waiver, and WTHC has not exercised the WTHC Declaration Rights, the WTTC Facility, (y) if (and only if) Seller has not obtained the Knoxville Billing Approval, the Knoxville Facilities, and (z) if (and only if) Seller elects to cure any title exceptions contained in a Title Objection Notice pursuant to Section 6.9 other than a Mandatory Cure Item, makes commercially reasonable efforts to do so, but is unable to cure such item(s) prior to the applicable Closing Date, then the applicable Facility shall become an Escrow Facility hereunder (a “Title Cure Escrow Facility”). If there exists one or more Escrow Facilities as of an Initial Closing Date, then, subject to the satisfaction of the Escrow Facility Threshold and other applicable Closing Conditions, then: (i) on the applicable Closing Date the Closing shall proceed with respect to all Facilities subject to such Closing other than any such Escrow Facilities, (ii) the Closing with respect to any such Escrow Facility shall be deferred for a period not to exceed the End Date, (iii) the portion of the Purchase Price otherwise payable at such Closing shall be reduced by an amount equal to the aggregate Facility Purchase Price of the applicable Escrow Facilities applicable to such Closing, (iv) notwithstanding Section 2.5(b), on the Phase II Initial Closing Date, a percentage of the Deposit equal to the aggregate Pro-Rata Percentage of all Escrow Facilities shall not be applied towards that portion of the Purchase Price otherwise payable at such Closing (as such Purchase Price was reduced pursuant to the foregoing clause (iii)), and such non-applied portion of the Deposit shall instead be retained, held, and disbursed by the Title Company pursuant to the terms of this Agreement, or disbursed at one or more Subsequent Closings (as set forth in Section 7.5(c)) or upon termination of the Agreement (in accordance with Section 10.2).
66



(b)Promptly following the designation of any Facility as an Escrow Facility, each of the Parties shall use their respective reasonable best efforts to take, or cause to be taken, all actions that are necessary, proper or advisable to cause such Escrow Facility to become a Cured Facility and to consummate and make effective the sale, conveyance, assignment, transfer and delivery of such Escrow Facility, including using reasonable best efforts to cause the Closing Conditions in Section 7.4 to be satisfied.
7.3Subsequent Closings. The closing of the transactions contemplated hereby with respect to each Escrow Facility (each, a “Subsequent Closing”) shall take place on the last Business Day of the calendar month in which (a) such Escrow Facility becomes a Cured Facility, and (b) all of the applicable Closing Conditions are satisfied (other than those conditions that by their terms are to be satisfied at the Closing, so long as each such condition is capable of being satisfied) or, to the extent permitted by applicable Law, waived with respect to the applicable Escrow Facility (each such date, a “Subsequent Closing Trigger Date”); provided that (x) if there are less than seven (7) days remaining in a calendar month when the Subsequent Closing Trigger Date occurs, the applicable Subsequent Closing shall occur on the last Business Day in the immediately following calendar month, so long as all of the applicable Closing Conditions are satisfied (other than those conditions that by their terms are to be satisfied at the Closing, so long as each such condition is capable of being satisfied) or, to the extent permitted by applicable Law, waived with respect to the applicable Escrow Facility and (y) Seller and Purchaser may mutually elect to have the applicable Subsequent Closing occur on a date other than the last Business Day of the month, in which case, such Subsequent Closing will occur on such date agreed upon by Seller and Purchaser.
7.4Conditions to each Subsequent Closing.
(a)Mutual Conditions to the Subsequent Closing. The respective obligations of Seller, on the one hand, and Purchaser, on the other hand, to consummate the transactions contemplated hereby with respect to any Escrow Facility at any Subsequent Closing shall be subject to the satisfaction at or prior to the Subsequent Closing Date of each of the following conditions (any of which conditions may be waived by the mutual written agreement of Seller, on the one hand, and Purchaser, on the other hand, in whole or in part):
(i)With respect to the applicable Escrow Facility either (A) such Escrow Facility shall have become a Cured Facility (and shall remain a Cured Facility as of such Subsequent Closing Date and shall not otherwise be Out of Compliance as of such Subsequent Closing Date), or (B) the End Date shall have occurred.
(ii)the Closing Conditions set forth in Sections 7.1(a)(i) (Preclusive Order), 7.1(a)(ii) (Required Consents) and 7.1(a)(iii) (Regulatory Approvals; Governmental Consents; Licenses) with respect to the Initial Closing shall be satisfied as of the Subsequent Closing Date with respect to the transactions contemplated to occur thereon pursuant hereto; mutatis mutandis.
(b)Purchaser Conditions to the Subsequent Closing. The obligations of Purchaser to consummate the transactions contemplated hereby with respect to any Escrow Facility at any Subsequent Closing shall also be subject to the satisfaction at or prior to the Subsequent Closing Date or waiver by Purchaser in Purchaser’s sole discretion, of each of the following conditions:
67



(i)all the representations and warranties of Seller contained in this Agreement, solely as they relate to the Escrow Facilities, Business, assets and liabilities conveyed, purchased or assumed at such Subsequent Closing, shall be true and correct in all material respects as of the Subsequent Closing Date, with the same effect as though such representations and warranties had been made on and as of the Subsequent Closing Date (except to the extent expressly made as of an earlier date, in which case as of such earlier date), except where the failure to be true and correct would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect;
(ii)all of the covenants of Sellers contained in this Agreement to be performed by Sellers on or before the Subsequent Closing Date with respect to the Escrow Facilities, Business, assets and liabilities conveyed, purchased or assumed at such Subsequent Closing shall have been performed in all material respects, except where the failure to so perform would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect;
(iii)each Seller participating in the Subsequent Closing shall have delivered to Purchaser a certificate of a duly authorized officer of Seller dated as of the Subsequent Closing Date stating that the Closing Conditions in Sections 7.4(b)(i) and 7.4(b)(ii) have been satisfied with respect to such Seller;
(iv)the Closing Conditions in Sections 7.1(b)(ix) (Delivery of Bill of Sale Assignment and Assumption Agreements, Deeds, OTAs, Interim Documents), 7.1(b)(x) (Seller Encumbrance Releases), 7.1(b)(xi) (Title Policies), 7.1(b)(xii) (AAP Matters) with respect to the Initial Closing shall be satisfied as of the Subsequent Closing Date with respect to the applicable Escrow Facilities and the transactions contemplated to occur on the Subsequent Closing Date pursuant hereto; mutatis mutandis.
(v)With respect to the transactions contemplated by the OTAs applicable to the Facilities included in such Subsequent Closing:
(A)all the representations and warranties of Current Operators contained in such OTAs, solely as they relate to the Escrow Facilities, Business, assets and liabilities conveyed, purchased or assumed at such Subsequent Closing, shall be true and correct in all material respects as of such Subsequent Closing Date, with the same effect as though such representations and warranties had been made on and as of such Subsequent Closing Date (except to the extent expressly made as of an earlier date, in which case as of such earlier date), except where the failure to be true and correct would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect;
(B)all of the covenants of Current Operators contained in such OTAs to be performed by Current Operators on or before the Subsequent Closing Date with respect to the Escrow Facilities, Business, assets and liabilities conveyed, purchased or assumed at such Subsequent Closing shall have been performed in all material respects on or before such Subsequent Closing, except where such failure would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect; and
(c)Seller Conditions to Subsequent Closing. The obligations of Seller to consummate the transactions contemplated hereby with respect to any Escrow Facility at any Subsequent Closing shall also be subject to the satisfaction at or prior to the Subsequent Closing Date or waiver by Seller in Seller’s sole discretion, of each of the following conditions:
68



(i)all the representations and warranties of Purchaser contained in this Agreement shall be true and correct in all material respects as of the Subsequent Closing Date with the same effect as though such representations and warranties had been made on and as of the Subsequent Closing Date (except to the extent expressly made as of an earlier date, in which case as of such earlier date);
(ii)all of the covenants of Purchaser contained in this Agreement to be performed by Purchaser on or before the Subsequent Closing Date with respect to the Escrow Facilities, Business, assets and liabilities conveyed, purchased or assumed at such Subsequent Closing shall have been performed in all material respects on or before the Subsequent Closing Date;
(iii)each Purchaser participating in such Subsequent Closing shall have delivered to Seller a certificate of a duly authorized officer of Purchaser dated as of the Subsequent Closing Date stating that the conditions specified in Sections 7.4(c)(i) and 7.4(c)(ii) have been satisfied;
(iv)Purchaser shall have executed and delivered (or shall have caused the applicable OTA Transferee to execute and deliver) a Bill of Sale and Assignment and Assumption Agreement for each applicable Escrow Facility, the Seller Leased Parcel Lease Agreements for the Seller Leased Parcels, and any applicable Transaction Documents or Interim Documents for each applicable Escrow Facility; and
(v)Purchaser shall have delivered to Seller by wire transfer of immediately available funds the Purchase Price in accordance with Section 7.5.
(d)In the event any of the Closing Conditions in this Section 7.4 are not satisfied upon the Subsequent Closing Date, which failure is not due to the default of either Party hereunder, the Subsequent Closing shall be deferred until all such conditions are satisfied, but in no event later than the End Date.
7.5Subsequent Closing Purchase Price; Adjustment; Payment. At each Subsequent Closing:
(a)If such Escrow Facility has become a Cured Facility, the Facility Purchase Price with respect thereto shall be as set forth in the Facility Allocation; provided, that if such Facility was subject to a Casualty Loss the sale thereof shall include a conveyance to Purchaser of all of Sellers’ rights to the balance of any insurance proceeds which have not been used for the repair and restoration of such Escrow Facility, if any;
69



(b)If such Escrow Facility has not become a Cured Facility the following shall apply: (i) if an Escrow Facility remains subject to a Regulatory OoC as of the End Date, absent an election by Purchaser to treat such Escrow Facility(ies) as a Cured Facility(ies), such Escrow Facility(ies) shall cease to be subject to this Agreement and the Purchase Price shall be reduced by the amount of the Purchase Price allocated for such Escrow Facility(ies) pursuant to the Facility Allocation and any portion of the Deposit being held in relation to such Escrow Facility(ies) shall be released to Purchaser; (ii) if an Escrow Facility remains subject to a Casualty OoC as of the End Date, absent an election by Purchaser to treat such Escrow Facility(ies) as a Cured Facility(ies), such Escrow Facility(ies) shall cease to be subject to this Agreement and the Purchase Price shall be reduced by the amount of the Purchase Price allocated for such Escrow Facility(ies) pursuant to the Facility Allocation and any portion of the Deposit being held in relation to such Escrow Facility(ies) shall be released to Purchaser; (iii) if an Escrow Facility remains subject to a Census OoC as of the date which is five (5) Business Days prior to the End Date, then (A) no less than three (3) Business Days prior to the End Date (the “Census Date”), the Parties shall calculate (x) the Average Resident Census, and (y) the amount (expressed as a percentage) by which such Average Resident Census is less than (A) with respect to a Census Facility, the Current Resident Census, and (B) with respect to an Exempt Facility, the Census Floor applicable to such Facility (the “Census Percentage Decrease”); and (B) at the applicable Subsequent Closing, the applicable Facility Purchase Price with respect thereto shall be decreased (but not increased) so as to equal the Census Discounted Facility Purchase Price, (iv) solely with respect to the Knoxville Facilities, if Seller have not obtained the Knoxville Billing Approval as of the End Date, absent an election by Purchaser to treat such Escrow Facility(ies) as a Cured Facility(ies), such Escrow Facility(ies) shall cease to be subject to this Agreement and the Purchase Price shall be reduced by the amount of the Purchase Price allocated for such Escrow Facility(ies) pursuant to the Facility Allocation and any portion of the Deposit being held in relation to such Escrow Facility(ies) shall be released to Purchaser, (v) solely with respect to the WTTC Facility, if Seller have not obtained the WTTC Waiver as of the End Date, absent an election by Purchaser to treat such Escrow Facility as a Cured Facility, such Escrow Facility shall cease to be subject to this Agreement and the Purchase Price shall be reduced by the amount of the Purchase Price allocated for such Escrow Facility pursuant to the Facility Allocation and any portion of the Deposit being held in relation to such Escrow Facility shall be released to Purchaser and (vi) solely with respect to any Title Cure Escrow Facility(ies), if Seller have not caused such Title Cure Escrow Facility(ies) to become a Cured Facility as of the End Date, absent an election by Purchaser to treat such Title Cure Escrow Facility(ies) as a Cured Facility(ies), such Title Cure Escrow Facility(ies) shall cease to be subject to this Agreement and the Purchase Price shall be reduced by the amount of the Purchase Price allocated for such Title Cure Escrow Facility(ies) pursuant to the Facility Allocation and any portion of the Deposit being held in relation to such Title Cure Escrow Facility(ies) shall be released to Purchaser.
(c)Purchaser and Seller shall instruct the Title Company to disburse to Seller at each Subsequent Closing any portion of the Deposit which relates to an Escrow Facility which is being conveyed at such Subsequent Closing and which was retained by the Title Company pursuant to Sections 7.2(a)(iv), and such portion of the Deposit shall be applied towards the Facility Purchase Price of such Facility (as adjusted pursuant to this Section 7.5). At such Subsequent Closing, Purchaser shall pay the balance of the applicable Facility Purchase Price (as adjusted pursuant to this Section 7.5) in immediately available funds by wire transfer to one or more bank accounts designated in writing by Seller to Purchaser at least two (2) Business Days prior to such Subsequent Closing
7.6Failure of Closing Condition Not Evidence of Breach. The Parties acknowledge and agree that the failure of a Closing Condition (including the failure of he conditions in Sections 7.1(a)(iv) and 7.1(b)(ii)) shall not, in and of itself, evidence a breach by any Party of any obligation or covenant hereunder.
Article VIII
POST-CLOSING RIGHTS AND OBLIGATIONS
8.1Assumed Liabilities; Excluded Liabilities. After each applicable Closing, Purchaser shall duly and timely pay and perform all of the Assumed Liabilities in the Ordinary Course as they become due. After each applicable Closing, Seller shall duly and timely pay and perform all of the Excluded Liabilities in the Ordinary Course as they become due.
Article IX
INDEMNIFICATION
70



9.1Survival of Representations, Warranties and Covenants. All representations, warranties, pre-Closing covenants and obligations of Seller, on the one hand, and Purchaser, on the other hand, contained in this Agreement or in any document to be executed and delivered pursuant to this Agreement at the Closings (each, a “Closing Document”) shall survive the Initial Closing for eighteen (18) months and automatically terminate thereafter without any action on the part of any Party hereto; provided, however, that (a) the representations and warranties set forth in Sections 4.1 (Corporate), 4.5 (Title to Purchased Assets; Absence of Encumbrances), 4.14 (Brokers and Finders), 5.1 (Corporate), and 5.3 (Brokers and Finders) shall survive indefinitely after the Initial Closing for such Facility; and (b) the representations and warranties set forth in Sections 4.3 (Taxes) and 4.20 (Employee Benefits)shall survive until thirty (30) days after the expiration of the statute of limitations period (including all extensions thereof) applicable to the underlying subject matter being represented and (c) the representations and warranties set forth in Sections 4.11 and 4.12 shall survive until the three year anniversary of the Initial Closing Date. The representations and warranties contained in Sections 4.1, 4.3, 4.5, 4.14, 4.20, 5.1, 5.3 and 5.4 are sometimes collectively referred to herein as the “Fundamental Representations.” Except as otherwise set out in this Agreement, post-Closing covenants and obligations of the Parties shall survive the Initial Closing Date for three (3) years and automatically terminate without any action on the part of any Party hereto; provided, however, that (a) non-monetary obligations for access and/or retention of records, confidentiality, general cooperation, delivery of property received belonging to the other Party, and further assurances, shall survive the Initial Closing Date for the period of the statute of limitations or the specific period set forth herein; (b) Assumed Liabilities will survive the Initial Closing Date until thirty (30) days after the expiration of the statute of limitations period (including all extensions thereof) applicable for such Assumed Liability; and (c) Seller’s obligations with respect to Excluded Liabilities will survive the Initial Closing Date until thirty (30) days after the expiration of the statute of limitations period (including all extensions thereof) applicable for such Excluded Liability. Notwithstanding the foregoing, any covenant, obligation, representation or warranty in respect of which indemnity may be sought hereunder shall survive the time at which it would otherwise terminate pursuant to this Section 9.1 (such time, the “Expiration Date”) if a Notice of Indemnification shall have been given to the applicable Indemnifying Party on or before the applicable Expiration Date; provided, however, that such survival shall automatically expire if Indemnified Party does not bring a judicial action against Indemnifying Party with respect to any such breach within the one hundred eighty (180) day period following the Expiration Date. In the absence of filing such action, the Escrow Funds, if any, held by the Title Company shall be released to the Seller.
9.2Indemnification by Seller. Subject to Section 9.1 and any cure periods set forth in this Agreement, Seller or its successors and assigns, as applicable, shall indemnify and hold harmless Purchaser, its successors and assigns (including the respective Purchaser Parties and Purchaser Assignees), each OTA Transferee and its successors and assigns, and their respective Affiliates (collectively, “Purchaser Indemnified Parties”) from and against any Loss incurred or suffered by such Purchaser Indemnified Party arising out of or resulting from:
(a)a breach of any representation or warranty made by Seller in this Agreement or any other Transaction Document;
(b)a failure by Seller to perform or comply with the covenants on the part of Seller set forth in this Agreement or any other Transaction Document; and
(c)any Excluded Liability.
9.3Indemnification by Purchaser. Subject to Section 9.1 and any cure periods set forth in this Agreement, Purchaser or its successors and assigns, as applicable, shall indemnify and hold harmless Seller and its Affiliates (“Seller Indemnified Parties”), from and against any Loss incurred or suffered by such Seller Indemnified Party arising out of or resulting from:
71



(a)a breach of any representation or warranty made by Purchaser in this Agreement or any other Transaction Document;
(b)a failure by Purchaser to perform or comply with any covenant of Purchaser in this Agreement or any other Transaction Document; and
(c)any Assumed Liability.
9.4Indemnification Limitations.
(a)Notwithstanding Section 9.2, if the Initial Closing occurs:
(i)an Indemnifying Party shall not have any obligation to indemnify an Indemnified Party whatsoever from and against any Loss pursuant to Section 9.2(a) or Section 9.3(a) unless and until the aggregate claims for such Losses (and with respect to any of the Purchaser Indemnified Parties, combined with claims for Losses by the applicable OTA Transferee for breaches of Seller’s representations and warranties under the applicable OTA) exceed One Hundred Fifty Thousand Dollars ($150,000) (the “Indemnification Threshold”), at which time the Indemnified Parties shall be entitled to recover all Losses from Dollar one, including the Indemnification Threshold, but subject to the Indemnification Cap; and
(ii)the Indemnified Parties shall not be entitled to recover Losses pursuant to Section 9.2(a) or Section 9.3(a) for an aggregate amount in excess of the Escrow Funds (the “Indemnification Cap”), provided, however, that Losses relating to: (A) breach of any of the Fundamental Representations, (B) any Pre-Closing R&W Breach (the existence of which does not breach Purchaser’s representations and warranties set forth in Section 5.8(b)), and which is (x) properly and timely identified in a Pre-Closing R&W Breach Notice delivered to Seller prior to the Initial Closing in accordance with Section 6.15, (y) existed as of the Execution Date (as opposed to one which first arose subsequent to the Execution Date and prior to an applicable Closing) and (z) was not cured by Seller prior to the Closing Date (an “Execution Date R&W Breach”), and (C) the Interim Indemnity shall not be subject to the limits set forth in this Sections 9.4(a)(i) and 9.4(a)(ii) and shall not be included in the determination of whether the Indemnification Cap has been reached. Notwithstanding the limitations on indemnification set forth in Section 9.1 and this Section 9.4, such limitations shall not apply to any claim against Seller or Purchaser for Fraud. For all purposes of this Article IX, when determining the amount of the Losses arising out of or resulting from a breach of a representation or warranty of Seller or Purchaser, any “Material Adverse Effect” or other materiality qualifier contained in any such representation or warranty will be disregarded.
(b)Seller shall have no obligation to indemnify (whether under this Article or otherwise) both (i) Purchaser, or a Purchaser Party or an assignee of Purchaser, and (ii) an OTA Transferee, with respect to any single Loss and shall not be required to pay duplicative damages. Further, Seller shall not owe obligations to more than one of the Purchaser Indemnified Parties with respect to any single Loss and shall not be required to pay duplicative damages.
72



(c)Purchaser shall use its commercially reasonable efforts (for this purpose, being those efforts Purchaser would otherwise use if it did not have an indemnity backstop provided by Seller), at Sellers’ expense, to promptly collect from each applicable insurer, reimbursement arrangement, and other contractual source of recovery (collectively “Alternate Arrangements”) all Losses that are recoverable thereunder; provided, however, that nothing in this Section 9.4(c) shall limit the remedies available to any Party hereto for any breaches of Fundamental Representations or for Fraud, in either case in connection with the transactions contemplated hereby. In the event that an Indemnifying Party makes any payment to any Indemnified Party for indemnification for which such Indemnified Party could have collected under an Alternate Arrangement, the Indemnifying Party will be entitled to pursue claims and conduct litigation on behalf of such Indemnified Party and any of its successors, to pursue and collect on any indemnification or other remedy available to such Indemnified Party thereunder with respect to such claim and generally to be subrogated to the rights of such Indemnified Party and such Indemnified Party shall take such actions and execute such documents as are reasonably necessary to vest such subrogation right in the applicable Indemnifying Parties. Except pursuant to a settlement agreed to by the Indemnifying Party, the Indemnified Party will not waive or release any contractual right to recover from an Alternate Arrangement any Loss subject to indemnification hereby without the prior written consent of the Indemnifying Party not to be unreasonably withheld, conditioned or delayed. The Indemnified Party will, and will cause its Affiliates (including the Members of the Company Group) to, cooperate with the Indemnifying Party, at the Indemnifying Party’s expense, with respect to any such effort to pursue and collect with respect thereto.
(d)The amount of any and all indemnifiable Losses hereunder shall be determined net of any amounts actually received by any Indemnified Party under or pursuant to any Alternate Arrangements (net of any costs incurred in connection with the collection thereof, including deductibles and increase in premiums resulting therefrom). In any case where an Indemnified Person recovers under any Alternative Arrangement, any amount in respect of a matter for which such Indemnified Party was indemnified pursuant to hereto, such Indemnified Party will promptly pay over to the Indemnifying Party an amount equal to the lesser of (A) the actual amount received under such Alternative Arrangements, net of any Taxes payable in respect thereof and any costs incurred in connection with the collection thereof, including deductibles, and (B) the actual amount of the indemnification payment previously paid by or on behalf of the Indemnifying Party with respect to such Losses.
(e)Sellers shall not be required to indemnify any Purchaser Indemnified Party and Purchaser shall not be required to indemnify any Seller Indemnified Party to the extent of any Losses that a court of competent jurisdiction shall have determined by final judgment to have resulted from the bad faith, gross negligence or willful misconduct of the Person seeking indemnification or its Affiliate.
(f)Purchaser shall take and shall cause its Affiliates to take all reasonable steps to mitigate any Loss upon becoming aware of any event which would reasonably be expected to, or does, give rise thereto. Sellers shall take and cause its Affiliates to take all reasonable steps to mitigate any Loss upon becoming aware of any event which would reasonably be expected to, or does, give rise thereto.
(g)Any indemnification payments made pursuant to this Agreement shall be treated as an adjustment to the Purchase Price (as determined for U.S. federal income tax purposes) and shall be reflected as an adjustment to the consideration allocated to a specific asset, if any, giving rise to the adjustment and if any such adjustment does not relate to a specific asset, such adjustment shall be allocated in accordance with the allocation principles set forth in Section 2.6.
73



9.5Assumption of Defense. An Indemnified Party shall promptly give notice (each, a “Notice of Indemnification”) to each Indemnifying Party after obtaining knowledge of any matter as to which recovery may be sought against such Indemnifying Party because of the indemnity set forth above, and, if such indemnity shall arise from the claim of a third party and Indemnifying Party provides written notice to the Indemnified Party stating that the Indemnifying Party is responsible for the entire claim within ten (10) days after the Indemnifying Party’s receipt of the applicable Notice of Indemnification, shall permit such Indemnifying Party to assume the defense of any such claim or any proceeding resulting from such claim; provided, however, that failure to give any such Notice of Indemnification promptly shall not affect the indemnification provided under this Article IX, except and only to the extent such Indemnifying Party shall have been actually prejudiced as a result of such failure or if such Notice of Indemnification is not given to Indemnifying Party prior the applicable Expiration Date. If an Indemnifying Party assumes the defense of such third party claim, such Indemnifying Party shall have full and complete control over the conduct of such proceeding on behalf of Indemnified Party and shall, subject to the provisions of this Section 9.4(b), have the right to decide all matters of procedure, strategy, substance and settlement relating to such proceeding; provided, further, however, that any counsel chosen by such Indemnifying Party to conduct such defense shall be reasonably satisfactory to Indemnified Party; and provided, further, however, that Indemnifying Party shall not without the written consent of Indemnified Party consent to the entry of any judgment or enter into any settlement with respect to the matter which (a) does not include a provision whereby the plaintiff or the claimant in the matter releases Indemnified Party from all liability with respect thereto, and (b) in the case of Purchaser, does not include any provision that would impose any obligation (including an obligation to refrain from taking action) upon Seller. Indemnified Party may participate in such proceeding and retain separate co-counsel at its sole cost and expense (and, for the avoidance of doubt, such cost and expense shall not constitute a Loss for purposes of the Indemnification Obligations).
9.6Non-Assumption of Defense. If no Indemnifying Party is permitted or elects to assume the defense of any such claim by a third party or proceeding resulting therefrom, Indemnified Party shall diligently defend against such claim or litigation in such manner as it may deem appropriate and, in such event, Indemnifying Party or Parties shall reimburse Indemnified Party for all reasonable and actually incurred out-of-pocket costs and expenses, legal or otherwise, incurred by Indemnified Party and its Affiliates in connection with the defense against such claim or proceeding, within thirty (30) days after the receipt of detailed invoices.
9.7Indemnified Party’s Cooperation as to Proceedings. Indemnified Party will cooperate in all reasonable respects with any Indemnifying Party in the conduct of any proceeding as to which such Indemnifying Party assumes the defense, except to the extent Indemnified Party could reasonably be expected to be prejudiced thereby. Indemnifying Party or Parties shall promptly reimburse Indemnified Party for all reasonable out-of-pocket costs and expenses, legal or otherwise, incurred by Indemnified Party or its Affiliates in connection therewith, within thirty (30) days after the receipt of detailed invoices therefor.
9.8Damages Disclaimed. EXCEPT IN THE EVENT OF FRAUD OR AS SUCH MAY BE PART OF ANY CLAIM OF ANY THIRD PARTY THAT IS NOT A PURCHASER INDEMNIFIED PARTY OR A TRANSFEREE INDEMNIFIED PARTY (AS DEFINED IN THE OTA), UNDER NO CIRCUMSTANCES SHALL SELLER, PURCHASER, PURCHASER PARTIES, OR PURCHASER ASSIGNEES BE RESPONSIBLE OR LIABLE (WHETHER UNDER THIS ARTICLE IX OR OTHERWISE IN THIS AGREEMENT) IN ANY WAY HEREUNDER FOR LOST PROFITS, INCIDENTAL, CONSEQUENTIAL, SPECIAL OR PUNITIVE DAMAGES, DIMINUTION IN VALUE, OR ANY EXEMPLARY DAMAGES, REGARDLESS OF WHETHER THE ACTION IS FOUNDED IN CONTRACT, TORT, STATUTORY OR OTHERWISE.
9.9Individual Liability Disclaimed. For the avoidance of doubt, except in the event of Fraud, no individual officer, director, member, managing member, shareholder, equity holder, partner, employee, agent, or representative of either Party shall have any liability for any claims of the other Party related to this Agreement, or any agreements, certificates or instruments delivered in connection herewith, in any way.
74



9.10Exclusive Remedy Post-Closing. With the exception of Fraud and injunctive relief for specific performance or an action required to be performed by a Party under this Agreement after each Closing, the exclusive remedy of any Party with respect to the matters subject to such Closing shall be indemnity under this Article IX, regardless of the legal theory under which such liability or obligation may be sought to be imposed, whether sounding in contract or tort, or whether at Law or in equity, or otherwise, shall be as provided in this Article IX. The Indemnified Parties may not avoid the limitations on liability herein by seeking damages for breach of contract, tort, or pursuant to any other theory of liability, all of which are hereby waived. Notwithstanding the foregoing, the remedies under Article X shall remain for Facilities which have not become Transferred Facilities.
9.11Application of Indemnity Escrow Funds. Any payment Seller is obligated to make to Purchaser Indemnified Parties pursuant to this Article IX or pursuant to Article X of an OTA shall be paid first, to the extent there are sufficient Indemnity Escrow Funds, by release of Indemnity Escrow Funds to Purchaser Indemnified Parties, as applicable, by the Title Company in accordance with the terms of the Escrow Agreement, and shall accordingly reduce the Indemnity Escrow Funds and, second, to the extent the Indemnity Escrow Funds are insufficient to pay any remaining sums due, then Seller shall promptly pay all of such additional sums due and owing to Purchaser Indemnified Parties in cash by wire transfer of immediately available funds.
9.12Non-Recourse Parties. All claims or causes of action (whether in contract or in tort, in Law or in equity) that may be based upon, arise out of or relate to this Agreement or the other Transaction Documents, or the negotiation, execution or performance of this Agreement or the other Transaction Documents (including any representation or warranty made in or in connection with this Agreement or the other Transaction Documents or as an inducement to enter into this Agreement or the other Transaction Documents), may be made only against the entities that are expressly identified as parties hereto and thereto. (i) No Person who is not a named party to this Agreement or the other Transaction Documents, and (ii) no past, present or future director, officer, employee, incorporator, member, partner, equityholder, shareholder, manager, advisor, Affiliate, agent, attorney or representative of the Seller, the Purchaser or of any named party to this Agreement or the other Transaction Documents, together with any past, present or future director, officer, employee, incorporator, member, partner, equityholder, shareholder, manager, advisor, Affiliate, agent, attorney or representative thereof (collectively, “Non-Party Affiliates”), shall have any liability (whether in contract or in tort, in Law or in equity, or based upon any theory that seeks to impose liability of an entity party against its owners or Affiliates) for any liabilities arising under, in connection with or related to this Agreement, such other Transaction Document or the transactions contemplated by this Agreement or for any claim based on, in respect of, or by reason of this Agreement, such other Transaction Document or the transactions contemplated by this Agreement or the negotiation or execution hereof or thereof; and each party waives and releases all such liabilities and claims against any such Non-Party Affiliates. If any Person who is a party hereto would constitute an Non-Party Affiliate but for such Person’s being a party hereto, such Person’s liability shall be limited to any liability such Person may have in their capacity as a party hereto, and such person shall have no liability in any capacity which would have made such Person an Non-Party Affiliate but for such Person’s being a party hereto.
9.13Interim Indemnity; Guaranty.
(a)Subject to the terms and conditions of the Interim Indemnity Guaranty (as defined in subsection (b) below), in the event that any Facilities are subject to an Interim Document following a Closing, then Seller or its successors and assigns, as applicable, shall indemnify and hold harmless the Purchaser Indemnified Parties from and against (collectively, the “Interim Indemnity”):
75



(i)any and all reasonable out-of-pocket costs necessary to cure any survey deficiencies identified by Governmental Authorities at such Facilities in the course of inspections of such Facilities conducted by such Governmental Authorities for purposes of enabling the parties to satisfy the Licensure Condition; provided, however, Seller shall have no liability to Purchaser, OTA Transferees or any Purchaser Indemnified Party with respect to items first arising from the actions or inactions of Purchaser, a Purchaser Indemnified Party or the OTA Transferees with respect to a Facility subject to an Interim Document from and after the Initial Closing Date; and
(ii)any recoupment made against any Purchaser Indemnified Parties’ Medicaid receivables generated during the Interim Period to the extent that such recoupment relates to the period prior to the Interim Period during which Seller owned or operated the applicable Facility.
(b)In the event that any Facilities are subject to an Interim Document following a Closing, and, as of the Closing, such Facility was subject to a Survey Condition, then, at the applicable Closing, Seller shall cause AmPharm Inc., a Tennessee corporation, to deliver a guaranty in the form attached hereto as Exhibit N (the “Interim Indemnity Guaranty”), which shall secure the Seller’s Interim Indemnity obligation with respect to such Facility.
9.14Execution Date R&W Breach Guaranty. In the event that as of an applicable Closing there exists an Execution Date R&W Breach applicable to the Facilities subject to such Closing, Seller shall cause AmPharm Inc., a Tennessee corporation, to deliver a guaranty in the form attached hereto as Exhibit O (the “Execution Date R&W Guaranty”), which shall secure the Seller’s Indemnity obligations relating to any Execution Date R&W Breach.
9.15CID Guarantees. At the Initial Closing, Seller shall cause MFO AHP LLC, a Michigan limited liability company, to deliver the guaranty attached hereto as Exhibit P (the “CID Guaranty”) in favor of the Purchaser Indemnified Parties, which shall secure the Obligations (as such term is defined in the CID Guaranty).
Article X
TERMINATION AND BREACH
10.1Termination and Breach Events. Notwithstanding anything herein to the contrary, in addition to the termination rights set forth in Section 6.9, this Agreement may be terminated, and the transactions contemplated hereby abandoned at any time:
(a)by mutual written consent of Seller and Purchaser;
(b)by either Seller or Purchaser, upon prior written notice to the other Party, if the Initial Closing shall not have occurred by the Outside Date; provided that the right to terminate this Agreement under this Section 10.1(b) shall not be available to any Party whose breach of representation or warranty or failure to fulfill in any material respect any covenants and agreements of such Party set forth in this Agreement was a cause of the failure of the Initial Closing to occur on or before the Outside Date; provided, that such termination shall not apply to any Facilities that have become Transferred Facilities prior to the date of such termination;
(c)by either Seller or Purchaser (i) in the event that any Law shall have been enacted or Order issued by any Governmental Authority that directly prohibits the consummation of all Closings that have not occurred as of the date of such enactment or issuance,, and such Law or Order shall have become final and non-appealable, or (ii) with respect to a particular Facility in the event that any Law shall have been enacted or Order issued by any Governmental Authority that directly prohibits the consummation of the Closing with respect to such Facility, and such Law or Order shall have become final and non-appealable; provided that the right to terminate this Agreement under this Section 10.1(c) shall not be available to any Party whose breach of representation or warranty or failure to fulfill in any material respect any covenants and agreements of such Party set forth in this Agreement was a cause of the failure of the event or condition giving rise to the right to terminate this Agreement; or
76



(d)
(i)With respect to an Initial Closing, by either Seller or Purchaser if the other Party has (i)(A) breached this Agreement in any manner that would result in a failure of a Closing Condition to the Initial Closing to be satisfied, and (B) failed to cure any such breach within thirty (30) days of receipt of written notice (a “Cure Right”) of such breach or failure (which notice shall specify in reasonable detail the nature of such breach and the Party’s intention to terminate this Agreement if such breach is not cured), or (ii) failed to consummate the Initial Closing upon satisfaction of its Closing Conditions; provided that the right to terminate this Agreement under this Section 10.1(d)(i) shall not be available to any Party: (x) whose breach of representation or warranty or failure to fulfill in any material respect any covenants and agreements of such Party set forth in this Agreement was a cause of the failure of the event or condition giving rise to the right to terminate the Agreement; (y) who itself is then in breach of this Agreement in any manner that would result in a failure of a Closing Condition to the Initial Closing to be satisfied; or (x) who would not then be entitled terminate this Agreement pursuant to Section 10.1(c) (Legal Restraint) if, at such time, the counterparty hereto (Purchaser or Seller, as applicable) would then be entitled to terminate this Agreement pursuant to such Section 10.1(c) (Legal Restraint); provided further that there shall be no Cure Right or right to extension for a failure to close by the Outside Date, or for the failure of a party to close upon satisfaction of its Closing Conditions; and provided further that this right to terminate (and the restriction on a party’s right to terminate) shall not apply to Escrow Facilities for such period as such Facilities are deemed to be an Escrow Facility under this Agreement (except as otherwise provided in Section 10.1(d)(ii)).
(ii)With respect to any Subsequent Closing, solely with respect to the Escrow Facilities, by either Seller or Purchaser if the other Party has (i)(A) breached this Agreement in any manner that would result in a failure of a Closing Condition to a Subsequent Closing to be satisfied, and (B) failed to cure any such breach within thirty (30) days of receipt of written notice (a “Subsequent Closing Cure Right”) of such breach or failure (which notice shall specify in reasonable detail the nature of such breach and the Party’s intention to terminate this Agreement with respect to the Escrow Facilities if such breach is not cured), or (ii) failed to consummate a Subsequent Closing upon satisfaction of its Closing Conditions; provided that the right to terminate this Agreement under this Section 10.1(d)(ii) shall not be available to any Party: (x) whose breach of representation or warranty or failure to fulfill in any material respect any covenants and agreements of such Party set forth in this Agreement was a cause of the failure of the event or condition giving rise to the right to terminate the Agreement; (y) who itself is then in breach of this Agreement in any manner that would result in a failure of a Closing Condition to a Subsequent Closing to be satisfied; or (x) who would not then be entitled terminate this Agreement pursuant to Section 10.1(c) (Legal Restraint) if, at such time, the counterparty hereto (Purchaser or Seller, as applicable) would then be entitled to terminate this Agreement pursuant to such Section 10.1(c) (Legal Restraint); provided further that there shall be no Subsequent Closing Cure Right or right to extension for a failure to close by the End Date, or for the failure of a party to close upon satisfaction of its Closing Conditions for such Subsequent Closing.
10.2Effect of Termination or Breach.
77



(a)If this Agreement is terminated pursuant to any of Sections 10.1(a) (Mutual Consent), 10.1(b) (Outside Date) or 10.1(c) (Legal Impediment), none of the Parties shall be liable to the other Parties for any liabilities and damages that occurred prior to such termination, for Facilities that are not Transferred Facilities, other than liability for intentional and material breaches of this Agreement that occurred prior to such termination. Further, if this Agreement is terminated pursuant to any of Sections 10.1(a) (Mutual Consent), 10.1(b) (Outside Date), or 10.1(c) (Legal Impediment) the Deposit shall be returned to Purchaser.
(b)If an uncured material breach gives rise to a right of Seller or Purchaser to terminate this Agreement pursuant to Section 10.1(d) (Material Breach), then:
(i)If Purchaser is the breaching Party, Seller shall have the right to keep the Deposit as liquidated damages and (x) with respect to the Phase I Initial Closing, terminate the Agreement, (y) with respect to the Phase II Initial Closing, terminate this Agreement with respect to the Phase II Facilities (but such termination will only be with regard to the Phase II Facilities that are not yet Transferred Facilities, and this Agreement shall remain in full force and effect with for all Phase I Facilities and all Transferred Facilities that have been subject to a Closing), or (z) with respect to a Subsequent Closing, terminate this Agreement with respect to the Escrow Facilities subject to said Subsequent Closing, but shall not have the right to sue for damages or pursue specific performance.
(ii)THE PARTIES ACKNOWLEDGE AND AGREE THAT (a) IT WOULD BE IMPRACTICAL OR EXTREMELY DIFFICULT TO DETERMINE SELLER’S ACTUAL DAMAGES IN THE EVENT OF PURCHASER’S DEFAULT UNDER THIS AGREEMENT, AND (b) TAKING INTO ACCOUNT ALL OF THE CIRCUMSTANCES EXISTING ON THE DATE OF THIS AGREEMENT, THE DEPOSIT IS A REASONABLE ESTIMATE OF SELLER’S ACTUAL DAMAGES IN SUCH EVENT. CONSEQUENTLY, IN THE EVENT OF PURCHASER’S DEFAULT UNDER THIS AGREEMENT PRIOR TO CLOSING, SELLER’S SOLE AND EXCLUSIVE REMEDY AT LAW SHALL BE TO TERMINATE THIS AGREEMENT WITH RESPECT TO ALL FACILITIES THAT ARE NOT TRANSFERRED FACILITIES OR ESCROW FACILITIES AND TO RECEIVE THE DEPOSIT.
(iii)If Seller is the breaching Party, Purchaser shall have the right to either (A) terminate the Agreement, receive a return of the Deposit, recover from Seller Purchaser’s out of pocket costs and expenses incurred in connection with this Agreement, the OTAs, and the transactions contemplated herein and therein, and if and only if, specific performance could not have provided an adequate remedy had Seller chosen to pursue it, Purchaser shall have all rights and remedies under law and equity in connection with such breach or default by Seller; provided, monetary damages shall not exceed Ten Million Dollars ($10,000,000.00); or (B) pursue specific performance solely to require Closing (but not to obtain money for losses; further, the Deposit shall be left in escrow pending the outcome of any action for specific performance). In the event a Closing has occurred, Purchaser shall have the same rights but only with regard to the Facilities that are not yet Transferred Facilities; the Agreement shall remain in full force and effect for all Transferred Facilities that have had a Closing.
(c)In all instances in which this Agreement is terminated and, at the time of such termination there exist one or more Excluded Facilities, any portion of the Deposit relating to such Excluded Facilities shall be returned to Purchaser.
(d)Upon a termination prior to a Closing, this Agreement shall become void and of no further force and effect, except for the provisions of Section 6.4(a) (relating to confidentiality as if the Closing had occurred), Article IX (relating to indemnification), Article X (relating to termination, breach, and damages, and any related provisions of the Agreement to the extent necessary to give effect to the remedies hereunder) and Article XI (relating to certain miscellaneous provisions).
78



(e)If this Agreement is terminated after a Closing, then this Agreement shall become void and of no further force and effect with regard to any Facilities that are not yet Transferred Facilities, except for the provisions of Section 6.4(a)-(c), Article IX (relating to indemnification), Article X (relating to termination, breach and damages, and any related provisions of the Agreement to the extent necessary to give effect to the remedies hereunder), and Article XI (relating to certain miscellaneous provisions); provided, however, this Agreement shall remain in full force and effect for all Transferred Facilities that have had a Closing.
(f)Notwithstanding anything in this Agreement to the contrary, including, without limitation, Section 9.8, in the event that this Agreement is terminated pursuant to Section 10.1(d) (Material Breach) due to (i) Fraud or (ii) willful and intentional acts of Seller in contravention of this Agreement, in each case, as determined by non-appealable final judicial determination, and the remedy of specific performance is not available to Purchaser or a practical remedy for Purchaser, Purchaser shall be entitled to pursue any and all remedies and damages available at law or equity against Seller, including without limitation, recovery of consequential, speculative, lost profits, diminution in value, exemplary, indirect, and punitive damages from Seller, not to exceed an aggregate amount of Ten Million Dollars ($10,000,000.00).
10.3Third Party Reports Following Termination. In connection with any termination of this Agreement, Purchaser agrees to promptly deliver to Seller an inventory of all Third Party Reports. Upon request of Seller, Purchaser will assign and promptly deliver to Seller all or any portion of the Third Party Reports.
Article XI
MISCELLANEOUS
11.1Schedules. The information contained in the Schedules shall be deemed to qualify the specific Section (or subsection, as appropriate) of this Agreement to which it corresponds, and shall be cumulative so that if the existence of the fact or item or its contents disclosed in any particular Schedule is relevant to any other Schedule, then such fact or item shall be deemed to be disclosed with respect to the other Schedule to the extent such relevance is reasonably apparent whether or not a specific cross-reference appears. The headings contained in the Schedules are included for convenience only and are not intended to limit the effect of the disclosures contained in such Schedule or to expand the scope of the information required to be disclosed in such Schedule. Descriptions of documents in the Schedules are summaries only and are qualified in their entirety by the specific terms of such documents. Matters reflected in the Schedules are not necessarily limited to matters required by this Agreement to be reflected herein; additional matters are set forth for informational purposes and the fact that any item of information is disclosed in the Schedules shall not be construed to mean that such information is required to be disclosed by this Agreement. Any information and the dollar thresholds set forth herein shall not be used as a basis for interpreting the term “material” or other similar terms in this Agreement or constitute an admission that such items are required to be disclosed under this Agreement. Any Schedules not attached hereto on the Execution Date or not complete as of the Execution Date shall be delivered within ten (10) days of the Execution Date.
11.2Expenses. Except as otherwise provided in this Agreement, each of the Parties shall bear its own expenses in connection with the negotiation and the consummation of the transactions contemplated by this Agreement. Subject to the foregoing, no expenses of Seller relating in any way to the purchase and sale of the Purchased Assets hereunder and the transactions contemplated hereby, including legal, accounting or other professional expenses of Seller shall be charged to or paid by Purchaser or included in any of the Assumed Liabilities. No expenses of Purchaser relating in any way to the purchase and sale of the Purchased Assets hereunder and the transactions contemplated hereby, including legal, accounting or other professional expenses of Purchaser shall be charged to or paid by any Seller or included in any of the Excluded Liabilities. The foregoing shall not limit, however, any Party’s right to include such expenses in any claim for damages against any other Party who breaches any legally binding provision of this Agreement to the extent provided in this Agreement.
79



11.3Entirety of Agreement. This Agreement (including the Schedules and all other schedules and exhibits hereto which are incorporated into and are a part of this Agreement), together with any certificates and other instruments delivered hereunder, including the Closing Documents and the Transaction Documents, state the entire agreement of the Parties, merge all prior negotiations, agreements and understandings, if any, whether written or oral, and state in full all representations, warranties, covenants and agreements that have induced this Agreement. Each Party agrees that in dealing with third parties, no contrary representations will be made.
11.4Notices. All notices and other communications given or made pursuant hereto shall be in writing and shall be deemed to have been duly given or made as of the date delivered if delivered (i) personally or by a nationally recognized overnight courier service or (ii) prior to the Initial Closing, via email to the Parties at the following addresses (or at such other address for a Party as shall be specified by like notice, except that notices of changes of address shall be effective upon receipt):
If to Seller, addressed to:
c/o American Health Partners
201 Jordan Rd, Suite 200
Franklin, TN 37067
Attn: Jason Bailey
Attn: Philip Clark, Esq.
Email: jbailey@amhealthpartners.com
Email: PClark@amhealthpartners.com
With a copy to (which shall not constitute notice):
Foley & Lardner LLP
301 E. Pine Street, Suite 1200
Orlando, Florida 32801
Attn: Matthew E. Jassak, Esq.
Email: MJassak@foley.com
If to Purchaser, addressed to:
c/o Eagle Arc Partners
17 State St., Suite 2525
New York, NY 10004
Attn: Elliott Mandelbaum
Attn: Samuel Rieder
Email: elliott@eaglearc.com
Email: samuel@eaglearc.com
80



With a copy to (which shall not constitute notice):
UB Greensfelder LLP
1660 West 2nd Street, Suite 1100
Cleveland, Ohio 44113
Attention: Daniel Gottesman, Esq.
Email: dgottesman@ubglaw.com
or to such other address or to such other Person as either Party shall have last designated by such notice to the other Party.
11.5Amendments; Waivers. This Agreement may be modified or amended only by an instrument in writing, duly executed by Purchaser and Seller. No waiver by any Party of any term, provision, condition, covenant, agreement, representation or warranty contained in this Agreement (or any breach thereof) shall be effective unless it is in writing executed by the Party against which such waiver is to be enforced. No waiver shall be deemed or construed as a further or continuing waiver of any such term, provision, condition, covenant, agreement, representation or warranty (or breach thereof) on any other occasion or as a waiver of any other term, provision, condition, covenant, agreement, representation or warranty (or of the breach of any other term, provision, condition, covenant, agreement, representation or warranty) contained in this Agreement on the same or any other occasion.
11.6Counterparts; Facsimile. For the convenience of the Parties, this Agreement may be executed in any number of counterparts, each such executed counterpart shall be deemed an original and all such counterparts together shall constitute one and the same instrument. Facsimile transmission or electronic pdf. of any signed original counterpart transmission shall be deemed the same as the delivery of an original.
11.7Assignment; Binding Nature; No Beneficiaries.
(a)This Agreement may not be assigned by any Party hereto (excluding any collateral assignment for the benefit of the Financing Sources) without the written consent of the other Party hereto, except that (i) the indemnification and other rights hereunder of a Party may be assigned to any bank or other financial institution which is or becomes a lender to such Party or any of its successors and assigns and (ii) this Agreement may be assigned by Purchaser to any of its Affiliates, any Purchaser Party or any Purchaser Assignee without the written consent of Seller provided that Purchaser remains liable for any obligations under this Agreement in accordance with Section 3.5.
(b)Notwithstanding anything to the contrary, no assignment by Purchaser shall (i) expand any of Seller’s obligations and liabilities hereunder or change any of the terms or conditions of this Agreement, the Transaction Documents or the transactions contemplated by this Agreement or the Transaction Documents; (ii) except with respect to assignments to Purchaser Parties or to Purchaser Assignees which are consented to by the Seller and to the extent set forth in Section 3.5, relieve Purchaser of liability to Seller for all obligations and liabilities to be performed by or on behalf of Purchaser hereunder or pursuant to the Transaction Documents with respect to Seller and its Affiliates; provided that Seller need not consent to an assignment to a Purchaser Party or Purchaser Assignee set forth in Section 3.5 if, after such assignment, the Purchaser remains primarily liable to Seller for the assigned liabilities and obligations; and (iii) except with respect to assignments to Purchaser Parties and to Purchaser Assignees listed on Schedule 3.5, be made if it would reasonably be expected to prevent, or materially impede, interfere with, hinder or delay the consummation of the transactions contemplated by this Agreement or the Transaction Documents.
81



(c)Notwithstanding anything to the contrary, no assignment by Seller shall (i) expand any of Purchaser’s obligations and liabilities hereunder or change any of the terms or conditions of this Agreement, the Transaction Documents or the transactions contemplated by this Agreement or the Transaction Documents; (ii) relieve Seller of liability to Purchaser for all obligations and liabilities to be performed by or on behalf of Seller hereunder or pursuant to the Transaction Documents with respect to Purchaser and its Affiliates; and (iii) be made if it would reasonably be expected to prevent, or materially impede, interfere with, hinder or delay the consummation of the transactions contemplated by this Agreement or the Transaction Documents.
(d)Except as otherwise set forth herein, this Agreement shall be binding upon, inure to the benefit of, and be enforceable by the Parties and their respective heirs, personal representatives, legatees, successors and permitted assigns. Except as otherwise expressly provided in Article IX, this Agreement shall not confer any rights or remedies upon any Person other than the Parties, the OTA Transferees and their respective heirs, personal representatives, legatees, successors and permitted assigns. Each OTA Transferee shall be a third party beneficiary of the representations and warranties of Seller under Article IV and the indemnification provisions of Article IX; provided, however, Seller shall have no obligation to indemnify (whether under Article IX or otherwise) both (i) Purchaser, or a Purchaser Party or an assignee of Purchaser, and (ii) an OTA Transferee with respect to any single Loss and shall not be required to pay duplicative damages. Further, Seller shall not owe obligations to more than one of the Purchaser Indemnified Parties with respect to any single Loss and shall not be required to pay duplicative damages. For avoidance of doubt, multiple Purchaser Indemnified Parties could incur separate Losses (i.e., not a “single Loss”) from the same matter for which indemnification is being sought.
11.8Headings. The headings in this Agreement are inserted for convenience only and shall not constitute a part hereof.
11.9Construction. If an ambiguity or question of intent or interpretation arises under this Agreement, this Agreement shall be construed as if drafted jointly by the Parties and no presumption or burden of proof shall arise favoring or disfavoring any Party by virtue of the authorship of any of the provisions of this Agreement.
11.10Governing Law.
(a)This Agreement shall be governed by and construed in accordance with the domestic Laws of the State of Delaware without giving effect to any choice or conflict of law provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the application of the Laws of any jurisdiction other than the State of Delaware.
(b)The Parties hereby waive compliance with any applicable bulk sale or bulk transfer law or other analogous legislation in force in any jurisdiction of the U.S. in which the Businesses are located.
11.11Forum; Waiver of Jury Trial.
(a)Except as otherwise provided in Section 2.5(b), in any Action between the Parties arising out of or relating to this Agreement, any of the transactions contemplated by this Agreement, any Transaction Document or any of the transactions contemplated thereby, each of the Parties (i) irrevocably and unconditionally consents and submits to the exclusive jurisdiction and venue of federal courts located in the State of Tennessee, and (ii) irrevocably consents to service of process by first-class certified mail, return receipt requested, postage prepaid.
82



(b)Each of the Parties hereby irrevocably waives any and all right to trial by jury of any claim or cause of action in any legal proceeding arising out of or related to this Agreement or any Financing or the transactions or events contemplated hereby or any course of conduct, course of dealing, statements (whether verbal or written) or actions of any Party or the actions of any Financing Source in connection with any Financing (including any action, proceeding or counterclaim against any Financing Source). The Parties each agree that any and all such claims and causes of action shall be tried by the court without a jury. Each of the Parties hereto further waives any right to seek to consolidate any such legal proceeding in which a jury trial has been waived with any other legal proceeding in which a jury trial cannot or has not been waived.
11.12Remedies Cumulative. Except as otherwise provided herein, the remedies provided for or permitted by this Agreement shall be cumulative and the exercise by any Party of any remedy provided for herein shall not preclude the assertion or exercise by such Party of any other right or remedy provided for herein.
11.13Severability. The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement.
11.14Enforcement.
(a)The Parties agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached and that any breach of this Agreement could not be adequately compensated in all cases by monetary damages alone. Except as otherwise set forth in Agreement, the Parties acknowledge and agree that, prior to the valid termination of this Agreement pursuant to Section 10.1, the Parties shall be entitled to an injunction, specific performance and other equitable relief to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof, in addition to any other remedy to which they are entitled at Law or in equity.
(b)Nothing set forth in this Section 11.14 shall require Seller to institute any proceeding for (or limit Seller’s right to institute any proceeding for) specific performance under this Section 11.14 prior or as a condition to exercising any termination right under Section 10.1, nor shall the commencement of any legal proceeding pursuant to this Section 11.14 or anything set forth in this Section 11.14 restrict or limit Seller’s right to terminate this Agreement in accordance with the terms of Section 10.1 or pursue any other remedies under this Agreement.
(c)To the extent any Party brings any Action to enforce specifically the performance of the terms and provisions of this Agreement (other than an Action to specifically enforce any provision that expressly survives termination of this Agreement pursuant to Section 9.1) when expressly available to such Party pursuant to the terms of this Agreement, the Outside Date shall automatically be extended by (i) the amount of time during which such Action is pending, plus twenty (20) Business Days, or (ii) such other time period established by the court presiding over such Action.
11.15No Recourse to Financing Sources. Notwithstanding anything herein to the contrary, Seller (on behalf of itself, its Affiliates and the equityholders, directors, officers, employees, consultants, financial advisors, accountants, legal counsel, investment bankers, and other agents, advisors and representatives of each of them) (a) acknowledges and agrees that it
83



(and such other Persons) shall have no recourse against the Financing Sources, and the Financing Sources shall be subject to no liability or claims by Seller (or such other Persons) in connection with the Financing or in any way relating to this Agreement or any of the transactions contemplated hereby or thereby, whether at law, in equity, in contract, in tort or otherwise, (b) waives any rights or claims of any kind or nature that Seller or any such other Persons may have against any Financing Source relating to this Agreement, the Financing, or the transactions contemplated hereby or thereby, and (c) agrees not to commence (and, if commenced, agrees to dismiss or otherwise terminate, and not to assist) any action, arbitration, audit, hearing, investigation, litigation, complaint, suit or proceeding against any Financing Source in connection with any of the foregoing. Without limiting the foregoing, no Financing Source shall be subject to any special, consequential, punitive, or indirect damages in connection with this Agreement, the Financing, or the transactions contemplated hereby or thereby. Notwithstanding the foregoing, nothing in this paragraph is intended to or shall release the Purchaser, Purchaser Parties, Purchaser Assignees, or OTA Transferees of any obligations under this and the related agreements, or release any of the foregoing or any Financing Source in any other relationships which may exist unrelated to the transactions contemplated hereby.
[Signature page follows]

84



IN WITNESS WHEREOF, each Party has duly executed and delivered this Agreement as of the Execution Date.
SELLER PARTIES
PROPERTY OWNERS
APPLINGWOOD PROPCO LLC
BRIGHT GLADE PROPCO LLC
COVINGTON PROPCO LLC
CRESTVIEW HEALTH PROPCO LLC
DYERSBURG PROPCO LLC
MCKENZIE PROPCO LLC
NORTHBROOKE PROPCO LLC
PARIS PROPCO LLC
UNION CITY PROPCO LLC
WEST TENNESSEE PROPCO LLC
CLARKSVILLE PROPCO LLC
LEWIS COUNTY PROPCO LLC
MILLENNIUM PROPCO LLC
VANAYER PROPCO LLC
BETHESDA PROPCO LLC
DECATUR COUNTY PROPCO LLC
LEXINGTON PROPCO LLC
MCNAIRY PROPCO LLC
MEADOWBROOK PROPCO LLC
MT. JULIET PROPCO LLC
SAVANNAH PROPCO LLC
VANCO PROPCO LLC
WESTWOOD PROPCO LLC
each, a Delaware limited liability company
By: AHPSNF HOLDCO LLC,
a Delaware limited liability company
By: /s/ JEFFREY A. BOGLE Name: Jeffrey A.




PROPERTY OWNERS (CONT.)
Bogle Title: Authorized Representative FOREST COVE LONG TERM FACILITY, LLC CKT PROPERTIES, LLC HARBOR VIEW PROPERTIES, LLC CUMBERLAND LONG TERM FACILITY, LLC NORTHSIDE LONG TERM FACILITY, LLC KNOXVILLE PROPCO I, LLC WELLPARK PROPCO, LLC WAVERLY LONG TERM FACILITY, LLC each, a Tennessee limited liability company
By: AHPSNF HOLDCO LLC,
a Delaware limited liability company
By:/s/ JEFFREY A. BOGLE Name: Jeffrey A.




CURRENT OPERATORS
Bogle Title:Authorized Representative APPLINGWOOD HEALTHCARE CENTER LLC BRIGHT GLADE HEALTH AND REHABILITATION CENTER LLC COVINGTON CARE NURSING AND REHABILITATION CENTER LLC CRESTVIEW HEALTH CARE AND REHABILITATION LLC DYERSBURG NURSING AND REHABILITATION LLC FOREST COVE NURSING AND REHAB CENTER, LLC HUMBOLDT HEALTHCARE AND REHAB CENTER, LLC MCKENZIE HEALTHCARE AND REHABILITATION CENTER LLC NORTHBROOKE HEALTHCARE AND REHAB CENTER LLC PARIS HEALTH CARE NURSING AND REHABILITATION CENTER LLC UNION CITY NURSING AND REHABILITATION CENTER LLC WEST TENNESSEE TRANSITIONAL CARE LLC CLARKSVILLE NURSING AND REHABILITATION CENTER LLC HARBOR VIEW NURSING AND REHABILITATION CENTER, LLC LEWIS COUNTY NURSING AND REHABILITATION CENTER LLC MILLENNIUM NURSING AND REHAB CENTER LLC VANAYER HEALTHCARE AND REHAB CENTER LLC BETHESDA HEALTH CARE CENTER LLC CUMBERLAND HEALTH CARE AND REHABILITATION LLC, DECATUR COUNTY HEALTH CARE AND REHABILITATION LLC LEXINGTON HEALTH CARE AND REHABILITATION LLC MCNAIRY COUNTY HEALTH CARE CENTER LLC MEADOWBROOK HEALTH AND REHABILITATION CENTER LLC MT. JULIET HEALTH CARE CENTER LLC NORTHSIDE HEALTH CARE NURSING AND REHABILITATION CENTER, LLC SAVANNAH HEALTH CARE AND REHABILITATION CENTER LLC VANCO HEALTH CARE AND REHABILITATION LLC WAVERLY HEALTH CARE AND REHABILITATION CENTER, LLC WESTWOOD HEALTH CARE AND REHABILITATION CENTER LLC KNOXVILLE HEALTHCARE CENTER I, LLC WELLPARK HEALTHCARE CENTER, LLC each, a Tennessee limited liability company
By: American Health Companies, LLC
a Tennessee limited liability company
By:/s/ JEFFREY A. BOGLE Name: Jeffrey A.




PURCHASER
Bogle Title: Authorized Representative 1900 PARR AVENUE TN LLC 2031 AVONDALE STREET TN LLC 800 VOLUNTEER DRIVE TN LLC 726 KENTUCKY AVENUE S TN LLC 1245 E COLLEGE ST TN LLC 5275 MILLENNIUM DRIVE AL LLC 1645 FLORENCE RD TN LLC 1630 E REELFOOT AVE TN LLC 460 HANNINGS LANE TN LLC 524 WEST MAIN STREET TN LLC 7424 MIDDLEBROOK PIKE TN LLC 7512 MIDDLEBROOK PIKE TN LLC 1536 APPLING CARE LANE TN LLC 5070 SANDERLIN AVENUE TN LLC 765 BERT JOHNSTON AVENUE TN LLC 45 FOREST COVE TN LLC 1513 N 2ND STREET TN LLC 121 PHYSICIANS DR TN LLC 597 WEST FOREST AVENUE TN LLC 444 ONE ELEVEN PLACE TN LLC 704 DUPREE ROAD TN LLC 4343 ASHLAND CITY HIGHWAY TN LLC 119 KITTRELL STREET TN LLC 727 EAST CHURCH STREET TN LLC 175 HOSPITAL DRIVE TN LLC 835 EAST POPLAR AVENUE TN LLC 2650 NORTH MT JULIET ROAD TN LLC 202 EAST MTCS ROAD TN LLC 900 PROFESSIONAL PARK DRIVE TN LLC 813 S DICKERSON RD TN LLC 895 POWERS BLVD TN LLC each, a Delaware limited liability company
By:/s/ SAMUEL RIEDER    
Name: Samuel Rieder    
Its: Authorized Signer    




EXHIBIT A
SELLER PARTIES
Property Owners:
1.    Applingwood Propco LLC, a Delaware limited liability company
2.    Bright Glade Propco LLC, a Delaware limited liability company
3.    Covington Propco LLC, a Delaware limited liability company
4.    Crestview Health Propco LLC, a Delaware limited liability company
5.    Dyersburg Propco LLC, a Delaware limited liability company
6.    Forest Cove Long Term Facility, LLC, a Tennessee limited liability company
7.    CKT Properties, LLC, a Tennessee limited liability company
8.    McKenzie Propco LLC, a Delaware limited liability company
9.    Northbrooke Propco LLC, a Delaware limited liability company
10.    Paris Propco LLC, a Delaware limited liability company
11.    Union City Propco LLC, a Delaware limited liability company
12.    West Tennessee Propco LLC, a Delaware limited liability company
13.    Clarksville Propco LLC, a Delaware limited liability company
14.    Harbor View Properties, LLC, a Tennessee limited liability company
15.    Lewis County Propco LLC, a Delaware limited liability company
16.    Millennium Propco LLC, a Delaware limited liability company
17.    VanAyer Propco LLC, a Delaware limited liability company
18.    Bethesda Propco LLC, a Delaware limited liability company
19.    Cumberland Long Term Facility, LLC, a Tennessee limited liability company
20.    Decatur County Propco LLC, a Delaware limited liability company
21.    Lexington Propco LLC, a Delaware limited liability company
22.    McNairy Propco LLC, a Delaware limited liability company
23.    Meadowbrook Propco LLC, a Delaware limited liability company
24.    Mt. Juliet Propco LLC, a Delaware limited liability company
25.    Northside Long Term Facility, LLC, a Tennessee limited liability company
26.    Savannah Propco LLC, a Delaware limited liability company
27.    Vanco Propco LLC, a Delaware limited liability company
28.    Waverly Long Term Facility, LLC, a Tennessee limited liability company
29.    Westwood Propco LLC, a Delaware limited liability company
30.    Knoxville Propco I, LLC, a Tennessee limited liability company
31.    WellPark Propco, LLC, a Tennessee limited liability company
Current Operators:
1.    Applingwood Healthcare Center LLC d/b/a AHC Applingwood, a Tennessee limited liability company
2.    Bright Glade Health and Rehabilitation Center LLC d/b/a AHC Bright Glade, a Tennessee limited liability company
3.    Covington Care Nursing and Rehabilitation Center LLC d/b/a AHC Covington Care, a Tennessee limited liability company
A-1


4.    Crestview Health Care and Rehabilitation LLC d/b/a AHC Crestview, a Tennessee limited liability company
5.    Dyersburg Nursing and Rehabilitation LLC d/b/a AHC Dyersburg, a Tennessee limited liability company
6.    Forest Cove Nursing and Rehab Center, LLC d/b/a AHC Forest Cove, a Tennessee limited liability company
7.    Humboldt Healthcare and Rehab Center, LLC d/b/a AHC Humboldt, a Tennessee limited liability company
8.    McKenzie Healthcare and Rehabilitation Center LLC d/b/a AHC McKenzie, a Tennessee limited liability company
9.    Northbrooke Healthcare and Rehab Center LLC d/b/a AHC Northbrooke, a Tennessee limited liability company
10.    Paris Health Care Nursing and Rehabilitation Center LLC d/b/a AHC Paris, a Tennessee limited liability company
11.    Union City Nursing and Rehabilitation Center LLC d/b/a AHC Union City, a Tennessee limited liability company
12.    West Tennessee Transitional Care LLC d/b/a AHC West Tennessee Transitional Care
13.    Clarksville Nursing and Rehabilitation Center LLC d/b/a American Health Communities of Clarksville, a Tennessee limited liability company
14.    Harbor View Nursing and Rehabilitation Center, LLC d/b/a AHC Harbor View, a Tennessee limited liability company
15.    Lewis County Nursing and Rehabilitation Center LLC d/b/a AHC Lewis County, a Tennessee limited liability company
16.    Millennium Nursing and Rehab Center LLC d/b/a AHC Millennium, a Tennessee limited liability company
17.    VanAyer Healthcare and Rehab Center LLC d/b/a AHC VanAyer, a Tennessee limited liability company
18.    Bethesda Health Care Center LLC d/b/a AHC Bethesda, a Tennessee limited liability company
19.    Cumberland Health Care and Rehabilitation, LLC d/b/a AHC Cumberland, a Tennessee limited liability company
20.    Decatur County Health Care and Rehabilitation LLC d/b/a AHC Decatur County, a Tennessee limited liability company
21.    Lexington Health Care and Rehabilitation LLC d/b/a AHC Lexington, a Tennessee limited liability company
22.    McNairy County Health Care Center LLC d/b/a AHC McNairy, a Tennessee limited liability company
23.    Meadowbrook Health and Rehabilitation Center LLC d/b/a AHC Meadowbrook, a Tennessee limited liability company
24.    Mt. Juliet Health Care Center LLC d/b/a AHC Mt. Juliet, a Tennessee limited liability company
25.    Northside Health Care Nursing and Rehabilitation Center, LLC d/b/a AHC Northside, a Tennessee limited liability company
26.    Savannah Health Care and Rehabilitation Center LLC d/b/a AHC Savannah, a Tennessee limited liability company
2



27.    Vanco Health Care and Rehabilitation LLC d/b/a AHC Vanco, a Tennessee limited liability company
28.    Waverly Health Care and Rehabilitation Center, LLC d/b/a AHC Waverly, a Tennessee limited liability company
29.    Westwood Health Care and Rehabilitation Center LLC d/b/a AHC Westwood, a Tennessee limited liability company
30.    Knoxville Healthcare Center I, LLC d/b/a AHC Knoxville, a Tennessee limited liability company
31.    WellPark Healthcare Center, LLC d/b/a AHC WellPark, a Tennessee limited liability company

3



EXHIBIT B
PURCHASER PARTIES
1900 PARR AVENUE TN LLC
2031 AVONDALE STREET TN LLC
800 VOLUNTEER DRIVE TN LLC
726 KENTUCKY AVENUE S TN LLC
1245 E COLLEGE ST TN LLC
5275 MILLENNIUM DRIVE AL LLC
1645 FLORENCE RD TN LLC
1630 E REELFOOT AVE TN LLC
460 HANNINGS LANE TN LLC
524 WEST MAIN STREET TN LLC
7424 MIDDLEBROOK PIKE TN LLC
7512 MIDDLEBROOK PIKE TN LLC
1536 APPLING CARE LANE TN LLC
5070 SANDERLIN AVENUE TN LLC
765 BERT JOHNSTON AVENUE TN LLC
45 FOREST COVE TN LLC
1513 N 2ND STREET TN LLC
121 PHYSICIANS DR TN LLC
597 WEST FOREST AVENUE TN LLC
444 ONE ELEVEN PLACE TN LLC
704 DUPREE ROAD TN LLC
4343 ASHLAND CITY HIGHWAY TN LLC
119 KITTRELL STREET TN LLC
727 EAST CHURCH STREET TN LLC
175 HOSPITAL DRIVE TN LLC
835 EAST POPLAR AVENUE TN LLC
2650 NORTH MT JULIET ROAD TN LLC
202 EAST MTCS ROAD TN LLC
900 PROFESSIONAL PARK DRIVE TN LLC
813 S DICKERSON RD TN LLC
895 POWERS BLVD TN LLC
Each, a Delaware limited liability company

B-1


EXHIBIT C
FACILITIES
Facility Address City State Zip Licensed Beds
1. AHC Applingwood
1536 Appling Care Lane Cordova TN 38018 78
2. AHC Bright Glade
5070 Sanderlin Avenue Memphis TN 38117 77
3.AHC Covington Care 765 Bert Johnston Avenue Covington TN 38019 98
4. AHC Crestview 704 Dupree Road Brownsville TN 38012 115
5. AHC Dyersburg 1900 Parr Avenue Dyersburg TN 38024 130
6. AHC Forest Cove 45 Forest Cove Jackson TN 38301 170
7. AHC Humboldt 2031 Avondale Street Humboldt TN 38343 89
8. AHC Mckenzie 175 Hospital Drive Mc Kenzie TN 38201 99
9. AHC Northbrooke 121 Physicians Dr Jackson TN 38305 120
10. AHC Paris 800 Volunteer Drive Paris TN 38242 127
11. AHC Union City 1630 E Reelfoot Ave Union City TN 38261 115
12. AHC WTTC 597 West Forest Avenue Jackson TN 38301 67
13. AHC Of Clarksville 900 Professional Park Drive Clarksville TN 37040 113
14. AHC Harbor View 1513 N 2Nd Street Memphis TN 38107 103
15. AHC Lewis County 119 Kittrell Street Hohenwald TN 38462 131
16. AHC Millenium 5275 Millennium Drive Huntsville AL 35806 91
17. AHC Vanayer 460 Hannings Lane Martin TN 38237 91
18. AHC Bethesda 444 One Eleven Place Cookeville TN 38501 120
19. AHC Cumberland 4343 Ashland City Highway Nashville TN 37218 124
20. AHC Decatur County 726 Kentucky Avenue S Parsons TN 38363 125
21. AHC Lexington 727 East Church Street Lexington TN 38351 118
22. AHC McNairy County 835 East Poplar Avenue Selmer TN 38375 126
23. AHC Meadowbrook 1245 E College St Pulaski TN 38478 83
24. AHC Mt Juliet 2650 North Mt Juliet Road Mount Juliet TN 37122 106
25. AHC Northside 202 East Mtcs Road Murfreesboro TN 37130 68
26. AHC Savannah 1645 Florence Rd Savannah TN 38372 120
27. AHC Vanco 813 S Dickerson Rd Goodlettsville TN 37072 90
28. AHC Waverly 895 Powers Blvd Waverly TN 37185 100
29. AHC Westwood 524 West Main Street Decaturville TN 38329 90
30. AHC Knoxville 7424 Middlebrook Pike Knoxville TN 37909 176
31. AHC WellPark 7512 Middlebrook Pike Knoxville TN 37909 30

C-1


EXHIBIT C-1
CENSUS FACILITIES
Facility Address City State Zip Licensed Beds
1. AHC Covington Care 765 Bert Johnston Avenue Covington TN 38019 98
2. AHC Crestview 704 Dupree Road Brownsville TN 38012 115
3. AHC Dyersburg 1900 Parr Avenue Dyersburg TN 38024 130
4. AHC Forest Cove 45 Forest Cove Jackson TN 38301 170
5. AHC Humboldt 2031 Avondale Street Humboldt TN 38343 89
6. AHC Mckenzie 175 Hospital Drive Mc Kenzie TN 38201 99
7. AHC Northbrooke 121 Physicians Dr Jackson TN 38305 120
8. AHC Paris 800 Volunteer Drive Paris TN 38242 127
9. AHC Union City 1630 E Reelfoot Ave Union City TN 38261 115
10. AHC Of Clarksville 900 Professional Park Drive Clarksville TN 37040 113
11. AHC Harbor View 1513 N 2Nd Street Memphis TN 38107 103
12. AHC Lewis County 119 Kittrell Street Hohenwald TN 38462 131
13. AHC Millenium 5275 Millennium Drive Huntsville AL 35806 91
14. AHC Vanayer 460 Hannings Lane Martin TN 38237 91
15. AHC Bethesda 444 One Eleven Place Cookeville TN 38501 120
16. AHC Cumberland 4343 Ashland City Highway Nashville TN 37218 124
17. AHC Decatur County 726 Kentucky Avenue S Parsons TN 38363 125
18. AHC Lexington 727 East Church Street Lexington TN 38351 118
19. AHC McNairy County 835 East Poplar Avenue Selmer TN 38375 126
20. AHC Mt Juliet 2650 North Mt Juliet Road Mount Juliet TN 37122 106
21. AHC Savannah 1645 Florence Rd Savannah TN 38372 120
22. AHC Vanco 813 S Dickerson Rd Goodlettsville TN 37072 90
23. AHC Waverly 895 Powers Blvd Waverly TN 37185 100
24. AHC Westwood 524 West Main Street Decaturville TN 38329 90
25. AHC Knoxville 7424 Middlebrook Pike Knoxville TN 37909 176
26. AHC Applingwood 1536 Appling Care Lane Cordova TN 38018 78
27. AHC Bright Glade 5070 Sanderlin Avenue Memphis TN 38117 77
28. AHC Meadowbrook 1245 E College St Pulaski TN 38478 83
29. AHC Northside 202 East Mtcs Road Murfreesboro TN 37130 68


D-1


EXHIBIT C-2
EXEMPT FACILITIES
Facility Address City State Zip Licensed Beds
1. AHC WTTC 597 West Forest Avenue Jackson TN 38301 67
2. AHC Wellpark 7512 Middlebrook Pike Knoxville TN 37909 30

D-1


EXHIBIT D
REAL PROPERTY

D-1


Legal Description Schedule
1.    AHC Crestview, 704 N. Dupree Road, Brownsville, TN 38012
The Land referred to herein below is situated in the County of Haywood, State of Tennessee, and described as follows:
BEGINNING ON A FOUND STEEL STAKE IN A FENCE LINE 45.00 FEET WESTERLY FROM THE CENTERLINE OF DUPREE AVENUE (ALSO KNOWN AS STATE ROUTE 76), SAID STEEL STAKE BEING THE SOUTHEAST CORNER OF A TRACT IN THE NAME OF DOROTHY COCHRAN, DEED BOOK 88, PAGE 160, AND BEING THE NORTHEAST CORNER OF THE SUBJECT PROPERTY; THENCE WITH THE WEST MARGIN OF DUPREE AVENUE, SOUTH 03 DEGREES 04 MINUTES 17 SECONDS EAST A DISTANCE OF 413.40 FEET TO A FOUND IRON PIN AT THE NORTHEAST CORNER OF A TRACT IN THE NAME OF FIRST ASSEMBLIES OF GOD CHURCH, DEED BOOK 103, PAGE 244; THENCE WITH THE NORTH LINE OF SAID CHURCH PROPERTY, SOUTH 85 DEGREES 24 MINUTES 07 SECONDS WEST A DISTANCE OF 291.22 FEET TO A FOUND STEEL STAKE IN A FENCE LINE, AND IN THE EAST LINE OF ANOTHER TRACT BELONGING TO FIRST ASSEMBLIES OF GOD CHURCH, DEED BOOK 214, PAGE 429; THENCE WITH THE EAST LINE OF THE FIRST ASSEMBLIES OF GOD TRACT, NORTH 22 DEGREES 01 MINUTE 05 SECONDS WEST A DISTANCE OF 396.77 FEET TO A FOUND STEEL POST AT A FENCE CORNER AND THE SOUTHWEST CORNER OF THE DOROTHY COCHRAN PROPERTY; THENCE WITH THE SOUTH LINE OF COCHRAN, NORTH 80 DEGREES 42 MINUTES 18 SECONDS EAST A DISTANCE OF 423.58 FEET TO THE BEGINNING, CONTAINING 3..27 ACRES, MORE OR LESS.
BEING THE SAME PROPERTY CONVEYED TO CRESTVIEW HEALTH PROPCO LLC, A DELAWARE LIMITED LIABILITY COMPANY, BY DEED FROM CRESTVIEW LONG TERM FACILITY, LLC, A TENNESSEE LIMITED LIABILITY COMPANY, FORMERLY KNOWN AS CRESTVIEW LONG TERM FACILITY, INC., A TENNESSEE CORPORATION, OF RECORD IN RECORD BOOK 198, PAGE 5, IN THE REGISTER'S OFFICE OF HAYWOOD COUNTY, TENNESSEE.
D-1


2.    AHC Of Clarksville, 900 Professional Park Drive, Clarksville, TN 37040
The Land referred to herein below is situated in the County of Montgomery, State of Tennessee, and described as follows:
LOT 7, CLARKSVILLE PROFESSIONAL PARK, SECTION 2 PLAT BOOK F, PAGES 427-428 - REGISTER’S OFFICE, MONTGOMERY COUNTY, TENNESSEE.
BEGINNING ON A SET IRON PIN IN THE EASTERN LINE OF LOT 2 OF AUTUMN WINDS SUBDIVISION (PLAT BOOK F, PAGE 707), SAID IRON PIN BEING THE SOUTHWEST CORNER OF LOT 6 OF CLARKSVILLE PROFESSIONAL PARK SECTION 2 (PLAT BOOK F, PAGE 427-428) AND BEING THE NORTHWEST CORNER OF LOT 7 OF SAID CLARKSVILLE PROFESSIONAL PARK SECTION 2 DESCRIBED HEREIN, THENCE WITH THE SOUTHERN LINE OF LOT 6, NORTH 89 DEGREES 04 MINUTES 50 SECONDS EAST FOR A DISTANCE OF 355.92 FEET TO AN "X" CUT IN A CONCRETE SIDEWALK AND IN THE WESTERN RIGHT-OF-WAY OF PROFESSIONAL PARK DRIVE (A PAVED PUBLIC STREET WITH A 60 FEET WIDE RIGHT-OF-WAY); THENCE WITH THE WESTERN RIGHT-OF-WAY OF PROFESSIONAL PARK DRIVE AS FOLLOWS: RUNNING WITH A CURVE TURNING TO THE LEFT, HAVING AN ARC LENGTH OF 155.68 FEET, WITH A RADIUS OF 380.00 FEET AND HAVING A CHORD BEARING OF SOUTH 12 DEGREES 39 MINUTES 19 SECONDS EAST FOR A CHORD DISTANCE OF 154.59 FEET TO AN EXISTING IRON PIN: THENCE SOUTH 24 DEGREES 23 MINUTES 35 SECONDS EAST FOR A DISTANCE OF 268.51 FEET TO A POINT; THENCE WITH A CURVE TURNING TO THE RIGHT, HAVING AN ARC LENGTH OF 179.56 FEET, WITH A RADIUS OF 320.00 FEET AND HAVING A CHORD BEARING OF SOUTH 08 DEGREES 19 MINUTES 04 SECONDS EAST FOR A CHORD DISTANCE OF 177.22 FEET; THENCE SOUTH 07 DEGREES 45 MINUTES 27 SECONDS WEST FOR A DISTANCE OF 292.96 FEET TO AN EXISTING IRON PIN AT THE NORTHEAST CORNER OF LOT 8 OF PROFESSIONAL PARK COMMONS SUBDIVISION (PLAT BOOK F, PAGE 777); THENCE WITH THE NORTHERN LINE OF LOT 8, LOT 9 AND LOT 10 OF SAID SUBDIVISION, NORTH 82 DEGREES 47 MINUTES 06 SECONDS WEST FOR A DISTANCE OF 614.83 FEET TO AN EXISTING PLANTED STONE AT THE NORTHWEST CORNER OF LOT 10 AND BEING THE SOUTHEAST CORNER OF LOT 3 OF AUTUMN WIND SUBDIVISION; THENCE WITH THE EASTERN LINE OF LOT 3 AND LOT 2 OF SAID AUTUMN WINDS SUBDIVISION, NORTH 08 DEGREES 59 MINUTES 59 SECONDS EAST FOR A DISTANCE OF 787.78 FEET TO THE POINT OF BEGINNING.
BEING THE SAME PROPERTY CONVEYED CLARKSVILLE PROPCO LLC, A DELAWARE LIMITED LIABILITY COMPANY, BY DEED FROM CLARKSVILLE LONG TERM FACILITY, LLC, A TENNESSEE LIMITED LIABILITY COMPANY, FORMERLY KNOWN AS CLARKSVILLE LONG TERM FACILITY, INC., A TENNESSEE CORPORATION, OF RECORD IN VOLUME 2084, PAGE 1067, IN THE REGISTER’S OFFICE OF MONTGOMERY COUNTY, TENNESSEE.
D-2


D-3


3.    AHC Bethesda, 444 One Eleven Place, Cookeville, TN 38501
The Land referred to herein below is situated in the County of Putnam, State of Tennessee, and described as follows:
BEING A TRACT OR PARCEL OF LAND LYING IN THE 1ST CIVIL DISTRICT OF PUTNAM COUNTY, TENNESSEE, AND IS MORE PARTICULARLY DESCRIBED: BEGINNING AT AN IRON ROD (NEW) POINT IN THE EAST MARGIN OF HIGHWAY 111, BEING THE SOUTHWEST MOST CORNER OF THE HEREIN DESCRIBED TRACT WHICH IS ALSO CALLED LOT 2A OF THE RE-SUBDIVISION OF LOT 2, ONE ELEVEN PLACE, RECORDED IN PLAT CABINET B, FILE 89, PUTNAM COUNTY REGISTER’S OFFICE, TENNESSEE, THENCE ALONG SAID MARGIN NORTH 16 DEGREES 18 MINUTES 35 SECONDS EAST 396.47 FEET TO A CONCRETE MONUMENT (OLD); THENCE CONTINUING ALONG SAID MARGIN NORTH 29 DEGREES 35 MINUTES 44 SECONDS EAST 644.78 FEET TO AN IRON ROD (NEW) AT THE NORTH EDGE OF AN 18 INCH TREE WHICH IS AT THE INTERSECTION OF THE HIGHWAY 111 RIGHT OF WAY FENCE AND AN OLD FENCE LINE AT THE SOUTH MARGIN OF AN UNIMPROVED ROAD MORE COMMONLY KNOWN AS MCCULLEY ROAD; THENCE LEAVING THE EAST MARGIN OF HIGHWAY 111, AND FOLLOWING THE SOUTH MARGIN OF MCCULLEY ROAD SOUTH 83 DEGREES 57 MINUTES 00 SECONDS EAST 193.11 FEET TO AN IRON ROD (NEW) TO A FENCE LINE THAT FOLLOWS THE WEST BOUNDARY LINE OF MURREY HILLS SUBDIVISION, WHICH IS RECORDED IN DEED BOOK 76, PAGE 29, REGISTER’S OFFICE OF PUTNAM COUNTY, TENNESSEE; THENCE FOLLOWING THE OLD FENCE LINE AND THE WEST BOUNDARY LINE OF SAID SUBDIVISION SOUTH 6 DEGREES 57 MINUTES 00 SECONDS WEST 995.04 FEET TO A PIPE (OLD) AT THE NORTHEAST CORNER OF THE RESUBDIVISION OF LOT 2B ONE ELEVEN PLACE, RECORDED IN PLAT CABINET B, SLIDE 117, ALSO BEING THE SOUTHEAST CORNER OF THIS HEREIN DESCRIBED TRACT; THENCE ALONG THE NORTH LINE OF SAID SUBDIVISION, NORTH 82 DEGREES 24 MINUTES 00 SECONDS WEST 505.86 FEET TO THE POINT OF BEGINNING.
THERE IS A 15.00 FOOT ELECTRIC EASEMENT ALONG THE WESTERN BOUNDARY OF THE ABOVE DESCRIBED PROPERTY.
INCLUDED IN THE FOREGOING DESCRIPTION, BUT EXPRESSLY EXCLUDED THEREFROM, IS PROPERTY CONVEYED BY THE FOLLOWING, ALL OF RECORD IN THE REGISTER'S OFFICE OF PUTNAM COUNTY, TENNESSEE:
1.    ORDER OF REVIVOR VESTED IN MINNIE HUNTER JOHNSON, SUCCESSOR IN INTEREST TO THE ESTATE OF J. T. JOHNSON, DECEASED, IN DEED BOOK 177, PAGE 813; AND
D-4


2.    ORDER OF REVIVOR VESTED IN MINNIE HUNTER JOHNSON, SUCCESSOR IN INTEREST TO THE ESTATE OF J. T. JOHNSON, DECEASED, IN BOOK 7708, PAGE 464.
BEING THE SAME PROPERTY CONVEYED TO BETHESDA PROPCO LLC, A DELAWARE LIMITED LIABILITY COMPANY, BY DEED FROM COOKEVILLE LONG TERM FACILITY, LLC, A TENNESSEE LIMITED LIABILITY COMPANY, FORMERLY KNOWN AS COOKEVILLE LONG TERM FACILITY, INC., A TENNESSEE CORPORATION, FORMERLY KNOWN AS TANDEM HEALTH CARE OF TENNESSEE, INC., A TENNESSEE CORPORATION, OF RECORD IN RECORD BOOK 1295, PAGE 285, IN THE REGISTER'S OFFICE OF PUTNAM COUNTY, TENNESSEE.
D-5


4.    AHC Applingwood, 1536 Appling Care Lane, Cordova, TN 38018
The Land referred to herein below is situated in the County of Shelby, State of Tennessee, and described as follows:
TRACT NO. 1
PART OF THE AMENDED APPLINGWOOD PLANNED DEVELOPMENT AREA "A-1" (P.D. 94-352CC) OF RECORD IN PLAT BOOK 154, PAGE 41, S.C.R.O. SITUATED IN SHELBY COUNTY, TENNESSEE. COMMENCING AT THE TANGENT INTERSECTION OF THE NORTH DEDICATED R.O.W. LINE OF DEXTER GROVE DRIVE (68 FOOT R.O.W., NOT IMPROVED) WITH THE WEST R.O.W. LINE OF APPLING ROAD (108 FOOT R.O.W); THENCE NORTH 41 DEGREES 40 MINUTES 01 SECOND WEST ALONG SAID WEST LINE 136.00 FEET TO A POINT OF CURVE; THENCE NORTHWESTWARDLY, ALONG SAID WEST LINE ALONG A CURVE TO THE RIGHT, HAVING A RADIUS OF 1179.00 FEET (CENTRAL ANGLE = 09 DEGREES 17 MINUTES 42 SECONDS; CHORD BEARING = NORTH 37 DEGREES 01 MINUTE 10 SECONDS WEST; CHORD DISTANCE = 191.05 FEET) AN ARC DISTANCE OF 191.26 FEET TO A POINT; THENCE (LEAVING SAID WEST LINE) SOUTH 61 DEGREES 22 MINUTES 09 SECONDS WEST A DISTANCE OF 286.48 FEET TO A POINT OF CURVE; THENCE SOUTHWESTWARDLY ALONG A CURVE TO THE RIGHT, HAVING A RADIUS OF 177.00 FEET (CENTRAL ANGLE = 03 DEGREES 18 MINUTES 15 SECONDS; CHORD BEARING = SOUTH 63 DEGREES 01 MINUTE 17 SECONDS WEST; CHORD DISTANCE = 10.21 FEET) AN ARC DISTANCE OF 10.21 FEET TO A POINT OF REVERSE CURVE; THENCE SOUTHWESTWARDLY ALONG A CURVE TO THE LEFT, HAVING A RADIUS OF 14.50 FEET (CENTRAL ANGLE = 04 DEGREES 17 MINUTES 17 SECONDS; CHORD BEARING = SOUTH 62 DEGREES 31 MINUTES 46 SECONDS WEST; CHORD DISTANCE = 1.08 FEET) AN ARC DISTANCE OF 1.09 FEET TO A POINT; THENCE NORTH 36 DEGREES 39 MINUTES 53 SECONDS WEST A DISTANCE OF 27.72 FEET TO A FOUND MAG-NAIL IN THE CENTER OF APPLING CARE LANE, BEING THE TRUE POINT OF BEGINNING; THENCE ALONG THE CENTER OF APPLING CARE LANE, SOUTHWESTWARDLY ALONG A CURVE TO THE RIGHT, HAVING A RADIUS OF 149.94 FEET (CENTRAL ANGLE = 22 DEGREES 49 MINUTES 47 SECONDS; CHORD BEARING = SOUTH 78 DEGREES 35 MINUTES 07 SECONDS WEST; CHORD DISTANCE = 59.35 FEET) AN ARC DISTANCE OF 59.74 FEET TO A SET MAG-NAIL; THENCE ALONG THE CENTER OF APPLING CARE LANE PART OF THE WAY, NORTH 90 DEGREES 00 MINUTES 00 SECONDS WEST A DISTANCE OF 300.38 FEET TO A SET IRON PIN IN THE EAST LINE OF BRIDGEWATER SUBDIVISION (P.B. 10, PG. 50, S.C.R.O); THENCE ALONG THE EASTERN LINE OF LOTS 103, 104 AND 105 OF SAID SUBDIVISION, NORTH 00 DEGREES 40 MINUTES 49 SECONDS WEST A DISTANCE OF 354.54 FEET TO A SET IRON PIN AT THE SOUTHWEST CORNER OF DANCY INVESTMENTS, INC. (INSTRUMENT NO.
D-6


JV 1643, PLAT BOOK 154, PAGE 41, S.C.R.O); THENCE WITH THE SOUTH LINE OF DANCY INVESTMENTS, INC., NORTH 88 DEGREES 19 MINUTES 56 SECONDS EAST A DISTANCE OF 257.15 FEET TO A SET IRON PIN AT THE NORTHWEST CORNER OF LOT 2, PHASE V, AREA A-1, APPLINGWOOD P.D. (PLAT BOOK 163. PAGE 4, S.C.R.O); THENCE WITH THE WESTERN LINE OF LOT 2 AND LOT 1 OF SAID PHASE V OF APPLINGWOOD P.D., SOUTH 16 DEGREES 47 MINUTES 47 SECONDS EAST A DISTANCE OF 365.86 FEET TO THE POINT OF BEGINNING.
TRACT NO. 2
EASEMENT FOR INGRESS-EGRESS FOR THE BENEFIT OF TRACT NO. 1
BEING A DESCRIPTION OF PRIVATE DRIVE, UNBUILDABLE LOT A, BEING PART OF THE APPLINGWOOD PLANNED DEVELOPMENT FINAL PLAT PHASE V (PLAT BOOK 163, PAGE 4) OF RECORD AT THE SHELBY COUNTY REGISTER'S OFFICE (S.C.R.O.) SITUATED IN SHELBY COUNTY, TENNESSEE AND BEING MORE PARTICULARLY DESCRIBED AS FOLLOWS:
COMMENCING AT THE TANGENT INTERSECTION OF THE NORTH DEDICATED R.O.W. LINE OF DEXTER GROVE DRIVE (68' R.O.W. - NOT IMPROVED) WITH THE WEST R.O.W. LINE OF APPLING ROAD (108' R.O.W.); THENCE NORTH 41 DEGREES 40 MINUTES 01 SECONDS WEST ALONG SAID WEST LINE 136.00 FEET TO A POINT OF CURVE; THENCE NORTHWESTWARDLY, ALONG SAID WEST LINE, ALONG A CURVE TO THE RIGHT, HAVING A RADIUS OF 1179.00 FEET (CENTRAL ANGLE = 09 DEGREES 17 MINUTES 42 SECONDS; CHORD BEARING = NORTH 37 DEGREES 01 MINUTES 10 SECONDS WEST; CHORD DISTANCE = 191.05 FEET) AN ARC DISTANCE OF 191.26 FEET TO THE TRUE POINT OF BEGINNING; THENCE SOUTH 61 DEGREES 22 MINUTES 09 SECONDS WEST A DISTANCE OF 286.48 FEET TO A POINT OF CURVE; THENCE SOUTHWESTWARDLY ALONG A CURVE TO THE RIGHT, HAVING A RADIUS OF 177.00 FEET (CENTRAL ANGLE = 03 DEGREES 18 MINUTES 15 SECONDS; CHORD BEARING = SOUTH 63 DEGREES 01 MINUTES 17 SECONDS WEST; CHORD DISTANCE = 10.21 FEET) AN ARC DISTANCE OF 10.21 FEET TO A POINT OF REVERSE CURVE; THENCE SOUTHWESTWARDLY ALONG A CURVE TO THE LEFT HAVING A RADIUS OF 14.50 FEET ( CENTRAL ANGLE = 04 DEGREES 17 MINUTES 17 SECONDS; CHORD BEARING = SOUTH 62 DEGREES 31 MINUTES 46 SECONDS WEST; CHORD DISTANCE = 1.08 FEET) AN ARC DISTANCE OF 1.09 FEET TO A POINT; THENCE NORTH 36 DEGREES 39 MINUTES 53 SECONDS WEST A DISTANCE OF 27.72 FEET TO A POINT: THENCE NORTH 16 DEGREES 47 MINUTES 47 SECONDS WEST A DISTANCE OF 13.08 FEET TO A POINT; THENCE NORTHEASTWARDLY ALONG A CURVE TO THE LEFT, HAVING A RADIUS OF 137.00 FEET (CENTRAL ANGLE = 05 DEGREES 13 MINUTES 34 SECONDS; CHORD BEARING = NORTH 63 DEGREES 58 MINUTES 56 SECONDS EAST; CHORD DISTANCE = 12.49 FEET) AN ARC DISTANCE OF 12.50 FEET TO A POINT; THENCE NORTH 61 DEGREES 22 MINUTES 09 SECONDS EAST A DISTANCE OF 284.55 FEET TO A POINT IN THE WEST R.O.W.
D-7


LINE OF APPLING ROAD (108' R.O.W.); THENCE SOUTHEASTWARDLY ALONG SAID WEST LINE, ALONG A CURVE TO THE LEFT, HAVING A RADIUS OF 1179.00 FEET (CENTRAL ANGLE = 01 DEGREE 56 MINUTES 46 SECONDS; CHORD BEARING = SOUTH 31 DEGREES 23 MINUTES 56 SECONDS EAST; CHORD DISTANCE = 40.05 FEET) AN ARC DISTANCE OF 40.05 FEET TO THE POINT OF BEGINNING.
TRACT NO. 3
EASEMENT FOR INGRESS-EGRESS FOR THE BENEFIT OF TRACT NO. 1
BEING A DESCRIPTION OF A MUTUAL USE, NON-EXCLUSIVE, PRIVATE INGRESS/EGRESS EASEMENT, BEING PART OF THE APPLINGWOOD PLANNED DEVELOPMENT FINAL PLAT PHASE IV (PLAT BOOK 157, PAGE 18) AND PART OF FINAL PLAT PHASE VI (PLAT BOOK 162, PAGE 41) OF RECORD AT THE SHELBY COUNTY REGISTER'S OFFICE (S.C.R.O.) SITUATED IN SHELBY COUNTY, TENNESSEE AND BEING MORE PARTICULARLY DESCRIBED AS FOLLOWS:
COMMENCING AT THE TANGENT INTERSECTION OF THE NORTH DEDICATED R.O.W. LINE OF DEXTER GROVE DRIVE (68' R.O.W.- NOT IMPROVED) WITH THE WEST R.O.W. LINE OF APPLING ROAD (108' R.O.W); THENCE NORTH 41 DEGREES 40 MINUTES 01 SECONDS WEST ALONG SAID WEST LINE A DISTANCE OF 136.00 FEET TO A POINT OF CURVE; THENCE NORTHWESTWARDLY, ALONG SAID WEST LINE, ALONG A CURVE TO THE RIGHT, HAVING A RADIUS OF 1179.00 FEET (CENTRAL ANGLE = 09 DEGREES 17 MINUTES 42 SECONDS; CHORD BEARING = NORTH 37 DEGREES 01 MINUTES 10 SECONDS WEST; CHORD DISTANCE = 191.05 FEET) AN ARC DISTANCE OF 191.26 FEET TO A POINT;
THENCE SOUTH 61 DEGREES 22 MINUTES 09 SECONDS WEST A DISTANCE OF 286.48 FEET TO A POINT OF CURVE; THENCE SOUTHWESTWARDLY ALONG A CURVE TO THE RIGHT, HAVING A RADIUS OF 177.00 FEET (CENTRAL ANGLE = 03 DEGREES 18 MINUTES 15 SECONDS; CHORD BEARING = SOUTH 63 DEGREES 01 MINUTES 17 SECONDS WEST; CHORD DISTANCE = 10.21 FEET) AN ARC DISTANCE OF 10.21 FEET TO A POINT OF REVERSE CURVE; THENCE SOUTHWESTWARDLY ALONG A CURVE TO THE LEFT, HAVING A RADIUS OF 14.50 FEET (CENTRAL ANGLE = 04 DEGREES 17 MINUTES 17 SECONDS; CHORD BEARING = SOUTH 62 DEGREES 31 MINUTES 46 SECONDS WEST; CHORD DISTANCE = 1.08 FEET) AN ARC DISTANCE OF 1.09 FEET TO THE TRUE POINT OF BEGINNING; THENCE SOUTH 88 DEGREES 04 MINUTES 57 SECONDS WEST A DISTANCE OF 74.77 FEET TO A POINT; THENCE NORTH 90 DEGREES 00 MINUTES 00 SECONDS WEST A DISTANCE OF 266.53 FEET TO A POINT; THENCE NORTH 00 DEGREES 00 MINUTES 00 SECONDS EAST A DISTANCE OF 12.99 FEET TO A POINT OF CURVE; THENCE NORTHEASTWARDLY ALONG A CURVE TO THE RIGHT, HAVING A RADIUS OF 53.00 FEET (CENTRAL ANGLE = 40 DEGREES 59 MINUTES 30 SECONDS; CHORD BEARING = NORTH 69 DEGREES 30 MINUTES 15 SECONDS EAST; CHORD DISTANCE = 37.11 FEET) AN ARC DISTANCE OF 37.92 FEET TO A POINT; THENCE SOUTH 90 DEGREES 00 MINUTES 00 SECONDS EAST A DISTANCE OF 231.74 FEET TO A POINT OF CURVE; THENCE NORTHEASTWARDLY ALONG A CURVE TO THE LEFT, HAVING A RADIUS OF 137.00 FEET (CENTRAL ANGLE = 23 DEGREES 24 MINUTES 17 SECONDS; CHORD BEARING = NORTH 78 DEGREES 17 MINUTES 52 SECONDS EAST; CHORD DISTANCE = 55.57 FEET) AN ARC DISTANCE OF 55.96 FEET TO A POINT; THENCE SOUTH 16 DEGREES 47 MINUTES 47 SECONDS EAST A DISTANCE OF 13.08 FEET TO A POINT; THENCE SOUTH 36 DEGREES 39 MINUTES 53 SECONDS EAST A DISTANCE OF 27.72 FEET TO THE POINT OF BEGINNING.
D-8


TRACT NO 4
TOGETHER WITH ALL EASEMENTS AND RIGHTS SET FORTH IN THAT CERTAIN RECIPROCAL MAINTENANCE, INGRESS AND EGRESS EASEMENT RECORDED IN INSTRUMENT NO. FT 4121, AS AMENDED BY AMENDED AND RESTATED RECIPROCAL MAINTENANCE, INGRESS AND EGRESS AGREEMENT RECORDED IN INSTRUMENT NO. FU 6982, IN THE REGISTER'S OFFICE OF SHELBY COUNTY, TENNESSEE.
BEING THE SAME PROPERTY CONVEYED TO APPLINGWOOD PROPCO LLC, A DELAWARE LIMITED LIABILITY COMPANY, BY DEED FROM APPLINGWOOD LONG TERM FACILITY, LLC, A TENNESSEE LIMITED LIABILITY COMPANY, F/K/A APPLINGWOOD LONG TERM FACILITY, INC., A TENNESSEE CORPORATION, OF RECORD IN INSTRUMENT NO. 21042954, IN THE REGISTER’S OFFICE OF SHELBY COUNTY, TENNESSEE.
D-9


5.    AHC Covington Care, 765 Bert Johnston Avenue, Covington, TN 38019
The Land referred to herein below is situated in the County of Tipton, State of Tennessee, and described as follows:
BEGINNING ON A FOUND STEEL POST IN THE SOUTHERN MARGIN OF BERT JOHNSTON AVENUE (60' R/W), SAID STEEL POST BEING THE NORTHWEST CORNER OF TRACT BELONGING TO THE CITY OF COVINGTON (RECORD BOOK 710, PAGE 638, R.O.T.C.T.), AND BEING THE NORTHEAST CORNER OF THE SUBJECT PROPERTY; THENCE WITH THE WESTERN LINE OF THE CITY OF COVINGTON PROPERTY, SOUTH 01 DEGREE 52 MINUTES 22 SECONDS EAST A DISTANCE OF 450.05 FEET TO A FOUND STEEL POST IN A BARBED WIRE FENCE, BEING THE SOUTHEAST CORNER OF THE SUBJECT TRACT AND THE NORTHEAST CORNER OF WILMOTH WHITLEY (WILL BOOK I, PAGE 418, COUNTY COURT CLERK'S OFFICE; TIPTON CO.); THENCE WITH THE NORTHERN LINE OF WHITLEY, NORTH 90 DEGREES 00 MINUTES 00 SECONDS WEST A DISTANCE OF 438.00 FEET TO A RE-SET IRON PIN AT AN INTERIOR CORNER OF WHITLEY; THENCE WITH THE EASTERN LINE OF WHITLEY, NORTH 00 DEGREES 00 MINUTES 00 SECONDS EAST A DISTANCE OF 449.81 FEET TO A RE-SET IRON PIN IN THE SOUTHERN MARGIN OF BERT JOHNSTON AVENUE; THENCE WITH THE SOUTHERN MARGIN OF BERT JOHNSTON AVENUE, SOUTH 90 DEGREES 00 MINUTES 00 SECONDS EAST A DISTANCE OF 423.29 FEET TO THE BEGINNING.
BEING THE SAME PROPERTY CONVEYED TO COVINGTON PROPCO LLC, A DELAWARE LIMITED LIABILITY COMPANY, BY DEED FROM COVINGTON CARE LONG TERM FACILITY, LLC, A TENNESSEE LIMITED LIABILITY COMPANY FORMERLY KNOWN AS COVINGTON CARE LONG TERM FACILITY, INC., A TENNESSEE CORPORATION, OF RECORD IN RECORD BOOK 1896, PAGE 575, IN THE REGISTER’S OFFICE OF TIPTON COUNTY, TENNESSEE.
D-10


6.    AHC Westwood, 524 West Main Street, Decaturville, TN 38329
LYING AND BEING SITUATED IN THE TOWN OF DECATURVILLE, IN THE FOURTH CIVIL DISTRICT OF DECATUR COUNTY, TENNESSEE, BEING THE SAME PROPERTY THAT WAS CONVEYED TO WESTWOOD MANOR, INC. BY WARRANTY DEED FROM JAMES W. LUNSFORD AND WIFE, MARY LUNSFORD AS RECORDED IN DEED BOOK 116, PAGE 660 IN THE OFFICE OF THE REGISTER, DECATUR COUNTY, TENNESSEE, AND BEING MORE PARTICULARLY DESCRIBED AS FOLLOWS:
BEGINNING ON A FOUND 1/2" IRON PIN BY A STEEL POST LOCATED IN THE NORTHERLY MARGIN OF WEST MAIN STREET (STATE RT. 100), SAID IRON PIN BEING LOCATED 50 FEET FROM THE CENTERLINE OF SAID HIGHWAY, BEING THE SOUTHWEST CORNER OF CONNIE BARTHOLOMEW, JR. (DEED BOOK 118, PAGE 385 RODCT); RUNS THENCE WITH THE NORTHERLY MARGIN OF SAID HIGHWAY, SOUTH 46 DEGREES 11 MINUTES 51 SECONDS WEST A DISTANCE OF 296.74 FEET TO A FOUND BROKEN CONCRETE MONUMENT, THE SAME BEING THE SOUTHEAST CORNER OF THE PARCEL OWNED BY LUNSFORD FARMS, LP (DEED BOOK 179, PAGE 358 RODCT); THENCE LEAVING THE HIGHWAY AND RUNNING WITH THE EASTERN LINE OF LUNSFORD, NORTH 68 DEGREES 00 MINUTES 01 SECONDS WEST A DISTANCE OF 602.50 FEET TO A FOUND STEEL POST IN THE EASTERN LINE OF JOHN E. WYATT (DEED BOOK 109, PAGE 707 RODCT); THENCE WITH THE EASTERN LINE OF WYATT, NORTH 03 DEGREES 55 MINUTES 46 SECONDS WEST A DISTANCE OF 381.09 FEET TO A FOUND STEEL POST NEAR A WIRE FENCE AND IN THE SOUTHERN LINE OF JAMES ROBERTS (DEED BOOK 108, PAGE 61 RODCT); THENCE WITH THE SOUTHERN LINE OF ROBERTS, RUNNING WITH OR NEAR AN OLD WIRE FENCE, NORTH 85 DEGREES 45 MINUTES 15 SECONDS EAST A DISTANCE OF 369.07 FEET TO A FOUND 1/2" IRON PIN; THENCE WITH THE WESTERN FINE OF LUNSFORD FARMS, LP (DEED BOOK 179, PAGE 358 RODCT), SOUTH 44 DEGREES 36 MINUTES 25 SECONDS EAST A DISTANCE OF 337.93 FEET TO A FOUND 1/2" IRON PIN BY A STEEL POST AT THE SOUTHWEST CORNER OF LUNSFORD AND THE NORTHWEST CORNER OF BARTHOLOMEW; THENCE WITH THE WESTERN LINE OF BARTHOLOMEW, SOUTH 45 DEGREES 56 MINUTES 59 SECONDS EAST A DISTANCE OF 269.29 FEET TO THE POINT OF BEGINNING, CONTAINING 7.156 ACRES.
THIS PROPERTY IS A PORTION OF THE PROPERTY THAT WAS THE J. W. STOUT SUBDIVISION, RECORDED IN PLAT CABINET 1, SLIDE 3A, IN THE OFFICE OF THE REGISTER, DECATUR COUNTY, TENNESSEE. THIS SUBDIVISION PLAT WAS REVOKED BY AN INSTRUMENT RECORDED IN DEED BOOK 718, PAGE 312, RODCT.
D-11


INCLUDED IN THE FOREGOING DESCRIPTION, BUT EXPRESSLY EXCLUDED THEREFROM, IS PROPERTY CONVEYED TO TOWN OF DECATURVILLE, TENNESSEE, BY DEED OF RECORD IN DEED BOOK 119, PAGE 256, IN THE REGISTER'S OFFICE OF DECATUR COUNTY, TENNESSEE.
BEING THE SAME PROPERTY CONVEYED TO WESTWOOD PROPCO LLC, A DELAWARE LIMITED LIABILITY COMPANY, BY DEED FROM WESTWOOD LONG TERM FACILITY, LLC, A TENNESSEE LIMITED LIABILITY COMPANY, FORMERLY KNOWN AS WESTWOOD LONG TERM FACILITY, INC., A TENNESSEE CORPORATION OF RECORD IN BOOK 359, PAGE 515, IN THE REGISTER'S OFFICE OF DECATUR COUNTY, TENNESSEE.
D-12


7.    AHC Dyersburg, 1900 Parr Avenue, Dyersburg, TN 38024
The Land referred to herein below is situated in the County of Dyer, State of Tennessee, and described as follows:
BEGINNING AT A POINT IN THE EASTERN MARGIN OF PARR AVENUE (40' R.O.W.), SAID POINT BEING LOCATED SOUTH 89 DEGREES 56 MINUTES 26 SECONDS WEST A DISTANCE OF 5.7 FEET FROM A FOUND IRON PIPE, SAID POINT BEING THE NORTHWEST CORNER OF A TRACT BELONGING TO DYERSBURG HOSPITAL CORPORATION (RECORD BOOK 696, PAGE 311), AND BEING THE SOUTHWEST CORNER OF THE SUBJECT PROPERTY, THENCE WITH THE EASTERN MARGIN OF PARR AVENUE, SIX (6) COURSES: NORTH 18 DEGREES 05 MINUTES 23 SECONDS EAST A DISTANCE OF 54.51 FEET; THENCE NORTH 22 DEGREES 30 MINUTES 00 SECONDS EAST A DISTANCE OF 50.00 FEET; THENCE NORTH 26 DEGREES 30 MINUTES 00 SECONDS EAST A DISTANCE OF 60.00 FEET; THENCE NORTH 27 DEGREES 22 MINUTES 00 SECONDS EAST A DISTANCE OF 175.00 FEET; THENCE NORTH 24 DEGREES 15 MINUTES 00 SECONDS EAST A DISTANCE OF 80.00 FEET; THENCE NORTH 16 DEGREES 30 MINUTES 00 SECONDS EAST A DISTANCE OF 90.00 FEET TO THE SOUTHWEST CORNER OF ELTON A. KING AND WIFE, CAROLYN J. KING (DEED BOOK 109, PAGE 115); THENCE WITH THE SOUTHERN LINE OF KING, TWO (2) COURSES: NORTH 67 DEGREES 23 MINUTES 52 SECONDS EAST, PASSING A FOUND IRON PIPE IN A PAVED DRIVE AT 6.9 FEET, CONTINUING FOR A TOTAL DISTANCE OF 125.35 FEET TO A FOUND 3/4” IRON PIPE; THENCE NORTH 88 DEGREES 36 MINUTES 52 SECONDS EAST A DISTANCE OF 245.04 FEET TO A FOUND IRON PIPE IN THE WESTERN LINE OF SHERRIE G. REVELL (RECORD BOOK 485, PAGE 140); THENCE WITH THE WESTERN LINE OF REVELL, SOUTH 00 DEGREES 33 MINUTES 08 SECONDS EAST A DISTANCE OF 519.89 FEET TO A FOUND IRON PIPE IN THE NORTHERN LINE OF WEST TENNESSEE HEALTH CARE, INC. (RECORD BOOK 308, PAGE 362); THENCE WITH THE NORTHERN LINE OF WEST TENNESSEE HEALTH CARE, INC., AND WITH THE NORTHERN LINE OF DYERSBURG HOSPITAL CORPORATION, SOUTH 89 DEGREES 56 MINUTES 26 SECONDS WEST, PASSING A FOUND IRON PIPE AT 561.7 FEET, CONTINUING FOR A TOTAL DISTANCE OF 567.39 FEET TO THE BEGINNING, CONTAINING 230,438 SQUARE FEET, OR 5.290 ACRES.
BEING THE SAME PROPERTY CONVEYED TO DYERSBURG PROPCO LLC, A DELAWARE LIMITED LIABILITY COMPANY, BY DEED FROM DYERSBURG LONG TERM FACILITY, LLC, A TENNESSEE LIMITED LIABILITY COMPANY, FORMERLY KNOWN AS DYERSBURG LONG TERM FACILITY, INC., A TENNESSEE CORPORATION, OF RECORD IN RECORD BOOK 973, PAGE 739, IN THE REGISTER'S OFFICE OF DYER COUNTY, TENNESSEE.
D-13


8.    AHC Vanco, 813 S Dickerson Rd Goodlettsville TN 37072
The Land referred to herein below is situated in the County of Davidson, State of Tennessee, and described as follows:
TRACT 1
A TRACT OF LAND IN THE TENTH COUNCILMANIC DISTRICT OF DAVIDSON COUNTY, TENNESSEE, CITY OF GOODLETTSVILLE, TENNESSEE., BEING THE SAME PROPERTY DEPICTED IN THE FINAL PLAT OF RIVERGATE MANOR SUBDIVISION RECORDED AS INSTRUMENT NOS. 200312160179600 AND 200312160179601 IN THE OFFICE OF THE REGISTER, DAVIDSON COUNTY, TENNESSEE, SAID PROPERTY BEING MORE PARTICULARLY DESCRIBED AS FOLLOWS:
BEGINNING ON A FOUND IRON PIN IN THE NORTHWESTERLY RIGHT-OF-WAY OF DICKERSON ROAD (U.S. 41, 31-W) SAID IRON PIN BEING LOCATED 40 FEET FROM THE CENTERLINE OF SAID ROAD, BEING THE SOUTHEASTERN CORNER OF CHARLES R. BURTON, JR. (BOOK 1725, PAGE 489, RODCT) AND BEING THE NORTHEASTERN CORNER OF THE TRACT DESCRIBED HEREIN; THENCE WITH THE NORTHWESTERN RIGHT-OF-WAY OF DICKERSON ROAD, TWO COURSES AS FOLLOWS: SOUTH 23 DEGREES 30 MINUTES 26 SECONDS WEST A DISTANCE OF 465.04 FEET TO A FOUND IRON PIN; THENCE SOUTH 23 DEGREES 57 MINUTES 58 SECONDS WEST A DISTANCE OF 270.03 FEET TO A FOUND IRON PIN AT A NORTHEASTERN CORNER OF COLONY, LTD. (BOOK 6079, PAGE 640, RODCT); THENCE WITH THE NORTHERN LINE OF COLONY, LTD., NORTH 66 DEGREES 06 MINUTES 04 SECONDS WEST A DISTANCE OF 294.30 FEET TO A FOUND IRON PIN; THENCE WITH THE EASTERN LINE OF COLONY, LTD., ALSO BEING THE CENTERLINE OF A TENNESSEE VALLEY AUTHORITY ELECTRIC LINE EASEMENT (BOOK 1153, PAGE 645, RODCT), NORTH 18 DEGREES 37 MINUTES 21 SECONDS WEST A DISTANCE OF 156.33 FEET TO A FOUND IRON PIN; THENCE WITH THE EASTERN LINE OF COLONY, LTD., NORTH 23 DEGREES 52 MINUTES 44 SECONDS EAST A DISTANCE OF 139.23 FEET TO A FOUND IRON PIN; THENCE WITH THE NORTHERN LINE OF COLONY, LTD., NORTH 68 DEGREES 15 MINUTES 55 SECONDS WEST A DISTANCE OF 40.61 FEET TO A FOUND IRON PIN; THENCE WITH THE EASTERN LINE OF COLONY, LTD., NORTH 11 DEGREES 16 MINUTES 19 SECONDS EAST A DISTANCE OF 322.42 FEET TO A FOUND IRON PIN IN THE SOUTHERN LINE OF MCFERRIN MISSIONARY BAPTIST CHURCH (INSTRUMENT NO. 200201080002643, RODCT); THENCE WITH THE SOUTHERN LINE OF MCFERRIN MISSIONARY BAPTIST CHURCH, SOUTH 84 DEGREES 20 MINUTES 42 SECONDS EAST, PASSING A FOUND IRON PIN ON LINE AT 171.11 FEET, SAID IRON PIN BEING THE SOUTHWESTERN CORNER OF BURTON, THENCE CONTINUING WITH THE SOUTHERN LINE OF BURTON FOR ANOTHER 364.00 FEET, FOR A TOTAL DISTANCE OF 535.11 FEET TO THE POINT OF BEGINNING.
D-14


TRACT 2
EASEMENT FOR INGRESS AND EGRESS AS SET FORTH IN AGREEMENT FOR INGRESS-EGRESS EASEMENT BY AND AMONG, DAN F. SANDERS, WILLIAM H. BELL JR. AND JAMES W. AYERS, AS GRANTORS AND VANCO, INC. A TENNESSEE CORPORATION, AS GRANTEE, DATED MAY 25, 1978, RECORDED JUNE 14, 1978 IN BOOK 5298, PAGE 323 WHICH EASEMENT IS DESCRIBED AS FOLLOWS:
BEING A PORTION OF TRACT NO. 3 ACCORDING TO AN UNRECORDED DUCRYE BY MARSHALL H. RAGAN, LICENSE NO. 332M DATED FEBRUARY 14, 1978, DESCRIBED AS FOLLOWS:
BEING A PORTION OF TRACT NO. 3, DESCRIBED AS FOLLOWS:
BEGINNING AT AN IRON PIN ON THE WESTERLY MARGIN OF DICKERSON PIKE; SAID POINT BEING NORTH 19 DEGREES 32 MINUTES 00 SECONDS EAST, 142.97 FEET FROM THE NORTHEAST CORNER OF THE NASHVILLE ELECTRIC SERVICE PROPERTY AS RECORDED IN BOOK 2291, PAGE 153, REGISTER'S OFFICE FOR SAID COUNTY; THENCE NORTH 70 DEGREES 28 MINUTES 00 SECONDS WEST, 294.30 FEET TO AN IRON PIN; THENCE NORTH 19 DEGREES 32 MINUTES 00 SECONDS EAST 50 FEET TO AN IRON PIN; THENCE SOUTH 70 DEGREES 28 MINUTES 00 SECONDS WEST, 294.30 TO AN IRON PIN ON THE WESTERLY MARGIN OF DICKERSON PIKE; THENCE ALONG THE WESTERLY MARGIN OF DICKERSON PIKE, SOUTH 19 DEGREES 32 MINUTES 00 SECONDS WEST, 50.00 FEET TO THE POINT OF BEGINNING.
BEING THE SAME PROPERTY CONVEYED TO VANCO PROPCO LLC, A DELAWARE LIMITED LIABILITY COMPANY, BY DEED FROM VANCO LONG TERM FACILITY, LLC, A TENNESSEE LIMITED LIABILITY COMPANY, FORMERLY KNOWN AS VANCO LONG TERM FACILITY, INC., A TENNESSEE CORPORATION OF RECORD IN INSTRUMENT NO. 202104190051890, IN THE REGISTER'S OFFICE OF DAVIDSON COUNTY, TENNESSEE.
D-15


9.    AHC Lewis County, 119 Kittrell Street, Hohenwald, TN 38462
The Land referred to herein below is situated in the County of LEWIS, State of Tennessee, and described as follows:
TRACT I:
LYING AND BEING SITUATED IN THE CITY OF HOHENWALD, THIRD CIVIL DISTRICT, LEWIS COUNTY, TENNESSEE AND BEING MORE PARTICULARLY DESCRIBED AS FOLLOWS:
BEGINNING ON A FOUND 2” IRON PIPE IN AN OLD WIRE AND WOOD RAIL FENCE ON THE EAST BOUNDARY OF A TRACT IN THE NAME OF DEMPS GOODMAN (DB NN, PG 511), SAID IRON PIPE BEING THE NORTHWEST CORNER OF THE PROPERTY OF VOLUNTEER HEALTHCARE SYSTEMS, INC. (DB A-43, PG 281), AND BEING THE SOUTHWEST CORNER OF THE SUBJECT TRACT; THENCE WITH THE EASTERN LINE OF GOODMAN, RUNNING WITH THE OLD FENCE, NORTH 03 DEGREES 10 MINUTES 34 SECONDS EAST A DISTANCE OF 526.26 FEET TO A FOUND IRON PIPE IN AN OLD FENCE CORNER AT THE SOUTHWEST CORNER OF DONNIE GOODMAN VERHAAK (DB A-37, PAGE 630); THENCE WITH AN OLD FENCE AND SOUTHERN LINE OF VERHAAK, LESLIE L. POPE (DB A-12, PG 230), AND CECIL D. O’DELL, JR. (DB A-21, PG 695), SOUTH 83 DEGREES 00 MINUTES 06 SECONDS EAST A DISTANCE OF 374.19 FEET TO A FOUND IRON PIPE AT THE NORTHWEST CORNER OF VIRENDER ANAND (DB A-45, PG 589); THENCE WITH THE WESTERN LINE OF ANAND, SOUTH 02 DEGREES 57 MINUTES 54 SECONDS WEST A DISTANCE OF 493.51 FEET TO A FOUND RAILROAD SPIKE IN A PAVED DRIVE AT THE NORTHEAST CORNER OF A 40 FEET WIDE PUBLIC STREET (DB A-65, PG 584); THENCE WITH THE NORTHERN MARGIN OF THE PUBLIC STREET, AND WITH THE NORTHERN BOUNDARY OF VOLUNTEER HEALTHCARE SYSTEMS, INC. NORTH 88 DEGREES 01 MINUTES 00 SECONDS WEST A DISTANCE OF 375.25 FEET TO THE BEGINNING.
PARCEL 1:
THIS PROPERTY IS SUBJECT TO AN EASEMENT IN FAVOR OF THE CITY OF HOHENWALD, TENNESSEE, TO CONSTRUCT, BUILD AND/OR MAINTAIN A SEWER LINE. THIS EASEMENT IS NOT DESCRIBED, SO IT IS NOT SHOWN ON THIS PLAT, DEED BOOK VV, PAGE 497 AND 498.
PARCEL 2:
THIS PROPERTY WAS BENEFITTED BY EASEMENTS FOR A DRIVEWAY ACROSS THE PROPERTY WHICH NOW BELONGS TO VOLUNTEER HEALTHCARE SYSTEMS, INC. THESE EASEMENTS ARE RECORDED IN WARRANTY DEED BOOK A-10, PAGE 533, WARRANTY DEED BOOK A-16, PAGE 749, AND IN WARRANTY DEED BOOK TT, PAGE 383, R.O.L.C.T.
D-16


IN JUNE, 1994, THESE EASEMENTS WERE CONVEYED TO THE CITY OF HOHENWALD, TENNESSEE, AND DEDICATED TO PUBLIC USE. THIS CONVEYANCE AND DEDICATION IS RECORDED IN DEED BOOK A-65, PAGE 584, R.O.L.C.T.
TRACT II:
BEGINNING ON AN EXISTING 2 INCH IRON PIPE AT THE SOUTHWEST CORNER OF A 4.38 ACRE TRACT BELONGING TO LEWIS COUNTY LONG TERM FACILITY, INC. (TAX MAP 36-M, GR. A, PARCEL 21.01 – RB 18, PG. 436), SAID IRON PIPE BEING A POINT IN THE EASTERN LINE OF AN 8.93 ACRE TRACT BELONGING TO MAURY REGIONAL HOSPITAL (TAX MAP 36-M, GR. A, PARCEL 23.00 – RB 27, PG. 713) AND BEING THE NORTHWEST CORNER OF A 5.376 ACRE TRACT BELONGING TO MAURY REGIONAL HOSPITAL (TAX MAP 36-M, GR. A, PARCEL 21.00 – DB A-71, PG. 737) OF WHICH THIS TRACT IS A PART; THENCE WITH THE SOUTHERN LINE OF LEWIS COUNTY LONG TERM FACILITY, INC., SOUTH 83 DEGREES 15 MINUTES 56 SECONDS EAST FOR A DISTANCE OF 335.25 FEET TO A SET MAG-NAIL IN ASPHALT AT THE NORTHWEST CORNER OF KITTRELL STREET (A PAVED PUBLIC STREET WITH A 40 FEET WIDE RIGHT-OF-WAY AS RECORDED IN DEED BOOK A-65, PAGE 584), SAID MAG-NAIL BEING LOCATED NORTH 83 DEGREES 15 MINUTES 56 SECONDS WEST A DISTANCE OF 40.00 FEET FROM AN EXISTING RAILROAD SPIKE AT THE NORTHEAST CORNER OF KITTRELL STREET; THENCE WITH THE WESTERN RIGHT-OF-WAY OF KITTRELL STREET, SOUTH 07 DEGREES 33 MINUTES 18 SECONDS WEST FOR A DISTANCE OF 81.00 FEET TO A SET IRON PIN; THENCE WITH A NEW DIVISION LINE OF THE MAURY REGIONAL HOSPITAL PROPERTY, NORTH 81 DEGREES 23 MINUTES 12 SECONDS WEST FOR A DISTANCE OF 335.72 FEET TO A SET IRON PIN IN THE EASTERN LINE OF THE MAURY REGIONAL HOSPITAL 8.93 ACRE TRACT; THENCE WITH SAID EASTERN LINE, NORTH 07 DEGREES 55 MINUTES 38 SECONDS EAST FOR A DISTANCE OF 70.00 FEET TO THE POINT OF BEGINNING.
D-17


10.    AHC Humboldt, 2031 Avondale Street, Humboldt, TN 38343:
The Land referred to herein below is situated in the County of Gibson, State of Tennessee, and described as follows:
LYING AND BEING IN THE 3RD CIVIL DISTRICT OF GIBSON COUNTY, TENNESSEE AND BEING MORE PARTICULARLY DESCRIBED AS FOLLOWS:
PARCEL NUMBER ONE: BEGINNING ON A SET IRON STAKE IN THE WEST MARGIN OF AVONDALE ROAD, SAME BEING THE SOUTHEAST CORNER OF A TRACT IN THE NAME OF STATEN (VOLUME 38, PAGE 398, R.O.G.C.), RUNS THENCE SOUTH 89 DEGREES 34 MINUTES 28 SECONDS WEST WITH THE SOUTH BOUNDARIES OF STATEN AND FLOYD HENLY, PASSING STATEN'S SOUTHWEST CORNER AT 105.20 FEET, IN ALL 164.51 FEET TO A SET IRON STAKE IN THE SOUTHWEST CORNER OF HENLY (VOLUME 3, PAGE 326, R.O.G.C.); THENCE SOUTH 89 DEGREES 34 MINUTES 28 SECONDS WEST WITH THE SOUTH BOUNDARY OF A TRACT IN THE NAME OF FIRST BAPTIST CHURCH, (VOLUME 10, PAGE 327/328, R.O.G.C.) FOR A DISTANCE OF 565.00 FEET TO A SET IRON STAKE BY A 36 INCH OAK TREE; THENCE SOUTH 163.61 FEET TO A SET IRON STAKE IN THE NORTH BOUNDARY OF PARCEL NUMBER TWO: THENCE NORTH 89 DEGREES 26 MINUTES 46 SECONDS EAST WITH THE NORTH BOUNDARY OF PARCEL NO. 2 FOR 461.15 FEET TO A SET IRON STAKE IN THE NORTHWEST CORNER OF A TRACT IN THE OF, OR FORMERLY IN THE NAME OF BOB CROCKER; THENCE NORTH 89 DEGREES 26 MINUTES 45 SECONDS EAST WITH THE NORTH BOUNDARY OF CROCKER FOR 148.78 FEET TO A SET IRON STAKE IN THE SOUTHWEST CORNER OF A TRACT IN THE NAME OF CANNIE MALCOLM POTTER (DEED BOOK 85, PAGE 663, R.O.G.C.); THENCE TWO (2) COURSES WITH THE BOUNDARIES OF POTTER AS FOLLOWS, NORTH 01 DEGREES 45 MINUTES 15 SECONDS WEST FOR 81.00 FEET TO A SET IRON STAKE IN THE NORTHWEST CORNER OF POTTER; THENCE NORTH 89 DEGREES 26 MINUTES 46 SECONDS EAST FOR 139.00 FEET TO A SET IRON STAKE IN THE WEST MARGIN OF AVONDALE ROAD; THENCE NORTH 01 DEGREES 45 MINUTES 15 SECONDS WEST WITH THE WEST MARGIN OF AVONDALE ROAD FOR 81.00 FEET TO THE POINT OF BEGINNING.
PARCEL NUMBER TWO: BEGINNING ON A SET IRON STAKE IN THE WEST BOUNDARY OF A TRACT IN THE NAME OF CECIL HUNT AND WIFE, GERTIE HUNT (DEED BOOK 121, PAGE 439, R.O.G.C.), NOW THE PROPERTY OF ROBERT THOMAS, AND SHARON KAIL, SAME BEING 300.04 FEET SOUTH 89 DEGREES 30 MINUTES 56 SECONDS WEST OF THE NORTHEAST CORNER OF BARRETT LANE AND THE WEST MARGIN OF AVONDALE ROAD, RUNS THENCE WITH THE WEST BOUNDARY OF THOMAS AND KAIL, GEORGE JERNIGAN AND WIFE, MRS.
D-18


NELLIE JERNIGAN, AND BOB CROCKER FOR A DISTANCE OF 196.03 FEET TO A SET IRON STAKE IN THE NORTHWEST CORNER OF CROCKER; THENCE SOUTH 89 DEGREES 26 MINUTES 46 SECONDS WEST WITH THE SOUTH BOUNDARY OF PARCEL NO. 1 FOR 461.15 FEET TO A FOUND IRON PIN AXLE ON THE EAST BANK OF A LARGE DRAIN DITCH; NORTH 88 DEGREES, 07 MINUTES AND 13 SECONDS WEST 14.45 FEET; THENCE SOUTH 01 DEGREE 01 MINUTES 43 SECONDS WEST WITH THE EAST BANK OF SAID DRAIN DITCH AND THE WEST BOUNDARY OF A TRACT IN THE NAME OF EZRE PILLOW AND WIFE, ROSS IRENE PILLOW (DEED BOOK 97, PAGE 541, R.O.G.C.) FOR 195.38 FEET TO A SET IRON STAKE IN THE NORTHWEST CORNER OF PROPOSED BARRETT LANE EXTENDED WEST; THENCE BY A SEVERANCE LINE OF PARCEL NUMBER TWO AND THE NORTH MARGIN OF PROPOSED BARRETT LANE WEST EXTENDED FOR A DISTANCE OF 459.39 FEET TO THE POINT OF BEGINNING.
BEING THE SAME PROPERTY CONVEYED TO C.K.T. PROPERTIES, INCORPORATED, A TENNESSEE CORPORATION, BY DEED FROM C.K.T. PROPERTIES, A PARTNERSHIP COMPOSED OF FRED COLVETT; SHARON KAIL; AND ROBERT THOMAS, OF RECORD IN VOLUME 332, PAGE 678, DATED JULY 31, 1989, AND AS CORRECTED IN VOLUME 332, PAGE 847, IN THE REGISTER'S OFFICE OF GIBSON COUNTY, TENNESSEE. AND AS FURTHER CORRECTED BY QUIT CLAIM DEED RECORDED IN VOLUME RECORD BOOK 1095 PAGE 964 IN THE REGISTER'S OFFICE OF GIBSON COUNTY, TENNESSEE. C.K.T. PROPERTIES, INCORPORATED, A TENNESSEE CORPORATION IS NOW KNOWN AS CKT PROPERTIES, LLC. A TENNESSEE LIMITED LIABILITY COMPANY, AS EVIDENCE BY CERTIFICATE OF CONVERSION OF RECORD IN VOLUME 1095, PAGE 995, SAID REGISTER'S OFFICE.
D-19


11.    AHC Millenium, 5275 Millenium Drive, Huntsville, AL 35806
The Land referred to herein below is situated in the County of Madison, State of Alabama, and is described as follows:
LOT 2 OF THE FINAL PLAT OF A RESUBDIVISION OF LOT I OF PHASE I OF WILLOW WAY SUBDIVISION, RECORDED AS INSTRUMENT NO. 20100608000305630, IN THE OFFICE OF THE JUDGE OF PROBATE OF MADISON COUNTY, ALABAMA.
TOGETHER WITH THE RECIPROCAL EASEMENT AGREEMENT BETWEEN HUNTSVILLE LONG TERM FACILITY, INC. AND BEHAVIORAL HEALTHCARE CENTER AT HUNTSVILLE, INC., DATED OCTOBER 31, 2010 RECORDED ON NOVEMBER 1, 2010 AS INSTRUMENT NO. 20101101000631310.
D-20


12.    AHC Forest Cove, 45 Forest Cove, Jackson, TN 38301
LYING IN THE FOURTH WARD OF THE CITY OF JACKSON, MADISON COUNTY, TENNESSEE, BEING A PART OF THE PROPERTY DEPICTED IN A PLAT OF FOREST COVE SUBDIVISION AS RECORDED IN PLAT BOOK 2, PAGE 101, IN THE OFFICE OF THE REGISTER, MADISON COUNTY, TENNESSEE, AND IS MORE PARTICULARLY DESCRIBED AS FOLLOWS:
BEGINNING ON AN EXISTING IRON PIN IN THE WEST MARGIN OF FOREST COVE (50' R/W), SAID IRON PIN BEING THE SOUTHEAST CORNER OF THE WEST TENNESSEE HEALTHCARE, INC. PROPERTY, (DB 696, PG 1583), SAID IRON PIN ALSO BEING LOCATED SOUTH 04 DEGREES 17 MINUTES 00 SECONDS WEST A DISTANCE OF 472.5 FEET FROM THE CENTERLINE OF WEST FOREST AVENUE; THENCE WITH THE WESTERN MARGIN OF A CUL-DE-SAC AT THE SOUTH END OF FOREST COVE, SOUTHWESTERLY ALONG A CURVE TO THE RIGHT, WITH A RADIUS OF 25.00 FEET, AN ARC DISTANCE OF 21.03 FEET, AND A CHORD OF SOUTH 28 DEGREES 22 MINUTES 55 SECONDS WEST A DISTANCE OF 20.42 FEET TO ON EXISTING IRON PIN; THENCE WITH THE WESTERN MARGIN OF THE CUL-DE-SAC, WITH A CURVE TO THE LEFT, HAVING A RADIUS OF 50.00 FEET, AN ARC DISTANCE OF 120.59 FEET, AND A CHORD OF SOUTH 16 DEGREES 37 MINUTES 34 SECONDS EAST A DISTANCE OF 93.42 FEET TO AN EXISTING IRON PIN ON THE SOUTH SIDE OF SAID CUL-DE-SAC AND IN THE WESTERN LINE OF ANOTHER TRACT IN THE NAME OF WEST TENNESSEE HEALTHCARE, INC. (DB 696, PG 1583); THENCE WITH THE WEST LINE OF THE WEST TENNESSEE HEALTHCARE, INC. PROPERTY, SOUTH 04 DEGREES 17 MINUTES 00 SECONDS WEST, PASSING A FOUND IRON PIN ON LINE AT 104.33 FEET, IN ALL, A DISTANCE OF 160.00 FEET TO A POINT IN THE CENTER OF A LARGE DITCH, BEING A POINT IN THE NORTHERN LINE OF LOT 4 OF THE MEDICAL ARTS SUBDIVISION (PLAT BOOK 3, PAGE 240); THENCE RUNNING ALONG THE APPROXIMATE CENTERLINE OF THE LARGE DITCH, WITH THE NORTHERN LINE OF LOT 4 AND LOT 3 OF THE MEDICAL ARTS SUBDIVISION AS FOLLOWS: SOUTH 70 DEGREES 00 MINUTES 00 SECONDS WEST A DISTANCE OF 29.00 FEET; THENCE SOUTH 40 DEGREES 00 MINUTES 00 SECONDS WEST A DISTANCE OF 160.00 FEET; THENCE SOUTH 70 DEGREES 00 MINUTES 00 SECONDS WEST A DISTANCE OF 192.20 FEET; THENCE SOUTH 49 DEGREES 00 MINUTES 00 SECONDS WEST A DISTANCE OF 266.00 FEET TO THE INTERSECTION OF ANOTHER LARGE DITCH FROM THE NORTH, AND BEING A POINT IN THE EAST LINE OF THE JOHN H. OMAR SUBDIVISION (PLAT BOOK 1, PAGE 205, R.O.M.C.T); THENCE RUNNING UP THE DITCH, WITH THE EAST LINE OF THE JOHN H. OMAR SUBDIVISION, TWO COURSES AS FOLLOWS: NORTH 09 DEGREES 37 MINUTES 00 SECONDS EAST A DISTANCE OF 500.00 FEET; THENCE NORTH 05 DEGREES 54 MINUTES 21 SECONDS EAST A DISTANCE OF 154.71 FEET TO A POINT IN THE DITCH AT THE SOUTHWEST CORNER OF THE WEST TENNESSEE HEALTHCARE, INC. PROPERTY; THENCE WITH THE SOUTH LINE OF THE WEST TENNESSEE HEALTHCARE, INC. PROPERTY, SOUTH 89 DEGREES 00 MINUTES 00 SECONDS EAST A DISTANCE OF 407.00 FEET TO THE BEGINNING.
D-21


BEING THE SAME PROPERTY CONVEYED TO FOREST COVE LONG TERM FACILITY, INC., A TENNESSEE CORPORATION, BY DEED FROM FOREST COVE NURSING AND REHAB CENTER, INC., F/K/A FOREST COVE MANOR, INC., A TENNESSEE CORPORATION, OF RECORD IN BOOK D708, PAGE 815, IN THE REGISTER'S OFFICE OF MADISON COUNTY, TENNESSEE.
D-22


13.    AHC Northbrooke, 121 Physicians Dr., Jackson, TN 38305:
The Land referred to herein below is situated in the County of Madison, State of Tennessee, and described as follows:
BEGINNING AT AN IRON PIN IN THE WEST MARGIN OF PHYSICIANS DRIVE (25 FEET FROM THE CENTERLINE) AND BEING THE NORTHEAST CORNER OF LOT 9 OF THE JACKSON MEDICAL PARK; RUNS THENCE WITH THE NORTH LINE OF THE JACKSON MEDICAL PARK (LOTS 9, 10, AND 11), NORTH 89 DEGREES 37 MINUTES 46 SECONDS WEST A DISTANCE OF 458.91 FEET TO AN IRON PIN AT THE SOUTHEAST CORNER OF WEST TENNESSEE HEALTHCARE, INC. (DB 549, PG 506), SAID IRON PIN BEING IN A LARGE DRAINAGE DITCH; THENCE WITH THE EASTERN LINE OF WEST TENNESSEE HEALTHCARE, INC. AS FOLLOWS:
NORTH 31 DEGREES 56 MINUTES 36 SECONDS EAST A DISTANCE OF 193.08 FEET TO AN IRON PIN; THENCE NORTH 39 DEGREES 24 MINUTES 30 SECONDS EAST A DISTANCE OF 243.92 FEET TO AN IRON PIN; THENCE NORTH 01 DEGREE 31 MINUTES 09 SECONDS WEST A DISTANCE OF 33.49 FEET TO AN IRON PIN BEING THE NORTHWEST CORNER OF THIS TRACT AND THE SOUTHWEST CORNER OF ANOTHER TRACT BELONGING TO WEST TENNESSEE HEALTHCARE, INC. (DB 563, PG 901); THENCE WITH THE SOUTHERN LINE OF WEST TENNESSEE HEALTHCARE, INC., NORTH 73 DEGREES 56 MINUTES 08 SECONDS EAST A DISTANCE OF 165.81 FEET TO AN IRON PIN IN THE WEST MARGIN OF PHYSICIANS DRIVE; RUNS THENCE WITH THE WESTERN MARGIN OF PHYSICIANS DRIVE AS FOLLOWS: SOUTH 16 DEGREES 03 MINUTES 52 SECONDS EAST A DISTANCE OF 76.60 FEET TO AN IRON PIN; THENCE WITH A CURVE TO THE RIGHT, HAVING A RADIUS OF 644.12 FEET, AN ARC DISTANCE OF 191.11 FEET (CHORD BEARING SOUTH 07 DEGREES 33 MINUTES 52 SECONDS EAST A DISTANCE OF 190.41 FEET) TO A SPIKE IN AN ASPHALT DRIVE; THENCE SOUTH 00 DEGREES 56 MINUTES 08 SECONDS WEST A DISTANCE OF 172.29 FEET TO THE POINT OF BEGINNING, CONTAINING 2.9718 ACRES AND BEING LOT 101, SECTION 1, UNIVERSITY MEDICAL PARK AS RECORDED IN BOOK P7, PAGE 104, IN THE REGISTER'S OFFICE, MADISON COUNTY, TENNESSEE.
BEING THE SAME PROPERTY CONVEYED TO NORTHBROOKE PROPCO LLC, A DELAWARE LIMITED LIABILITY COMPANY BY DEED FROM NORTHBROOKE LONG TERM FACILITY, LLC., A TENNESSEE LIMITED LIABILITY COMPANY, FORMERLY KNOWN AS NORTHBROOKE LONG TERM FACILITY, INC., A TENNESSEE CORPORATION, OF RECORD IN BOOK D763, PAGE 556, IN THE REGISTER'S OFFICE OF MADISON COUNTY, TENNESSEE.
D-23


14.    AHC WTTC, 597 West Forest Avenue, Jackson, TN 38301:
The Land referred to herein below is situated in the County of Madison, State of Tennessee, and described as follows:
LYING AND BEING IN THE FIFTH CIVIL DISTRICT OF MADISON COUNTY, TENNESSEE, TO-WIT:
A PARCEL OF LAND LOCATED IN THE CITY OF JACKSON, MADISON COUNTY, TENNESSEE, BEING A PORTION OF THAT TRACT OF LAND CONVEYED UNTO JACKSON MADISON COUNTY GENERAL HOSPITAL DISTRICT BY QUITCLAIM DEED OF CORRECTION OF RECORD IN DEED BOOK 697, PAGE 1059, IN THE REGISTER'S OFFICE OF SAID COUNTY, AND BEING MORE PARTICULARLY DESCRIBED AS FOLLOWS: BEGIN AT A FOUND 1/2-INCH IRON ROD WITH ALUMINUM IDENTIFICATION CAP STAMPED "PLS INC JACKSON TN" (TYPICAL OF ALL IRON RODS REFERRED TO HEREIN AS SET OR RECOVERED) ON THE NORTH RIGHT-OF-WAY LINE OF FOREST AVENUE (60-FOOT RIGHT-OF-WAY), SAID IRON ROD BEING AT THE SOUTHWEST CORNER OF PROPERTY IN THE NAME OF WEST TENNESSEE HEALTHCARE, INC. (DEED BOOK 649, PAGE 181) AND AT THE SOUTHEAST CORNER OF PROPOSED LOT 201, JACKSON — MADISON MEDICAL OFFICE PARK, SECTION 11; THENCE, WITH SAID NORTH RIGHT-OF-WAY LINE, NORTH 87 DEGREES 04 MINUTES 02 SECONDS WEST, 660.14 FEET, TO AN IRON ROD SET AT THE SOUTHWEST CORNER OF PROPOSED LOT 201 AND ON THE EAST RIGHT-OF-WAY LINE OF PROPOSED MEDICAL CENTER DRIVE; THENCE, WITH THE EAST RIGHT-OF-WAY LINE OF PROPOSED MEDICAL CENTER DRIVE, NORTH 39 DEGREES 01 MINUTES 34 SECONDS WEST, 26.41 FEET, TO AN IRON ROD SET; THENCE, NORTH 14 DEGREES 25 MINUTES 14 SECONDS WEST, 345.12 FEET, TO A POINT OF CURVATURE; THENCE, WITH THE ARC OF A CURVE TURNING TO THE RIGHT, HAVING AN ARC LENGTH OF 213.86 FEET, A RADIUS OF 305.50 FEET, AND A CHORD BEARING AND LENGTH OF NORTH 04 DEGREES 04 MINUTES 45 SECONDS EAST, 209.52 FEET, TO AN IRON ROD SET AT THE NORTHWEST CORNER OF PROPOSED LOT 201 AND THE SOUTHWEST CORNER OF PROPOSED LOT 202; THENCE, LEAVING THE EAST RIGHT-OF-WAY LINE OF PROPOSED MEDICAL CENTER DRIVE WITH THE SOUTH LINE OF PROPOSED LOT 202, THE FOLLOWING COURSES: SOUTH 87 DEGREES 10 MINUTES 31 SECONDS EAST, 284.94 FEET, TO AN IRON ROD SET; THENCE, NORTH 03 DEGREES 02 MINUTES 53 SECONDS EAST, 3.70 FEET, TO AN IRON ROD SET; THENCE, SOUTH 87 DEGREES 02 MINUTES 58 SECONDS EAST, 284.78 FEET, TO AN IRON ROD SET; THENCE, SOUTH 03 DEGREES 38 MINUTES 41 SECONDS WEST, 121.37 FEET, TO AN IRON ROD SET; THENCE, SOUTH 41 DEGREES 32 MINUTES 19 SECONDS EAST, 77.53 FEET, TO AN IRON ROD SET; THENCE, SOUTH 86 DEGREES 43 MINUTES 11 SECONDS EAST, 154.63 FEET, TO AN IRON ROD SET AT THE NORTHEAST CORNER OF PROPOSED LOT 202 AND THE SOUTHEAST CORNER OF PROPOSED LOT 202; THENCE, WITH THE EAST LINE OF LOT 202, SOUTH 03 DEGREES 01 MINUTES 29 SECONDS WEST, 385.05 FEET, TO THE POINT OF BEGINNING.
D-24


BEING THE SAME PROPERTY CONVEYED TO WEST TENNESSEE PROPCO LLC, BY DEED FROM JACKSON LONG TERM FACILITY, LLC, A TENNESSEE LIMITED LIABILITY COMPANY, FORMERLY KNOWN AS JACKSON LONG TERM FACILITY, INC., A TENNESSEE CORPORATION, OF RECORD IN BOOK D763, PAGE 560, IN THE REGISTER'S OFFICE OF MADISON COUNTY, TENNESSEE.
D-25


15.    AHC Shannondale, 7424 Middlebrook Pike, Knoxville, TN 37909:
Lot 1R2
BEING LOT 1R2, FINAL PLAT OF RESUBDIVISION OF LOT 1 SHANNONDALE RETIREMENT COMMUNITY, AS SHOWN IN INSTRUMENT NO. 202403040042415, IN THE REGISTER'S OFFICE OF KNOX COUNTY, TENNESSEE, TO WHICH PLAT REFERENCE IS MADE FOR A MORE DETAILED DESCRIPTION.
BEING THE SAME PROPERTY CONVEYED TO KNOXVILLE PROPCO I, LLC BY DEED FROM PRESBYTERIAN HOMES OF TENNESSEE, INC., A TENNESSEE NOT-FOR-PROFIT CORPORATION OF RECORD IN INSTRUMENT NO. 202406240064811, REGISTER’S OFFICE FOR KNOX COUNTY, TENNESSEE.
BEING PART OF THE SAME PROPERTY CONVEYED TO PRESBYTERIAN HOMES OF TENNESSEE, INC., A GENERAL WELFARE CORPORATION BY DEED FROM JAMES C. VANOSDALE; WILLIAM H. VANOSDALE; ONEIDA VANOSDALE STAATS; BLANNIE COX VANOSDALE (WIDOW OF RUSSELL G. VANOSDALE, DECEASED); THEODORE VANOSDALE; GRACE VANOSDALE BEAN; LOT77E BELLE VANOSDALE HINTON; DAVID A. VANOSDALE; RUTH VANOSDALE RHEA (FOR HERSELF AND AS DEVISEE OF MARGARET LYDIA VANOSDALE, DECEASED) (ALL OF THE PARTIES OF THE FIRST PART BEING THE HEIRS AND DEVISEES OF DAM C. VANOSDALE, DECEASED, AND HIS WIFE FLORENCE VANOSDALE, DECEASED), OF RECORD IN DEED BOOK 1246, PAGE 839; TO PRESBYTERIAN HOMES OF TENNESSEE, INC., BY DEED FROM SARAH BARBEE, (WIDOW), OF RECORD IN DEED BOOK 1472, PAGE 210; TO PRESBYTERIAN HOMES OF TENNESSEE, INC., A TENNESSEE NOT-FOR-PROFIT CORPORATION, BY DEEDS FROM LARRY D. MAPLES, AS DEVISEE UNDER THE LAST WILL AND TESTAMENT OF JUANITA LONG THOMAS, AND WIFE, SHARON MAPLES, OF RECORD IN INSTRUMENT NO. 201311260033629; FROM JUNE L. MAPLES, AN UNMARRIED WIDOW, OF RECORD IN INSTRUMENT NO. 201311260033633; FROM PEOPLE'S DEVELOPMENT COMPANY, INC., A TENNESSEE CORPORATION, OF RECORD IN INSTRUMENT NO. 201408220011359; AND FROM RFH, LP, A TENNESSEE LIMITED PARTNERSHIP, OF RECORD IN INSTRUMENT NO. 201507310007180, IN THE REGISTER'S OFFICE OF KNOX COUNTY, TENNESSEE.
D-26


16.    AHC Wellpark, 7512 Middlebrook Pike, Knoxville, TN 37909:
Lot 1R1
BEING LOT 1R1, FINAL PLAT OF RESUBDIVISION OF LOT 1 SHANNONDALE RETIREMENT COMMUNITY, AS SHOWN IN INSTRUMENT NO. 02403040042415, IN THE REGISTER'S OFFICE OF KNOX COUNTY, TENNESSEE, TO WHICH PLAT REFERENCE IS MADE FOR A MORE DETAILED DESCRIPTION.
BEING THE SAME PROPERTY CONVEYED TO WELLPARK PROPCO, LLC BY DEED FROM PRESBYTERIAN HOMES OF TENNESSEE, INC., A TENNESSEE NOT-FOR-PROFIT CORPORATION OF RECORD IN INSTRUMENT NO. 202406240064810, REGISTER’S OFFICE FOR KNOX COUNTY, TENNESSEE.
BEING PART OF THE SAME PROPERTY CONVEYED TO PRESBYTERIAN HOMES OF TENNESSEE, INC., A GENERAL WELFARE CORPORATION BY DEED FROM JAMES C. VANOSDALE; WILLIAM H. VANOSDALE; ONEIDA VANOSDALE STAATS; BLANNIE COX VANOSDALE (WIDOW OF RUSSELL G. VANOSDALE, DECEASED); THEODORE VANOSDALE; GRACE VANOSDALE BEAN; LOTTIE BELLE VANOSDALE HINTON; DAWD A. VANOSDALE; RUTH VANOSDALE RHEA (FOR HERSELF AND AS DEVISEE OF MARGARET LYDIA VANOSDALE, DECEASED) (ALL OF THE PAR77ES OF THE FIRST PART BEING THE HEIRS AND DEVISEES OF DAWD C. VANOSDALE, DECEASED, AND HIS WIFE FLORENCE VANOSDALE, DECEASED), OF RECORD IN DEED BOOK 1246, PAGE 839; TO PRESBYTERIAN HOMES OF TENNESSEE, INC., BY DEED FROM SARAH BARBEE, (WIDOW), OF RECORD IN DEED BOOK 147Z PAGE 210; TO PRESBYTERIAN HOMES OF TENNESSEE, INC., A TENNESSEE NOT-FOR-PROFIT CORPORATION, BY DEEDS FROM LARRY D. MAPLES, AS DEVISEE UNDER THE LAST WILL AND TESTAMENT OF JUANITA LONG THOMAS, AND WIFE, SHARON MAPLES, OF RECORD IN INSTRUMENT NO. 201311260033629; FROM JUNE L MAPLES, AN UNMARRIED WIDOW, OF RECORD IN INSTRUMENT NO. 201311260033633; FROM PEOPLE'S DEVELOPMENT COMPANY, INC., A TENNESSEE CORPORATION, OF RECORD IN INSTRUMENT NO.201408220011359; AND FROM RFH, LP, A TENNESSEE LIMITED PARTNERSHIP, OF RECORD IN INSTRUMENT NO. 201507310007180, IN THE REGISTER'S OFFICE OF KNOX COUNTY, TENNESSEE.
D-27


17.    AHC Lexington, 727 East Church Street, Lexington, TN 38351:
The Land referred to herein below is situated in the County of Henderson, State of Tennessee, and described as follows:
LYING AND BEING SITUATED IN THE CITY OF LEXINGTON, FIFTH CIVIL DISTRICT, HENDERSON COUNTY, TENNESSEE AND BEING THAT LAND CONVEYED TO LEXINGTON MANOR, INC., A TENNESSEE CORPORATION, BY DEED OF CHARLIE WALKER ET UX, ET AL, AS APPEARS OF RECORD IN DEED BOOK 119, PAGE 184, REGISTER’S OFFICE HENDERSON COUNTY, TENNESSEE; AND BEING THAT LAND CONVEYED TO LEXINGTON MANOR, INC., A TENNESSEE CORPORATION, BY DEED OF CHARLIE WALKER ET UX, ET AL, AS APPEARS OF RECORD IN DEED BOOK 119, PAGE 395, REGISTERS OFFICE HENDERSON COUNTY, TENNESSEE, SAID LAND APPEARS ON MAP 91 AS PARCEL 9.01, ASSESSOR OF PROPERTY'S OFFICE HENDERSON COUNTY, TENNESSEE, AND BEING MORE PARTICULARLY DESCRIBED AS FOLLOW:
BEGINNING ON A FOUND IRON PIN IN THE NORTH MARGIN OF EAST CHURCH STREET (US HIGHWAY 412), SAID IRON PIN BEING LOCATED APPROXIMATELY 1060 FEET EAST OF THE CENTERLINE OF EASTGATE STREET, BEING THE SOUTHEAST CORNER OF A TRACT IN THE NAME OF HELMS REALTY (DEED BOOK 175, PAGE 236), AND BEING THE SOUTHWEST CORNER OF THE SUBJECT TRACT; THENCE WITH THE EAST LINE OF HELMS REALTY, NORTH 06 DEGREES 00 MINUTES 00 SECONDS EAST A DISTANCE OF 431.70 FEET TO A FOUND STEEL POST IN THE CENTERLINE OF A TVA ELECTRIC TRANSMISSION LINE, SAID STEEL POST BEING THE SOUTHEAST CORNER OF LINDA FAYE BELEW (DEED BOOK 156, PAGE 171) AND THE SOUTHWEST CORNER OF BARRY AND WALKER (DEED BOOK 91, PAGE 42); THENCE WITH THE CENTER OF THE TVA ELECTRIC LINE AND WITH BARRY AND WALKER’S SOUTHERN LINE, NORTH 81 DEGREES 37 MINUTES 46 SECONDS EAST, PASSING A FOUND CONCRETE MONUMENT AT 309.30 FEET, IN ALL, A DISTANCE OF 314.46 FEET TO A FOUND STEEL POST; THENCE WITH THE WEST LINE OF BARRY AND WALKER (DEED BOOK 91, PAGE 42), SOUTH 05 DEGREES 57 MINUTES 27 SECONDS WEST A DISTANCE OF 509.52 FEET TO A SET IRON PIN IN THE NORTH MARGIN OF EAST CHURCH STREET; THENCE WITH THE NORTH MARGIN OF SAID STREET, NORTH 84 DEGREES 02 MINUTES 33 SECONDS WEST, PASSING A FOUND CONCRETE MONUMENT BY A UTILITY POLE AT 5.00 FEET, IN ALL, A DISTANCE OF 305.00 FEET TO THE BEGINNING.
BEING THE SAME PROPERTY CONVEYED TO LEXINGTON PROPCO LLC, A DELAWARE LIMITED LIABILITY COMPANY BY DEED FROM LEXINGTON LONG TERM FACILITY, LLC, A TENNESSEE LIMITED LIABILITY COMPANY, FORMERLY KNOWN AS LEXINGTON LONG TERM FACILITY, INC, A TENNESSEE CORPORATION, OF RECORD IN DEED BOOK 289, PAGE 755, IN THE REGISTER'S OFFICE OF HENDERSON COUNTY, TENNESSEE.
D-28


D-29


18.    AHC VanAyer, 460 Hannings Lane, Martin, TN 38237:
TRACT 1:
THE FOLLOWING IS A DESCRIPTION OF A SURVEY MADE OF THE PROPERTY CURRENTLY REGISTERED IN THE NAME OF NATIONWIDE HEALTH PROPERTIES, INC., A MARYLAND CORPORATION, AS RECORDED IN DEED BOOK 340, PAGE 167, IN THE OFFICE OF THE REGISTER, WEAKLEY COUNTY, TENNESSEE. THIS PROPERTY LIES WITHIN THE SECOND CIVIL DISTRICT OF WEAKLEY COUNTY, WITHIN THE CITY LIMITS OF MARTIN, TENNESSEE, AND MORE PARTICULARLY DESCRIBED AS FOLLOWS:
BEGINNING ON A FOUND IRON PIN IN THE SOUTH MARGIN OF HANNINGS LANE EXTENDED, SAID IRON PIN BEING THE NORTHWEST CORNER OF A TRACT IN THE NAME OF WESLEY AT MARTIN, INC., DEED BOOK 337, PAGE 238, AND BEING THE NORTHEAST CORNER OF THE SUBJECT TRACT; THENCE WITH THE WEST LINE OF WESLEY AT MARTIN, INC., SOUTH 00 DEGREES 16 MINUTES 37 SECONDS WEST AT A DISTANCE OF 599.82 FEET TO A FOUND IRON PIN AT AN INTERIOR CORNER OF WESLEY AT MARTIN, INC.; THENCE WITH THE NORTH LINE OF WESLEY AT MARTIN, INC., NORTH 89 DEGREES 46 MINUTES 27 SECONDS WEST A DISTANCE OF 258.96 FEET TO A FOUND IRON PIN IN THE EAST RIGHT-OF-WAY OF U.S. 45-E BYPASS, SAID IRON PIN BEING ONE FOOT EAST TO THE CHAIN-LINK FENCE; THENCE WITH THE RIGHT-OF-WAY OF SAID BYPASS, TWO COURSES: NORTH 10 DEGREES 18 MINUTES 10 SECONDS WEST A DISTANCE OF 207.89 FEET TO A CONCRETE MARKER; THENCE NORTH 03 DEGREES 20 MINUTES 38 SECONDS WEST A DISTANCE OF 364.50 FEET TO A CONCRETE MARKER IN THE SOUTH RIGHT-OF-WAY OF HANNINGS LANE EXTENDED; THENCE WITH THE SOUTH RIGHT-OF- WAY OF HANNINGS LANE, TWO COURSES: NORTH 72 DEGREES 50 MINUTES 57 SECONDS EAST A DISTANCE OF 109.48 FEET TO A CONCRETE MARKER BY THE END OF THE CHAIN LINK FENCE; THENCE SOUTH 89 DEGREES 29 MINUTES 36 SECONDS EAST A DISTANCE OF 215.69 FEET TO THE BEGINNING, CONTAINING 4.08 ACRES. SURVEYED BY DENNY A. BUSH, TENNESSEE RLS #1577, ON SEPTEMBER 25, 2001. BEARINGS ARE BASED ON A SURVEY BY J.T. MOORE ON MARCH 1985, WHICH WAS MAGNETIC ON THAT DATE.
TRACT 2:
EASEMENT(S) BENEFITING TRACT 1, EASEMENT FOR AN ELECTRIC TRANSMISSION LINE THAT CROSSES THE SOUTHWEST CORNER OF THE PROPERTY. THIS EASEMENT IS 75 FEET WIDE, OR 37.5 FEET EACH SIDE OF AN EXISTING ELECTRIC LINE. THIS IS A PERMANENT EASEMENT, OF RECORD IN DEED BOOK 81, PAGE 217, IN THE REGISTER'S OFFICE OF WEAKLEY COUNTY, TENNESSEE.
D-30


TRACT 3:
EASEMENT(S) BENEFITING TRACT 1, A PERMANENT EASEMENT FOR THE CONSTRUCTION AND/OR MAINTENANCE OF A SEWER LINE ACROSS THE NORTHERN EDGE OF THIS PROPERTY WAS GRANTED TO THE CITY OF MARTIN, TN BY VANAYER ENTERPRISES, INC., OF RECORD IN DEED BOOK 335, PAGE 647, IN THE REGISTER'S OFFICE OF WEAKLEY COUNTY, TENNESSEE. THIS EASEMENT IS 20' WIDE, RUNNING ALONG WITH AND PARALLEL TO HANNINGS LANE, AND IS MORE PARTICULARLY DESCRIBED AS FOLLOWS:
BEGINNING ON A FOUND IRON PIN IN THE SOUTH MARGIN OF HANNINGS LANE, SAID IRON PIN BEING THE NORTHEAST CORNER OF VANAYER ENTERPRISES, INC. PROPERTY (DB 184, PG 280), AND BEING THE NORTHWEST CORNER OF WESLEY AT MARTIN, INC. (DB 337, PG 238); THENCE WITH THE WESTERN LINE OF WESLEY AT MARTIN, INC., SOUTH 00 DEGREES 16 MINUTES 37 SECONDS WEST A DISTANCE OF 20.00 FEET; THENCE RUNNING 20’ SOUTH OF AND PARALLEL WITH THE SOUTH MARGIN OF HANNINGS LANE, TWO (2) COURSES: NORTH 89 DEGREES 29 MINUTES 36 SECONDS WEST A DISTANCE OF 212.67 FEET; THENCE SOUTH 72 DEGREES 50 MINUTES 57 SECONDS WEST A DISTANCE OF 22.12 FEET; THENCE NORTH 16 DEGREES 30 MINUTES 08 SECONDS WEST A DISTANCE OF 20.00 FEET TO A POINT IN THE SOUTHERN MARGIN OF HANNINGS LANE; THENCE WITH THE SOUTHERN MARGIN OF HANNINGS LANE, TWO (2) COURSES: NORTH 72 DEGREES 50 MINUTES 57 SECONDS EAST A DISTANCE OF 25.00 FEET; THENCE SOUTH 89 DEGREES 29 MINUTES 36 SECONDS EAST A DISTANCE OF 215.69 FEET TO THE BEGINNING, CONTAINING 4,754.8 SQUARE FEET, OR 0.109 ACRES.
BEING THE SAME PROPERTY CONVEYED TO VANAYER PROPCO LLC, A DELAWARE LIMITED LIABILITY COMPANY, BY DEED FROM VANAYER LONG TERM FACILITY, LLC, A TENNESSEE LIMITED LIABILITY COMPANY, FORMERLY KNOWN AS VANAYER LONG TERM FACILITY, INC., A TENNESSEE CORPORATION, OF RECORD IN BOOK D453, PAGE 142, IN THE REGISTER'S OFFICE OF WEAKLEY COUNTY, TENNESSEE.
D-31


19.    AHC McKenzie, 175 Hospital Drive McKenzie, TN 38201
The Land referred to herein below is situated in the County of Carroll, State of Tennessee, and described as follows:
PARCEL 1:
BEGINNING ON AN EXISTING 1/2 INCH IRON PIN AT THE NORTHEAST CORNER OF SPIVEY (TAX MAP 11, PARCEL 40.09 - DEED BOOK. 309, PAGE. 373), SAID IRON PIN BEING LOCATED 103.65 FEET SOUTHEAST OF THE CENTERLINE OF U.S. HIGHWAY 79 (HIGHLAND DRIVE) AND APPROXIMATELY 205 FEET NORTHEAST OF THE CENTERLINE OF HOSPITAL DRIVE AND BEING THE NORTHWEST CORNER OF THE TRACT DESCRIBED HEREIN; THENCE WITH THE SOUTHEASTERN RIGHT-OF-WAY OF U.S. HIGHWAY 79, RUNNING 103.65 FEET FROM AND PARALLEL WITH THE CENTERLINE OF SAID HIGHWAY, NORTH 52 DEGREES 56 MINUTES 00 SECONDS EAST FOR A DISTANCE OF 222.60 FEET TO A SET IRON PIN NEAR THE END OF A WIRE FENCE, SAID IRON PIN BEING A POINT IN THE SOUTHERN RIGHT-OF- WAY OF STATE ROUTE 22; THENCE WITH THE SOUTHERN RIGHT-OF-WAY OF STATE ROUTE 22 AS FOLLOWS:
NORTH 87 DEGREES 40 MINUTES 00 SECONDS EAST FOR A DISTANCE OF 201.93 FEET TO AN EXISTING CONCRETE RIGHT-OF-WAY MONUMENT; THENCE SOUTH 37 DEGREES 39 MINUTES 32 SECONDS EAST FOR A DISTANCE OF 105.00 FEET TO A SET IRON PIN LOCATED 7.7 FEET SOUTHWEST OF AN EXISTING RIGHT-OF-WAY MONUMENT; THENCE SOUTH 67 DEGREES 07 MINUTES 34 SECONDS EAST FOR A DISTANCE OF 119.03 FEET TO A SET IRON PIN LOCATED 7.2 FEET SOUTH OF AN EXISTING RIGHT-OF-WAY MONUMENT; THENCE SOUTH 67 DEGREES 07 MINUTES 34 SECONDS EAST FOR A DISTANCE OF 98.40 FEET TO A SET IRON PIN LOCATED 3.2 FEET SOUTHEAST OF AN EXISTING RIGHT-OF-WAY MONUMENT; THENCE SOUTH 70 DEGREES 03 MINUTES 39 SECONDS EAST FOR A DISTANCE OF 189.53 FEET TO A SET IRON PIN LOCATED 11.47 FEET NORTHWEST OF AN EXISTING RIGHT-OF-WAY MONUMENT AND BEING THE NORTHWEST CORNER OF JONATHAN DOSTER (TAX MAP 11, PARCEL 39.00 - DEED BOOK. 350, PAGE. 456); THENCE WITH THE WESTERN LINE OF DOSTER, SOUTH 03 DEGREES 37 MINUTES 58 SECONDS EAST FOR A DISTANCE OF 233.53 FEET TO AN EXISTING IRON PIN AT THE SOUTHWEST CORNER OF DOSTER AND BEING A NORTHERN CORNER OF MCKENZIE HOSPITAL CORP. (TAX MAP 11, PARCEL 40.03 -DEED BOOK. 315, PAGE.
D-32


343); THENCE WITH THE NORTHWESTERN LINE IF MCKENZIE HOSPITAL CORP., SOUTH 60 DEGREES 37 MINUTES 17 SECONDS WEST FOR A DISTANCE OF 282.91 FEET TO AN EXISTING IRON PIN, SAID IRON PIN BEING LOCATED 0.7 FOOT NORTHWEST OF THE BACK OF AN ASPHALT CURB AND 2.3 FEET NORTHEAST OF THE BACK OF A CONCRETE CURB; THENCE WITH THE NORTHERN LINE OF MCKENZIE HOSPITAL CORP., RUNNING ALONG THE NORTHERN MARGIN OF A PAVED PRIVATE DRIVE AS FOLLOWS: NORTH 50 DEGREES 45 MINUTES 57 SECONDS WEST FOR A DISTANCE OF 25.97 FEET TO AN EXISTING IRON PIN; THENCE NORTH 60 DEGREES 56 MINUTES 52 SECONDS WEST FOR A DISTANCE OF 32.69 FEET TO AN EXISTING IRON PIN; THENCE NORTH 43 DEGREES 56 MINUTES 49 SECONDS WEST FOR A DISTANCE OF 10.02 FEET TO AN EXISTING IRON PIN; THENCE NORTH 73 DEGREES 52 MINUTES 49 SECONDS WEST FOR A DISTANCE OF 56.04 FEET TO AN EXISTING IRON PIN; THENCE NORTH 85 DEGREES 43 MINUTES 40 SECONDS WEST FOR A DISTANCE OF 70.11 FEET TO AN "X" CUT IN CONCRETE OVER A CULVERT; THENCE SOUTH 83 DEGREES 06 MINUTES 09 SECONDS WEST FOR A DISTANCE OF 81.46 FEET TO AN EXISTING IRON PIN LOCATED 5.0 FEET NORTH OF THE BACK OF THE CONCRETE CURB; THENCE WITH THE EASTERN LINE OF MCKENZIE HOSPITAL CORP., NORTH 38 DEGREES 45 MINUTES 00 SECONDS WEST, PASSING AN EXISTING RAILROAD SPIKE AT THE SOUTHEAST CORNER OF SPIVEY AT A DISTANCE OF 297.78 FEET AND CONTINUING WITH THE EASTERN LINE OF SPIVEY FOR A TOTAL DISTANCE OF 527.28 FEET TO THE POINT OF BEGINNING.
PERPETUAL INGRESS AND EGRESS EASEMENT COMMENCING AT A THE INTERSECTION OF THE SOUTHEASTERN RIGHT-OF-WAY OF U.S. HIGHWAY 79 AKA HIGHLAND DRIVE (50 FEET FROM CENTERLINE) WITH THE EASTERN RIGHT-OF-WAY OF HOSPITAL DRIVE AKA MEDICAL CENTER DRIVE (25 FEET FROM CENTERLINE), SAID POINT BEING THE NORTHWEST CORNER OF SPIVEY (TAX MAP 11, PARCEL 40.09 - DEED BOOK. 309, PAGE. 373), THENCE WITH THE EASTERN RIGHT-OF-WAY OF HOSPITAL DRIVE AS FOLLOWS: SOUTH 38 DEGREES 45 MINUTES 00 SECONDS EAST FOR A DISTANCE OF 387.00 FEET; THENCE SOUTH 31 DEGREES 00 MINUTES 00 SECONDS EAST FOR A DISTANCE OF 112.53 FEET TO THE TRUE POINT OF BEGINNING OF THIS EASEMENT; THENCE WITH THE NORTHERN MARGIN OF AN EXISTING PAVED DRIVE AS FOLLOWS: NORTH 72 DEGREES 23 MINUTES 01 SECONDS EAST FOR A DISTANCE OF 115.92 FEET; THENCE NORTH 77 DEGREES 07 MINUTES 28 SECONDS EAST FOR A DISTANCE OF 76.68 FEET; THENCE NORTH 83 DEGREES 06 MINUTES 25 SECONDS EAST FOR A DISTANCE OF 22.32 FEET TO AN EXISTING IRON PIN AT THE SOUTHWESTERN CORNER OF THE NURSING HOME TRACT (TAX MAP 11, PARCEL 40.07); THENCE WITH THE NORTHERN MARGIN OF THE EXISTING PAVED DRIVE AND THE SOUTHERN LINE OF THE NURSING HOME TRACT AS FOLLOWS: NORTH 83 DEGREES 06 MINUTES 09 SECONDS EAST FOR A DISTANCE OF 81.46 FEET TO AN "X" CUT IN CONCRETE; THENCE SOUTH 85 DEGREES 43 MINUTES 40 SECONDS EAST FOR A DISTANCE OF 70.11 FEET TO AN EXISTING IRON PIN; THENCE SOUTH 73 DEGREES 52 MINUTES 49 SECONDS EAST FOR A DISTANCE OF 56.04 FEET TO AN EXISTING IRON PIN; THENCE SOUTH 43 DEGREES 56 MINUTES 49 SECONDS EAST FOR A DISTANCE OF 10.02 FEET TO AN EXISTING IRON PIN; THENCE SOUTH 60 DEGREES 56 MINUTES 52 SECONDS EAST, CROSSING THE PAVED ENTRANCE TO THE NURSING HOME TRACT FOR A DISTANCE OF 32.69 FEET TO AN EXISTING IRON PIN; THENCE SOUTH 50 DEGREES 45 MINUTES 57 SECONDS EAST FOR A DISTANCE OF 25.97 FEET TO AN EXISTING IRON PIN AT THE MOST SOUTHERN SOUTHEAST CORNER OF THE NURSING HOME TRACT; THENCE SOUTH 39 DEGREES 14 MINUTES 03 SECONDS WEST, CROSSING THE PAVED DRIVE FOR A DISTANCE OF 25.00 FEET; THENCE ALONG THE SOUTHERN MARGIN OF THE PAVED DRIVE AS FOLLOWS: NORTH 50 DEGREES 45 MINUTES 57 SECONDS WEST FOR A DISTANCE OF 23.74 FEET; THENCE NORTH 60 DEGREES 56 MINUTES 52 SECONDS WEST FOR A DISTANCE OF 27.63 FEET; THENCE NORTH 73 DEGREES 52 MINUTES 49 SECONDS WEST FOR A DISTANCE OF 58.77 FEET; THENCE NORTH 85 DEGREES 43 MINUTES 40 SECONDS WEST FOR A DISTANCE OF 64.06 FEET; THENCE SOUTH 83 DEGREES 06 MINUTES 09 SECONDS WEST FOR A DISTANCE OF 99.29 FEET; THENCE SOUTH 77 DEGREES 07 MINUTES 28 SECONDS WEST FOR A DISTANCE OF 73.87 FEET; THENCE SOUTH 72 DEGREES 23 MINUTES 01 SECONDS WEST FOR A DISTANCE OF 107.54 FEET TO A POINT IN THE EASTERN RIGHT-OF-WAY OF HOSPITAL DRIVE; THENCE WITH THE EASTERN MARGIN OF HOSPITAL DRIVE, NORTH 31 DEGREES 00 MINUTES 18 SECONDS WEST, CROSSING THE PAVED DRIVE FOR A DISTANCE OF 30.85 FEET TO THE POINT OF BEGINNING.
D-33


BEING THE SAME PROPERTY CONVEYED TO MCKENZIE PROPCO, LLC, A DELAWARE LIMITED LIABILITY COMPANY BY DEED FROM MCKENZIE LONG TERM FACILITY, LLC., A TENNESSEE LIMITED LIABILITY COMPANY, FORMERLY KNOWN AS MCKENZIE LONG TERM FACILITY, INC., A TENNESSEE CORPORATION, OF RECORD IN DEED BOOK 398, PAGE 1, IN THE REGISTER'S OFFICE OF CARROLL COUNTY, TENNESSEE.
D-34


20.    AHC Bright Glade, 5070 Sanderlin Avenue, Memphis, TN 38117:
The Land referred to herein below is situated in the County of Shelby, State of Tennessee, and described as follows:
BEGINNING AT A FOUND IRON PIN ON THE NORTH EDGE OF A CONCRETE SIDEWALK IN THE NORTHERN RIGHT-OF-WAY OF SANDERLIN ROAD (PAVED PUBLIC STREET, 68' R.O.W.), SAID IRON PIN BEING LOCATED 34.33 FEET WEST OF THE TANGENT INTERSECTION OF THE NORTHERN RIGHT-OF- WAY OF SANDERLIN ROAD WITH THE WESTERN RIGHT-OF-WAY OF WINTON STREET; THENCE WITH THE NORTHERN RIGHT-OF-WAY OF SANDERLIN ROAD, RUNNING WITH THE NORTHERN EDGE OF A CONCRETE SIDEWALK AS FOLLOWS: NORTH 88 DEGREES 33 MINUTES 28 SECONDS WEST A DISTANCE OF 169.99 FEET TO A FOUND IRON PIN; THENCE NORTH 89 DEGREES 53 MINUTES 31 SECONDS WEST A DISTANCE OF 215.52 FEET TO A FOUND CHISEL MARK IN THE NORTHERN EDGE OF THE CONCRETE SIDEWALK AT THE SOUTHEAST CORNER OF LAURELWOOD PEDIATRIC PROPERTIES AND SANDERLIN PLACE (RECORDED IN INSTRUMENT NO. 05022983); THENCE WITH THE EASTERN LINE OF LAURELWOOD PEDIATRIC PROPERTIES AND SANDERLIN PLACE, AND WITH THE EASTERN LINE OF ANOTHER TRACT IN THE NAME OF SANDERLIN PLACE (RECORDED IN INSTRUMENT NO. 03071767), NORTH 07 DEGREES 48 MINUTES 09 SECONDS EAST A DISTANCE OF 432.84 FEET TO A FOUND 1" IRON PIPE WITH A PINCHED TOP IN THE SOUTHERN LINE OF NELL LOVE CRUTCHER (RECORDED IN BOOK 2659, PAGE 202); THENCE WITH THE SOUTHERN LINE OF CRUTCHER, AND WITH THE SOUTHERN LINE OF RANDALL HOLCOMB (RECORDED IN CZ 8441), NORTH 89 DEGREES 44 MINUTES 35 SECONDS EAST A DISTANCE OF 374.11 FEET TO A FOUND IRON PIN IN THE WESTERN RIGHT-OF- WAY OF WINTON STREET (68 FEET R.O.W.); THENCE WITH THE WESTERN RIGHT-OF-WAY OF WINTON STREET, SOUTH 01 DEGREES 43 MINUTES 11 SECONDS WEST A DISTANCE OF 401.92 FEET TO A FOUND IRON PIN; THENCE WITH A CURVE TO THE RIGHT, HAVING AN ARC LENGTH OF 54.02 FEET, WITH A RADIUS OF 34.50 FEET, AND A CHORD OF SOUTH 46 DEGREES 34 MINUTES 51 SECONDS WEST FOR A DISTANCE OF 48.67 FEET TO THE BEGINNING.
INCLUDED IN THE FOREGOING DESCRIPTION, BUT EXPRESSLY EXCLUDED THEREFROM, IS PROPERTY CONVEYED BY THE FOLLOWING, ALL OF RECORD IN THE REGISTER'S OFFICE OF SHELBY COUNTY, TENNESSEE:
1.    DEED TO THE CITY OF MEMPHIS, A MUNICIPAL CORPORATION, IN INSTRUMENT NO. W4 2182; AND, IN THE REGISTER'S OFFICE OF SHELBY COUNTY, TENNESSEE.
2.    DEED TO CITY OF MEMPHIS, A MUNICIPAL CORPORATION, IN INSTRUMENT NO. Z4 2479;
D-35


BEING THE SAME PROPERTY CONVEYED TO BRIGHT GLADE PROPCO LLC, A DELAWARE LIMITED LIABILITY COMPANY, BY DEED FROM BRIGHT GLADE LONG TERM FACILITY, LLC, A TENNESSEE LIMITED LIABILITY COMPANY, FORMERLY KNOWN AS BRIGHT GLADE LONG TERM FACILITY, INC, A TENNESSEE CORPORATION, OF RECORD IN INSTRUMENT NO. 21045212, IN THE REGISTER'S OFFICE OF SHELBY COUNTY, TENNESSEE.
D-36


21.    AHC Harbor View, 1513 N 2nd Street, Memphis, TN 38107
The Land referred to herein below is situated in the County of Shelby, State of Tennessee, and described as follows:
TRACT 1
BEGINNING ON A SET IRON PIN IN THE WESTERN RIGHT-OF-WAY OF NORTH SECOND STREET (28 FEET FROM CENTERLINE), SAID IRON PIN BEING LOCATED ABOUT 4 FEET NORTH OF THE PROJECTED CENTERLINE OF MAHANNAH AVENUE, BEING THE SOUTHEAST CORNER OF A TRACT BELONGING TO THE CITY OF MEMPHIS (BOOK 1693, PAGE 184 – PARCEL ID 3900100004), BEING THE NORTHEAST CORNER OF THE ANDERSON TULLY COMPANY TRACT DESCRIBED IN BOOK 4959, PAGE 162 AND THE NORTHEAST CORNER OF THE PROPERTY DESCRIBED HEREIN; THENCE WITH THE WESTERN RIGHT- OF-WAY OF NORTH SECOND STREET, RUNNING WITH A CURVE TURNING TO THE RIGHT, HAVING AN ARC LENGTH OF 376.07 FEET, WITH A RADIUS OF 2100.00 FEET, WITH A CHORD BEARING OF SOUTH 09 DEGREES 49 MINUTES 21 SECONDS EAST AND A CHORD LENGTH OF 375.57 FEET TO A SET IRON PIN AT THE NORTHEAST CORNER OF A TRACT BELONGING TO FORD FARMS (INSTRUMENT NO. CS-6513 - PARCEL ID 03900100013); THENCE WITH THE NORTHERN LINE OF FORD FARMS, NORTH 88 DEGREES 43 MINUTES 01 SECONDS WEST, PASSING A CHAIN-LINK FENCE CORNER AT 6.5 FEET, THEN CONTINUING WITH THE FENCE FOR A TOTAL DISTANCE OF 248.01 FEET TO A FOUND 1-1/2" IRON PIPE AT THE END OF THE FENCE; THENCE WITH THE WESTERN LINE OF FORD FARMS, SOUTH 13 DEGREES 26 MINUTES 04 SECONDS EAST FOR A DISTANCE OF 254.90 FEET TO A SET IRON PIN;
THENCE WITH THE NORTHERN LINE OF FORD FARMS, NORTH 88 DEGREES 43 MINUTES 01 SECONDS WEST, PASSING AN IRON PIN SET ON LINE AT 265 FEET, CONTINUING FOR A TOTAL DISTANCE OF 498.60 FEET TO A POINT IN THE EASTERN LINE OF THE MEMPHIS HARBOR COMMISSION (BOOK 1461, PAGE 66), SAID POINT BEING NEAR THE LOW-WATER LINE OF THE OLD WOLF RIVER CHANNEL;
THENCE WITH THE EASTERN LINE OF THE MEMPHIS HARBOR COMMISSION, RUNNING NEAR THE LOW-WATER LINE OF THE OLD WOLF RIVER CHANNEL, NORTH 16 DEGREES 55 MINUTES 02 SECONDS WEST FOR A DISTANCE OF 625.92 FEET TO A SET IRON PIN AT THE SOUTHERN CORNER OF A SMALL TRACT BELONGING TO THE CITY OF MEMPHIS (BOOK 4335, PAGE 500); THENCE WITH THE SOUTHEASTERN LINE OF SAID TRACT, NORTH 53 DEGREES 52 MINUTES 32 SECONDS EAST FOR A DISTANCE OF 90.94 FEET TO A SET IRON PIN IN THE SOUTHERN LINE OF ANOTHER TRACT BELONGING TO THE CITY OF MEMPHIS (PARCEL ID 03900100001); THENCE WITH THE SOUTHERN LINE OF THE CITY OF MEMPHIS TRACT, SOUTH 86 DEGREES 00 MINUTES 00 SECONDS EAST, PASSING A FOUND REBAR ON LINE AT 724.9 FEET CONTINUING FOR A DISTANCE OF 733.60 FEET TO THE POINT OF BEGINNING, CONTAINING 430,385 SQUARE FEET OR 9.880 ACRES.
D-37


TRACT 2
BEGINNING ON A SET IRON PIN IN THE WESTERN RIGHT-OF-WAY OF NORTH SECOND STREET (37 FEET FROM APPARENT CENTERLINE), SAID IRON PIN BEING LOCATED 770.5 FEET NORTHERLY FROM THE NORTHEAST CORNER OF A CONCRETE SEAWALL, BEING THE NORTHEAST CORNER OF A TRACT BELONGING TO THE CITY OF MEMPHIS (BOOK 4646, PAGE 488 - PARCEL ID 03900100007 AND PARCEL ID 03900100008) AND BEING THE SOUTHEAST CORNER OF THE TRACT DESCRIBED HEREIN; THENCE WITH THE NORTHERN LINE OF THE CITY OF MEMPHIS TRACT AS FOLLOWS: NORTH 85 DEGREES 46 MINUTES 31 SECONDS WEST FOR A DISTANCE OF 60.00 FEET TO A SET IRON PIN; THENCE SOUTH 00 DEGREES 53 MINUTES 31 SECONDS EAST FOR A DISTANCE OF 35.00 FEET TO A FOUND 1-1/2 INCH IRON PIPE IN AN OLD CHAIN-LINK FENCE; THENCE NORTH 85 DEGREES 46 MINUTES 31 SECONDS WEST FOR A DISTANCE OF 134.06 FEET TO A SET IRON PIN; THENCE SOUTH 00 DEGREES 53 MINUTES 31 SECONDS EAST FOR A DISTANCE OF 67.31 FEET TO A SET IRON PIN; THENCE NORTH 85 DEGREES 6 MINUTES 31 SECONDS WEST FOR A DISTANCE OF 30.00 FEET TO A SET IRON PIN; THENCE SOUTH 48 DEGREES 00 MINUTES 16 SECONDS WEST FOR A DISTANCE OF 115.70 FEET TO A SET IRON PIN;
THENCE NORTH 85 DEGREES 09 MINUTES 39 SECONDS WEST FOR A DISTANCE OF 204.31 FEET TO A SET IRON PIN IN THE EASTERN LINE OF THE MEMPHIS HARBOR COMMISSION (BOOK 1461, PAGE 66); THENCE WITH THE EASTERN LINE OF THE MEMPHIS HARBOR COMMISSION AS FOLLOWS: RUNNING WITH A CURVE TURNING TO THE LEFT, HAVING AN ARC LENGTH OF 245.89 FEET AND A RADIUS OF 2553.06, WITH A CHORD BEARING OF NORTH 16 DEGREES 20 MINUTES 41 SECONDS WEST AND A CHORD DISTANCE OF 245.80 FEET TO A SET IRON PIN; THENCE NORTH 19 DEGREES 06 MINUTES 14 SECONDS WEST FOR A DISTANCE OF 359.23 FEET TO AN EXISTING IRON PIN AT THE SOUTHWEST CORNER OF A TRACT BELONGING TO HARBOR VIEW PROPERTIES, INC. (INSTRUMENT NO. 061555544 - PARCEL ID 03900100003 AND PARCEL ID 03900100012); THENCE WITH THE SOUTHERN LINE OF HARBOR VIEW PROPERTIES, INC., SOUTH 88 DEGREES 43 MINUTES 01 SECONDS EAST, PASSING AN IRON PIN ON LINE AT 233.6 FEET AND CONTINUING FOR A TOTAL DISTANCE OF 498.60 FEET TO AN EXISTING IRON PIN; THENCE WITH THE EASTERN LINE OF HARBOR VIEW PROPERTIES, INC., NORTH 13 DEGREES 26 MINUTES 04 SECONDS WEST FOR A DISTANCE OF 254.90 FEET TO A FOUND 1-1/2 INCH IRON PIPE AT THE WESTERN END OF A CHAIN-LINK FENCE; THENCE WITH THE SOUTHERN LINE OF HARBOR VIEW PROPERTIES, INC., SOUTH 88 DEGREES 43 MINUTES 01 SECONDS EAST FOR A DISTANCE OF 232.97 FEET TO A SET IRON PIN IN THE WESTERN RIGHT-OF-WAY OF NORTH SECOND STREET (43 FEET WEST OF APPARENT CENTERLINE); THENCE WITH THE WESTERN RIGHT-OF-WAY OF NORTH SECOND STREET AS FOLLOWS: SOUTH 12 DEGREES 48 MINUTES 31 SECONDS EAST FOR A DISTANCE OF 76.11 FEET TO A SET IRON PIN; THENCE SOUTH 00 DEGREES 53 MINUTES 31 SECONDS EAST FOR A DISTANCE OF 586.74 FEET TO THE POINT OF BEGINNING.
D-38


BEING THE SAME PROPERTY CONVEYED TO MEMPHIS CENTER CITY REVENUE FINANCE CORPORATION, A PUBLIC NOT-FOR-PROFIT TENNESSEE CORPORATION, BY DEED FROM HARBOR VIEW PROPERTIES, INC., A TENNESSEE CORPORATION, OF RECORD IN INSTRUMENT NO. 09006104, AS CORRECTION OF QUIT CLAIM DEED RECORD IN INSTRUMENT NO. 18076171 IN THE REGISTER'S OFFICE OF SHELBY COUNTY, TENNESSEE.
ALSO, BEING THE SAME PROPERTY LEASED TO HARBOR VIEW PROPERTIES, INC. FROM MEMPHIS CENTER CITY REVENUE FINANCE CORPORATION, A PUBLIC NOT-FOR-PROFIT TENNESSEE CORPORATION, AS EVIDENCED BY LEASE AGREEMENT, OF RECORD IN INSTRUMENT NO. 09006103; AS AFFECTED BY SUBORDINATION, NON-DISTURBANCE AND ATTORNMENT AGREEMENT IN INSTRUMENT NO. 18052726; AND LANDLORD’S ESTOPPEL CERTIFICATE IN INSTRUMENT NO. 18076172, IN THE REGISTER'S OFFICE OF SHELBY COUNTY, TENNESSEE.
D-39


22.    AHC Mt Juliet, 2650 North Mt Juliet Road, Mount Juliet, TN 37122:
The Land referred to herein below is situated in the County of Wilson, State of Tennessee, and described as follows:
LYING AND BEING SITUATED IN FIRST CIVIL DISTRICT OF WILSON COUNTY, TENNESSEE, IN THE CITY OF MT. JULIET, AND BEING MORE PARTICULARLY DESCRIBED AS FOLLOWS:
BEGINNING ON A SET IRON PIN IN THE MOST SOUTHEASTERN CORNER OF THE SURVEY AND IN THE WESTERLY MARGIN OF MT. JULIET ROAD (PAVED PUBLIC ROAD, 80’ RIGHT-OF-WAY), SAME BEING 251.49 FEET NORTH 25 DEGREES 28 MINUTES 59 SECONDS EAST OF ANOTHER IRON PIN IN THE SOUTHEAST CORNER OF A TRACT IN THE NAME OF TOWNE CENTRE PARTNERS (DEED BOOK 969, PAGE 252 AND DEED BOOK 811, PAGE 1573); THENCE SIX (6) COURSES WITH THE NORTHERLY AND EASTERLY BOUNDARIES OF THE TOWNE CENTRE PARTNERS AS FOLLOWS:
D-40


NORTH 79 DEGREES 38 MINUTES 21 SECONDS WEST A DISTANCE OF 277.28 FEET TO A FOUND IRON PIN; THENCE NORTH 56 DEGREES 18 MINUTES 33 SECONDS WEST A DISTANCE OF 74.38 FEET TO A FOUND IRON PIN; THENCE NORTH 10 DEGREES 21 MINUTES 39 SECONDS EAST A DISTANCE OF 45.33 FEET TO A FOUND IRON PIN; THENCE NORTH 79 DEGREES 38 MINUTES 21 SECONDS WEST A DISTANCE OF 247.50 FEET TO A FOUND IRON PIN; THENCE SOUTH 10 DEGREES 21 MINUTES 39 SECONDS WEST A DISTANCE OF 25.00 FEET TO A FOUND IRON PIN; THENCE NORTH 79 DEGREES 31 MINUTES 05 SECONDS WEST A DISTANCE OF 100.13 FEET TO A FOUND IRON PIN IN THE EASTERN LINE OF MORSE AND HEATHERLY (DEED BOOK 451, PAGE 510); THENCE WITH THE EASTERN LINE OF MORSE AND HEATHERLY, NORTH 09 DEGREES 35 MINUTES 15 SECONDS EAST A DISTANCE OF 246.29 FEET TO A FOUND IRON PIN BY A FENCE CORNER AT THE SOUTHEAST CORNER OF LOT 9 OF THE CRESTVIEW ACRES SUBDIVISION (PLAT BOOK 7, PAGE 7); THENCE WITH THE OLD FENCE AND EASTERN LINE OF LOT 9 AND LOT 6 OF SAID SUBDIVISION, NORTH 09 DEGREES 35 MINUTES 15 SECONDS EAST A DISTANCE OF 213.17 FEET TO A FOUND IRON PIPE BY AN OLD FENCE CORNER AT THE SOUTHWEST CORNER OF LOT 5 OF SAID SUBDIVISION; THENCE WITH THE OLD FENCE AND SOUTHERN LINE OF LOT 5, SOUTH 80 DEGREES 31 MINUTES 54 SECONDS EAST A DISTANCE OF 107.21 FEET TO A FOUND IRON PIPE; THENCE WITH THE OLD FENCE AND THE SOUTHERN LINE OF LOT 4, SOUTH 80 DEGREES 32 MINUTES 03 SECONDS EAST A DISTANCE OF 23.70 FEET TO A FOUND IRON PIN BY A FENCE CORNER; THENCE WITH THE OLD FENCE AND THE EASTERN LINE OF LOT 4, NORTH 08 DEGREES 19 MINUTES 15 SECONDS EAST A DISTANCE OF 28.74 FEET TO A FOUND IRON PIPE; THENCE WITH THE OLD FENCE AND THE SOUTHERN LINE OF LOT 4 AND LOT 3 OF SAID SUBDIVISION, SOUTH 83 DEGREES 32 MINUTES 16 SECONDS EAST A DISTANCE OF 223.87 FEET TO A FOUND IRON PIPE; THENCE WITH THE SOUTHERN LINE OF LOT 2, SOUTH 84 DEGREES 23 MINUTES 37 SECONDS EAST A DISTANCE OF 75.74 FEET TO A FOUND IRON PIN BY AN OLD FENCE CORNER, SAID IRON PIN BEING THE NORTHWEST CORNER OF HAYS BUSINESS PARK, LLC (DEED BOOK 1234; PAGE 548); THENCE WITH THE WESTERN LINE OF HAYS BUSINESS PARK, LLC, SOUTH 09 DEGREES 46 MINUTES 52 SECONDS WEST A DISTANCE OF 319.62 FEET TO A SET IRON PIN; THENCE WITH THE SOUTHERN LINE OF HAYS BUSINESS PARK, LLC, AND WITH THE SOUTHERN LINE OF U.S. COMMUNITY CREDIT UNION (DEED BOOK 1175, PAGE 944), SOUTH 82 DEGREES 36 MINUTES 14 SECONDS EAST A DISTANCE OF 326.96 FEET TO A SET IRON PIN IN THE WESTERN MARGIN OF MT. JULIET ROAD AS ESTABLISHED BY A CONVEYANCE TO THE CITY OF MT. JULIET (BOOK 1229, PAGE 2345); THENCE WITH THE WESTERN MARGIN OF SAID ROAD, RUNNING WITH A CURVE TURNING TO THE RIGHT, HAVING A RADIUS OF 2245.83 FEET, WITH A CHORD BEARING OF SOUTH 12 DEGREES 17 MINUTES 48 SECONDS WEST, WITH A CHORD DISTANCE OF 12.04 FEET AND AN ARC DISTANCE OF 12.04 FEET TO A SET IRON PIN AT THE NORTHEAST CORNER OF CARLA SIRCY (DEED BOOK 1319, PAGE 1702); THENCE WITH THE NORTH LINE OF SIRCY, NORTH 82 DEGREES 36 MINUTES 14 SECONDS WEST A DISTANCE OF 326.36 FEET TO A SET IRON PIN; THENCE WITH THE WESTERN LINE OF SIRCY, SOUTH 09 DEGREES 49 MINUTES 47 SECONDS WEST A DISTANCE OF 80.00 FEET TO AN EXISTING IRON PIN BY A CHAIN LINK FENCE CORNER AT THE NORTHWEST CORNER OF ASHLEY (DEED BOOK 428, PAGE 298); THENCE WITH THE WESTERN LINE OF ASHLEY, SOUTH 10 DEGREES 36 MINUTES 21 SECONDS WEST A DISTANCE OF 100.07 FEET TO A FOUND IRON PIN BY A CHAIN LINK FENCE CORNER; THENCE WITH THE SOUTHERN LINE OF ASHLEY, SOUTH 79 DEGREES 38 MINUTES 21 SECONDS EAST A DISTANCE OF 280.48 FEET TO A FOUND IRON PIN IN THE WESTERN MARGIN OF MT. JULIET ROAD; THENCE WITH THE WESTERN MARGIN OF SAID ROAD, SOUTH 25 DEGREES 28 MINUTES 59 SECONDS WEST A DISTANCE OF 51.80 FEET TO THE POINT OF BEGINNING.
BEING THE SAME PROPERTY CONVEYED TO MT. JULIET PROPCO LLC, A DELAWARE LIMITED LIABILITY COMPANY, BY DEED FROM MT. JULIET LONG TERM FACILITY, LLC, A TENNESSEE LIMITED LIABILITY COMPANY, FORMERLY KNOWN AS MT. JULIET LONG TERM FACILITY, INC., A TENNESSEE CORPORATION, OF RECORD IN BOOK 2067, PAGE 1252, IN THE REGISTER'S OFFICE OF WILSON COUNTY, TENNESSEE.
D-41


23.    AHC Northside, 202 East MTCS Road, Murfreesboro, TN 37130:
The Land referred to herein below is situated in the County of Rutherford, State of Tennessee, and described as follows:
BEING ALL OF LOT 4, SECTION I, BEASLEY PROFESSIONAL PARK, ACCORDING TO SURVEY AND PLAT OF SAME APPEARING OF RECORD IN PLAT BOOK 14, PAGE 186, REGISTER'S OFFICE FOR RUTHERFORD COUNTY, TENNESSEE, TO WHICH PLAT REFERENCE IS MADE FOR A MORE DETAILED DESCRIPTION OF SAID LOT.
BEING THE SAME PROPERTY CONVEYED TO NORTHSIDE LONG TERM FACILITY, INC., BY DEED FROM NORTHSIDE HEALTH CARE NURSING AND REHABILITATION CENTER, INC., A TENNESSEE CORPORATION, OF RECORD IN RECORD BOOK 1514, PAGE 3439, IN THE REGISTER'S OFFICE OF RUTHERFORD COUNTY, TENNESSEE.
D-42


24.    AHC Cumberland, 4343 Ashland City Highway, Nashville, TN 37218:
The Land referred to herein below is situated in the County of Davidson, State of Tennessee, and described as follows:
TRACT 1:
LYING IN THE FIRST CIVIL DISTRICT OF DAVIDSON COUNTY, TENNESSEE, IN THE FIRST COUNCILMANIC DISTRICT, BEING MORE PARTICULARLY DESCRIBED AS FOLLOWS:
BEGINNING ON A FOUND CONCRETE MONUMENT IN THE EASTERN RIGHT-OF-WAY OF STEWART LANE (40' R/W), SAID CONCRETE MONUMENT BEING THE SOUTHWEST CORNER OF COWELL AND LOGUE AS RECORDED IN INSTRUMENT NO. 200812150120050 (FORMERLY BELONGING TO HOYT WALKER) AND BEING THE NORTHWEST CORNER OF THE TRACT DESCRIBED HEREIN; THENCE WITH THE SOUTHERN LINE OF COWELL AND LOGUE, SOUTH 82 DEGREES 05 MINUTES 47 SECONDS EAST A DISTANCE OF 127.40 FEET TO A FOUND CONCRETE MONUMENT; THENCE WITH THE EASTERN LINE OF COWELL AND LOGUE, NORTH 08 DEGREES 47 MINUTES 33 SECONDS EAST A DISTANCE OF 99.06 FEET TO A FOUND CONCRETE MONUMENT IN THE SOUTHERN RIGHT-OF-WAY OF HYDES FERRY PIKE (ALSO KNOWN AS ASHLAND CITY HIGHWAY OR STATE ROUTE 12, WITH A 66' R/W); THENCE WITH THE SOUTHERN RIGHT-OF-WAY OF SAID HIGHWAY, RUNNING WITH A CURVE TO THE RIGHT, HAVING AN ARC LENGTH OF 258.11 FEET, WITH A RADIUS OF 6331.20 FEET, A CHORD BEARING OF SOUTH 74 DEGREES 55 MINUTES 06 SECONDS EAST AND A CHORD DISTANCE OF 258.09 FEET TO A SET 5/8 INCH IRON PIN AT ABOUT 2 FEET WEST OF A CONCRETE CURB, SAID IRON PIN BEING THE NORTHWEST CORNER OF A TRACT BELONGING TO BLK, LLC (TAX MAP 69, PARCEL 121, INSTRUMENT NO. 20061206150932), ALSO BEING THE NORTHWEST CORNER OF A RIGHT-OF-WAY EASEMENT; THENCE WITH THE WESTERN LINE OF BLK, LLC AND THE WESTERN LINE OF SAID RIGHT-OF-WAY EASEMENT, SOUTH 01 DEGREE 38 MINUTES 12 SECONDS WEST A DISTANCE OF 497.00 FEET TO A FOUND CONCRETE MONUMENT IN THE NORTHERN LINE OF ASHLAND PLACE CONDOMINIUMS (INSTRUMENT # 200707310090537); THENCE WITH THE LINE OF ASHLAND PLACE CONDOMINIUMS AS FOLLOWS: SOUTH 50 DEGREES 14 MINUTES 57 SECONDS WEST A DISTANCE OF 85.00 FEET TO A FOUND CONCRETE MONUMENT; THENCE SOUTH 03 DEGREES 50 MINUTES 07 SECONDS EAST A DISTANCE OF 203.57 FEET TO A FOUND CONCRETE MONUMENT IN THE NORTHERN RIGHT-OF-WAY OF THE ILLINOIS CENTRAL GULF RAILROAD (50 FEET FROM CENTERLINE OF TRACK); THENCE WITH THE NORTHERN RIGHT-OF-WAY OF SAID RAILROAD, RUNNING WITH A CURVE TO THE LEFT, HAVING AN ARC LENGTH OF 350.28 FEET, WITH A RADIUS OF 1960.01 FEET, A CHORD BEARING OF SOUTH 82 DEGREES 46 MINUTES 16 SECONDS WEST AND A CHORD DISTANCE OF 349.81 FEET TO A FOUND CONCRETE MONUMENT IN THE EASTERN RIGHT-OF- WAY OF STEWART LANE; THENCE WITH THE EASTERN RIGHT-OF-WAY OF STEWART LANE, NORTH 01 DEGREE 38 MINUTES 12 SECONDS EAST A DISTANCE OF 785.38 FEET TO THE POINT OF BEGINNING, CONTAINING 6.737 ACRES OR 293,444 SQUARE FEET.
D-43


TOGETHER WITH ALL RIGHTS GRANTED TO CUMBERLAND MANOR, INC. UNDER THAT CERTAIN EASEMENT RECORDED IN BOOK 6570, PAGE 248 IN THE REGISTER'S OFFICE OF DAVIDSON COUNTY, TENNESSEE.
BEING THE SAME PROPERTY CONVEYED TO CUMBERLAND MANOR, INC., SINCE HAVING CHANGED ITS NAME TO CUMBERLAND MANOR NURSING CENTER, INC., OF RECORD IN DEED BOOK 7587, PAGE 962, AT THE REGISTER'S OFFICE FOR DAVIDSON COUNTY, TENNESSEE.
D-44


25.    AHC Paris, 800 Volunteer Drive, Paris, TN 38242:
The Land referred to herein below is situated in the County of Henry, State of Tennessee, and described as follows:
REVISED LOT NO. 17 OF THE ADAMS PLACE SUBDIVISION, A PLAT RECORDED IN PLAT CABINET E, SLIDE 131, ROHCT, WHICH IS MORE PARTICULARLY DESCRIBED AS FOLLOWS:
BEGINNING ON A FOUND IRON IN IN THE WESTERN RIGHT-OF-WAY OF VOLUNTEER DRIVE, 30 FEET FROM CENTERLINE, SAID IRON PIN BEING THE SOUTHEAST CORNER OF PARIS SPECIAL SCHOOL DISTRICT (DEED BOOK 255, PAGE 491), SAID IRON PIN ALSO BEING THE NORTHEAST CORNER OF THE TRACT DESCRIBED HEREIN; THENCE WITH THE WESTERN RIGHT-OF-WAY OF VOLUNTEER DRIVE, SOUTH 06 DEGREES 18 MINUTES 48 SECONDS WEST A DISTANCE OF 569.25 FEET TO A FOUND IRON PIN AT THE NORTHEAST CORNER OF LOT 18 OF JIM ADAMS BUSINESS PARK (PLAT CAB. E, SLIDE 115); THENCE NORTH 86 DEGREES 50 MINUTES 28 SECONDS WEST, PASSING A FOUND IRON PIN ON LINE AT THE NORTHWEST CORNER OF LOT 18 AND THE NORTHEAST CORNER OF LOT 17-A OF JIM ADAMS BUSINESS PARK (PLAT CABINET E, SLIDE 121) AT A DISTANCE OF 300.00 FEET, CONTINUING WITH THE NORTHERN LINE OF LOT 17-A FOR A TOTAL DISTANCE OF 488.68 FEET TO A FOUND IRON PIN IN THE EASTERN LINE OF LOT 16 OF JIM ADAMS BUSINESS PARK (PLAT CABINET D. SLIDE 199); THENCE WITH THE EASTERN LINE OF LOT 16, NORTH 03 DEGREES 00 MINUTES 00 SECONDS EAST A DISTANCE OF 5.00 FEET TO A FOUND CONCRETE MONUMENT AT THE NORTHEAST CORNER OF LOT 16; THENCE WITH THE EASTERN LINE OF THE REMAINDER OF THE JIM ADAMS TRACT AS FOLLOWS: NORTH 03 DEGREES 09 MINUTES 32 SECONDS EAST A DISTANCE OF 297.23 FEET TO A FOUND IRON PIN; THENCE NORTH 82 DEGREES 36 MINUTES 08 SECONDS WEST A DISTANCE OF 100.63 FEET TO A FOUND IRON PIN; THENCE NORTH 70 DEGREES 40 MINUTES 07 SECONDS EAST A DISTANCE OF 124.98 FEET TO A FOUND IRON PIN; THENCE NORTH 30 DEGREES 00 MINUTES 53 SECONDS EAST A DISTANCE OF 83.09 FEET TO A FOUND IRON PIN; THENCE NORTH 45 DEGREES 58 MINUTES 32 SECONDS EAST A DISTANCE OF 85.55 FEET TO A FOUND IRON PIN; THENCE NORTH 68 DEGREES 09 MINUTES 09 SECONDS EAST A DISTANCE OF 100.79 FEET TO A FOUND IRON PIN; THENCE NORTH 46 DEGREES 03 MINUTES 35 SECONDS EAST A DISTANCE OF 48.45 FEET TO A FOUND IRON PIN IN THE SOUTHERN LINE OF THE PARIS SPECIAL SCHOOL DISTRICT PROPERTY; THENCE WITH THE SOUTHERN LINE OF THE PARIS SPECIAL SCHOOL DISTRICT TRACT, SOUTH 86 DEGREES 01 MINUTE 21 SECONDS EAST A DISTANCE OF 284.92 FEET TO THE POINT OF BEGINNING.
D-45


BEING THE SAME PROPERTY CONVEYED TO PARIS PROPCO LLC, A DELAWARE LIMITED LIABILITY COMPANY BY DEED FROM PARIS LONG TERM FACILITY, LLC., A TENNESSEE LIMITED LIABILITY COMPANY, FORMERLY KNOWN AS PARIS LONG TERM FACILITY, INC., A TENNESSEE CORPORATION, OF RECORD IN RECORD BOOK 563, PAGE 495, IN THE REGISTER'S OFFICE OF HENRY COUNTY, TENNESSEE.
D-46


26.    AHC Decatur County, 726 S. Kentucky Avenue, Parsons, TN 38363:
The Land referred to herein below is situated in the County of Decatur, State of Tennessee, and described as follows:
PARCEL I:
LYING IN THE CITY OF PARSONS, IN THE SIXTH CIVIL DISTRICT OF DECATUR COUNTY, TENNESSEE, AND BEING THAT LAND CONVEYED TO AMERICAN HEALTH CENTERS, INC., BY JAMES W. AYERS ET UX, AS APPEARS IN DEED BOOK 121, PAGE 711, REGISTER’S OFFICE, DECATUR COUNTY, TENNESSEE, AND BEING MORE PARTICULARLY DESCRIBED AS FOLLOWS:
BEGINNING ON A FOUND IRON PIN IN THE WESTERN RIGHT-OF-WAY OF KENTUCKY AVENUE SOUTH, SAID IRON PIN BEING LOCATED 10 FEET FROM A CENTERLINE OF SAID STREET, BEING THE NORTHEAST CORNER OF ANOTHER TRACT BELONGING TO AMERICAN HEALTH CENTERS, INC. (DEED BOOK 135, PAGE 461) AND BEING THE SOUTHEAST CORNER OF THE PROPERTY DESCRIBED HEREIN; THENCE WITH THE NORTHERN LINE OF AMERICAN HEALTH CENTERS, INC., NORTH 89 DEGREES 19 MINUTES 53 SECONDS WEST A DISTANCE OF 344.32 FEET TO A FOUND CONCRETE MONUMENT BY A 15” CEDAR, SAID MONUMENT BEING THE SOUTHEAST CORNER OF JAMES W. AYERS (DEED BOOK 108, PG 798); THENCE NORTH 00 DEGREES 18 MINUTES 16 SECONDS EAST, PASSING A FOUND CONCRETE MONUMENT IN AN OLD FENCE AT 200.17 FEET, CONTINUING WITH THE EASTERN LINE OF WAYNE HALL (DEED BOOK 124, PG 303), PASSING A FOUND 1/2” IRON PIN IN THE OLD FENCE AT 289.91 FEET, CONTINUING WITH THE EASTERN LINE OF CHRISTOPHER VILLAFLOR (DEED BOOK 113, PG 164), A TOTAL DISTANCE OF 400.00 FEET TO A FOUND IRON PIN; THENCE WITH THE NORTHERN LINE OF VILLAFLOR, SOUTH 89 DEGREES 39 MINUTES 31 SECONDS WEST A DISTANCE OF 66.29 FEET TO A FOUND IRON PIN AT THE SOUTHEAST CORNER OF JAMES KING (DEED BOOK 116, PG 88) AND THE SOUTHEAST CORNER OF A 12 FEET WIDE DRIVEWAY EASEMENT; THENCE NORTH 00 DEGREES 42 MINUTES 45 SECONDS EAST, PASSING A FOUND IRON PIN AT THE NORTHEAST CORNER OF THE DRIVEWAY EASEMENT AT 12.00 FEET, CONTINUING WITH THE EASTERN LINE OF KING, AND WITH THE EASTERN LINE OF PHILLIPS MORRIS (DEED BOOK 121, PG 574) AND BEN SMITH (DEED BOOK 104, PG 543) A TOTAL DISTANCE OF 186.83 FEET TO A FOUND 1/2” IRON PIN AT THE SOUTHEAST CORNER OF A DEAD-END ALLEY; THENCE WITH THE EASTERN MARGIN OF THE ALLEY, NORTH 20 DEGREES 52 MINUTES 56 SECONDS WEST A DISTANCE OF 11.20 FEET TO A FOUND 1/2” IRON PIN AT THE SOUTHWEST CORNER OF JAMES W.
D-47


AYERS (DEED BOOK 87, PG 342); THENCE WITH THE SOUTHERN LINE OF AYERS, NORTH 69 DEGREES 03 MINUTES 10 SECONDS EAST A DISTANCE OF 150.32 FEET TO A FOUND 1/2” IRON PIN AT THE SOUTHEASTERN CORNER OF AYERS AND IN THE WESTERN RIGHT-OF- WAY OF TENTH STREET (AN UN-DEVELOPED STREET); THENCE WITH THE WESTERN RIGHT-OF-WAY OF TENTH STREET, SOUTH 20 DEGREES 52 MINUTES 56 SECONDS EAST A DISTANCE OF 70.20 FEET TO A FOUND IRON PIN; THENCE WITH THE SOUTHERN RIGHT-OF-WAY OF TENTH STREET, SOUTH 89 DEGREES 24 MINUTES 37 SECONDS EAST A DISTANCE OF 71.23 FEET TO A FOUND 1/2” IRON PIN IN THE WESTERN EDGE OF PAVEMENT OF KENTUCKY AVENUE SOUTH; THENCE WITH THE WESTERN RIGHT-OF-WAY OF KENTUCKY AVENUE SOUTH, SOUTH 16 DEGREES 25 MINUTES 53 SECONDS EAST, PASSING A FOUND CONCRETE MONUMENT WITH A BRASS CAP AT 397.36 FEET, A TOTAL DISTANCE OF 613.36 FEET TO A THE POINT OF BEGINNING.
DRIVEWAY EASEMENT:
LYING IN THE CITY OF PARSONS, IN THE SIXTH CIVIL DISTRICT OF DECATUR COUNTY, TENNESSEE, AND BEING THAT DRIVEWAY EASEMENT CONVEYED TO JAMES W. AYERS BY DEED FROM BEN W. SMITH, JR., ET UX, AS APPEARS IN DEED BOOK 121, PAGE 401, REGISTER'S OFFICE, DECATUR COUNTY, TENNESSEE, AND BEING MORE PARTICULARLY DESCRIBED AS FOLLOWS:
BEGINNING ON THE SOUTHWEST CORNER OF SMITH TRACT AND RUNS NORTH 09 DEGREES 24 MINUTES 02 SECONDS WEST WITH THE EASTERLY MARGIN OF TENNESSEE AVENUE FOR 12.19 FEET TO A P.K. NAIL; THENCE SOUTH 89 DEGREES 19 MINUTES 54 SECONDS EAST FOR 192.54 FEET TO AN IRON PIN; THENCE SOUTH 00 DEGREES 42 MINUTES 45 SECONDS WEST FOR 12 FEET TO AN IRON PIN IN SMITH’S SOUTH BOUNDARY; THENCE NORTH 89 DEGREES 19 MINUTES 54 SECONDS WEST WITH SMITH’S SOUTH BOUNDARY FOR 190.33 FEET TO THE POINT OF BEGINNING. SAID EASEMENT IN GROSS SHALL TERMINATE IF THE BUILDING LOCATED ON THE ADJOINING SMITH TRACT SHALL CEASE TO BE USED AS A PHARMACY WITH A DRIVE-UP WINDOW. THIS EASEMENT CONTAINS 0.053 ACRE (DEED CALLS FOR 0.398 ACRE).
BEING THE SAME PROPERTY CONVEYED TO DECATUR COUNTY PROPCO LLC, A DELAWARE LIMITED LIABILITY COMPANY, BY DEED FROM DECATUR COUNTY LONG TERM FACILITY, LLC, A TENNESSEE LIMITED LIABILITY COMPANY, OF RECORD IN BOOK 359, PAGE 511, IN THE REGISTER'S OFFICE OF DECATUR COUNTY, TENNESSEE.
D-48


27.    AHC Meadowbrook, 1245 E College St., Pulaski, TN 38478:
The Land referred to herein below is situated in the County of Giles, State of Tennessee, and described as follows:
ALL THAT TRACT OR PARCEL OF LAND CONTAINING 2.305 ACRES MORE OR LESS SITUATED, LYING AND BEING IN THE SEVENTH CIVIL DISTRICT, CITY OF PULASKI, GILES COUNTY, TENNESSEE, BEING MORE PARTICULARLY DESCRIBED AS FOLLOWS:
BEGIN AT A POINT LOCATED AT THE NORTHEAST CORNER OF THE HEREIN DESCRIBED TRACT, ALSO KNOWN AS TAX PARCEL NUMBER 097-051.00, NOW OR FORMERLY OWNED BY PULASKI MANOR INC., AND RECORDED IN DEED BOOK 229, PAGE 405, REGISTER'S OFFICE FOR GILES COUNTY, TENNESSEE, SAID POINT ALSO BEING ON THE SOUTH RIGHT OF WAY MARGIN OF EAST COLLEGE STREET, ALSO KNOWN AS US HIGHWAY 64, SAID POINT BEING THE TRUE POINT OF BEGINNING; THENCE RUN SOUTH 04°15'00" WEST FOR A DISTANCE OF 399.20 FEET TO A POINT; THENCE RUN NORTH 77°02'00" WEST FOR A DISTANCE OF 278.30 FEET TO A POINT; THENCE RUN NORTH 10°37'00” EAST FOR A DISTANCE OF 389.30 FEET TO A POINT ON THE SOUTH RIGHT OF WAY MARGIN OF EAST COLLEGE STREET; THENCE RUN SOUTH 78°24'35" EAST ALONG SAID RIGHT OF WAY MARGIN FOR A DISTANCE OF 233.83 FEET TO A POINT AND BEING BACK AT THE TRUE POINT OF BEGINNING LAND CONTAINING 100,415.95 SQ. FT. OR 2.305 ACRES.
BEING THE SAME PROPERTY CONVEYED TO MEADOWBROOK PROPCO LLC, A DELAWARE LIMITED LIABILITY COMPANY, BY DEED FROM MEADOWBROOK LONG TERM FACILITY, LLC, A TENNESSEE LIMITED LIABILITY COMPANY, FORMERLY KNOWN AS MEADOWBROOK LONG TERM FACILITY, INC., A TENNESSEE CORPORATION, OF RECORD IN BOOK D389, PAGE 468, IN THE REGISTER'S OFFICE OF GILES COUNTY, TENNESSEE.
D-49


28.    AHC Savannah, 1645 Florence Rd. Savannah, TN 38372
The Land referred to herein below is situated in the County of Hardin, State of Tennessee, and described as follows:
BEGINNING AT THE POINT OF INTERSECTION ON THE EASTERN RIGHT-OF-WAY OF STATE ROUTE 69 (33 FEET FROM CENTERLINE) WITH THE SOUTHERN RIGHT-OF-WAY OF AUSTIN STREET (25 FEET FROM CENTERLINE), SAID POINT BEING THE NORTHWEST CORNER OF THE TRACT DESCRIBED HEREIN; THENCE WITH THE SOUTHERN RIGHT-OF-WAY OF AUSTIN STREET, SOUTH 66 DEGREES 49 MINUTES 27 SECONDS EAST A DISTANCE OF 445.18 FEET TO A FOUND 1/2" IRON PIN AT THE NORTHWEST CORNER OF SOUTHWOOD, L.P. (DEED BOOK 137 PAGE 471, R.O.H.C.T.); THENCE WITH THE WESTERN LINE OF SOUTHWOOD, L.P., SOUTH 23 DEGREES 10 MINUTES 33 SECONDS WEST, PASSING A FOUND 1/2" IRON PIN AT 342.89 FEET, BEING THE NORTHWEST CORNER OF FREEDOM CHAPEL CHURCH (DEED BOOK 122, PAGE 132, R.O.H.C.T.), AND CONTINUING WITH THE WESTERN LINE OF FREEDOM CHAPEL CHURCH, A TOTAL DISTANCE OF 551.47 FEET TO A FOUND STEEL POST IN THE EASTERN RIGHT-OF-WAY OF STATE ROUTE 69; THENCE WITH THE EASTERN RIGHT-OF-WAY OF STATE ROUTE 69, RUNNING 33 FEET EAST OF, AND PARALLEL WITH THE CENTERLINE AS FOLLOWS:
NORTH 21 DEGREES 46 MINUTES 01 SECOND WEST A DISTANCE OF 205.33 FEET; THENCE NORTH 20 DEGREES 17 MINUTES 17 SECONDS WEST A DISTANCE OF 141.15 FEET; THENCE NORTH 16 DEGREES 08 MINUTES 55 SECONDS WEST A DISTANCE OF 114.21 FEET; THENCE NORTH 11 DEGREES 00 MINUTES 07 SECONDS WEST A DISTANCE OF 128.20 FEET; THENCE NORTH 05 DEGREES 02 MINUTES 43 SECONDS WEST A DISTANCE OF 124.02 FEET TO THE POINT OF BEGINNING, CONTAINING 137,583 SQUARE FEET, OR 3.16 ACRES. BEING THE SAME PROPERTY CONVEYED TO SAVANNAH PROPCO LLC, A DELAWARE LIMITED LIABILITY COMPANY BY DEED FROM SAVANNAH LONG TERM FACILITY, LLC., A TENNESSEE LIMITED LIABILITY COMPANY, FORMERLY KNOWN AS SAVANNAH LONG TERM FACILITY, INC., A TENNESSEE CORPORATION, OF RECORD IN RECORD BOOK 762, PAGE 615, IN THE REGISTER'S OFFICE OF HARDIN COUNTY, TENNESSEE.
D-50


29.    AHC McNairy County, 835 East Poplar Avenue, Selmer, TN 38375
The Land referred to herein below is situated in the County of McNairy, State of Tennessee, and described as follows:
TRACT NO. 1:
BEGINNING AT A 2" IRON PIPE FOUND IN THE SOUTHERN RIGHT OF WAY LINE OF TENNESSEE STATE ROUTE 15 BY-PASS (U.S. HIGHWAY 64), SAID PIPE BEING LOCATED ONE FOOT SOUTH OF A CONTROL ACCESS FENCE AND POST AT STATION 23+30 AND 150 FEET RIGHT OF CENTERLINE AS SHOWN ON SHEET 7 OF THE TENNESSEE DEPARTMENT OF TRANSPORTATION PLANS FOR PROJECT NO. 55004- 3220-04 (1977), AND SAID PIPE BEING THE NORTHEAST CORNER OF MOORE (DEED BOOK 154, PAGE 470) AND THE NORTHEAST CORNER OF AN EASEMENT; THENCE NORTH 59 DEGREES 11 MINUTES 00 SECONDS EAST WITH THE SOUTHERN RIGHT OF WAY OF SAID S.R. 15 A DISTANCE OF 461.76 FEET TO A CONCRETE RIGHT-OF-WAY MARKER, THENCE NORTH 55 DEGREES 41 MINUTES 27 SECONDS EAST WITH THE SOUTHERN RIGHT OF WAY OF S.R. 15 AND PASSING AN IRON PIPE AT 187.84 FEET, IN ALL 206.84 FEET TO A POINT IN THE CENTER OF A DITCH, THENCE WITH THE CENTER OF SAID DITCH THE FOLLOWING SIX CALLS: SOUTH 11 DEGREES 03 MINUTES 33 SECONDS EAST 68.74 FEET; SOUTH 30 DEGREES 53 MINUTES 42 SECONDS WEST 143.31 FEET; SOUTH 15 DEGREES 12 MINUTES 11 SECONDS WEST 52.13 FEET; SOUTH 22 DEGREES 33 MINUTES 53 SECONDS WEST 141.56 FEET; SOUTH 09 DEGREES 36 MINUTES 50 SECONDS WEST 147.99 FEET; SOUTH 11 DEGREES 39 MINUTES 26 SECONDS WEST 49.95 FEET TO A POINT IN THE CENTER OF CROOKED CREEK; THENCE WITH THE CENTER OF CROOKED CREEK AND THE NORTHERN LINE OF MOORE (DEED BOOK 154, PAGE 470), THE FOLLOWING FOUR CALLS: SOUTH 56 DEGREES 19 MINUTES 18 SECONDS WEST 76.15 FEET; SOUTH 60 DEGREES 21 MINUTES 31 SECONDS WEST 99.96 FEET; SOUTH 54 DEGREES 39 MINUTES 43 SECONDS WEST 62.41 FEET; SOUTH 50 DEGREES 22 MINUTES 07 SECONDS WEST 60.24 FEET; THENCE NORTH 22 DEGREES 26 MINUTES 24 SECONDS WEST, LEAVING SAID CREEK AND WITH THE EASTERN BOUNDARY OF MOORE (DEED BOOK 154, PAGE 470) AND THE EAST MARGIN OF AN EASEMENT AND PASSING AN IRON PIPE AT 23.91 FEET, IN ALL 410.42 FEET TO THE POINT OF BEGINNING.
TRACT NO. 2:
EASEMENT FOR INGRESS-EGRESS AND PARKING FOR THE BENEFIT OF TRACT NO. 1
A 50-FOOT WIDE STRIP OF LAND LOCATED ALONG AND ADJACENT TO THE WEST BOUNDARY OF THE ABOVE DESCRIBED LAND AND BEING MORE PARTICULARLY DESCRIBED AS FOLLOWS:
D-51


BEGINNING ON AN IRON PIPE, SAME BEING THE NORTHWEST CORNER OF THE ABOVE DESCRIBED LAND THEN RUNNING SOUTH 59 DEG. 11' 00" WEST 25.27 FEET TO AN IRON PIN, SAME BEING THE CENTER OF THE 50-FOOT RIGHT-OF-WAY HEREIN DESCRIBED, THE CENTERLINE OF WHICH IS DESCRIBED AS FOLLOWS: THENCE SOUTH 22 DEG. 26' 24" EAST APPROXIMATELY 410 FEET TO THE CENTER OF CROOKED CREEK; FOR TRAVEL AND PARKING SO LONG AS IT IN NO WAY IMPEDES OR OBSTRUCTS THE DEVELOPMENT OR USE OF ANY OR ALL OF SAID 50-FOOT STRIP FOR A PUBLIC STREET. UPON DEDICATION OF SAID ROADWAY AS A PUBLIC STREET, THE GRANTEE'S RIGHTS GRANTED HEREUNDER SHALL TERMINATE SO IT WILL NOT HAVE ANY GREATER RIGHT THAN THE PUBLIC AT LARGE.
BEING THE SAME PROPERTY CONVEYED TO MCNAIRY PROPCO, LLC, A DELAWARE LIMITED LIABILITY COMPANY BY DEED FROM MCNAIRY COUNTY LONG TERM FACILITY, LLC., A TENNESSEE LIMITED LIABILITY COMPANY, FORMERLY KNOWN AS MCNAIRY COUNTY LONG TERM FACILITY, INC., A TENNESSEE CORPORATION, OF RECORD IN RECORD BOOK 6, PAGE 574, IN THE REGISTER'S OFFICE OF MCNAIRY COUNTY, TENNESSEE.
D-52


30.    AHC Union City, 1630 E. Reelfoot Ave.,Union City TN 38261
The Land referred to herein below is situated in the County of Obion, State of Tennessee, and described as follows:
LYING AND BEING SITUATED IN THE CITY OF UNION CITY, THIRTEENTH CIVIL DISTRICT, OBION COUNTY, TENNESSEE, AND BEING MORE PARTICULARLY DESCRIBED AS FOLLOWS:
TRACT NO. 1:
BEGINNING ON A FOUND IRON PIPE IN THE NORTH MARGIN OF REELFOOT AVENUE (STATE ROUTE 22), SAID IRON PIPE BEING LOCATED 2.3 FEET NORTH OF THE NORTH EDGE OF A CONCRETE SIDEWALK, BEING THE SOUTHEAST CORNER OF LINDA MILES HOLMES (DEED BOOK 26-R, PAGE 16), AND BEING THE SOUTHWEST CORNER OF THE SUBJECT PROPERTY; THENCE WITH THE EAST LINE OF HOLMES, AND WITH THE EAST LINE OF TAMMY CROWELL (DEED BOOK 28-A, PAGE 891) AND LARRY BROWN (DEED BOOK 26-V, PAGE 945), NORTH 01 DEGREES 21 MINUTES 03 SECONDS EAST A DISTANCE OF 376.06 FEET TO A FOUND IRON PIN IN THE SOUTHERN LINE OF A TRACT BELONGING TO THE CITY OF UNION CITY (DEED BOOK 12-S, PAGE 291), ALSO BEING THE SOUTHWEST CORNER OF A PERMANENT EASEMENT THAT WAS CONVEYED TO UNION CITY MANOR, INC. IN DEED BOOK 20- E, PAGE 667; THENCE WITH THE SOUTH LINE OF SAID EASEMENT AND CITY OF UNION CITY TRACT, SOUTH 89 DEGREES 06 MINUTES 00 SECONDS EAST A DISTANCE OF 279.18 FEET TO A RE-SET IRON PIN AT THE SOUTHEAST CORNER OF SAID EASEMENT; THENCE CONTINUING WITH THE SOUTH LINE OF THE CITY OF UNION CITY TRACT, SOUTH 89 DEGREES 06 MINUTES 00 SECONDS EAST A DISTANCE OF 206.00 FEET TO AN EXISTING IRON PIN AT THE NORTHWEST CORNER OF UNION CITY MEDICAL CENTER, LLC (DEED BOOK 37, PAGE 139); THENCE WITH THE WESTERN LINE OF UNION CITY MEDICAL CENTER, LLC, SOUTH 01 DEGREES 21 MINUTES 06 SECONDS WEST A DISTANCE OF 373.59 FEET TO AN EXISTING IRON PIN IN THE NORTHERN MARGIN OF REELFOOT AVENUE; THENCE WITH THE NORTHERN MARGIN OF REELFOOT AVENUE, NORTH 89 DEGREES 23 MINUTES 29 SECONDS WEST, PASSING A FOUND IRON PIPE 2.5 FEET NORTH OF THE NORTH EDGE OF THE CONCRETE SIDEWALK AT 206.00 FEET, IN ALL, A DISTANCE OF 485.20 FEET TO THE BEGINNING.
BEING ONE CONTIGUOUS TRACT OF LAND, AND CONTAINING 181,851 SQUARE FEET, OR 4.175 ACRES
TRACT NO. 2: EASEMENT(S) BENEFITING TRACT 1
LYING AND BEING SITUATED IN THE CITY OF UNION CITY, THIRTEENTH CIVIL DISTRICT, OBION COUNTY, TENNESSEE AND BEING THAT EASEMENT
D-53


CONVEYED TO UNION CITY MANOR, INC., A TENNESSEE CORPORATION, BY DEED OF THE CITY OF UNION CITY, A TENNESSEE MUNICIPAL CORPORATION, AS APPEARS OF RECORD IN DEED BOOK 20-E, PAGE 667, REGISTER'S OFFICE, OBION COUNTY, TENNESSEE AND BEING MORE PARTICULARLY DESCRIBED AS FOLLOWS: BEGINNING ON A FOUND IRON PIN AT THE NORTHEAST CORNER OF THE JEAN JACKSON LOT (NOW LARRY BROWN), ALSO BEING THE NORTHWEST CORNER OF THE UNION CITY MANOR, INC. PROPERTY; THENCE NORTH 01 DEGREE 20 MINUTES 45 SECONDS EAST A DISTANCE OF 66.15 FEET TO A POINT IN THE SOUTH MARGIN OF BISHOP STREET; THENCE WITH THE SOUTH MARGIN OF BISHOP STREET, NORTH 89 DEGREES 51 MINUTES 50 SECONDS EAST A DISTANCE OF 279.27 FEET TO A POINT; THENCE SOUTH 01 DEGREE 21 MINUTES 00 SECONDS WEST A DISTANCE OF 71.20 FEET TO AN IRON PIN IN THE NORTH LINE OF THE UNION CITY MANOR, INC. PROPERTY (ALSO BEING THE NORTHWEST CORNER OF LOT 4 OF THE SUN RISE SUBDIVISION); THENCE WITH THE NORTH LINE OF UNION CITY MANOR, INC., NORTH 89 DEGREES 06 MINUTES 00 SECONDS WEST A DISTANCE OF 279.18 FEET TO THE BEGINNING.
TRACT NO. 3: EASEMENT(S) BENEFITING TRACT 1
SITUATED IN THE CITY OF UNION CITY, THE 1316 CIVIL DISTRICT OF OBION COUNTY, TENNESSEE:
BEGINNING AT AN EXISTING 5/8 INCH IRON PIN AND CAP AT THE NORTHWEST CORNER OF UNION CITY MEDICAL CENTER, LLC (DEED BOOK 37, PG. 139), SAID IRON PIN BEING THE NORTHEAST CORNER OF UNION CITY MANOR, INC. (DEED BOOK 22-Z, PAGE 254), BEING A POINT IN THE SOUTHERN LINE OF A TRACT BELONGING TO THE CITY OF UNION CITY (DEED BOOK 12-S, PG. 291) AND BEING THE SOUTHEAST CORNER OF THE EASEMENT DESCRIBED HEREIN; THENCE WITH THE NORTHERN LINE OF UNION CITY MANOR, INC., NORTH 89 DEGREES 06 MINUTES 00 SECONDS WEST FOR A DISTANCE OF 206.00 FEET TO AN EXISTING IRON PIN AND CAP AT THE SOUTHEAST CORNER OF AN EASEMENT THAT WAS CONVEYED TO UNION CITY MANOR, INC. BY THE CITY OF UNION CITY IN DEED BOOK 20¬E, PAGE 667; THENCE WITH THE EASTERN LINE OF SAID EASEMENT, NORTH 01 DEGREE 21 MINUTES 00 SECONDS EAST FOR A DISTANCE OF 71.20 FEET TO A POINT IN THE SOUTHERN RIGHT-OF-WAY OF BISHOP STREET (PAVED CITY STREET WITH A 50 FEET WIDE RIGHT- OF-WAY); THENCE WITH THE SOUTHERN RIGHT-OF-WAY OF BISHOP STREET, SOUTH 89 DEGREES 28 MINUTES 54 SECONDS EAST FOR A DISTANCE OF 206.02 FEET TO A POINT; THENCE SOUTH 01 DEGREE 21 MINUTES 06 SECONDS WEST FOR A DISTANCE OF 72.57 FEET TO THE POINT OF BEGINNING.
TRACT NO. 4:
D-54


EASEMENT(S) BENEFITING TRACT 1 CONTAINED IN RECIPROCAL ACCESS EASEMENT AGREEMENT OF RECORD IN BOOK 55-C, PAGE 829, IN THE REGISTER'S OFFICE OF OBION COUNTY, TENNESSEE.
BEING THE SAME PROPERTY CONVEYED TO UNION CITY PROPCO LLC, A DELAWARE LIMITED LIABILITY COMPANY BY QUITCLAIM DEED FROM UNION CITY LONG TERM FACILITY, LLC, A TENNESSEE LIMITED LIABILITY COMPANY, FORMERLY KNOWN AS UNION CITY LONG TERM FACILITY, INC., A TENNESSEE CORPORATION, OF RECORD IN RECORD BOOK 280, PAGE 45, IN THE REGISTER'S OFFICE OF OBION COUNTY, TENNESSEE.
D-55


31.    AHC Waverly, 895 E. Powers Blvd, Waverly, TN 37185
BEGINNING AT AN EXISTING 3/8 INCH IRON PIN IN THE NORTH RIGHT-OF-WAY LINE OF POWERS BOULEVARD (40 FEET FROM CENTERLINE), SAID PIN BEING LOCATED EASTERLY, 213.3 FEET, MORE OR LESS, FROM THE CENTER LINE OF STATE ROUTE NO. 13; THENCE, NORTH 05 DEGREES 14 MINUTES 03 SECONDS EAST, 180.19 FEET TO A CONCRETE MONUMENT AT THE SOUTHEAST CORNER OF THE CITY OF WAVERLY WATER TANK TRACT (TAX MAP 53, PARCEL 17.02 - DEED BK. 184, PAGE 2416 AND DEED BK. 184, PG. 2270); THENCE WITH THE EASTERN LINE OF THE CITY OF WAVERLY, NORTH 12 DEGREES 28 MINUTES 10 SECONDS WEST, 82.85 FEET TO A POINT, BEING THE NORTHEAST CORNER OF THE CITY OF WAVERLY AND THE SOUTHEAST CORNER OF A TRACT BELONGING TO KRC FAMILY PARTNERSHIP, L.P. (TAX MAP 53, PARCEL 7.00 — DEED BK. 187, PG 2477); THENCE WITH THE EASTERN LINE OF KRC FAMILY PARTNERSHIP, L.P., NORTH 07 DEGREES 36 MINUTES 23 SECONDS EAST, 417.43 FEET TO A SET IRON PIN, BEING A CORNER IN THE EASTERN LINE OF KRC FAMILY PARTNERSHIP, LP. AND BEING THE SOUTHWEST CORNER OF ANOTHER TRACT BELONGING TO KRC FAMILY PARTNERSHIP, L.P. (TAX MAP 53, PARCEL 16.00 - DEED BK. 187, PG. 2477); THENCE WITH THE SOUTHERN LINE OF KRC FAMILY PARTNERSHIP, L.P., NORTH 85 DEGREES 23 MINUTES 26 SECONDS EAST, 399.54 FEET TO A SET IRON PIN, BEING THE NORTHWEST CORNER OF LOT 1 OF WOODLAND HILLS SUBDIVISION (PLAT BK. B, PG. 211); THENCE WITH THE WESTERN LINE OF LOT 1 OF WOODLAND HILLS SUBDIVISION, SOUTH 01 DEGREE 51 MINUTES 36 SECONDS EAST, 675.20 FEET TO AN EXISTING 1/2 INCH IRON PIN AT THE SOUTHWEST CORNER OF SAID LOT 1 AND BEING A POINT IN THE NORTH RIGHT-OF-WAY LINE OF POWERS BOULEVARD (40 FEET FROM CENTERLINE); THENCE WITH THE NORTH RIGHT-OF-WAY LINE OF POWERS BOULEVARD, SOUTH 86 DEGREES 13 MINUTES 00 SECONDS WEST, 475.00 FEET TO THE POINT OF BEGINNING.
CONTAINING 6.86 ACRES, MORE OR LESS.
BEING THE SAME PROPERTY CONVEYED TO WAVERLY LONG TERM FACILITY, INC., A TENNESSEE CORPORATION, BY DEED FROM AUTUMNFIELD OF DANVILLE, INC., A KENTUCKY CORPORATION, OF RECORD IN BOOK WD197, PAGE 1674, IN THE REGISTER'S OFFICE OF HUMPHREYS COUNTY, TENNESSEE.

D-56


EXHIBIT E
DEPOSIT AGREEMENT
E-1


ESCROW AGREEMENT
THIS ESCROW AGREEMENT (this “Agreement”) is made this 21st day of October, 2024, by and among the entities listed as “Property Owner” and “Current Operator” set forth on Exhibit A (collectively, “Seller”) and the entities listed as “Purchaser” set forth on Exhibit A (the “Purchaser”), and Landmark Abstract Agency, LLC (“Escrow Agent”).
Preliminary Statement
In connection with the execution and delivery by Seller and Purchaser of that certain Asset Purchase Agreement of even date herewith entered into between the Seller and Purchaser (the “APA”), Purchaser has agreed to deliver to Escrow Agent a deposit of Ten Million 00/100 Dollars ($10,000,000.00) (the “Deposit”) in good funds by federal wire transfer, pursuant to the APA. Escrow Agent shall hold the Deposit pursuant to the terms hereof.
The Purchaser, Seller, and Escrow Agent further agree that any additional deposits due under and in connection with the APA will be governed pursuant to the terms hereof.
Escrow Agent agrees to act as such upon the terms and conditions set forth in this Agreement.
NOW, THEREFORE, the parties hereto agree as follows:
1.    Escrow Agent. Seller and Purchaser hereby engage Escrow Agent to serve as escrow agent under the terms hereof, and upon execution thereof, pursuant to the terms of the APA. Escrow Agent hereby accepts such engagement and agrees to hold and release the Deposit in accordance with the terms hereof. The Deposit shall be deposited with Escrow Agent by wire transfer. All interest, investment income or other proceeds will accrue to and be reported to applicable taxing authorities, including the Internal Revenue Service, for the account of Purchaser.
2.    Deposit. The parties hereto agree that the Escrow Agent shall invest the Deposit in a separate interest bearing money market account at ____________ Bank for the benefit of Purchaser. The investment shall be subject to the rules, regulations, policies, and procedures of the depository institution and the provisions of applicable law. All interest will accrue and be reported to the Internal Revenue Service for the account of ________________1, and interest will accrue at the rate provided by the institution in which the Deposit is deposited. Interest shall be payable at the time the Deposit is disbursed in accordance with the terms of this Agreement; provided, however, that nothing herein shall diminish Escrow Agent’s obligation to apply the full amount of the Deposit in accordance with the terms of these escrow trust instructions.
3.    Release of Deposit.
(a)    Except as otherwise contemplated by Section 3(c), in no case shall the above-mentioned Deposit be surrendered except in accordance with written instructions signed
E-1


1 NTD: Purchaser to designate a single purchaser entity by Purchaser and Seller. Upon receipt by Escrow Agent joint written instructions of Seller and Purchaser directing Escrow Agent to release the Deposit, Escrow Agent shall deliver the Deposit, as and to the party indicated in said written instructions, within three (3) Business Days after receiving such instructions, by wire transfer of immediately available funds. In the event Escrow Agent does not receive such joint written instructions, the Deposit shall be held and released pursuant to the remainder of this Section 3.
(b)    If there is a dispute with respect to the distribution of the Deposit, Purchaser and Seller shall use their reasonable best efforts to resolve such dispute, and the Deposit shall continue to be held by Escrow Agent until the earlier to occur of (i) joint written instructions of Purchaser and Seller are delivered to Escrow Agent or (ii) Escrow Agent’s receipt of a certified copy of an order of any court of competent jurisdiction or directive from any governmental authority of competent jurisdiction, , in which event, Escrow Agent shall release the Deposit to the party designated thereinIn the event of a dispute regarding the Deposit, Escrow Agent may elect to commence an action in interpleader and in conjunction therewith remit the Deposit to a court of competent jurisdiction in Tennessee pending resolution of such dispute . The parties agree that the cost of any such action shall be deducted from the Deposit prior to disbursement to the parties.
4.    Notices. All notices, requests, demands, waivers and communications required or permitted to be given under this Agreement shall be in writing signed by or on behalf of the party making such notice, request, demand, waiver or communication and shall be deemed to be given (i) on the day delivered (or if that day is not a Business Day, or if delivered after the close of business on a Business Day, on the next day that is a Business Day) when delivered by personal delivery or overnight courier, (ii) on the third (3rd) Business Day after mailed by registered or certified mail, postage prepaid, return receipt requested, or (iii) upon transmission when sent by facsimile transmission or email transmission (provided that such facsimile or email is followed by an original of such notice by mail or personal delivery as provided herein). Mailed notices shall be addressed as set forth below, but any party may change the address set forth below by written notice to other parties in accordance with this paragraph.
To Seller:
c/o American Health Partners
201 Jordan Rd, Suite 200
Franklin, TN 37067
Attn: Jason Bailey
Attn: Philip Clark, Esq.
Email: jbailey@amhealthpartners.com
Email: PClark@amhealthpartners.com
With a copy to:
Foley & Lardner LLP
301 East Pine Street, Suite 1200
Orlando, FL 32801
D-2



Attn: Matthew E. Jassak
Email: MJassak@foley.com
To Purchaser:
c/o Eagle Arc Partners
17 State St., Suite 2525
New York, NY 10004
Attn: Elliott Mandelbaum
Attn: Samuel Rieder
Email: elliott@eaglearc.com
Email: samuel@eaglearc.com
With a copy to:
UB Greensfelder LLP
1660 West 2nd Street, Suite 1100
Cleveland, Ohio 44113
Attention: Daniel Gottesman, Esq.
Email: dgottesman@ubglaw.com
To Escrow Agent:
Landmark Abstract Agency, LLC
207 Rockaway Turnpike
Lawrence, NY 11559
Email: jrekant@laatitle.com
Attention: Jacob Rekant
5.    Liability and Duties of Escrow Agent. Acceptance by Escrow Agent of its duties under this Agreement is subject to the following terms and conditions:
(a)    The parties acknowledge that Escrow Agent is acting solely as a stakeholder at their request and for their convenience, that Escrow Agent shall not be deemed to be the agent of either of the parties, and that Escrow Agent shall not be liable to either of the parties for any act or omission on its part taken or made in good faith, and not in disregard of this Agreement orthe APA, but shall be liable for its negligent acts and willful misconduct;
(b)    Seller and Purchaser shall jointly and severally indemnify Escrow Agent for, and hold it harmless against all costs, claims and expenses, including but not limited to reasonable attorneys’ fees, incurred in connection with the performance of Escrow Agent’s duties hereunder, except with respect to actions or omissions taken or made by Escrow Agent in bad faith, in disregard of this Agreement or involving negligence or willful misconduct on the part of Escrow Agent;
(c)    Escrow Agent shall be fully protected in acting on and relying upon any written notice, instruction, direction or other document which Escrow Agent in good faith believes to be genuine and to have been signed or presented by the proper party or parties;
D-3


(d)    Escrow Agent may seek the advice of legal counsel in the event of any dispute or question as to the construction of any of the provisions of this Agreement or its duties hereunder, and it shall incur no liability and shall be fully protected in respect of any action taken or suffered by it in good faith in accordance with the opinion of such counsel; and
(e)    Escrow Agent may resign and be discharged from its duties hereunder at any time by giving written notice of such resignation to each of Seller and Purchaser specifying a date, not less than thirty (30) days after the date of such notice, when such resignation will take effect. Upon the effective date of such resignation, Escrow Agent shall deliver the funds held in escrow to such person or persons as Seller and Purchaser shall in writing jointly direct, and upon such delivery Escrow Agent shall be relieved of all duties and liabilities thereafter accruing under this Agreement. Seller and Purchaser shall have the right at any time upon joint action to substitute a new Escrow Agent by giving notice thereof to Escrow Agent then acting. If, however, Seller and Purchaser shall fail to name such a successor escrow agent within twenty (20) days after the notice of resignation from Escrow Agent, Escrow Agent may apply to a court of competent jurisdiction for appointment of a successor escrow agent.
6.    Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Tennessee.
7.    Waiver of Jury Trial. EACH OF SELLER, PURCHASER AND ESCROW AGENT HEREBY WAIVE A TRIAL BY JURY OF ANY AND ALL ISSUES ARISING IN ANY ACTION OR PROCEEDING BETWEEN ESCROW AGENT, SELLER AND PURCHASER OR THEIR RESPECTIVE SUCCESSORS OR ASSIGNS, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR ANY OF ITS PROVISIONS OR ANY NEGOTIATIONS IN CONNECTION HEREWITH.
8.    Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original and it will not be necessary in making proof of this Agreement or the terms of this Agreement to produce or account for more than one of such counterparts. All counterparts shall constitute one and the same instrument. Each party may execute this Agreement via a facsimile (or transmission of a .pdf file) of this Agreement. In addition, facsimile or .pdf signatures of authorized signatories of the parties shall be valid and binding and delivery of a facsimile or .pdf signature by any party shall constitute due execution and delivery of this Agreement.
9.    Entirety; Modifications. This Agreement and the APA together embody the entire agreement between the parties with respect to the Deposit and supersedes all prior agreements and understandings related to the Deposit. This Agreement may be amended or supplemented only by an instrument in writing executed by the party against whom enforcement is sought. No course of conduct shall constitute a waiver of any of the terms and conditions of this Agreement, unless such waiver is specified in writing, and then only to the extent so specified. A waiver of any of the terms and conditions of this Agreement on one occasion shall not constitute a waiver of the other terms of this Agreement, or of such terms and conditions on any other occasion.
D-4


11.    Binding Effect; Successors. This Agreement shall be binding upon the respective parties hereto and their heirs, executors, successors and assigns. If Escrow Agent consolidates, merges or converts into, or transfers all or substantially all of its corporate trust business to, another entity authorized to exercise fiduciary powers, the successor entity without any further act shall be the successor Escrow Agent.
12.    Termination of Escrow. This Agreement shall terminate upon the release by Escrow Agent of the Deposit in accordance with this Agreement.
13.    Definitions. The following terms shall have the following meanings in this Agreement:
“Business Day” means any day that is not (i) a Saturday or Sunday, or (ii) a legal holiday on which banks are authorized or required by Law to be closed in New York, New York, or (iii) one of the following Jewish Holidays, with the dates of said holidays for 2024 set forth in parentheticals: Purim (March 24), Passover (April 23 - April 30), Shavuot (June 12 - June 13), “Nine Days” (August 5 – August 13), Rosh Hashana (October 3 - 4), Yom Kippur (October 12), and Sukkot (October 17 – October 23), Shemini Atzeres (October 24) and Simchas Torah (October 25).
[Signature page follows]

D-5


IN WITNESS WHEREOF, the parties hereto have caused this Escrow Agreement to be executed as of the day and year first above written.
PURCHASER:
1900 PARR AVENUE TN LLC
2031 AVONDALE STREET TN LLC
800 VOLUNTEER DRIVE TN LLC
726 KENTUCKY AVENUE S TN LLC
1245 E COLLEGE ST TN LLC
5275 MILLENNIUM DRIVE AL LLC
1645 FLORENCE RD TN LLC
1630 E REELFOOT AVE TN LLC
460 HANNINGS LANE TN LLC
524 WEST MAIN STREET TN LLC
7424 MIDDLEBROOK PIKE TN LLC
7512 MIDDLEBROOK PIKE TN LLC
1536 APPLING CARE LANE TN LLC
5070 SANDERLIN AVENUE TN LLC
765 BERT JOHNSTON AVENUE TN LLC
45 FOREST COVE TN LLC
1513 N 2ND STREET TN LLC
121 PHYSICIANS DR TN LLC
597 WEST FOREST AVENUE TN LLC
444 ONE ELEVEN PLACE TN LLC
704 DUPREE ROAD TN LLC
4343 ASHLAND CITY HIGHWAY TN LLC
119 KITTRELL STREET TN LLC
727 EAST CHURCH STREET TN LLC
175 HOSPITAL DRIVE TN LLC
835 EAST POPLAR AVENUE TN LLC
2650 NORTH MT JULIET ROAD TN LLC
202 EAST MTCS ROAD TN LLC
900 PROFESSIONAL PARK DRIVE TN LLC
813 S DICKERSON RD TN LLC
895 POWERS BLVD TN LLC
each, a Delaware limited liability company
By:    
Name:
Its:

Purchaser and Seller
Signature Page to Escrow Agreement


SELLER:
APPLINGWOOD PROPCO LLC
BRIGHT GLADE PROPCO LLC
COVINGTON PROPCO LLC
CRESTVIEW HEALTH PROPCO LLC
DYERSBURG PROPCO LLC
MCKENZIE PROPCO LLC
NORTHBROOKE PROPCO LLC
PARIS PROPCO LLC
UNION CITY PROPCO LLC
WEST TENNESSEE PROPCO LLC
CLARKSVILLE PROPCO LLC
LEWIS COUNTY PROPCO LLC
MILLENNIUM PROPCO LLC
VANAYER PROPCO LLC
BETHESDA PROPCO LLC
DECATUR COUNTY PROPCO LLC
LEXINGTON PROPCO LLC
MCNAIRY PROPCO LLC
MEADOWBROOK PROPCO LLC
MT. JULIET PROPCO LLC
SAVANNAH PROPCO LLC
VANCO PROPCO LLC
WESTWOOD PROPCO LLC
each, a Delaware limited liability company
By:    
Name:
Its:
FOREST COVE LONG TERM FACILITY, LLC
CKT PROPERTIES, LLC
HARBOR VIEW PROPERTIES, LLC
CUMBERLAND LONG TERM FACILITY, LLC
NORTHSIDE LONG TERM FACILITY, LLC
KNOXVILLE PROPCO I, LLC
WELLPARK PROPCO, LLC
WAVERLY LONG TERM FACILITY, LLC
each, a Tennessee limited liability company
By:    
Name:
Its:

{1325/002/00304038.1}[Purchaser Signature Page to Escrow Agreement]


ESCROW AGENT:
LANDMARK ABSTRACT AGENCY, LLC
By: Name: Jacob Rekant, Esq.
[End of Signatures]

Escrow Agent
Signature Page to Escrow Agreement


EXHIBIT F
FORM OF BILL OF SALE AND ASSIGNMENT AND ASSUMPTION AGREEMENT

F-1


BILL OF SALE, ASSIGNMENT AND ASSUMPTION AGREEMENT
Title: President THIS BILL OF SALE, ASSIGNMENT AND ASSUMPTION AGREEMENT (this “Agreement”) is made and entered into as of the __ day of _____ 2024 (the “Effective Date”) by and between the parties set forth on Schedule 1 hereto (individually and collectively, as the context so requires, as “Seller” and as “Sellers”, respectively), and the parties set forth on Schedule 2 hereto (individually and collectively, as the context so requires, as “Purchaser” and as “Purchasers”, respectively).
RECITALS
This Agreement is made with reference to the following facts:
A.    Concurrently with this Agreement, Sellers are selling to Purchasers, and Purchasers are purchasing from Sellers, all of Sellers’ right, title and interest in and to the Real Property described in that certain Asset Purchase Agreement by and between Sellers and Purchasers dated as of _________, 2024 (the “Purchase Agreement”). Any capitalized terms used herein and not otherwise defined shall have the meanings ascribed thereto in the Purchase Agreement.
B.    In connection with such sale and purchase and in accordance with the Purchase Agreement, each Seller desires to assign all of its respective right, title and interest to Purchaser, and Purchaser desires to assume from such Seller, all duties and obligations (to the extent such duties and obligations first arise or accrue on or after the Effective Date), in, to and under the Purchased Assets.
NOW, THEREFORE, in consideration of the foregoing, the covenants and agreements herein contained, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Purchasers and Sellers, intending to be legally bound, hereby covenant and agree as follows:
AGREEMENT
1.    The recitals as set forth above are agreed to be true and correct and are incorporated herein by this reference.
2.    As of the Effective Date, each Seller hereby grants, bargains, sells, assigns, transfers, conveys, and sets over to Purchaser, all of its respective right, title, and interest in, to and under the Purchased Assets. As of the Effective Date, Purchaser hereby accepts such assignment of the Purchased Assets and assumes all duties, liabilities, and obligations of each Seller with respect to the Purchased Assets arising on and after the Effective Date.



3. It is understood and agreed that, except as set forth in the Purchase Agreement, each Seller has not made, does not make, and specifically disclaims all warranties, representations, covenants, and guaranties of any kind or character whatsoever, whether express, implied or statutory, or whether written or oral, with respect to the condition of the Purchased Assets including, without limitation, as to merchantability or fitness for a particular purpose, the design or condition of the Purchased Assets, the quality or capacity of the Purchased Assets, workmanship or compliance of the Purchased Assets with the requirements of any law, rule, specification or contract pertaining thereto, or patent infringement or latent defects. By acceptance of this Agreement, Purchaser acknowledges and agrees that each Seller conveys and Purchaser accepts the Purchased Assets on an “as is, where is, with all faults” basis, without any representation or warranty of any kind whatsoever, except as set forth in the Purchase Agreement. In the event of any inconsistency between this document and the Purchase Agreement, the Purchase Agreement shall control.
4.    This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns.
5.    This Agreement shall in all respects be governed by, and construed in accordance with, the laws of the State of Tennessee.
6.    This Agreement is for the sole benefit of the Parties hereto and their permitted assigns and nothing herein expressed or implied shall give or be construed to give to any person, other than the parties hereto and such permitted assigns, any legal or equitable rights hereunder, whether as a third-party beneficiaries or otherwise.
7.    Sellers hereby covenant and agree that upon Purchasers’ request, Sellers will do, execute, and deliver or cause to be done, executed or delivered, all such further acts, deeds, assignments, transfers, and conveyances as may be reasonably required by Purchasers in order to assign, transfer, and convey unto and vest in Purchasers and its successors and assigns right, title and interest to the Purchased Assets sold, conveyed, and transferred by this Agreement and as set forth in the Purchase Agreement.
8.    This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument. The delivery of an executed counterpart of this Agreement by email, DocuSign, or other electronic means shall constitute effective delivery of such counterpart for all purposes with the same force and effect as the delivery of an original, executed counterpart.
{Signature Page Follows.}




IN WITNESS WHEREOF, Sellers and Purchasers have caused this Bill of Sale, Assignment and Assumption Agreement to be executed and delivered as of the date first written above.
SELLERS:




PURCHASERS:




Schedule 1
Seller Parties




Schedule 2
Purchaser Parties




EXHIBIT G
FORM OF POST-CLOSING ESCROW AGREEMENT

G-1

Foley Draft 10/15/24
INDEMNIFICATION ESCROW AGREEMENT
THIS INDEMNIFICATION ESCROW AGREEMENT (this “Agreement”) is made as of [__________], 2024 (the “Effective Date”) by and among the parties identified as Indemnitors on Schedule 1 attached hereto (collectively, “Indemnitor”) and (ii) the parties identified as Indemnitees on Schedule 1 attached hereto (collectively, “Indemnitee”), and (iii) Landmark Abstract Agency, LLC, a New York limited liability company (“Escrow Agent”).
WHEREAS, Indemnitor and Indemnitee are parties to that certain [Asset Purchase Agreement] [or] [Operations Transfer Agreements set forth on Schedule 2 attached hereto] dated as of [___], 2024 (as amended, the “Transaction Document”) pursuant to which Indemnitor has agreed (subject to the terms, conditions and limitations set forth therein) [to transfer to Indemnitee, and Indemnitee has agreed (subject to the terms, conditions and limitations set forth therein) to accept from Indemnitor, the operations of those certain] [or] [to sell to Indemnitee, and Indemnitee has agreed (subject to the terms, conditions and limitations set forth therein) to purchase from Indemnitee certain real estate and other assets relating to the] skilled nursing facilities identified on Schedule 1 attached hereto (collectively, the “Facilities”);
WHEREAS, pursuant to the Transaction Document, on the Effective Date, Indemnitor agreed to deposit [INSERT APPLICABLE AMOUNT] Dollars ($[_________________]) (the “[Initial]2 Escrow Funds”) with Escrow Agent, to secure Indemnitor’s indemnity obligations under the Transaction Document;
[WHEREAS, pursuant to the Transaction Documents, upon the occurrence of any subsequent closing of the transactions contemplated by the Transaction Documents (each, a “Subsequent Deposit Date”), Indemnitor agreed to deposit additional funds in accordance and subject to the terms of the Transaction Document (the “Additional Escrow Funds” and together with the Initial Escrow Funds, the “Escrow Funds”) with Escrow Agent, to further secure Indemnitor’s indemnity obligations under the Transaction Document;]
NOW, THEREFORE, in consideration of the mutual covenants and premises herein contained, and intending to be legally bound hereby, the parties hereto agree as follows:
1.    Indemnitee and Indemnitor do hereby appoint Escrow Agent to be and act as escrow agent, and Escrow Agent hereby accepts its appointment to hold in an escrow account (hereinafter referred to as the “Escrow Account”) the Escrow Funds upon the terms and conditions as set forth in this Agreement.
2.    On the Effective Date, Indemnitor shall cause to be deposited with Escrow Agent, into the Escrow Account, the [Initial] Escrow Funds. [On any Subsequent Deposit Date, Indemnitor shall cause to be deposited with Escrow Agent, into the Escrow Account, the Additional Escrow Funds]. Any income generated on the Escrow Funds shall be the sole property of and paid to the Indemnitor. The Escrow Funds retained by Escrow Agent will be held
2 NTD – Delete if all Facilities included in Initial Closing.
1

Foley Draft 10/15/24
in a separate interest bearing money market account at ___________ Bank for the benefit of Indemnitor. The investment shall be subject to the rules, regulations, policies, and procedures of
the depository institution and the provisions of applicable law. All interest will accrue and be reported to the Internal Revenue Service for the account of ________________ ,3 and interest will accrue at the rate provided by the institution in which the Escrow Funds are deposited. Interest shall be payable at the time the Escrow Funds are disbursed in accordance with the terms of this Agreement.
3.    The Escrow Agent shall hold the Escrow Funds, if and when received by it, in accordance with the terms of this Agreement. The Escrow Funds shall be paid in accordance with written instructions executed by Indemnitee and Indemnitor in accordance with the provisions of this Agreement and [FOR APA: Sections 2.5(c) and Article IX] [or] [FOR OTA: Article X] of the Transaction Document. From time to time on or before the Final SD Release Date (as defined below), Indemnitee may give notice to Indemnitor and Escrow Agent specifying in reasonable detail the nature and dollar amount of any indemnity claim it or any [Purchaser Indemnified Parties] [or][Transferee Indemnified Parties] (as defined in the Transaction Document) may have under [FOR APA: Article IX] [or] [FOR OTA: Article X]of the Transaction Document. Any notice under the preceding sentence is referred to herein as a “Notice” and any claim for payment from the Escrow Fund under the preceding sentence is referred to herein as a “Claim.” If Indemnitor gives notice to Indemnitee and Escrow Agent disputing all or any portion of a Claim (a “Counter Notice”) within thirty (30) days following receipt by Escrow Agent and Indemnitor of the Notice regarding such Claim, such Claim shall be resolved as provided in this Section 3. If no Counter Notice is received by Escrow Agent within such thirty (30) day period, then the dollar amount claimed by Indemnitee as set forth in its Notice shall be deemed established for purposes of this Agreement and, at the end of such thirty (30) day period, Escrow Agent shall pay to Indemnitee the dollar amount claimed in the Notice from (and only to the extent of) the Escrow Fund. If a Counter Notice is given with respect to only a portion of a Claim, Escrow Agent shall, at the end of such thirty (30) day period, pay to Indemnitee the remaining, undisputed dollar amount claimed by Indemnitee as set forth in its Notice, to the extent Escrow Agent did not receive a Counter Notice, from (and only to the extent of) the Escrow Fund and shall only make a payment with respect to the disputed dollar amount set forth in the Counter Notice in accordance with (i) joint written instructions of Indemnitee and Indemnitor or (ii) a final, non-appealable order of a court of competent jurisdiction. If a Counter Notice is given with respect to all of a Claim, Escrow Agent shall make payment with respect thereto only in accordance with (i) joint written instructions of Indemnitee and Indemnitor or (ii) a final, non-appealable order of a court of competent jurisdiction. Any court order shall be accompanied by a legal opinion by counsel for the presenting party satisfactory to Escrow Agent to the effect that the order is final and non-appealable. Escrow Agent shall act on such court order and legal opinion without further question. Escrow Agent shall not be responsible for any delay in the electronic wire transfer of funds.
4.    Notwithstanding any terms to the contrary herein, [but subject in all respects to the requirements of Section 6,] with respect to the [Initial] Escrow Funds:
3 NTD: Seller to advise on which entity will be beneficiary of Interest income.


Foley Draft 10/15/24
(a)    Indemnitee explicitly agrees that upon receipt of written instructions from Indemnitor delivered on or after the first (1st) Business Day following the first (1st) anniversary of the Effective Date (the “First Release Date”), Escrow Agent shall release to Indemnitor [INSERT 33% OF ORIGINAL ESCROW AMOUNT] and 00/100 Dollars ($[_____________].00) from the [Initial] Escrow Funds (minus the amount of: (i) indemnification Claims paid from the [Initial] Escrow Funds prior to the First Release Date, and (ii) pending indemnification Claims by any Indemnitee against the [Initial] Escrow Funds; provided that in the event that any amount is withheld by the Escrow Agent due to any pending Claim, then as soon as practicable following resolution of such Claim, the portion of such amount that is not applicable and applied to such pending Claim shall be released to Indemnitor).
(b)    Indemnitee explicitly agrees that upon receipt of written instructions from Indemnitor delivered on or after the first (1st) Business Day following the second (2nd) anniversary of the Effective Date (the “Second Release Date”), Escrow Agent shall release to Indemnitor the positive difference, if any, between the remaining balance of the [Initial] Escrow Funds minus [INSERT 33% OF ORIGINAL ESCROW AMOUNT] and 00/100 Dollars ($[___________].00) from the [Initial] Escrow Funds (minus the amount of any pending indemnification Claims against the [Initial] Escrow Funds by any Indemnitee; provided that in the event that any amount is withheld by the Escrow Agent due to any pending Claim against the [Initial] Escrow Funds, then as soon as practicable following resolution of such Claim, the portion of such amount that is not applicable and applied to such pending Claim shall be released to Indemnitor); provided that, in no event shall such release cause the remaining amount of the [Initial] Escrow Funds to be less than [INSERT 34% OF ORIGINAL ESCROW AMOUNT] plus the amount of any pending indemnification Claims against the [Initial] Escrow Funds by an Indemnitee.
(c)    Indemnitee explicitly agrees that upon receipt of written instructions from Indemnitor delivered on or after the first (1st) Business Day following the third (3rd) anniversary of the Effective Date (the “Final Release Date”), Escrow Agent shall release to Indemnitor all remaining funds from the from the [Initial] Escrow Funds (minus the amount of any pending indemnification Claims by any Indemnitee against the [Initial] Escrow Funds; provided that in the event that any amount is withheld by the Escrow Agent due to any pending Claim against the [Initial] Escrow Funds, then as soon as practicable following resolution of such Claim, the portion of such amount that is not applicable and applied to such pending Claim shall be released to Indemnitor); provided, however, that if the Indemnitee does not provide written evidence to Escrow Agent and Indemnitor that they have filed a judicial action against the Indemnitor with respect to any such pending Claim within one hundred eighty (180) days period following the Final Release Date, the [Initial] Escrow Funds, if any, held by the Escrow Agent shall be released to the Indemnitor.
[5.    Notwithstanding any terms to the contrary herein, but subject in all respects to the requirements of Section 6, with respect to any Additional Escrow Funds:


Foley Draft 10/15/24
(a)    Indemnitee explicitly agrees that upon receipt of written instructions from Indemnitor delivered on or after the first (1st) Business Day following the first (1st) anniversary of the Subsequent Deposit Date (the “First SD Release Date”), Escrow Agent shall release to Indemnitor [INSERT 33% OF ADDITIONAL ESCROW AMOUNT] and 00/100 Dollars ($[_______].00) from the Additional Escrow Funds (minus the amount of: (i) indemnification Claims paid from the Additional Escrow Funds prior to the First SD Release Date, and (ii) pending indemnification Claims by any Indemnitee against the Additional Escrow Funds; provided that in the event that any amount is withheld by the Escrow Agent due to any pending Claim, then as soon as practicable following resolution of such Claim, the portion of such amount that is not applicable and applied to such pending Claim shall be released to Indemnitor).
(b)    Indemnitee explicitly agrees that upon receipt of written instructions from Indemnitor delivered on or after the first (1st) Business Day following the second (2nd) anniversary of the Subsequent Deposit Date (the “Second SD Release Date”), Escrow Agent shall release to Indemnitor the positive difference, if any, between the remaining balance of the Additional Escrow Funds minus [INSERT 33% OF ADDITIONAL ESCROW AMOUNT] and 00/100 Dollars ($[__________].00) from the Additional Escrow Funds (minus the amount of any pending indemnification Claims against the Additional Escrow Funds by any Indemnitee; provided that in the event that any amount is withheld by the Escrow Agent due to any pending Claim against the Additional Escrow Funds, then as soon as practicable following resolution of such Claim, the portion of such amount that is not applicable and applied to such pending Claim shall be released to Indemnitor); provided that, in no event shall such release cause the remaining amount of the Additional Escrow Funds to be less than [INSERT 34% OF ADDITIONAL ESCROW AMOUNT] plus the amount of any pending indemnification Claims against the Additional Escrow Funds by an Indemnitee.
(c)    Indemnitee explicitly agrees that upon receipt of written instructions from Indemnitor delivered on or after the first (1st) Business Day following the third (3rd) anniversary of the Subsequent Deposit Date (the “Final SD Release Date”), Escrow Agent shall release to Indemnitor all remaining funds from the from the Additional Escrow Funds (minus the amount of any pending indemnification Claims by any Indemnitee against the Additional Escrow Funds; provided that in the event that any amount is withheld by the Escrow Agent due to any pending Claim against the Additional Escrow Funds, then as soon as practicable following resolution of such Claim, the portion of such amount that is not applicable and applied to such pending Claim shall be released to Indemnitor); provided, however, that if the Indemnitee does not provide written evidence to Escrow Agent and Indemnitor that they have filed a judicial action against the Indemnitor with respect to any such pending Claim within one hundred eighty (180) days period following the Final SD Release Date, the Additional Escrow Funds, if any, held by the Escrow Agent shall be released to the Indemnitor.]


Foley Draft 10/15/24
6. If Indemnitee gives notice to Indemnitor and Escrow Agent disputing the calculation of the amounts set forth in the request for release of Escrow Funds by Indemnitor (a “Release Counter Notice”) pursuant to Section 4 or Section 5 of this Agreement (a “Indemnitor Release Request”) within five (5) Business Days following receipt by Escrow Agent and Indemnitee of the Indemnitor Release Request, such Indemnitor Release Request shall be resolved as provided in this Section 6. If no Release Counter Notice is received by Escrow Agent within such five (5) Business Day period, then the dollar amount claimed by Indemnitor as set forth in its Indemnitor Release Request shall be deemed established for purposes of this Agreement and, at the end of such five (5) Business Day period, Escrow Agent shall pay to Indemnitor the dollar amount claimed in the Indemnitor Release Request from (and only to the extent of) the Escrow Fund. If a Release Counter Notice is given with respect to only a portion of a Indemnitor Release Request, Escrow Agent shall, at the end of such five (5) Business Day period, pay to Indemnitor the remaining, undisputed dollar amount claimed by Indemnitor as set forth in its Indemnitor Release Request, to the extent Escrow Agent did not receive a Release Counter Notice, from (and only to the extent of) the Escrow Fund and shall only make a payment with respect to the disputed dollar amount set forth in the Release Counter Notice in accordance with (i) joint written instructions of Indemnitee and Indemnitor or (ii) a final, non-appealable order of a court of competent jurisdiction. If a Release Counter Notice is given with respect to all of an Indemnitor Release Request, Escrow Agent shall make payment with respect thereto only in accordance with (i) joint written instructions of Indemnitee and Indemnitor or (ii) a final, non-appealable order of a court of competent jurisdiction. Any court order shall be accompanied by a legal opinion by counsel for the presenting party satisfactory to Escrow Agent to the effect that the order is final and non-appealable.
7.    In the event of any disagreement between Indemnitee and Indemnitor resulting in conflicting instructions to, or adverse claims or demands upon the Escrow Agent with respect to the release of the Escrow Funds, the Escrow Agent shall refuse to comply with such instruction, claim or demand so long as such disagreement shall continue, and in so refusing the Escrow Agent shall not release the Escrow Funds, or make any other disposition of the Escrow Account. The Escrow Agent shall not be or become liable in any way to Indemnitee or Indemnitor for its failure or refusal to comply with any such conflicting instructions or adverse claims or demands, and it shall be entitled to continue so to refrain from acting until such conflicting or adverse demands (a) shall have been adjusted by agreement and it shall have been notified in writing thereof by Indemnitee and Indemnitor or (b) shall have finally been determined in a court of competent jurisdiction. Additionally, at its discretion the Escrow Agent may proceed with filing an interpleader action. Upon depositing the Escrow Funds with a court of competent jurisdiction, the Escrow Agent shall be released from any further obligation, responsibility or liability under this Agreement. In addition, the Escrow Agent shall be entitled to be reimbursed out of the Escrow Funds for its costs and reasonable attorney’s fees that are incurred in connection with filing the interpleader action.
8.    It is understood and agreed by the parties to this Agreement as follows:
(a)    The Escrow Agent is not a trustee for any party for any purpose, and is merely acting as a depository and a ministerial capacity hereunder with the limited duties herein prescribed.


Foley Draft 10/15/24
(b)    The Escrow Agent has no responsibility in respect of any instructions, certificate or notice delivered to it or of the Escrow Account, other than faithfully to carry out the obligations undertaken in this Agreement and to follow the directions in such instructions or notice provided in accordance with the terms hereof.
(c)    Indemnitor and Indemnitee hereby agree, jointly and severally, to indemnify and hold harmless the Escrow Agent from and against all costs, damages, judgment, reasonable attorney’s fees, expenses, obligations, and liabilities of any kind or nature, which Escrow Agent in good faith may incur or sustain in connection with this Agreement. The Escrow Agent shall not be liable for any actions taken or omitted by it in good faith and may rely upon, and act in accordance with the advice of its counsel without liability on its part for any action taken or omitted in accordance with such advice.
(d)    The Escrow Agent may conclusively rely upon and act in accordance with any certificate, instructions, notice, letter, telegram, cablegram or other written instrument believed to be genuine and to have been signed or communicated by the proper party or parties.
(e)    The Escrow Agent shall not be required to defend any legal proceeding which may be instituted against it in respect of the subject matter of this Agreement unless requested to do so by Indemnitee or Indemnitor and indemnified to the Escrow Agent’s satisfaction against the cost and expense of such defense. If any such legal proceeding is instituted against it, the Escrow Agent agrees promptly to give notice of such proceeding to Indemnitee and Indemnitor. The Escrow Agent shall not be required to institute legal proceedings of any kind.
(f)    The Escrow Agent shall not, by act, delay, omission or otherwise, be deemed to have waived any right or remedy it may have, either under this Agreement or generally, unless such waiver be in writing, and no waiver shall be valid unless it is in writing, signed by the Escrow Agent, and only to the extent expressly therein set forth. A waiver by the Escrow Agent under the terms of this Agreement shall not be construed as a bar to, or waiver of, the same or any other such right or remedy that it would otherwise have on any other occasion.
(g) The Escrow Agent may resign as such hereunder by giving thirty (30) days’ written notice hereof to Indemnitee and Indemnitor. Within ten (10) days after receipt of such notice, Indemnitee and Indemnitor shall furnish to the Escrow Agent written instructions for the release of the Escrow Funds. If the Indemnitee and Indemnitor fail to furnish the written instructions within the ten (10) day period, the Escrow Agent may petition any court of competent jurisdiction for the appointment of a successor Escrow Agent and, upon such appointment, deliver the Escrow Funds to such successor. By doing so, the Escrow Agent shall not incur any liability to any party to this Agreement and shall be released from any further obligation, responsibility and liability under this Agreement. Furthermore, Escrow Agent shall be entitled to be reimbursed out of the Escrow Funds for its costs and reasonable attorney’s fees that are incurred as a result of having to petition the court for the appointment of a successor.


Foley Draft 10/15/24
9.    All notices, demands or other communications given hereunder shall be in writing and shall be deemed to have been duly delivered (i) upon the delivery (or refusal to accept delivery) by messenger or overnight express delivery service (or, if such date is not on a business day, on the business day next following such date), or (ii) on the third (3rd) business day next following the date of its mailing by certified mail, postage prepaid, at a post office maintained by the United States Postal Service, or (iii) upon receipt by email transmission (provided, however, if such email transmission occurs outside of the hours of 9:00 A.M. – 5:00 P.M. of the recipient’s local time, such notice shall be deemed given on the following business day; further provided that notice by email shall be contingent on such delivering party also providing notice by one of the methods described in (i) or (ii), above), addressed as follows:
If to Indemnitor, at: c/o American Health Partners
201 Jordan Road
Franklin, TN 37067
Attn: Jason Bailey
Email:
jbailey@amhealthpartners.com
with a copy to (which shall not constitute notice): Foley & Lardner LLP
301 East Pine Street, Suite 1200
Orlando, FL 32801
Attn: Matthew E. Jassak
Email: MJassak@foley.com
If to Indemnitee, at: [____________]
with a copy to (which shall not constitute notice): [____________]
if to Escrow Agent: Landmark Abstract Agency
207 Rockaway Turnpike
Lawrence, NY 11559
Attn: Jacob Rekant
Email: jrekant@laatitle.com

10.    Any term not defined in this Agreement shall have the meaning as set forth in the Transaction Document.
11.    This Agreement may be modified, altered, amended, canceled or terminated only by the written agreement of the parties hereto.


Foley Draft 10/15/24
12.    This Agreement shall be governed by and construed in accordance with the laws of the State of Tennessee and shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors in interest and assigns.
13.    This Agreement may be executed in any one or more counterparts, each of which, when so executed, shall be deemed an original, and all such counterparts together shall constitute the same instrument. The execution of this Agreement by facsimile or email signature shall be binding and enforceable as an original; provided, that any party delivering a facsimile or email document shall thereafter execute and deliver to the other party an original instrument, effective as of the date of the facsimile or email instrument, as soon as reasonably possible thereafter.
[NO FURTHER TEXT ON THIS PAGE; SIGNATURE PAGE FOLLOWS]



Foley Draft 10/15/24
IN WITNESS WHEREOF, the parties hereby have caused this Agreement to be executed and delivered as of the date first above written.
INDEMNITOR:
[INSERT APPLICABLE SELLERS/OLD
OPERATORS]
By:    
Name:     
Title:    
INDEMNITEE:
[INSERT APPLICABLE BUYERS/NEW
OPERATORS]
By:    
Name:     
Title:    
[Signatures continue on next page]

1

Foley Draft 10/15/24
ESCROW AGENT:
Landmark Abstract Agency, LLC,
a New York limited liability company
By:     
Name: Jacob Rekant
Title:    

1

Foley Draft 10/15/24
SCHEDULE 1
Indemnitors:
1.    [INSERT APPLICABLE SELLERS/OLD OPERATORS]
Indemnitees:
1.    [INSERT APPLICABLE BUYERS/NEW OPERATORS]
Facilities:
1.    [INSERT APPLICABLE FACILITIES]

1

Foley Draft 10/15/24
SCHEDULE 2
List of Transaction Documents

1

Foley Draft 10/15/24
EXHIBIT H
FORM OF DEEDS

H-1


THIS INSTRUMENT PREPARED BY AND
WHEN RECORDED RETURN TO:
Foley & Lardner LLP
Matthew E. Jassak, Esq.
301 East Pine Street, Suite 1200
Orlando, Florida 32801
ADDRESS OF NEW OWNER: SEND TAX BILL TO: MAP-PARCEL:
    
    
    
    
    
    
    

SPECIAL WARRANTY DEED
THIS SPECIAL WARRANTY DEED is executed as of ____________, 2024, by ______________, LLC, a Tennessee limited liability company, whose address is c/o American Health Partners, 201 Jordan Rd, Suite 200, Franklin, TN 37067 (“Grantor”), in favor of ______________, LLC, a _____________ limited liability company, whose address is ______________________________________ (“Grantee”).
W I T N E S S E T H:
Grantor, for and in consideration of the sum of Ten and No/100 Dollars ($10.00) and other valuable considerations, receipt whereof is hereby acknowledged, by these presents does grant, bargain, sell, alien, remise, release, transfer, convey and confirm unto Grantee, its successors and assigns forever, all that certain tract or parcel of land situated in ___________ County, Tennessee, as more particularly described on Exhibit A attached hereto and incorporated herein by this reference (the “Property”).
TOGETHER with all the improvements, tenements, hereditaments and appurtenances thereto belonging or in anywise appertaining.
This is improved property commonly known as [INSERT PROPERTY ADDRESS HERE].
TO HAVE AND TO HOLD the said real estate, with the appurtenances, estate, title and interest thereto belonging or in any wise appertaining, to the said GRANTEE and its successors and assigns, forever.
Grantor covenants with said Grantee that Grantor is lawfully seized and possessed of said real estate in fee simple and has a good right and lawful authority to sell and convey it.
1


GRANTOR further covenants and binds itself, its successors and assigns to warrant specially and forever defend the title to said real estate against the lawful claims of all persons claiming by, through and under GRANTOR, but not further or otherwise.
The Property is subject to taxes for year 2025 and subsequent years, not yet due and payable, and all easements, covenants, conditions, restrictions, and other matters of record; however, this reference shall not serve to reimpose the same.
Wherever used, the singular number shall include the plural, the plural the singular, and the use of any gender shall be applicable to all genders.
[SIGNATURE PAGE FOLLOWS]

2


IN WITNESS WHEREOF, Grantor has caused these presents to be executed the day and year first above written.
GRANTOR:
____________________________________ LLC, a Tennessee limited liability company
By:    
Name:
Title:
STATE OF __________
COUNTY OF ________
Before me, the undersigned, a Notary Public in and for the County and State aforesaid, personally appeared __________, with whom I am personally acquainted (or proved to me on the basis of satisfactory evidence), and who upon oath acknowledged himself/herself to be the _____________ of ___________, the within bargainor, a limited liability company, and that he/she as such _____________, and being authorized so to do, executed the foregoing instrument for the purposes therein contained, by signing the name of the limited liability company by himself/herself as __________________________.
Witness my hand and seal, at office in ___________, ________________, this the    day of _________________, 20___.
    
Notary Public
My Commission Expires:    

1


STATE OF ________)
COUNTY OF ______)
The actual consideration or value, whichever is greater, for this transfer is _____________ and __/100 Dollars ($____________).
    
AFFIANT
Sworn to and subscribed before me this _________ day of ___________________, 2024.
    
Notary Public
My Commission Expires:    

1


EXHIBIT A
LEGAL DESCRIPTION
[LEGAL DESCRIPTION TO BE INSERTED - NOTE: TN REQUIRES THAT A DERIVATION IS CLAUSE IS ADDED AT THE END OF THE LEGAL DESCRIPTION]]

1


This instrument prepared by:
Matthew E. Jassak, Esq.
Foley & Lardner LLP
301 East Pine Street, Suite 1200
Orlando, Florida 32801
Return to After Recording and
Send Tax Notices To:
STATUTORY WARRANTY DEED
STATE OF ALABAMA    )
MADISON COUNTY    )
KNOW ALL MEN BY THESE PRESENTS, that for and in consideration of the sum of _______________ and No/100 DOLLARS ($_______.00) and other good and valuable consideration to the undersigned grantor, MILLENNIUM PROPCO LLC, a Delaware limited liability company (hereinafter, the "GRANTOR"), in hand paid by the grantee herein, the receipt and sufficiency of which are hereby acknowledged, the GRANTOR does hereby GRANT, BARGAIN, SELL AND CONVEY unto _____________________ LLC, a ______________ limited liability company (hereinafter, the "GRANTEE"), the following described real estate (the “PROPERTY”) situated in Madison County, Alabama, to-wit:
LOT 2 OF THE FINAL PLAT OF A RESUBDIVISION OF LOT 1 OF PHASE 1 OF WILLOW WAY SUBDIVISION, RECORDED AS INSTRUMENT NO. 20100608000305630, IN THE OFFICE OF THE JUDGE OF PROBATE OF MADISON COUNTY, ALABAMA.
TOGETHER WITH THE RECIPROCAL EASEMENT AGREEMENT BETWEEN HUNTSVILLE LONG TERM FACILITY, INC, AND BEHAVIORAL HEALTHCARE CENTER AT HUNTSVILLE, INC., DATED OCTOBER 31, 2010, RECORDED ON NOVEMBER 1, 2010 AS
INSTRUMENT NO. 20101101000631310.
The Property is conveyed subject to:
1.    All taxes for the year 2025 and subsequent years, not yet due and payable.
2.    Any prior reservation or conveyance, together with release of damages of minerals of every kind and character, including, but not limited to, oil, gas, sand and gravel in, on and under subject property.
3.    All other matters of record.
1


TO HAVE AND TO HOLD the Property to said GRANTEE, its successors and assigns, forever.
And the GRANTOR will warrant and forever defend the right and title to the Property unto the GRANTEE against all the lawful claims of all persons claiming by, through or under GRANTOR, but against none other.
Pursuant to the provisions of Ala. Code § 40-22-1 (1975), the following information is offered in lieu of submitting Form RT-1:
Grantor’s Name and Mailing Address: Grantee’s Name and Mailing Address:
Millennium Propco LLC  
201 Jordan Road, Suite 200  
Franklin, Tennessee 37067  

Property Address:
5275 Millennium Drive
Huntsville, Alabama 35806
Tax Parcel ID: 14-09-30-1-002-001.002
Date of Sale: ___________, 2024
Purchase Price: $
The Purchase Price can be verified in: Closing Statement

Grantor attests, to the best of its knowledge and belief, that the information submitted in lieu of the RT-1 Real Estate Sales Validation Form is true and accurate, and Grantor understands that any false statements contained in such information may result in the imposition of the penalty indicated in Code of Alabama 1975 § 40-22-1(h).
[Signature on following page.]

2


IN WITNESS WHEREOF, GRANTOR has caused its duly authorized officer to hereunto set his signature as the act of such GRANTOR, as of this ________ day of _____ , 2024.
MILLENNIUM PROPCO LLC,
a Delaware limited liability company
By:    
Name:
Its:
STATE OF     )
COUNTY OF     )
I, the undersigned, a Notary Public in and for said County, in said State, hereby certify that _________________ , whose name as ________________ of MILLENNIUM PROPCO LLC, a Delaware limited liability company, is signed to the foregoing instrument, and who is known to me, acknowledged before me on this day, that being informed of the contents thereof, he, as such Manager and with full authority, executed the same voluntarily for and as the act of said limited liability company.
Given under my hand and official seal, this the ___ day of ________________, 2024.
    
Notary Public
My Commission Expires:     
[NOTARIAL SEAL]

1


EXHIBIT I
FORM OF OPERATIONS TRANSFER AGREEMENT

1

Foley Comments 10/17/24
OPERATIONS TRANSFER AGREEMENT

1


TABLE OF CONTENTS
Page
Article I TRANSFER OF OPERATIONS. 2
1.1...... Transfer of Operations. 2
Article II ASSETS, LIABILITIES AND OTHER MATTERS. 2
2.1...... Assets. 2
2.2...... Nursing Home License; Medicare and Medicaid Provider Agreements. 4
2.3...... Transfer of Resident Trust Funds. 6
2.4...... Assumption of Liabilities. 6
2.5...... Employees and Employee Benefits. 7
2.6...... Consents to Assignment 10
2.7...... Excluded Assets. 11
Article III THE CLOSING.. 11
3.1...... Time and Place of Closing. 11
3.2...... Closing Matters. 11
3.3...... Closing and Post-Closing Adjustments: Costs and Prorations. 12
Article IV REPRESENTATIONS AND WARRANTIES OF TRANSFEROR.. 14
4.1...... Corporate. 14
4.2...... Notices. 15
4.3...... Litigation. 15
4.4...... Taxes. 15
4.5...... Employee Benefit Plans. 15
4.6...... Employees. 16
4.7...... Encumbrances. 18
4.8...... Certain Healthcare Matters; Compliance Generally. 19
4.9...... Resident Agreements. 21
4.10.... Absence of Changes. 22
4.11.... Inventory. 22
4.12.... Contracts. 22
4.13.... Resident Trust Funds. 22
4.14.... Environmental Laws. 23
4.15.... Improvements. 23
4.16.... Insurance. 23
4.17.... Reserved. 23
4.18.... Financial Statements; Undisclosed Liabilities. 23
4.19.... Broker 24
4.20.... Intellectual Property. 24
4.21.... NO WARRANTY OF CONDITION.. 24
4.22.... Disclosure Updates. 25
Article V REPRESENTATIONS AND WARRANTIES OF TRANSFEREE.. 25
5.1...... Corporate. 25
5.2...... Litigation. 26
5.3...... Broker 26
5.4...... Transferee’s Reliance. 26
Article VI COVENANTS AND AGREEMENTS. 27
6.1...... Conduct of Business. 27
6.2...... Forbearances. 28
1


6.3...... Non-Competition and Non-Solicitation. 29
6.4...... Access. 30
6.5...... Announcement and Disclosure. 31
6.6...... Appropriate Action; Consents; Filings. 32
6.7...... Access to Current Records. 32
6.8...... Further Assurances. 33
6.9...... No Negotiation. 33
6.10.... Accounts Receivable. 33
6.11.... Cost Reports. 38
6.12.... Assistance in Proceedings. 39
6.13.... Corporate Contracts; Overhead and Shared Services. 39
6.14.... Business Relationships. 39
6.15.... Information Systems, Records in Electronic Form, Software and Data. 39
6.16.... Stimulus Funds. 40
6.17.... Notice of Breach. 40
6.18.... Post-Closing Insurance. 40
6.19.... PCA.. 41
Article VII CONDITIONS PRECEDENT TO THE OBLIGATIONS OF PARTIES. 41
7.1...... Conditions to Obligations of Transferee. 41
7.2...... Conditions to Obligations of Transferor 42
7.3...... Interim Arrangements. 43
Article VIII DELAYED CLOSING.. 44
8.1...... Delayed Closing. 44
Article IX TERMINATION.. 44
9.1...... Termination. 44
9.2...... Procedure and Effect of Termination. 45
Article X INDEMNIFICATION.. 45
10.1.... Survival of Representations, Warranties and Covenants. 45
10.2.... Indemnification by Transferor 46
10.3.... Indemnification by Transferee. 46
10.4.... Indemnification Limitations. 46
10.5.... Assumption of Defense. 49
10.6.... Non-Assumption of Defense. 49
10.7.... Indemnified Party’s Cooperation as to Proceedings. 49
10.8.... Indemnification for Resident Trust Property. 50
10.9.... Damages Disclaimed. 50
10.10.. Individual Liability Disclaimed. 50
10.11.. Exclusive Remedy Post-Closing. 50
10.12.. Application of Escrow Funds. 51
10.13.. Non-Recourse Parties. 51
10.14.. Transferor Guarantors. 52
10.15.. Interim Indemnity Guaranty. 52
Article XI ASSIGNMENT. 52
11.1.... Assignment 52
Article XII MISCELLANEOUS. 52
12.1.... Disclosure Schedules. 52
12.2.... Payment of Expenses. 53
12.3.... Entire Agreement; Assignment; Etc. 53
2


12.4.... Captions. 53
12.5.... Severability. 53
12.6.... Enforcement. 53
12.7.... Modification or Amendment 54
12.8.... Construction of Agreement 54
12.9.... Notices. 54
12.10.. Remedies Cumulative. 55
12.11.. Governing Law; Consent to Jurisdiction. 55
12.12.. Forum; Waiver of Jury Trial. 55
12.13.. Time of Essence. 55
12.14.. Counterparts. 55
12.15.. Representation Waiver 56
12.16.. Third-Party Beneficiary. 56
12.17.. Transferor Representative. 56
12.18.. Attorney-Client Privilege. 57
12.19.. Guaranty; Obligations of Transferee Guarantor 57
12.20.. Guaranty; Obligations of Seller 57


3


OPERATIONS TRANSFER AGREEMENT
THIS OPERATIONS TRANSFER AGREEMENT, together with all exhibits and schedules (this “OTA”), dated as of October __, 2024 (the “Execution Date”), is by and among ____________ LLC, a [Tennessee/Delaware] limited liability company (“Seller”); [OPCO ENTITY] , a Tennessee limited liability company, an Affiliate of Seller which operates the Facility (“Transferor”); and ____________ LLC, a ___________ limited liability company (“Transferee”); and ____________ LLC, a ___________ limited liability company (“Transferee Guarantor”). Each of Seller, Transferor, and Transferee may be referred to herein as a “Party” and collectively as the “Parties.” Capitalized terms used herein but not defined shall have the same meaning ascribed to such terms in the Purchase Agreement. A glossary of capitalized terms is set forth in Exhibit A attached hereto.
WHEREAS, Transferor is the licensed operator of the skilled nursing facility located at [_______________], commonly known as AHC _____________ (the “Facility”);
WHEREAS, Tennessee Health Management, LLC, a Tennessee limited liability company (the “Manager”), an Affiliate of the Seller and Transferor, is the day-to-day manager of the Facility;
WHEREAS, Seller and certain Seller Affiliates have agreed to sell the real property and assets comprising the Facility to _____________, LLC (“Purchaser”) pursuant to that certain Asset Purchase Agreement dated as of October __, 2024 (the “Purchase Agreement”), by and between Seller, certain Seller Affiliates and Purchaser;
WHEREAS, Transferor owns certain Assets used in connection with the operation of the Facility;
WHEREAS, Transferor desires to divest itself of the operations or management of the Facility that it currently operates and all of its interest in certain tangible and intangible property and related other interests relating to the operation and/or management of the Facility, all upon the terms and conditions contained in this OTA;
WHEREAS, concurrent with the Closing under the Purchase Agreement, Transferee has agreed to lease the Facility from Purchaser or its Affiliates pursuant to a Lease Agreement, by and between Transferee and Purchaser;
WHEREAS, the Parties hereto desire for Transferor, subject to the satisfaction of the conditions contained herein, to cease operating the Facility and surrender all rights in and to the Facility, except as provided in this OTA, and for Transferee to commence operation of the Facility as of the Effective Time (or pursuant to IMA as set out in this OTA); and
WHEREAS, the Parties wish to provide for an orderly and lawful transition of the operations of the Facility from Transferor to Transferee.
1


NOW, THEREFORE, in consideration of the premises, the mutual obligations of the Parties contained in this OTA, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto, intending to be legally bound, hereby agree as follows:
Article I
TRANSFER OF OPERATIONS
1.1Transfer of Operations. Transferor agrees that Transferor’s and Manager’s rights and obligations in and to the Facility and all of its rights to occupy or otherwise operate the Facility shall terminate as of the Effective Time, except those rights or obligations which survive or are retained by such Transferor or Manager pursuant to this OTA. Transferor agrees to convey, assign and deliver (or to cause Manager to convey, assign and deliver) to Transferee the Assets and all of Transferor’s and Manager’s right, title and interest in and to the business operations of the Facility, effective as of the Effective Time. For the avoidance of doubt, to the extent any obligation of Transferor hereunder requires the action of Manager, Transferor shall cause Manager to comply with the terms and provisions of this OTA so as to satisfy such obligation of Transferor hereunder.
Article II
ASSETS, LIABILITIES AND OTHER MATTERS
2.1Assets. Upon the terms and subject to the conditions set forth in this OTA, on the Closing Date, and except for the Excluded Assets, to the fullest extent of its interest, Transferor shall sell, transfer, convey and/or assign (or shall cause Manager to sell, transfer, convey and/or assign) to Transferee, free and clear of all Encumbrances of any nature whatsoever except for Permitted Encumbrances, all of Transferor’s and Manager’s right, title and interest in and to the items set forth below (the “Assets”):
(a)all computers, computer equipment and hardware, office equipment, trucks, vehicles and other transportation equipment, parts, supplies and other tangible personal property owned by and in Transferor’s possession as of the date of this OTA or acquired by Transferor prior to the Closing Date which are used primarily in connection with the operation of its Facility;
(b)software licenses related exclusively to the operation of the Facility, if applicable and to the extent assignable (and if licensor consent to such assignment is required, to the extent such consent is granted), subject to any license transfer fees which would be the responsibility of Transferee, all to the extent provided pursuant to an Assumed Contract (as defined below);
(c)all inventory and supplies including, but not limited to, office, foodstuffs, medical, disposables, prescription medications and pharmaceutical inventories and supplies and other inventories, supplies and articles of personal property of every kind and nature attached to or used in connection with the Facility, but only to the extent such inventory and supplies are owned by Transferor (collectively “Inventory”);
(d)all contracts, agreements, leases (excluding real estate leases), purchase orders relating exclusively to the Facility (collectively, the “Contracts”), whether oral or written, to the extent transferable and to the extent expressly assumed in writing by Transferee in its sole discretion; excluding, however, rights, claims or responsibilities thereunder existing and relating to the period of time prior to the Effective Time. A preliminary list of those Contracts which Transferee has identified as Assumed Contracts as of the Execution Date is attached hereto as Schedule 2.1(d), which Transferee may modify by adding (but not deleting) Contracts until the date which is thirty (30) days prior to Closing after which time such Schedule shall be deemed final. All Contracts as to which Transferor receives from Transferee timely notice of assumption are referred to as the “Assumed Contracts.”
2


(e)all menus, operating manuals for equipment at the Facility, marketing, sales and promotional materials, and all operating policy and procedure manuals (the “Policy and Procedure Manuals”) for Transferee to use for a period of one hundred fifty (150) days after the Closing. After one-hundred fifty (150) days (the “Policy Return Date”), Transferee shall return all Policy and Procedure Manuals to Transferor; provided, however, to the extent that Transferee uses the Policy and Procedure Manuals between the Closing Date and the Policy Return Date, Transferee shall be required to place its name thereon and remove the name of Transferor and its Affiliates;
(f)to the extent of its interest therein, all rights to telephone and facsimile numbers used by the Facility, any “yellow page” and other advertising rights of such Facility, and all of the rights of Transferor in the name used for the Facility (excluding the marks set forth on Exhibit 2.7);
(g)all files, charts, and other information located at the Facility in Transferor’s possession or control relating to all (i) current Residents of the Facility as of the Closing Date (including, but not limited to, all resident records, billing and collection records, medical records, therapy records, pharmacy records, clinical records, and Resident Trust Funds records), (ii) Residents who previously occupied the Facility or used the Facility prior to the Effective Time and are not Residents of the Facility as of the Effective Time (including, but not limited to, all patient records, medical records, therapy records, pharmacy records, clinical records, and Resident Trust Funds records), (iii) employment records for the Transferee Employees (including all medical and health records and all non-medical records including payroll and schedule records, evaluations, etc.), (iv) administrative compliance records including, but not limited to, all state surveys and plans of correction, and (v) correspondence and any other written data which is utilized in connection with the operation of the Facility or the Business (collectively, “Current Records”);
(h)licenses, certificates, permits, waivers, consents, authorizations, variances, approvals, accreditations, guaranties, certificates of occupancy, utility lease agreements, covenants, commitments, and warranties relating to the Facility and the Assets, if any, issued to or on behalf of Transferor relating to the Assets or the Facility, provided same are transferable and assumed by Transferee (“Permits”);
(i)goodwill;
(j)such Transferor’s right, title and interest as trustee or otherwise to residents/patient funds held in trust (collectively, “Resident Trust Funds”) to the extent permitted by Law shall be transferred to Transferee on the Closing Date. Transferee shall accept such assignment on behalf of such a resident/patient and shall indemnify and hold Transferor harmless in connection with any such resident/patient to the extent of the Resident Trust Property received by Transferee;
(k)to the extent permitted by applicable Law and in accordance with the terms and conditions set forth herein, Transferor’s rights and interests in and to its provider number and provider and reimbursement agreement under the Medicare program;
(l)all other assets, properties, rights, business and tangible personal property of every kind and nature owned by Transferor on the Closing Date, known or unknown, fixed or unfixed, choate or inchoate, accrued, absolute, contingent or otherwise, whether or not specifically referred to in this OTA relating exclusively to the Facility and its operations to the extent transferable and not expressly excluded pursuant to Section 2.7.
3


2.2Nursing Home License; Medicare and Medicaid Provider Agreements.
(a)Within one (1) Business Day of the Execution Date, Transferee shall file an application for a license to operate the Facility (the “New License”) with the [State of Tennessee Department of Health, Office of Health Care Facilities and Board for Licensing Health Care Facilities / Alabama Department of Public Health, Bureau of Health Provider Standards] (the “Department”), and Transferee shall file applications for the Ancillary Permits and Approvals as and when permitted or required under the laws of the applicable issuing authority. Transferee will provide Transferor with documentation of its filed application for the New License promptly after its filing of the application. Transferee shall diligently proceed to secure the New License and the Ancillary Permits and Approvals and shall (i) from time to time, upon request of Transferor, advise Transferor of the status of Transferee’s efforts to secure the New License and the Ancillary Permits and Approvals, and (ii) upon receipt, provide Transferor with copies of the document(s) evidencing the New License. For purposes hereof, “Ancillary Permits and Approvals” shall mean all ancillary permits or licenses required for the operation of the Facility from and after the Closing Date including, but not limited to, the Medicare tie in notice and Medicaid provider agreement, business licenses, food service permits, elevator permits, vending machine permits, beauty shop licenses and CLIA waivers. Hereinafter, the New License and the Ancillary Permits and Approvals will be collectively referred to as the “Regulatory Approvals.” The Parties will use reasonable efforts to cooperate by providing such information necessary for Transferee to file the application for the Regulatory Approvals contemplated under this Section 2.2.
(b)To the extent permitted by Law:
(i)Effective as of the Effective Time, Transferor’s rights and interests in and to its Medicare provider number and provider and reimbursement agreement (the “Medicare Agreement”) shall be assigned to Transferee.
(ii)Effective as of the Effective Time, Transferee shall have the right to bill Medicaid using Transferor’s Medicaid provider number and Transferor’s provider and reimbursement agreement (the “Medicaid Agreement”).4
(iii)Transferee shall provide all notices and make all necessary filings as required under applicable Law in order for Transferee to become the certified Medicare and Medicaid provider at the Facility. So long as Transferee is utilizing its commercially reasonable efforts to become the certified Medicare and Medicaid provider at the Facility, Transferee shall be permitted to bill under the Medicare Agreement and Medicaid Agreement, utilizing Transferor’s Submitter ID and NPI numbers and/or Medicaid provider number, as applicable, during the period (the “Transition Period”) that commences on the Effective Time and that ends on the earlier of (A) in the case of Medicare, the issuance of the Medicare tie-in notice or in the case of Medicaid, the issuance of the new Medicaid number and related provider agreement to Transferee, or (B) the date which is twelve (12) months following the Effective Time. If, notwithstanding Transferee’s continuing commercially reasonable efforts, the Medicare tie-in notice shall not have been issued or a new Medicaid provider agreement shall not have been issued to Transferee within such 12-month period, as applicable, Transferor, upon Transferee’s
4 NTD: AHC Knoxville to contemplate that New Operator will bill under the prior owner (pre-AHC) to bill Medicaid and that Current operator has not received tie-in notice from Medicare w/r/t both AHC Knoxville and AHC WellPark.
4


written request, shall agree to such reasonable extensions of the Transition Period as may be necessary for Transferee to complete the certification process. In no event shall Transferee bill under the Medicare Agreement or Medicaid Agreement following expiration of the Transition Period. Transferee shall indemnify and hold Transferor harmless from and against any and all liabilities arising out of Transferee’s use of the Medicare Agreement and/or Medicaid Agreement following the Effective Time.
(c)For the Facilities with VA Contracts:5 Following the Execution Date, Transferor shall use its commercially reasonable efforts to provide Transferee with all documents and information necessary for Transferee to seek the novation (the “Novation”) of contract number [___________] (the “VA Contract”) between [___________] and the Department of Veterans Affairs (the “VA”). Transferor shall use its commercially reasonable efforts to cooperate with Transferee in seeking the Novation of the VA Contract including, but not limited to, signing any novation agreement and other forms reasonably requested by Transferee or the VA. Transferee shall be entitled to bill under the VA Contract pursuant to that certain Subcontract Pending Novation substantially in the form attached hereto as Exhibit 2.2(c) (the “VA Subcontract”). For the avoidance of doubt, Transferee will continue to receive payment from the VA for services rendered after the Closing Date and any such payments will be considered Accounts Receivable hereunder, subject to the provisions of Section 6.10. Transferee acknowledges that (i) the Novation is not expected to occur until after the Closing Date and, therefore, the issuance of such Novation shall not be a condition to close, and (ii) Transferee shall reimburse Transferor for all reasonable out-of-pocket expenses (including, without limitation, any audit costs) incurred by Transferor in securing the necessary deliverables for the Novation.
[Alternative for Ensign/PACS:
For the Facilities with VA Contracts: Following the Execution Date, Transferor shall use its commercially reasonable efforts to provide Transferee with all documents and information necessary for Transferee to seek the replacement of contract number [_________] (the “VA Contract”) between [____________] and the Department of Veterans Affairs (the “VA”) with a Veterans Care Agreement (the “VCA Replacement”) between Transferee and the VA , or if a VCA Replacement is not forthcoming, then a novation (the “VCA Novation”). Transferor shall use its commercially reasonable efforts to cooperate with Transferee in seeking the VCA Replacement and/or VCA Novation, as appropriate. Transferee shall be entitled to bill under the VA Contract pursuant to that certain Subcontract substantially in the form attached hereto as Exhibit 2.2(c) (the “VA Subcontract”). Transferee acknowledges that (i) the VCA Replacement is not expected to occur until after the Closing Date and, therefore, the issuance of such VCA Replacement shall not be a condition to close, and (ii) Transferee shall reimburse Transferor for all reasonable out-of-pocket expenses (including, without limitation, any audit costs) incurred by Transferor in securing the necessary deliverables for the VCA Replacement.]
2.3Transfer of Resident Trust Funds. To the extent permitted by applicable Law at the Closing, Transferor shall deliver to Transferee (a) original copies of the trust fund records, (b) a written statement that sets forth the Resident Trust Funds (with no negative balances), and (c) an assignment of the Resident Trust Funds to Transferee. Within ten (10) Business Days following the Closing Date, Transferor shall prepare and deliver to Transferee a true, correct and complete accounting, properly reconciled and balanced, of the Resident Trust Funds as of the
5 NTD: Section 2.9(c) is only applicable to Applingwood, Bright Glade, Covington Care, Lexington, McKenzie, Northbrooke and Savannah.
5


Effective Time. Transferee hereby agrees that it will accept such Resident Trust Funds and hold the same in trust for the residents, in accordance with applicable statutory and regulatory requirements.
2.4Assumption of Liabilities.
(a)Upon the terms and subject to the conditions set forth in this OTA, at the Effective Time, Transferee agrees to assume the following liabilities relating to the Assets, subject to the provisions of Section 2.4(b): (i) all obligations and liabilities under the Assumed Contracts to the extent arising from the period from and after the Effective Time, (ii) any Taxes with respect to the operation of the Business at the Facility to the extent arising from the period from and after the Effective Time, (iii) all liabilities under the terms of the Permits to the extent arising from the period from and after the Effective Time; (iv) certain liabilities of Transferor specified in a subsequent agreement of the Parties, to the extent Transferee accepts a specific and equivalent credit from Transferor at Closing; and (v) all obligations and liabilities (in each case, whether or not accrued, whether fixed, contingent or otherwise, and whether known or unknown) to the extent arising from the operation of the Facility from and after the Effective Time (collectively, “Assumed Liabilities”).
(b)Except for the Assumed Liabilities, Transferor shall retain all of its liabilities and obligations of any kind or nature, at any time existing or asserted, whether or not accrued, whether fixed, contingent or otherwise, whether known or unknown, arising out of and by reason of the ownership or operation of the Assets and the Facility prior to the Effective Time. Except to the extent expressly and unambiguously expressed herein to the contrary, Transferee is not the successor to liability of Transferor and is not herein assuming any liability or detriment from, arising from, out of, or relating to, Transferor’s ownership of the Assets, the Facility or any activity of Transferor prior to the Effective Time or conduct of Transferor after the Effective Time. Transferee does not and shall not assume (except to the extent included in Assumed Liabilities) any payable of Transferor, governmental claim or charge, liability of any governmental claim or charge, liability for any general liability, malpractice, professional liability, resident rights violations, or violation of employee rights or contracts, whether such claims arise in law, equity, tort, contract, statute, common law, or from any other source or precedent. Without limiting the generality of the foregoing, Transferor shall retain and Transferee shall not assume any (i) Medicaid and/or Medicare liabilities or overpayments for the period prior to the Effective Time, all of which Transferor agrees to satisfy in full as and when due upon expiration of any applicable period for the contesting or appeal of such liabilities, (ii) accrued expenses which were incurred prior to the Effective Time, (iii) Encumbrances affecting the Assets other than Permitted Encumbrances, (iv) liability or obligation of Transferor arising out of or based upon Transferor’s ownership and operation of the Facility prior to the Effective Time, (v) liability or obligation relating to any RAC, ZPIC, or MAC audits as well as any and all investigations from a Governmental Entity or any entity acting with the authority of the foregoing or by a whistleblower or other private citizen claiming a violation of a healthcare related statute or a violation of the Medicare, Medicaid or other third party payor agreement, in each case for the period prior to the Effective Time, (vi) liability or obligation relating to or arising from any physical plant LSC deficiencies and/or fire safety standards violations identified on any applicable survey of the Facility as a deficiency that was not cured prior to the Closing (each an “Open Deficiency”), (vii) capital repairs or physical improvements required to remove or resolve an Open Deficiency, (viii) any costs, expenses, liability or obligation with respect to any Stimulus Funds, including, without limitation, any CMS accelerated and advance payment program or related to any Paycheck Protection Program SBA Loans or CARES Act Provider Relief Fund Monies, (xi) liability or obligation of Transferor arising out of or based upon Transferor’s ownership and operation of the Facility prior to the Effective Time and/or the Excluded Assets, (x) any employment claims or any other obligations under any employment agreement, pension, retirement plan, profit-sharing plan, stock purchase or stock option plan, medical or other benefits or insurance plan, compensation or bonus agreement, vacation or severance pay plan or agreement or any other employee benefit plan or collective bargaining agreement, in each case, relating to any Transferee Employee prior to the Closing Date, (xi) any costs, expenses, or obligations arising under any contracts not assumed by Transferee, and/or (xii) any costs, expenses, or obligations arising under Transferor’s handing of Resident Trust Funds prior to the Closing Date. Transferor shall retain all of its applicable foregoing liabilities and obligations (“Retained Liabilities”).
6


2.5Employees and Employee Benefits. The Parties hereby agree that:
(a)No less than twenty (20) days prior to the Closing, Transferor shall update the list of employees on Schedule 4.6(a) to reflect new hires and terminations of employment that occurred after the Execution Date regarding the Facility.
(b)Not less than fourteen (14) days prior to the Closing, Transferee shall (or shall cause one of its Affiliates), subject to Transferee’s policies, procedures and standard background checks, to offer in writing employment to substantially all of those employees listed on such revised Schedule 4.6(a) who meet Transferee’s employment eligibility requirements, effective as of the Effective Time (and subject to such employee’s continued employment with Transferor as of immediately prior to the Effective Time), on the terms and conditions set forth in this Section 2.5. Employees who accept Transferee’s (or its Affiliate’s) offers of employment and commence employment with Transferee are referred to herein as “Transferee Employees.” The employment of each Transferee Employee shall be effective as of the Effective Time. Nothing contained in this OTA shall constitute a guaranty of employment or continued employment of any kind for any current or former employee of Transferor, whether or not such employee is hired by Transferee.
(c)As of 11:59:59 p.m. on the Closing Date, Transferor shall terminate the employment of all employees at the Facility including, without limitation, Persons temporarily absent from active employment by reason of disability, illness, injury, workers’ compensation, approved leave of absence or layoff. Transferee’s or its Affiliate’s offer of employment to Transferor employees pursuant to Section 2.5(b) above shall commence at the Effective Time, such that those Transferor employees who accept employment offered by Transferee or its Affiliate shall not experience a period of unemployment in connection with the transactions contemplated herein. Notwithstanding the foregoing, Transferor shall be solely responsible for any liabilities related to or arising out of employment of any such employees of Transferor and the termination of employment of such employees by Transferor.
(d)Not less than fourteen (14) days prior to the Closing, Transferee shall (i) identify to Transferor all Transferor employees identified on Schedule 4.6(a) to whom Transferee and its Affiliates will not offer employment, and (ii) identify to Transferor all employees of Affiliates of Transferor (such as, without limitation, dieticians, clinicians, division vice-presidents, sales people, and such other similar positions) providing services to the Facility to whom Transferee or its Affiliates would propose to make offers (such individuals under subsection (ii) being “Affiliated-Service Transferee Employees”) subject to consent in the sole discretion of the applicable Transferor Affiliate. To the extent that Transferor’s applicable Affiliate provides such consent, then the requirements regarding employment and hiring of Affiliated-Service Transferee Employees by Transferee and its Affiliates will be the same for Transferee and its Affiliates as those for Transferee Employees under this Section 2.5.
(e)The Parties shall work together in good faith to coordinate reasonably regarding employee changes that occur between the date of the scheduling updates in this Section and the Effective Time so that each Party can update its schedules and records accordingly.
7


(f)Transferor shall pay the employees at the Facility in accordance with its standard payroll practice, all earned wages due and payable and accrued benefits as of the Closing Date (irrespective of the termination of employment contemplated to occur as of the Closing Date), including but not limited to, paid time off, personal leave, and vacation benefits as of the Effective Time, and any severance, retention bonus or other change in control payment payable to any Transferee Employee or Affiliated Service Transferee Employee, as applicable, that become due or owed as a result of the consummation of the transactions contemplated by this OTA. Transferor agrees to not materially change the current levels of compensation and benefits for employees at the Facility from the Execution Date until the Closing Date except as may be required by applicable law or as provided by Transferor’s personnel policies in the ordinary course of business, such as those pertaining to post hiring or annual performance evaluations.
(g)All Transferee Employees hired by Transferee who accept and commence employment with Transferee following the Effective Time shall be employed by Transferee on an “at will” basis. Transferee shall initially employ such number of Transferee Employees on such terms and conditions so as not to trigger WARN Act liability, including: (i) comparable base salary or rates of pay as in effect immediately prior to the Closing Date for employees of similar tenure performing comparable services at Transferee’s other skilled nursing facilities, and (ii) subject only to any eligibility requirements, employee benefits that are comparable in the aggregate to the benefits that are provided by Transferee to its employees in comparable positions under the Plans at its other skilled nursing facility operations In furtherance and not in limitation of the foregoing, Transferee shall treat prior service with Transferor as service with Transferee for purposes of determining eligibility to receive and participate in all benefits programs maintained by Transferee. It is understood that Transferee shall not be responsible to pay any disability or workers’ compensation benefits to or for any Transferor’s employee who is receiving such benefits or who experienced a disability or injury covered under Transferor’s or Seller’s benefit plans or workers compensation insurance program on or before the Closing, and that Transferor or Seller, as applicable, shall continue to be responsible for payment of such benefits until such obligation terminates under the applicable benefit plans or Laws. From and after the date which is thirty (30) days prior to Closing, Transferee, at reasonable times and upon prior written notice to and coordination with Transferor, shall be entitled to meet with the employees of the Facilities and distribute employment applications and benefit enrollment packages. This OTA shall not create and shall not be deemed to create or grant to any Transferee Employee any third-party beneficiary rights or claims or any cause of action of any kind or nature.
(h)Pursuant to Treasury Regulations Section 1.409A-1(h)(4), Transferor and Transferee agree that on the Closing Date, each Transferee Employee shall be treated as having a “separation from service” for purposes of Section 409A of the Code and Treasury Regulations Section 1.409A-1(h).
(i)Subject to Section 2.5(m), Transferor or Seller shall retain the liability for the claims respecting all employees of Transferor (including the Transferee Employees) that are incurred under any Plan prior to the Effective Time.
(j)Transferor, Seller and, to the extent applicable, Seller Affiliates, expressly assume and retain any liability arising under COBRA with respect to any “M&A qualified beneficiaries” (as that term is defined in the COBRA regulations). To satisfy this liability, Transferee agrees to cooperate as reasonably necessary (at no out-of-pocket cost to Transferee) so that Transferor may satisfy all such obligations.
8


(k)Transferee shall be responsible for any and all liabilities arising out of or with respect to any Transferee Employee arising with respect to employment by Transferee after the Effective Time.
(l)The Parties acknowledge and agree that all provisions contained in this Section 2.5 with respect to employees are included for the sole benefit of the respective Parties and shall not create any right (i) in any other Person, including any employees, former employees, any participant in any Plan or Transferee Plan or any beneficiary thereof, or (ii) to continued employment with any Transferor or Transferee, or particular benefits or coverage in any Plan or Transferee Plan. For the avoidance of doubt, (A) the provisions of this Section 2.5 shall not constitute an amendment to any Plan or Transferee Plan, and (B) in no event shall any employee, former employee, any participant in any Plan or Transferee Plan or any beneficiary thereof or any other Person described herein be a third party beneficiary for purposes of this OTA.
(m)Immediately following the Closing, Transferee shall, if permissible under Transferee’s current benefit plans, provide Transferee Employees who accept employment with Transferee, as well as eligible dependents of such employees (collectively, with the Transferee Employees, “Affected Participants”) the opportunity to participate in the applicable employee benefit plans, programs or policies maintained or established by Transferee that are comparable to the plans and benefits Transferee provides at its other skilled nursing facility operations (each, a “Transferee Plan”), which may include medical, dental, vision, and/or any other applicable group medical plan, program, insurance coverage or arrangement (collectively “Group Health Plan”). If elected, the benefits offered to such Transferee Employees must extinguish Transferor’s COBRA insurance coverage obligations for such electing Transferee Employees and eligible dependents; provided that, except to the extent required by applicable Law, this section is not intended to require Transferee to satisfy COBRA obligations to employees who were already on COBRA as of Closing. With respect to each Transferee Plan in which Affected Participants become eligible to participate, subject to the consent of any applicable insurer, Transferee shall: (i) waive any eligibility waiting periods, any evidence of insurability requirements and the application of any pre-existing condition limitations under such Plan, except to the extent that such waiting period, evidence of insurability requirement, or pre-existing condition limitations would not have been satisfied or waived under the comparable Plan in which the Affected Participant participated immediately prior to the Effective Time; and (ii) provide each Affected Participant credit for copays and deductibles under any Transferee Group Health Plan to place each Affected Participant in the same place that such Affected Participant was in under the Transferor’s Group Health Plans immediately prior to the Closing.
2.6Consents to Assignment. Notwithstanding anything to the contrary contained herein, this OTA shall not constitute an agreement to assign or transfer any contract or lease, or any claim, right or benefit arising thereunder or resulting therefrom, if an attempted assignment or transfer thereof, without the consent of a third party thereto or of the issuing Governmental Entity, as the case may be, would constitute a breach thereof. The Parties shall cooperate to obtain any consents of any parties necessary to permit the assignment of the Assumed Contracts. Transferor and Transferee acknowledge that certain of the Assumed Contracts may not, by their terms, be assignable and, accordingly, none of such non-assignable Assumed Contracts shall be deemed assigned to or assumed by Transferee unless and until the same shall become so assignable. If and when any necessary consent shall be obtained or any such Assumed Contract shall otherwise become assignable, Transferor shall take all necessary action to assign all of its rights and obligations thereunder to Transferee and Transferee shall, without the payment of any pre-closing liabilities, assume such rights and obligations. Until such time as the Assumed Contracts are assigned to Transferee, Transferor shall not enter into any amendments of such non-assignable Assumed Contracts without the prior written consent of Transferee. Until such time as the non-assignable Assumed Contracts are assumed by Transferee, (a) Transferee shall perform and discharge fully all of the obligations of Transferor under any of such non-assignable Assumed Contracts to the extent the same would have constituted assumed liabilities if the Assumed Contracts had been assumed by Transferee as of the Closing Date and to the extent the same relate to the period of time after the Closing Date, and Transferee shall indemnify, hold harmless, protect and defend Transferor and its respective officers, employees, managers and members, from and against any and all damages, demands, costs, expenses and liabilities arising out of Transferee’s failure to make payments or perform any other obligations which relate to the period of time after the Closing Date occurring under the Assumed Contracts or non-assignable Assumed Contracts after the Closing Date, and (b) Transferor shall, without further consideration therefore, pay, assign and remit to Transferee promptly all monies received or which may be received or obtained in respect of the non-assignable Assumed Contracts related to periods after the Closing Date and Transferor shall take such reasonable actions as shall be necessary to confer on Transferee any other benefits that may be available under such non-assignable Assumed Contracts.
9


2.7Excluded Assets. Notwithstanding anything herein to the contrary, Transferee shall not purchase, and Transferor shall retain, any right, title and interest in the assets listed on Exhibit 2.7 (collectively, “Excluded Assets”).
Article III
THE CLOSING
3.1Time and Place of Closing. Subject to the satisfaction or waiver of all of the conditions precedent set forth in this OTA, the consummation of the transactions contemplated under this OTA (the “Closing”) shall take place on the same date as the closing with respect to the Facility under the Purchase Agreement, or on such other date as shall be mutually agreed upon by the Parties hereto and Purchaser. The date on which the Closing occurs is referred to herein as the “Closing Date.” Notwithstanding the actual time at which the Closing occurs, the time (“Effective Time”) as of which the Closing shall be deemed to be effective, and the risk of loss shall pass from Transferor to Transferee, shall be 12:00:01 a.m. (Central Time) on the day after the Closing Date, unless otherwise mutually agreed to between the Parties.
3.2Closing Matters. Upon the terms and subject to the conditions set forth in this OTA, at the Closing:
(a)Transferor shall deliver to Transferee a bill of sale in the form attached hereto as Exhibit 3.2(a) (the “Bill of Sale”) and such endorsements, assignment instruments, and other instruments of transfer and conveyance as shall be reasonable or necessary to convey, transfer, assign and deliver the Assets to Transferee pursuant to the terms of this OTA and to convey, transfer, assign and deliver any and all interest it has in the furniture, fixtures and equipment of the Facility to the Purchaser under the Purchase Agreement (if applicable);
(b)Transferor shall deliver an assignment of its interests to the items listed in Article II including, without limitation, the Assumed Contracts, pursuant to an assignment and assumption agreement in the form attached hereto as Exhibit 3.2(b) (the “Assignment and Assumption Agreement”);
(c)Transferor and Transferee shall execute and deliver to the other a Certificate in the form attached hereto as Exhibit 3.2(c) (“Bring Down Certificate”);
(d)Transferor and Transferee shall execute a closing statement with respect to the prorations contemplated by Section 3.3 hereof, and the Party owing pursuant to such statement shall pay the amount due in immediately available funds at Closing;
10


(e)Not later than ten (10) days after the Closing, Transferor shall execute and deliver to Transferee a detailed schedule and an assignment of all Resident Trust Funds;
(f)Transferor shall execute and deliver to Transferee an assignment of any and all security deposits or advance deposits from Residents, and Transferee shall deliver to Transferor a written receipt for such funds indicating that Transferee is accepting such funds in trust for the Residents;
(g)Transferor shall deliver to Transferee, to the extent that they are not posted at the Facility, certificates, licenses, permits, authorizations and/or approvals issued for or with respect to such Facility by any Governmental Entity;
(h)Transferor shall deliver to Transferee, or leave at the Facility, the originals (or copies) of all Assumed Contracts in effect on the Closing Date;
(i)Transferor shall deliver to Transferee a current and complete list of the names of each Resident in the Facility;
(j)Not later than ten (10) days after the Closing, Transferor shall deliver a detailed Accounts Receivable aging as of the Effective Time noting all balances owed to Transferor for dates of service prior to the Effective Time as described in Section 6.10 below; and
(k)Transferor shall provide to Transferee an updated Schedule 4.6(a) that lists Transferor’s employees as of the Closing Date.
3.3Closing and Post-Closing Adjustments: Costs and Prorations. In addition to any other items agreed upon by the Parties, the following items are to be apportioned between Transferor and Transferee on a pro-rata basis as to ownership as of the Closing Date, in accordance with the general principle that Transferor shall be entitled to the revenue and Accounts Receivable attributable to, and responsible for such expenses and obligations attributable to, the Facility for the period up to and including the Closing Date, and Transferee shall be entitled to the revenue and Accounts Receivable attributable to, as well as responsible for such expenses and obligations attributable to the operation of the Facility after the Closing Date:
(a)Water, gas, electric, telephone and other utility charges, and sewer and wastewater charges, shall be prorated, to the extent possible prior to the Closing, as of the Closing Date. For metered service, Transferor shall pay or cause to be paid the utility bills for services rendered prior to the readings, and Transferee shall pay the utility bills for the services rendered after the readings. If any metered utility is read on any day other than the Closing Date, Transferor and Transferee shall prorate such utility charges consistent with the most recent bills, and then reconcile following the Closing as provided in Section 3.3(i). In furtherance of the foregoing, Transferee shall work to transition the utilities serving the Facility into the name of Transferee effective as of the Effective Time, and Transferor shall reasonably cooperate with Transferee.
(b)Subject to and consistent with Section 6.10, all revenue and Accounts Receivable attributable to any period ending on or prior to the Closing Date shall belong to Transferor, and all revenue (including rent and Residents’ occupancy fees) and Accounts Receivable attributable to any period after the Closing Date shall belong to Transferee.
11


(c)For expenses of the Facility, Transferee shall remit to Transferor any invoices which reflect a service or delivery date on or before the Closing Date, and Transferee shall assume responsibility for the payment of any invoices which reflect a service or delivery date after the Closing Date. Notwithstanding the foregoing, Transferee acknowledges and agrees that it shall have no right, title or interest in and to any retroactive workers compensation insurance program payments whether or not the same are paid prior to or after the Closing Date if and to the extent they relate to any period prior to the Closing Date.
(d)Any and all deposits of Transferor with respect to the Facility expressly assumed by Transferee hereunder, without limitation, any and all such equipment leases (that are Assumed Contracts), security and/or utility deposits paid to and/or cash or other collateral held by any equipment lessor or by any utility, insurance company or surety, shall remain the sole and exclusive property of Transferor, and Transferee shall have no right or interest therein or thereto, and to the extent that Transferor has not received a return of any such deposit prior to the Closing Date, Transferee shall reimburse Transferor on the Closing Date the full amount of any such security deposit assumed by Transferee.
(e)Any bed Tax or similar provider Taxes or fees shall be pro-rated between Transferor and Transferee, based on the period of its operation of the Facility occurring before and after the Closing Date, as the case may be, including, but not limited to, any such assessments made by the State in which the Facility is located and/or paid by Transferor prior to or on the Closing Date that would apply to operation of the Facility after the Closing Date.
(f)Subject to Sections 2.4(b) and 3.3(h), in the event that there is a governmental assessment against the property upon which the Facility is situated, Transferor shall be responsible for that which relates to the period prior to the Effective Time and Transferee shall be responsible for that which relates to the period after the Effective Time.
(g)Transferor shall pay the reasonable cost of Transferee’s compliance with those physical plant Life Safety Code (“LSC”) deficiencies and/or fire safety standards violations that were identified by a Governmental Authority on a pre-Closing Date survey of the Facility as a deficiency and that was not cured by Transferor prior to the Closing (“Deficiencies”).
(h)Transferor shall be responsible for any and all fines, and the reasonable cost to bring the Facility into substantial compliance to the extent the Facility is cited for compliance violations attributable to the operation of the Facility prior to Closing by any Governmental Authority or Government Reimbursement Program which relates to equipment, furniture, fixtures or the condition of the building or grounds, or operational issues (collectively, “Compliance Violations”). For the avoidance of doubt, Deficiencies and Compliance Violations will not include (i) any violations (other than monetary penalties) where a plan of correction has been accepted by a Governmental Authority, except for (1) liabilities or obligations relating to or arising from any Open Deficiencies, or (2) capital repairs or physical improvements required to remove or resolve Open Deficiencies; or (ii) any citation for which Transferor currently holds a waiver issued by a Governmental Authority.
(i)All such prorations shall be made on the basis of actual days elapsed in the relevant accounting, billing or revenue period and shall be based on the most recent information available to Transferor and Transferee. Transferor and Transferee shall reasonably cooperate to produce prior to the Closing a schedule of prorations to be made under this Section 3.3 at the Closing that is as complete and accurate as reasonably possible. All prorations that can be accurately or reasonably estimated as of the Closing shall be made at the Closing. All other prorations, and adjustments to initial estimated prorations, shall be made by the Parties with due diligence and cooperation within one hundred twenty (120) days following the Closing, or such later time as may be required to obtain necessary information for proration, by payment in immediately available funds by wire transfer to one or more bank accounts designated in writing
12


of the Party yielding a net credit from such prorations from the other Party, and for the avoidance of doubt, such amounts shall not count toward or be subject to the applicable Indemnification Threshold or the OTA Indemnification Cap.
Article IV
REPRESENTATIONS AND WARRANTIES OF TRANSFEROR
In order to induce Transferee to enter into this OTA, Transferor hereby represents and warrants to Transferee as of the Execution Date and as of the Closing Date (or in the case of representations and warranties that by their terms speak as of a specified date, as of such specified date), as follows (all of which are qualified by the contents of the PCA and the Schedules attached hereto (it being understood that any matter disclosed on any Schedule will be deemed to apply and qualify the Section or Subsection of this Article IV to which it corresponds in number and each other Section or Subsection of this Article IV to the extent that it is reasonably apparent on its face that such information is applicable to such other Section or Subsection)) as follows:
4.1Corporate.
(a)Organization. Transferor is an entity duly organized, validly existing and in good standing under the Laws of the jurisdiction of its organization.
(b)Power and Authority; Authorization; Enforceability. Transferor has all necessary corporate, partnership or similar power and authority to own, operate and lease the Assets, and to carry on its business as and where such is now being conducted, including the Business. Transferor has all necessary corporate, partnership or similar power and authority to enter into the documents and instruments to be executed and delivered by Transferor pursuant hereto and to carry out the transactions contemplated hereby. The execution and delivery of this OTA and the performance of this OTA by Transferor has been duly and validly authorized. This OTA constitutes the legal, valid and binding obligation of Transferor, enforceable against Transferor in accordance with its terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium and other similar Laws and equitable principles relating to or limiting creditors’ rights generally.
(c)Qualification. With respect to the Business, Transferor is duly qualified or licensed to do business, and is in good standing, in all jurisdictions (domestic and foreign) in which the character or the location of the assets owned or leased by it, or the nature of the business conducted by it requires such licensing or qualification.
(d)No Conflicts or Violations. Subject to obtaining the consents, neither the execution and delivery of this OTA, the consummation of the transactions contemplated hereby and thereby, nor the fulfillment of the terms hereof by Transferor shall (i) violate or result in a breach of any of the material terms and provisions of, constitute a default under, conflict with, or result in any acceleration of rights, benefits or obligations of any party under any Assumed Contract to which Transferor is a party or by which it is bound, (ii) violate any Order of any Governmental Authority applicable to Transferor, (iii) result in the creation of any material Encumbrance upon any Asset pursuant to the terms of any such Assumed Contract, (iv) constitute a violation by Transferor of any applicable Law, (v) result in the breach of any of the material terms or conditions of, or constitute a default under, or otherwise cause any impairment of, any permit, license or other governmental authorization held by Transferor, or (vi) conflict with or violate any organizational document of Transferor.
13


4.2Notices. Except as listed in Schedule 4.2, neither the Facility nor Transferor has received, during the last two (2) years, written notice: (a) that the Facility will be subject to a rate reduction for Medicaid or Medicare services provided therein as a result of a Medicare or Medicaid audit; or (b) from any Governmental Entity that identifies that the Facility is in violation of Law which has not been cured. Transferor shall disclose any rate reduction or bed count reduction of which it becomes aware and any rate reduction proposal or bed count reduction proposal of which it becomes aware, in each case, prior to Closing, that will affect the Facility.
4.3Litigation. Except as disclosed on Schedule 4.3, there is no Action pending or, to Transferor’s Knowledge, threatened against Transferor with respect to the Assets or the Business. Transferor is not subject to any Order relating to the Assets or the Business. Except as disclosed on Schedule 4.3, all Actions listed on Schedule 4.3 are covered by insurance in place in favor of Transferor, which insurance, to Transferor’s Knowledge, is sufficient to cover any damages or Losses in connection with such Action.
4.4Taxes.
(a)All Tax Returns required to be filed by or on behalf of Transferor on or before the Closing Date with respect to the Business or the Assets have been duly and timely filed (or subject to proper extensions) with the appropriate taxing authority in all jurisdictions in which such Tax Returns are required to be filed, and all such Tax Returns are true, complete and correct in all material respects.
(b)All Taxes of Transferor shown on any such Tax Return with respect to the Business and the Assets that are due and payable on the Execution Date have been fully and timely paid.
(c)There are no Encumbrances for Taxes upon the Assets other than statutory liens for Taxes not yet due or payable.
4.5Employee Benefit Plans.
(a)Schedule 4.5(a) lists all Employee Benefit Plans including, without limitation, any welfare plan within the meaning of Section 3(1) of ERISA, or any pension plan within the meaning of Section 3(2) of ERISA, that Transferor or Affiliate sponsors, maintains, contributes or is obligated to sponsor, maintain, or contribute to the benefit of any current or former employees or other service provider of the Business (or any dependent or beneficiary thereof), or under which Seller, Seller Affiliates, or Transferor has any material liability with respect any current or former employee or other service provider of the Business (each, a “Plan”). Transferor has delivered or otherwise made available in the Data Room to Transferee true, accurate and complete copies of each Plan (or, if the Plan has not been reduced to writing, a written summary of all material terms).
(b)Each Plan that is intended to be qualified under Section 401(a) of the Code (each a “Qualified Plan”) has received a favorable determination, opinion, or advisory letter from the IRS indicating that such Qualified Plan (or the master, prototype, or volume submitter form on which it is established) is so qualified under the Code in form, and no fact or event has occurred since the issuance of the most recent such letter that creates a material risk of revocation of any such letter. Transferor has made available to Transferee a copy of such determination, opinion, or advisory letter.
14


(c)Neither Transferor nor any ERISA Affiliate thereof currently sponsors, maintains, or contributes to (or has an obligation to sponsor, maintain or contribute to) or sponsored, maintained or contributed to (or had an obligation to sponsor, maintain or contribute to) any “employee pension benefit plan” (as defined in Section 3(2) of ERISA) for which Transferor or any ERISA Affiliate has any liability covering employees of the Business that is subject to Title IV of ERISA or Code Section 412, including any “multi-employer plan” as defined in Section 3(37) or 4001(a)(3) of ERISA, or any “multiple employer plan” subject to Section 4063 or 4064 of ERISA. “ERISA Affiliate” means any Person that is considered a single employer with such Person under Section 414(b), (c), (m) or (o) of the Code, any Transferor, Transferor Affiliate or Joint Venture Interest.
(d)With respect to each Plan, Transferor, or its Affiliates, as applicable, have funded, administered and maintain each Plan in material compliance with all applicable Laws, including ERISA and the Code, and there is no litigation or proceeding pending (other than routine claims for benefits) or, to the Knowledge of Transferor, threatened or anticipated with respect to any Plan in connection with the Business.
(e)Except as required under COBRA, no Plan provides or promises benefits, including death or medical or other health-related benefits, with respect to current or former Service Providers of the Business beyond retirement or other termination of service, and Transferor or its Affiliates have no obligation to provide or contribute toward the cost of any such benefits.
(f)Neither the execution and delivery of this OTA and any related documents nor the consummation of the transactions contemplated hereby will, either alone or in combination with any other event, (i) increase any benefits payable under any Plan, including acceleration of the payment or vesting of any benefit under any Plan, or (ii) entitle any employee to severance payable by Transferee or any Affiliate thereof; provided, however, that benefits due and payable from a Plan may be paid or made available due to a termination of employment from Transferor in the ordinary course of administration of any such Plan.
4.6Employees.
(a)Schedule 4.6(a) contains a true and correct list of (i) (x) all of the current employees of the Business, (y) all of the employees of the Therapy Business which provide services at the Facility, and (z) all of the employees of the Manager which provide services directly at the Facility, in each case, as of September 1, 2024, including those employees on a leave of absence of any kind, (ii) each such employee’s name, title, and location of employment, (iii) each such employee’s employment status (i.e., whether employees is actively employed or not actively employed due to illness, short-term disability, sick leave, authorized leave of absence, layoff for lack of work or service in the Armed Forces of the United States or for any other reason), (iv) each such employee’s hourly wage rate, salary level or annual rate of compensation, including bonuses and incentive pay, (v) the hours worked by each such employee during the preceding twelve months, the exempt or non-exempt status of each employee (whether or not paid at an hourly or salary rate), (vi) each employee’s date of hire or commencement of most recent employment, (vii) a description of any fringe benefits (other than the standard fringe benefits offered by Transferor to all qualifying employees), (viii) existing contractual arrangement with employees, if any (it being understood that all Parties do not consider any “at-will” arrangements with employees to be Contracts) and (ix) the employer of each such employee. As of the Execution Date, the parties acknowledge that Schedule 4.6(a) has been provided with employee names redacted. Schedule 4.6(a) shall be provided to Transferee without redaction on the day immediately following the Execution Date.
(b)Except as disclosed on Schedule 4.6(b), all salary, wages, commissions, bonuses and other cash compensation due and payable to employees of Transferor as of the Closing Date shall be paid in full on or promptly following the Closing Date (but no later than the next regularly scheduled pay-period) in accordance with Transferor’s standard payroll practices.
15


(c)All workers directly engaged by Transferor (excluding any engagement through a staffing agency) and classified by Transferor as independent contractors since January 1, 2022, have in good faith satisfied the requirements of applicable Law to be so classified, and Transferor has in good faith fully and accurately reported each such person’s compensation on IRS Forms 1099 during such period when required to do so.
(d)Transferor has complied, in all material respects, with all applicable Laws pertaining to labor or employment practices or relations (including, but not limited to, the terms and conditions of employment, management-labor relations, employee classification, records retention, equal opportunity employment, non-discrimination, disability accommodation, human rights, statutory and regulatory employer notice requirements (including requirements pursuant to the Fair Credit Reporting Act, the United States Immigration and Nationality Act, as amended, federal, state, provincial and local minimum wage laws, regulations and ordinances, federal and state family, medical and military leave laws and regulations, occupational safety and health laws and regulations, and any other similar applicable Law mandating employer notice of employer and/or employee rights and responsibilities under such Law), statutory and contractual leaves of absence, wage and hour issues, immigration, occupational safety and health, workers’ compensation, pay equity and human rights and the employment or termination of employment of their employees, including all such Laws relating to equal employment opportunities, payment of wages (including, but not limited to, payment of hourly wages, overtime, salaries, commissions, bonuses, profit sharing, unemployment compensation, benefits, and vacation, sick or other earned time off benefits due and payable to such employees under any policy, practice, Contract, program or applicable Law) or illegal discrimination).
(e)Except as set forth in Schedule 4.6(e), there are no outstanding, pending or, to Transferor’s Knowledge, threatened, actions, causes of action, claims, complaints, grievances, demands, orders, prosecutions, or suits against Transferor (including its and their respective directors, officers, agents, or employees) claiming that Transferor has violated any applicable employment Laws before any Governmental Authority or labor relations board, including the National Labor Relations Board, the Department of Labor, and the Equal Employment Opportunity Commission regarding any employees of the Business. No written notice has been received by Transferor of the intent of any Governmental Authority responsible for the enforcement of labor or employment Laws to conduct an investigation of Transferor regarding any employees of the Business and no such investigation is in progress.
(f)Except as set out on Schedule 4.6(f), Transferor is not a party to any collective bargaining agreement relating to the Business.
(g)Except as set forth in Schedule 4.6(g), since January 1, 2022, Transferor has not experienced any labor disputes, any union organization attempts or any work stoppages, walk outs, strikes, or lock outs due to labor disagreements. There are no unfair labor practice charges or complaints pending or threatened against Transferor. There is no labor strike, dispute, request, petition or pending election for representation, slowdown or stoppage pending, or to Transferor’s Knowledge, threatened or anticipated against or affecting Transferor.
(h)Transferor maintains an Employment Eligibility Form on Form I-9 for each employee currently employed in the United States in accordance with applicable Law.
(i)Except as set forth in Schedule 4.6(i) or with respect to employees subject to a collective bargaining agreement, all employees of Transferor are employed at-will, may be terminated at any time with or without notice and for any reason or no reason at all, without material cost or penalty to Transferor.
16


(j)Except with respect to transactions contemplated by this OTA, Transferor has not implemented any employee layoffs that could implicate the WARN Act or any similar applicable foreign, state or local Law, and no such events are currently planned, anticipated or announced. To Transferor’s Knowledge, no officer or executive of Transferor (i) has any present intention to terminate his or her employment within the first twelve (12) months following the Closing Date, or (ii) is a party to any confidentiality, non-competition, proprietary rights or other such agreement that would materially restrict the performance of such employee’s employment duties, or the ability of Transferor to conduct the Business.
4.7Encumbrances.
(a)Transferor has good and marketable title to, or in the case of personal property held under a lease or other Assumed Contract (subject to the terms of the lease or other Assumed Contract), an enforceable leasehold interest in, or right to use, the Assets, and none of the Assets are subject to any Encumbrance other than Permitted Encumbrances.
(b)With respect to any matter in excess of Fifty Thousand Dollars ($50,000.00), all contractors, subcontractors and other Persons furnishing work, labor, materials or supplies for the development and construction of the Facility and/or Assets have been paid, or prior to Closing shall be paid, whether the work is in progress or completed, for all work performed, material, supplies and the like up to and including the Closing Date, and there are no claims against any Transferor or Facility, or any of the Assets in connection therewith which may give rise to a mechanic’s lien against any Facility, the Assets or any portion thereto, except as set forth on Schedule 4.7(b).
(c)Except as disclosed on Schedule 4.7(c), there are no Encumbrances against Transferor’s A/R, provider agreements, bank accounts or licenses, and to the extent there are such liens extant, the obligations they secure will be paid in full at Closing and the liens on such assets will be released at Closing unless otherwise indicated as or such constitute an Assumed Liability.
4.8Certain Healthcare Matters; Compliance Generally.
(a)Government Reimbursement Programs.
(i)Except as set forth on Schedule 4.8(a)(i), the Facility is (A) qualified for participation in, and has current and valid provider contracts with, the applicable Government Reimbursement Programs and/or their fiscal intermediaries or paying agents in which the Facility participates, all of which Government Reimbursement Programs are listed on Schedule 4.8(a)(i), and is in compliance with the conditions of participation or requirements applicable with respect to such participation, and (B) eligible for payment under the applicable Government Reimbursement Programs in which the Facility participates for services rendered to qualified beneficiaries.
(ii)(i)    Except as set forth on Schedule 4.8(a)(ii), all Cost Reports required to be filed for each of the Facility have been prepared and filed in good faith in accordance with applicable Laws when due, and are true, correct, and complete in all material respects (and true and complete copies of Cost Reports for the past two (2) fiscal years have been set out in the Data Room).
17


(iii)All amounts shown as due from the Facility in the Cost Reports either were remitted with such Cost Reports or will be remitted when required by applicable Law and are appropriately reflected in the Financial Statements, and all amounts shown in the Notices of Program Reimbursement as due have been, or prior to the Closing will be, paid when required by applicable Law.
(iv)Except as set forth on Schedule 4.8(a)(iv), Transferor has not, during the last two (2) years, received written notice of any dispute or claim by any Governmental Authority, fiscal intermediary or other Person regarding the Facility and the Government Reimbursement Programs or the participation by the Facility in such Government Reimbursement Programs that have not been cured, and to Transferor’s Knowledge, there are no (A) threatened recoupment claims for services provided by the Business, or (B) threatened suspensions, terminations, or restrictions to any contracts with Government Reimbursement Programs and/or their fiscal intermediaries or paying agents.
(v)Except as set forth in Schedule 4.8(a)(v), there are no (A) current, pending or outstanding Government Reimbursement Program audits or appeals, (B) Cost Reports that are subject to audits, (C) Cost Reports that remain “open” or unsettled, and (D) current or pending Government Reimbursement Program or Private Program recoupment efforts (other than those conducted in the Ordinary Course), in each case with respect to the Facility.
(vi)Within the past two (2) years, Transferor has not received notice of any action that has been threatened, taken or recommended by any government authority to revoke, withdraw or suspend its license to operate the Facility or to terminate or decertify any participation of the Facility in the Medicaid or Medicare programs. Within the past two (2) years, Transferor has not received written notice with respect to the Facility that it has been charged or implicated in any violation of any state or federal statute or regulation involving false, fraudulent or abusive practices relating to its participation in state or federally sponsored reimbursement programs, including but not limited to false or fraudulent billing practices. Within the past two years, Transferor has not received written notice with respect to a civil investigative demand, warrant or other written request for information with respect to the Facility from the U.S. Department of Justice, the U.S. Federal Bureau of Investigation, the Office of the Inspector General of the U.S. Department of Health and Human Services or any other federal or state agency or authority with jurisdiction over investigating and enforcing state or federal healthcare fraud and abuse laws.
(b)Permits. The Facility’s Permits and CLIA waivers are set forth on Schedule 4.8(b)(i). All such Permits are all of the material Licenses necessary for the ownership and operation of the Facility as currently conducted. Such Permits are in full force and effect, have not been pledged as collateral security, no proceeding is pending or, to Transferor’s Knowledge, threatened, seeking the revocation or limitation of any such Permit. The Facility is duly licensed as a skilled nursing facility, as required under the Laws of the State of [Tennessee/Alabama], for at least that number of beds as currently listed on the Permits. Schedule 4.8(b)(ii) sets forth a true, correct, and complete list of the number and types of licensed beds at the Facility and whether such beds are Medicaid and/or Medicare certified. Except as set forth on Schedule 4.8(b)(iii), there are no proceedings or actions pending or, to Transferor’s Knowledge, contemplated to reduce the number of licensed or certified beds of any Facility. Except as set forth on Schedule 4.8(b)(iv), Transferor has not received written notice of any violations of the LSC, fire, building and other applicable codes, ordinances, current zoning requirements, rules, and regulations that have not been cured or for which Transferor has received a waiver under applicable Law. Schedule 4.8(b)(v) sets forth a complete and accurate list of LSC waivers, decertification proceedings, licensure revocations, and termination and suspension proceedings for the past two (2) years.
18


(c)Compliance Generally. The Facility has been operated in compliance in all material respects with all applicable Laws, including all Healthcare Requirements, governing the conduct or operation of the Business, and Licenses. Except as set forth on Schedule 4.8(c)(i), Transferor has not received any written notice of any violation of any such Law or License that has not been cured and, to Transferor’s Knowledge, no notice of such violation has been threatened. There are no outstanding or, to Transferor’s Knowledge, threatened or potential Order, subpoena, or investigation from any Governmental Authority, whistleblower suits, or suits brought pursuant to federal or state False Claims Acts or Laws relating to any Governmental Reimbursement Program of or relating to any alleged or actual, violation of any Laws. Except as set forth on Schedule 4.8(c)(ii), there have been no written notices of violations of Referral Laws relating to the operation of the Facility, nor to Transferor’s Knowledge are there any conditions at the Facility which would reasonably be expected to cause a violation of Referral Laws or analogous state statute. To Transferor’s Knowledge, Transferor has not (i) made any contributions, payments or gifts to or for the private use of any governmental official, employee or agent where either the payment or the purpose of such contribution, payment or gift is illegal under the laws of the United States or the jurisdiction in which made, (ii) established or maintained any unrecorded fund or asset for any such purpose or made any false or artificial entries on its books, (iii) given or received any payments or other forms of remuneration in connection with the referral of patients that would violate the Referral Laws or any analogous state statute, or (iv) made any payments to any person with the intention or understanding that any part of such payment was to be used for inducing a referral or any purpose other than that described in the documents supporting the payment. Transferor has instituted, and the Facility is operated in compliance in all material respects with, a compliance plan which follows all applicable Healthcare Requirements.
(d)Convictions; Exclusions. Neither Transferor nor any current director, officer, or employee has been excluded from participating in the Medicare program or any other Government Reimbursement Program or is subject to a corporate integrity agreement. No current officer, director, or managing employee (as that term is defined in 42 U.S.C. § 1320a-5(b)) of Transferor has been (i) excluded from participating in the Medicare program or any other applicable Government Reimbursement Program; (ii) subject to sanction pursuant to 42 U.S.C. § 1320a-7a or 1320a-8; or (iii) to Transferor’s Knowledge, convicted of, a criminal offense under or in connection with (A) the Referral Laws, (B) any Law relating to fraud, theft, embezzlement, breach of fiduciary responsibility, or other financial misconduct in connection with the delivery of a health care item or service or with respect to any act or omission in a program operated by or financed in whole or in part by Governmental Authority, (C) any Law relating to the unlawful manufacture, distribution, prescription, or dispensing of a controlled substance, (D) any Law relating to the interference with or obstruction of any investigation into the criminal offenses described herein, or (E) any offense which would permit the exclusion of any Facility from a Government Reimbursement Program.
(e)Audits; Settlements. Transferor has provided to Transferee true and complete copies of all survey reports, notices, and waivers of deficiencies, plans of correction, and any other investigation reports issued with respect to the Facility together with material correspondence with any Governmental Authority issued within two (2) years of the Execution Date (and from the Execution Date until the Closing Date) concerning the Facility by any Governmental Authority, ZPIC audit, RAC auditor or other contract auditor on behalf of a Governmental Authority, an identification of any material settlement agreements and, to Transferor’s Knowledge, any material unresolved matters raised in writing by any such Governmental Authority, RAC auditor or other contract auditor on behalf of a Governmental Authority. Except as set forth on Schedule 4.8(e), (i) Transferor has not had any cited deficiencies on its most recent survey (standard or complaint) that have resulted in a written notice of civil money penalties or a denial of payment for new admissions as of the Closing Date that have not been cured, and (ii) Transferor has not had any deficiencies at “level G” or above, or an IJ at Level I or above on its most recent survey (standard or complaint) that have not been cured. All deficiencies and violations cited in any survey or resurvey have been corrected or corrective action plans have been submitted and approved therefor and will be fully implemented/corrected prior to Closing. The Facility is not currently designated as a Special Focus Facility (as such term is defined by the Centers for Medicare and Medicaid Services Special Focus Facility Program) and has not received any written notice of inclusion or intended inclusion as a Special Focus Facility.
19


4.9Resident Agreements. A copy of the current standard form of Admission Agreement used by the Facility has been provided to Transferee or otherwise made available to Transferee in the Data Room. To Transferor’s Knowledge, there are no other agreements with residents of the Facility which materially deviate from the standard form.
4.10Absence of Changes. Except as otherwise disclosed in Schedule 4.10 or the other Schedules, or as contemplated by this OTA, from January 1, 2024, to the Execution Date, (a) the Business has been conducted in all material respects in the Ordinary Course, and (b) to Transferor’s Knowledge, there has been no change, event, or loss materially and adversely affecting the Business or the Facility.
4.11Inventory. On the Closing Date, Transferor shall maintain its normal inventory of supplies, which will be in sufficient quantities of supplies required by Law in all material respects and consistent with past practices for operation of the Facility.
4.12Contracts.
(a)As of the Execution Date, true, correct, and complete copies of all of the Material Contracts of the Facility have been made available to Transferee or otherwise made available in the Data Room. As of Closing, true, correct, and complete copies of all of the Assumed Contracts set forth on Schedule 2.1(d) as revised and supplemented prior to Closing will have been made available to Transferee or otherwise made available in the Data Room. Except as set forth in Schedule 4.12(a), (i) each of the Assumed Contracts is valid, binding and enforceable in accordance with its terms subject to bankruptcy, insolvency, reorganization, moratorium and similar laws affecting the rights of creditors generally and by general principles of equity (regardless of whether such enforceability is considered in the proceeding in equity or at law), and (ii) there is not any existing material default or material event of default, or any event which, with or without notice or lapse of time or both, would constitute a material default under any Assumed Contract by Transferor or, to Transferor’s knowledge, by any other party to the Assumed Contract. In addition, with respect to each Assumed Contract that is a lease of equipment or other personal property, except as set forth in Schedule 4.12(a), (i) such lease creates a valid leasehold interest in all property purported to be leased thereunder, (ii) all rent and other required payments have been timely paid by Transferor through the date hereof, and (iii) Transferor is in lawful possession of all of such property. Solely to the extent such changes are required in order to track the addition of Assumed Contracts from Schedule 2.1(d), this Schedule 4.12(a) may be updated by Transferor until thirty (30) days prior to Closing to reflect such required changes, after which time this Schedule 4.12(a) shall be deemed final.
(b)The execution and delivery of this OTA by Transferor and the consummation of the transactions contemplated hereby by Transferor do not require any consent under, constitute (with or without notice or lapse of time or both) a default under, result in any breach of, or give any Person any rights of termination, acceleration or cancellation of, any Assumed Contract.
20


4.13Resident Trust Funds. The Resident Trust Funds transferred hereunder are the only such funds required to be held by Transferor on behalf of such residents pursuant to applicable Law.
4.14Environmental Laws. Transferor has not received any written notice of alleged, actual or potential responsibility for, or any inquiry or investigation regarding the presence or release of any Hazardous Substance at the Facility in violation of any Environmental Law, which Hazardous Substances were allegedly manufactured, used, generated, processed, treated, stored, disposed or otherwise, handled at, or transported or released from such Facility or regarding compliance with Environmental Laws. Transferor has not received any written notice of any other claim, demand or action by an individual or entity alleging any actual or threatened injury or damage to any Person or entity, property, natural resource or the environment arising from or relating to the presence or release of any Hazardous Substances at, on, under, in, to or from its Facility in connection with any operations or activities of Transferor thereat.
4.15Improvements. Except as disclosed on any PCA, Transferor has not received any written notice for any assessments for public improvements against the Facility which remain unpaid including, without limitation, those for construction of sewer, water, gas and electric lines and mains, streets, roads, sidewalks and curbs.
4.16Insurance. Transferor has provided to Transferee or otherwise made available in the Data Room, a true and correct list of all general liability, professional liability, fire, casualty, fidelity, workers’ compensation and other insurance policies currently held by or on behalf of Transferor relating to the Facility, and a description of any self-insurance arrangements by or affecting the Facility, including any reserves established thereunder. Each of said policies is in full force and effect and shall be maintained by Transferor in full force and effect until the Closing, and all premiums due thereunder have been paid and shall be paid by Transferor until the Closing. Transferor has maintained or caused to be maintained insurance policies that have insured the Facility and the Assets continuously since the date Transferor first operated the Facility.
4.17Reserved.
4.18Financial Statements; Undisclosed Liabilities.
(a)Transferor has delivered to Transferee or otherwise made available in the Data Room, prior to the Execution Date, the Financial Statements. Except as set forth on Schedule 4.18(a), the Financial Statements, in all material respects, are complete and accurate and present fairly the financial position of the Facility as of the dates and periods indicated, in accordance with GAAP subject to normal year-end adjustments and absence of notes and, to the extent consistent with GAAP, Transferor’s past practices in preparing financial statements, subject, in the case of any quarterly Financial Statements included therein, to normal year-end audit adjustments.
(b)Except as reflected or reserved for or disclosed in the Financial Statements, Transferor has no material liabilities relating to the Business of a type or nature to be reflected, in accordance with GAAP and, to the extent consistent with GAAP, Transferor’s past practices in preparing financial statements, on the face of a balance sheet except for (i) liabilities incurred in the Ordinary Course since December 31, 2023, consistent with past practice, (ii) obligations arising or resulting from the terms of any Assumed Contract, and (iii) Excluded Liabilities.
4.19Broker. Except as set forth on Schedule 4.19, Transferor has not engaged, nor is liable to pay any fees, costs or commissions to, any broker, finder, agent or financial advisor (each a “Broker” and collectively, “Brokers”) in connection with the transactions contemplated hereby.
21


4.20Intellectual Property. To Transferor’s Knowledge, (a) Transferor owns or possesses all licenses or other rights to use all Intellectual Property necessary to conduct the Business as presently conducted, (b) Transferor has not received any written notice from any third party that the Business as currently conducted misappropriates or infringes upon any Intellectual Property rights of others, and (c) Transferor has not received any written notice that any third party is infringing any Intellectual Property owned by Transferor and used exclusively in connection with the Business.
4.21NO WARRANTY OF CONDITION. THE ASSETS ARE BEING SOLD, TRANSFERRED, ASSIGNED AND DELIVERED BY TRANSFEROR AND RECEIVED BY TRANSFEREE AS IS WHERE IS, AND WITH ALL FAULTS, AND WITHOUT ANY REPRESENTATIONS OR WARRANTIES WHATSOEVER, EXPRESS OR IMPLIED, WRITTEN OR ORAL, WHETHER STATUTORY, ARISING BY OPERATION OF LAW, ARISING BY CUSTOMS OR USAGES OF TRADE, OR OTHERWISE, EXCEPT SOLELY AS EXPRESSLY SET FORTH IN THIS ARTICLE IV TO THIS OTA, THE PURCHASE AGREEMENT, AND THE OTHER TRANSACTION DOCUMENTS, AND SUBJECT TO ANY AND ALL LIMITATIONS AND QUALIFICATIONS HEREIN; IT BEING THE INTENTION OF TRANSFEROR AND TRANSFEREE TO EXPRESSLY REVOKE, RELEASE, WAIVE, DISCLAIM, NEGATE AND EXCLUDE ALL EXPRESS AND IMPLIED REPRESENTATIONS AND WARRANTIES (EXCEPT SOLELY AS EXPRESSLY SET FORTH IN THIS ARTICLE IV TO THIS OTA AND SUBJECT TO ANY AND ALL LIMITATIONS AND QUALIFICATIONS HEREIN) INCLUDING, WITHOUT LIMITATION, AS TO (a) THE CONDITION OF THE ASSETS OR ANY ASPECT THEREOF INCLUDING, WITHOUT LIMITATION, ANY AND ALL EXPRESS OR IMPLIED REPRESENTATIONS AND WARRANTIES OF OR RELATED TO MERCHANTABILITY, FITNESS FOR A PARTICULAR USE OR PURPOSE OR NON-INFRINGEMENT; (b) THE NATURE OR QUALITY OF CONSTRUCTION, STRUCTURAL DESIGN, OR ENGINEERING OF THE ASSETS OR ANY OTHER ASSET OR PROPERTY, IF ANY; (c) THE QUALITY OF THE LABOR OR MATERIALS INCLUDED IN THE ASSETS; (d) ANY FEATURES OR CONDITIONS AT OR WHICH AFFECT THE ASSETS WITH RESPECT TO ANY PARTICULAR PURPOSE, USE, POTENTIAL, OR OTHERWISE; (e) THE SIZE, SHAPE, CONFIGURATION, CAPACITY, QUANTITY, QUALITY, CASH FLOW, EXPENSES, VALUE, MAKE, MODEL OR CONDITION OF THE ASSETS; (f) ALL EXPRESS OR IMPLIED REPRESENTATIONS OR WARRANTIES CREATED BY ANY AFFIRMATION OF FACT OR PROMISE OR BY ANY DESCRIPTION OF THE ASSETS; (g) ANY STRUCTURAL OR CONDITION OR HAZARD OR THE ABSENCE THEREOF HERETOFORE, NOW OR HEREAFTER AFFECTING IN ANY MANNER ANY OF THE ASSETS; AND (h) ALL OTHER EXPRESS OR IMPLIED WARRANTIES AND REPRESENTATIONS BY TRANSFEROR WHATSOEVER, EXCEPT AS EXPRESSLY SET FORTH IN THIS ARTICLE IV AND SUBJECT TO ANY AND ALL LIMITATIONS AND QUALIFICATIONS HEREIN. FURTHERMORE, TRANSFEROR MAKES NO REPRESENTATIONS OR WARRANTIES, EXPRESS OR IMPLIED, AS TO THE FUTURE PROFITABILITY, FUTURE CASH FLOW OR VIABILITY OF THE BUSINESS RELATED TO THE ASSETS, ALL OF WHICH TRANSFEREE MUST DETERMINE FROM ITS INVESTIGATION OF THE RECORDS OF TRANSFEROR AND THE FACILITY AND TRANSFEREE’S OWN BUSINESS ACUMEN.
4.22Disclosure Updates. At any time, and from time to time on or prior to the Closing Date, Transferor may supplement or amend the Schedules and/or information in the Data Room (collectively, a “Disclosure Update”), with respect to any matter which has not yet been subject to the Closing. No such Disclosure Update shall be evidence, in and of itself, that corresponding
22


representations and warranties are no longer true and correct in all material respects. It is specifically agreed that the Schedules and/or information in the Data Room may be amended to add immaterial, as well as material, items. No such Disclosure Update shall have any affect for purposes of the condition set forth in Section 10.2(a) or the indemnification provisions of Article X with respect to the facts and circumstances underlying such Disclosure Update or otherwise be deemed to cure any breach, and the delivery of any such Disclosure Update shall not limit or otherwise affect the remedies available hereunder to the party receiving such notice.
Article V
REPRESENTATIONS AND WARRANTIES OF TRANSFEREE
In order to induce Transferor to enter into this OTA, Transferee hereby represents and warrants to Transferor as of the Execution Date and as of the Closing Date (or in the case of representations and warranties that by their terms speak as of a specified date, as of such specified date), as follows:
5.1Corporate.
(a)Organization. Transferee is an entity duly organized, validly existing and in good standing under the Laws of the jurisdiction of its organization.
(b)Power and Authority; Authorization; Enforceability. Transferee has all necessary corporate, partnership or similar power and authority to enter into the documents and instruments to be executed and delivered by Transferee pursuant hereto and to carry out the transactions contemplated hereby. The execution and delivery of this OTA and the performance of this OTA by Transferee has been duly and validly authorized. This OTA constitutes the legal, valid and binding obligation of Transferee, enforceable against Transferee in accordance with its terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium and other similar Laws and equitable principles relating to or limiting creditors’ rights generally.
(c)Qualification. Transferee is duly qualified or licensed to do business, and is in good standing, in all jurisdictions (domestic and foreign) in which the character or the location of the assets owned or leased by it, or the nature of the business conducted by it requires such licensing or qualification.
(d)No Conflicts or Violations. Neither the execution and delivery of this OTA or the other Transaction Documents, the consummation of the transactions contemplated hereby and thereby, nor the fulfillment of the terms hereof by Transferee shall (i) violate or result in a breach of any of the material terms and provisions of, constitute a default under, conflict with, or result in any acceleration of rights, benefits or obligations of any party under any contracts to which Transferee is a party or by which it is bound, (ii) violate any Order of any Governmental Authority applicable to Transferee, or (iii) constitute a violation by Transferee of any applicable Law, or (iv) conflict with or violate any organizational document of Transferee.
5.2Litigation. There are no proceedings, orders, or determinations by or with any arbitrator, court, or other governmental body, authority or agency, or to Transferee’s Knowledge, threatened against or by Transferee or any of its Affiliates that challenge (or could challenge) or seek (or could seek) to prevent, enjoin, or otherwise delay the consummation of the transactions contemplated under this OTA or the execution and delivery of any agreement in connection therewith.
23


5.3Broker. Except as set forth in Schedule 5.3, Transferee has not engaged, nor is liable to pay any fees, costs or commissions to any Broker(s) in connection with the transactions contemplated hereby.
5.4Transferee’s Reliance.
(a)Transferee acknowledges that prior to the Execution Date, it has conducted such independent investigation of the Assets and the Facility and Transferor to its own full satisfaction. In connection with Transferee’s investigation, Transferee may have received from Transferor certain projections, forward-looking statements and other forecasts and certain business plan information. Transferee acknowledges that there are uncertainties inherent in attempting to make such estimates, projections and other forecasts and plans, that Transferee is familiar with such uncertainties, that Transferee is taking full responsibility for making its own evaluation of the adequacy and accuracy of all estimates, projections and other forecasts and plans so furnished to it (including the reasonableness of the assumptions underlying such estimates, projections, forecasts or plans), and that (except in the case of Fraud) Transferee shall not have or make any claim against any Person with respect thereto. Accordingly, Transferee acknowledges that Transferor or any other Person have not and do not make any direct or indirect representation or warranty with respect to such forward-looking estimates, projections, forecasts or plans (including the reasonableness of the assumptions underlying such estimates, projections, forecasts or plans).
(b)Transferee acknowledges that Transferor or any other Person have not made any representation or warranty, expressed or implied, as to the accuracy or completeness of any information regarding Transferor, the Assets and the Facility furnished or made available to Transferee and its representatives, except as expressly set forth in Article IV and Article IV of the Purchase Agreement, and Transferor or any other Person (including any officer, director, manager, member or partner of any of Transferor) shall not have or been subject to any liability to Transferee (except in the case of Fraud), or any other Person, resulting from Transferee’s use of any information, documents or material made available to Transferee in any confidential information memoranda, “data rooms,” management presentations, due diligence or in any other form in expectation of the transactions contemplated hereby. Transferee acknowledges that except as expressly set forth in Article IV and Article IV of the Purchase Agreement, the Facility and the Assets have been acquired without any representation or warranty as to merchantability or fitness for any particular purpose of their respective assets, in an “as is” condition and on a “where is” basis. For the avoidance of doubt, nothing in this Section 5.4 is intended to limit or modify the representations and warranties contained in this Article V. Transferee acknowledges that, except for the representations and warranties contained in Article IV and Article IV of the Purchase Agreement, neither Transferor nor any other Person has made any other express or implied representation or warranty by or on behalf of Transferor.
(c)As of the Execution Date, Transferee has no actual knowledge (i) that any of Transferor’s representations or warranties set forth in the OTA or the Transaction Documents are not true and correct in all material respects, or (ii) that Transferor is in material breach of any of its covenants and/or obligations under the OTA or the Transaction Documents.
Article VI
COVENANTS AND AGREEMENTS
24


6.1Conduct of Business. From and after the date hereof and pending the Closing, unless Transferee shall otherwise consent in writing, Transferor shall utilize commercially reasonable efforts to (a) maintain and operate its applicable Assets and Facility in the Ordinary Course, (b) maintain, repair and replace where appropriate, consistent with past practice, with no less than like kind, the real and personal property, equipment, furniture and fixtures, leasehold improvements in substantially the same condition that exists on the date hereof, reasonable wear and tear excepted and subject to the requirements to repair and replace as set forth in the Purchase Agreement; (c) refrain from delaying such repair and/or replacement as a result of the pending transfer, except where such delay is consistent with past practice; (d) replace inventory, supplies and equipment consistent with past practice; (e) operate the Facility so as not to intentionally breach any covenant or warranty contained in this OTA; (f) preserve Transferor’s existing relationships with suppliers, distributors, customers and others having business relations with Transferor such that the Facility will not be impaired; (g) maintain all existing policies of insurance (or comparable policies) of or relating to the Assets and the Facility in full force and effect; (h) keep available the services of the present officers and employees of Transferor involved in the day to day operation of the Facility; (i) maintain the quality of care to the residents; (j) invoice and collect revenue in the Ordinary Course; (k) to safeguard, maintain and preserve all Facility employee and medical records transferred under this OTA in accordance with the provisions of, and for the periods prescribed by all applicable Laws, which shall in no event be less than the steps taken by Transferor in the operation of the Facility prior to the transactions contemplated under this OTA; (l) avoid immediate jeopardy violations, maintain provider agreements without suspension, qualification or limitation or revocation, and avoid what is commonly known as a “ban on admission” or imposition of civil money penalties or the providing of substandard care; (m) undertake or implement all actions, payments, and plans of correction required in connection with a Open Deficiency; (n) complete any capital repairs or physical improvements required to remove or resolve a Open Deficiency; (o) notify Transferee if Transferor becomes aware of any violation or non-compliance with any Law, except where any such violation or non-compliance would not reasonably be expected to be material and adverse to the Business or Facility; (p) actively market the Facility to potential patients and residents in the Ordinary Course; (q) not materially change the current levels of compensation and benefits for Transferor Employees except as may be required by applicable Law or as provided by Transferor’s personnel policies in the Ordinary Course, such as those pertaining to post hiring or annual performance evaluations; and (r) not enter into any material Contract whether oral or written which would be binding on the Facility or the Transferee from and after the Closing.
6.2Forbearances. Without limiting the effect of any other provision of this OTA, between the date hereof and the earlier of the termination of this OTA or the Closing Date, Transferor shall not do any of the following with respect to the Assets or Facility without the prior written consent of Transferee:
(a)sell, lease, transfer, convey or otherwise dispose of (other than in the Ordinary Course), or cause or permit any Encumbrance (other than Permitted Encumbrances) to exist on, any of the Assets which will not be released at or prior to the Closing;
(b)cancel any Assumed Contract or materially default in the performance of any Assumed Contract, or obligation, or waive any material default or potential material default by any other Party, or waive, release, compromise, settle or assign any rights or claims under any Assumed Contract;
(c)notwithstanding anything else contained in this Article VI, enter into any contract or other transaction that would be material to the Facility, other than in the Ordinary Course and shall not, whether consistent with past practice or otherwise, enter into or amend any material Contract which is not at will on the part of Transferor or terminable by Transferor on thirty (30) days or less written notice;
(d)violate in any material respect, terminate or permit the lapse of, or failure to preserve any material licenses, permits and other authorizations including, but not limited to, the certificate of need, if any, or any provider agreements including, without limitation, its provider agreements with Medicare and Medicaid which are necessary for the operation of the Facility as it exists on the date hereof;
25


(e)release, compromise or settle any material claim, action or legal proceeding that would be material and adverse to the Business or Facility, or may be construed as an obligation of Transferee, other than in the Ordinary Course;
(f)enter into any transaction with any owner, officer, director, manager or Affiliate of Transferor or any of their Affiliates, or any relative or Affiliate of any such owner, officer, director, manager or Affiliate other than consistent with past practice or in contemplation of the transactions to be carried out pursuant to this OTA or the Purchase Agreement;
(g)materially change employment terms for any executive or group of employees or institute, amend or terminate any employee plan other than consistent with past practice or in contemplation of the transactions to be carried out pursuant to this OTA or the Purchase Agreement;
(h)remove, discharge or transfer residents from the Facility to a nursing facility owned, operated or managed by Transferor or any of its Affiliates, nor shall there be any voluntary transfers by Transferor of residents from the Facility to any other nursing facility, where such transfer is not in the ordinary course of business and not (i) for reasons relating to the health and well-being of the resident transferred, (ii) for the election to transfer by the resident or his or her family or attorney-in-fact, or (iii) otherwise required by Law;
(i)(i) remove or relocate to any Affiliate, any administrator, director of nursing or other key employee, or (ii) hire new employees except in the Ordinary Course; or
(j)enter into any agreement, or adopt any resolution, to do any of the things described in subsections (a) through (i) above or otherwise commit any act which would cause Transferor to breach any covenant, representation or warranty contained in this OTA.
6.3Non-Competition and Non-Solicitation.
(a)Non-Competition Covenant. For a period commencing upon the Closing and ending three (3) years after the Closing, neither Seller, Transferor nor their Affiliates shall directly or indirectly own, operate or manage any skilled nursing facility within ___________6 County (the “Non-Competition Covenant”). In connection with a violation of the Non-Competition Covenant, Transferee shall have all remedies at law and/or equity to enforce such Non-Competition Covenant. Transferor further acknowledges that the scope and duration of the provisions of this Section 6.3(a) are reasonable. The terms and provisions of this Section 6.3(a) shall survive the Closing. For avoidance of doubt, the provisions of this Section 6.3(a) shall not be applicable to Seller’s, Transferor’s, or their Affiliate’s ownership and operation of any Escrow Facilities prior to any Subsequent Closing, or to the ownership and operation of any Excluded Facility by Seller, Transferor or their Affiliates from and after the date such Excluded Facility is terminated in accordance with the provisions of the Purchase Agreement.
(b)Non-Solicitation Covenant.
(i)Transferee agrees that neither Transferee nor any of their Affiliates shall solicit or attempt to solicit for employment or hire any employee of the Facility, the Transferor or its Affiliates during the period commencing upon termination of this OTA prior to Closing and for a period of one (1) year following the termination of this OTA; provided,
6 NTD: To reflect county in which subject facility is located.
26


however, that this Section 6.3(b)(i) will not prohibit Transferee or any of their Affiliates from (a) hiring any Person who is presented by a bona-fide professional placement agency which was not directed by Transferee or their Affiliates to target the Business Employees, (b) soliciting via a general solicitation or hiring any Person who first contacts Transferee or their Affiliates in response to general solicitation, or (c) soliciting or hiring any Person who has been terminated by the Transferor at least three (3) months prior to commencement of any solicitation of such Person by Transferee or their Affiliates or any employment discussions between Transferee or their Affiliates and such Person. The provisions of this Section 6.3(b)(i) shall terminate with respect to the Facility upon the consummation of the Closing.
(ii)    Transferor agrees that neither Transferor nor any of their Affiliates shall solicit or attempt to solicit for employment or hire any of Transferee’s Employees for a period of two (2) years following the Closing; provided, however, that this Section 6.3(b)(ii) will not prohibit Transferor or any of their Affiliates from (a) hiring any Person who is presented by a bona-fide professional placement agency which was not directed by Seller or any of their respective Affiliates to target the Transferee’s Employees, (b) soliciting via a general solicitation or hiring any Person who first contacts Transferor or any of their Affiliates in response to general solicitation, or (c) soliciting or hiring any Person who was has been terminated by the Transferee or their Affiliates at least three (3) months prior to commencement of any solicitation of such Person by Transferor or any of their Affiliates or any employment discussions between Transferor or any of their Affiliates and such Person. The provisions of this Section 6.3(b)(ii) shall survive the Closing.
6.4Access.
(a)From and after the Execution Date, Transferee shall have the right from time to time, upon not less than two (2) business day’s prior notice to Transferor (which notice shall be by email to pclark@amhealthpartners.com and jbailey@amhealthpartners.com and shall specify the time, date and location of such proposed inspections) to enter upon the Facility at reasonable times during normal business hours (or as otherwise reasonably scheduled with Transferor) solely for the purpose of conducting non-invasive inspections for purposes of third-party (i) property surveys and architectural reports, (ii) property condition inspections in connection with the preparation of a property condition report, (iii) engineering, (iv) geo-technical, and (v) Phase I and other non-invasive environmental inspections and tests, at Transferee’s sole risk, cost and expense. Notwithstanding the foregoing, Transferor shall have the right to delay Transferee’s entry into buildings if reasonable based upon circumstances such as the presence of CMS surveyors or health protocols. Transferor or Transferor’s agent shall have the right to accompany Transferee during any activities performed by Transferee or its representatives on the Facility. Notwithstanding anything to the contrary herein, no Phase II environmental inspections or other invasive inspections or sampling of soil or materials, including without limitation construction materials, either as part of the Phase I inspections or any other inspections, shall be performed without the prior written consent of Transferor, which may be withheld in its sole and absolute discretion, and if consented to by Transferor, the proposed scope of work and the party who will perform the work shall be subject to Transferor’s review and approval.
27


(b)In all events, during any entry to the Facility or in connection with its inspections, testing or other examinations of the Facility, Transferee shall not injure or otherwise cause bodily harm to any person thereon. Further, Transferee shall repair or restore any damage caused by Transferee, or their respective employees, contractors, representatives or agents, to the real or personal property constituting or located at the Facility; provided that nothing herein shall require Transferee to repair or remediate any pre-existing conditions discovered during such diligence except to the extent exacerbated by Transferee. From and after the Execution Date, Transferor’s prior written consent (which shall not be unreasonably withheld, conditioned or delayed) must be obtained prior to any communications with any of the Facility’s residents (or resident families), employees and suppliers. Transferee shall pay all costs incurred for any such inspections of the Facility initiated by Transferee. Transferee shall indemnify and hold Transferor harmless from and against any and all claims for death of or injury to persons or damage to property to the extent arising out of or as a result of the negligent or wrongful acts or omissions of Transferee, any authorized representatives, or designees of Transferee conducting Transferee’s due diligence investigation; provided, however, that the foregoing indemnity and hold harmless obligation shall not extend to, and in no event shall Transferee be liable to Transferor for any (i) diminution in the market value of any of the Assets and/or of the Facility resulting from the information disclosed by any such investigation or tests (unless due to the negligence or willful misconduct of any Transferee or breach of any Transferee’s obligations under this OTA), (ii) negligence or willful misconduct of any of the Transferor or any agent, contractor, or employee of any of the Transferor, or (iii) pre-existing condition(s) on or about the Facility except and to the extent such pre-existing condition(s) are exacerbated by Transferee’s entry onto and investigation of any of the Facility. Prior to entry to the Facility, Transferee, as well as their respective consultants and contractors, shall provide evidence of sufficient insurance, including general liability coverage not less than $2,000,000 per occurrence and $3,000,000 in the aggregate, to protect Transferor from any losses they may incur as a result of any Transferee’s inspections of the Facility. This Section shall survive the Closing or earlier termination of this OTA.
6.5Announcement and Disclosure.
(a)No Party shall issue an initial public announcement, report, statement or press release (collectively, a “Public Announcement”) regarding this OTA or the transactions contemplated hereby without the prior written consent of the other Party, except as otherwise required by Law. Notwithstanding the foregoing, a Public Announcement by Transferor to its employees same shall not be a breach of the foregoing covenant.
(b)Except as may be necessary to enforce this OTA, or to comply with applicable Laws including securities Laws, for three (3) years after the last Closing, Transferor shall (i) treat and hold as confidential any proprietary and confidential information of Transferor exclusively related to the Assets or the Assumed Liabilities related to the Facility (collectively, “Confidential Information”), and (ii) refrain from using any of the Confidential Information except in connection with this OTA. The term “Confidential Information” shall not include information that is or becomes generally available to the public by actions of Persons other than Transferor or that pertains to any of the Excluded Assets or the Excluded Liabilities. If Transferor is required to disclose any Confidential Information in order to comply with, or avoid violating, any applicable Law, Transferor will use commercially reasonable efforts to provide Transferee with prompt notice thereof to the extent legally permissible. With the exception of securities filings reasonably required of a public company like Transferor’s indirect parent, to the extent legally permissible and at Transferee’s sole expense, Transferor shall provide Transferee, in advance of any such disclosure, with copies of any Confidential Information that Transferor intends to disclose (and, if applicable, the text of the disclosure language itself) and shall reasonably cooperate with Transferee, at Transferee’s sole expense, if permitted by applicable Law, to the extent Transferee may reasonably seek to limit such disclosure in a manner consistent with applicable Law.
28


(c)Except as may be necessary to enforce this OTA or any other Transaction Document, for three (3) years after the last Closing, Transferee shall (i) treat and hold as confidential any proprietary and confidential information of Transferor or any of its Affiliates that does not exclusively relate to the Assets or the Assumed Liabilities related to the Facility, including any proprietary and confidential information relating to any of the Excluded Assets or the Excluded Liabilities (collectively, “Transferor Confidential Information”), and (ii) refrain from using any of Transferor Confidential Information except in connection with this OTA. The term “Transferor Confidential Information” shall not include information that is or becomes generally available to the public by actions of Persons other than Transferee or any of its Affiliates. If Transferee is required to disclose any Transferor Confidential Information in order to avoid violating any applicable Law, Transferee will use commercially reasonable efforts to provide Transferor with prompt notice thereof to the extent legally permissible. To the extent legally permissible and at Transferor’s sole expense, Transferee shall provide Transferor, in advance of any such disclosure, with copies of any Transferor Confidential Information that Transferee intends to disclose (and, if applicable, the text of the disclosure language itself) and shall reasonably cooperate with Transferor, at Transferor’s sole expense, if permitted by applicable Law, to the extent Transferor may reasonably seek to limit such disclosure in a manner consistent with applicable Law.
6.6Appropriate Action; Consents; Filings. Each of the Parties shall use its commercially reasonable efforts to obtain from any Governmental Entities or third parties any consents, licenses, permits, waivers, approvals, authorizations or orders required to be obtained, or made, by such Party in connection with the authorization, execution and delivery of this OTA and the consummation of the transactions contemplated hereby and shall provide such notices, and Transferee shall post such escrows, as required by the applicable Governmental Entities and Laws, and each Party shall comply with any written agreements with third parties to consummate the transaction. The Parties shall cooperate with each other in connection with the making of all such filings, including the timing of such filings and providing copies of all such documents to the non-filing Parties and their advisors prior to filing and, if requested, to accept all reasonable additions, deletions or changes to such filings suggested in connection therewith. On the first (1st) Business day after the Execution Date, Transferee will submit a full and complete change of ownership application for licensure with the [State of Tennessee Health Facilities Commission, Division of Licensure and Regulation / Alabama Department of Public Health, Bureau of Health Provider Standards].
6.7Access to Current Records. From and after the Closing Date, Transferee shall allow Transferor and its Affiliates, agents and representatives to have reasonable access to (upon reasonable notice and during normal business hours), and to make copies of the Current Records (at Transferor’s expense), to the extent reasonably necessary to enable Transferor to, among other things, investigate and defend malpractice, employee or other claims, to support medical review requests from Medicare or Medicaid, to support Medicare and Medicaid claims appeals, to file or defend Cost Reports and tax returns, to complete/revise, as needed, any patient assessments which may be required for Transferor to seek reimbursement for services rendered prior to the Closing Date and to enable Transfer to complete, in accordance with Transferor’s policies and procedures, any and all post-Closing Date accounting, reconciliation and closing procedures including, but not limited to, a month end close out of all accounts including, but not limited to, accounts payable and Medicare and Medicaid billing. Transferor agrees not to use or disclose any of the information obtained from Transferee except solely for the purposes described herein, and further agrees to maintain this information as confidential. Likewise, from and after the Closing Date, Transferor shall allow Transferee and its agents reasonable access to the Current Records including, without limitation, relevant records (including, for the avoidance of doubt, emails), to the extent Transferee reasonably requires such access in connection with, without limitation, accounting, billing, tax filings or securities filings, Medicare and/or Medicaid filings and appeals. Transferor shall use its commercially reasonable efforts to provide such items which require expedited handling to Transferee within five (5) Business Days of Transferee’s request. Transferee agrees not to use or disclose any of the information obtained from Transferor except solely for the purposes described herein, and further agrees to maintain this information as confidential; provided that Transferee Employees and Affiliated-Service Transferee Employees may use the content of their emails to conduct of the ongoing business of Transferee in the ordinary course. Transferee shall assure that any successor operator of the Facility is legally obligated to provide Transferor access to the Current Records in the manner required by this Section 6.7.
29


6.8Further Assurances. From time to time after the Closing, Transferor shall, at the reasonable request of Transferee and at Transferee’s expense but without further consideration, execute and deliver any further deeds, bills of sale, endorsements, assignments, and other instruments of conveyance and transfer, and take such other actions as Transferee may reasonably request and consistent with this OTA in order to (a) more effectively transfer, convey, assign and deliver to Transferee, and to place Transferee in actual possession and operating control of, and to vest, perfect or confirm, of record or otherwise, in Transferee all right, title and interest in, to and under the Assets or the Facility, (b) assist in the collection or reduction to possession of any and all of the Assets or the Facility or to enable Transferee to exercise and enjoy all rights and benefits with respect thereto, (c) with respect to any payor agreement that is non-transferrable, reasonably cooperate with Transferee to assist Transferee in securing a new agreement, or (d) otherwise carry out the intents and purposes of this OTA. In the case of rights (including, without limitation, under any Contract) which cannot be transferred effectively without the consent of third parties, Transferor shall use its commercially reasonable efforts (within commercially reasonable limits) to obtain such consent and to assure to Transferee the benefits thereof during the terms thereof.
6.9No Negotiation. Until such time as this OTA may be terminated pursuant to Article IX, Transferor shall not directly or indirectly solicit, initiate, encourage or entertain any inquiries or proposals from, or discuss or negotiate with any Person other than Transferee or its representatives relating to an acquisition or other disposition of any material Assets of the Facility or any other asset which is required by the OTA to be transferred to Transferee at Closing. Notwithstanding the foregoing, Transferor shall not be in any way limited from initiating or participating in discussions concerning any transactions involving the Excluded Assets.
6.10Accounts Receivable.
(a)Accounts Receivable. Transferor shall retain whatever right, title and interest in and to all outstanding Accounts Receivable with respect to the Facility which relate to periods ending on or before the Effective Time, including any Accounts Receivable arising from rate adjustments which relate to a period ending on or before the Effective Time even if such adjustments occur after the Effective Time, including any Medicaid lag payments (collectively, “Transferor’s A/Rs”). Transferor acknowledges that Transferee owns all revenues, Accounts Receivable and payment rights arising from services provided by or at the Facility after the Effective Time (collectively, “Transferee’s A/Rs”). As of the Effective Time, Transferor hereby irrevocably assigns to Transferee any and all interest it may have in the Transferee’s A/R with the authority and power to bill and collect the same, and disclaims all right, title and interest therein and thereto. Transferor further agrees to authorize Transferee to endorse checks representing Transferee’s A/Rs which are made payable to the trade name or any similar names or payees of the Seller, and deposit same in Transferee’s account.
(b)Receipts by Transferee. In furtherance and not in limitation of the requirements set forth in Section 6.10(a), payments received by Transferee after the Effective Time from third party payors including, but not limited to, Medicare, Medicaid, VA, managed care and health insurance, shall be handled as follows:
30


(i)If such payments either specifically indicate on the accompanying remittance advice, or if Transferor and Transferee agree that such payments relate to the period ending before the Effective Time, they shall be forwarded by Transferee to Transferor, along with the applicable remittance advice, as soon as reasonably practicable but in any event within ten (10) calendar days after receipt thereof; and
(ii)If such payments indicate on the accompanying remittance advice, or if Transferor and Transferee agree that such payments relate to the period after the Effective Time, they shall be retained by Transferee.
(c)Receipts by Transferor. Payments received by Transferor after the Effective Time from third party payors including, but not limited to, Medicare, Medicaid, VA, managed care and health insurance, shall be handled as follows:
(i)If such payments either specifically indicate on the accompanying remittance advice, or if Transferor and Transferee agree that such payments relate to the period after the Effective Time, they shall be forwarded by Transferor to Transferee, along with the applicable remittance advice, as soon as reasonably practicable but in any event within ten (10) calendar days after receipt thereof; and
(ii)If such payments indicate on the accompanying remittance advice, or if Transferor and Transferee agree that they relate to the period ending on or before the Effective Time, they shall be retained by Transferor.
(d)Other Receipts. If the remittance advice indicates or the Parties agree that any payment relates to periods both prior to or on and after the Effective Time, the Party receiving the payment shall forward the amount relating to the other Party’s operation of the Business, along with the applicable remittance advice, as soon as reasonably practicable but in any event within ten (10) calendar days after receipt thereof. If the remittance advice does not indicate the period to which a payment relates or whether it is for Transferor or Transferee, or if there is no accompanying remittance advice, or the payment is not otherwise identifiable using commercially reasonable efforts, and if the Parties do not otherwise agree as to how to apply such payment, then 100% of such payments received within the first ninety (90) days after the Effective Time shall be deemed to have been collected in respect of Transferor’s A/R due from the payee in respect of services provided on or prior to the Effective Time. All such payments received in excess of the amount of Transferor’s A/Rs due from said payee and all such payments received more than ninety (90) days after the Effective Time shall be deemed to have been collected in respect of Transferee’s A/Rs from said payee. All such payments received by Transferee but which are deemed to be due Transferor under this Section 6.10 shall be forwarded by Transferee to Transferor as soon as reasonably practicable but in any event within ten (10) calendar days after receipt thereof, and all such payments received by Transferor but which are deemed to be due Transferee under this Section 6.10 shall be forwarded by Transferor to Transferee as soon as reasonably practicable but in any event within ten (10) calendar days after receipt thereof. All such payments received by Transferor which are deemed to have been collected in respect to Transferor’s A/Rs shall be retained by Transferor and all such payments received by Transferee which are deemed to have been collected in respect to Transferee’s A/Rs shall be retained by Transferee. Transferee shall pay to Transferor any and all reimbursements including retroactive rate adjustments, appeal settlements and/or Cost Report settlements for all cost report periods with fiscal years ended prior to the Effective Time that it receives after the Effective Time (but nothing herein creates an obligation of Transferee to pursue such funds on Transferor’s behalf). During the five (5) year period following the Effective Time, Transferee shall also make a good faith effort to reconcile its Cost Report reimbursements and/or settlements with documentation Transferor provides to Transferee regarding Transferor Bad Debt and shall pay to Transferor any and all reimbursements and/or settlements related to Transferor Bad Debt pursuant to Section 6.11.
31


(e)Medicaid Applications. In connection with Transferor’s attempts to collect Medicaid funds for services rendered to those Residents with pending Medicaid applications (collectively, the “Pending Medicaid Applicants”), each set out on Schedule 6.10(e), (i) Transferor shall provide Transferee with copies of all pending Medicaid applications, (ii) Transferee shall provide Transferor with a written monthly progress report on the Medicaid application status of each Pending Medicaid Applicant until such time as all Pending Medicaid Applicants have been approved or denied by Medicaid, and (iii) if Transferee receives any notice or correspondence regarding such applications, Transferee shall provide such notice or correspondence to Transferor within seven (7) Business Days following receipt. Transferor and Transferee shall cooperate with each other and provide each other with such documents and information as each party shall reasonably request to enable such party to contest any denial or negative determinations by Medicaid with respect to the Pending Medicaid Applicants.
(f)Accounting for Accounts Receivable.
(i)At least five (5) days prior to Closing, Transferor shall deliver to Transferee a schedule of Transferor’s A/R, listing by Resident the amount due to Transferor (which Schedule shall be attached hereto as Schedule 6.10(f)(i). As soon as reasonably possible, but not later than fifteen (15) Business Days after the Closing Date, Transferor shall provide Transferee with a schedule of Transferor’s A/R, listing by Resident the amounts due to Transferor as of the Effective Time.
(ii)For a period of twelve (12) months following the Effective Time or until Transferee receives payment of all Transferee’s A/R, whichever is sooner, Transferor shall provide Transferee (no less frequently than monthly) with (A) an accounting setting forth all amounts received by Transferor with respect to the Accounts Receivable using the same type of schedule as that provided by Transferor pursuant to Section 6.10(f)(i), and (B) copies of all remittance advices relating to such amounts received and any other reasonable supporting documentation as may be requested by Transferee to determine Transferee’s A/Rs and Transferor’s A/Rs that have been paid. Transferor shall deliver such accounting to Transferee at the following address: _________________________________________.
(iii)For a period of twelve (12) months following the Effective Time or until Transferor receives payment of all Transferor’s A/Rs, whichever is sooner, Transferee shall provide Transferor (no less frequently than monthly) with (A) an accounting setting forth all amounts received by Transferee with respect to Accounts Receivable using the same type of schedule as that provided by Transferor pursuant to Section 6.10(f)(ii), and (B) copies of all remittance advices relating to such amounts received and any other reasonable supporting documentation as may be required for Transferor to determine Transferee’s A/Rs and Transferor’s A/Rs that have been paid. Transferee shall deliver such accounting to Transferor at the following address: c/o American Health Partners, 201 Jordan Road, Suite 200, Franklin, Tennessee 37067, Attention: Jason Bailey.
(iv)On two (2) occasions during the one (1) year period following the Effective Time, Transferor and Transferee shall, upon reasonable notice and during normal business hours, have the right to inspect all cash receipts of the other Party in order to confirm the other Party’s compliance with the obligations imposed on it under Sections 6.10 and 6.11. Notwithstanding the foregoing, if such information can be transmitted through electronic mail, then Transferor and Transferee may satisfy their obligations under this Section 6.10 in that manner.
32


(v)To enable Transferor to close its books with respect to the period ending on the Closing Date, Transferee will permit appropriate personnel of Transferor reasonable access to the Facility, in a manner that does not materially interfere with the operation of the Facility, for a period of no more than thirty (30) days after the Closing Date. During that period, Transferee will permit certain individuals employed by Transferor or its Affiliate immediately before the Closing Date to provide reasonably necessary assistance to Transferor in its closing of the books. Those individuals are the persons previously employed by Seller or Transferor in following positions: Executive Director; Business Office Manager; Accounts Receivable Assistant; Accounts Payable Coordinator; and Payroll Benefits Coordinator.
(vi)Any amounts to be paid by Transferor to Transferee under this Article VI shall be made by electronic transfer using the wire instructions set forth on Exhibit 6.10(f).
(g)Transferor Collection Activities. After the Closing Date, Seller and Transferor shall have the right, and any agent or representative retained by the foregoing shall have the right on behalf of Seller and Transferor, to engage in commercially reasonable collection activities with respect to any unpaid Transferor’s A/R’s, including private pay amounts; provided, however, following the Closing Date, Seller and Transferor may not bring any action for eviction to collect payment of Transferor’s A/Rs from any then-current Resident of the Facility, and Seller and Transferor shall communicate in advance with Transferee regarding any collection efforts.
(h)Delivery of Mail. To the extent that Transferee or any of its Affiliates receives any mail or packages addressed to Seller, Transferor or any of their Affiliates not relating to the Assets or the Assumed Liabilities, Transferee shall promptly deliver such mail or packages to Transferor. After the Closing Date, Transferee may deliver to Transferor any checks or drafts made payable to Transferor or its Affiliates that constitutes an Asset, and Transferor shall promptly deposit or cause to be deposited such checks or drafts and, upon receipt of funds, reimburse Transferee within ten (10) Business Days for the amounts of all such checks or drafts, or, if so requested by Transferee, endorse such checks or drafts to Transferee for collection. To the extent Transferor or its Affiliates receives any mail or packages addressed to Transferor or its Affiliates but relating to the Assets or the Assumed Liabilities relating to the Facility, Transferor shall promptly deliver such mail or packages to Transferee. After the Closing Date, to the extent that Transferee receives any cash or checks or drafts made payable to Transferee that constitutes an Excluded Asset, Transferee shall promptly use such cash to, or deposit such checks or drafts and upon receipt of funds from such checks or drafts, reimburse Transferor within ten (10) Business Days for such amount received, or, if so requested by Transferor, endorse such checks or drafts to Transferor for collection. The Parties may not assert any set off, hold back, escrow or other restriction against any payment described in this Section 6.10(h).
33


(i)Transferor acknowledges and agrees that Transferee’s A/R, and all other present and future Accounts (as defined in the Uniform Commercial Code) arising from or related to services rendered at the Facility on or after the Effective Time, and any books and records relating thereto, in each case arising from or related to services rendered at the Facility on and after the Effective Time are the property of Transferee. Effective as of the Effective Time, to secure Transferee’s rights to Transferee’s A/R, Transferor shall grant to Transferee a first priority lien and security interest in and to the Transferee’s A/R and, before the Effective Time, shall execute and deliver to Transferee the Security Agreement, in substantially the same form as attached hereto as Exhibit 6.10(h) (the “Security Agreement”). Transferee shall establish bank accounts to receive payments of Transferee’s A/R after the Closing Date (“Transferee Depository Accounts”). Transferor hereby acknowledges and agrees that Transferor maintains a separate governmental account where all payments for services rendered at the Facility are deposited by governmental third-party payors and a non-governmental account where all payments for services rendered at such Facility are deposited by non-governmental third-party payors (each a “Facility Account” and collectively, the “Facility Accounts”). From the date which is ninety (90) days after the Closing Date until the date on which Medicare payments for services provided by Transferee on or after the Effective Time are being directly electronically transferred to Transferees’ Accounts and Transferee’s A/R are no longer being deposited into the Facility Accounts (the “Cutover Date”), Transferor will establish daily bank account sweeps (the “Sweep Mechanisms”) whereby all funds deposited into the Facility Accounts will automatically sweep from the governmental Facility Account to such Facility’s non-governmental Facility Account and then from such Facility’s non-governmental Facility Account directly into the designated Transferee Depository Accounts. The sweeps from the Facility Accounts shall be made to Transferee Depository Accounts designated by Transferee, it being acknowledged and agreed that Transferee may establish and designate one Transferee Depository Account for all sweeps from Facility Accounts. During the period from the Closing Date to the Cutover Date, Transferor shall provide Transferee viewing access to the Facility Accounts. On or after the Closing Date, Transferor hereby authorizes the filing of the financing statements under the Uniform Commercial Code on the Transferee’s A/R in the Facility Accounts in the form attached to the Security Agreement (“UCC Financing Statements”). No later than fifteen (15) days following the Closing Date, the Parties shall execute a Deposit Account Control Agreement (“DACA”) for each Facility Account (other than accounts which receive payments by governmental entities) in form and substance reasonably satisfactory to Transferee and Transferor, and account control agreements (i.e. a Collection Account Agreements or Deposit Account Instructions and Service Agreement) (collectively, “DAISA”) for each Facility Account which receive payments for services at the Facility from governmental entities shall be entered into by and among Transferor as account holders and debtors and Transferee as senior secured party and each respective bank at which such accounts are held, in form and substance reasonably satisfactory to Transferee and Transferor. Transferor shall, no later than thirty (30) days prior to the Closing, provide Transferee with the proposed form of DACA and DAISA from Transferor’s applicable depository bank(s).
(j)In addition to the foregoing, Transferor shall execute such documents as may be reasonably required by Transferee’s lender including, but not limited to, an estoppel and security agreement, a collateral assignment of this OTA, a facility account transition agreement and account control agreements, in each case, on such forms as may be mutually acceptable to Transferor and Transferee.
6.11Cost Reports.
(a)Transferor shall prepare and file with its fiscal intermediary the final Medicare Cost Reports covering its operation of the Business through the Effective Time as soon as reasonably practicable after the Effective Time, but in no event later than the date on which such final Cost Report is required to be filed by applicable Law under the terms of the Medicare program, and will provide the fiscal intermediary or CMS with any information needed to support claims for reimbursement made by Transferor either in said final Cost Report or in any Cost Reports filed for prior cost reporting periods. Simultaneously with such filing, Transferor shall provide Transferee with a copy of the final Medicare Cost Reports and such supporting documentation reasonably requested by Transferee in writing.
(b)After the Closing Date, Transferor shall promptly and diligently provide Transferee with reasonable and appropriate documentation regarding the Medicare bad debts incurred by Transferor prior to the Effective Time associated with the Facility (“Transferor Bad Debt”) for purposes of facilitating Transferee’s preparation of related Cost Reports. Transferor agrees to reasonably cooperate by providing reasonably requested pre-Effective Time data to Transferee in connection with Transferee’s preparation of Cost Reports with respect to the period after the Effective Time.
34


(c)Transferee shall timely prepare and file with CMS and the appropriate state agency for the Facility, its initial Cost Report for the fiscal year commencing with the fiscal year in which the Closing Date occurs and will include Transferor Bad Debt in its initial Cost Report.
(d)Transferee shall notify Transferor within ten (10) Business Days of receipt of any notice of adverse audit adjustments, overpayment, recoupment, fine, penalty, late charge or assessment accruing in relation to Transferor Bad Debt. Transferee agrees to appeal at the request of, on behalf of, and at the sole expense of Transferor, any Medicare claims audit, Cost Report audit, overpayment, recoupment, fines, penalties, late charges and assessment accruing in relation to Transferor Bad Debt. Transferor and Transferee shall each reasonably cooperate with the other respective Party, with respect to any such matters including, but not limited to, timely providing any requested documentation within the other Party’s possession or control relating to such matters. Transferee is not responsible for (i) the actual results of any such appeal, or (ii) Transferor’s failure to provide information and/or documents necessary to process any such appeal.
(e)Transferor and Transferee shall comply with all patient identity and information protection Laws in providing information under this Section 6.11.
(f)In the event that, following the applicable Effective Time, Transferee or any of its Affiliates suffers any offsets against reimbursement under any third party payor or reimbursement programs owed to such Party relating to amounts owing under any such program by Transferor or any of its Affiliates for services rendered prior to the Effective Time, Transferor shall immediately upon written demand from Transferee pay to such Party the amounts so billed or offset, even if Transferor appeals the adverse claim. To the extent that Transferor is successful in any appeal of any adverse audit adjustments, overpayment, recoupment, fine, penalty, late charge or assessment by any third party payor accruing for any period prior to the Effective Time, and Transferee or its Affiliates receive any monies from a third party payor or reimbursement program as a result of Transferor’s successful appeal, then Transferee and/or its Affiliates agree that it will promptly refund to Transferor any amounts previously paid by Transferor to such Party for any reimbursement offsets in accordance with the preceding sentence.
6.12Assistance in Proceedings. Transferee shall cooperate with any Transferor and its counsel in the contest or defense of, and make available its personnel and provide any testimony and access to its Current Records in connection with, any proceeding involving or relating to (a) any contemplated transaction herein, or (b) any action, activity, circumstance, condition, conduct, event, fact, failure to act, incident, occurrence, plan, practice, situation, status or transaction on or before the Closing Date involving Transferor, the Facility or its Business.
6.13Corporate Contracts; Overhead and Shared Services. Transferee acknowledges that the Facility currently benefits from the Corporate Contracts and currently receive Overhead and Shared Services from various Affiliates of Seller and Transferor. Transferee further acknowledges that, as it relates to the operation of the Facility after Closing, all such benefits from the Corporate Contracts and the provision of Overhead and Shared Services shall cease, and any agreement of the Facility with Seller, Transferor or any of their Affiliates in respect to the Corporate Contracts or the provision of Overhead and Shared Services shall terminate, as of the Closing Date. No Overhead and Shared Services shall be provided by Seller, Transferor or any of their Affiliates to the Facility unless otherwise contemplated by the Transaction Documents.
6.14Business Relationships. After the Closing Date, each Party will reasonably cooperate with the other Parties in its efforts to continue and maintain for the benefit of those business relationships of Transferor existing prior to the Closing Date and relating to the business to be operated by Transferee after the Closing, including relationships with lessors, employees, regulatory authorities, licensors, patients, suppliers and others. The foregoing notwithstanding, Transferor does not make any representation or warranty as to the prospects or outlook for such business relationships as carried on by Transferee after the Closing Date.
35


6.15Information Systems, Records in Electronic Form, Software and Data.
(a)Transferor shall use reasonable efforts to permit the electronic transfer of current data in fully operational form for use in Transferee’s computer applications. Transferor further agrees that in order to assist Transferee in ensuring the continued operation of the Facility after the Closing Date in compliance with applicable Law and in a manner which does not jeopardize the health and welfare of the Residents of the Facility, Transferor shall, for a period of sixty (60) days after the Closing Date, provide Transferee access to Transferor’s electronic medical records system to enable Transferee, at its expense, to print and/or copy the medical treatment records and physician orders for each Resident as of the Closing Date that was a Resident as of the period between and including the Effective Time and the date that is eighteen (18) months prior to the Effective Time, and cooperate with Transferee regarding the delivery of all such Current Records to Transferee, in electronic form (including the provision to Transferee of the last eighteen (18) months of Minimum Data Set history in the format submitted to CMS by Transferor), in order to enable Transferee to obtain the necessary copies of such medical records and physician orders.
(b)At least thirty (30) days prior to the Closing Date, Transferor shall provide Transferee and its representatives with access to the Facility so that Transferee can install lines necessary for computer hardware, together with servers, computer hardware and software. In addition, Transferor shall cooperate with Transferee and provide Transferee with such assistance as Transferee may reasonably request in order to provide for an orderly, efficient and safe transition of the operations from Transferor to Transferee and the continued operation of the Facility after the Closing Date in compliance with applicable Law and in a manner which does not jeopardize the health and welfare of the Residents of the Facility. During such time as Transferor provides Transferee with access to the Facility under this Section 6.15(b), Transferee shall not connect with or hook into Transferor’s computer lines or computers. Such access shall be prescheduled with Transferor and shall not interrupt normal business operation. Transferee shall indemnify Transferor for any damage resulting from such access or installation of the lines. If, for any reason, this OTA terminates prior to the Closing Date, Transferor shall remove any lines installed, at Transferee’s cost and expense, and Transferee shall remit payment to Transferor within five (5) days of receiving an invoice for such costs and expenses of removal.
6.16Stimulus Funds. After the Closing Date, Transferor shall timely file any and all reports with respect to any Stimulus Funds received by Transferor prior to the Closing Date. To the extent that any Governmental Authority determines that any Stimulus Funds received by Transferor are required to be repaid, Transferor shall timely repay any and all such Stimulus Funds.
6.17Notice of Breach. If Transferee becomes aware prior to the Closing Date that any of the representations and warranties of Seller or Transferor under the Transaction Documents are no longer true and correct in all material respects, or were not true and correct as of the Execution Date (a “Pre-Closing R&W Breach”), Transferee shall promptly notify Seller and Transferor in writing pursuant to the terms of Section 12.9 below of such Pre-Closing R&W Breach and specifically identify any matters that make the representations and warranties set forth in the Transaction Documents not true and correct in all material respects and whether Transferee believes, in its good faith and commercially reasonable judgment, such Pre-Closing R&W Breach can be cured to make the representations and warranties of Seller and/or Transferor under the Transaction Documents true and correct prior to the Closing Date (such notice is referred to herein as the “Pre-Closing R&W Breach Notice”). Seller and Transferor shall use commercially reasonably efforts to cure any Pre-Closing R&W Breach but shall have no obligations to cure any such Pre-Closing R&W Breach prior to Closing.
36


6.18Post-Closing Insurance. In connection with the consummation of the Closing under this OTA, Transferor shall obtain an endorsement to Transferor’s existing policies of insurance covering general liability and professional liability, which endorsement shall have an effective date as of the Closing and shall provide for continued insurance at current levels to cover claims related to pre-Closing operations of the Facility and the Business. Transferor covenants and agrees that it shall cause such endorsement to be maintained consistent with the foregoing sentence with respect to the Facility and the Business for a period of three (3) years following the Closing.
6.19PCA. Notwithstanding anything herein to the contrary, Seller and Transferor shall have no duty to perform any repairs or replacements identified in any property condition assessment included within the PCA.
Article VII
CONDITIONS PRECEDENT TO THE OBLIGATIONS OF PARTIES
7.1Conditions to Obligations of Transferee. The obligations of Transferee hereunder are subject to the fulfillment of all of the following conditions precedent unless such fulfillment is waived in writing by Transferee, subject to the limitations contained herein, as the case may be:
(a)Representations and Warranties. The representations and warranties of Transferor set forth in Article IV shall be true and correct in all material respects (or, with respect to any representation qualified as to materiality, true and correct) on and as of the Closing Date as if made on and as of the Closing Date, except to the extent any such representation or warranty expressly is made as of an earlier date or with respect to a particular period, in which case such representation or warranty shall have been true and correct in all material respects (or, with respect to any representation qualified as to materiality, true and correct) as of such date or with respect to such period, except, in each case, where the failure to be true and correct would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
(b)No Litigation. Without limiting the generality of any representation, no injunction, temporary restraining order, judgment or other order of any court or governmental agency or instrumentality shall have issued or have been entered which would be violated by the consummation of the transactions contemplated hereby; and no suit, action or other proceeding brought by the United States, the State of Tennessee [Alabama] or any political subdivision, which any Facility is located or any agency or instrumentality thereof shall be pending in which it is sought to restrain or prohibit this OTA or the consummation of the transactions contemplated hereby.
(c)Compliance with Covenants. All of the covenants of Transferor contained in this OTA to be performed by Transferor on or before the Closing Date shall have been performed in all material respects on or before the Closing, except where such failure would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
(d)No Material Adverse Effect. Since the Execution Date, there shall have been no Material Adverse Effect that has occurred which remains outstanding as of the Closing Date.
37


(e)Purchase Agreement. All the conditions for closing of the Facility under the Purchase Agreement have been satisfied or waived other than the closing of the transactions contemplated under this OTA.
(f)Termination of Management Agreements. Any management agreements between Transferor and Seller and/or its Affiliates shall have been terminated and any existing Leases related to the Facility between Transferor and Seller and/or its Affiliates shall have been terminated.
(g)New License. Transferee shall have either (i) received the New License as of the Closing Date (or shall have obtained reasonable assurances from the Department that the New License has been or will be issued by the Department effective as of the Effective Time or promptly thereafter), or (ii) the Parties shall have entered into the Interim Documents in accordance with Section 7.3.
(h)Closing Certificate. Transferor shall have delivered to Transferee a certificate of a duly authorized officer of Transferor dated as of the Closing Date stating that the conditions specified in Sections 7.1(a) and 7.1(c) have been satisfied.
(i)Good Standing Certificate. Transferor shall have delivered to Transferee a certificate of the Secretary of State in which the Facility is located as of a recent date as to the legal existence and good standing of Transferor.
(j)Transaction Documents. Transferor shall have executed and delivered the Transaction Documents contemplated herein.
(k)Consents. Transferor shall have obtained those consents necessary to assign the Assumed Contracts set forth on Schedule 7.1(k).
(l)Other Operations Transfer Agreements. All the conditions for closing of the facilities subject to the Other Operations Transfer Agreements shall have been satisfied or waived, other than the closing of the transactions contemplated under this OTA, and excluding any facility under any of the Other Operations Transfer Agreements which is subject to a Delayed Closing.
(m)Resident Trust Deposits. Transferor shall have delivered any and all assignment and assumptions of resident trust deposits.
7.2Conditions to Obligations of Transferor. The obligations of Transferor hereunder are subject to the fulfillment of all of the following conditions precedent unless such fulfillment is waived in writing by Transferor, subject to the limitations contained herein, as the case may be:
(a)Representations and Warranties. The representations and warranties of Transferee set forth in Article V shall be true and correct in all material respects (or, with respect to any representation qualified as to materiality, true and correct) on and as of the Closing Date as if made on and as of the Closing Date, except to the extent any such representation or warranty expressly is made as of an earlier date or with respect to a particular period, in which case such representation or warranty shall have been true and correct in all material respects (or, with respect to any representation qualified as to materiality, true and correct) as of such date or with respect to such period.
38


(b)No Litigation. Without limiting the generality of any representation, no injunction, temporary restraining order, judgment or other order of any court or governmental agency or instrumentality shall have issued or have been entered which would be violated by the consummation of the transactions contemplated hereby; and no suit, action or other proceeding brought by the United States, the State of [Tennessee/Alabama], any political subdivision, which any Facility is located or any agency or instrumentality thereof shall be pending in which it is sought to restrain or prohibit this OTA or the consummation of the transactions contemplated hereby.
(c)Compliance with Covenants. Transferee shall have performed and complied, in all material respects, with all terms, agreements, covenants and conditions of this OTA to be performed or complied with by it at or prior to the Closing.
(d)Authorization. Transferee shall have approved and authorized the transactions contemplated by this OTA.
(e)Purchase Agreement. All the conditions for closing of the Facility under the Purchase Agreement have been satisfied or waived other than the closing of the transactions contemplated under this OTA.
(f)New License. Transferee shall have either (i) received the New License as of the Closing Date (or shall have obtained reasonable assurances from the Department that the New License has been or will be issued by the Department effective as of the Effective Time or promptly thereafter), or (ii) the Parties shall have entered into the Interim Documents in accordance with Section 7.3.
(g)Closing Certificate. Transferee shall have delivered to Transferor a certificate of a duly authorized officer of Transferee dated as of the Closing Date stating that the conditions specified in Sections 7.2(a) and 7.2(c) have been satisfied.
(h)Good Standing Certificates. Transferee shall have delivered to Transferor a certificate of the Secretary of State of ___________ as of a recent date as to the legal existence of Transferee, along with a Certificate of Authority from the Secretary of State of [Tennessee/Alabama].
(i)Transaction Documents. Transferee shall have executed and delivered the Transaction Documents contemplated herein.
(j)Other Operations Transfer Agreements. All the conditions for closing of the facilities subject to the Other Operations Transfer Agreements shall have been satisfied or waived, other than the closing of the transactions contemplated under this OTA, and excluding any facility under any of the Other Operations Transfer Agreements which is subject to a Delayed Closing.
7.3Interim Arrangements. Notwithstanding anything in this OTA to the contrary, in the event Transferee has not obtained the New License as of the Closing Date under the Purchase Agreement, and provided that all other Closing conditions in this Article VII shall have been satisfied or waived by such date or shall be satisfied simultaneously with the Closing, the Parties agree to consummate the Closing under the Purchase Agreement and this OTA (the “IMA Closing Date”); provided, however, that any assets or agreements which pursuant to applicable Law cannot be transferred to Transferee until issuance of the New License (including, but not limited to, the Permits and the provider agreements) shall be retained by Transferor, and shall not be transferred to Transferee until the date on which Transferee receives the New License. In such an event, all references to the “Closing Date” or “Closing” hereunder shall mean the IMA Closing Date unless the context requires otherwise. In such event, the Parties agree to the following:
39


(a)On the IMA Closing Date, Transferee and Transferor shall enter into (i) an interim management agreement for the management of the Facility in the form attached hereto as Exhibit 7.3(a)(i) (the “Interim Management Agreement”) and (ii) an interim sublease for the sublease of the Facility from Transferee to Transferor in the form attached hereto as Exhibit 7.3(a)(ii) (the “Interim Sublease” and together with the Interim Management Agreement, the “Interim Documents”). The Interim Management Agreement provides, among other things, that Transferee shall receive the benefit of all revenue and be responsible for all expenses accruing in connection with the operation of the Facility during the period from the IMA Closing Date to date on which the New License is issued to Transferee (the “Interim Management Period”). The Interim Sublease provides, among other things, that Transferee shall be responsible for all costs and expenses associated with the lease and occupancy of the Facility during the Interim Management Period.
(b)Notwithstanding anything herein to the contrary, any Losses relating to the operation of the Facility which accrue during the Interim Management Period shall be Assumed Liabilities of Transferee, and neither Purchaser nor Transferee shall be entitled to indemnification from Seller or Transferor for any such Losses.
(c)If there is any conflict between the terms of this OTA and the terms of the Interim Documents, the terms of the Interim Documents shall control in each case. Without limiting the generality of the foregoing, if this OTA obligates or requires Transferor to take any action or refrain from taking any action during Interim Management Period and the provisions of the Interim Documents Agreement require them to do something different, then the provisions of the Interim Documents shall control.
Article VIII
DELAYED CLOSING
8.1Delayed Closing. Notwithstanding anything in this OTA to the contrary, in the event the sale of the Facility under the Purchase Agreement does not occur or is delayed as a result of the provisions of Sections [2.9]7 6.8 or Section 7.2 through Section 7.5 of the Purchase Agreement (a “Delayed Closing”), the transfer of operations from Transferor associated with the Facility to Transferee shall occur, if at all, on the date of the eventual sale of such Facility pursuant to the Purchase Agreement. All of the provisions of this OTA shall apply to such transfer of operations, other than the Closing Date for such transfer of operations being adjusted accordingly in accordance with the Purchase Agreement.
Article IX
TERMINATION
9.1Termination. This OTA may be terminated, and the transactions contemplated hereby abandoned at any time prior to the Closing:
(a)by either Transferor or Transferee if (i) the Closing under the Purchase Agreement with respect to the Facility has not occurred by the End Date (unless such date has been extended under the Purchase Agreement in accordance with its terms); or (ii) the Purchase Agreement has been terminated in accordance with its terms (either in full, or with respect to the Facility);
(b)by the mutual written consent of Transferor Representative and Transferee; or
7 NTD: Solely applicable to WTTC
40


(c)by Transferor, due to a failure of a Closing condition set forth in Section 7.2 of this OTA which is not cured, or which cannot reasonably be cured, prior to the End Date; or
(d)by Transferee, due to a failure of a Closing condition set forth in Section 7.1 of this OTA which is not cured, or which cannot reasonably be cured, prior to the End Date.
9.2Procedure and Effect of Termination.
(a)In the event of termination of this OTA pursuant to this Article IX, the terminating Party shall give written notice thereof to the other Parties and this OTA shall terminate, and the transactions contemplated hereby shall be abandoned, without further action by any of the Parties.
(b)If this OTA is terminated as provided herein, no Party shall have any liability or further obligation hereunder to any other Party to this OTA, except (i) as provided in Section 6.5 or Article X, and/or (ii) as otherwise provided for in the Purchase Agreement, and (iii) nothing herein will relieve any Party from liability for any breach of this OTA.
Article X
INDEMNIFICATION
10.1Survival of Representations, Warranties and Covenants. All representations, warranties, pre-closing covenants and obligations of Transferor, including with respect to the Facility, on the one hand, and Transferee, on the other hand, contained in this OTA or in any document to be executed and delivered pursuant to this OTA at the Closing shall survive the Closing for such Facility for eighteen (18) months and automatically terminate thereafter without any action on the part of any Party hereto; provided, however, that (a) the representations and warranties set forth in Sections 4.1 (Corporate), 4.7 (Encumbrances), 4.19 (Broker), 5.1 (Corporate), and 5.3 (Broker) shall survive indefinitely after the Closing for such Facility, (b) the representations and warranties set forth in Sections 4.4 (Taxes), shall survive until thirty (30) days after the expiration of the statute of limitations period (including all extensions thereof) applicable to the underlying subject matter being represented, and (c) the representations and warranties set forth in Sections 4.5 (Employee Benefit Plans) and 4.8 (Healthcare) shall survive until the three-year anniversary of the Closing Date for such Facility. The representations and warranties contained in Sections 4.1, 4.4, 4.7, 4.19, 5.1, and 5.3 are sometimes collectively referred to herein as the “Fundamental Representations.” Except as otherwise set out in this OTA, post-Closing covenants and obligations of the Parties shall survive the Closing Date for such Facility for three (3) years and automatically terminate without any action on the part of any Party hereto; provided, however, that (a) non-monetary obligations for access and/or retention of records, confidentiality, general cooperation, delivery of property received belonging to the other Party, and further assurances, shall survive for the Closing Date for the period of the statute of limitations or the specific period set forth herein, (b) Transferee’s obligations with respect to Assumed Liabilities will survive the Closing Date for the period of the underlying obligation plus the relevant statute of limitations (including all extensions thereof) applicable for such Assumed Liability, and (c) Transferor’s obligations with respect to Retained Liabilities will survive the Closing Date for the period of the underlying obligation plus the relevant statute of limitations (including all extensions thereof) applicable for such Retained Liability. Notwithstanding the foregoing, any covenant, obligation, representation or warranty in respect of which indemnity may be sought hereunder shall survive the time at which it would otherwise terminate pursuant to this Section 10.1 (such time, the “Expiration Date”) if a Notice of Indemnification shall have been given to the applicable Indemnifying Party on or before the applicable Expiration Date; provided, however, that such survival shall automatically expire if Indemnified Party does not bring a judicial action against Indemnifying Party within one hundred eighty (180) days following the Expiration Date, and further, in the absence of the filing of such an action, the Escrow shall be released one hundred eighty (180) days after the three-year anniversary of the Closing Date.
41


10.2Indemnification by Transferor. Subject to Section 10.1 and any cure periods set forth in this OTA, Transferor and Seller or their respective successors and assigns, as applicable, shall jointly and severally indemnify and hold harmless Transferee and its Affiliates (collectively, “Transferee Indemnified Parties”) from and against any Loss incurred or suffered by such Transferee Indemnified Party arising out of or resulting from:
(a)a breach of any representation or warranty made by Transferor in this OTA or any other Transaction Document;
(b)a failure by Transferor to perform or comply with the covenants on the part of Transferor set forth in this OTA or any other Transaction Document; and
(c)any Retained Liabilities, and any obligations arising with respect to an Excluded Asset from and after the Closing Date.
10.3Indemnification by Transferee. Subject to Section 10.1 and any cure periods set forth in this OTA, Transferee or its successors and assigns, as applicable, shall indemnify and hold harmless Transferor, Seller and their respective Affiliates (“Transferor Indemnified Parties”), from and against any Loss incurred or suffered by such Transferor Indemnified Party arising out of or resulting from:
(a)a breach of any representation or warranty made by Transferee in this OTA or any other Transaction Document;
(b)a failure by Transferee to perform or comply with any covenant of Transferee in this OTA or any other Transaction Document; and
(c)any Assumed Liability, and any obligations arising with respect to an Asset from and after the Closing Date.
10.4Indemnification Limitations. Notwithstanding Section 10.2, if the Closing occurs:
(a)An Indemnifying Party shall not have any obligation to indemnify an Indemnified Party with respect to a Facility whatsoever from and against any Loss pursuant to Section 10.2(a) or Section 10.3(a) unless and until (i) the aggregate claims for such Losses pursuant to Section 10.2(a) or Section 10.3(a) exceed Fifty Thousand Dollars ($50,000.00) with respect to the Facility (the “Facility Indemnification Threshold”), or (ii) the aggregate claims for such Losses pursuant to Section 10.2(a) or Section 10.3(a) of this OTA, as applicable, combined with Losses pursuant to Section 10.2(a) or Section 10.3(a) of the Other Operations Transfer Agreements, as applicable, exceed Two Hundred Thousand Dollars ($200,000.00) in the aggregate (the “Aggregate Indemnification Threshold”) (the foregoing (i) and (ii) each, an “Indemnification Threshold”), at which time the Indemnified Parties shall be entitled to recover all such Losses, including the amount of the applicable Indemnification Threshold.
42


(b)Indemnified Parties shall not be entitled to recover Losses under the Purchase Agreement, Section 10.2(a) or Section 10.3(a) of this OTA and Section 10.2(a) or 10.3(a) of the Other Operations Transfer Agreements (which, for the avoidance of doubt shall be aggregated), in excess of the amount of the OTA Indemnification Cap; provided, however, that Losses relating to: (A) Fraud or any breach of any of the Fundamental Representations, and (B) any Pre-Closing R&W Breach, the existence of which does not breach Transferee’s representations and warranties set forth in Section 5.4(c), and which is (x) properly and timely identified in a Pre-Closing R&W Breach Notice delivered to Seller or Transferor prior to the Closing of the Facility under the Purchase Agreement in accordance with Section 6.17, (y) existed as of the Execution Date (as opposed to one which first arose subsequent to the Execution Date and prior to the Closing) and (z) was not cured by Seller or Transferor prior to the Closing Date (an “Execution Date R&W Breach”), shall not be subject to the foregoing limits and shall not be subject to the OTA Indemnification Cap or included in the determination of whether the OTA Indemnification Cap has been reached. For all purposes of this Article X, when determining the amount of the Losses arising out of or resulting from a breach of a representation or warranty of Transferor or Transferee, any Material Adverse Effect or other materiality qualifier contained in any such representation or warranty will be disregarded.
(c)Any Losses for which any Indemnified Party would be entitled to indemnification under this Article X shall be reduced by the amount of insurance proceeds actually received or recovered under any insurance policies for the benefit of such Indemnified Party (including any title policies) and any cash payments, setoffs or recoupment of any payments actually recovered by such Indemnified Party in respect of such Losses. Each Indemnified Party shall use commercially reasonable efforts to mitigate losses for which such Indemnified Party is subject to indemnification under this Article X. If, after Indemnifying Party has made an indemnification payment to an Indemnified Party with respect to Losses in satisfaction of its obligations under this Article X, Indemnified Party actually recovers from any third parties amounts in respect of such Losses, Indemnified Party shall as promptly as practicable forward to Indemnifying Party such amounts, but not in excess of the indemnification payment received by Indemnified Party. For the avoidance of doubt, Transferor shall have no obligation to indemnify (whether under this Article or otherwise) both (i) Purchaser, or an assignee of Purchaser, and (ii) a Transferee with respect to any single Loss and shall not be required to pay duplicative damages, and, subject to Section 10.4(b), the OTA Indemnification Cap shall be the maximum aggregate liability for indemnification claims under the Purchase Agreement and Section 10.2(a) or 10.3(a) of this OTA and the Other Operations Transfer Agreements. In no event shall the Indemnified Parties receive duplicative Losses under such agreements.
(d)Transferee shall use its commercially reasonable efforts (for this purpose, being those efforts Transferee would otherwise use if it did not have an indemnity backstop provided by Seller and Transferor), at Sellers’ expense, to promptly collect from each applicable insurer, reimbursement arrangement, and other contractual source of recovery (collectively “Alternate Arrangements”) all Losses that are recoverable thereunder; provided, however, that nothing in this Section 10.4(d) shall limit the remedies available to any Party hereto for any breaches of Fundamental Representations or for Fraud, in either case in connection with the transactions contemplated hereby. In the event that an Indemnifying Party makes any payment to any Indemnified Party for indemnification for which such Indemnified Party could have collected under an Alternate Arrangement, the Indemnifying Party will be entitled to pursue claims and conduct litigation on behalf of such Indemnified Party and any of its successors, to pursue and collect on any indemnification or other remedy available to such Indemnified Party thereunder with respect to such claim and generally to be subrogated to the rights of such Indemnified Party and such Indemnified Party shall take such actions and execute such documents as are reasonably necessary to vest such subrogation right in the applicable Indemnifying Parties. Except pursuant to a settlement agreed to by the Indemnifying Party, the Indemnified Party will not waive or release any contractual right to recover from an Alternate Arrangement any Loss subject to indemnification hereby without the prior written consent of the Indemnifying Party not to be unreasonably withheld, conditioned or delayed. The Indemnified Party will, and will cause its Affiliates (including the Affiliates of the Indemnified Party) to, cooperate with the Indemnifying Party, at the Indemnifying Party’s expense, with respect to any such effort to pursue and collect with respect thereto.
43


(e)The amount of any and all indemnifiable Losses hereunder shall be determined net of any amounts actually received by any Indemnified Party under or pursuant to any Alternate Arrangements (net of any costs incurred in connection with the collection thereof, including deductibles and increase in premiums resulting therefrom, and net of any subrogation rights related thereto). In any case where an Indemnified Person recovers under any Alternative Arrangement, any amount in respect of a matter for which such Indemnified Party was indemnified pursuant to hereto, such Indemnified Party will promptly pay over to the Indemnifying Party an amount equal to the lesser of (A) the actual amount received under such Alternative Arrangements, net of any Taxes payable in respect thereof and any costs incurred in connection with the collection thereof, including deductibles and subrogation rights, and (B) the actual amount of the indemnification payment previously paid by or on behalf of the Indemnifying Party with respect to such Losses.
(f)Seller and Transferor shall not be required to indemnify any Indemnified Party and Transferee shall not be required to indemnify any Indemnified Party to the extent of any Losses that a court of competent jurisdiction shall have determined by final judgment to have resulted from the bad faith, gross negligence or willful misconduct of the Person seeking indemnification or its Affiliate.
(g)Transferor shall take and shall cause its Affiliates to take all reasonable steps to mitigate any Loss upon becoming aware of any event which would reasonably be expected to, or does, give rise thereto. Transferee shall take and cause its Affiliates to take all reasonable steps to mitigate any Loss upon becoming aware of any event which would reasonably be expected to, or does, give rise thereto.
(h)Any indemnification payments made pursuant to this OTA shall be treated as an adjustment to the allocated Purchase Price for the Facility as set forth and in accordance with the Purchase Agreement (as determined for U.S. federal income tax purposes).
10.5Assumption of Defense. An Indemnified Party shall promptly give notice (each, a “Notice of Indemnification”) to each Indemnifying Party after obtaining knowledge of any matter as to which recovery may be sought against such Indemnifying Party because of the indemnity set forth above and, if such indemnity shall arise from the claim of a third party and Indemnifying Party provides written notice to Indemnified Party stating that Indemnifying Party is responsible for the entire claim within ten (10) days after Indemnifying Party’s receipt of the applicable Notice of Indemnification, shall permit such Indemnifying Party to assume the defense of any such claim or any proceeding resulting from such claim; provided, however, that failure to give any such Notice of Indemnification promptly shall not affect the indemnification provided under this Article X, except and only to the extent such Indemnifying Party shall have been actually prejudiced as a result of such failure or if such Notice of Indemnification is not given to Indemnifying Party prior the applicable Expiration Date. If an Indemnifying Party assumes the defense of such third party claim, such Indemnifying Party shall have full and complete control over the conduct of such proceeding on behalf of Indemnified Party and shall, subject to the provisions of this Section 10.5, have the right to decide all matters of procedure, strategy, substance and settlement relating to such proceeding; provided, further, however, that any counsel chosen by such Indemnifying Party to conduct such defense shall be reasonably satisfactory to Indemnified Party; and provided, further, however, that Indemnifying Party shall not without the written consent of Indemnified Party consent to the entry of any judgment or enter into any settlement with respect to the matter which (a) does not include a provision whereby the plaintiff or the claimant in the matter releases Indemnified Party from all liability with respect thereto; (b) in the case of Transferee as Indemnifying Party, does not include any provision that would impose any obligation (including an obligation to refrain from taking action) upon Seller; (c) does not impose an injunction or other equitable relief upon the Indemnified Party; and (d) does not result in or include a finding or admission of a violation of Law by the indemnified party. Indemnified Party may participate in such proceeding and retain separate co-counsel at its sole cost and expense (and, for the avoidance of doubt, such cost and expense shall not constitute a Loss for purposes of the Indemnification Obligations).
44


10.6Non-Assumption of Defense. If no Indemnifying Party is permitted or elects to assume the defense of any such claim by a third party or proceeding resulting therefrom, Indemnified Party shall diligently defend against such claim or litigation in such manner as it may deem appropriate and, in such event, Indemnifying Party or Parties shall reimburse Indemnified Party for all reasonable and actually incurred out-of-pocket costs and expenses, legal or otherwise, incurred by Indemnified Party and its Affiliates in connection with the defense against such claim or proceeding, within thirty (30) days after the receipt of detailed invoices.
10.7Indemnified Party’s Cooperation as to Proceedings. Indemnified Party will cooperate in all reasonable respects with any Indemnifying Party in the conduct of any proceeding as to which such Indemnifying Party assumes the defense, except to the extent Indemnified Party could reasonably be expected to be prejudiced thereby. Indemnifying Party or Parties shall promptly reimburse Indemnified Party for all reasonable out-of-pocket costs and expenses, legal or otherwise, incurred by Indemnified Party or its Affiliates in connection therewith, within thirty (30) days after the receipt of detailed invoices therefor.
10.8Indemnification for Resident Trust Property.
(a)Seller and Transferor will jointly and severally indemnify, protect, defend and hold Transferee harmless for, from and against all liabilities, claims and demands, including reasonable attorneys’ fees and costs, in the event the corpus of the Resident Trust Property transferred to Transferee does not represent the correct balance of Resident Trust Property delivered to Transferor as custodian, and for claims which arise from actions or omissions of Transferor with respect to the Resident Trust Property held or handled by Transferor at any time.
(b)Transferee will indemnify, protect, defend and hold Transferor harmless for, from and against all liabilities, claims and demands, including reasonable attorneys’ fees and costs, in the event a claim is made against Transferor by a resident or his or her family for his/her Resident Trust Property where such Resident’s funds or other property were properly transferred to Transferee pursuant to the terms hereof.
10.9Damages Disclaimed. EXCEPT AS SUCH MAY BE PART OF ANY CLAIM OF ANY THIRD PARTY THAT IS NOT A TRANSFEREE INDEMNIFIED PARTY OR A PURCHASER INDEMNIFIED PARTY (AS DEFINED IN THE PURCHASE AGREEMENT), UNDER NO CIRCUMSTANCES (WHETHER UNDER THIS ARTICLE OR OTHERWISE) SHALL ANY PARTY BE RESPONSIBLE OR LIABLE IN ANY WAY HEREUNDER FOR LOSS OF PROFITS, INCIDENTAL, CONSEQUENTIAL, SPECIAL OR PUNITIVE DAMAGES, DIMINUTION IN VALUE, OR ANY EXEMPLARY DAMAGES, REGARDLESS OF WHETHER THE ACTION IS FOUNDED IN CONTRACT, TORT, STATUTORY OR OTHERWISE.
10.10Individual Liability Disclaimed. For the avoidance of doubt, except in the event of Fraud, no individual officer, director, member, managing member, shareholder, equity holder, partner, employee, agent, or representative of either Party shall have any liability for any claims of the other Party related to this OTA, or any agreements, certificates or instruments delivered in connection herewith, in any way.
45


10.11Exclusive Remedy Post-Closing. With the exception of Fraud and injunctive relief for specific performance or an action required to be performed by a Party under this OTA after the Closing, the exclusive remedy of any Party after the Closing shall be indemnity under this Article X, regardless of the legal theory under which such liability or obligation may be sought to be imposed, whether sounding in contract or tort, or whether at Law or in equity, or otherwise, shall be as provided in this Article X. The Indemnified Parties may not avoid the limitations on liability herein by seeking damages for breach of contract, tort, or pursuant to any other theory of liability, all of which are hereby waived. Notwithstanding the foregoing, upon prior written notice to Transferor Representative, Transferee may assign all, but not less than all, of its rights, duties and obligations under this OTA to a wholly owned subsidiary of Transferee or Purchaser, provided that no such assignment shall relieve Transferee or Transferee Guarantor from their obligations under this OTA.
10.12Application of Escrow Funds. At the Closing, Seller, Transferor, the Title Company and Transferee shall create a post-Closing indemnification escrow account pursuant to the terms of an Escrow Agreement to be entered into by Seller, Transferor, Transferee, the Affiliates of Transferee party to the Other Operations Transfer Agreement and the Title Company in the form attached hereto as Exhibit C (or such other form mutually acceptable to the parties thereto) (the “Indemnity Escrow Agreement”). At each Closing, Seller shall deposit with the Title Company the Escrow Funds to be held pursuant to the Indemnity Escrow Agreement. The Escrow Funds will be used, if necessary, to satisfy any Losses as a result of indemnification claims payable to any Transferee Indemnified Party under Article X of this OTA and will be held and disbursed in accordance with the provisions of this OTA and the Indemnity Escrow Agreement. The Indemnity Escrow Agreement shall provide for the release to Seller of any Escrow Funds not subject to pending indemnification claims in three equal installments - thirty-three percent (33%) of the Escrow Funds less any amounts already released by Title Company to Transferee in satisfaction of indemnification claims on each of the one-year and two-year anniversary of the Closing Date and the balance on the three-year anniversary of the Closing Date. Any payment Transferor is obligated to make to any Transferee Indemnified Party pursuant to Article X of this OTA or the Other Operations Transfer Agreements, shall be paid first, to the extent there are sufficient Escrow Funds, by release of Escrow Funds to the Indemnified Parties, as applicable, by the Title Company in accordance with the terms of the Escrow Agreement, and shall accordingly reduce the Escrow Funds and, second, to the extent the Escrow Funds are insufficient to pay any remaining sums due, then Seller shall promptly pay all of such additional sums due and owing to Indemnified Parties in cash by wire transfer of immediately available funds.
10.13Non-Recourse Parties. With the exception of Fraud, all claims or causes of action (whether in contract or in tort, in Law or in equity) that may be based upon, arise out of or relate to this OTA or the other Transaction Documents, or the negotiation, execution or performance of this OTA or the other Transaction Documents (including any representation or warranty made in or in connection with this OTA or the other Transaction Documents or as an inducement to enter into this OTA or the other Transaction Documents), may be made only against the entities that are expressly identified as parties hereto and thereto. (i) No Person who is not a named party to this OTA or the other Transaction Documents, and (ii) no past, present or future director, officer, employee, incorporator, member, partner, equityholder, shareholder, manager, advisor, Affiliate, agent, attorney or representative of the Seller, the Purchaser or of any named party to this OTA or the other Transaction Documents, together with any past, present or future director, officer, employee, incorporator, member, partner, equityholder, shareholder, manager, advisor, Affiliate, agent, attorney or representative thereof (collectively, “Non-Party Affiliates”), shall have any liability (whether in contract or in tort, in Law or in equity, or based upon any theory that seeks to impose liability of an entity party against its owners or Affiliates) for any liabilities arising under, in connection with or related to this OTA, such other Transaction Document or the transactions contemplated by this OTA or for any claim based on, in respect of, or by reason of this OTA, such other Transaction Document or the transactions contemplated by this OTA or the negotiation or execution hereof or thereof; and each party waives and releases all such liabilities and claims against any such Non-Party Affiliates. If any Person who is a party hereto would constitute an Non-Party Affiliate but for such Person’s being a party hereto, such Person’s liability shall be limited to any liability such Person may have in their capacity as a party hereto, and such person shall have no liability in any capacity which would have made such Person an Non-Party Affiliate but for such Person’s being a party hereto.
46


10.14Transferor Guarantors. In the event that as of the Closing of the Facility pursuant to the Purchase Agreement there exists an Execution Date R&W Breach, at such Closing, Transferor shall cause AmPharm, Inc., a Tennessee corporation to deliver a guaranty in the form attached hereto as Exhibit E (the “Execution Date R&W Guaranty”) which shall secure the Transferor’s indemnity obligations relating to any Execution Date R&W Breach.
10.15Interim Indemnity Guaranty.
(a)Subject to the terms and conditions of the Interim Indemnity Guaranty (as defined in subsection (b) below), in the event that the Facility is subject to an Interim Document following the IMA Closing Date, then Transferor or its successors and assigns, as applicable, shall indemnify and hold harmless the Transferee Indemnified Parties from and against (collectively, the “Interim Indemnity”):
(i)any and all reasonable out-of-pocket costs necessary to cure any survey deficiencies identified by Governmental Authorities at such Facility in the course of inspections of such Facility conducted by such Governmental Authorities for purposes of enabling the parties to satisfy the Licensure Condition; provided, however, Transferor and Seller shall have no liability to Purchaser, Transferee or any Purchaser Indemnified Party or Transferee Indemnified Party with respect to deficiencies first arising from the actions or inactions of Purchaser, a Purchaser Indemnified Party, Transferee or a Transferee Indemnified Party with respect to such Facility from and after the Closing Date under the Purchase Agreement; and
(ii)any recoupment made against any Transferee Indemnified Party’s Medicaid receivables generated during the Interim Period to the extent that such recoupment relates to the period prior to the Interim Period during which Seller owned or operated the applicable Facility.
(b)In the event that the Facility is subject to an Interim Document following a Closing under the Purchase Agreement, at the applicable Closing under the Purchase Agreement, Transferor shall cause AmPharm Inc., a Tennessee corporation, to deliver a guaranty in the form attached hereto as Exhibit F (the “Interim Indemnity Guaranty”), which shall secure the Transferor’s Interim Indemnity obligation.
Article XI
ASSIGNMENT
11.1Assignment. Neither this OTA, nor any rights, interests or obligations hereunder, may be assigned or transferred, in whole or in part, by operation of law or otherwise by Transferor or Transferee without the prior written consent of the other Party which shall not be unreasonably withheld, conditioned or delayed, and any such assignment that is not consented to shall be null and void.
Article XII
MISCELLANEOUS
47


12.1Disclosure Schedules. The information contained in the Schedules shall be deemed to qualify to the specific Section (or subsection, as appropriate) of this OTA to which it corresponds, and shall be cumulative so that if the existence of the fact or item or its contents disclosed in any particular schedule is relevant to any other schedule, then such fact or item shall be deemed to be disclosed with respect to the other schedule to the extent such relevance is reasonably apparent whether or not a specific cross-reference appears. The headings contained in the Schedules are included for convenience only and are not intended to limit the effect of the disclosures contained in such schedule or to expand the scope of the information required to be disclosed in such schedule. Descriptions of documents in the Schedules are summaries only and are qualified in their entirety by the specific terms of such documents. Matters reflected in the Schedules are not necessarily limited to matters required by this OTA to be reflected herein; additional matters are set forth for informational purposes and the fact that any item of information is disclosed in the Schedules shall not be construed to mean that such information is required to be disclosed by this OTA. Any information and the dollar thresholds set forth herein shall not be used as a basis for interpreting the term “material” or other similar terms in this OTA or constitute an admission that such items are required to be disclosed under this OTA.
12.2Payment of Expenses. Except as otherwise provided in this OTA, each of the Parties shall bear its own expenses in connection with the negotiation and the consummation of the transactions contemplated by this OTA. Subject to the foregoing, no expenses of Transferor relating in any way to the purchase and sale of the Assets hereunder and the transactions contemplated hereby, including legal, accounting or other professional expenses of Transferor shall be charged to or paid by Transferee or included in any of the Assumed Liabilities. No expenses of Transferee relating in any way to the purchase and sale of the Assets hereunder and the transactions contemplated hereby, including legal, accounting or other professional expenses of Transferee shall be charged to or paid by any Transferor or included in any of the Excluded Liabilities. The foregoing shall not limit, however, any Party’s right to include such expenses in any claim for damages against any other Party who breaches any legally binding provision of this OTA to the extent provided in this OTA.
12.3Entire Agreement; Assignment; Etc.. This OTA (including the Schedules and all other schedules and exhibits hereto which are incorporated into and are a part of this OTA), the Other Operations Transfer Agreements, together with the Purchase Agreement, and with any certificates and other instruments delivered hereunder, state the entire agreement of the Parties, merge all prior negotiations, agreements and understandings, if any, whether written or oral, and state in full all representations, warranties, covenants and agreements that have induced this OTA. Each Party agrees that in dealing with third parties no contrary representations will be made. This OTA shall not be assignable by operation of Law or otherwise. The Parties acknowledge that Purchaser is a third party beneficiary of this OTA to the extent provided below.
12.4Captions. The Article, Section and paragraph captions in this OTA are for convenience of reference only, do not constitute part of this OTA and shall not be deemed to limit or otherwise affect any of the provisions hereof.
12.5Severability. The invalidity or unenforceability of any provision of this OTA shall not affect the validity or enforceability of any other provision of this OTA.
12.6Enforcement.
(a)The Parties agree that irreparable damage would occur in the event that any of the provisions of this OTA were not performed in accordance with their specific terms or were otherwise breached and that any breach of this OTA could not be adequately compensated in all cases by monetary damages alone. The Parties acknowledge and agree that, prior to the valid termination of this OTA pursuant to Section 9.1, the Parties shall be entitled to an injunction, specific performance and other equitable relief to prevent breaches of this OTA and to enforce specifically the terms and provisions hereof, in addition to any other remedy to which they are entitled at Law or in equity, but in all events subject to the limitations set forth in this OTA.
48


(b)Nothing set forth in this Section 12.6 shall require Transferor to institute any proceeding for (or limit Transferor’s right to institute any proceeding for) specific performance under this Section 12.6 prior or as a condition to exercising any termination right under Section 9.1, nor shall the commencement of any legal proceeding pursuant to this Section 12.6 or anything set forth in this Section 12.6 restrict or limit Transferor’s right to terminate this OTA in accordance with the terms of Section 9.1 or pursue any other remedies under this OTA.
(c)To the extent any Party brings any Action to enforce specifically the performance of the terms and provisions of this OTA (other than an Action to specifically enforce any provision that expressly survives termination of this OTA pursuant to Section 9.1) when expressly available to such Party pursuant to the terms of this OTA, each Termination Date shall automatically be extended by (i) the amount of time during which such Action is pending, plus twenty (20) Business Days, or (ii) such other time period established by the court presiding over such Action.
12.7Modification or Amendment. The Parties may modify or amend this OTA at any time, only by a written instrument duly executed and delivered by Transferee and Transferor. Notwithstanding the foregoing, prior to the Closing, the Parties may not amend, modify or terminate this OTA without the prior written consent of Purchaser.
12.8Construction of Agreement. If an ambiguity or question of intent or interpretation arises under this OTA, this OTA shall be construed as if drafted jointly by the Parties, and no presumption or burden of proof shall arise favoring or disfavoring any Party by virtue of the authorship of any of the provisions of this OTA.
12.9Notices. All notices and other communications given or made pursuant hereto shall be in writing and shall be deemed to have been duly given or made as of the date delivered if delivered personally or by a nationally-recognized overnight courier service to the Parties at the following addresses (or at such other address for a Party as shall be specified by like notice, except that notices of changes of address shall be effective upon receipt):
If to Transferor, addressed to:
c/o American Health Companies, LLC
201 Jordan Road, Suite 200
Franklin, TN 37067
Attn: Philip Clark, General Counsel
With a copy to (which shall not constitute notice):
Foley & Lardner LLP
301 E. Pine Street, Suite 1200
Orlando, Florida 32801
Attn: Matthew E. Jassak, Esq.
If to Transferee, addressed to:
49


With a copy to (which shall not constitute notice):
or to such other address or to such other Person as either Party shall have last designated by such notice to the other Party.
12.10Remedies Cumulative. Except as otherwise provided herein, the remedies provided for or permitted by this OTA shall be cumulative and the exercise by any Party of any remedy provided for herein shall not preclude the assertion or exercise by such Party of any other right or remedy provided for herein.
12.11Governing Law; Consent to Jurisdiction. This OTA shall be governed by and construed in accordance with the domestic Laws of the State of Tennessee without giving effect to any choice or conflict of law provision or rule (whether of the State of Tennessee or any other jurisdiction) that would cause the application of the Laws of any jurisdiction other than the State of Tennessee.
12.12Forum; Waiver of Jury Trial.
(a)With respect to any Action between any of the Parties arising out of or relating to this OTA, or any of the transactions contemplated by this OTA, (i) each of the Parties irrevocably and unconditionally consents and submits to the exclusive jurisdiction and venue of either the state or federal courts located in the State of Tennessee, and (ii) each of the Parties irrevocably consents to service of process by first-class certified mail, return receipt requested, postage prepaid.
(b)Each of the Parties hereby irrevocably waives any and all right to trial by jury of any claim or cause of action in any legal proceeding arising out of or related to this OTA or the transactions or events contemplated hereby or any course of conduct, course of dealing, statements (whether verbal or written) or actions of any Party. The Parties each agree that any and all such claims and causes of action shall be tried by the court without a jury. Each of the Parties hereto further waives any right to seek to consolidate any such legal proceeding in which a jury trial has been waived with any other legal proceeding in which a jury trial cannot or has not been waived.
12.13Time of Essence. With regard to all dates and time periods set forth or referred to in this OTA, time is of the essence unless such delay is caused by factors outside the control of the Party in which case a reasonable delay shall be granted to the requesting Party.
12.14Counterparts. This OTA may be executed in the original or by facsimile or electronic .pdf in any number of counterparts, each of which shall be deemed to be an original and all of which together shall constitute one and the same instrument. The exchange of copies of this OTA and of signature pages by facsimile transmission or e-mail shall constitute effective execution and delivery of this OTA as to the Parties and may be used in lieu of the original OTA for all purposes. Signatures of the Parties transmitted by facsimile or e-mail shall be deemed to be their original signatures for all purposes.
12.15Representation Waiver. Each of the Parties hereto acknowledges and agrees, on its own behalf and on behalf of its members, partners, officers, employees and Affiliates, that Transferor is a client of Foley & Lardner LLP and Bradley Arant Boult Cummings LLP (collectively, the “Firms”) in the preparation, negotiation and execution of this OTA and the other Transaction Documents. After the Closing, it is possible that the Firms will represent Transferor and/or its Affiliates in the future in connection with issues that may arise under this OTA and the other Transaction Documents or any claims that may be made thereunder. Each of the Firms (or any successor) may serve as counsel to Transferor and/or its Affiliates or any member, partner, manager, officer, employee, representative or Affiliate of such Persons in connection with any claim arising out of or relating to this OTA or the other Transaction Documents. Each of the Parties hereto consents thereto, and waives any conflict of interest arising therefrom, and each such Party shall cause any Affiliate thereof to consent to waive any conflict of interest arising from such representation. Each of the Parties hereto acknowledges that such consent and waiver is voluntary, that it has been carefully considered, and that the Parties have consulted with counsel or have been advised they should do so in connection therewith.
50


12.16Third-Party Beneficiary. Purchaser shall be a third-party beneficiary of the representations and warranties of Transferor under Article IV and the indemnification provisions of Article X; provided, however, that Transferor shall have no obligation to indemnify (whether under this Article or otherwise) both (a) Purchaser, or an assignee of Purchaser other than Transferee, and (b) any Transferee with respect to any single Loss.
12.17Transferor Representative.
(a)Transferor hereby irrevocably constitutes and appoints Seller as its representative (“Transferor Representative”) and its true and lawful attorney-in-fact, with full power and authority in each of their names and on behalf of each of them to act on behalf of Transferor in the absolute discretion of Transferor Representative for purposes of this OTA, the Purchase Agreement and the transactions to be carried out pursuant hereto and thereto, and the execution of this OTA, by Transferor will constitute ratification and approval of such designation on the terms set forth herein. All decisions, actions, consents and instructions by Transferor Representative with respect to this OTA will be binding upon Transferor, and Transferor will not have the right to object to, dissent from, protest or otherwise contest the same. Transferee will be entitled to rely on any decision, action, consent or instruction of Transferor Representative as being the decision, action, consent or instruction of Transferor. By way of example and not limitation, Transferor Representative will be authorized and empowered, as agent of and on behalf of Transferor to (i) execute and deliver and take all actions under the OTA on behalf of Transferor; (ii) give and receive notices and communications as provided herein; (iii) object to any claims of an Indemnified Party; (iv) agree to, negotiate, enter into settlements and compromises of, and comply with orders of courts and awards of arbitrators with respect to, such claims or Losses; (v) waive after the Closing Date any breach or default of Transferee of any obligation to be performed by it under this OTA; (vi) receive service of process on behalf of Transferor in connection with any claims against Transferor arising under or in connection with this OTA; and (vii) take all other actions that are either (A) necessary or appropriate in the judgment of Transferor Representative for the accomplishment of the foregoing, or (B) specifically mandated by the terms of this OTA. Notices or communications to or from Transferor Representative will constitute notice to or from Transferor.
(b)The grant of authority provided for in this Section 12.17 is coupled with an interest and is being granted, in part, as an inducement to Transferee to enter into this OTA, and will be irrevocable and survive the dissolution, liquidation or bankruptcy of any Transferor, and will be binding on any successor thereto.
12.18Attorney-Client Privilege. Neither of Transferor or Transferee is waiving, and each will not be deemed to have waived or diminished, any of its attorney work product protections, attorney-client privileges or similar protections and privileges as a result of disclosing its Confidential Information (including Confidential Information related to pending or threatened litigation) to the others, regardless of whether such Party has asserted, or is or may be entitled to assert, such privileges and protections. The Parties (a) share a common legal and commercial interest in all of the Confidential Information that is subject to such privileges and protections; (b) are or may become joint defendants in proceedings to which such Party’s Confidential Information covered by such protections and privileges relates; (c) intend that such privileges and protections remain intact should any Party become subject to any actual or threatened proceeding to which the Confidential Information covered by such protections and privileges relates; and (d) intend that after the Closing the Proprietary Party whose Confidential Information is at issue shall have the right to assert such protections and privileges. No Party shall admit, claim or contend, in proceedings involving any Party or otherwise, that any Party waived any of its attorney work-product protections, attorney-client privileges or similar protections and privileges with respect to any information, documents or other material not disclosed to a Party due to any Party disclosing its Confidential Information (including Confidential Information related to pending or threatened litigation) to another Party.
51


12.19Guaranty; Obligations of Transferee Guarantor. Transferee Guarantor unconditionally guarantees the full and prompt payment and performance of all of Transferee’s obligations to Transferor, Seller, and Transferor Indemnified Parties in accordance with this OTA or any other agreement between Transferor and Transferee arising in connection with the Transaction. The liability of Transferee Guarantor under this Section 12.19 will in no way be affected or impaired by any failure or delay by Transferor in enforcing payment of any amount required under this OTA, in enforcing the performance of any obligations under this OTA, in enforcing payment under this Section 12.19, or in exercising any right or power in respect thereto, or to any compromise, waiver, settlement, change, subordination, modification, or disposition of any payments due under this OTA or any performance required under this OTA or any of the other Transaction Documents, and Transferee Guarantor hereby waives all defenses of suretyship. The amendment or modification of this OTA will not affect Transferee Guarantor’s liability under this Section 12.19, unless such Transferee Guarantor’s liability is amended or modified in a writing signed by the Parties.
12.20Guaranty; Obligations of Seller. Seller unconditionally guarantees the full and prompt payment and performance of all of Transferor’s obligations to Transferee, Transferee Guarantor, and Transferee Indemnified Parties in accordance with this OTA or any other agreement between Transferor and Transferee arising in connection with the Transaction. The liability of Seller under this Section 12.20 will in no way be affected or impaired by any failure or delay by Transferee in enforcing payment of any amount required under this OTA, in enforcing the performance of any obligations under this OTA, in enforcing payment under this Section 12.20, or in exercising any right or power in respect thereto, or to any compromise, waiver, settlement, change, subordination, modification, or disposition of any payments due under this OTA or any performance required under this OTA or any of the other Transaction Documents, and Seller hereby waives all defenses of suretyship. The amendment or modification of this OTA will not affect Seller’s liability under this Section 12.20, unless such Seller’s liability is amended or modified in a writing signed by the Parties.
[The Next Page is the Signature Page]

52


IN WITNESS WHEREOF, each of the undersigned in the capacity indicated below has executed this OTA as of the day and year first above written.
TRANSFEROR:
    LLC, a Tennessee limited
liability company
By:    
Name:    
Title: Authorized Signatory
SELLER:
    LLC, a
[Delaware/Tennessee] limited liability company
By:    
Name:    
Title: Authorized Signatory
TRANSFEREE:
    LLC, a    
limited liability company
By:    
Name:    
Title:    
TRANSFEREE GUARANTOR:
     LLC, a    
limited liability company
By:    
Name:    
Title:    

1


Exhibit A
Definitions
Definitions. In addition to the terms otherwise defined herein, the following terms shall have the following meaning:
“Accounts Receivable” has the meaning set forth in the Purchase Agreement.
“Action” has the meaning set forth in the Purchase Agreement.
“Affected Participants” has the meaning set forth in Section 2.5(m).
“Affiliate” has the meaning set forth in the Purchase Agreement.
“Affiliated-Service Transferee Employees” has the meaning set forth in Section 2.5(d).
“Aggregate Indemnification Threshold” has the meaning set forth in Section 10.4(a).
“Ancillary Permits and Approvals” has the meaning set forth in Section 2.2(a).
“Assets” has the meaning set forth in Section 2.1.
“Assignment and Assumption Agreement” has the meaning set forth in Section 3.2(b).
“Assumed Contracts” has the meaning set forth in Section 2.1(d).
“Assumed Liabilities” has the meaning set forth in Section 2.4(a).
“Bill of Sale” has the meaning set forth in Section 3.2(a).
“Bring Down Certificate” has the meaning set forth in Section 3.2(c).
“Broker” has the meaning set forth in Section 4.19.
“Business Days” has the meaning set forth in the Purchase Agreement.
“Business” means the business conducted by Transferor exclusively at or exclusively related to the Facility.
“Closing” has the meaning set forth in Section 3.1.
“Closing Date” has the meaning set forth in Section 3.1.
“CMS” means the Centers for Medicare and Medicare Services.
“COBRA” means the Consolidated Omnibus Budget Reconciliation Act of 1985 or similar state law.
1


“Code” has the meaning set forth in the Purchase Agreement.
“Compliance Violations” has the meaning set forth in Section 3.3(h).
“Confidential Information” has the meaning set forth in Section 6.5(b).
“Contracts” has the meaning set forth in Section 2.1(d).
“Corporate Contracts” has the meaning set forth in the Purchase Agreement.
“Cost Reports” means all cost reports exclusively related to the Facility filed by Transferor prior to the Execution Date pursuant to the requirements of any applicable Government Reimbursement Programs for cost-based payments or reimbursement due to or claimed by Transferor from any applicable Government Reimbursement Programs or their fiscal intermediaries or payor agents.
“Current Records” has the meaning set forth in Section 2.1(g).
“Data Room” has the meaning set forth in the Purchase Agreement.
“Deficiencies” has the meaning set forth in Section 3.3(g).
“Department” has the meaning set forth in Section 2.2(a).
“Disclosure Update” has the meaning set forth in Section 4.22.
“Escrow Facility” shall have the meaning set forth in the Purchase Agreement.
“Escrow Funds” shall mean the amount determined pursuant to Exhibit D, which shall be held by Escrow Agent pursuant to the terms of the Indemnity Escrow Agreement.
“Effective Time” has the meaning set forth in Section 3.1.
“Employee Benefit Plan” means any plan, program, agreement or policy for the benefit of any current or former employee, director, independent contractor, or owner (or any dependent or beneficiary thereof) that is (a) a welfare plan within the meaning of Section 3(1) of ERISA, (b) a pension plan within the meaning of Section 3(2) of ERISA, (c) a stock bonus, stock purchase, stock option, restricted stock, stock appreciation right or similar equity-based plan, or (d) any other compensation, deferred-compensation, retirement, welfare-benefit, bonus, incentive, retention, severance pay, sick leave, vacation pay, salary continuation, disability, dental, vision, medical, life insurance or fringe-benefit plan, program, agreement or policy.
“Encumbrance” has the meaning set forth in the Purchase Agreement.
“End Date” has the meaning set forth in the Purchase Agreement.
“Environmental Law” has the meaning set forth in the Purchase Agreement.
2


“ERISA” means the Employee Retirement Income Security Act of 1974, as amended.
“ERISA Affiliate” has the meaning set forth in Section 4.5(c).
“Excluded Assets” shall mean the Assets which are not being transferred to Transferee from Transferor as described in Section 2.7.
“Execution Date” has the meaning set forth in the Preamble.
“Expiration Date” has the meaning set forth in Section 10.1.
“Facility” has the meaning set forth in the Recitals.
“Facility Indemnification Threshold” has the meaning set forth in Section 10.4(a).
“Financial Statements” means the unaudited balance sheets and profit and loss statements relating to the operations of the Business for the 2024 fiscal year.
“Firms” has the meaning set forth in Section 12.15.
“Fraud” has the meaning set forth in the Purchase Agreement.
“Fundamental Representations” has the meaning set forth in Section 10.1.
“GAAP” means U.S. generally accepted accounting principles, as in effect on the Execution Date, consistently applied.
“Government Reimbursement Program” means the Medicare program, any relevant state Medicaid program and any other similar or successor federal, state or local health care payment programs with or sponsored by any Governmental Authority.
“Governmental Authority” or “Governmental Entity” means any federal, state, or local government or any court of competent jurisdiction, administrative agency or commission or other domestic governmental or quasi-governmental authority or instrumentality.
“Group Health Plan” has the meaning set forth in Section 2.5(m).
“Hazardous Substances” means any chemicals, materials, compounds or substances defined, regulated, listed or otherwise classified under any applicable Law as a “hazardous substance,” “extremely hazardous substance,” “hazardous material,” “hazardous waste,” “universal waste,” “mixed waste,” “bio-hazardous waste,” “medical waste,” “radioactive waste,” “pharmaceutical waste,” “commingled waste,” “mold,” “toxic substance,” “toxin,” “pollutant” or “contaminant,” including petroleum (including petroleum products, constituents, additives, or derivatives thereof), asbestos, asbestos-containing materials, and polychlorinated biphenyls.
“Healthcare Requirements” means the requirements of or with respect to Government Reimbursement Programs, Referral Laws, Patient Privacy Requirements, the False Claims Act, 31, U.S.C.
3


Section 3729 et seq. as amended, and 42 USC Section 1320a-7k(d), 42 U.S.C. 1320a-7a(a).
“HIPAA” means the Health Insurance Portability and Accountability Act of 1996.
“IMA Closing Date” has the meaning set forth in Section 7.3.
“Indemnification Obligation” means the indemnification obligations of an Indemnifying Party under this OTA.
“Indemnification Threshold” has the meaning set forth in Section 10.4(a).
“Indemnified Party” and “Indemnified Parties” means any Person entitled to indemnification under Article X of this OTA.
“Indemnifying Party” and “Indemnifying Parties” means any Person required to provide indemnification under Article X of this OTA.
“Intellectual Property” has the meaning set forth in the Purchase Agreement (excluding such intellectual property listed as an Excluded Asset).
“Interim Documents” has the meaning set forth in Section 7.3(a).
“Interim Management Agreement” has the meaning set forth in Section 7.3(a).
“Interim Management Period” has the meaning set forth in Section 7.3(a).
“Interim Sublease” has the meaning set forth in Section 7.3(a).
“Inventory” has the meaning set forth in Section 2.1(c).
“Knowledge” means, (i) when used with respect to Transferor, the actual awareness of a particular fact or matter upon due inquiry as of the Execution Date of any of the following: Michael Bailey - CEO AHP, Jeff Bogle - CFO AHP, Robin Bradley - COO AHP, Jason Bailey - SVP, Corporate Development AHP, Philip Clark - General Counsel AHP, Charlie Canon - AHC Controller, Greg Haynes - SVP, AHC Operations, in each case, after reasonable inquiry (provided that reasonable inquiry does not require any invasive or penetration testing) or, (ii) in the case of Transferee, the actual knowledge of any officer or director of Transferee of a particular fact or matter as of the Execution Date but without independent investigation. Transferee acknowledges that no individual named above shall have any liability under this OTA in connection with the transactions contemplated hereby and shall not be named individually in any suit, demand or proceeding relating to this OTA or the transactions contemplated hereby.
“Law” means any statute, law, rule or regulation or ordinance of any Governmental Authority.
“Loss” or “Losses” has the meaning set forth in the Purchase Agreement.
4


“LSC” has the meaning set forth in Section 3.3(g).
“Manager” has the meaning set forth in the Recitals.
“Medicaid Agreement” shall have the meaning set forth in Section 2.2(b)(ii).
“Material Adverse Effect” shall have the meaning set forth in the Purchase Agreement.
“Medicare Agreement” shall have the meaning set forth in Section 2.2(b)(i).
“New License” shall have the meaning set forth in Section 2.2(a).
“Non-Competition Covenant” has the meaning set forth in Section 6.3.
“Non-Party Affiliates” has the meaning set forth in Section 10.13.
“Non-Solicitation Covenant” has the meaning set forth in Section 6.3.
“Notice of Indemnification” has the meaning set forth in Section 10.5.
“Open Deficiency” has the meaning set forth in Section 2.4(b).
“Order” has the meaning set forth in the Purchase Agreement.
“Ordinary Course” has the meaning set forth in the Purchase Agreement.
“OTA” has the meaning set forth in the Preamble.
“OTA Indemnification Cap” shall mean an aggregate escrow amount applicable to the Facility and the other Facilities subject to the Other Operations Transfer Agreements, as determined in accordance with Exhibit D.
“Other Operations Transfer Agreements” means those certain Operations Transfer Agreements dated the same date hereof, by and between the Affiliates of Transferor and the Affiliates of Transferee for the purposes of transferring the operations of the Facilities set forth on Exhibit B.
“Overhead and Shared Services” means ancillary corporate or shared services provided to or in support of any Facility that are general corporate, overhead or other services or provided to both (a) the Facility, and (b) any other business or facility of Seller and its Affiliates that is not a Facility including, without limitation, access to hardware and software related to financial and clinical operations, use of intellectual property, travel and entertainment services, temporary labor services, purchasing and supply services, personal telecommunications services, computer hardware and software services, energy/utilities services, treasury services, public relations, legal and risk management services (including workers’ compensation), payroll services, sales and marketing support services, information technology and telecommunications services, accounting services, tax services, internal audit services, executive management services, investor relations services, human resources and employee relations management services, employee benefits services, credit, collections and accounts payable services, logistics services, property management services, environmental support services, training, federal and state reimbursement services, state licensing and Medicare and Medicaid certification and maintenance support, in each case including services relating to the provision of access to information, operating and reporting systems and databases and all hardware and software or other intellectual property used in connection therewith.
5


“Party” and “Parties” have the meaning set forth in the Preamble.
“Patient Privacy Requirements” means the applicable requirements of the Administrative Simplification Provisions of the Health Insurance Portability and Accountability Act of 1996 as amended by the American Recovery and Reinvestment Act of 2009 and the implementing regulations thereunder governing the privacy of individually identifiable health information and the security of such information maintained in electronic form or of any similar state Laws.
“PCA” means the Property Condition Assessment prepared by Bureau Veritas with respect to the Facility.
“Pending Medicaid Applicants” has the meaning set forth in Section 6.10(e).
“Permits” has the meaning set forth in Section 2.1(h).
“Permitted Encumbrance” has the meaning set forth in the Purchase Agreement.
“Person” means an individual, partnership, venture, unincorporated association, organization, syndicate, corporation, limited liability company, or other entity, trust, trustee, executor, administrator or other legal or personal representative or any government or any agency or political subdivision thereof.
“Plan” has the meaning set forth in Section 4.5(a).
“Pre-Closing R&W Breach” has the meaning set forth in Section 6.17.
“Pre-Closing R&W Breach Notice” has the meaning set forth in Section 6.17.
“Public Announcement” has the meaning set forth in Section 6.5(a).
“Purchase Agreement” has the meaning set forth in the Recitals.
“Purchaser” has the meaning set forth in the Recitals.
“Qualified Plan” has the meaning set forth in Section 4.5(b).
“Referral Laws” means Section 1128B(b) of the Social Security Act, as amended, 42 USC Section 1320a 7(b) (Criminal Penalties Involving Medicare or State Health Care Programs), commonly referred to as the “Federal Anti-Kickback Statute,” Section 1877 of the Social Security Act, as amended, 42 USC Section 1395nn and related regulations (Prohibition Against Certain Referrals), commonly referred to as “Stark Law,” 42 USC Section 1320a-7a(a)(5).
6


“Regulatory Approvals” shall have the meaning set forth in Section 2.2(a).
“Resident” means a resident of the Facilities.
“Resident Trust Funds” has the meaning set forth in Section 2.1(j).
“Restricted Party” has the meaning set forth in Section 6.3.
“Retained Liabilities” has the meaning set forth in Section 2.4(b).
“Seller” has the meaning set forth in the Purchase Agreement.
“Tax” and “Taxes” have the meaning set forth in the Purchase Agreement.
“Termination Date” has the meaning set forth in the Purchase Agreement.
“Transaction Documents” has the meaning set forth in the Purchase Agreement.
“Transferee” has the meaning set forth in the Preamble.
“Transferee Employees” has the meaning set forth in Section 2.5(b).
“Transferee Guarantor” has the meaning set forth in the Preamble.
“Transferee Indemnified Parties” has the meaning set forth in Section 10.2.
“Transferee Plan” has the meaning set forth in Section 2.5(m).
“Transferor” has the meaning set forth in the Preamble.
“Transferor Bad Debt” has the meaning set forth in Section 6.11(b).
“Transferor Confidential Information” has the meaning set forth in Section 6.5(c).
“Transferor Indemnified Parties” has the meaning set forth in Section 10.3.
“Transferor Representative” has the meaning set forth in Section 12.17(a).
“Transition Period” has the meaning set forth in Section 2.2(b)(iii).
“WARN Act” means the Worker Adjustment and Retraining Notification Act of 1988, as amended.
For the Facilities with VA Contracts:
7


“[Novation / VCA Replacement]” has the meaning set forth in Section 2.2(c).
“VA” has the meaning set forth in Section 2.2(c).
“VA Contract” has the meaning set forth in Section 2.2(c).
“VA Subcontract” has the meaning set forth in Section 2.2(c).

8


Exhibit B
Other Facilities
[NTD: to only include Facilities applicable to each Operator]
Facility Address City State Zip Operator
Crestview 704 Dupree Road Brownsville TN 38012 PACS
McKenzie 175 Hospital Drive Mc Kenzie TN 38201 PACS
Clarksville 900 Professional Park Drive Clarksville TN 37040 PACS
Natchez Trace (Lewis) 119 Kittrell Street Hohenwald TN 38462 PACS
Bethesda 444 One Eleven Place Cookeville TN 38501 PACS
Cumberland 4343 Ashland City Highway Nashville TN 37218 PACS
Lexington 727 East Church Street Lexington TN 38351 PACS
McNairy 835 East Poplar Avenue Selmer TN 38375 PACS
Mt. Juliet 2650 North Mt Juliet Road Mount Juliet TN 37122 PACS
Northside 202 East Mtcs Road Murfreesboro TN 37130 PACS
Vanco 813 S Dickerson Rd Goodlettsville TN 37072 PACS
Waverly 895 Powers Blvd Waverly TN 37185 PACS
Facility Address City State Zip Operator
Applingwood 1536 Appling Care Lane Cordova TN 38018 Links
Bright Glade 5070 Sanderlin Avenue Memphis TN 38117 Links
Covington Care 765 Bert Johnston Avenue Covington TN 38019 Links
Forest Cove 45 Forest Cove Jackson TN 38301 Links
Northbrooke 121 Physicians Dr Jackson TN 38305 Links
WTTC 597 West Forest Avenue Jackson TN 38301 Links
Harborview 1513 N 2nd Street Memphis TN 38107 Links
Facility Address City State Zip Operator
Millenium 5275 Millennium Drive Huntsville AL 35806 Ensign
VanAyer 460 Hannings Lane Martin TN 38237 Ensign
Decatur 726 Kentucky Avenue S Parsons TN 38363 Ensign
Meadowbrook 1245 E College St Pulaski TN 38478 Ensign
Savannah 1645 Florence Rd Savannah TN 38372 Ensign
1


Westwood 524 West Main Street Decaturville TN 38329 Ensign
Knoxville 7424 Middlebrook Pike Knoxville TN 37909 Ensign
WellPark 7512 Middlebrook Pike Knoxville TN 37909 Ensign
Union City 1630 E. Reelfoot Ave Union City TN 38261 Ensign
Facility Address City State Zip Operator
Dyersburg 1900 Parr Avenue Dyersburg TN 38024 Champion
Humboldt 2031 Avondale Street Humboldt TN 38343 Champion
Paris 800 Volunteer Drive Paris TN 38242 Champion


2


Exhibit C
Form of Indemnity Escrow Agreement

1


Exhibit D
Calculation of OTA Indemnification Cap / Escrow Funds
[Insert Allocation Chart]
A.    The OTA Indemnification Cap shall mean the aggregate amount of Escrow Funds allocated to the Facility and the Facilities subject to the Other Operations Transfer Agreements; provided, however, the Escrow Funds and the OTA Indemnification Cap shall only include those Facilities set forth on Exhibit B which have been subject to the Initial Closing or a Subsequent Closing pursuant to the Purchase Agreement.
B.    Notwithstanding the above, to the extent the Facility Purchase Price (as defined in the Purchase Agreement) for the Facility as of the Execution Date (the “Original Purchase Price”) is reduced at or prior to Closing in accordance with the terms of the Purchase Agreement (the “Reduced Purchase Price”), the Escrow Funds allocated to the Facility as of the Execution Date set forth above (the “Original Escrow Funds”) shall be similarly reduced pursuant to the following formula (the “Reduced Escrow Funds”):
-    Modification Percentage * Original Escrow Funds = the Reduced Escrow Funds
For purposes of this Exhibit D, the “Modification Percentage” shall mean a percentage calculated by dividing the Reduced Purchase Price by the Original Purchase Price (i.e. Modification Percentage = Reduced Purchase Price / Original Purchase Price).
C.    The OTA Indemnification Cap applicable to the Facility and the Facilities subject to the Other Operations Transfer Agreements shall be similarly reduced to reflect the Reduced Escrow Funds applicable to the Facility and the Facilities subject to the Other Operations Transfer Agreements.

1


Exhibit E
Form of Execution Date R&W Guaranty

1


Exhibit F
Form of Interim Indemnity Guaranty

1


Exhibit 2.2(c)
VA Subcontract
[For the Facilities with VA Contracts.]

1


Exhibit 2.7
Excluded Assets
(a)    Any cash, cash equivalents, or bank accounts;
(b)    All Accounts Receivable;
(c)    All prepaid expenses or prepaid deposits of the Facility;
(d)    All Corporate Contracts and Overhead and Shared Services, including any Contracts for or assets related to Overhead and Shared Services, and all Contracts that are not Assumed Contracts;
(e)    Licenses and permits that are not assignable or transferable without third party consent (unless such consent is obtained), to Transferee;
(f)    Assets of Transferor disposed of in the Ordinary Course prior to the Effective Time; provided that Transferor shall not dispose of any material Assets without the prior written consent of Transferee (other than Inventory used at the Facility in the Ordinary Course, which may be used and disposed of provided that it shall also be replenished to a quantity that is required by Law);
(g)    Any management agreement between Transferor and Seller or its Affiliates, as the case may be;
(h)    The minute books and ownership records of Transferor, including all organizational documents, stock registers and such other similar records of Transferor as they pertain solely to the ownership, organization, or existence of Transferor and duplicate copies of such records;
(i)    Any claims for refunds of taxes and other governmental charges imposed on Transferor of whatever nature including, but not limited to, those with respect to the Facility or the business attributable to periods ending on or prior to the Closing Date;
(j)    All shares of any capital stock, membership interests or partner interests in any partnership, of Transferor;
(k)    All of Transferor’s email accounts;
(l)    All rights of Transferor under this OTA or the other Transaction Documents;
(m)    Except to the extent conveyed pursuant to the Purchase Agreement, all insurance policies of Transferor or any of its Affiliates and all rights of every nature and description under or arising out of such insurance policies, including the right to make claims thereunder, to the proceeds thereof and to any insurance refunds relating thereto;
1


(n)    Transferor’s Tax Returns for periods up to and including the Closing Date and all rights of Transferor to any recoveries or refunds in respect of Taxes for periods up to and including the Closing Date, whether or not any refund of or credit for claims have been filed prior to the Closing Date;
(o)    Transferor’s attorney-client privilege;
(p)    All Employee Benefit Plans (including Plans) and all assets related thereto;
(q)    Transferor’s information technology systems, emails, software licenses, corporate minute books, records, marketing materials, policies and procedures, and all assets that are used at the corporate level and do not solely relate to the operations of the Business;
(r)    All claims or rights of Transferor with and among any other Transferor or amounts due from related parties;
(s)    All funds and accounts of all employee retirement, deferred compensation, health, welfare or benefit plans and programs, including assets representing a surplus or overfunding of any Employee Benefit Plan;
(t)    All unclaimed property of any third party as of the Closing, including, without limitation, property which is subject to applicable escheat Laws;
(u)    All assets of Transferor not used in connection with or held in whole or in part for use in connection with the Business;
(v)    The items of personal property brought to the Facility by employees of Transferor or its Affiliates that are not used or held for use with the Business and the operation of any of the Facility;
(w)    All tradenames, trademarks, service marks, domain names (URLs) and websites owned by Seller or its Affiliates including, without limitation, any use of the names “AHC” or “American Health Companies,” in whole or in part, or any derivation thereof, and all references to any of the foregoing on social media channels (including, without limitation, Facebook, Twitter and YouTube) associated with any or all of the Facility or Seller or its Affiliates;
(x)    Except to the extent listed in Purchased Assets and specific to the Facility, any asset transferred to Purchaser, its Affiliate or assignee under the terms of the Purchase Agreement;
(y)    Except for the Policy and Procedure Manuals, any assets listed as an “Excluded Asset” pursuant to the terms of the Purchase Agreement; and
(z)    All claims, rights, interests and proceeds (whether received in cash or by credit to amounts otherwise due to a third party) with respect to amounts overpaid by Transferor
2


to any third party with respect to periods prior to the Closing (e.g., such overpaid amounts may be determined by billing audits undertaken by Transferor or Transferor’s consultants) to the extent not offset against any underpayments by any applicable third party payor in respect of services rendered prior to the Closing.

3


Exhibit 3.2(a)
Form of Bill of Sale

1


Exhibit 3.2(b)
Form of Assignment and Assumption Agreement

1


Exhibit 3.2(c)
Form of Bring Down Certificate

1


Exhibit 6.10(f)
Wire Instructions
If to Seller:
ABA#:
Bank Name:
Bank Address:
Account Name:
Account Number:
SWIFT CODE:        
If to Purchaser:
    
    

1


EXHIBIT J
FORM OF INTERIM MANAGEMENT AGREEMENT

1


INTERIM MANAGEMENT AGREEMENT
between
[_____________________], LLC
(“Transferor”)
and
[_____________________], LLC
(“Manager”)
and
[______________________]
(“Transferee Guarantor”)
for
AHC    
EFFECTIVE AS OF DECEMBER 1, 2024

1

TABLE OF CONTENTS



ARTICLE 1 DEFINITION OF TERMS. 1
ARTICLE 2 APPOINTMENT OF MANAGER.. 5
2.1...... Appointment. 5
2.2...... Authority and Responsibility of Manager. 5
2.3...... Limitations on Authority of Manager 8
2.4...... Licenses and Permits. 8
2.5...... Pre-Term Services and Receivables. 8
ARTICLE 3 SUBLEASE.. 9
3.1...... Sublease of the Facility. 9
ARTICLE 4 TERM AND TERMINATION.. 9
4.1...... Term.. 9
4.2...... Actions to be Taken Upon Termination. 9
4.3...... Termination Payment 9
ARTICLE 5 COMPENSATION OF MANAGER.. 9
5.1...... Management Fee. 9
5.2...... Payment of Expenses and Fees. 10
ARTICLE 6 INDEMNIFICATION AND HOLD HARMLESS. 10
6.1...... Indemnification. 10
ARTICLE 7 WORKING CAPITAL AND REPLACEMENT OF INVENTORIES AND SUPPLIES 11
7.1...... Working Capital 11
7.2...... Inventories and Supplies. 11
ARTICLE 8 REPAIRS, MAINTENANCE AND REPLACEMENTS. 11
8.1...... Routine Repairs and Maintenance. 11
8.2...... Liens. 11
ARTICLE 9 BOOKKEEPING AND BANK ACCOUNTS. 11
9.1...... Books and Records. 11
9.2...... Transferor Bank Account, Facility Accounts, Expenditures. 12
ARTICLE 10 ACCESS AND USE OF FACILITY.. 12
10.1.... Access. 12
10.2.... Use. 12
ARTICLE 11 INSURANCE.. 12
11.1.... Property and Operational Insurance. 12
11.2.... General Insurance Provisions. 12
11.3.... Cost and Expense. 13
ARTICLE 12 TAXES. 13
12.1.... Real Estate and Personal Property Taxes. 13
ARTICLE 13 PERSONNEL.. 13
13.1.... Personnel. 13
ARTICLE 14 LOSS OF RIGHT TO OPERATE.. 13
14.1.... Loss of Right to Operate. 14
ARTICLE 15 DEFAULTS. 14
15.1.... Defaults and Events of Default by Manager 14
15.2.... Defaults and Events of Default by Transferor 15
15.3.... Remedies Upon an Event of Default. 15
ARTICLE 16 ASSIGNMENT. 15
16.1.... Assignment. 15
1

TABLE OF CONTENTS
(Continued)

ARTICLE 17 MISCELLANEOUS. 16
17.1.... Independent Contractor 16
17.2.... Further Assurances. 16
17.3.... Confidentiality. 16
17.4.... Consents. 16
17.5.... Applicable Law.. 16
17.6.... Headings. 16
17.7.... Notices. 16
17.8.... HIPAA Compliance. 17
17.9.... Environmental Matters. 17
17.10.. Sole Agreements. 17
17.11.. Waiver 17
17.12.. Partial Invalidity. 17
17.13.. Construction. 18
17.14.. Limit on Recourse. 18
17.15.. Disclaimer 18
17.16.. Authority. 18
17.17.. Survival 18
17.18.. Counterparts. 18

2


INTERIM MANAGEMENT AGREEMENT
THIS INTERIM MANAGEMENT AGREEMENT (this “Agreement”) is made effective as of December 1, 2024 (the “Effective Date”), by and between __________________, LLC, a Tennessee limited liability company (“Transferor”), and _______________________, LLC, a ________________ limited liability company (“Manager”), and____________________ solely for the purpose of acknowledging its obligations as the Transferee Guarantor, hereunder.
RECITALS
A.    Transferor is the licensed operator of that certain health care facility known as AHC _______________, located at ___________________________ (the “Facility”).
B.    Manager is engaged in the business of managing licensed health care facilities, and Transferor desires to engage Manager to manage the Facility in accordance with the terms and conditions of this Agreement.
C.    Transferor and Manager, have executed that certain Operations Transfer Agreement dated October ___, 2024 (the “OTA”), pursuant to which Manager has acquired certain Assets of Transferor, and Transferor and Manager wish to provide for the interim management of the Facility by Manager pending the issuance of a new License to Manager by the [Tennessee Health Facilities Commission, Division of Licensure and Regulation/ Alabama Department of Public Health, Bureau of Health Provider Standards] to operate the Facility.
NOW, THEREFORE, in consideration of the premises and the mutual covenants herein contained, the parties hereto agree as follows:
ARTICLE 1
DEFINITION OF TERMS
The following terms when used in this Agreement shall have the meanings indicated: “Accounting Period” means a calendar month.
“Affiliate” means an entity that controls or owns, or is directly or indirectly controlled or owned by, or under common control with, either Manager or Transferor.
“Agreement” shall mean this Interim Management Agreement as amended from time to time as provided herein.
“Assets” shall have the meaning set forth in the OTA.
“Damages” shall have the meaning set forth in Section 6.1 hereof.
“Deductions” shall mean amounts refunded, adjusted, owed or credited to residents or third parties (including, but not limited to, third party or governmental payors) as a result of contractual allowances, erroneous payments, overpayments or for any other reason including, without limitation, any claims, assessments, adjustments or other amounts required to be paid; gratuities to employees at the Facility; and any cash refunds, rebates or discounts to residents of the Facility, cash discounts and credits of a similar nature, given, paid or returned in the course of obtaining Revenue or components thereof; provided, however, Deductions shall not include any amounts related to the Preexisting Accounts Receivable.
1


“Default” shall have the meaning with respect to Transferor or Manager, as the case may be, as forth in Article 15.
“Effective Date” shall have the meaning set forth in the Preamble of this Agreement.
“Effective Time” shall mean 12:01 a.m. on the Effective Date and shall be interpreted to be the same as the Effective Time under the OTA (and in the event of a conflict, the OTA shall control).
“Employment Laws” means any federal, state or local law (including the common law), statute, ordinance, rule, regulation, order or directive with respect to employment, conditions of employment, benefits, compensation, or termination of employment that currently exists or may exist at any time during the Term including, but not limited to, Title VII of the Civil Rights Act of 1964, the Age Discrimination in Employment Act, the Workers Adjustment and Retraining Act, the Occupational Safety and Health Act, the Immigration Reform and Control Act of 1986, the Polygraph Protection Act of 1988, and the Americans With Disabilities Act of 1990.
“Environmental Law(s)” shall have the meaning set forth in the Purchase Agreement.
“Event of Default” shall have the meaning with respect to Transferor or Manager, as the case may be, as forth in Article 15.
“Facility” shall have the meaning set forth in Recitals of this Agreement.
“GAAP” means generally accepted accounting principles in the United States.
“Hazardous Substances” shall have the meaning set forth in the OTA.
“HIPAA” shall have the meaning set forth in Section 17.8 hereof.
“Impositions” means all real estate and personal property taxes, levies, assessments and similar charges including, without limitation, the following: all water, sewer or similar fees, rents, rates, charges, excises or levies; vault license fees or rentals; license fees; permit fees; inspection fees and other authorization fees and other governmental fees, whether general or special, ordinary or extraordinary, foreseen or unforeseen, or hereinafter levied or assessed (including all interest and penalties thereon), which at any time during or in respect of the Term may be assessed, levied, confirmed or imposed on Transferor or Manager with respect to the Facility or the operation thereof, or otherwise in respect of or be a lien upon the Facility or any property of Transferor located thereon. Impositions shall not include any income or franchise taxes payable by Transferor or Manager.
“Indemnitees” shall have the meaning set forth in Section 6.1 hereof.
2


“Inventories and Supplies” means all provisions in storerooms, refrigerators, pantries and kitchens, medical supplies, other merchandise intended for sale, fuel, mechanical supplies, stationery, linen, utensils, dishware, glassware, flatware, uniforms, rugs, drapes, bedspreads, wall and floor coverings, mats, shower curtains, janitorial equipment and supplies, and other expenses, supplies and similar items.
“Lease” means that certain Lease Agreement dated as of December 1, 2024, between Manager, as the “Tenant” thereunder, with ___________________ LLC, a ______________ limited liability company as the “Landlord” thereunder.
“Law(s)” shall have the meaning set forth in the OTA.
“License” means any license, permit, decree, act, order, authorization or other approval or instrument which is necessary in order to operate the Facility in accordance with applicable Law or otherwise in accordance with this Agreement.
“Litigation” means (i) any cause of action commenced in a federal, state or local court in the United States relating to the Facility and/or the ownership or operation thereof; and (ii) any claim brought before an administrative agency or body (for example, without limitation, employment discrimination claims) relating to the Facility and/or the ownership or operation thereof.
“Management Fee” shall have the meaning set forth in Section 5.1.1.
“Manager” shall have the meaning set forth in the Preamble of this Agreement.
“Net Earnings” means the Net Patient Revenue less the Operating Expenses and the Rent.
“Net Patient Revenue” shall mean, for each Accounting Period, Revenue minus Deductions. Notwithstanding anything to the contrary contained herein, the calculation of Net Patient Revenue shall be made using the accrual method of accounting in accordance with GAAP.
“Operating Account” shall have the meaning set forth in Section 2.2.4.
“Operating Approvals” shall have the meaning set forth in Section 2.4.1.
3


“Operating Expenses” means any or all, as the context requires, of the following: (i) all costs and expenses incurred in connection with the ownership, operation, management and maintenance of the Facility including, without limitation, all departmental expenses, Personnel Costs, Rent, quality assessment fees, administrative and general expenses, advertising and business promotion expenses, heat, light, power, electricity, gas, telephone, television and other utilities, and routine repairs, maintenance and minor alterations treated as Operating Expenses under Section 8.1; (ii) the cost and expense of the Inventories and Supplies consumed in the operation of the Facility; (iii) a reasonable reserve for uncollectible accounts receivable as reasonably determined by Transferor in accordance with GAAP; (iv) except as otherwise set forth herein, the reasonable cost and expense of audit, accounting, legal, technical, and other professional consultants and operational experts who are retained by Manager or Transferor, relating to the Facility and/or the ownership or operation thereof; (v) the reasonable costs and expenses for preparation of Medicare and Medicaid cost reports and billing submissions; (vi) insurance costs for the insurance coverages required under this Agreement or by applicable Laws; (vii) any and all taxes and Impositions imposed or assessed against Transferor or the Facility and based on or related to the ownership or operations of the Facility, excluding any federal or state income taxes or franchise assessed against Transferor or Manager and based on their net income or net worth; (viii) those costs and expenses that are expressly identified as Operating Expenses in this Agreement; (ix) the cost and expense incurred by either Transferor or Manager in connection with Manager’s efforts to maintain and secure all necessary licensure, certification and billing authorizations for its operation of the Facility, including without limitation annual licensing fees; and (x) any other costs and expenses incurred as are specifically provided for elsewhere in this Agreement or are reasonably necessary for the proper and efficient operation of the Facility. Notwithstanding anything to the contrary contained herein, (1) the calculation of Operating Expenses shall be made using the accrual method of accounting in accordance with GAAP, and (2) Operating Expenses shall not include any costs and expenses related to the period prior to the Effective Time except to the extent expressly assumed by Manager under the OTA.
“OTA” has the meaning set forth in the Recitals of this Agreement.
“Purchase Agreement” shall mean that certain Asset Purchase Agreement dated October ___, 2024, by and between the Seller Parties and Buyer Parties thereto.
“Personnel Costs” means the actual out-of-pocket payroll costs and expenses incurred by Manager or any of its Affiliates in connection with hiring or leasing the personnel Manager is required to provide pursuant to Article 13.
“Prepaid Expenses” shall have the meaning ascribed to such term under GAAP.
“Preexisting Accounts Receivable” shall have the same meaning as “Transferor’s A/Rs” in the OTA, and for the avoidance of doubt, shall mean including, without limitation, any and all Accounts Receivable related to the period prior to the Effective Date.
“Rent” means all rent and additional monies due pursuant to the terms of the Lease.
“Revenue” shall mean all revenue earned from the operation of the Facility after the Effective Time including, but not limited to, fees for health care services, occupancy, and ancillary services received for services and supplies provided to residents of the Facility, income from food and beverage, and catering sales at the Facility, income from vending machines located at the Facility, and proceeds, if any, from business interruption or other loss of income insurance claims made with respect to the Facility; provided, however, Revenue shall not include the Preexisting Accounts Receivable.
“Sublease” shall have the meaning set out in Section 3.1.
4


“Term” means the term of this Agreement as set forth in Section 4.1.
“Termination” means the expiration of this Agreement in accordance with its terms, or a termination of this Agreement as provided in Article 4.
“Transferee Employees” shall have the meaning set forth in the OTA.
“Transferor” shall have the meaning set forth in the Preamble of this Agreement.
“Working Capital” means the amount of cash necessary to pay Operating Expenses and Rent as each becomes due and payable.
ARTICLE 2
APPOINTMENT OF MANAGER
2.1.Appointment.
2.1.1.On and subject to the terms of this Agreement, Transferor hereby retains Manager commencing on the Effective Date to direct, supervise and manage the Facility through the Term, to the extent allowable by applicable Laws.
2.1.2.The performance of all activities by Manager hereunder shall be on behalf of Transferor as required by Law.
2.2.Authority and Responsibility of Manager.
2.2.1.In the performance of its duties hereunder, Manager shall be and act as an independent contractor, with the sole duty to supervise, manage, operate, control and direct the performance of the Facility, subject to the rights of Transferor and other restrictions described herein.
2.2.2.Manager shall perform its duties and obligations in accordance with all Laws including, without limitation, process all claims in accordance with such applicable Laws and the terms of such provider agreement.
2.2.3.Manager shall maintain (i) the quality care provided at the Facility, (ii) the quality of staff training and supervision, and (iii) the protection of the health and welfare of the residents of the Facility.
2.2.4.Consistent with the OTA, Transferor and Manager shall assure that all Revenues earned from the operations of the Facility during the Term shall be placed in one or more accounts and maintained for payment of the Operating Expenses of the Facility, including the Management Fee (each, an “Operating Account”). The Operating Account shall be in the name of Transferor; however, Transferor shall assure that Manager has check-writing authority from such account in accordance with the terms of this Agreement and such Operating Account may be segregated from the other operating accounts of Transferor. Notwithstanding anything to the contrary contained herein, Manager shall (i) be responsible for and obligated to pay all Operating Expenses, and (ii) use funds in the Operating Account to first pay the Operating Expenses and then the Management Fee. Checks may be drawn upon the Operating Account only by persons authorized by Transferor or Manager in writing to sign checks.
5


2.2.5.Subject to Sections 2.3 and 2.5, and except as otherwise provided herein, Manager shall have the authority to manage the Facility in accordance with all applicable Laws. During the Term, Manager shall be in charge of day-to-day operations of the Facility, and without limiting the foregoing, Manager shall perform the following:
2.2.5.1.Assist, obtain as delegated and take all reasonable steps to keep in full force and effect, either in its own name on behalf of Transferor or in Transferor’s name, as may be required by the Laws, any and all Licenses;
2.2.5.2.Establish and revise, as necessary, resident care and health care policies and procedures and general administrative policies and procedures including, without limitation, policies and procedures for the control of revenue and expenditures (which shall be subject to Transferor approval), for the purchasing of Inventories and Supplies and services, for the control of credit, and for the scheduling of maintenance. Manager shall verify that the foregoing policies and procedures are implemented in a sound manner;
2.2.5.3.Manage the cash flow of the Facility including, without limitation, billing all patients and governmental or other third-party payors for all services provided by or at the Facility during the Term, collecting and depositing all Net Patient Revenue in the Operating Account and paying Operating Expenses and other accounts payable related to the operation of the Facility during the Term from the Operating Account;
2.2.5.4.Maintain all books and records relating to the operation of the Facility during the Term and prepare monthly and annual financial statements for the Facility on a GAAP basis or such other basis as reasonably determined by the Manager and consistently applied;
2.2.5.5.Procure Inventories and Supplies and such other non-capital items, and any services from third parties, as are necessary to keep, operate and maintain the Facility;
2.2.5.6.Prepare, keep and provide Transferor with access to all contracts, books, records, documents, policies and other information necessary for the lawful operation and sound financial management of the Facility during the Term;
2.2.5.7.Establish prices, rates and charges for services provided at the Facility and negotiate all third party payor contracts;
2.2.5.8.Perform or retain professionals to perform necessary audit, accounting, legal, cost reporting, case management, verification services, and other professional services in connection with the operation of the Facility during the Term;
2.2.5.9.Retain all necessary contractors or vendors for ancillary medical, diagnostics, laboratory, pharmacy, social, therapy, dietary, dental, podiatry, behavioral or other required health services;
2.2.5.10.Retain professionals for risk management services relating to the types of insurance required to be maintained by Manager under this Agreement, provided the costs and expenses of providing such services are to be paid as described in Article 11;
2.2.5.11.Reasonably cooperate, participate in and be responsible for any survey, inspection or site investigation conducted by a governmental, regulatory, certifying or accrediting entity with authority or jurisdiction over the Facility;
6


2.2.5.12.Reasonably cooperate and assist Transferor with any legal dispute in which Transferor is involved relating to the ownership, management or operation of the Facility;
2.2.5.13.Reasonably cooperate with Transferor and its certified public accountants in connection with any audit, review or reports conducted or prepared in connection with the ownership or operation of the Facility;
2.2.5.14.Market and advertise the Facility;
2.2.5.15.Manage the performance of all covenants, duties and obligations of Transferor and Manager pursuant to all agreements with residents;
2.2.5.16.Execute, negotiate, renew and/or cancel agreements with residents of the Facility in accordance with Laws;
2.2.5.17.Institute and prosecute such legal actions as Manager determines may be necessary to collect delinquent Revenue;
2.2.5.18.Plan, execute and supervise repairs and maintenance at the Facility;
2.2.5.19.Prepare (or cause to be prepared with the necessary supporting documentation) and file with the applicable federal and state governmental agencies or other third party payors any and all reports (including, without limitation, cost reports) required for the proper payment or reimbursement to Transferor and the Facility for services provided to residents during the Term;
2.2.5.20.Notify Transferor immediately upon receipt of any notice regarding an actual or potential non-compliance with any Laws including, but not limited to, immediate jeopardy citations or substandard quality of care citations, which could reasonably be expected to result in suspension or termination of the Facility’s Licenses, Medicaid provider agreement(s), and/or Medicare provider agreement;
2.2.5.21.Procure residents at the Facility (for which Manager shall be exclusively responsible);
2.2.5.22.Notify Transferor promptly upon receipt of any notices received by Manager that could result in suspension or termination of the License, Medicaid provider agreement(s), and/or Medicare provider agreement of any other health facilities operated by Manager; and
2.2.5.23.Perform such other obligations required to be performed by Manager pursuant to this Agreement.
2.2.6.In the event that any violation or alleged violation of any Legal Requirement or obligation or claim is made, for any reason by any person or entity, arising from or applicable to the operations of the Facility including, but not limited to, patient care during the Term, whether such violations or claims may result in the imposition of penalties, fines, court or administrative orders, litigation, including third-party and governmental claims, or License revocation or decertification as to the operations of the Facility or as to Transferor, Manager shall (i) immediately notify Transferor in writing of any such event, and (ii) as directed by Transferor, take all reasonable actions necessary to protect Transferor from any Damages arising therefrom including, but not limited to, contesting any such actions against Transferor or the Facility, whether through administrative or court proceedings, and which, if related to the period from and after the Effective Time shall be at Manager’s sole cost and expense with Transferor’s written approval, and if related to period prior to the Effective Time shall be at the expense of the party provided under the OTA.
7


2.3.Limitations on Authority of Manager. Notwithstanding any other provision in this Agreement to the contrary, the performance of all activities by Manager pursuant to this Agreement shall be on behalf of Transferor, and Transferor does not delegate to Manager any powers, duties or responsibilities that Transferor is not authorized by Law to delegate. Transferor and its governing board retain ultimate authority and legal responsibility for the operation and control of the Facility, subject to indemnity from Manager as expressly set forth herein. However, notwithstanding the legal and statutory liability and responsibility of Transferor for the continued operation of the Facility, the parties acknowledge that under this Agreement, Manager shall be in control, on a day-to-day basis, of the operation and maintenance of the Facility pursuant to the terms of this Agreement.
2.4.Licenses and Permits.
2.4.1.Transferor agrees upon request by Manager to sign promptly and without charge applications for Licenses, applications for transfer to Manager of Transferor’s provider agreements, permits or other instruments necessary for operation of the Facility, for it to be able to bill under the Medicare and Medicaid programs, and for the issuance by CMS of tie in notices, tying Manager’s to-be-issued skilled nursing facility License to the provider agreements assigned by Transferor to Manager (collectively, “Operating Approvals”) and to provide such information and perform such acts relative to the operation of the Facility and for billing under Medicare and Medicaid, including Transferor’s Submitter ID and NPI numbers, as are required by Laws in order for Manager to obtain and/or maintain any Operating Approval.
2.4.2.The parties understand and agree that certain deficiencies or situations of non-compliance with various Laws (such as building codes, OSHA, ADA, health care regulations and the like) may occur from time to time in the normal course of business operations. Such occurrences will not constitute a breach or Default by Manager hereunder, provided Manager takes reasonable actions to cure, and successfully cures, such deficiencies or situations of non-compliance. The costs (including any fines for non-compliance) of curing such deficiencies or circumstances of non-compliance shall constitute Operating Expenses.
2.4.3.Manager shall use best efforts to obtain the Operating Approvals in Manager’s own name as soon as practicable.
2.5.Pre-Term Services and Receivables. Solely to the extent agreed in connection with the OTA and any BSSA, Manager shall assist (with Transferor’s cooperation) in collecting all of the Preexisting Accounts Receivable, and shall pursue claims for the pre-Effective Time and the post-Effective Time periods, in commercially reasonable fashion to prevent causing unreasonable interference with or delay in receiving the claims being pursued.
ARTICLE 3
SUBLEASE
3.1.Sublease of the Facility. During the Term, Manager has subleased the Facility to Transferor pursuant to the Interim Sublease Agreement dated as of the Effective Date and attached hereto as Exhibit A (the “Sublease”).
ARTICLE 4
TERM AND TERMINATION
8


4.1.Term. This Agreement shall commence on the Effective Date and shall expire on the earlier of (i) the date that Manager or an Affiliate thereof obtains the Operating Approvals to operate the Facility, and (ii) at the end of six (6) months from the Effective Date (the “Term”); provided, however, that Transferor in its reasonable discretion, shall consent (such consent not to be unreasonably withheld, delayed, or conditioned) to extend the six (6) month period if necessary upon request of Manager so long as Manager is exercising its best efforts to obtain the Operating Approvals. Manager shall promptly inform Transferor in writing of its receipt of the Operating Approvals.
4.2.Actions to be Taken Upon Termination. Upon Termination, the following shall be applicable:
4.2.1.Manager shall safeguard and retain for benefit of Transferor all books and records respecting the Facility in a manner as required by the OTA;
4.2.2.Manager and Transferor shall satisfy all other respective obligations set forth in this Agreement required to be completed by such party upon Termination; and
4.2.3.Except in the event of Termination for Default, the Sublease shall terminate, and Manager shall become the new operator of the Facility.
4.2.4.The provisions of this Section 4.2 shall survive Termination.
4.3.Termination Payment. Upon Termination, after payment of all accrued Operating Expenses as of the date of such Termination, Manager shall receive all the accrued and unpaid Management Fees to the extent of available proceeds from operations for dates of service commencing on and after the Effective Date.
ARTICLE 5
COMPENSATION OF MANAGER
5.1.Management Fee.
5.1.1.In consideration of management services performed hereunder, Manager shall be eligible to retain one hundred percent (100%) of the Net Earnings of the Facility (the “Management Fee”) during the Term.
5.1.2.The Management Fee shall be calculated for each Accounting Period and retained by Manager within ten (10) days following the end of each period. Manager is authorized to withdraw the Management Fee from the Operating Account to the extent there are sufficient funds to pay all Operating Expenses with respect to the applicable Accounting Period. If there are insufficient funds to pay the Operating Expenses and/or the Management Fee in any Accounting Period, the shortfall shall be the sole liability of Manager, not the liability of Transferor, and, for clarity purposes, Manager shall have no recourse against Transferor for any Operating Expenses or the Management Fee.
5.1.3.Manager shall be responsible for (and shall defend, protect, indemnify and hold Transferor harmless against) any penalties, overpayments or other refunds related to the operation of the Facility during the Term.
5.2.Payment of Expenses and Fees. Transferor and Manager agree that Net Patient Revenue shall be paid or distributed during each Accounting Period in the following order:
5.2.1.First, to pay the Operating Expenses;
9


5.2.2.Second, to pay Manager the Management Fee.
ARTICLE 6
INDEMNIFICATION AND HOLD HARMLESS
6.1.Indemnification. Manager (and Transferee Guarantor under the OTA) shall defend, protect, indemnify and hold harmless Transferor and its officers, members, managers, employees and agents (collectively, the “Indemnitees”) from and against any and all demands, claims, actions or causes of action, assessments, losses, damages, liabilities, costs and expenses including, without limitation, interest, penalties, losses associated with applicable surety bonds, and reasonable attorneys’ fees and expenses (hereinafter collectively called “Damages”) which may be suffered by, imposed on, incurred by, or asserted against such Indemnitees in any manner relating to or arising out of any act, event or transaction related to (i) this Agreement, (ii) the Sublease, (iii) the operations of the Facility after the Effective Time, (iv) claims submitted with respect to services rendered after the Effective Time, or (v) billing and collection services with respect to the Facility performed by Manager, its Affiliate, or another third party after the Effective Time. Notwithstanding the foregoing, Manager shall have no obligation to any Indemnitee under this Article 6 to the extent that any Damages are found in a final judgment by a court of competent jurisdiction (i) to have arisen from the intentionally wrongful misconduct or gross negligence of such Indemnitee, or (ii) to the extent that the Damages are attributable to any matter for which Transferor has an obligation to indemnify Manager pursuant to Article X of the OTA. This indemnification obligation shall survive Termination for the period of five (5) years or the applicable statute of limitations, whichever is longer.
ARTICLE 7
WORKING CAPITAL AND REPLACEMENT OF INVENTORIES AND SUPPLIES
7.1.Working Capital. In the event that additional Working Capital is required to pay Operating Expenses, Manager shall immediately deposit the amount of required Working Capital into the appropriate Operating Account. Manager shall be solely liable, without recourse of any kind to Transferor, for any and all required Working Capital needs and requirements.
7.2.Inventories and Supplies. Manager will maintain Inventories and Supplies at levels reasonably determined by Manager to be necessary to operate the Facility in compliance with the terms of this Agreement. Purchases of Inventories and Supplies shall be Operating Expenses.
ARTICLE 8
REPAIRS, MAINTENANCE AND REPLACEMENTS
8.1.Routine Repairs and Maintenance. Manager shall (i) maintain the Facility (A) in good repair and in substantially the same condition as of the Effective Time, and (B) in conformity with applicable Laws, and (ii) shall make or cause to be made such routine maintenance, repairs and minor alterations, the cost of which can be expensed under GAAP, or such other basis as reasonably determined by Manager and consistently applied, as are necessary to maintain the Facility consistent with such standards. The cost and expense associated with Manager’s obligations under this Section shall be treated as an Operating Expense.
8.2.Liens. Manager shall use its commercially reasonable efforts to prevent any liens from being filed against the Facility which arise from any maintenance, repairs, alterations, improvements, renewals or replacements in or to a Facility. Manager and Transferor shall cooperate fully in obtaining the release of any such liens, and the cost of obtaining the lien release shall be an Operating Expense.
10


ARTICLE 9
BOOKKEEPING AND BANK ACCOUNTS
9.1.Books and Records.
9.1.1.Manager shall maintain all books and records relating to the operation of the Facility on an accrual basis in accordance with GAAP or such other basis as reasonably determined by Manager and consistently applied. Transferor may examine such records in a manner consistent with the OTA.
9.1.2.Upon the written request of the Secretary of Health and Human Services, the Comptroller General or any of their duly authorized representatives, Manager will make available those contracts, books, documents and records necessary to certify the nature and extent of the costs of providing services under the terms of this Agreement. Such inspection shall be available up to four (4) years after the rendering of such services. If Manager carries out any of the duties of this Agreement through a subcontract with a value of Ten Thousand Dollars ($10,000) or more over a 12-month period with a related individual or organization, Manager agrees to include this requirement in any such subcontract.
9.2.Transferor Bank Account, Facility Accounts, Expenditures. Subject to the terms and conditions set forth in the OTA, the Security Agreement, and the DACA and DAISA (all as defined in the OTA): (a) all Revenues derived from operation of the Facility during the Term shall be deposited in the Operating Account; (b) one or more representatives of Manager reasonably approved by Transferor shall be named as signatories on the Operating Account (each, an “Authorized Representative”); (c) Transferor shall take such actions as may be reasonably necessary to add each Authorized Representative as a signatory for the Operating Account; (d) withdrawals from the Operating Account pursuant to the terms of this Agreement may be made by any Authorized Representative; and (e) reasonable petty cash funds shall be maintained at the Facility.
ARTICLE 10
ACCESS AND USE OF FACILITY
10.1.Access. During the Term, Manager shall have complete access to the Facility to the extent necessary to perform its obligations under this Agreement.
10.2.Use. Manager shall cause the Facility to be used solely for the operation of a licensed healthcare facility consistent with the manner in which the Facility is being used as of the Effective Date, including all activities in connection therewith which are customary and usual to such an operation, and consistent with the License.
ARTICLE 11
INSURANCE
11.1.Property and Operational Insurance. During the Term, Manager shall provide, procure and maintain the following insurance policies (i) with financially responsible insurance companies qualified to do business in the state where the Facility is located, (ii) at commercially reasonable amounts to protect against applicable risks and losses during the Term or as otherwise required by Laws, and (iii) with Transferor named as an additional insured: comprehensive general liability, casualty and property, professional liability, and employment and workers’ compensation liability coverage. Professional liability insurance shall be in the minimum amount of $1,000,000 per incident with an aggregate of at least $3,000,000 per year. The cost of obtaining and maintaining such insurance policies shall be an Operating Expense. Manager shall obtain commercially reasonable tail policies at the end of the Term, or in its future operations shall maintain appropriate insurance policies for future periods with retroactive dates that cover the Term.
11


11.2.General Insurance Provisions.
11.2.1.Upon reasonable request, Transferor and its Affiliates shall be entitled to examine, at Manager’s corporate headquarters, all insurance policies maintained by Manager regarding the Facility or have copies of such insurance policies delivered to the requesting Transferor.
11.2.2.Upon request, Manager shall deliver to Transferor certificates of insurance with respect to all policies so procured and, in the case of insurance policies about to expire, shall deliver certificates with respect to the renewal thereof.
11.2.3.All certificates of insurance provided for under this Article 11 shall state that the insurance shall not be canceled or materially changed without at least thirty (30) days’ prior written notice to both Manager and Transferor.
11.3.Cost and Expense. Any reserves, losses, costs or expenses related to the Term that are uninsured shall be treated as a cost of insurance and shall be Operating Expenses.
ARTICLE 12
TAXES
12.1.Real Estate and Personal Property Taxes. All Impositions which are attributable to the Term (or the responsibility of Manager under the OTA) shall be paid by Manager as Operating Expenses before any fine, penalty or interest is added thereto or lien placed upon the Facility. Transferor shall, within ten (10) days after its receipt of any invoice, bill, assessment, notice or other correspondence relating to any imposition, furnish Manager with a copy thereof. Manager shall, within thirty (30) days of payment, furnish Transferor with copies of official tax bills and assessments that Manager has received, and evidence of payment or contest thereof. Manager may initiate proceedings to contest any Imposition (in which case each party agrees to sign the required applications and otherwise cooperate with the other party in expediting the matter), and all reasonable costs of any negotiations or proceedings with respect to any such contest shall be an Operating Expense.
ARTICLE 13
PERSONNEL
13.1.Personnel.
13.1.1.Employees of Transferor who are hired by Manager pursuant to the terms of the OTA will become employees of Manager at the Effective Time.
13.1.2.Commencing at the Effective Time, Manager shall hire, discharge, supervise and pay all Transferee Employees, contractors and other personnel necessary for the management and operation of the Facility in accordance with this Agreement and applicable Employment Laws. All Transferee Employees will be employed directly by Manager and not Transferor. Manager shall not discriminate against any employee or prospective employee because of race, creed, color, national origin, gender, or any other classification protected by any Employment Laws. Transferor shall formally appoint the administrator of the Facility to the extent required by applicable Law, with Manager to employ such person; provided, however, Transferor agrees not to unreasonably refuse to accept Manager’s recommendations for such appointment and for the credentialing, compensation, recruiting, hiring, training, supervising, vetting, controlling and terminating and discharging of Facility personnel.
12


13.1.3.All wages, salaries and benefits, and costs and expenses of any kind, for Transferee Employees related to the Term shall be Operating Expenses.
ARTICLE 14
LOSS OF RIGHT TO OPERATE
14.1.Loss of Right to Operate. If any License that is material to the operation of the Facility is revoked, withdrawn, not renewed or placed on probation, Manager and Transferor shall each, in good faith, use commercially reasonable efforts (including the diligent pursuit of all available appeals) to have such License reinstated. If, notwithstanding such efforts, such License is not reinstated prior to the expiration of thirty (30) days after the License was revoked, withdrawn, not renewed or placed on probation, Transferor shall have the right, in its sole discretion, to immediately terminate this Agreement pursuant to the applicable provisions of Article 4 and Article 15.
ARTICLE 15
DEFAULTS
15.1.Defaults and Events of Default by Manager. The following shall each constitute a “Default” by, and an “Event of Default” with respect to, Manager for purposes of this Agreement:
15.1.1.Manager has (i) become the subject of a decree or order for relief under any bankruptcy, insolvency or similar law affecting creditors’ rights now existing or hereafter in effect; (ii) initiated, either in an original proceeding or by way of answer in any state insolvency or receivership proceeding, an action for liquidation, arrangement, composition, readjustment, dissolution, or similar relief; (iii) consented to any order for relief entered with respect to Manager under the Federal Bankruptcy Code; or (iv) failed to cause the dismissal of any proceeding instituted against the party under the Federal Bankruptcy Code, or the removal of any trustee appointed with respect to the party’s property under the Federal Bankruptcy Code, within ninety (90) days of the commencement of such proceeding or appointment of such trustee, as the case may be.
15.1.2.Manager commits any act or fails to take any action that is specifically identified as a “Default” or an “Event of Default” by Manager under any provision of this Agreement that is not cured, in full or in part, for a period of thirty (30) days after written notice thereof by Transferor to Manager, or if such Default or Event of Default cannot be cured within such thirty (30) day period, then such additional period as shall be reasonable provided Manager commences to cure such Default or Event of Default within such thirty (30) day period and proceeds diligently to prosecute such cure to completion.
15.1.3.Manager commits any act, or fails to take any act, that results in the suspension, termination, revocation or loss of any License required by the Facility to operate as a nursing home, that becomes a final agency action after waiver or exhaustion of all administrative and judicial review or appeal rights; provided, however, the suspension, termination, revocation or loss of any such License shall not constitute a Default or an Event of Default while administrative and judicial review or appeal rights are being pursued, or if a provisional License is issued to permit the continued operation of the Facility and the License is reinstated after expiration of the provisional License.
13


15.1.4.Manager materially fails to keep, observe or perform any covenant, agreement, term or provision of this Agreement and the continuation of such failure, in full or in part, for a period of thirty (30) days after written notice thereof by Transferor to Manager, or if such default cannot be cured within such thirty (30) day period, then such additional period as shall be reasonable provided Manager commences to cure such default within such thirty (30) day period and proceeds diligently to prosecute such cure to completion.
15.2.Defaults and Events of Default by Transferor. The following shall each constitute a “Default” by, and an “Event of Default” with respect to, Transferor for purposes of this Agreement: Transferor has (i) become the subject of a decree or order for relief under any bankruptcy, insolvency or similar law affecting creditors’ rights now existing or hereafter in effect; (ii) initiated, either in an original proceeding or by way of answer in any state insolvency or receivership proceeding, an action for liquidation, arrangement, composition, readjustment, dissolution, or similar relief; (iii) consented to any order for relief entered with respect to Transferor under the Federal Bankruptcy Code; or (iv) failed to cause the dismissal of any proceeding instituted against the party under the Federal Bankruptcy Code, or the removal of any trustee appointed with respect to the party’s property under the Federal Bankruptcy Code, within ninety (90) days of the commencement of such proceeding or appointment of such trustee, as the case may be.
15.3.Remedies Upon an Event of Default.
15.3.1.Upon the occurrence of an Event of Default, the non-defaulting party shall have the right to institute any and all proceedings permitted by law or at equity including, without limitation, actions for specific performance and/or Damages.
15.3.2.Upon the occurrence of an Event of Default by either party, any amounts owed to the non-defaulting party shall accrue interest at an annual rate of twelve percent (12%), compounded annually, on the principal balance due commencing on the original due date of such payment through the date of payment.
15.3.3.The rights granted hereunder are intended to be cumulative, and shall not be in substitution for, but shall be in addition to, any and all rights and remedies available to the non- defaulting party (including, without limitation, injunctive relief and Damages) by reason of applicable provisions of law or equity.
ARTICLE 16
ASSIGNMENT
16.1.Assignment.
16.1.1.Neither Manager nor Transferor shall assign or transfer its interest in this Agreement without the prior written consent of the other party, not to be unreasonably withheld, provided, however, Manager may delegate, assign or transfer its interest in this Agreement to an Affiliate upon ten (10) days prior written notice to Transferor (provided, however, such assignment shall not relieve Manager from its obligations hereunder). For purposes of this Agreement, the following shall be considered an assignment or transfer of this Agreement: (i) any assignment, transfer, sale or disposition of the majority of the ownership interest of either party, voluntarily or involuntarily, by the parties who owned such ownership interest on the Effective Date, (ii) any issuance of ownership interests in a party or other transaction that results in a change in the control of a party, or (iii) any merger, consolidation or other similar transaction to which Manager or Transferor is a party.
14


16.1.2.In the event either party consents to an assignment of this Agreement by the other, no further assignment shall be made without the express consent in writing of such party, unless such assignment may otherwise be made without such consent pursuant to the terms of this Agreement. An assignment by either Transferor or Manager of its interest in this Agreement shall not relieve Transferor or Manager, as the case may be, from their respective obligations under this Agreement.
ARTICLE 17
MISCELLANEOUS
17.1.Independent Contractor. Nothing contained herein shall be deemed or construed to create a partnership, joint venture, employment relationship or otherwise create any liability for one party with respect to indebtedness, liabilities or obligations of the other party except as otherwise may be expressly set forth herein.
17.2.Further Assurances. Except as specifically provided in this Agreement, Transferor or Manager, as the case may be, shall cause to be executed and delivered to the other party all such other instruments and shall take or cause to be taken such further or other action as may reasonably and in good faith be deemed by the other party to be necessary or desirable in order to further assure the performance by Transferor or Manager, as the case may be, of any of their respective obligations under this Agreement.
17.3.Confidentiality. The parties hereto agree that the matters set forth in this Agreement are strictly confidential and other than as required by applicable licensing and healthcare laws, securities laws, or the like, each party will make every effort to ensure that the information is not disclosed to any outside person or entities (including the press) without the written consent of the other party. Notwithstanding the foregoing, this Agreement may be filed with the licensing department in the state where the Facility is located to the extent required by law or necessary for approval hereof.
17.4.Consents. Wherever in this Agreement the consent or approval of Transferor or Manager is required and such consent is not expressly indicated to be at the sole discretion of a party, such consent or approval shall not be unreasonably withheld or delayed, shall be in writing and shall be executed by a duly authorized officer or agent of the party granting such consent or approval, and if either Transferor or Manager fails to respond within thirty (30) days to a request by the other party for a consent or approval, such consent or approval shall be deemed to have been given.
17.5.Applicable Law. This Agreement shall be construed under and shall be governed by the laws of the state where the Facility is located. Each party waives any objection to venue in such state.
17.6.Headings. Headings of Articles and Sections are inserted only for convenience and in no way limit the scope of the particular Articles or Sections to which they refer.
17.7.Notices. All notices and other communications given or made pursuant to the notice provisions set out in the OTA.
17.8.HIPAA Compliance. The parties agree that the services provided under this Agreement will comply in all material respects with all federal and state-mandated regulations, rules or orders applicable to the services provided herein including, but not limited to, regulations promulgated under Title 11, Subtitle F of the Health Insurance Portability and Accountability Act (Public Law 104-91) (“HIPAA”). Furthermore, the parties shall amend this Agreement or execute any additional documentation to amend the Agreement to conform with HIPAA or any new or revised legislation, rules and regulations to which they are subject now or in the future including, without limitation, the Standards for Privacy of Individually Identifiable Health Information or similar legislation in order to ensure that the parties are at all times in conformance with all Laws. Toward this end, Manager and Transferor agree to the Business Associate Provisions, attached hereto as Exhibit B and incorporated by reference herein, upon execution of this Agreement.
15


17.9.Environmental Matters.
17.9.1.Except as otherwise set forth in the OTA, Manager shall indemnify, defend and hold Transferor and its Affiliates (and their respective directors, officers, shareholders, employees and agents) harmless from and against all Damages (including, without limitation, reasonable engineers’ and attorneys’ fees and expenses, and the cost of Litigation) arising from the presence of Hazardous Substances on or in the Facility during the Term, and shall cause the same to be removed together with contaminated soil and containers and shall otherwise remove the problems, all as required by applicable Environmental Laws, provided that if such Hazardous Substances existed on or at the Facility prior to the commencement of the Term, Manager shall have no obligation to indemnify Transferor or any of Transferor’s Affiliates with respect to such pre-existing Hazardous Substances.
17.9.2.All costs and expenses of the removal of Hazardous Substances arising from Manager’s operation of the Facility pursuant to Section 17.9.1, and of the aforesaid compliance with all Environmental Laws, shall be treated as an Operating Expense.
17.10.Sole Agreements. This Agreement, together with the OTA and the other agreements executed as required by the OTA, (i) constitutes the sole agreement between the parties regarding the matters contained herein, (ii) supersedes all prior understandings and writings, and (iii) may be altered, modified or amended only by a writing signed by both parties hereto. In the event of a conflict between this Agreement and the OTA, the terms of this Agreement shall control.
17.11.Waiver. The failure of either party to insist upon a strict performance of any of the terms or provisions of this Agreement, or to exercise any option, right or remedy herein contained, shall not be construed as a waiver or as a relinquishment for the future of such term, provision, option, right or remedy, but the same shall continue and remain in full force and effect. No waiver by either party of any term or provision hereof shall be deemed to have been made unless expressed in writing and signed by such party.
17.12.Partial Invalidity. If any portion of this Agreement shall be declared invalid by order, decree or judgment of a court, this Agreement shall be construed as if such portion had not been inserted herein except when such construction would operate as an undue hardship on Manager or Transferor, or constitute a substantial deviation from the general intent and purpose of said parties as reflected in this Agreement.
17.13.Construction. No provisions of this Agreement shall be construed in favor of, or against, any particular party by reason of any presumption with respect to the drafting of this Agreement; both parties, being represented by counsel, having fully participated in the negotiation of this instrument.
17.14.Limit on Recourse. Transferor’s and Manager’s obligations under this Agreement are not with recourse to any manager, officer, director, employee, member, shareholder or agent of Transferor or Manager, respectively, except to the extent such person is acting as the Transferee Guarantor under the OTA.
16


17.15.Disclaimer. None of the services or assistance offered to Transferor by Manager, or payments made to Manager, shall in any manner be construed as an inducement for the referral of any patients or for the arrangement of any services covered under a Federal healthcare program. The parties do not intend the terms of this Agreement to provide for, and nothing in this Agreement shall be deemed or in any manner construed to be, the solicitation, receipt, offer or payment of remuneration for the furnishing of any item or service for which payment may be made in whole or in part under a Federal healthcare program, or in return for purchasing, leasing, ordering or arranging for, or recommending purchasing, leasing, ordering, any good, facility, service or item for which payment may be made in whole or in part under a Federal healthcare program. Such services and assistance are wholly intended to improve the delivery of health care services to the population served by the parties. In the event any Law, now existing or enacted or promulgated after the Effective Date of this Agreement, are interpreted by judicial decision, a regulatory agency or legal counsel in such a manner as to indicate that the structure of this Agreement may be in violation of such Laws or regulations, Transferor and Manager shall attempt in good faith to amend this Agreement as necessary. To the maximum extent possible, any such amendment shall preserve the underlying economic and financial arrangement between Transferor and Manager.
17.16.Authority. Each individual who has signed this Agreement warrants that such execution has been duly authorized by the party for which he or she is signing.
17.17.Survival. For avoidance of doubt, the parties’ obligations under Sections 2.2.6, 2.3, and 2.5, and Articles 4, 5, 6, 9, 11, 12, 15, and 17 shall survive Termination.
17.18.Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original. Executed counterparts may be delivered by facsimile (and/or Adobe PDF), and shall be effective when received, with the original copy sent by overnight delivery service. This Agreement shall be of no force or effect unless and until it has been executed and delivered by both parties and Transferee Guarantor.

17


IN WITNESS WHEREOF, the parties have executed this Interim Management Agreement as or the date first written above.
TRANSFEROR:
___________________, LLC a Tennessee limited liability company ____________________ LLC a _____________ limited liability company
By:    
Name:     
Title:    

1


MANAGER:
By:    
Name:     
Title:    


EXHIBIT A
Form of Interim Sublease Agreement
1


EXHIBIT B8
Business Associate Provisions
Signature Page to Interim Management Agreement- AHC Facility Manager (as “Business Associate” for purposes of this Exhibit B) will perform any services contemplated under the Agreement involving Protected Health Information received from, or created or received by Manager on behalf of, Transferor (the, “Covered Entity” for purposes of this Exhibit B) in accordance with the following Business Associate Provisions (this “BAA”):
1.    Definitions. Terms used, but not otherwise defined, in this BAA shall have the same meaning as those terms in the Privacy Rule and Security Rule.
a.    Breach. “Breach” shall have the same meaning as the term “breach” in 45 CFR 164.402.
b.    Designated Record Set. “Designated Record Set” shall have the same meaning as the term “designated record set” in 45 CFR 164.501.
c.    Electronic Protected Health Information or Electronic PHI. “Electronic Protected Health Information” or “Electronic PHI” shall mean Protected Health Information that is transmitted in or maintained by electronic media.
d.    Individual. “Individual” shall have the same meaning as the term “individual” in 45 CFR 160.103 and shall include a person who qualifies as a personal representative in accordance with 45 CFR 164.502(g).
e.    Privacy Rule. “Privacy Rule” shall mean the Standards for Privacy of Individually Identifiable Health Information at 45 CFR Part 160 and Part 164, Subparts A and E, as amended from time to time.
f.    Protected Health Information or PHI. “Protected Health Information” or “PHI” shall have the same meaning as the term “protected health information” in 45 CFR 160.103, limited to the information created or received by Covered Entity from or on behalf of Business Associate.
g.    Required By Law. “Required By Law” shall have the same meaning as the term “required by law” in 45 CFR 164.103.
h.    Secretary. “Secretary” shall mean the Secretary of the Department of Health and Human Services or his designee.
i.    Security Incident. “Security Incident” shall mean the attempted or successful unauthorized access, use, disclosure, modification, or destruction of information or interference with system operations in an information system. An attempted unauthorized access means any attempted unauthorized access that prompts Covered Entity to investigate the attempt, or review
8 POL Note: Under review by POL specialists or change its current security measures and shall not include trivial attempts to breach the system operations such as pings and port scans, which the Parties deem reported by virtue of this BAA.
1


j.    Security Rule. “Security Rule” shall mean the Security Standards for the Protection of Electronic PHI at 45 CFR Part 160, and Part 164, Subparts A and C.
k.    Unsecured PHI. “Unsecured PHI” shall have the same meaning as the term “unsecured protected health information” in 45 CFR 164.402.
2.    Obligations of Covered Entity.
a.    Regulatory Compliance. Covered Entity agrees that it shall comply with relevant portions of the Privacy Rule and the Security Rule as those regulations apply directly to Covered Entity.
b.    Use of Protected Health Information. Covered Entity shall not use and shall ensure that its directors, officers, employees, contractors and agents do not use PHI in any manner other than as permitted or required by the Agreement, this BAA or as Required By Law.
c.    Safeguards Against Misuse of Information. Covered Entity agrees that it will implement appropriate safeguards to prevent the use or disclosure of PHI other than pursuant to the terms and conditions of this BAA. Covered Entity agrees that it will implement administrative, physical, and technical safeguards that reasonably and appropriately protect the confidentiality, integrity, and availability of the Electronic PHI that it creates, maintains, or transmits on behalf of Business Associate. Covered Entity agrees to comply with the applicable requirements of Part 164, Subpart C of the Security Rule.
d.    Mitigation. Covered Entity agrees to mitigate, to the extent practicable, any harmful effect that is known to Covered Entity of a use or disclosure of PHI by Covered Entity in violation of the requirements of this BAA, including any Breach.
e.    Reporting Breaches. In all cases of suspected or actual breaches of this BAA, Covered Entity shall maintain evidence demonstrating that all notifications below were made without unreasonable delay. Covered Entity shall report to Business Associate:
i.    Without delay, but in no event later than five (5) business days of having actual knowledge of or a reasonable belief of a disclosure of PHI by Covered Entity, its employees, representatives, agents, or subcontractor that is not specifically permitted by this BAA;
ii.    Without delay, but in no event later than five (5) business days of having actual knowledge of or a reasonable belief of any Security Incident; and
iii. Promptly by telephone following the first day on which Covered Entity becomes aware of a Breach of Unsecured PHI. Covered Entity shall provide a full written report to Business Associate’s Privacy Officer no later than five (5) business days after providing verbal notice. Covered Entity shall include the following information in the written report, to the extent known: (A) detailed information about the Breach, and immediate remedial action to stop the Breach; (B) names and contact information of the Individual(s) whose PHI has been, or is reasonably believed to have been, subject to the Breach; and (C) such other information as Business Associate may request.
2


f.    Agreements by Third Parties. In accordance with 45 CFR §§ 164.308(b)(2) and 164.502(e)(1)(ii), Covered Entity shall enter into a written agreement with any agent or subcontractor that will create, receive, maintain, or transmit PHI and/or Electronic PHI on behalf of Covered Entity pursuant to which such agent or subcontractor agrees to: (1) be bound by restrictions, terms and conditions that are at least as restrictive as those that apply to Covered Entity pursuant to this BAA with respect to such PHI, and (2) implement reasonable and appropriate safeguards to protect such information.
g.    Access to Information. In the event that Covered Entity maintains PHI in a Designated Record Set, Covered Entity shall, within ten (10) business days of a request by Business Associate for access to PHI about an Individual, make available to Business Associate such PHI for so long as such information is maintained. If Covered Entity uses or maintains PHI electronically in a Designated Record Set and if the Individual requests an electronic copy of such information, Covered Entity must provide Business Associate, or the Individual or person properly designated by the Individual, as directed by Business Associate, access to the PHI in the electronic form and format requested by the Individual, if it is readily producible in such form and format; or, if not, in a readable electronic form and format. In the event any Individual requests access to PHI directly from Covered Entity, Covered Entity shall within two (2) business days forward such request to Business Associate. Any denials of access to the PHI requested shall be the responsibility of Business Associate.
h.    Availability of PHI for Amendment. In the event that Covered Entity maintains PHI in a Designated Record Set, Covered Entity shall, within ten (10) business days of receipt of a request from Business Associate for the amendment of an Individual’s PHI, provide such information to Business Associate for amendment and incorporate any such amendments in the PHI as required by 45 CFR 164.526.
i. Accounting of Disclosures. Covered Entity agrees to implement an appropriate record keeping process to document such disclosures of PHI as would be required for Business Associate to respond to a request by an Individual for an accounting of disclosures of PHI in accordance with 45 CFR 164.528. Within thirty (30) calendar days of notice by Business Associate to Covered Entity that it has received a request for an accounting of disclosures of PHI regarding an Individual, Covered Entity shall make available to Business Associate such information as is in Covered Entity’s possession and is required for Business Associate to make the accounting required by 45 CFR 164.528. At a minimum, Covered Entity shall provide Business Associate with the following information: (i) the date of the disclosure; (ii) the name of the entity or person who received the PHI, and if known, the address of such entity or person; (iii) a brief description of the PHI disclosed; and (iv) a brief statement of the purpose of such disclosure which includes an explanation of the basis for such disclosure. In the event the request for an accounting is delivered directly to Covered Entity, Covered Entity shall, within two (2) business days, forward such request to Business Associate. It shall be Business Associate’s responsibility to prepare and deliver any such accounting requested.
3


j.    Access and Inspection. Covered Entity agrees to make its internal practices, books, and records, including policies and procedures, relating to the use and disclosure of PHI received from, or created or received by Covered Entity on behalf of, Business Associate available to the Secretary, in a time and manner designated by the Secretary, for purposes of the Secretary determining Business Associate’s and Covered Entity’s compliance with the Privacy Rule.
k.    Delegated Obligations. To the extent Covered Entity is delegated to carry out Business Associate’s obligations under the Privacy Rule, Covered Entity shall comply with the requirements of the Privacy Rule that apply to Business Associate in the performance of such delegated obligations.
3.    Permitted Uses and Disclosures.
a.    Use or Disclosure of PHI. Except as otherwise limited in this BAA, Covered Entity may use or disclose PHI to perform functions activities, or services for, or on behalf of, Business Associate as specified in the Agreement, provided that such use or disclosure would not violate the Privacy Rule if done by Business Associate.
b.    Use for Business Purposes. Except as otherwise limited in this BAA, Covered Entity may use PHI (i) for Covered Entity’s proper management and administrative services; or (ii) to carry out the legal responsibilities of Covered Entity.
c.    Disclosure for Business Purposes. Except as otherwise limited in this BAA, Covered Entity may disclose PHI for Covered Entity’s proper management and administrative services, provided that (i) such disclosures are Required By Law; or (ii) prior to making any such disclosure, Covered Entity obtains (A) reasonable assurances from the third party that such PHI will be held confidential and used or further disclosed only as Required By Law or for the purposes for which it was disclosed to such third party; and (B) the third party agrees to immediately notify Covered Entity of any breaches of the confidentiality of the PHI, to the extent it has obtained knowledge of such breach.
d.    Data Aggregation. Except as otherwise limited in this BAA, Covered Entity may use PHI to provide Data Aggregation services to Business Associate as permitted by 45 CFR 164.504(e)(2)(i)(B) and if so requested by Business Associate.
4.    Obligations of Business Associate.
a. Notifications to Covered Entity. To the extent that a limitation, revocation, or restriction may affect Covered Entity’s use or disclosure of PHI, Business Associate shall notify Covered Entity of (i) any limitations in its notice of privacy practices in accordance with 45 CFR 164.520; (ii) any changes in, or revocation of permission by an Individual to use or disclose PHI; or (iii) any restriction to the use or disclosure of PHI that Business Associate has agreed to in accordance with 45 CFR 164.522.
4


b.    Requests. Business Associate shall not request Covered Entity to use or disclose PHI in any manner that would not be permissible under the Privacy Rule if done by Business Associate.
c.    Minimum Necessary PHI. When Business Associate discloses PHI to Covered Entity, Business Associate shall provide the minimum amount of PHI necessary for the accomplishment of Covered Entity’s purpose.
5.    Term and Termination.
a.    Term. This BAA shall terminate when all of the PHI provided by Business Associate to Covered Entity, or created or received by Covered Entity on behalf of Business Associate, is destroyed or returned to Business Associate, or, if it is infeasible to return or destroy the PHI, until protections are extended to such information, in accordance with the termination provisions in this Section 5.
b.    Termination for Cause. If Covered Entity breaches its obligations under this BAA, Business Associate may, at its option: (i) exercise any of its rights of access and inspection under Section 2(j) of this BAA; (ii) require Covered Entity to submit to a plan of monitoring and reporting, as Business Associate may determine necessary to maintain compliance with this BAA ; or (iii) terminate this BAA and the Agreement, after providing Covered Entity thirty (30) calendar days to cure the breach to the extent that cure is feasible. Covered Entity shall ensure that it maintains the termination rights in this Section for itself in any agreement it enters into with an agent or subcontractor pursuant to Section 2(f) hereof.
c.    Effect of Termination. Upon termination of the Agreement and this BAA, Covered Entity shall maintain no copies of the PHI and shall return or destroy all PHI that it maintains in any form. This provision applies to PHI that is in the possession of subcontractors or agents of Covered Entity. In the event that Covered Entity determines that returning or destroying the PHI is infeasible, Covered Entity shall provide to Business Associate notification of the conditions that make return or destruction infeasible. Covered Entity shall extend the protections of this BAA to such PHI and limit further uses and disclosures of such PHI to those purposes that make the return or destruction infeasible, for so long as Covered Entity maintains such PHI. This section shall survive termination of the Agreement and this BAA.
6.    Miscellaneous.
a. Amendment. Upon the enactment of any law or regulation affecting the use and/or disclosure of PHI, or the publication of any court decision relating to any such law, or the publication of any interpretive policy, opinion or guidance of any governmental agency charged with the enforcement of any such law or regulation, Business Associate may, by written notice to Covered Entity, amend this BAA to comply with such law or regulation. Covered Entity shall have thirty (30) calendar days to raise an objection to the proposed amendment. If Covered Entity objects to the amendment, the Parties shall negotiate in good faith to amend the BAA In a manner that complies with the law or regulation.
5


b.    Regulatory Reference. A reference in this BAA to a section in the Privacy Rule or Security Rule means the section as in effect or as amended.
c.    Entire BAA. This BAA constitutes the entire agreement between the Parties with respect to its subject matter and supersedes all past and contemporaneous business associate agreements or provisions, promises, and understandings, whether oral or written, between the Parties that relate to Covered Entity’s obligations as a business associate of Business Associate.
***

6


EXHIBIT K
FORM OF INTERIM SUBLEASE

1

[ENSG Draft 10.11.24]
INTERIM SUBLEASE AGREEMENT
THIS INTERIM SUBLEASE AGREEMENT (this “Sublease”) is made effective as of November 1, 2024 (the “Effective Date”), by and between ________________________ LLC, a ______________ limited liability company (“Sublessor”), and ____________________, LLC., a Tennessee limited liability company (“Sublessee”). Capitalized terms used herein and not otherwise defined shall have the meaning set out in the Interim Management Agreement (as defined below).
RECITALS
Pursuant to that certain Operations Transfer Agreement dated _____________, 2024 (the “OTA”) by and between Sublessor and Sublessee, Sublessor has acquired certain Assets of Sublessee;
Also concurrent with the execution of this Sublease, Sublessor has entered into an [Sublease/Lease Agreement] dated as of November 1, 2024, as the “[Tenant/Subtenant]” thereunder, with _________________ LLC, a _____________ limited liability company as the [“Landlord/Sublandlord”] thereunder (the “Lease”) for that certain health care facility known as AHC ____________________, located at ______________________________________ (the “Facility”);
Sublessor, as the new subtenant of the Facility, desires to sublease to Sublessee, and Sublessee desires to sublease from Sublessor, the Facility pursuant to the terms of this Sublease; and Further concurrent with the execution of this Sublease, Sublessor has entered into an Interim Management Agreement (the “Management Agreement”) to manage the Facility on behalf of Sublessee for an interim period.
NOW, THEREFORE, in consideration of the promises, covenants and agreements contained herein, the receipt and sufficiency of which is hereby agreed and acknowledged, Sublessee and Sublessor, intending to be legally bound, agree as follows:
1.    Sublease. Sublessor hereby subleases to Sublessee for the Term, upon all of the conditions set forth in this Sublease, the use of the Facility.
2.    Term. The term of this Sublease shall be coterminous with the Management Agreement; provided that, in the event of a termination of the Management Agreement for an event of default by Manager which results in the termination of the Lease, termination of possession thereunder, eviction, or a similar remedy, then at Sublessee’s sole option, this Sublease shall continue to allow the parties to assist in transition of the Facility, the management rights, and the Assets to a substitute Manager.
3.    Delivery of Sublease Area. Upon the mutual execution and delivery of this Sublease, Sublessor will deliver possession of the Facility to Sublessee.
1

[ENSG Draft 10.11.24]
4.    Sublease Fee; Management Company. During the Term, Sublessor will charge Sublessee a $10.00 annual rental fee for the use of the Facility. The Management Agreement shall be further consideration hereunder, and the Manager shall occupy the Facility pursuant to the terms of this Sublease and shall manage the daily operations in the Facility.
5.    Operating, Maintenance and Insurance Covenants. Sublessor and Sublessee acknowledge and agree that the operation, maintenance and insurance of the Facility during the term of the Sublease shall be governed by the terms of the Management Agreement and the OTA. A default by Sublessee or Sublessor of their respective obligations under the Management Agreement and/or the OTA shall be a default by Sublessee or Sublessor (as applicable) in its obligations under this Sublease. In the event of a conflict between this Sublease and either the Management Agreement or the OTA, Sublessor and Sublessee agree the provisions of the Management Agreement or the OTA (as applicable) shall control.
6.    Notices. All notices and other communications given or made pursuant to the notice provisions set out in the OTA.
7.    Entire Agreement. This Sublease, together with the Management Agreement, the OTA, and the other agreements executed as required by the OTA, (i) constitutes the sole agreement between the parties regarding the matters contained herein, (ii) supersedes all prior understandings and writings, and (iii) may be altered, modified or amended only by a writing signed by both parties hereto. In the event of a conflict between this Sublease and the Management Agreement, the Management Agreement shall control. In the event of a conflict between this Sublease and the OTA, the OTA shall control.
8.    Amendments. This Sublease may be amended at any time only by the written agreement of Sublessee and Sublessor. All amendments, changes, revisions and discharges of this Sublease, in whole or in part, and from time to time, shall be binding upon the parties despite any lack of legal consideration, so long as the same shall be in writing and executed by the parties.
9.    No Third Party Benefit. This Sublease is intended to benefit only the parties to this Sublease, and no other person or entity has or shall acquire any rights under this Sublease.
10.    Nonrecourse to Related Parties. Sublessor’s and Sublessee’s obligations under this Agreement are not with recourse to any manager, officer, director, employee, member, shareholder or agent of either, except to the extent such person is acting as the Transferee Guarantor under the OTA.
11.    Counterparts. This Sublease may be executed in counterparts, each of which shall be deemed an original. Executed counterparts may be delivered by facsimile (and/or Adobe PDF), and shall be effective when received, with the original copy sent by overnight delivery service. This Sublease shall be of no force or effect unless and until it has been executed and delivered by both parties.
2

[ENSG Draft 10.11.24]
12.    Construction; Choice of Law. This Sublease shall be construed under and shall be governed by the laws of the state where the Facility is located. Each party waives any objection to venue in such state.
[Signatures appear on next page]
3


IN WITNESS WHEREOF, the parties have executed this Sublease as of the date first written above.
SUBLESSOR:
______________________, LLC
a ____________ limited liability company
By:    
Printed Name:    
Its:    
SUBLESSEE:
______________________, LLC
a Tennessee limited liability company
By:    
Printed Name:    
Its:    

1


EXHIBIT L
LIST OF REQUIRED CONSENTS

1


EXHIBIT M
CURRENT RESIDENT CENSUS
Facility ADC As of 10/20
Applingwood 70
Bethesda 81
Bright Glade 67
Clarksville 100
Covington Care 80
Crestview 83
Cumberland Manor 111
Decatur County 72
Dyersburg 93
Forest Cove 75
Harbor View 86
Humboldt 60
Lewis Co 75
Lexington 77
McKenzie 68
McNairy County 85
Meadowbrook 64
Millennium 79
Mt. Juliet 87
Northbrooke 85
Northside 67
Paris 100
Savannah 105
Union City 78
Van Ayer 64
Vanco Manor 82
Waverly 60
Westwood 40
VVTTC 58
Knoxville 112
Wellpark 26
2,390.0


1


EXHIBIT N
FORM OF INTERIM INDEMNITY GUARANTY

1


INTERIM INDEMNITY GUARANTY
This INTERIM INDEMNITY GUARANTY (this “Guaranty”) dated as of ________________, 2024 (the “Effective Date”), is executed by AMPHARM, LLC, a Delaware limited liability company (the “Guarantor”), to and for the benefit of each party set forth on Exhibit A attached hereto (collectively, “Transferee” or “Transferees”).
RECITALS:
A.    Pursuant to that certain Asset Purchase Agreement dated October __, 2024 (the “APA by and between the Seller Parties set forth on Exhibit B hereto (the “Seller”) and the parties set forth on Exhibit C (the “Purchaser”), Seller agreed to sell, and the Purchaser agreed to purchase, certain skilled nursing facilities from the Seller.
B.    Pursuant to Section 3.6 of the APA, certain affiliates of Seller and certain of the Transferees entered into those certain Operations Transfer Agreements dated October __, 2024 (the “OTAs”), with respect to the transition of the operations of the Facilities.
C.    Guarantor is an affiliate of Seller and will receive substantial benefit as a result of the closing of the transactions contemplated by the APA (and the anticipated subsequent closing of the OTAs), and has agreed to deliver this Guaranty to Transferee to induce Purchaser and Transferees to consummate the Closing under the APA and the subsequent closing under the OTAs.
NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Guarantor hereby agrees as follows:
A G R E E M E N T S:
1.    Guaranty.
a.    Subject to the provisions of this Guaranty, Guarantor hereby unconditionally, absolutely and irrevocably guarantees to the Transferees, jointly and severally, the punctual payment and performance when due, of the Obligations (as defined herein).
b.    “Obligations” means any of the following Losses incurred by Transferees with respect to the Facilities set forth on Exhibit D (the “Applicable Facilities”)9 (a) any and all reasonable out-of-pocket costs necessary to cure any survey deficiencies identified by Governmental Authorities at the Applicable Facilities in the course of inspections conducted by such Governmental Authorities for purposes of enabling the parties to satisfy the Licensure Condition; provided, however, Guarantor shall have no liability hereunder with respect to deficiencies at the Applicable Facilities first ari
9 NTD: To reflect Facilities subject to IMA due to last survey having occurred more than 15 months prior to the Initial Closing Date.
1


sing from the actions or inactions of Purchaser or the Transferees at the Applicable Facilities from and after the Initial Closing Date; and (ii) any recoupment made against any Transferee’s Medicaid receivables at the Applicable Facilities generated during the Interim Period which recoupments relate to the period prior to the Interim Period during which Seller owned or operated the Applicable Facilities.
c.    This Guaranty is a present and continuing guaranty of obligations and not of collectability. One or more successive actions may be brought against the Guarantor, as often as the Transferees deem advisable, until all of the Obligations are paid and performed in full.
2.    Representations and Warranties. The following shall constitute representations and warranties of the Guarantor, and the Guarantor hereby acknowledges that the Transferees are relying on such representations and warranties:
(a)    The Guarantor is an entity duly organized, validly existing and in good standing under the Laws of the jurisdiction of its organization.
(b)    The Guarantor has all necessary corporate, partnership or similar power and authority to enter into the documents and instruments to be executed and delivered by Guarantor pursuant hereto and to carry out the transactions contemplated hereby. The execution and delivery of this Guaranty and the performance of this Guaranty by Guarantor has been duly and validly authorized. This Guaranty constitutes the legal, valid and binding obligation of Guaranty, enforceable against Transferor in accordance with its terms.redline
(c)    The Guarantor is not in default, and no event has occurred which, with the passage of time and/or the giving of notice, would constitute a default, under any agreement to which the Guarantor is a party, the effect of which will impair performance by the Guarantor of its obligations under this Guaranty. Neither the execution and delivery of this Guaranty nor compliance with the terms and provisions hereof will violate any applicable law, rule, regulation, judgment, decree or order, or will conflict with or result in any breach of any of the terms, covenants, conditions or provisions of any indenture, mortgage, deed of trust, instrument, document, agreement or contract of any kind that creates, represents, evidences or provides for any lien, charge or encumbrance upon any of the property or assets of the Guarantor, or any other indenture, mortgage, deed of trust, instrument, document, agreement or contract of any kind to which the Guarantor is a party or to which the Guarantor or the property of the Guarantor may be subject.
(d)    There are no litigation, arbitration, governmental or administrative proceedings, actions, examinations, claims or demands pending, or to the knowledge of the Guarantor, threatened in writing that could adversely affect performance by the Guarantor of the Obligations under this Guaranty.
2


(e)    Neither this Guaranty nor, to Guarantor’s knowledge, any statement or certification as to facts previously furnished or required herein to be furnished to the Transferee by the Guarantor, contains any material inaccuracy or untruth in any representation, covenant or warranty or omits to state a fact material to this Guaranty.
3.    Continuing Guaranty. The Guarantor agrees that, except as expressly set forth in this Guaranty, the performance of the Obligations by the Guarantor shall not be subject to any counterclaim, set-off, abatement, deferment or defense based upon any claim that the Guarantor may have against the Transferees or any Purchaser Indemnified Party, and shall remain in full force and effect without regard to, and shall not be released, discharged or affected in any way by, any circumstance or condition other than as a result of the termination of this Guaranty as provided for in Section 7 hereof.
4.    Waivers. The Guarantor expressly and unconditionally waives and agrees not to assert or take advantage of (i) all notices which may be required by statute, rule of law or otherwise, now or hereafter in effect, to preserve intact any rights against the Guarantor, including, without limitation, any demand, presentment and protest, proof of notice of non-payment under any of the Transaction Documents or any failure on the part of the Guarantor or its affiliates to perform or comply with any covenant, agreement, term or condition of any of the Transaction Documents, (ii) any requirement of diligence on the part of any person or entity, and (iii) any notice of any sale, transfer or other disposition of any right, title or interest of the Transferee under any of the Transaction Documents. Notwithstanding anything herein to the contrary, Guarantor shall be entitled to assert any defense, claim, set-off or other right which any Seller may have against Purchaser or any of Transferees or their Affiliates or any other Purchaser Indemnified Party with respect to the Obligations.
5.    Subordination. The Guarantor agrees that any and all present and future debts and obligations of the Seller and/or Transferors to the Guarantor are hereby subordinated to the claims of the Transferee.
6.    Defense.
(a) Transferee shall promptly give notice (each, a “Notice of Indemnification”) to Guarantor after obtaining written notice of any matter as to which recovery may be sought against such Guarantor relating to the Obligations set forth above and, if Guarantor provides written notice to Transferee stating that Guarantor is responsible for the entire claim within ten (10) days after Guarantor’s receipt of the applicable Notice of Indemnification, shall permit such Guarantor to assume the defense of any such claim or any proceeding resulting from such claim; provided, however, that failure to give any such Notice of Indemnification promptly shall not affect the Obligations of Guarantor under this Agreement except, and only to the extent, that Guarantor shall have been actually prejudiced as a result of such failure or if such Notice of Indemnification is not given to Guarantor prior the expiration of the Term. If Guarantor assumes the defense of such claim, Guarantor shall have full and complete control over the conduct of such proceeding on behalf of Transferee and shall, subject to the provisions of this Section 6, have the right to decide all matters of procedure, strategy, substance and settlement relating to such proceeding; provided, further, however, that any counsel chosen by such Guarantor to conduct such defense shall be reasonably satisfactory to Transferee; and provided, further, however, that Guarantor shall not without the written consent of Transferee consent to the entry of any judgment or enter into any settlement with respect to the matter which does not include a provision whereby the claimant in the matter releases Transferee from all liability with respect thereto.
3


(b)    If Guarantor does not elect to assume the defense of any such claim related to the Obligations, Transferee shall diligently defend against such claim or litigation in such manner as it may reasonably deem appropriate and, in such event, Guarantor shall reimburse Transferee for all reasonable and actually incurred out-of-pocket costs and expenses, legal or otherwise, incurred by Transferee and its affiliates in connection with the defense against such claim or proceeding, within thirty (30) days after the receipt of detailed invoices.
(c)    Transferee will cooperate in all reasonable respects with Guarantor in the conduct of any proceeding as to which such Guarantor assumes the defense, except to the extent Transferee could reasonably be expected to be prejudiced thereby. Guarantor shall promptly reimburse Transferee for all reasonable out-of-pocket costs and expenses, legal or otherwise, incurred by Transferee and its affiliates in connection therewith, within thirty (30) days after the receipt of detailed invoices therefor.
7.    Termination; Reinstatement. Guarantor’s obligations hereunder shall remain in full force and effect for a period of one hundred eighty (180) days after the expiration of the Interim Period for each of the Applicable Facilities (the “Term”); provided that if any claims have been made under this Guaranty prior to the expiration of the Term and such claims have not been satisfied by the Guarantor prior to the expiration of the Term (each, an “Unsatisfied Claim”), the Term shall be extended with respect to such Unsatisfied Claim until such Unsatisfied Claim have been indefeasibly paid and performed in full (the “Extended Term”); provided, however, that the Extended Term shall automatically expire if the Transferee does not bring a judicial action against the Guarantor with respect to any such Unsatisfied Claim within the sixty (60) day period following the expiration of the Term.
8.    Reserved.
9.    Transfers; Sales, Etc. Guarantor shall not intentionally take any action that would have a material adverse effect on the Guarantor’s ability to pay any of its liabilities or perform any of its Obligations under this Guaranty.
10. Enforcement Costs. If: (a) this Guaranty is placed in the hands of one or more attorneys for collection or is collected through any legal proceeding; (b) one or more attorneys is retained to represent the Transferees in any bankruptcy, reorganization, receivership or other proceedings affecting creditors’ rights and involving a claim under this Guaranty, or (c) one or more attorneys is retained to represent the Transferees in any other proceedings whatsoever in connection with this Guaranty, then the Guarantor shall pay to the Transferees upon demand all reasonable fees, costs and expenses incurred by the Transferees in connection therewith, including, without limitation, reasonable attorney’s fees, accountant fees, expert witness fees, and all court costs and filing fees (all of which are referred to herein as the “Enforcement Costs”), in addition to all other amounts due hereunder.
4


11.    Successors and Assigns. This Guaranty shall inure to the benefit of the Transferee and its successors and assigns.
12.    No Waiver of Rights. No delay or failure on the part of the Transferee to exercise any right, power or privilege under this Guaranty or any of the other Transaction Documents shall operate as a waiver thereof, and no single or partial exercise of any right, power or privilege shall preclude any other or further exercise thereof or the exercise of any other power or right, or be deemed to establish a custom or course of dealing or performance between the parties hereto. The rights and remedies herein provided are cumulative and not exclusive of any rights or remedies provided by law. No notice to or demand on the Guarantor in any case shall entitle the Guarantor to any other or further notice or demand in the same, similar or other circumstance.
13.    Modification. The terms of this Guaranty may be waived, discharged, or terminated only by an instrument in writing signed by the parties affected by the change, waiver, discharge or termination. No amendment, modification, waiver or other change of any of the terms of this Guaranty shall be effective without the prior written consent of the Transferees.
14.    Severability. If any provision of this Guaranty is deemed to be invalid by reason of the operation of law, or by reason of the interpretation placed thereon by any administrative agency or any court, the Guarantor and the Transferees shall negotiate an equitable adjustment in the provisions of the same in order to effect, to the maximum extent permitted by law, the purpose of this Guaranty and the validity and enforceability of the remaining provisions, or portions or applications thereof, shall not be affected thereby and shall remain in full force and effect.
15.    Applicable Law. This Guaranty is governed as to validity, interpretation, effect and in all other respects by laws and decisions of the State of Tennessee.
16.    Notices. All notices and other communications given or made pursuant hereto shall be in writing and shall be deemed to have been duly given or made as of the date delivered if delivered personally or by a nationally recognized overnight courier service to the Parties at the following addresses (or at such other address for a Party as shall be specified by like notice, except that notices of changes of address shall be effective upon receipt):
To the Transferee:
With a copy to:    UB Greensfelder LLP
1660 West 2nd Street, Suite 1100
Cleveland, Ohio 44113-1406
Attn: Daniel Gottesman
5


To the Guarantor:    AMPharm, LLC
201 Jordan Rd, Suite 200
Franklin, TN 37067
Attn: Michael Bailey
Attn: Philip S. Clark, Esq.
With copy to:    Foley & Lardner LLP
301 E. Pine Street, Suite 1200
Orlando, Florida 32801
Attn: Matthew E. Jassak, Esq.
or to such other address or to such other Person as either Party shall have last designated by such notice to the other Party.
17.    CONSENT TO JURISDICTION. TO INDUCE THE TRANSFEREE TO ACCEPT THIS GUARANTY, THE GUARANTOR IRREVOCABLY AGREES THAT, SUBJECT TO THE TRANSFEREE’S SOLE AND ABSOLUTE ELECTION, ALL ACTIONS OR PROCEEDINGS IN ANY WAY ARISING OUT OF OR RELATED TO THIS GUARANTY WILL BE LITIGATED IN STATE OR FEDERAL COURTS IN TENNESSEE. THE GUARANTOR HEREBY CONSENTS AND SUBMITS TO THE JURISDICTION OF ANY STATE OR FEDERAL COURT LOCATED IN TENNESSEE, WAIVES PERSONAL SERVICE OF PROCESS AND AGREES THAT ALL SUCH SERVICE OF PROCESS MAY BE MADE BY REGISTERED MAIL DIRECTED TO THE GUARANTOR AT THE ADDRESS STATED HEREIN AND SERVICE SO MADE WILL BE DEEMED TO BE COMPLETED UPON ACTUAL RECEIPT.
18.    WAIVER OF JURY TRIAL. THE GUARANTOR AND THE TRANSFEREES (BY ACCEPTANCE HEREOF), HAVING BEEN REPRESENTED BY COUNSEL, KNOWINGLY AND VOLUNTARILY WAIVES ANY RIGHT TO A TRIAL BY JURY IN ANY ACTION OR PROCEEDING TO ENFORCE OR DEFEND ANY RIGHTS UNDER THIS GUARANTY OR UNDER ANY AMENDMENT, INSTRUMENT, DOCUMENT OR AGREEMENT DELIVERED OR WHICH MAY IN THE FUTURE BE DELIVERED IN CONNECTION HEREWITH AND AGREES THAT ANY SUCH ACTION OR PROCEEDING WILL BE TRIED BEFORE A COURT AND NOT BEFORE A JURY.
19.    DAMAGES DISCLAIMED. UNDER NO CIRCUMSTANCES SHALL GUARANTOR BE RESPONSIBLE OR LIABLE IN ANY WAY HEREUNDER FOR LOST PROFITS, INCIDENTAL, CONSEQUENTIAL, SPECIAL OR PUNITIVE DAMAGES, DIMINUTION IN VALUE, OR ANY EXEMPLARY DAMAGES, REGARDLESS OF WHETHER THE ACTION IS FOUNDED IN CONTRACT, TORT, STATUTORY OR OTHERWISE.
20.    Defined Terms. Capitalized terms not defined in this Guaranty shall have the meanings set forth in the APA.
6


21.    Electronic Signatures and Counterparts. Signed facsimile and copies of original signatures (including without limit photocopies and those in PDF format) of this Guaranty shall legally bind the parties to the same extent as originals. This Guaranty may be executed in counterparts, each of which will be deemed an original, but all of which together will constitute the same instrument.
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

7


IN WITNESS WHEREOF, Guarantor has executed this Guaranty as of the date first above written.
AMPHARM, LLC
a Delaware limited liability company
By:    
Name:    
Its:    

1


EXHIBIT A
TRANSFEREES

1


EXHIBIT B
SELLERS

1


EXHIBIT C
PURCHASERS

1


EXHIBIT D
APPLICABLE FACILITIES

1


EXHIBIT O
FORM OF EXECUTION DATE R&W GUARANTY

1


EXECUTION DATE R&W BREACH GUARANTY
This EXECUTION DATE R&W BREACH GUARANTY (this “Guaranty”) dated as of ________________, 2024 (the “Effective Date”), is executed by AMPHARM, LLC, a Delaware limited liability company (the “Guarantor”), to and for the benefit of each party set forth on Exhibit A attached hereto (collectively, “Transferee” or “Transferees”).
RECITALS:
A.    Pursuant to that certain Asset Purchase Agreement dated October __, 2024 (the “APA”), by and between the Seller Parties set forth on Exhibit B hereto (the “Seller”) and the parties set forth on Exhibit C hereto (the “Purchaser”), Seller agreed to sell, and the Purchaser agreed to purchase, certain skilled nursing facilities from the Seller.
B.    Pursuant to Section 3.6 of the APA, certain affiliates of Seller and certain of the Transferees entered into those certain Operations Transfer Agreements dated October __, 2024 (the “OTAs”), with respect to the transition of the operations of the Facilities.
C.    Guarantor is an affiliate of Seller and will receive substantial benefit as a result of the consummation of the transactions contemplated by the APA and OTAs, and has agreed to deliver this Guaranty to Transferee to induce Purchaser and Transferees to consummate the transactions contemplated under the APA and the OTAs.
NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Guarantor hereby agrees as follows:
A G R E E M E N T S:
1.    Guaranty.
a.    Subject to the provisions of this Guaranty, Guarantor hereby unconditionally, absolutely and irrevocably guarantees to the Transferees, jointly and severally, the punctual payment and performance when due, of the Obligations (as defined herein).
b.    “Obligations” means any Losses incurred by Transferees arising from the Execution Date R&W Breach(es) set forth on Exhibit D (the “Breach Claims”) which Breach Claims are either (a) acknowledged in writing by Seller as a breach of Seller’s representations and warranties under the APA and OTAs as of the Execution Date, or (b) finally determined by a court of competent jurisdiction to be a breach of Seller’s representations and warranties under the APA and OTAs as of the Execution Date.
c.    This Guaranty is a present and continuing guaranty of obligations and not of collectability. One or more successive actions may be brought against the Guarantor, as often as the Transferees deem advisable, until all of the Obligations are paid and performed in full.
1


2.    Representations and Warranties. The following shall constitute representations and warranties of the Guarantor, and the Guarantor hereby acknowledges that the Transferees are relying on such representations and warranties:
(a)    The Guarantor is an entity duly organized, validly existing and in good standing under the Laws of the jurisdiction of its organization.
(b)    The Guarantor has all necessary corporate, partnership or similar power and authority to enter into the documents and instruments to be executed and delivered by Guarantor pursuant hereto and to carry out the transactions contemplated hereby. The execution and delivery of this Guaranty and the performance of this Guaranty by Guarantor has been duly and validly authorized. This Guaranty constitutes the legal, valid and binding obligation of Guaranty, enforceable against Transferor in accordance with its terms.
(c)    The Guarantor is not in default, and no event has occurred which, with the passage of time and/or the giving of notice, would constitute a default, under any agreement to which the Guarantor is a party, the effect of which will impair performance by the Guarantor of its obligations under this Guaranty. Neither the execution and delivery of this Guaranty nor compliance with the terms and provisions hereof will violate any applicable law, rule, regulation, judgment, decree or order, or will conflict with or result in any breach of any of the terms, covenants, conditions or provisions of any indenture, mortgage, deed of trust, instrument, document, agreement or contract of any kind that creates, represents, evidences or provides for any lien, charge or encumbrance upon any of the property or assets of the Guarantor, or any other indenture, mortgage, deed of trust, instrument, document, agreement or contract of any kind to which the Guarantor is a party or to which the Guarantor or the property of the Guarantor may be subject.
(d)    There are no litigation, arbitration, governmental or administrative proceedings, actions, examinations, claims or demands pending, or to the knowledge of the Guarantor, threatened in writing that could adversely affect performance by the Guarantor of the Obligations under this Guaranty.
(e)    Neither this Guaranty nor, to Guarantor’s knowledge, any statement or certification as to facts previously furnished or required herein to be furnished to the Transferee by the Guarantor, contains any material inaccuracy or untruth in any representation, covenant or warranty or omits to state a fact material to this Guaranty.
3.    Continuing Guaranty. The Guarantor agrees that, except as expressly set forth in this Guaranty, the performance of the Obligations by the Guarantor shall not be subject to any counterclaim, set-off, abatement, deferment or defense based upon any claim that the Guarantor may have against the Transferees or any Purchaser Indemnified Party, and shall remain in full force and effect without regard to, and shall not be released, discharged or affected in any way by, any circumstance or condition other than as a result of the termination of this Guaranty as provided for in Section 7 hereof.
2


4.    Waivers. The Guarantor expressly and unconditionally waives and agrees not to assert or take advantage of (i) all notices which may be required by statute, rule of law or otherwise, now or hereafter in effect, to preserve intact any rights against the Guarantor, including, without limitation, any demand, presentment and protest, proof of notice of non-payment under any of the Transaction Documents or any failure on the part of the Guarantor or its affiliates to perform or comply with any covenant, agreement, term or condition of any of the Transaction Documents, (ii) any requirement of diligence on the part of any person or entity, and (iii) any notice of any sale, transfer or other disposition of any right, title or interest of the Transferee under any of the Transaction Documents. Notwithstanding anything herein to the contrary, Guarantor shall be entitled to assert any defense, claim, set-off or other right which any Seller may have against Purchaser or any of Transferees or their Affiliates or any other Purchaser Indemnified Party with respect to the Obligations.
5.    Subordination. The Guarantor agrees that any and all present and future debts and obligations of the Seller and/or Transferors to the Guarantor are hereby subordinated to the claims of the Transferee.
6.    Defense.
(a)    Transferee shall promptly give notice (each, a “Notice of Indemnification”) to Guarantor after obtaining written notice of any matter as to which recovery may be sought against such Guarantor relating to the Obligations set forth above and, if Guarantor provides written notice to Transferee stating that Guarantor is responsible for the entire claim within ten (10) days after Guarantor’s receipt of the applicable Notice of Indemnification, shall permit such Guarantor to assume the defense of any such claim or any proceeding resulting from such claim; provided, however, that failure to give any such Notice of Indemnification promptly shall not affect the Obligations of Guarantor under this Agreement except, and only to the extent, that Guarantor shall have been actually prejudiced as a result of such failure or if such Notice of Indemnification is not given to Guarantor prior the expiration of the Term. If Guarantor assumes the defense of such claim, Guarantor shall have full and complete control over the conduct of such proceeding on behalf of Transferee and shall, subject to the provisions of this Section 6, have the right to decide all matters of procedure, strategy, substance and settlement relating to such proceeding; provided, further, however, that any counsel chosen by such Guarantor to conduct such defense shall be reasonably satisfactory to Transferee; and provided, further, however, that Guarantor shall not without the written consent of Transferee consent to the entry of any judgment or enter into any settlement with respect to the matter which does not include a provision whereby the claimant in the matter releases Transferee from all liability with respect thereto.
(b) If Guarantor does not elect to assume the defense of any such claim related to the Obligations, Transferee shall diligently defend against such claim or litigation in such manner as it may reasonably deem appropriate and, in such event, Guarantor shall reimburse Transferee for all reasonable and actually incurred out-of-pocket costs and expenses, legal or otherwise, incurred by Transferee and its affiliates in connection with the defense against such claim or proceeding, within thirty (30) days after the receipt of detailed invoices.
3


(c)    Transferee will cooperate in all reasonable respects with Guarantor in the conduct of any proceeding as to which such Guarantor assumes the defense, except to the extent Transferee could reasonably be expected to be prejudiced thereby. Guarantor shall promptly reimburse Transferee for all reasonable out-of-pocket costs and expenses, legal or otherwise, incurred by Transferee and its affiliates in connection therewith, within thirty (30) days after the receipt of detailed invoices therefor.
7.    Termination; Reinstatement. Guarantor’s obligations hereunder shall remain in full force and effect for a period of one hundred and eighty days after the Effective Date (the “Term”); provided that if any claims have been made under this Guaranty prior to the expiration of the Term and such claims have not been satisfied by the Guarantor prior to the expiration of the Term (each, an “Unsatisfied Claim”), the Term shall be extended with respect to such Unsatisfied Claim until such Unsatisfied Claim have been indefeasibly paid and performed in full (the “Extended Term”); provided, however, that the Extended Term shall automatically expire if the Transferee does not bring a judicial action against the Guarantor with respect to any such Unsatisfied Claim within the sixty (60) day period following the expiration of the Term.
8.    Reserved.
9.    Transfers; Sales, Etc. Guarantor shall not intentionally take any action that would have a material adverse effect on the Guarantor’s ability to pay any of its liabilities or perform any of its Obligations under this Guaranty.
10.    Enforcement Costs. If: (a) this Guaranty is placed in the hands of one or more attorneys for collection or is collected through any legal proceeding; (b) one or more attorneys is retained to represent the Transferees in any bankruptcy, reorganization, receivership or other proceedings affecting creditors’ rights and involving a claim under this Guaranty, or (c) one or more attorneys is retained to represent the Transferees in any other proceedings whatsoever in connection with this Guaranty, then the Guarantor shall pay to the Transferees upon demand all reasonable fees, costs and expenses incurred by the Transferees in connection therewith, including, without limitation, reasonable attorney’s fees, accountant fees, expert witness fees, and all court costs and filing fees (all of which are referred to herein as the “Enforcement Costs”), in addition to all other amounts due hereunder.
11.    Successors and Assigns. This Guaranty shall inure to the benefit of the Transferee and its successors and assigns.
12. No Waiver of Rights. No delay or failure on the part of the Transferee to exercise any right, power or privilege under this Guaranty or any of the other Transaction Documents shall operate as a waiver thereof, and no single or partial exercise of any right, power or privilege shall preclude any other or further exercise thereof or the exercise of any other power or right, or be deemed to establish a custom or course of dealing or performance between the parties hereto. The rights and remedies herein provided are cumulative and not exclusive of any rights or remedies provided by law. No notice to or demand on the Guarantor in any case shall entitle the Guarantor to any other or further notice or demand in the same, similar or other circumstance.
4


13.    Modification. The terms of this Guaranty may be waived, discharged, or terminated only by an instrument in writing signed by the parties affected by the change, waiver, discharge or termination. No amendment, modification, waiver or other change of any of the terms of this Guaranty shall be effective without the prior written consent of the Transferees.
14.    Severability. If any provision of this Guaranty is deemed to be invalid by reason of the operation of law, or by reason of the interpretation placed thereon by any administrative agency or any court, the Guarantor and the Transferees shall negotiate an equitable adjustment in the provisions of the same in order to effect, to the maximum extent permitted by law, the purpose of this Guaranty and the validity and enforceability of the remaining provisions, or portions or applications thereof, shall not be affected thereby and shall remain in full force and effect.
15.    Applicable Law. This Guaranty is governed as to validity, interpretation, effect and in all other respects by laws and decisions of the State of Tennessee.
16.    Notices. All notices and other communications given or made pursuant hereto shall be in writing and shall be deemed to have been duly given or made as of the date delivered if delivered personally or by a nationally recognized overnight courier service to the Parties at the following addresses (or at such other address for a Party as shall be specified by like notice, except that notices of changes of address shall be effective upon receipt):
To the Transferee:
With a copy to:    UB Greensfelder LLP
1660 West 2nd Street, Suite 1100
Cleveland, Ohio 44113-1406
Attn: Daniel Gottesman
To the Guarantor:    AMPharm, LLC
201 Jordan Rd, Suite 200
Franklin, TN 37067
Attn: Michael Bailey
Attn: Philip S. Clark, Esq.
With copy to:    Foley & Lardner LLP
301 E. Pine Street, Suite 1200
Orlando, Florida 32801
Attn: Matthew E. Jassak, Esq.
or to such other address or to such other Person as either Party shall have last designated by such notice to the other Party.
5


17.    CONSENT TO JURISDICTION. TO INDUCE THE TRANSFEREE TO ACCEPT THIS GUARANTY, THE GUARANTOR IRREVOCABLY AGREES THAT, SUBJECT TO THE TRANSFEREE’S SOLE AND ABSOLUTE ELECTION, ALL ACTIONS OR PROCEEDINGS IN ANY WAY ARISING OUT OF OR RELATED TO THIS GUARANTY WILL BE LITIGATED IN STATE OR FEDERAL COURTS IN TENNESSEE. THE GUARANTOR HEREBY CONSENTS AND SUBMITS TO THE JURISDICTION OF ANY STATE OR FEDERAL COURT LOCATED IN TENNESSEE, WAIVES PERSONAL SERVICE OF PROCESS AND AGREES THAT ALL SUCH SERVICE OF PROCESS MAY BE MADE BY REGISTERED MAIL DIRECTED TO THE GUARANTOR AT THE ADDRESS STATED HEREIN AND SERVICE SO MADE WILL BE DEEMED TO BE COMPLETED UPON ACTUAL RECEIPT.
18.    WAIVER OF JURY TRIAL. THE GUARANTOR AND THE TRANSFEREES (BY ACCEPTANCE HEREOF), HAVING BEEN REPRESENTED BY COUNSEL, KNOWINGLY AND VOLUNTARILY WAIVES ANY RIGHT TO A TRIAL BY JURY IN ANY ACTION OR PROCEEDING TO ENFORCE OR DEFEND ANY RIGHTS UNDER THIS GUARANTY OR UNDER ANY AMENDMENT, INSTRUMENT, DOCUMENT OR AGREEMENT DELIVERED OR WHICH MAY IN THE FUTURE BE DELIVERED IN CONNECTION HEREWITH AND AGREES THAT ANY SUCH ACTION OR PROCEEDING WILL BE TRIED BEFORE A COURT AND NOT BEFORE A JURY.
19.    DAMAGES DISCLAIMED. UNDER NO CIRCUMSTANCES SHALL GUARANTOR BE RESPONSIBLE OR LIABLE IN ANY WAY HEREUNDER FOR LOST PROFITS, INCIDENTAL, CONSEQUENTIAL, SPECIAL OR PUNITIVE DAMAGES, DIMINUTION IN VALUE, OR ANY EXEMPLARY DAMAGES, REGARDLESS OF WHETHER THE ACTION IS FOUNDED IN CONTRACT, TORT, STATUTORY OR OTHERWISE.
20.    Defined Terms. Capitalized terms not defined in this Guaranty shall have the meanings set forth in the APA.
21.    Electronic Signatures and Counterparts. Signed facsimile and copies of original signatures (including without limit photocopies and those in PDF format) of this Guaranty shall legally bind the parties to the same extent as originals. This Guaranty may be executed in counterparts, each of which will be deemed an original, but all of which together will constitute the same instrument.
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

6


IN WITNESS WHEREOF, Guarantor has executed this Guaranty as of the date first above written.
AMPHARM, LLC
a Delaware limited liability company
By:    
Name:    
Its:    

7


EXHIBIT A
TRANSFEREES

8


EXHIBIT B
SELLERS

9


EXHIBIT C
PURCHASERS

10


EXHIBIT D
LIST OF BREACH CLAIMS

11


EXHIBIT P
FORM OF CID GUARANTY

12

Foley Draft 10.21.24
CID GUARANTY
This CID GUARANTY (this “Guaranty”) dated as of _____________, 2024 (the “Effective Date”), is executed by MFO AHP LLC, a Michigan limited liability company (the “Guarantor”), to and for the benefit of each party set forth on Exhibit A attached hereto (individually and collectively as the context requires, “Purchaser”).
RECITALS:
A.    Pursuant to that certain Asset Purchase Agreement dated October 21, 2024 (the “APA”) by and between the Purchaser and the parties set forth on Exhibit B hereto (the “Seller”), Seller agreed to sell, and the Purchaser agreed to purchase, certain skilled nursing facilities from the Seller.
B.    Pursuant to Section 3.6 of the APA, certain affiliates of Seller set forth on Exhibit C hereto (the “Transferors”) and the parties set forth on Exhibit D hereto (the “Transferees”) entered into those certain Operations Transfer Agreements dated October 21, 2024 (the “OTAs”), with respect to the transition of the operations of the skilled nursing facilities set forth on Exhibit E (the “Facilities”).
C.    Guarantor is an Affiliate of Seller and will receive substantial benefit as a result of the consummation of the transactions contemplated by the APA and OTAs, and has agreed to deliver this Guaranty to Purchaser to induce Purchaser to consummate the transactions contemplated under the APA and the OTAs.
NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Guarantor hereby agrees as follows:
A G R E M E N T S:
1.    Guaranty.
a.    Subject to the provisions of this Guaranty, Guarantor hereby unconditionally, absolutely and irrevocably guarantees to the Purchaser, jointly and severally, the punctual payment and performance when due, of the Obligations (as defined herein).
b.    “Losses” shall have the meaning set forth in the APA, and shall include, but in no way be limited to, (i) attorneys’ fees and costs, (ii) internal and private party file and data storage costs and expenses, (iii) costs in connection with coordinating interviews, depositions, records requests, documentation and electronic data fees, litigation, copying and data base maintenance, and (iv) costs of successfully enforcing any indemnification obligations provided hereunder.
13


c. “Obligations” means any Losses incurred by the Purchaser arising from (1) Civil Investigative Demand No. 24-872 (the “Unity CID”) received by American Home Companies, LLC d/b/a American Health Partners (AHC) from the United States Department of Justice (the “DOJ”), (2) Civil Investigative Demand Nos. 2024-MDTN-1017 and 2023-MDTN-1033 from the DOJ, and that certain State of Tennessee Civil Investigative Demand dated December 18, 2023 from the State of Tennessee Office of the Attorney General received by Lewis County Nursing and Rehabilitation Center, LLC (collectively, the “Lewis County CID”), (3) the Corporate Integrity Agreement dated February 1, 2019 entered into by Tennessee Health Management, Inc. and the Office of the Inspector General of the Department of Health and Human Services (the “CIA”) and (4) any future civil investigative demands or corporate integrity agreements which are based on actions taken by the Seller Parties prior to the Effective Date, in each case, to the extent caused, contributed to, enhanced, or exacerbated by the direct or indirect actions or inactions of the Seller Parties, the Guarantor or any of their Affiliates prior to the Effective Date (collectively, the “Liabilities”). The indemnification by Guarantor pursuant to the preceding sentence shall include (i) any expenses incurred by the Purchaser to comply with any additional civil investigative demand, subpoena or other document/information request by the DOJ, the State of Tennessee, the State of Alabama or any third party claimant relating to the Liabilities (including the reasonable costs of employees and counsel (including in-house counsel) incurred in connection with reviewing or complying with such document/information request), (ii) any expenses incurred by the Purchaser to comply with any document retention requests or demands by the Guarantor, the DOJ, the State of Tennessee, the State of Alabama or any third party claimant to the extent arising from the Liabilities where such requested document retention is not otherwise required of nursing home operators in the State of Alabama or Tennessee, (iii) any Losses incurred by the Purchaser relating to compliance with the terms of any corporate integrity agreement and/or settlement agreement imposed against the Purchaser and the Facilities to the extent arising from the Liabilities, and (iv) any penalties, fines, judgments, or recoveries, including any amounts under a settlement agreement, imposed or assessed against or obtained from the Purchaser and the Facilities to the extent arising from the Liabilities. Notwithstanding the foregoing, the “Obligations” shall not include any Losses incurred by Purchaser to the extent caused, contributed to, enhanced, or exacerbated by the direct or indirect actions or inactions of the Purchaser or any Transferee or their Affiliates from and after the Effective Date.
14


d. For the avoidance of doubt, Guarantor shall have the sole right to settle any determinations, actions, or proceedings arising out of the CID against Guarantor or its Affiliates unless any such proposed settlement (i) binds any of the Purchaser or any Facility to any form of injunctive or equitable relief, (ii) subjects Purchaser to any Losses which are not reimbursed by Guarantor pursuant to this Guaranty; or (iii) subjects any Purchaser or any Facility to a corporate integrity agreement or any agreement of a similar nature. In the event that any proposed settlement involves any of clauses (i), (ii) or (iii) above, then Guarantor may not settle any determinations, actions, or proceedings arising out of the CID investigation without express written consent of the Purchaser, which consent shall not be unreasonably withheld, conditioned or delayed.
2.    Representations and Warranties. The following shall constitute representations and warranties of the Guarantor, and the Guarantor hereby acknowledges that the Purchaser are relying on such representations and warranties:
(a)    The Guarantor is an entity duly organized, validly existing and in good standing under the Laws of the jurisdiction of its organization.
(b)    The Guarantor has all necessary corporate, partnership or similar power and authority to enter into the documents and instruments to be executed and delivered by Guarantor pursuant hereto and to carry out the transactions contemplated hereby. The execution and delivery of this Guaranty and the performance of this Guaranty by Guarantor has been duly and validly authorized. This Guaranty constitutes the legal, valid and binding obligation of Guarantor, enforceable against Guarantor in accordance with its terms.
(c)    The Guarantor is not in default, and no event has occurred which, with the passage of time and/or the giving of notice, would constitute a default, under any agreement to which the Guarantor is a party, the effect of which will impair performance by the Guarantor of its obligations under this Guaranty. Neither the execution and delivery of this Guaranty nor compliance with the terms and provisions hereof will violate any applicable law, rule, regulation, judgment, decree or order, or will conflict with or result in any breach of any of the terms, covenants, conditions or provisions of any indenture, mortgage, deed of trust, instrument, document, agreement or contract of any kind that creates, represents, evidences or provides for any lien, charge or encumbrance upon any of the property or assets of the Guarantor, or any other indenture, mortgage, deed of trust, instrument, document, agreement or contract of any kind to which the Guarantor is a party or to which the Guarantor or the property of the Guarantor may be subject.
(d)    There are no litigation, arbitration, governmental or administrative proceedings, actions, examinations, claims or demands pending, or to the knowledge of the Guarantor, threatened in writing that could adversely affect performance by the Guarantor of the Obligations under this Guaranty.
(e) Neither this Guaranty nor, to Guarantor’s knowledge, any statement or certification as to facts previously furnished or required herein to be furnished to the Purchaser by the Guarantor, contains any material inaccuracy or untruth in any representation, covenant or warranty or omits to state a fact material to this Guaranty.
15


3.    Continuing Guaranty. The Guarantor agrees that, except as expressly set forth in this Guaranty, the performance of the Obligations by the Guarantor shall not be subject to any counterclaim, set-off, abatement, deferment or defense based upon any claim that the Guarantor may have against the Purchaser or any Purchaser Indemnified Party, and shall remain in full force and effect without regard to, and shall not be released, discharged or affected in any way by, any circumstance or condition other than as a result of the termination of this Guaranty as provided for in Section 7 hereof.
4.    Waivers. The Guarantor expressly and unconditionally waives and agrees not to assert or take advantage of (i) all notices which may be required by statute, rule of law or otherwise, now or hereafter in effect, to preserve intact any rights against the Guarantor, including, without limitation, any demand, presentment and protest, proof of notice of non-payment under any of the Transaction Documents or any failure on the part of the Guarantor or its affiliates to perform or comply with any covenant, agreement, term or condition of any of the Transaction Documents, (ii) any requirement of diligence on the part of any person or entity, and (iii) any notice of any sale, transfer or other disposition of any right, title or interest of the Purchaser under any of the Transaction Documents. Notwithstanding anything herein to the contrary, Guarantor shall be entitled to assert any defense, claim, set-off or other right which any Seller may have against Purchaser or its Affiliates or any other Purchaser Indemnified Party with respect to the Obligations.
5.    Subordination. The Guarantor agrees that any and all present and future debts and obligations of the Seller and/or Transferors to the Guarantor are hereby subordinated to the claims of the Purchaser.
6.    Defense.
(a) Purchaser shall promptly give notice (each, a “Notice of Indemnification”) to Guarantor after obtaining written notice of any matter as to which recovery may be sought against such Guarantor relating to the Obligations set forth above and, if Guarantor provides written notice to Purchaser stating that Guarantor is responsible for the entire claim within ten (10) days after Guarantor’s receipt of the applicable Notice of Indemnification, shall permit such Guarantor to assume the defense of any such claim or any proceeding resulting from such claim; provided, however, that failure to give any such Notice of Indemnification promptly shall not affect the Obligations of Guarantor under this Agreement except, and only to the extent, that Guarantor shall have been actually prejudiced as a result of such failure or if such Notice of Indemnification is not given to Guarantor prior the expiration of the Term. If Guarantor assumes the defense of such claim, Guarantor shall have full and complete control over the conduct of such proceeding on behalf of Purchaser and shall, subject to the provisions of this Section 6, have the right to decide all matters of procedure, strategy, substance and settlement relating to such proceeding; provided, further, however, that any counsel chosen by such Guarantor to conduct such defense shall be reasonably satisfactory to Purchaser; and provided, further, however, that Guarantor shall not without the written consent of Purchaser consent to the entry of any judgment or enter into any settlement with respect to the matter which does not comply with the provisions of Section 1(c) or include a provision whereby the claimant in the matter releases Purchaser from all liability with respect thereto.
16


(b)    If Guarantor does not elect to assume the defense of any such claim related to the Obligations, Purchaser shall diligently defend against such claim or litigation in such manner as it may reasonably deem appropriate and, in such event, Guarantor shall (i) reimburse Purchaser for all reasonable and actually incurred out-of-pocket costs and expenses, legal or otherwise, incurred by Purchaser and its affiliates in connection with the defense against such claim or proceeding, within thirty (30) days after the receipt of detailed invoices and (ii) consummate the punctual payment and performance of all other Obligations of Guarantor under this Agreement.
(c)    Purchaser will cooperate in all reasonable respects with Guarantor in the conduct of any proceeding as to which such Guarantor assumes the defense, except to the extent Purchaser could reasonably be expected to be prejudiced thereby. Guarantor shall promptly reimburse Purchaser for all reasonable out-of-pocket costs and expenses, legal or otherwise, incurred by Purchaser and its affiliates in connection therewith, within thirty (30) days after the receipt of detailed invoices therefor.
7.    Termination; Reinstatement. Guarantor’s obligations hereunder shall remain in full force and effect until the earlier to occur of (a) such time as the Liabilities shall have been fully resolved to the reasonable satisfaction of the Purchaser (which shall include, but not be limited to (i) written evidence from the DOJ that it does not intend to pursue further action with respect to the subject matter of the Lewis County CID and the Unity CID, (ii) confirmation from the OIG that the CIA has been terminated, or (iii) a written agreement pursuant to which the DOJ agrees that the Purchaser shall not be subject to successor liability with respect to the subject matter of the CIA, the Unity CID and Lewis County CID) or (b) the eight (8) year anniversary of the Effective Date (the “Term”); provided that if any claims have been made under this Guaranty prior to the expiration of the Term and such claims have not been satisfied by the Guarantor prior to the expiration of the Term (each, an “Unsatisfied Claim”), the Term shall be extended with respect to such Unsatisfied Claim until such Unsatisfied Claim have been indefeasibly paid and performed in full (the “Extended Term”); provided, however, that the Extended Term shall automatically expire if the Purchaser does not bring a judicial action against the Guarantor with respect to any such Unsatisfied Claim within the sixty (60) day period following the expiration of the Term.
8.    Financial Covenants. Guarantor covenants to Purchaser that during the term of this Guaranty:
(a)    Guarantor shall maintain a minimum Liquidity of at least Fifteen Million Dollars ($15,000,000).
17


(i)    For purposes of this Section 8(a), “Liquidity” means assets of Guarantor or its subsidiaries held in cash, certificates of deposit, savings, deposit or investment accounts held with a financial institution, other unencumbered marketable securities, accrued interest and immediately available and unfunded portions of the Guarantor’s lines of credit.
(d)    Guarantor shall maintain a minimum Net Worth of at least Fifty Million Dollars ($50,000,000).
(i)    For purposes of this Section 8(b), “Net Worth” shall mean, as of the date of calculation, Total Assets minus Total Liabilities; “Total Assets” shall mean the sum of (a) Liquidity; and (b) the fair market value of the assets of Guarantor and its subsidiaries, valued in accordance with GAAP; and “Total Liabilities” shall mean aggregate liabilities of Guarantor and its subsidiaries, as determined on a consolidated basis in accordance with GAAP, including, without duplication, each of the following (determined on a consolidated basis), to the extent the amount thereof would be reflected as a liability in accordance with GAAP: (a) all indebtedness, obligations or other liabilities for borrowed money; (b) all reimbursement obligations and other liabilities with respect to letters of credit, banker's acceptances, surety bonds or similar instruments; and (c) all obligations in respect of capital leases.
(c)    Guarantor shall deliver to Purchaser, at the addresses set forth below in Section 16, within one hundred twenty (120) days after the expiration of each calendar year during the term of this Guaranty, copies of Guarantor’s balance sheet, certified as true and correct by a financial officer of the Guarantor.
9.    Transfers; Sales, Etc. Guarantor shall not intentionally take any action that would have a material adverse effect on the Guarantor’s ability to pay any of its liabilities or perform any of its Obligations under this Guaranty.
10.    Enforcement Costs. If: (a) this Guaranty is placed in the hands of one or more attorneys for collection or is collected through any legal proceeding; (b) one or more attorneys is retained to represent the Purchaser in any bankruptcy, reorganization, receivership or other proceedings affecting creditors’ rights and involving a claim under this Guaranty, or (c) one or more attorneys is retained to represent the Purchaser in any other proceedings whatsoever in connection with this Guaranty, then the Guarantor shall pay to the Purchaser upon demand all reasonable fees, costs and expenses incurred by the Purchaser in connection therewith, including, without limitation, reasonable attorney’s fees, accountant fees, expert witness fees, and all court costs and filing fees (all of which are referred to herein as the “Enforcement Costs”), in addition to all other amounts due hereunder.
11.    Successors and Assigns. This Guaranty shall inure to the benefit of the Purchaser and its successors and assigns.
18


12.    No Waiver of Rights. No delay or failure on the part of the Purchaser to exercise any right, power or privilege under this Guaranty or any of the other Transaction Documents shall operate as a waiver thereof, and no single or partial exercise of any right, power or privilege shall preclude any other or further exercise thereof or the exercise of any other power or right, or be deemed to establish a custom or course of dealing or performance between the parties hereto. The rights and remedies herein provided are cumulative and not exclusive of any rights or remedies provided by law. No notice to or demand on the Guarantor in any case shall entitle the Guarantor to any other or further notice or demand in the same, similar or other circumstance.
13.    Modification. The terms of this Guaranty may be waived, discharged, or terminated only by an instrument in writing signed by the parties affected by the change, waiver, discharge or termination. No amendment, modification, waiver or other change of any of the terms of this Guaranty shall be effective without the prior written consent of the Purchaser.
14.    Severability. If any provision of this Guaranty is deemed to be invalid by reason of the operation of law, or by reason of the interpretation placed thereon by any administrative agency or any court, the Guarantor and the Purchaser shall negotiate an equitable adjustment in the provisions of the same in order to effect, to the maximum extent permitted by law, the purpose of this Guaranty and the validity and enforceability of the remaining provisions, or portions or applications thereof, shall not be affected thereby and shall remain in full force and effect.
15.    Applicable Law. This Guaranty is governed as to validity, interpretation, effect and in all other respects by laws and decisions of the State of Tennessee.
16.    Notices. All notices and other communications given or made pursuant hereto shall be in writing and shall be deemed to have been duly given or made as of the date delivered if delivered personally or by a nationally recognized overnight courier service to the Parties at the following addresses (or at such other address for a Party as shall be specified by like notice, except that notices of changes of address shall be effective upon receipt):
To the Purchaser:
With a copy to:    UB Greensfelder LLP
1660 West 2nd Street, Suite 1100
Cleveland, Ohio 44113-1406
Attn: Daniel Gottesman
To the Guarantor:    MFO AHP LLC
201 Jordan Rd, Suite 200
Franklin, TN 37067
Attn: Michael Bailey
Attn: Philip S. Clark, Esq.
With copy to:    Foley & Lardner LLP
301 E. Pine Street, Suite 1200
19



Orlando, Florida 32801
Attn: Matthew E. Jassak, Esq.
or to such other address or to such other Person as either Party shall have last designated by such notice to the other Party.
17.    CONSENT TO JURISDICTION. TO INDUCE THE PURCHASER TO ACCEPT THIS GUARANTY, THE GUARANTOR IRREVOCABLY AGREES THAT, SUBJECT TO THE PURCHASER’S SOLE AND ABSOLUTE ELECTION, ALL ACTIONS OR PROCEEDINGS IN ANY WAY ARISING OUT OF OR RELATED TO THIS GUARANTY WILL BE LITIGATED IN STATE OR FEDERAL COURTS IN TENNESSEE. THE GUARANTOR HEREBY CONSENTS AND SUBMITS TO THE JURISDICTION OF ANY STATE OR FEDERAL COURT LOCATED IN TENNESSEE, WAIVES PERSONAL SERVICE OF PROCESS AND AGREES THAT ALL SUCH SERVICE OF PROCESS MAY BE MADE BY REGISTERED MAIL DIRECTED TO THE GUARANTOR AT THE ADDRESS STATED HEREIN AND SERVICE SO MADE WILL BE DEEMED TO BE COMPLETED UPON ACTUAL RECEIPT.
18.    WAIVER OF JURY TRIAL. THE GUARANTOR AND THE PURCHASER (BY ACCEPTANCE HEREOF), HAVING BEEN REPRESENTED BY COUNSEL, KNOWINGLY AND VOLUNTARILY WAIVES ANY RIGHT TO A TRIAL BY JURY IN ANY ACTION OR PROCEEDING TO ENFORCE OR DEFEND ANY RIGHTS UNDER THIS GUARANTY OR UNDER ANY AMENDMENT, INSTRUMENT, DOCUMENT OR AGREEMENT DELIVERED OR WHICH MAY IN THE FUTURE BE DELIVERED IN CONNECTION HEREWITH AND AGREES THAT ANY SUCH ACTION OR PROCEEDING WILL BE TRIED BEFORE A COURT AND NOT BEFORE A JURY.
19.    DAMAGES DISCLAIMED. UNDER NO CIRCUMSTANCES SHALL GUARANTOR BE RESPONSIBLE OR LIABLE IN ANY WAY HEREUNDER FOR LOST PROFITS, INCIDENTAL, CONSEQUENTIAL, SPECIAL OR PUNITIVE DAMAGES, DIMINUTION IN VALUE, OR ANY EXEMPLARY DAMAGES, REGARDLESS OF WHETHER THE ACTION IS FOUNDED IN CONTRACT, TORT, STATUTORY OR OTHERWISE.
20.    Defined Terms. Capitalized terms not defined in this Guaranty shall have the meanings set forth in the APA.
21.    Electronic Signatures and Counterparts. Signed facsimile and copies of original signatures (including without limit photocopies and those in PDF format) of this Guaranty shall legally bind the parties to the same extent as originals. This Guaranty may be executed in counterparts, each of which will be deemed an original, but all of which together will constitute the same instrument.
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

20


IN WITNESS WHEREOF, Guarantor has executed this Guaranty as of the date first above written.
MFO AHP LLC,
a Michigan limited liability company
By:    
Name:    
Its:    

1


EXHIBIT A
PURCHASER
1.    1536 APPLING CARE LANE TN LLC
2.    5070 SANDERLIN AVENUE TN LLC
3.    765 BERT JOHNSTON AVENUE TN LLC
4.    704 DUPREE ROAD TN LLC
5.    1900 PARR AVENUE TN LLC
6.    45 FOREST COVE TN LLC
7.    2031 AVONDALE STREET TN LLC
8.    175 HOSPITAL DRIVE TN LLC
9.    121 PHYSICIANS DR TN LLC
10.    800 VOLUNTEER DRIVE TN LLC
11.    1630 E REELFOOT AVE TN LLC
12.    597 WEST FOREST AVENUE TN LLC
13.    900 PROFESSIONAL PARK DRIVE TN LLC
14.    1513 N 2ND STREET TN LLC
15.    119 KITTRELL STREET TN LLC
16.    5275 MILLENNIUM DRIVE AL LLC
17.    460 HANNINGS LANE TN LLC
18.    444 ONE ELEVEN PLACE TN LLC
19.    4343 ASHLAND CITY HIGHWAY TN LLC
20.    726 KENTUCKY AVENUE S TN LLC
21.    727 EAST CHURCH STREET TN LLC
22.    835 EAST POPLAR AVENUE TN LLC
23.    1245 E COLLEGE ST TN LLC
24.    2650 NORTH MT JULIET ROAD TN LLC
25.    202 EAST MTCS ROAD TN LLC
26.    1645 FLORENCE RD TN LLC
27.    813 S DICKERSON RD TN LLC
28.    895 POWERS BLVD TN LLC
29.    524 WEST MAIN STREET TN LLC
30.    7424 MIDDLEBROOK PIKE TN LLC
31.    7512 MIDDLEBROOK PIKE TN LLC

1


EXHIBIT B
SELLERS
1.    APPLINGWOOD PROPCO LLC
2.    BRIGHT GLADE PROPCO LLC
3.    COVINGTON PROPCO LLC
4.    CRESTVIEW HEALTH PROPCO LLC
5.    DYERSBURG PROPCO LLC
6.    MCKENZIE PROPCO LLC
7.    NORTHBROOKE PROPCO LLC
8.    PARIS PROPCO LLC
9.    UNION CITY PROPCO LLC
10.    WEST TENNESSEE PROPCO LLC
11.    CLARKSVILLE PROPCO LLC
12.    LEWIS COUNTY PROPCO LLC
13.    MILLENNIUM PROPCO LLC
14.    VANAYER PROPCO LLC
15.    BETHESDA PROPCO LLC
16.    DECATUR COUNTY PROPCO LLC
17.    LEXINGTON PROPCO LLC
18.    MCNAIRY PROPCO LLC
19.    MEADOWBROOK PROPCO LLC
20.    MT. JULIET PROPCO LLC
21.    SAVANNAH PROPCO LLC
22.    VANCO PROPCO LLC
23.    WESTWOOD PROPCO LLC
24.    FOREST COVE LONG TERM FACILITY, LLC
25.    CKT PROPERTIES, LLC
26.    HARBOR VIEW PROPERTIES, LLC
27.    CUMBERLAND LONG TERM FACILITY, LLC
28.    NORTHSIDE LONG TERM FACILITY, LLC
29.    KNOXVILLE PROPCO I, LLC
30.    WELLPARK PROPCO, LLC
31.    WAVERLY LONG TERM FACILITY, LLC

1


EXHIBIT C
TRANSFERORS
1.    APPLINGWOOD HEALTHCARE CENTER LLC
2.    BRIGHT GLADE HEALTH AND REHABILITATION CENTER LLC
3.    COVINGTON CARE NURSING AND REHABILITATION CENTER LLC
4.    CRESTVIEW HEALTH CARE AND REHABILITATION LLC
5.    DYERSBURG NURSING AND REHABILITATION LLC
6.    FOREST COVE NURSING AND REHAB CENTER, LLC
7.    HUMBOLDT HEALTHCARE AND REHAB CENTER, LLC
8.    MCKENZIE HEALTHCARE AND REHABILITATION CENTER LLC
9.    NORTHBROOKE HEALTHCARE AND REHAB CENTER LLC
10.    PARIS HEALTH CARE NURSING AND REHABILITATION CENTER LLC
11.    UNION CITY NURSING AND REHABILITATION CENTER LLC
12.    WEST TENNESSEE TRANSITIONAL CARE LLC
13.    CLARKSVILLE NURSING AND REHABILITATION CENTER LLC
14.    HARBOR VIEW NURSING AND REHABILITATION CENTER, LLC
15.    LEWIS COUNTY NURSING AND REHABILITATION CENTER LLC
16.    MILLENNIUM NURSING AND REHAB CENTER LLC
17.    VANAYER HEALTHCARE AND REHAB CENTER LLC
18.    BETHESDA HEALTH CARE CENTER LLC
19.    CUMBERLAND HEALTH CARE AND REHABILITATION LLC,
20.    DECATUR COUNTY HEALTH CARE AND REHABILITATION LLC
21.    LEXINGTON HEALTH CARE AND REHABILITATION LLC
22.    MCNAIRY COUNTY HEALTH CARE CENTER LLC
23.    MEADOWBROOK HEALTH AND REHABILITATION CENTER LLC
24.    MT. JULIET HEALTH CARE CENTER LLC
25.    NORTHSIDE HEALTH CARE NURSING AND REHABILITATION CENTER, LLC
26.    SAVANNAH HEALTH CARE AND REHABILITATION CENTER LLC
27.    VANCO HEALTH CARE AND REHABILITATION LLC
28.    WAVERLY HEALTH CARE AND REHABILITATION CENTER, LLC
29.    WESTWOOD HEALTH CARE AND REHABILITATION CENTER LLC
30.    KNOXVILLE HEALTHCARE CENTER I, LLC
31.    WELLPARK HEALTHCARE CENTER, LLC

1


EXHIBIT D
TRANSFEREES
1.    DOHENY BEACH HOLDINGS, LLC
2.    EAGLE LAKE HOLDINGS, LLC
3.    FLORIDA BAY HOLDINGS, LLC
4.    DUPREE SNF HEALTHCARE, LLC
5.    OKEENA HEALTH AND REHABILITATION CENTER LLC
6.    GOODHOPE BAY HOLDINGS, LLC
7.    AVONDALE HEALTH AND REHABILITATION CENTER LLC
8.    MCKENZIE SNF HEALTHCARE, LLC
9.    HANALEI RIVER HOLDINGS, LLC
10.    RIVERBEND HEALTH AND REHABILITATION CENTER LLC
11.    TURNER HEALTHCARE, INC.
12.    ISLAND PARK BEACH HOLDINGS, LLC
13.    CLARKSVILLE SNF HEALTHCARE, LLC
14.    JUNIPER COVE HOLDINGS, LLC
15.    HOHENWALD SNF HEALTHCARE, LLC
16.    SAND CREEK HEALTHCARE, INC.
17.    CANE CREEK HEALTHCARE, INC.
18.    COOKEVILLE SNF HEALTHCARE, LLC
19.    NASHVILLE SNF HEALTHCARE, LLC
20.    BEAR CREEK HEALTHCARE LLC
21.    LEXINGTON SNF HEALTHCARE, LLC
22.    SELMER SNF HEALTHCARE, LLC
23.    BIG CREEK HEALTHCARE, INC.
24.    MOUNT JULIET SNF HEALTHCARE, LLC
25.    MURFREESBORO SNF HEALTHCARE, LLC
26.    LACEFIELD HEALTHCARE LLC
27.    GOODLETTSVILLE SNF HEALTHCARE, LLC
28.    WAVERLY SNF HEALTHCARE, LLC
29.    BLACK WOLF HEALTHCARE LLC
30.    RIVER BLUFF HEALTHCARE, INC.
31.    MARBLE CITY HEALTHCARE, INC.

1


EXHIBIT E
THE FACILITIES
Appl ingwood 1536 Appl i ng Care Lane Cordova TN 38018
Bright Glade 5070 Sanderl in Avenue Memphis TN 38117
Covington Care 765 Bert Johnston Avenue Covington TN 38019
Crestview 704 Dupree Road Brownsville TN 38012
Dyersburg 1900 Parr Avenue Dyersburg TN 38024
Forest Cove 45 Forest Cove Jackson TN 38301
Humboldt 2031 Avondale Street, Pobox 446 Humboldt TN 38343
McKenzie 175 Hospital Drive Mc Kenzie TN 38201
Northbrooke 121 Physicians Dr Jackson TN 38305
Paris 800 Volunteer Drive Paris TN 38242
Union City 1630 E Reelfoot Ave Union City TN 38261
WTTC 597 West Forest Avenue Jackson TN 38301
Clarksville 900 Professional Park Drive Clarksville TN 37040
Harborview 1513 N 2Nd Street Memphis TN 38107
Natchez Trace (Lewis) 119 Kittrell Street Hohenwald TN 38462
Millenium 5275 Millennium Drive Huntsville AL 35806
VanAyer 460 Hannings Lane Martin TN 38237
Bethesda 444 One Eleven Place Cookeville TN 38501
Cumberland 4343 Ashland City Highway Nashville TN 37218
Decatur 726 Kentucky Avenue S Parsons TN 38363
Lexington 727 East Church Street Lexington TN 38351
McNairy 835 East Poplar Avenue Selmer TN 38375
Meadowbrook 1245 E College St Pulaski TN 38478
Mt. Juliet 2650 North Mt Juliet Road Mount Juliet TN 37122
Northsi de 202 East Mtcs Road Murfreesboro TN 37130
Savannah 1645 Florence Rd Savannah TN 38372
Vanco 813 S Dickerson Rd Goodlettsville TN 37072
Waverly 895 Powers Blvd Waverly TN 37185
Westwood 524 West Main Street Decaturville TN 38329
Knoxville 7424 Middlebrook Pike Knoxville TN 37909
Wel l spark 7512 Middlebrook Pike Knoxville TN 37909


1


EXHIBIT Q
SELLER LEASED PARCELS

1


picture2a.jpg
1


picture1a.jpg

2


EXHIBIT R
SELLER LEASED PARCEL LEASE AGREEMENT TERMS
Lease Terms:
1.    Year 1 Rent:
a.    Van Ayer:    $93,600
b.    Harbor View: $126,000
2.    Annual Rent Escalators: 3.0%
3.    Lease Term: 5 years with successive automatic 1-year renewal terms, unless such renewal term is terminated by either party by providing twelve (12) months’ advance notice prior to the commencement of each renewal term.
4.    Common Expense Sharing %: Pro-rata based on a square foot basis comparing the portion of the building included in the Seller Leased Parcel vs. the entire building. Parties will use good faith efforts to have the spaces separately metered as soon as reasonably practicable. Each party will otherwise handle all maintenance, upkeep and repairs to their respective portions of the building and common areas (i.e. parking).
5.    Shared Services: Seller to receive the following shared services, the cost of which shall be agreed upon by the parties: Laundry, dietary, utilities, internet/cable, pest control, waste management, and lawn care.
6.    Security Deposit: None

1


EXHIBIT S
THIRD PARTY REPORTS
-    Property Condition Evaluations for each Facility prepared by Bureau Veritas
-    Phase I Environmental Site Assessments for each Facility prepared by Bureau Veritas
-    ALTA/NSPS Land Title Surveys for each Facility prepared by American National
-    Zoning Compliance Reports for each Facility prepared by American National
In each case, copies of which are set forth in the Data Room.

1


EXHIBIT T-1
CHAMPION FACILITIES
AHC Dyersburg 1900 Parr Avenue Dyersburg TN 38024
AHC Humboldt 2031 Avondale Street, Pobox 446 Humboldt TN 38343
AHC Paris 800 Volunteer Drive Paris TN 38242


1


EXHIBIT T-2
ENSIGN FACILITIES
AHC Decatur County 726 Kentucky Avenue S Parsons TN 38363
AHC Meadowbrook 1245 E College St Pulaski TN 38478
AHC Millenium 5275 Millennium Drive Huntsville AL 35806
AHC Savannah 1645 Florence Rd Savannah TN 38372
AHC Union City 1630 E Reelfoot Ave Union City TN 38261
AHC Van Ayer 460 Hannings Lane Martin TN 38237
AHC Westwood 524 West Main Street Decaturville TN 38329
AHC Knoxville 7424 Middlebrook Pike Knoxville TN 37909
AHC Wellpark 7512 Middlebrook Pike Knoxville TN 37909


1


EXHIBIT T-3
LINKS FACILITIES
AHC Applingwood 1536 Appling Care Lane Cordova TN 38018
AHC Bright Glade 5070 Sanderlin Avenue Memphis TN 38117
AHC Covington Care 765 Bert Johnston Avenue Covington TN 38019
AHC Forest Cove 45 Forest Cove Jackson TN 38301
AHC Harbor View 1513 N 2Nd Street Memphis TN 38107
AHC Northbrooke 121 Physicians Dr Jackson TN 38305
AHC West Tennessee Transitional Care 597 West Forest Avenue Jackson TN 38301


1


EXHIBIT T-4
PACS FACILITIES
AHC Bethesda 444 One Eleven Place Cookeville TN 38501
AHC Crestview 704 Dupree Road Brownsville TN 38012
AHC Cumberland 4343 Ashland City Highway Nashville TN 37218
AHC Lewis County 119 Kittrell Street Hohenwald TN 38462
AHC Lexington 727 East Church Street Lexington TN 38351
AHC Mckenzie 175 Hospital Drive Mc Kenzie TN 38201
AHC Mcnairy County 835 East Poplar Avenue Selmer TN 38375
AHC Mt Juliet 2650 North Mt Juliet Road Mount Juliet TN 37122
AHC Northside 202 East Mtcs Road Murfreesboro TN 37130
AHC Of Clarksville 900 Professional Park Drive Clarksville TN 37040
AHC Vanco 813 S Dickerson Rd Goodlettsville TN 37072
AHC Waverly 895 Powers Blvd Waverly TN 37185

1
EX-19.1 3 ex191ctre-insidertradingpo.htm EX-19.1 Document




Exhibit 19.1
CareTrust REIT, Inc.
Policy on Insider Trading
Adopted as of May 14, 2014
Updated as of March 18, 2020 and November 3, 2023


INTRODUCTION

In the course of your association with CareTrust REIT, Inc. (the “Company”), you may come into possession of material information about the Company or its securities or about other entities that is not available to the investing public (“material nonpublic information”). You have a legal and ethical obligation to maintain the confidentiality of material nonpublic information. In addition, it is illegal and a violation of Company policy to trade in securities of the Company or any other entity while you are in possession of material nonpublic information about the Company or its securities or such other entity. The Company’s Board of Directors has adopted this Policy in order to promote compliance with the law and to avoid even the appearance of improper conduct by anyone associated with the Company. It is your personal responsibility to comply with this Policy and federal and state securities laws.

SCOPE OF COVERAGE

The restrictions set forth in this Policy apply to all Company officers, directors and employees, wherever located. The restrictions set forth in this Policy also apply to each of their spouses, minor children, family members sharing the same household, any other person or entity over whom the officer, director or employee exercises substantial influence or control over his, her or its securities trading decisions, and any trust or other entity in which an officer, director or employee has a substantial beneficial interest or as to which he or she serves as trustee or in a similar fiduciary capacity (each, a “Related Party” and, collectively, “Related Parties”). The Company may also determine that other persons should be subject to this Policy, such as contractors or consultants who have access to material nonpublic information.

This Policy applies to all transactions in securities of the Company, including common stock, preferred stock, bonds and other debt securities, options to purchase common stock, convertible debentures and warrants, as well as derivative securities that are not issued by the Company, such as exchange-traded put or call options or swaps relating to the Company’s securities. See the sections entitled “Special Transactions” and “Prohibited Transactions” for further discussion of certain types of securities and transactions.

To avoid even the appearance of impropriety, additional restrictions on trading Company securities apply to directors, officers and certain designated employees who have access to material nonpublic information about the Company or its securities. These policies are set forth in the Company’s Addendum A to Insider Trading Policy. The Company will notify you if you are subject to Addendum A. Addendum A generally prohibits those covered by it from trading in Company securities during “blackout periods” (as defined in Addendum A), and requires pre-clearance for all transactions in Company securities.

1






Exhibit 19.1
INDIVIDUAL RESPONSIBILITY

Persons subject to this Policy are individually responsible for complying with this Policy and ensuring the compliance of any Related Party whose transactions are subject to this Policy. Accordingly, you should make your family and household members aware of the need to confer with you before they trade in Company securities, and you should treat all transactions by any Related Party as if the transactions were for your own account for the purposes of this Policy and applicable securities laws. In all cases, the responsibility for determining whether an individual is in possession of material nonpublic information rests with that individual, and any action on the part of the Company or any other employee pursuant to this Policy (or otherwise) does not in any way constitute legal advice or insulate an individual from liability under applicable securities laws.

MATERIAL NONPUBLIC INFORMATION

What is Material Information? Under Company policy and United States laws, information is material if:

•there is a substantial likelihood that a reasonable investor would consider the information important in determining whether to trade in a security; or
•the information, if made public, could be expected to affect the market price of a company’s securities.

Information may be material even if it relates to future, speculative or contingent events and even if it is significant only when considered in combination with publicly available information. Material information can be positive or negative. Nonpublic information can be material even with respect to companies that do not have publicly traded stock, such as those with outstanding bonds or bank loans.

Depending on the facts and circumstances, information that could be considered material includes, but is not limited to:

•annual or quarterly results of operations and significant changes in financial performance or liquidity;
•earnings    announcements    or    estimates,    or    changes    to    previously    released announcements or estimates;
•significant developments regarding the Company’s business operations;
•significant write-downs or additions to reserves for bad debts;
•significant acquisitions and dispositions of properties;
•significant new lawsuits or regulatory matters, or significant developments in existing ones;
•proposals, plans or agreements, even if preliminary in nature, involving significant or strategic transactions, such as corporate mergers and acquisitions, tender offers, divestitures, recapitalizations, joint ventures or purchases or sales of substantial assets;
•offerings of securities or other significant changes in the Company’s capitalization, including extraordinary borrowings or other financing transactions out of the ordinary course;
•events regarding the Company’s securities (e.g., defaults, redemption, repurchase plans, stock splits, changes in dividends, changes to the rights of securityholders);
•changes in control of the Company or significant changes in senior management;
•significant cybersecurity incidents, data breaches or similar events; and
•changes in auditors or auditor notification that the Company may no longer rely on an audit report.
2






Exhibit 19.1

What is Nonpublic Information? Information is considered to be nonpublic unless it has been adequately disclosed to the public, which means that the information must be publicly disseminated and sufficient time must have passed for the securities markets to digest the information.

It is important to note that information is not necessarily public merely because it has been discussed in the press, which will sometimes report rumors. You should presume that information is nonpublic unless you can point to its official release by the Company in at least one of the following ways:

•public filings with the Securities and Exchange Commission (“SEC”);
•issuance of press releases;
•a pre-announced conference call or webcast open to the public; or
•information contained in proxy statements and prospectuses.
By contrast, information would likely not be considered widely disseminated if it is available only to the Company’s employees, or if it is only available to a select group of analysts, brokers and/or institutional investors. You may not attempt to “beat the market” by trading simultaneously with, or shortly after, the official release of material information. Although there is no fixed period for how long it takes the market to absorb information, out of prudence a person in possession of material nonpublic information should refrain from any trading activity for two full trading days following its official release.

Twenty-Twenty Hindsight. If securities transactions ever become the subject of scrutiny, they are likely to be viewed after-the-fact with the benefit of hindsight. As a result, before engaging in any transaction you should carefully consider how the transaction may be construed in the bright light of hindsight, and questions concerning the materiality of particular information should be resolved in favor of a determination of materiality. If you have any questions or uncertainties about this Policy or a proposed transaction, please ask the Chief Executive Officer.

“TIPPING” MATERIAL NONPUBLIC INFORMATION IS PROHIBITED

In addition to trading while in possession of material nonpublic information, it is also illegal and a violation of the Company’s Insider Trading Policy to convey such information to another (“tipping”) if you know or have reason to believe that the person will misuse such information by trading in securities or passing such information to others who will trade. This applies regardless of whether the “tippee” is related to the insider or is an entity, such as a trust or a corporation, and regardless of whether you receive any monetary benefit from the tippee. You may be found liable as a tipper if you receive a personal benefit (i.e. money, reputational gain, information exchange, gift) by your giving the tip. A tippee does not have to receive a personal benefit beyond the monetary profit from the transaction to be liable for insider trading.

SPECIAL TRANSACTIONS

The trading restrictions in this Policy do not apply in the case of the following transactions, except as specifically noted:

Stock Option Plans. The trading restrictions in this Policy do not apply to exercises of stock options where no Company common stock is sold in the market to fund the option exercise price or related taxes (i.e. a net exercise or where cash is paid to exercise the option) or to the exercise of a tax withholding right pursuant to which a person has elected to have the Company withhold shares subject to an option to satisfy tax withholding requirements.
3






Exhibit 19.1
The trading restrictions do apply, however, to sales of Company common stock received upon the exercise of options in which the proceeds are used to fund the option exercise price (i.e., a cashless exercise of options) or related taxes.

Restricted Stock and Stock Unit Awards. The trading restrictions in this Policy do not apply to the vesting of restricted stock or restricted stock units, or the exercise of a tax withholding right pursuant to which you elect to have the Company withhold shares of stock to satisfy tax withholding requirements upon the vesting of any restricted stock or restricted stock units. The trading restrictions do apply, however, to any market sale of restricted stock or the shares received upon vesting of restricted stock units.

Other Similar Transactions. Any other purchase of Company securities directly from the Company or sales of Company securities directly to the Company are not subject to the trading restrictions of this Policy.

GIFTS OF SECURITIES

A disposition of the Company’s securities by bona fide gift (including charitable donations and transfers for estate planning purposes) could create insider trading concerns under some circumstances if the donor is aware of material nonpublic information. Therefore, unless approved by the Chief Executive Officer, individuals subject to this Policy are not permitted to gift Company securities when aware of material nonpublic information about the Company or its securities or otherwise subject to a blackout period in accordance with Addendum A to this Policy. This approval requirement applies even if you are not otherwise subject to the pre-clearance requirements set forth in Addendum A of this Policy.

RESTRICTED TRANSACTIONS

Due to the heightened legal risk associated with the following transactions, the individuals subject to this Policy may not engage in the following transactions without obtaining pre-clearance from the Chief Executive Officer:

Publicly Traded Options. Absent pre-clearance, you may not trade in options, warrants, puts and calls or similar instruments on Company securities. Given the relatively short term of publicly traded options, transactions in options may create the appearance that a director, officer, or employee is trading based on material nonpublic information and focus a director’s, officer’s or other employee’s attention on short-term performance at the expense of the Company’s long- term objectives.

Short Sales. Absent pre-clearance, you may not engage in short sales of Company securities and, pursuant to Section 16(c) under the Securities Exchange Act of 1934, as amended (the ‘Exchange Act”), officers and directors are at all times prohibited from engaging in short sales . A short sale has occurred if the seller: (a) does not own the securities sold; or (b) does own the securities sold, but does not deliver them within 20 days or place them in the mail within 5 days of the sale. Short sales may reduce a seller’s incentive to seek to improve the Company’s performance, and often have the potential to signal to the market that the seller lacks confidence in the Company’s prospects.

Margin Accounts and Pledges. Because a margin sale or foreclosure sale may occur at a time when the pledgor is aware of material nonpublic information or otherwise is not permitted to trade in Company securities, absent pre-clearance, you may not hold Company securities in a margin account or otherwise pledge Company securities as collateral for a loan.
4






Exhibit 19.1

Hedging Transactions. Absent pre-clearance, you may not purchase financial instruments (including prepaid variable forward contracts, equity swaps, collars, and exchange funds), or otherwise engage in transactions, that hedge or offset, or are designed to hedge or offset, any decrease in the market value of Company securities. Hedging transactions may allow a director, officer, or employee to continue to own Company securities, but without the full risks and rewards of ownership. This may lead to the director, officer, or employee no longer having the same objectives as the Company’s other shareholders.

Short-Term Trading. If you purchase Company securities in the open market, absent pre-clearance, you may not sell any Company securities of the same class during the six months following the purchase (or vice versa). Short-term trading of Company securities may be distracting to the person and may unduly focus the person on the Company’s short-term stock market performance instead of the Company’s long-term business objectives. Additionally, directors and Section 16 Officers (as defined in Addendum A to this Policy) are subject to “short-swing” trading restrictions, as described in Addendum A.

Standing and Limit Orders. Absent pre-clearance, you may not place standing or limit orders on Company securities. Standing and limit orders create heightened risks for insider trading violations because there is no control over the timing of purchases or sales that result from standing instructions to a broker, and as a result the broker could execute a transaction when a director, officer, or other employee is in possession of material nonpublic information.

TRADING PLANS

Rule 10b5-1 under the Exchange Act (“Rule 10b5-1”) provides an affirmative defense from insider trading liability under the federal securities laws for trading plans that meet certain requirements of such rule (each, a “Trading Plan”). Therefore, notwithstanding the prohibition against insider trading, Rule 10b5-1 and Company policy permit employees, officers, directors and others subject to this Policy to trade in Company securities regardless of their awareness of material nonpublic information if the transaction is made pursuant to a Trading Plan that was entered into when the person was not in possession of material nonpublic information and that complies with the requirements set forth in Addendum B. Anyone subject to this Policy who wishes to enter into a Trading Plan must submit the Trading Plan to the Chief Executive Officer for pre-clearance at least 5 business days prior to the planned entry into the Trading Plan.

REPORTING VIOLATIONS/SEEKING ADVICE

You should report suspected violations of this Policy to the Chief Executive Officer. In addition, if you:

•receive material nonpublic information that you are not authorized to receive or that you do not legitimately need to know to perform your employment responsibilities, or
•receive confidential information and are unsure if it is within the definition of material nonpublic information or whether its release might be contrary to a fiduciary or other duty or obligation, you should not share it with anyone.
5






Exhibit 19.1
To seek advice about what to do under those circumstances, you should contact the Chief Executive Officer. Consulting your colleagues can have the effect of exacerbating the problem. Containment of the information, until the legal implications of possessing it are determined, is critical.

POST-TERMINATION TRANSACTIONS

This Policy, including the Addendums if applicable, continues to apply to transactions in Company securities even after termination of service with the Company. If an individual is in possession of material nonpublic information when his or her service terminates, that individual may not trade in Company securities until that information has become public or is no longer material. The pre-clearance procedures specified in Addendum A, however, will cease to apply to transactions in Company securities upon the expiration of any blackout period or other Company-imposed trading restrictions applicable at the time of the termination of service.

PENALTIES FOR VIOLATIONS OF THE INSIDER TRADING POLICY AND LAWS

In the United States and many other countries, the personal consequences to you of illegal insider trading can be severe. In addition to injunctive relief, disgorgement, and other ancillary remedies, U.S. law empowers the government to seek significant civil penalties against persons found liable of insider trading, including as tippers or tippees. The amount of a penalty could total three times the profits made or losses avoided. All those who violate U.S. insider trading laws, including tippers, tippees and remote tippees could be subject to the maximum penalty. The maximum penalty may be assessed even against tippers for the profits made or losses avoided by all direct and remote tippees. Further, civil penalties of the greater of $1 million or three times the profits made or losses avoided can be imposed on any person who “controls” a person who engages in illegal insider trading.

Criminal penalties may also be assessed for insider trading. Any person who “willfully” violates any provision of the Securities Exchange Act of 1934 (or rule promulgated thereunder) may be fined up to $5 million ($25 million for entities) and/or imprisoned for up to twenty years. The seriousness of securities law violations is reflected in the penalties such violations carry. Subject to applicable law, the resignation of a director who has violated this policy may also be sought or Company employees who violate this Policy may also be subject to discipline by the Company, up to and including termination of employment. Needless to say, a violation of law, or even an SEC investigation that does not result in prosecution, can tarnish a person’s reputation and irreparably damage a career and may also create negative publicity for the Company.

QUESTIONS

Because of the technical nature of some aspects of the federal securities laws, all directors, officers and employees should review this Policy (including the Addendums) carefully and contact the Chief Executive Officer if at any time (i) you have questions about this Policy or its application to a particular situation; or (ii) you plan to trade in the Company’s securities, but are unsure as to whether the transaction might be in conflict with the securities laws and/or this Policy.

ACKNOWLEDGEMENT

All directors, officers and other employees subject to this Policy (and any of the Addendums) must acknowledge their understanding of, and intent to comply with, the Company’s Insider Trading Policy on the form attached to this Policy.
6






Exhibit 19.1
CareTrust REIT, Inc.
Addendum A to Policy on Insider Trading
Adopted as of May 14, 2014
Updated as of March 18, 2020 and November 3, 2023


INTRODUCTION

This Addendum A explains requirements and procedures which apply to all directors, officers and certain designated employees of CareTrust REIT, Inc. (the “Company”) who have access to material nonpublic information about the Company or its securities, and is in addition to and supplements the Company’s Policy on Insider Trading. The names of the covered persons subject to this Addendum A are listed on attached Schedule A. The Company may from time to time designate other individuals who are subject to this Addendum A, including in connection with any event-specific blackout as described below, and will notify such individuals if they become subject to the blackout period or other requirements of this Addendum A (even if not named on Schedule A hereto). The Company may amend Schedule A from time to time as necessary to reflect changes to the persons subject to this Addendum A or the resignation or change of status of any individual. Please note that this Policy applies to all Company securities which you hold or may acquire in the future.

Please read this Addendum A carefully. When you have completed your review, please sign the attached acknowledgment form and return it to the Company’s Chief Executive Officer.

PRE-CLEARANCE PROCEDURES

Those subject to this Addendum A, and each of their respective Related Parties, may not engage in any transaction involving the Company’s securities (including the exercise of stock options, gifts, loans, contributions to a trust, or any other transfers) without first obtaining pre-clearance of the transaction from the Company’s Chief Executive Officer. Each proposed transaction will be evaluated to determine if it raises insider trading concerns or other concerns under federal laws and regulations. Any advice will relate solely to the restraints imposed by law and will not constitute advice regarding the investment aspects of any transaction. Clearance of a transaction is valid only for a 48-hour period. If the transaction order is not placed within that 48-hour period, clearance of the transaction must be re-requested. If clearance is denied, the fact of such denial must be kept confidential by the person requesting such clearance.

When a request for pre-clearance is made, the requestor should carefully consider whether he or she may be aware of any material nonpublic information about the Company or its securities, and should describe fully those circumstances to the Chief Executive Officer. The requestor should also indicate whether he or she has effected any non-exempt “opposite-way” transactions within the past six months, and should be prepared to report the proposed transaction on an appropriate Form 4 or Form
5. The requestor should also be prepared to comply with SEC Rule 144 and file Form 144, if necessary, at the time of any sale.

Notwithstanding the foregoing, pre-clearance is not required for any trades made pursuant to a Trading Plan adopted in accordance with the requirements of Addendum B to the Company’s Policy on Insider Trading (including the pre-clearance requirement for the Trading Plan set forth therein). Pre-clearance is also not required for the “Special Transactions” to which the Insider Trading Policy does not apply.
7






Exhibit 19.1

BLACKOUT PERIODS

Those individuals subject to this Addendum A (and their respective Related Parties) are subject to the following blackout periods, during which they may not trade in the Company’s securities (except by means of a Trading Plan established in compliance with Addendum B to the Company’s Policy on Insider Trading).

Quarterly Blackout. Because the announcement of the Company’s quarterly financial results will almost always have the potential to have a material effect on the market for the Company’s securities, you may not trade in the Company’s securities during the period beginning on the last day of the last month of the quarter and ending after the second full business day following the release of the Company’s earnings for that quarter.

Interim Earnings Guidance Blackout. The Company may on occasion issue interim earnings guidance or other potentially material information by means of a press release, SEC filing on Form 8-K or other means designed to achieve widespread dissemination of the information. If a person whose trades are subject to pre-clearance requests permission to trade in the Company’s securities, you should anticipate that trading will be blacked out while the Company is in the process of assembling the information to be released and until the information has been released and fully absorbed by the market. The Company may also designate an event-specific blackout as described below.

Event-Specific Blackout. From time to time, an event may occur that is material to the Company and is known by only a few directors, officers, and/or employees. In connection with such events, the Company may from time to impose an event-specific blackout. The existence of an event-specific blackout will not be announced, except that each director, officer and/or employee subject to an event-specific blackout will be notified of the existence thereof. Any person subject to an event-specific blackout may not trade in the Company’s securities during an event-specific blackout. Any person made aware of the existence of an event- specific blackout should not disclose the existence of the blackout to any other person.

Directors and Section 16 Officers (as defined below) may also be subject to event-specific blackouts pursuant to the SEC’s Regulation Blackout Trading Restriction, which prohibits certain sales and other transfers by insiders during certain pension plan blackout periods.

NOTE: Even if a blackout period is not in effect, at no time may you trade in Company securities if you are in possession of material nonpublic information about the Company or its securities. The failure of the Chief Executive Officer to notify you of an event-specific blackout will not relieve you of the obligation not to trade while in possession of material nonpublic information.

REPORTING AND FORM FILING REQUIREMENTS

Under Section 16(a) of the Securities Exchange Act of 1934 (the “Exchange Act”), directors and certain officers subject to Section 16 (the “Section 16 Officers”) of the Company must report to the SEC their holdings and must file forms with the SEC when they engage in certain transactions involving the Company’s equity securities. This requirement encompasses all “equity securities” of the Company, including, but not limited to, the Company’s common stock, and also includes any securities that are exchangeable for or convertible into, or that derive their value from, an equity security of the Company. These other securities are known as derivative securities, and include options, warrants, convertible securities, and stock appreciation rights.
8






Exhibit 19.1

Form 3: Initial Beneficial Ownership Statement. A person who becomes a director or Section 16 Officer of the Company must file a Form 3 within ten days of becoming a director or Section 16 Officer, even if the director or Section 16 Officer is not an owner of the Company’s equity securities at the time. The Form 3 must disclose the director’s or Section 16 Officer’s ownership of any Company equity securities the director or Section 16 Officer owns immediately prior to assuming office.

Form 4: Changes of Beneficial Ownership Statement. As long as a person remains a director or Section 16 Officer, and for up to six months after a person no longer holds such a position with the Company, a Form 4 must be filed before 10:00 p.m. Eastern Time on the second business day following the day that there is a change in the number of equity securities of the Company held from that previously reported to the SEC. There are exceptions to this requirement for acquisitions (but not dispositions) of gifts and a very limited class of employee benefit plan transactions.

Form 5: Annual Beneficial Ownership Statement. A Form 5 must be filed with the SEC by any individual who served as a director or Section 16 Officer of the Company during any part of the Company’s fiscal year to report: (1) all reportable transactions in Company equity securities exempt from the Form 4 filing requirement or unreported transactions of less than $10,000; (2) all transactions that should have been reported during the last fiscal year but were not; and (3) with respect to an individual’s first Form 5, all transactions which should have been reported but were not for the last two fiscal years.

A Form 5 need not be filed if all transactions otherwise reportable have been previously reported. If required, Form 5 must be filed within 45 days after the end of the Company’s fiscal year, which is February 14, or the first business day thereafter. Common types of transactions reportable on Form 5 include acquisitions (but not dispositions) by gift and unreported transactions of less than $10,000.

Family Holdings. Directors and Section 16 Officers are presumed to beneficially own Company securities held by any member of the director’s or Section 16 Officer’s immediate family sharing the director’s or Section 16 Officer’s household. As a result, directors and Section 16 Officers must report all holdings and transactions by immediate family members living in the director’s or Section 16 Officer’s household. For this purpose, “immediate family” includes a spouse, children, stepchildren, grandchildren, parents, grandparents, stepparents, siblings, and in-laws, and also includes adoptive relationships.

Trusts. Directors and Section 16 Officers may also be presumed to beneficially own Company securities held in a trust depending on the status of the director or Section 16 Officer or members of his or her immediate family members as the settlor, trustee, beneficiary or other position with respect to the trust. Please notify the Chief Executive Officer if you have any questions about whether you are required to report holdings or transactions of Company securities held in a trust.

Any questions concerning whether a particular transaction will necessitate reporting pursuant to Section 16, or any questions regarding the timing or filing requirements for such transaction should be directed to the Company’s Chief Executive Officer, or, if you prefer, your individual legal counsel. The Company must disclose in its Annual Report on Form 10-K and in its Proxy Statement any delinquent filings of Forms 3, 4 or 5 by directors and Section 16 Officers, and must post on its website, by the end of the business day after filing with the SEC, any Forms 3, 4 and 5 relating to the Company’s securities.

Reporting Exemptions for Certain Employee Benefit Plan Transactions. Rule 16b-3 under the Exchange Act provides exemptions for director and Section 16 Officer reporting of certain employee benefit plan events on Forms 4 and 5, including certain routine non-volitional transactions under tax-conditioned thrift, stock purchase and excess benefit plans. A transaction that results only in a change in the form of a person’s beneficial ownership (with no change in the holder’s pecuniary interest) is also exempt from reporting.
9






Exhibit 19.1
An exempt “change in the form of beneficial ownership” would include, for example, a distribution of benefit plan securities to an insider participant where the securities were previously attributable to the insider. Exercises or conversions of derivative securities would not, however, be considered mere changes in beneficial ownership and would be reportable. The vesting of most stock options, restricted stock and stock appreciation rights is also not subject to the reporting requirements.

SHORT-SWING TRADING PROFITS AND SHORT SALES

Short-Swing Trading Profits. In order to discourage directors and officers from profiting through short- term trading transactions in equity securities of the Company, Section 16(b) of the Exchange Act requires that any “short-swing profits” be disgorged to the Company. (This is in addition to the Form reporting requirements described above.) “Short-swing profits” are profits that result from any purchase and sale, or sale and purchase of the Company’s equity securities within a six-month period, unless there is an applicable exemption for either transaction. It is important to note that this rule applies to any matched transactions in the Company’s securities (including derivative securities), not only a purchase and sale or sale and purchase of the same shares, or even of the same class of securities. Furthermore, pursuant to the SEC’s rules, profit is determined so as to maximize the amount that the director or Section 16 Officer must disgorge, and this amount may not be offset by any losses realized. “Short-swing profits” may exceed economic profits.

Short-Swing Exemptions for Certain Reinvestment and Employee Benefit Plan Transactions. As indicated, to come within the short-swing rules, a purchase and sale (or sale and purchase) within any period of less than six months are matched to determine the amount, if any, of profit derived from the transactions. Rule 16b-3 has carved out certain limited exceptions to what constitutes a “purchase” for these matching purposes. Under this Rule certain transactions involving acquisitions of equity securities under employee benefit plans are not counted as “purchases” for short-swing purposes, provided that the benefit plan meets various statutory requirements. The CareTrust REIT, Inc. and CareTrust Partnership, L.P. Incentive Award Plan meets these requirements, and therefore an acquisition of equity securities under it generally speaking is not a “purchase” for short-swing purposes.

LIMITATIONS AND REQUIREMENTS ON RESALES OF THE COMPANY’S SECURITIES

Under the Securities Act, directors and certain officers who are affiliates1 of the Company who wish to sell Company securities generally must comply with the requirements of Rule 144 or be forced to register sale of the securities under the Securities Act. “Securities” under Rule 144 (unlike under Section 16) are broadly defined to include all securities, not just equity securities. Therefore, the Rule 144 requirements apply not only to the Company’s common and preferred stock, but also to bonds, debentures and any other form of security. Also, the safe harbor afforded by this rule is available whether or not the securities to be resold were previously registered under the Securities Act (except that the minimum holding period required to satisfy the safe harbor shall apply only to securities which were not registered under the Securities Act).

The relevant provisions of Rule 144 as they apply to resales by directors and officers seeking to take advantage of the safe harbor are as follows:
1 Rule 144 under the Securities Act defines “affiliate” of an issuer as “a person that directly, or indirectly through one or more intermediaries, controls, or is controlled by, or is under common control with, such issuer.”
10






Exhibit 19.1
Current public information. There must be adequate current public information available regarding the Company. This requirement is satisfied only if the Company has filed, with certain exceptions, all reports required by the Exchange Act during the twelve months preceding the sale.

Manner of sale.2 The sale of Company shares by a director or officer must be made in one of the following manners:

•in an open market transaction through a broker at the prevailing market price for no more than the usual and customary brokerage commission;
•to a market maker at the price held out by the market maker; or
•in a riskless principal transaction in which trades are executed at the same price, exclusive of any explicitly disclosed markup or markdown, commission equivalent or other fee, and where the transaction is permitted to be reported as riskless under the rules of a self-regulatory organization.3

Furthermore, the broker may not solicit or arrange for the solicitation of customers to purchase the shares. In addition, your broker likely has its own Rule 144 procedures (and must be involved in transmitting Form 144 (see item 4 below)), so it is important to speak with your broker prior to any sale.

Even if your stock certificates do not contain any restrictive legends, you should inform your broker that you may be considered an affiliate of the Company.

Number of shares which may be sold. The amount of equity securities that a director or officer may sell in a three-month period is limited to the greater of:

•one percent of the outstanding shares of the same class of the Company, or
•the average weekly reported trading volume in the four calendar weeks preceding the transactions.

The amount of debt securities that a director or officer may sell in a three-month period is limited to the greater of:

•the average weekly reported trading volume in the four calendar weeks preceding the sale, or
•10 percent of the principal amount of the tranche of debt securities (or 10 percent of the class of non-participatory preferred stock).

Notice of proposed sale. If the amount of securities proposed to be sold by a director or officer during any three-month period exceeds 5,000 shares or has an aggregate sale price in excess of $50,000, the officer or director must file a notice of sale with the SEC on Form 144 prior to, or concurrently with, the placing of the order to sell securities.

Holding Periods. Any securities of the Company acquired directly or indirectly from the Company or any affiliate of the Company in a transaction that was not registered with the SEC under the Securities Act (restricted securities) must be held for six months prior to reselling such securities. There is no statutory
2 The manner of sale requirements applies only to equity securities. Debt securities are not subject to any manner of sale requirements.
3 A riskless principal transaction is a transaction in which a broker or dealer (i) after having received a customer’s order to buy a security, purchases the security as principal in the market to satisfy the order to buy or (ii) after having received a customer’s order to sell a security, sells the security as principal to the market to satisfy the order to sell.
11






Exhibit 19.1
minimum holding period for securities which were registered under the Securities Act or acquired in an open-market transaction.

In certain situations (e.g., securities acquired through stock dividends, splits or conversions), “tacking” is permitted, that is, the new securities will be deemed to have been acquired at the same time as the original securities.
12






Exhibit 19.1
SCHEDULE A
Updated November 3, 2023



Name Position
David M. Sedgwick
Director, President and Chief Executive Officer
William M. Wagner
Chief Financial Officer, Treasurer
James Callister
Chief Investment Officer
Diana M. Laing
Director, Chair of the Board of Directors
Spencer G. Plumb
Director
Careina D. Williams
Director
Anne Olson
Director







13






Exhibit 19.1
image_2a.jpgCareTrust REIT, Inc.
Addendum B to Policy on Insider Trading
Adopted as of November 3, 2023

10B5-1 TRADING PLAN REQUIREMENTS
Rule 10b5-1(c) under the Securities Exchange Act of 1934 (“Rule 10b5-1”) provides an affirmative defense from insider trading liability under the federal securities laws for trading plans that meet certain requirements of such rule (each, a “Trading Plan”). The Company permits its employees (including officers) and directors (together, “Insiders”) that have adopted a Trading Plan in compliance with Rule 10b5-1 and this Addendum B to the Company’s Insider Trading Policy to engage in transactions over an extended period of time, even during a blackout period (as detailed below), as long as the Insider is not aware of material nonpublic information at the time the Insider entered into the Trading Plan and has acted in good faith with respect to the plan. Trades made outside of an existing Trading Plan will not benefit from the protection afforded by Rule 10b5-1, and Trading Plans do not exempt directors and Section 16 Officers from complying with Section 16 reporting requirements or the short-swing liability provisions of Section 16 under the Exchange Act.
As specified in the Company’s Insider Trading Policy, a Trading Plan must be approved by the Chief Executive Officer prior to its adoption or modification. Any Insider who wishes to enter into a Trading Plan must submit the Trading Plan to the Chief Executive Officer for pre-clearance at least 5 business days prior to the planned entry into the Trading Plan. Subject to pre-clearance of the Trading Plan, no additional pre-clearance will be required for transactions conducted pursuant to the Trading Plan.
Each Trading Plan adopted by an Insider must comply with the following requirements:

•Adoption—The Trading Plan must be adopted only when the Insider is not aware of any material nonpublic information AND may not be adopted at any time during which the Insider is subject to a blackout period under Addendum A to the Company’s Insider Trading Policy. The Insider must enter into the Trading Plan in good faith and not as part of a plan or scheme to evade the prohibitions of Rule 10b5-1.
•Form—The Trading Plan must be in the form of:
oa binding contract to purchase or sell the security;
oan instruction to another person to buy or sell the security; or
oa written plan for trading securities.

•Trading Arrangements—The Trading Plan must:
oeither:
specify the amounts of securities, prices, and dates for the transactions; or include a written algorithm or computer program that specifies the amounts of securities, prices, and dates for the transactions; and
14






Exhibit 19.1
onot permit the Insider adopting the plan (or anyone else with access to material, nonpublic information) to “exercise any subsequent influence over how, when, or whether to effect purchases or sales.”

•Content—The Trading Plan must:
ocontain a representation from the Insider adopting the Trading Plan that, at the time the Trading Plan is adopted, he or she is not aware of material, nonpublic information about the Company or its securities;
ocontain a representation from the Insider adopting the Trading Plan that the Trading Plan is being entered into in good faith and not as part of a plan or scheme to evade the prohibitions of Rule 10b5-1;
ohave a minimum duration of six months and a maximum duration of eighteen months, unless a shorter or longer term is approved by the Chief Executive Officer; and
ocontain and comply with such other terms, conditions and restrictions as may be required by Rule 10b5-1 and applicable SEC rules as in effect from time to time.

•Trades Under the Plan—Trading in the Company’s securities may not commence under the Trading Plan until the expiration of a waiting period which is (A) for directors and Section 16 Officers, the later of (i) 90 days after the Trading Plan is adopted, or (ii) two (2) business days following the filing of the Company’s Form 10-Q or Form 10-K containing financial results for the fiscal quarter in which the Trading Plan was adopted (subject to a maximum waiting period of 120 days) and (B) for other employees, 30 days after the Trading Plan is adopted (such period in which trades may not occur pursuant to clause (A) or (B), as applicable, the “Cooling-Off Period”);

•Restrictions on Overlapping Plans—Unless otherwise permitted by Rule 10b5-1, no more than one Trading Plan to effect open market purchases or sales of securities may be in effect at any time with respect to the Company’s securities beneficially owned by the Insider adopting the Trading Plan, except that, during the term of a Plan, such Insider may:
oadopt a Trading Plan in compliance with the requirements for Trading Plans set forth in this Addendum B, with any transactions to take effect upon the completion or expiration of the Insider’s current Trading Plan; provided, however, that if the Insider’s current Trading Plan is terminated before its originally scheduled completion date, then the Cooling-Off Period for the later-commencing Plan shall run from the date of such termination (and not from the date the later-commencing Plan was adopted); and
oenter into another contract, instruction or plan providing only for the sale of such securities as are necessary to satisfy tax withholding obligations arising exclusively from the vesting of a compensatory award, and provided that the Insider does not exercise control over the timing of such sales (a “Sell-to-Cover Plan”).

•Restrictions on Single-Trade Plans—other than Sell-to-Cover Plans, no more than one Trading Plan designed to effect the open-market purchase or sale in a single transaction of the total amount of the Company’s securities subject to the Trading Plan may be adopted within any twelve month period.
15






Exhibit 19.1
•After Adoption—After a Trading Plan is adopted, the purchases or sales must be made in compliance with the Trading Plan and the Insider must act in good faith with respect to the Trading Plan. The Insider adopting the Trading Plan cannot cause the Plan to be altered or deviated from, or enter into or alter a corresponding or hedging transaction position with respect to the securities to be purchased or sold under the Trading Plan.
•Plan Modifications or Terminations—Although modifications to an existing Trading Plan are not prohibited, an Insider should adopt a Trading Plan with the intention that it will not be amended or terminated prior to its expiration. Any modification or termination must be pre-cleared by the Chief Executive Officer pursuant to the Company’s pre-clearance procedures for Trading Plans, and any modification must satisfy all of the requirements set forth above with respect to the adoption of a Trading Plan, including the required Cooling-Off Period before any trades may commence under the modified plan. A modification of a Trading Plan includes any change to the amount, price, or timing of the purchase or sale of securities under such Plan, but does not include the substitution of the broker executing trades thereunder as long as such modified plan does not change the price, amount of securities to be purchased or sold or dates on which such purchases or sales are to be executed.

The Company and the Company’s directors and Section 16 Officers must make certain disclosures in SEC filings concerning the adoption, modification or termination of any Trading Plans. Section 16 Officers and directors of the Company must undertake to provide any information requested by the Company regarding Trading Plans for the purpose of providing the required disclosures or any other disclosures that the Company deems to be appropriate under the circumstances.

Each director and Section 16 Officer understands that the approval or adoption of a Trading Plan in no way reduces or eliminates such person’s obligations under Section 16 of the Exchange Act, including such person’s disclosure and short-swing trading liabilities thereunder. Sales transacted in accordance with the Trading Plan will be reported to the SEC on Form 4 within two days of the transaction and will reflect that the trade was made pursuant to a trading arrangement adopted under Rule 10b5-1.






















16






Exhibit 19.1
ACKNOWLEDGMENT FORM

I have received and read the CareTrust REIT, Inc. Policy on Insider Trading and the Addendums thereto applicable to officers, directors and certain designated employees, and I understand their contents. I agree to comply fully with the policies and procedures contained in the Policy on Insider Trading and the Addendums. If I am an employee of the Company, I acknowledge that the Policy on Insider Trading and the Addendums are statements of policies and procedures and do not, in any way, constitute an employment contract or an assurance of continued employment.



Printed Name
_____________________________________

Signature
_____________________________________


__________________________________    Date

EX-21.1 4 ctre20241231ex211q4.htm EX-21.1 Document
EXHIBIT 21.1
LIST OF SUBSIDIARIES OF CARETRUST REIT, INC.*
1 CareTrust GP, LLC** 86. Stillhouse Health Holdings LLC
2 CTR Partnership, L.P.** 87. Temple Health Holdings LLC
3 CareTrust Capital Corp.** 88. Tenth East Holdings LLC
4 18th Place Health Holdings LLC 89. Terrace Holdings AZ LLC
5 49th Street Health Holdings LLC 90. Trinity Mill Holdings LLC
6 4th Street Holdings LLC 91. Trousdale Health Holdings LLC
7 51st Avenue Health Holdings LLC 92. Tulalip Bay Health Holdings LLC
8 Anson Health Holdings LLC 93. Valley Health Holdings LLC
9 Arapahoe Health Holdings LLC 94. Verde Villa Holdings LLC
10 Arrow Tree Health Holdings LLC 95. Wayne Health Holdings LLC
11 Avenue N Holdings LLC 96. Willits Health Holdings LLC
12 Big Sioux River Health Holdings LLC 97. Willows Health Holdings LLC
13 Boardwalk Health Holdings LLC 98. Wisteria Health Holdings LLC
14 Bogardus Health Holdings LLC 99. CTR Arvada Preferred, LLC**
15 Burley Healthcare Holdings LLC 100. CTR Cascadia Preferred, LLC**
16 Casa Linda Retirement LLC 101. 160 North Patterson Avenue, LLC***
17 Cedar Avenue Holdings LLC 102. 4075 54th Street, LLC***
18 Cherry Health Holdings LLC 103. 8665 La Mesa Boulevard, LLC***
19 CM Health Holdings LLC 104. 7039 Alondra Boulevard, LLC***
20 Cottonwood Health Holdings LLC 105. 10625 Leffingwell Road, LLC***
21 Dallas Independence LLC 106. Serento Holding Company, LLC**/****
22 Dixie Health Holdings LLC 107. 17803 Imperial Hwy, LLC***/****
23 Emmett Healthcare Holdings LLC 108. 1740 San Dimas, LLC***/****
24 Ensign Bellflower LLC 109. CTRE Vista JV, LLC**/****
25 Ensign Highland LLC 110. 247 E. Bobier Drive, LLC***/****
26 Ensign Southland LLC 111. Pacific SNF Holding Company, LLC**/****
27 Everglades Health Holdings LLC 112. Morgan Hills 370 Realty LLC**/****
28 Expo Park Health Holdings LLC 113. Capitola 1935 Realty LLC***/****
29 Expressway Health Holdings LLC 114. 2985 N. G. Street Holding, LLC**/****
30 Falls City Health Holdings LLC 115. 2985 N. G. Street PropCo, LLC***/****
31 Fifth East Holdings LLC 116.
Lakewest SNF Realty, LLC+/****
32 Fig Street Health Holdings LLC 117. Alamitos Katella Holding Company, LLC**/****
33 Flamingo Health Holdings LLC 118. 3902 Katella Avenue, LLC***/****
34 Fort Street Health Holdings LLC 119. 3952 Katella Avenue, LLC***/****
35 Gazebo Park Health Holdings LLC 120. 8170 Murray Holding Company, LLC**/****
36 Gillette Park Health Holdings LLC 121. 8170 Murray PropCo, LLC***/****
37 Golfview Holdings LLC 122. CTRE EA TN HoldCo, LLC**/****
38 Granada Investments LLC 123. 1900 Parr Avenue TN LLC**/****
39 Guadalupe Health Holdings LLC 124. 2031 Avondale Street TN LLC**/****
40 Gulf Coast Buyer 1 LLC** 125. 800 Volunteer Drive TN LLC**/****
41 Hillendahl Health Holdings LLC 126. 1536 Appling Care Lane TN LLC**/****
42 Hillview Health Holdings LLC 127. 5070 Sanderlin Avenue TN LLC**/****
43 Irving Health Holdings LLC 128. 765 Bert Johnston Avenue TN LLC**/****
44 Ives Health Holdings LLC 129. 45 Forest Cove TN LLC**/****
45 Jefferson Ralston Holdings LLC 130. 121 Physicians Dr TN LLC**/****
46 Jordan Health Properties LLC 131. 597 West Forest Avenue TN LLC**/****
47 Josey Ranch Healthcare Holdings LLC 132. 1513 N 2nd Street TN LLC**/****
48 Kings Court Health Holdings LLC 133. 5275 Millennium Drive AL LLC**/****
49 Lafayette Health Holdings LLC 134. 1245 E College St TN LLC**/****
50. Lemon River Holdings LLC 135. 7424 Middlebrook Pike TN LLC**/****
51. Lockwood Health Holdings LLC 136. 7512 Middlebrook Pike TN LLC**/****
52. Long Beach Health Associates LLC 137. 460 Hannings Lane TN LLC**/****
53. Lowell Health Holdings LLC 138. 1630 E Reelfoot Ave TN LLC**/****
54. Lowell Lake Health Holdings LLC 139. 900 Professional Park Drive TN LLC**/****
55. Lufkin Health Holdings LLC 140. 119 Kittrell Street TN LLC**/****
56. Meadowbrook Health Associates LLC 141. 444 One Eleven Place TN LLC**/****
57. Memorial Health Holdings LLC 142. 4343 Ashland City Highway TN LLC**/****
58. Mesquite Health Holdings LLC 143. 2650 North Mt Juliet Road TN LLC**/****
59. Mission CCRC LLC 144. 202 East Mtcs Road TN LLC**/****
60. Moenium Holdings LLC 145. 813 S Dickerson Rd TN LLC**/****
61. Mountainview Communitycare LLC 146. 895 Powers Blvd TN LLC**/****
62. Northshore Healthcare Holdings LLC 147. 704 Dupree Road TN LLC**/****
63. Oleson Park Health Holdings LLC 148. 175 Hospital Drive TN LLC**/****
64. Orem Health Holdings LLC 149. 727 East Church Street TN LLC**/****
65. Paredes Health Holdings LLC 150. 835 East Poplar Avenue TN LLC**/****
66. Plaza Health Holdings LLC 151. 1070 Old Ocean Highway LLC**
67. Polk Health Holdings LLC 152. 86 Old Airport Road LLC**
68. Prairie Health Holdings LLC 153. 7166 Jordan Road LLC**
69. Price Health Holdings LLC 154. 1930 West Sugar Creek Road LLC**
70. Queen City Health Holdings LLC 155. 3514 Sidney Road LLC**
71. Queensway Health Holdings LLC 156. CTRE Loma Linda JV, LLC**
72. RB Heights Health Holdings LLC 157. CTRE 2024 PA Holdings, LLC
73. Regal Road Health Holdings LLC 158. PA HoldCo 1 Bethel Park LLC
74. Renee Avenue Health Holdings LLC 159. PA HoldCo 2 Bethel Park LLC
75. Rillito Holdings LLC 160. 60 Highland Road PA Owner LLC
76 Rio Grande Health Holdings LLC 161. PA HoldCo 1 Cannonsburg LLC
77 Salmon River Health Holdings LLC 162. PA HoldCo 2 Cannonsburg LLC
78 Salt Lake Independence LLC 163. 113 West McMurray Road PA Owner LLC
79 San Corrine Health Holdings LLC 164. PA HoldCo 1 Monroeville LLC
80. Saratoga Health Holdings LLC 165. PA HoldCo 2 Monroeville LLC
81. Silver Lake Health Holdings LLC 166. 885 MacBeth Drive PA Owner LLC
82. Silverada Health Holdings LLC 167. PA HoldCo 1 Whitehall LLC
83. Sky Holdings AZ LLC 168. PA HoldCo 2 Whitehall LLC
84. Snohomish Health Holdings LLC 169. 505 Weyman Road PA Owner LLC
85. South Dora Health Holdings LLC 170. CTRE JV HoldCo LLC
*    Unless otherwise indicated, the jurisdiction of formation or incorporation, as applicable, of each of the subsidiaries listed herein is Nevada.
**    Formed or incorporated in Delaware.
***     Formed in California.
****    Subsidiaries held through a joint venture.
+    Formed in Texas.


EX-23.1 5 ctre20241231ex231q4.htm EX-23.1 Document

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in Registration Statement No. 333-269998 on Form S-3 and Registration Statement No. 333-196634 on Form S-8 of our reports dated February 12, 2025, relating to the financial statements of CareTrust REIT, Inc., and the effectiveness of CareTrust REIT Inc.'s internal control over financial reporting appearing in this Annual Report on Form 10-K for the year ended December 31, 2024.

/s/ Deloitte & Touche LLP
Costa Mesa, California
February 12, 2025







EX-31.1 6 ctre20241231ex311q4.htm EX-31.1 Document

Exhibit 31.1
CERTIFICATION
I, David M. Sedgwick, certify that:
1. I have reviewed this Annual Report on Form 10-K of CareTrust REIT, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
By: /s/ David M. Sedgwick
David M. Sedgwick
President and Chief Executive Officer
Date: February 12, 2025

EX-31.2 7 ctre20241231ex312q4.htm EX-31.2 Document

Exhibit 31.2
CERTIFICATION
I, William M. Wagner, certify that:
1. I have reviewed this Annual Report on Form 10-K of CareTrust REIT, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
By: /s/ William M. Wagner
William M. Wagner
Chief Financial Officer and Treasurer
Date: February 12, 2025

EX-32.1 8 ctre20241231ex321q4.htm EX-32.1 Document

Exhibit 32.1
Certification of Chief Executive Officer and
Chief Financial Officer Pursuant to
18 U.S.C. Section 1350, As Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Annual Report on Form 10-K of CareTrust REIT, Inc. (the “Company”) for the fiscal year ended December 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), David M. Sedgwick, President and Chief Executive Officer of the Company, and William M. Wagner, as Chief Financial Officer and Treasurer of the Company, each hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to their knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
/s/ David M. Sedgwick
Name: David M. Sedgwick
Title: President and Chief Executive Officer
Date: February 12, 2025
/s/ William M. Wagner
Name: William M. Wagner
Title: Chief Financial Officer and Treasurer
Date: February 12, 2025

The foregoing certification is being furnished pursuant to 18 U.S.C. Section 1350. It is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, and it is not to be incorporated by reference into any filing of the Company, regardless of any general incorporation language in such filing.